data_2kwa_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kwa _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 15.0 p90 . . . . . 0 N--CA 1.44 -0.93 0 CA-C-O 121.147 0.499 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.613 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . 2.3 mp0 -131.95 135.9 46.93 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.799 -177.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.919 HG12 HG12 ' A' ' 19' ' ' ILE . 9.5 mt -101.94 124.83 56.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.967 178.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -121.32 165.49 15.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.09 0.472 . . . . 0.0 109.904 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -87.34 127.61 35.19 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.698 0.761 . . . . 0.0 110.358 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.602 HD21 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -68.32 -47.27 68.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.227 -174.36 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.61 -83.11 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -118.85 -44.73 2.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.673 0.273 . . . . 0.0 111.24 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.1 p -146.15 43.49 1.22 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.495 0.664 . . . . 0.0 110.83 -173.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HB1' ' HB3' ' A' ' 12' ' ' LEU . . . -144.45 156.59 44.26 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.398 178.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.655 ' CB ' ' HH ' ' A' ' 62' ' ' TYR . 35.6 ttp -128.01 134.71 49.27 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -175.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.602 ' HB2' HD21 ' A' ' 12' ' ' LEU . 39.5 ttp -125.16 130.07 51.42 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.918 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.919 HG12 HG12 ' A' ' 9' ' ' ILE . 7.3 mt -121.22 118.74 57.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.298 -173.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.613 ' HD3' ' HB2' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -103.52 139.75 38.44 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 176.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.696 ' HB2' HG12 ' A' ' 29' ' ' VAL . 15.1 m-85 . . . . . 0 C--N 1.322 -0.622 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.482 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 25.4 tm0? . . . . . 0 N--CA 1.457 -0.077 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.696 HG12 ' HB2' ' A' ' 21' ' ' PHE . 71.0 t -66.77 -48.58 79.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.66 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -51.89 -36.71 49.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.824 -176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.07 -34.63 8.09 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.253 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 28' ' ' GLN . 0.4 OUTLIER -79.73 -29.14 12.95 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.017 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -174.126 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.517 HG21 ' HG ' ' A' ' 58' ' ' LEU . 11.4 p -68.73 -28.71 41.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 118.879 0.763 . . . . 0.0 109.415 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -70.07 -39.65 75.51 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.517 175.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.79 -21.41 29.95 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.113 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.553 ' CB ' HD13 ' A' ' 58' ' ' LEU . . . -64.36 -27.49 69.05 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.156 -176.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.54 -44.53 96.89 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.692 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -78.88 -31.88 45.64 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.877 177.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -57.49 -44.57 85.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.23 0.538 . . . . 0.0 109.728 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.9 mt -71.44 -33.31 49.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.322 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.273 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.692 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 12.6 pt-20 -78.97 -18.89 52.95 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.129 -176.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.438 ' C ' ' HD3' ' A' ' 44' ' ' PRO . 42.4 mt-10 -85.16 -30.34 24.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.842 0.353 . . . . 0.0 110.749 174.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -127.11 64.46 61.06 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.937 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.438 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 80.1 Cg_endo -98.26 178.1 0.4 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 123.295 2.663 . . . . 0.0 114.033 -170.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -106.93 146.69 33.63 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.25 171.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HB2' ' HG3' ' A' ' 66' ' ' GLU . 71.5 Cg_exo -51.62 -15.31 2.66 Favored 'Trans proline' 0 N--CA 1.477 0.546 0 C-N-CA 124.019 3.146 . . . . 0.0 114.574 -173.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.8 15.22 41.11 Favored Glycine 0 C--O 1.223 -0.569 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.413 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -65.55 134.08 52.58 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.017 0.437 . . . . 0.0 110.905 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.8 mm -110.15 -59.73 3.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.437 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -161.69 157.3 24.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.719 0.295 . . . . 0.0 110.787 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.2 p -150.08 121.64 7.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.924 HG13 ' HB ' ' A' ' 59' ' ' THR . 5.7 pt -120.4 130.84 24.65 Favored Pre-proline 0 C--N 1.319 -0.746 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.498 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 5.6 Cg_exo -78.94 122.91 5.52 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.454 2.769 . . . . 0.0 111.674 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -111.11 50.08 0.84 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 -176.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.7 t80 76.58 -56.85 0.55 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.387 172.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.1 p -137.82 14.23 2.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.101 0.477 . . . . 0.0 110.741 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.8 t -138.7 152.57 48.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.033 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.553 HD13 ' CB ' ' A' ' 36' ' ' ALA . 5.4 mt -112.24 114.36 27.11 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.38 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.924 ' HB ' HG13 ' A' ' 52' ' ' ILE . 2.8 m -91.18 103.93 16.55 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 174.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.8 t -112.04 114.04 45.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.603 0.716 . . . . 0.0 111.188 -169.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.486 ' CE1' HG22 ' A' ' 59' ' ' THR . 84.9 m-85 -105.48 148.91 26.67 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.796 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.655 ' HH ' ' CB ' ' A' ' 17' ' ' MET . 2.8 p90 -166.54 172.94 10.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.329 0.585 . . . . 0.0 110.992 -175.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.534 ' OD1' ' HB3' ' A' ' 65' ' ' TYR . 6.7 t0 -98.49 119.55 37.4 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.841 -177.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.533 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -65.61 -20.22 66.23 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.04 -177.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.534 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -60.65 -33.6 73.05 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.102 0.477 . . . . 0.0 110.95 -178.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.56 ' HG3' ' HB2' ' A' ' 46' ' ' PRO . 0.8 OUTLIER -90.27 -22.23 21.7 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.862 0.839 . . . . 0.0 109.331 -173.813 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.533 HG22 ' HA ' ' A' ' 64' ' ' MET . 2.7 m -82.27 -37.7 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.414 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.927 ' HA ' HD22 ' A' ' 71' ' ' LEU . 32.3 m-85 -58.35 -31.65 67.8 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.093 0.473 . . . . 0.0 109.925 168.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.465 ' HB2' ' HE3' ' A' ' 69' ' ' LYS . 2.9 tppp? -60.59 -27.01 67.4 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.669 177.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -93.7 -76.13 0.48 Allowed 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.134 174.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.927 HD22 ' HA ' ' A' ' 68' ' ' TYR . 1.2 mm? 31.37 66.7 0.92 Allowed Pre-proline 0 N--CA 1.471 0.602 0 C-N-CA 124.312 1.045 . . . . 0.0 112.385 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.658 ' HD2' HG13 ' A' ' 75' ' ' ILE . 32.1 Cg_exo -59.7 153.1 58.22 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.804 2.336 . . . . 0.0 112.366 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -70.08 103.03 2.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.739 0.78 . . . . 0.0 110.541 -176.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 137.27 -34.08 2.23 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -173.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.658 HG13 ' HD2' ' A' ' 72' ' ' PRO . 18.4 mm -75.53 113.59 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 113.974 -1.113 . . . . 0.0 108.67 171.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.3 m -97.94 -3.27 38.75 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.546 -174.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.433 ' HB2' ' HB2' ' A' ' 80' ' ' GLU . 57.0 m -140.32 134.97 15.72 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.893 -172.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.603 ' HA ' HD21 ' A' ' 71' ' ' LEU . 64.9 Cg_exo -45.47 -58.35 1.66 Allowed 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 123.201 2.601 . . . . 0.0 113.33 175.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.511 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -56.48 -29.38 61.68 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.286 0.565 . . . . 0.0 111.158 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.505 ' HG3' ' HE2' ' A' ' 83' ' ' LYS . 40.2 tt0 -71.68 -25.39 62.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.519 -176.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.514 ' HB2' HG22 ' A' ' 75' ' ' ILE . 34.3 t -77.45 -38.35 49.56 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.558 HG11 ' CE2' ' A' ' 62' ' ' TYR . 46.2 t -63.28 -32.27 55.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.292 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.606 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 39.8 mtmt -51.33 -39.54 57.19 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.738 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -73.29 -39.57 65.24 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.89 -174.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -64.2 -35.08 79.63 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.718 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.0 m -86.34 -38.64 12.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.679 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 . . . . . 0 C--O 1.218 -0.599 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 176.65 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.545 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 6.1 p90 . . . . . 0 N--CA 1.436 -1.137 0 CA-C-O 121.372 0.606 . . . . 0.0 110.619 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -139.16 133.35 31.31 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.311 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.972 HG12 HG12 ' A' ' 19' ' ' ILE . 37.2 mt -101.57 119.77 50.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.072 177.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -114.03 165.55 12.5 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.066 -177.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -84.26 130.79 34.79 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.521 0.677 . . . . 0.0 110.461 177.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -75.89 -42.98 47.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.867 -175.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -161.78 -73.29 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -142.29 -31.63 0.53 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.5 p -144.93 40.65 1.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.4 0.619 . . . . 0.0 111.325 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.522 ' HB2' ' HB3' ' A' ' 12' ' ' LEU . . . -147.78 154.45 40.51 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.85 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -119.29 144.99 46.5 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 119.872 -0.731 . . . . 0.0 112.014 -175.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.43 ' HB2' HD21 ' A' ' 12' ' ' LEU . 26.9 ttt -130.2 129.04 42.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.488 176.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.972 HG12 HG12 ' A' ' 9' ' ' ILE . 6.4 mt -121.35 145.04 28.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.322 -175.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -136.54 139.92 42.58 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 171.143 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.729 ' HB2' HG13 ' A' ' 29' ' ' VAL . 54.2 m-85 . . . . . 0 C--N 1.328 -0.369 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 173.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? . . . . . 0 N--CA 1.455 -0.175 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.729 HG13 ' HB2' ' A' ' 21' ' ' PHE . 99.2 t -61.29 -49.84 82.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.6 178.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -43.79 -40.92 4.67 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 124.136 0.897 . . . . 0.0 112.284 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.36 -42.75 5.13 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.491 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -72.86 -27.17 24.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -172.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 29' ' ' VAL . 11.9 p -70.94 -27.45 30.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.369 0.604 . . . . 0.0 109.433 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -70.51 -35.69 73.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.63 172.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.28 -20.06 32.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.005 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.3 -24.74 67.48 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.192 -175.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.04 -46.64 83.53 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.633 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -76.45 -27.57 56.23 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.536 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -59.51 -45.13 92.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.094 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.529 HD11 HD23 ' A' ' 58' ' ' LEU . 68.3 mt -72.15 -33.39 46.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.43 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.633 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 9.9 pt-20 -77.14 -20.25 55.8 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.94 -175.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -80.66 -32.38 36.11 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 175.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -126.1 72.82 71.19 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.093 0.473 . . . . 0.0 109.732 176.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -98.17 -163.13 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.886 3.057 . . . . 0.0 114.044 -169.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -137.77 145.96 50.77 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 113.965 -1.471 . . . . 0.0 107.441 174.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -53.36 -15.8 6.3 Favored 'Trans proline' 0 N--CA 1.481 0.742 0 C-N-CA 123.635 2.89 . . . . 0.0 114.906 -169.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.571 ' HA3' ' HB2' ' A' ' 66' ' ' GLU . . . -107.31 17.03 37.75 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.491 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.419 ' HZ ' ' SG ' ' A' ' 51' ' ' CYS . 45.3 t80 -63.76 130.16 43.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.044 0.449 . . . . 0.0 111.391 176.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.2 mm -104.04 -61.84 2.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.026 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -161.8 156.83 23.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.848 0.356 . . . . 0.0 110.521 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.419 ' SG ' ' HZ ' ' A' ' 48' ' ' PHE . 7.4 p -145.96 119.51 9.1 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.744 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.8 pt -124.52 131.44 24.16 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-O 121.108 0.48 . . . . 0.0 111.462 -178.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 4.7 Cg_exo -78.44 149.18 24.14 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.141 2.561 . . . . 0.0 112.493 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.682 ' HB2' ' HB2' ' A' ' 57' ' ' SER . . . -120.99 17.96 11.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.025 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 71.75 -24.47 0.18 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.654 174.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.433 ' H ' ' C ' ' A' ' 54' ' ' ALA . 7.6 t -135.98 -9.12 2.06 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.524 0.678 . . . . 0.0 109.817 169.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.682 ' HB2' ' HB2' ' A' ' 54' ' ' ALA . 16.3 m -130.73 165.53 22.7 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.549 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.529 HD23 HD11 ' A' ' 40' ' ' ILE . 45.3 tp -132.16 125.97 32.51 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.744 ' HB ' HG13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -106.16 107.05 17.86 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.816 -177.02 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.85 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 47.3 t -109.05 115.36 49.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.507 0.67 . . . . 0.0 111.295 -174.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -105.14 146.74 28.78 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.294 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.699 ' HH ' ' HB3' ' A' ' 17' ' ' MET . 3.1 p90 -164.19 171.46 14.97 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.031 0.443 . . . . 0.0 110.664 -172.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.49 ' OD1' ' HB3' ' A' ' 65' ' ' TYR . 6.2 t0 -100.92 115.49 30.55 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.347 -177.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.566 ' HA ' HG21 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -59.71 -18.77 45.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.18 -177.562 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.627 ' CE2' ' HG2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -66.7 -34.98 79.06 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -177.396 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.627 ' HG2' ' CE2' ' A' ' 65' ' ' TYR . 5.4 mm-40 -89.4 -27.37 20.47 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.872 0.844 . . . . 0.0 109.484 -174.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.613 ' CG1' HG21 ' A' ' 82' ' ' VAL . 4.1 m -83.39 -22.96 8.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.83 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.874 ' HA ' HD11 ' A' ' 71' ' ' LEU . 15.5 t80 -75.14 -28.05 60.01 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 168.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -67.97 -28.7 67.67 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.071 170.527 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.744 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 11.9 t-80 -111.52 28.33 8.84 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.492 174.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.874 HD11 ' HA ' ' A' ' 68' ' ' TYR . 2.7 mt -94.77 95.37 1.49 Allowed Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.532 176.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.744 ' HD3' ' O ' ' A' ' 70' ' ' HIS . 8.8 Cg_exo -76.48 175.2 11.66 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 124.061 3.174 . . . . 0.0 112.769 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -60.79 -42.78 98.24 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -171.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.03 -25.12 74.47 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.779 -175.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.586 HG13 ' HD2' ' A' ' 72' ' ' PRO . 5.6 mm -85.26 120.93 36.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.233 -0.483 . . . . 0.0 109.779 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.5 m -110.52 3.78 19.83 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.151 0.5 . . . . 0.0 111.17 -174.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.531 ' HB3' ' CB ' ' A' ' 80' ' ' GLU . 28.2 t -134.59 126.16 17.96 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.148 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.656 ' HA ' HD12 ' A' ' 71' ' ' LEU . 74.6 Cg_exo -42.96 -56.57 2.15 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.762 2.975 . . . . 0.0 112.626 171.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -36.44 63.38 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.359 0.6 . . . . 0.0 111.422 175.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.531 ' CB ' ' HB3' ' A' ' 77' ' ' SER . 38.5 tt0 -73.47 -30.65 63.3 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.262 -174.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.573 ' HB3' HD23 ' A' ' 71' ' ' LEU . 67.6 p -73.05 -35.18 66.67 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.655 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 78' ' ' PRO . 6.8 t -61.59 -36.32 72.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.062 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -51.86 -40.07 59.97 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -67.41 -38.09 84.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.348 -177.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -65.91 -39.75 90.85 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.804 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.4 m -83.83 -46.39 18.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.35 -177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 C--O 1.219 -0.532 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -176.428 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.558 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 18.3 p90 . . . . . 0 N--CA 1.443 -0.784 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.504 ' HB2' ' NE ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -133.09 132.79 42.15 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.875 -179.157 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.751 HG12 HG12 ' A' ' 19' ' ' ILE . 14.9 mt -95.94 119.48 44.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.706 178.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -120.32 158.33 27.31 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.652 -176.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -82.89 129.34 35.0 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.453 0.644 . . . . 0.0 110.525 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.618 HD23 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -73.94 -38.67 64.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.601 -1.182 . . . . 0.0 110.98 -176.349 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.62 -87.16 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.497 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -103.47 -50.26 3.49 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -176.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.491 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 32.5 p -156.39 48.15 0.47 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 122.141 0.972 . . . . 0.0 109.966 -176.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' A' ' 12' ' ' LEU . . . -140.11 148.24 41.41 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.255 -1.339 . . . . 0.0 107.688 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.703 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 37.8 ttp -121.83 139.06 54.09 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.956 -174.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.618 ' HB2' HD23 ' A' ' 12' ' ' LEU . 49.8 ttm -124.89 132.21 53.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.054 0.454 . . . . 0.0 110.947 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.751 HG12 HG12 ' A' ' 9' ' ' ILE . 7.7 mt -124.98 120.88 59.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.654 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.504 ' NE ' ' HB2' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -114.08 134.32 54.96 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.992 177.048 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.558 ' HA ' ' CB ' ' A' ' 7' ' ' TYR . 32.1 m-85 . . . . . 0 C--N 1.327 -0.403 0 CA-C-O 120.567 0.222 . . . . 0.0 110.885 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.3 tm0? . . . . . 0 C--O 1.233 0.193 0 CA-C-O 120.912 0.387 . . . . 0.0 110.012 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.467 ' HA ' HG23 ' A' ' 32' ' ' ILE . 27.1 m -74.18 -25.82 20.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.686 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -59.9 -25.91 65.49 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.624 174.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -96.91 -32.86 6.29 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.417 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.467 HG23 ' HA ' ' A' ' 29' ' ' VAL . 0.5 OUTLIER -75.94 -23.59 16.27 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 C-N-CA 121.171 -0.212 . . . . 0.0 111.152 -177.058 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.465 HG23 ' HG ' ' A' ' 58' ' ' LEU . 10.5 p -65.53 -31.0 51.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.364 0.602 . . . . 0.0 109.471 176.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.415 ' HA ' ' CB ' ' A' ' 53' ' ' PRO . 53.3 t-80 -74.75 -38.0 62.35 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.708 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.58 -22.99 46.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.663 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.487 ' CB ' HD13 ' A' ' 58' ' ' LEU . . . -65.36 -25.84 67.76 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.836 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.51 -40.63 95.3 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.714 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.09 -29.61 26.65 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.859 176.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.448 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 2.7 t80 -60.34 -42.85 96.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.914 0.388 . . . . 0.0 110.401 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 51.6 mt -74.26 -38.42 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.037 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.714 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 8.4 pt-20 -71.15 -23.78 62.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.697 0.284 . . . . 0.0 110.927 -176.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -76.98 -32.54 57.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.017 177.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -134.82 68.38 71.26 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.032 0.444 . . . . 0.0 110.916 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -98.51 -176.31 0.21 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.539 2.826 . . . . 0.0 113.415 -174.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.49 ' HZ ' ' HB2' ' A' ' 62' ' ' TYR . 12.5 p90 -108.3 149.42 39.24 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -39.74 -36.35 1.19 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.003 3.135 . . . . 0.0 115.636 -172.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.414 ' HA3' ' HB3' ' A' ' 66' ' ' GLU . . . -98.37 15.41 61.27 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.97 -175.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.422 ' HZ ' ' SG ' ' A' ' 51' ' ' CYS . 32.4 t80 -62.03 132.84 54.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.264 0.554 . . . . 0.0 110.845 175.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.1 mm -106.24 -62.49 2.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.287 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -160.37 155.66 24.97 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.796 -170.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.422 ' SG ' ' HZ ' ' A' ' 48' ' ' PHE . 2.9 p -151.39 119.44 6.26 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.992 0.425 . . . . 0.0 110.024 176.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.733 HG13 ' HB ' ' A' ' 59' ' ' THR . 7.8 pt -121.43 138.6 28.44 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.436 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 11.1 Cg_endo -86.6 148.9 8.69 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.152 2.568 . . . . 0.0 112.424 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -143.5 66.68 1.3 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 69.4 t80 74.47 -60.74 0.51 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.417 0.687 . . . . 0.0 111.516 173.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.3 t -136.04 -5.75 2.12 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.287 0.565 . . . . 0.0 110.104 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 16.4 m -113.87 137.07 52.17 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.29 -174.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.487 HD13 ' CB ' ' A' ' 36' ' ' ALA . 3.8 mt -100.81 120.47 40.17 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.057 174.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.733 ' HB ' HG13 ' A' ' 52' ' ' ILE . 1.8 m -96.78 104.44 16.44 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.2 t -110.76 114.77 48.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.711 0.767 . . . . 0.0 111.064 -169.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -106.89 150.12 26.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.191 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.673 ' OH ' ' HB2' ' A' ' 17' ' ' MET . 3.1 p90 -166.62 167.77 15.08 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.371 -175.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.464 ' O ' HG13 ' A' ' 67' ' ' VAL . 1.3 t0 -100.64 115.85 31.17 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.179 0.514 . . . . 0.0 110.455 -174.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.611 ' HA ' HG23 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -61.83 -21.89 65.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.078 -174.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -69.21 -30.12 68.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.158 0.504 . . . . 0.0 109.843 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.414 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 1.2 tm-20 -92.08 -33.01 14.95 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.728 0.775 . . . . 0.0 109.131 -173.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.611 HG23 ' HA ' ' A' ' 64' ' ' MET . 3.4 m -67.21 -40.67 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.979 176.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.804 ' HA ' HD23 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -63.71 -25.82 68.38 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.519 173.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.498 ' HB2' ' HE2' ' A' ' 69' ' ' LYS . 5.3 tppt? -70.58 -21.24 62.7 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.75 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -104.87 -41.87 5.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.561 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.804 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER -7.36 84.6 0.03 OUTLIER Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 125.795 1.638 . . . . 0.0 113.703 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.426 ' HD2' HG13 ' A' ' 75' ' ' ILE . 32.3 Cg_exo -60.53 165.36 11.49 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.127 2.551 . . . . 0.0 112.921 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? -61.59 -42.29 98.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.84 0.352 . . . . 0.0 111.419 -173.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.35 -18.55 79.13 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.794 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.556 HG22 ' HB3' ' A' ' 81' ' ' SER . 6.2 mm -88.13 119.17 35.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.49 -0.355 . . . . 0.0 110.281 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -101.75 -9.31 20.94 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.93 0.395 . . . . 0.0 110.945 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.6 m -122.51 123.76 26.95 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.592 -175.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.648 ' HA ' HD22 ' A' ' 71' ' ' LEU . 46.4 Cg_exo -49.05 -46.71 24.36 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.55 2.833 . . . . 0.0 113.783 174.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.508 ' HA ' ' HH ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -60.93 -29.96 69.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.772 0.32 . . . . 0.0 111.286 175.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.401 ' O ' ' HG2' ' A' ' 84' ' ' ARG . 52.9 tt0 -75.07 -31.61 61.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.17 -175.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.556 ' HB3' HG22 ' A' ' 75' ' ' ILE . 37.3 p -72.88 -32.94 65.74 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.547 HG12 ' CD2' ' A' ' 62' ' ' TYR . 61.1 t -69.04 -37.0 76.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.161 -1.381 . . . . 0.0 111.282 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.703 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 39.4 mtmt -52.17 -43.23 64.01 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.454 0.645 . . . . 0.0 109.317 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 22.1 mmt180 -67.29 -31.42 71.71 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.866 -173.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.15 -35.28 69.03 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.005 0.431 . . . . 0.0 111.244 176.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.6 m -86.91 -39.18 12.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 C-N-CA 120.424 -0.511 . . . . 0.0 111.047 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 . . . . . 0 C--O 1.214 -0.809 0 C-N-CA 122.623 0.369 . . . . 0.0 111.923 179.828 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.547 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 6.9 p90 . . . . . 0 N--CA 1.437 -1.105 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.52 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . 30.5 tt0 -141.01 133.51 28.48 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.731 0.777 . . . . 0.0 110.206 174.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.679 HG12 HG12 ' A' ' 19' ' ' ILE . 9.2 mt -92.16 109.73 21.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.557 176.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.612 ' HG2' ' O ' ' A' ' 18' ' ' MET . 9.1 pt-20 -111.34 163.14 14.3 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.692 -170.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -88.36 131.49 34.81 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.282 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.581 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -76.22 -31.48 58.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.569 -176.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.45 -72.26 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.046 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -135.99 -35.34 0.78 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.3 p -152.89 41.53 0.58 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.714 0.768 . . . . 0.0 110.976 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -143.8 155.52 44.18 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 174.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.59 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 43.8 ttp -130.09 136.57 49.49 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.441 -172.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.612 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 49.3 ttm -126.82 141.94 51.68 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.808 176.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.679 HG12 HG12 ' A' ' 9' ' ' ILE . 7.5 mt -125.4 115.3 43.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 O-C-N 122.365 -0.209 . . . . 0.0 111.296 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.52 ' HD3' ' HB3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -98.64 136.4 38.76 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 174.54 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.879 ' HB2' HG21 ' A' ' 29' ' ' VAL . 3.9 m-85 . . . . . 0 C--N 1.327 -0.385 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? . . . . . 0 CA--C 1.531 0.239 0 CA-C-O 120.433 0.158 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.879 HG21 ' HB2' ' A' ' 21' ' ' PHE . 9.2 p -65.17 -42.12 93.4 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.061 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -48.99 -43.48 40.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.928 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.36 -5.23 87.32 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.14 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -115.88 -31.72 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.617 0 CA-C-N 117.766 0.783 . . . . 0.0 112.372 -174.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.441 ' O ' ' HB3' ' A' ' 53' ' ' PRO . 6.7 p -60.94 -36.81 74.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 118.391 0.541 . . . . 0.0 110.419 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.41 ' HA ' ' CB ' ' A' ' 53' ' ' PRO . 11.5 p-80 -79.31 -22.59 44.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.85 0.357 . . . . 0.0 110.636 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.88 -29.96 23.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.015 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.503 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -64.23 -22.39 66.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.244 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.47 -43.08 98.34 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.57 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.36 -27.97 27.33 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.835 176.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.503 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 3.9 t80 -56.91 -48.14 78.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.066 0.46 . . . . 0.0 110.252 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.454 HD11 HD21 ' A' ' 58' ' ' LEU . 58.9 mt -72.93 -36.94 52.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.485 -174.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.57 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 13.0 pt-20 -71.17 -19.4 62.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.654 0.264 . . . . 0.0 111.349 -174.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.4 ' C ' ' HD3' ' A' ' 44' ' ' PRO . 46.0 mt-10 -79.46 -28.68 41.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.88 0.372 . . . . 0.0 110.877 174.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -129.89 64.19 71.22 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.785 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 65.2 Cg_endo -98.99 177.98 0.34 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.264 2.643 . . . . 0.0 113.389 -174.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.535 ' CE2' HG13 ' A' ' 82' ' ' VAL . 6.6 p90 -108.21 147.41 35.53 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.279 173.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.21 12.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.486 1.033 0 C-N-CA 124.293 3.329 . . . . 0.0 114.852 -173.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . -131.12 19.32 4.91 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 175.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.613 ' HZ ' ' HB3' ' A' ' 51' ' ' CYS . 30.9 t80 -79.49 142.61 35.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.013 0.435 . . . . 0.0 110.404 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.481 HG12 ' HA ' ' A' ' 62' ' ' TYR . 35.5 mm -108.38 -59.19 3.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.212 -175.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -168.93 141.6 2.73 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.351 -173.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.613 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 1.6 p -129.22 118.75 22.86 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 173.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.723 HG13 ' HB ' ' A' ' 59' ' ' THR . 4.3 pt -121.18 134.87 24.54 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.877 -175.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.441 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 86.9 Cg_endo -87.2 139.88 5.37 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.303 2.669 . . . . 0.0 112.66 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.3 59.22 1.59 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.401 ' O ' HG11 ' A' ' 33' ' ' VAL . 75.8 t80 75.02 -50.69 0.67 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.576 0.75 . . . . 0.0 112.086 172.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.27 -12.9 1.19 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.111 0.481 . . . . 0.0 110.863 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.5 m -115.39 134.14 55.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.979 0.419 . . . . 0.0 111.162 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.454 HD21 HD11 ' A' ' 40' ' ' ILE . 46.0 tp -102.86 117.23 34.17 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.789 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.723 ' HB ' HG13 ' A' ' 52' ' ' ILE . 4.8 m -97.6 114.41 26.33 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -177.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.9 t -111.41 109.58 29.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.765 0.793 . . . . 0.0 111.375 -170.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -101.25 145.61 28.61 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.009 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.659 ' HH ' ' HA ' ' A' ' 79' ' ' PHE . 2.9 p90 -166.62 166.94 15.78 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -176.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.411 ' OD1' ' HD1' ' A' ' 65' ' ' TYR . 5.4 t70 -102.58 128.55 49.19 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.339 0.59 . . . . 0.0 109.45 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.55 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -62.24 -20.56 64.35 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.799 -172.297 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.411 ' HD1' ' OD1' ' A' ' 63' ' ' ASP . 4.5 p90 -64.54 -34.93 79.39 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.847 0.356 . . . . 0.0 111.632 -174.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.461 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 1.7 tm-20 -92.52 -28.4 16.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.68 0.752 . . . . 0.0 109.598 -172.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.55 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.1 m -72.93 -34.65 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.927 ' HA ' HD21 ' A' ' 71' ' ' LEU . 58.9 t80 -72.47 -22.63 61.04 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.888 173.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.497 ' HB2' ' HE2' ' A' ' 69' ' ' LYS . 9.0 tppt? -66.27 -26.07 67.17 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 173.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -89.37 -74.64 0.47 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.786 172.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.927 HD21 ' HA ' ' A' ' 68' ' ' TYR . 0.8 OUTLIER 24.14 65.44 0.4 Allowed Pre-proline 0 N--CA 1.473 0.714 0 O-C-N 124.88 1.362 . . . . 0.0 112.88 -178.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.577 ' HD2' HG13 ' A' ' 75' ' ' ILE . 35.1 Cg_exo -60.67 143.47 99.42 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.608 2.205 . . . . 0.0 111.8 -175.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -64.0 108.39 1.5 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.499 0.666 . . . . 0.0 110.106 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 135.36 -30.1 2.83 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -171.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.577 HG13 ' HD2' ' A' ' 72' ' ' PRO . 10.9 mm -87.12 125.23 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 114.422 -0.889 . . . . 0.0 108.622 170.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.5 t -103.68 -0.15 29.86 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.353 0.597 . . . . 0.0 110.274 -174.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.534 ' OG ' ' HD1' ' A' ' 79' ' ' PHE . 38.4 t -143.89 133.83 11.85 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.127 -170.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.605 ' HA ' HD23 ' A' ' 71' ' ' LEU . 86.1 Cg_exo -50.07 -50.35 13.63 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.668 2.912 . . . . 0.0 112.863 174.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.659 ' HA ' ' HH ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -63.2 -30.24 71.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.102 0.477 . . . . 0.0 110.921 178.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.434 ' CB ' ' HB3' ' A' ' 77' ' ' SER . 40.7 tt0 -73.31 -27.1 61.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.366 -175.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.551 ' HB3' HG23 ' A' ' 75' ' ' ILE . 88.8 p -79.31 -37.75 36.92 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.56 0.695 . . . . 0.0 109.176 178.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 78' ' ' PRO . 61.0 t -63.42 -31.44 52.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.157 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.529 ' HB3' ' HZ1' ' A' ' 83' ' ' LYS . 6.3 mtmp? -52.53 -43.63 65.26 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -64.56 -41.83 96.07 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.429 -174.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.34 -39.36 86.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.819 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.2 m -87.24 -41.49 14.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.968 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -175.467 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.606 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 35.2 p90 . . . . . 0 N--CA 1.448 -0.567 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.44 120.29 18.5 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -175.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.954 HG12 HG12 ' A' ' 19' ' ' ILE . 40.7 mt -89.71 123.74 42.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.036 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.0 174.17 7.08 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.834 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -95.08 135.51 36.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.526 0.679 . . . . 0.0 110.598 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -80.87 -44.7 17.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.517 -176.587 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -172.92 -74.32 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.432 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -127.15 -50.39 1.43 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.118 0.485 . . . . 0.0 111.172 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.8 p -144.9 41.03 1.28 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.588 0.709 . . . . 0.0 110.942 -172.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.02 157.29 44.42 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.651 176.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.767 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -123.21 145.84 48.31 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.888 -176.321 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.418 ' HB2' HD22 ' A' ' 12' ' ' LEU . 51.8 ttm -127.25 131.13 50.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.749 174.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.954 HG12 HG12 ' A' ' 9' ' ' ILE . 9.9 mt -114.07 124.85 71.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.84 -177.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.7 111.75 24.03 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.618 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.606 ' HA ' ' CB ' ' A' ' 7' ' ' TYR . 22.9 m-85 . . . . . 0 C--N 1.313 -1.021 0 CA-C-O 121.195 0.521 . . . . 0.0 111.258 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 . . . . . 0 N--CA 1.464 0.226 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.401 ' O ' HG12 ' A' ' 33' ' ' VAL . 1.5 p -62.57 -55.98 20.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.912 176.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -57.76 -29.03 64.48 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.859 -177.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.19 -15.7 58.6 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.228 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.409 ' O ' ' N ' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -115.18 -24.82 3.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.724 0 CA-C-N 117.41 0.605 . . . . 0.0 112.361 -174.351 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 55' ' ' PHE . 7.2 p -61.24 -34.57 61.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 118.785 0.72 . . . . 0.0 110.361 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -77.14 -32.09 56.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.837 0.351 . . . . 0.0 110.072 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.83 -20.8 30.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.46 -176.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 32' ' ' ILE . . . -66.46 -32.03 73.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.997 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.7 -41.07 97.1 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.892 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -73.84 -36.86 64.94 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.753 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.01 -35.43 75.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.231 0.539 . . . . 0.0 110.113 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.7 mt -81.95 -35.21 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.373 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.892 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 10.5 pt-20 -79.84 -21.77 43.75 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.751 -175.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.921 ' HG3' ' HG3' ' A' ' 43' ' ' GLN . 9.6 pt-20 -81.03 -29.89 35.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.121 0.486 . . . . 0.0 109.967 175.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.921 ' HG3' ' HG3' ' A' ' 42' ' ' GLU . 54.3 mt-30 -126.37 65.05 57.46 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.933 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.415 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 66.2 Cg_endo -93.36 -173.27 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.569 2.846 . . . . 0.0 114.017 -169.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -124.77 146.73 53.92 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.517 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -49.06 -18.63 1.92 Allowed 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 124.151 3.234 . . . . 0.0 115.265 -171.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.36 21.09 22.41 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.172 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.484 ' HZ ' ' SG ' ' A' ' 51' ' ' CYS . 45.2 t80 -66.69 130.41 43.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.993 0.425 . . . . 0.0 110.795 176.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.411 HG12 ' HA ' ' A' ' 62' ' ' TYR . 35.4 mm -102.55 -59.76 3.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.277 -177.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -162.82 154.39 17.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.738 0.304 . . . . 0.0 110.734 -174.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.484 ' SG ' ' HZ ' ' A' ' 48' ' ' PHE . 12.3 p -144.27 119.3 10.02 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 173.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.76 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.5 pt -124.95 132.83 24.39 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-O 121.127 0.489 . . . . 0.0 111.755 -178.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.55 136.9 7.68 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.02 2.48 . . . . 0.0 111.715 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -124.73 54.37 1.4 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.957 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.434 ' O ' HG13 ' A' ' 33' ' ' VAL . 57.9 m-85 74.13 -53.4 0.68 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.49 0.716 . . . . 0.0 112.285 171.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 21' ' ' PHE . 9.3 t -139.26 3.2 2.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.199 0.523 . . . . 0.0 110.477 176.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.3 m -125.7 146.3 49.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.059 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.407 ' HB3' ' HB ' ' A' ' 19' ' ' ILE . 45.8 tp -112.98 119.9 39.53 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.76 ' HB ' HG13 ' A' ' 52' ' ' ILE . 1.4 m -102.1 110.24 22.16 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.767 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 58.9 t -111.27 115.99 51.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.602 0.715 . . . . 0.0 111.185 -173.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -107.05 145.9 31.81 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.479 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.724 ' HH ' ' HA ' ' A' ' 79' ' ' PHE . 3.5 p90 -165.12 168.79 16.89 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.983 -175.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.421 ' OD1' ' HB3' ' A' ' 65' ' ' TYR . 7.2 t0 -101.97 114.35 28.38 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.495 -176.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.675 ' HA ' HG23 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -64.44 -20.82 66.41 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.075 -176.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.421 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -64.56 -27.52 69.01 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.793 0.33 . . . . 0.0 110.732 -179.203 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -90.69 -39.28 12.54 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.613 0.721 . . . . 0.0 109.271 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.675 HG23 ' HA ' ' A' ' 64' ' ' MET . 2.7 m -64.77 -34.43 70.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.235 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.674 ' HA ' HD23 ' A' ' 71' ' ' LEU . 7.3 m-85 -55.0 -28.39 51.64 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.841 0.456 . . . . 0.0 111.456 172.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -41.91 95.83 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.598 0.713 . . . . 0.0 109.415 177.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -91.0 -23.93 20.24 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.842 -174.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.675 HD22 ' HA ' ' A' ' 78' ' ' PRO . 0.6 OUTLIER -26.53 94.37 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.895 0 O-C-N 124.867 1.355 . . . . 0.0 111.546 176.106 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.489 ' HD2' HG13 ' A' ' 75' ' ' ILE . 24.1 Cg_exo -67.65 140.16 50.72 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.551 2.834 . . . . 0.0 111.603 -175.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.0 tp60 -63.01 99.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.463 0.649 . . . . 0.0 109.917 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 140.02 -24.1 2.72 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -172.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.535 HG21 ' HB3' ' A' ' 81' ' ' SER . 2.4 mm -96.29 126.94 48.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 171.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 t -112.25 -0.25 15.55 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.266 0.555 . . . . 0.0 110.109 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.6 t -118.61 111.99 37.44 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.282 -175.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.675 ' HA ' HD22 ' A' ' 71' ' ' LEU . 91.3 Cg_exo -47.98 -46.3 22.37 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.55 2.833 . . . . 0.0 113.062 173.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.724 ' HA ' ' HH ' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -61.18 -37.3 82.42 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.226 -0.19 . . . . 0.0 111.437 176.709 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 19.8 tt0 -82.07 -19.35 40.43 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.402 -174.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.535 ' HB3' HG21 ' A' ' 75' ' ' ILE . 83.3 p -74.25 -37.63 63.71 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.615 HG21 ' O ' ' A' ' 78' ' ' PRO . 26.8 t -65.67 -30.92 51.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.675 177.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.76 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 21.4 mtpt -49.94 -48.5 51.87 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 174.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -61.48 -38.65 88.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.494 -173.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -73.06 -33.72 65.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.137 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.7 m -87.01 -42.5 15.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 CA-C-O 118.911 -0.566 . . . . 0.0 112.043 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.76 ' HG2' ' O ' ' A' ' 83' ' ' LYS . 8.1 pt-20 . . . . . 0 N--CA 1.451 -0.384 0 CA-C-N 118.69 0.677 . . . . 0.0 111.912 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.467 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . 17.2 p90 . . . . . 0 N--CA 1.44 -0.93 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.407 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -147.69 120.31 8.57 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 176.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.878 HG12 HG12 ' A' ' 19' ' ' ILE . 15.8 mt -76.83 117.76 22.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.839 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 18' ' ' MET . 8.7 pt-20 -116.92 162.49 17.67 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.804 -174.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.523 HE21 ' HA ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -86.05 138.06 32.23 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.596 0.712 . . . . 0.0 110.102 177.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.755 HD21 HG22 ' A' ' 59' ' ' THR . 0.4 OUTLIER -94.59 -50.29 5.26 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.711 -1.132 . . . . 0.0 110.595 -171.535 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.45 142.45 3.59 Favored Glycine 0 N--CA 1.433 -1.501 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 70.4 -73.02 0.1 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.207 0.603 . . . . 0.0 111.148 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.5 p -173.62 53.51 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.597 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.14 156.43 44.33 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.537 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.875 ' HB3' ' HH ' ' A' ' 62' ' ' TYR . 1.1 ptp -123.4 155.98 36.33 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.084 -177.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.609 ' HB2' HD23 ' A' ' 12' ' ' LEU . 48.3 ttm -136.24 137.55 40.91 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 172.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.878 HG12 HG12 ' A' ' 9' ' ' ILE . 8.3 mt -117.21 107.29 21.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.674 -177.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.569 HH21 ' CD ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -90.65 136.11 33.27 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.255 -0.578 . . . . 0.0 109.472 176.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.569 ' HB3' HG12 ' A' ' 29' ' ' VAL . 14.8 m-85 . . . . . 0 C--N 1.323 -0.578 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 170.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.173 0 CA-C-O 120.739 0.304 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.569 HG12 ' HB3' ' A' ' 21' ' ' PHE . 31.0 m -67.4 -42.89 87.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.315 -178.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -49.14 -40.67 33.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.539 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.82 -33.31 24.66 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.101 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -88.83 -26.41 5.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.463 0 O-C-N 122.422 -0.458 . . . . 0.0 112.116 -171.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 55' ' ' PHE . 7.8 p -63.49 -30.67 50.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.342 0.592 . . . . 0.0 109.627 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -74.98 -43.29 54.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.253 175.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.47 -22.23 57.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.132 -176.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.419 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -65.5 -27.64 68.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.527 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.61 -41.54 98.3 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.572 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.65 -21.2 30.33 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.18 176.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.419 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 10.6 t80 -66.88 -44.85 79.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.211 0.529 . . . . 0.0 110.06 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.508 HD13 HD22 ' A' ' 58' ' ' LEU . 34.0 mt -78.49 -31.49 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.696 -174.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.572 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 11.0 pt-20 -69.79 -21.96 63.37 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.777 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -85.09 -29.94 24.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.666 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -130.23 70.13 82.15 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 120.796 0.332 . . . . 0.0 111.003 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -97.39 -175.46 0.24 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.418 2.746 . . . . 0.0 113.091 -176.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.476 ' CZ ' HG13 ' A' ' 67' ' ' VAL . 9.5 p90 -116.36 148.61 42.05 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -45.25 -26.09 2.28 Favored 'Trans proline' 0 N--CA 1.482 0.836 0 C-N-CA 124.159 3.24 . . . . 0.0 115.579 -169.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.541 ' HA3' ' CB ' ' A' ' 66' ' ' GLU . . . -103.21 14.41 55.13 Favored Glycine 0 C--O 1.228 -0.268 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.743 -176.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.432 ' HZ ' ' SG ' ' A' ' 51' ' ' CYS . 31.3 t80 -68.1 139.98 56.21 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.492 0.663 . . . . 0.0 111.024 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.997 HG22 ' HG2' ' A' ' 50' ' ' GLU . 38.7 mm -112.4 -63.84 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.477 -174.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.997 ' HG2' HG22 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -152.39 169.41 22.61 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.14 0.495 . . . . 0.0 111.356 -177.445 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.432 ' SG ' ' HZ ' ' A' ' 48' ' ' PHE . 11.2 p -158.8 123.95 4.26 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 169.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.79 HG13 ' HB ' ' A' ' 59' ' ' THR . 7.9 pt -123.02 136.38 26.85 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-O 120.952 0.406 . . . . 0.0 111.724 -177.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -85.88 129.12 3.41 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.163 2.575 . . . . 0.0 112.364 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -115.09 43.92 1.9 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.887 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.413 ' O ' HG12 ' A' ' 33' ' ' VAL . 62.2 t80 72.77 -40.55 0.48 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.734 0.813 . . . . 0.0 112.742 175.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.0 t -139.22 -17.71 1.02 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.177 0.513 . . . . 0.0 110.985 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 m -113.44 134.87 54.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.177 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.508 HD22 HD13 ' A' ' 40' ' ' ILE . 52.3 tp -103.06 112.25 25.0 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 177.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.79 ' HB ' HG13 ' A' ' 52' ' ' ILE . 10.7 m -92.49 106.77 18.69 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -177.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.832 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 41.1 t -107.52 120.92 59.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.46 0.648 . . . . 0.0 111.559 -173.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.592 ' HB2' ' HG3' ' A' ' 50' ' ' GLU . 85.7 m-85 -106.39 147.34 29.38 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.185 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.875 ' HH ' ' HB3' ' A' ' 17' ' ' MET . 3.0 p90 -166.7 170.49 12.45 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.673 -176.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.5 ' O ' HG12 ' A' ' 67' ' ' VAL . 6.1 t70 -104.71 123.3 47.37 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.466 0.65 . . . . 0.0 110.773 -176.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.506 ' O ' HG21 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -61.3 -23.88 66.02 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.766 -175.71 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.492 ' HD1' ' OD1' ' A' ' 63' ' ' ASP . 0.8 OUTLIER -68.28 -28.82 67.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.383 0.611 . . . . 0.0 110.187 -176.293 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.541 ' CB ' ' HA3' ' A' ' 47' ' ' GLY . 1.0 OUTLIER -91.47 -29.76 16.83 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.65 0.738 . . . . 0.0 109.522 -175.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.506 HG21 ' O ' ' A' ' 64' ' ' MET . 2.0 m -71.24 -35.89 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 176.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.949 ' HA ' HD21 ' A' ' 71' ' ' LEU . 76.7 t80 -69.33 -22.61 63.75 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.501 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -61.27 -38.51 87.01 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 173.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -83.33 -70.25 0.57 Allowed 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 113.867 -1.515 . . . . 0.0 109.523 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.949 HD21 ' HA ' ' A' ' 68' ' ' TYR . 0.8 OUTLIER 23.43 68.08 0.36 Allowed Pre-proline 0 N--CA 1.478 0.928 0 O-C-N 124.854 1.346 . . . . 0.0 112.977 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.583 ' HD2' HG13 ' A' ' 75' ' ' ILE . 28.6 Cg_exo -62.42 153.13 72.88 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.657 2.238 . . . . 0.0 112.613 -176.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -68.21 109.26 3.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.368 0.604 . . . . 0.0 110.223 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 131.92 -31.11 3.11 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -174.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.583 HG13 ' HD2' ' A' ' 72' ' ' PRO . 17.4 mm -80.63 117.82 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 114.076 -1.062 . . . . 0.0 108.972 171.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.3 m -97.08 -1.8 44.56 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.536 -174.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.6 t -144.53 136.52 13.06 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.525 -170.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.587 ' HA ' HD23 ' A' ' 71' ' ' LEU . 98.5 Cg_exo -47.26 -57.08 2.52 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.457 2.771 . . . . 0.0 113.343 173.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.536 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -59.01 -30.73 68.21 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.171 0.51 . . . . 0.0 110.907 -179.049 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 46.2 tt0 -74.83 -26.23 59.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.191 -176.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.522 ' HB3' HG22 ' A' ' 75' ' ' ILE . 96.9 p -73.26 -36.87 66.44 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.6 t -67.87 -24.87 31.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.525 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 47.0 mtpt -55.1 -35.36 64.53 Favored 'General case' 0 C--O 1.214 -0.816 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.18 176.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -71.09 -37.18 72.41 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.067 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -69.51 -35.18 75.27 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.999 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.6 m -86.02 -45.07 16.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.92 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 . . . . . 0 C--O 1.221 -0.427 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 179.865 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.2 p90 . . . . . 0 N--CA 1.446 -0.674 0 CA-C-O 120.934 0.397 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.517 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 18.7 mp0 -132.6 131.57 41.58 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.899 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 1.003 HG12 HG12 ' A' ' 19' ' ' ILE . 49.1 mt -97.7 122.94 49.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.292 173.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -119.01 164.3 15.69 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.102 0.477 . . . . 0.0 110.115 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -84.79 128.22 34.5 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.393 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.587 HD23 ' HB2' ' A' ' 18' ' ' MET . 0.2 OUTLIER -75.89 -39.64 56.02 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.773 -173.074 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -163.76 -77.98 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -138.03 -28.82 0.86 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 177.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.7 p -148.35 36.35 0.82 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.466 0.65 . . . . 0.0 111.557 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.49 ' HB1' ' HB3' ' A' ' 12' ' ' LEU . . . -143.98 156.69 44.5 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.307 176.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.698 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -125.08 147.19 49.11 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.411 -175.618 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.587 ' HB2' HD23 ' A' ' 12' ' ' LEU . 19.0 ttt -136.21 123.45 21.81 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.932 176.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 1.003 HG12 HG12 ' A' ' 9' ' ' ILE . 9.8 mt -110.66 146.35 15.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 123.014 0.526 . . . . 0.0 110.262 -175.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.517 ' HD2' ' O ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -139.56 134.49 32.24 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.45 173.131 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.619 ' HB2' HG11 ' A' ' 29' ' ' VAL . 4.7 m-85 . . . . . 0 C--N 1.328 -0.338 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.225 -0.194 0 CA-C-O 120.956 0.408 . . . . 0.0 109.968 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.619 HG11 ' HB2' ' A' ' 21' ' ' PHE . 53.4 t -65.64 -57.95 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.763 -176.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -57.51 -23.05 47.95 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.592 0.234 . . . . 0.0 111.465 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.99 -39.89 5.66 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.046 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -80.39 -26.99 11.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.768 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.465 HG11 ' O ' ' A' ' 29' ' ' VAL . 10.7 p -68.08 -29.24 43.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -73.29 -34.36 65.71 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.495 177.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.11 -22.09 27.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.598 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.85 -22.99 65.99 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.125 -174.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.406 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . . . -62.52 -44.84 95.37 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.84 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -81.05 -27.85 35.59 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.979 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -59.53 -44.68 93.12 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.516 HD12 HD21 ' A' ' 58' ' ' LEU . 47.3 mt -76.58 -44.26 34.41 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.349 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.84 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 9.5 pt-20 -65.54 -27.37 68.4 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.125 0.416 . . . . 0.0 112.125 -171.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.471 ' C ' ' HD3' ' A' ' 44' ' ' PRO . 45.9 mt-10 -92.63 -18.77 22.63 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 121.156 -0.218 . . . . 0.0 111.441 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.454 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 21.8 mt-30 -131.09 58.55 39.73 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-O 120.744 0.306 . . . . 0.0 110.25 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.471 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 43.0 Cg_endo -104.64 -167.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.988 3.126 . . . . 0.0 113.75 -171.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.667 ' HZ ' ' HB2' ' A' ' 62' ' ' TYR . 12.8 p90 -111.71 147.22 36.33 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 168.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.89 -16.4 0.82 Allowed 'Trans proline' 0 N--CA 1.481 0.747 0 C-N-CA 124.219 3.279 . . . . 0.0 115.1 -172.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.57 7.53 61.49 Favored Glycine 0 C--O 1.226 -0.357 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.769 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -61.44 136.36 58.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.32 0.581 . . . . 0.0 111.803 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.421 HG12 ' HA ' ' A' ' 62' ' ' TYR . 39.2 mm -109.19 -62.4 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.399 -177.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -163.43 157.12 19.49 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.432 -173.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.406 ' SG ' ' HA ' ' A' ' 37' ' ' ALA . 6.0 p -151.75 118.84 5.87 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 174.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.705 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.2 pt -116.13 134.25 22.81 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.826 -175.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -84.37 141.43 9.01 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.095 2.53 . . . . 0.0 112.305 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -130.87 54.11 1.93 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.734 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.2 t80 76.66 -59.4 0.5 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.492 171.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.2 p -130.64 -2.05 4.27 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.26 0.552 . . . . 0.0 110.943 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.0 t -122.24 155.36 36.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.791 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.516 HD21 HD12 ' A' ' 40' ' ' ILE . 47.6 tp -127.33 116.56 20.71 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.598 -177.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.705 ' HB ' HG13 ' A' ' 52' ' ' ILE . 1.1 m -96.22 107.39 19.72 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.698 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 44.1 t -107.44 120.58 59.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.747 0.784 . . . . 0.0 111.867 -171.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -111.44 147.07 36.05 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.675 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.729 ' HH ' ' HA ' ' A' ' 79' ' ' PHE . 3.3 p90 -165.65 172.0 12.4 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -174.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -103.53 117.34 34.2 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.431 0.634 . . . . 0.0 109.979 -177.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.511 ' HA ' HG21 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -64.77 -19.55 65.87 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.176 -176.687 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.06 -29.98 70.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.712 0.292 . . . . 0.0 111.107 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 0.6 OUTLIER -89.16 -26.88 21.05 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 122.067 0.937 . . . . 0.0 108.829 -172.113 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.54 ' CG2' ' HB3' ' A' ' 78' ' ' PRO . 3.7 m -82.62 -40.21 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.488 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.541 ' HA ' HD22 ' A' ' 71' ' ' LEU . 2.8 m-85 -58.66 -29.0 66.24 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 171.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 4.3 tppp? -53.49 -41.87 66.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.68 175.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -94.97 -71.84 0.65 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.693 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.541 HD22 ' HA ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER 38.17 68.96 1.61 Allowed Pre-proline 0 N--CA 1.468 0.459 0 O-C-N 124.146 0.904 . . . . 0.0 111.802 179.024 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -63.6 140.64 76.17 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.878 2.385 . . . . 0.0 111.775 -176.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -61.39 109.42 1.15 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.56 0.695 . . . . 0.0 110.925 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 135.49 -32.43 2.55 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 107.939 -2.064 . . . . 0.0 107.939 -169.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.9 mm -95.62 113.6 30.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 113.387 -1.406 . . . . 0.0 107.713 168.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.3 t -105.62 -4.26 21.31 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.467 0.651 . . . . 0.0 109.85 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.483 ' OG ' ' HD1' ' A' ' 79' ' ' PHE . 21.2 t -126.69 125.66 24.4 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.007 -176.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.54 ' HB3' ' CG2' ' A' ' 67' ' ' VAL . 94.8 Cg_exo -50.57 -42.8 48.26 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.644 2.896 . . . . 0.0 112.936 176.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.729 ' HA ' ' HH ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -57.13 -37.07 71.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.672 177.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.452 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 28.5 tt0 -80.29 -19.8 45.83 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.683 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.413 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 24.0 t -67.97 -31.12 70.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.519 HG23 HG12 ' A' ' 67' ' ' VAL . 12.4 t -83.41 -24.81 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.528 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.452 ' HG3' ' HA ' ' A' ' 80' ' ' GLU . 40.7 mtpt -52.66 -40.89 63.3 Favored 'General case' 0 C--O 1.213 -0.844 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 175.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -58.83 -41.59 87.24 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.971 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -66.39 -37.15 84.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.397 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.7 m -87.25 -48.09 15.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.688 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 . . . . . 0 C--O 1.219 -0.511 0 C-N-CA 122.877 0.471 . . . . 0.0 112.012 -177.509 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.616 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 50.2 p90 . . . . . 0 CA--C 1.514 -0.416 0 CA-C-O 121.707 0.765 . . . . 0.0 112.419 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.726 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . 27.4 mp0 -126.79 138.47 53.36 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.247 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.824 HG12 HG12 ' A' ' 19' ' ' ILE . 29.4 mt -106.94 128.2 61.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.476 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -120.2 163.31 17.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.263 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.6 HE21 ' HA ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -92.86 124.4 36.82 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.281 0.562 . . . . 0.0 110.153 178.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.582 HD23 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -69.87 -43.14 72.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.148 -174.033 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 173.19 -89.16 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.758 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -92.62 -60.35 1.84 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.917 0.389 . . . . 0.0 111.661 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.8 p -149.73 45.77 0.94 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.569 0.7 . . . . 0.0 110.978 -175.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.82 156.94 47.4 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.149 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.698 ' CB ' ' HH ' ' A' ' 62' ' ' TYR . 28.7 ttp -126.84 134.43 50.53 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.582 ' HB2' HD23 ' A' ' 12' ' ' LEU . 50.5 ttm -118.18 132.72 56.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.049 0.452 . . . . 0.0 110.19 177.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.824 HG12 HG12 ' A' ' 9' ' ' ILE . 6.1 mt -127.24 127.66 69.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.98 -177.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.726 ' HD3' ' HB2' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -111.83 131.27 55.45 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.616 ' HA ' ' CB ' ' A' ' 7' ' ' TYR . 6.6 m-85 . . . . . 0 C--N 1.323 -0.565 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.496 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 4.0 mm100 . . . . . 0 C--O 1.223 -0.299 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.596 ' CG2' ' HB2' ' A' ' 21' ' ' PHE . 6.6 p -62.23 -53.43 47.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.531 -177.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -53.51 -44.06 68.78 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.666 0.604 . . . . 0.0 111.354 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.44 -38.64 17.02 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.55 -0.834 . . . . 0.0 112.88 -178.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 28' ' ' GLN . 0.3 OUTLIER -83.58 -28.51 7.58 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -172.696 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.535 HG11 ' O ' ' A' ' 29' ' ' VAL . 14.9 p -68.6 -30.35 47.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 175.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -70.59 -40.21 73.37 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.689 -1.142 . . . . 0.0 109.931 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.53 -22.02 28.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.995 -177.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.92 -28.91 70.15 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.568 0.223 . . . . 0.0 111.498 -174.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.39 -39.13 92.23 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.081 0.943 . . . . 0.0 108.706 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.458 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.85 -23.12 29.15 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.249 178.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -69.5 -41.71 75.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.15 0.5 . . . . 0.0 109.829 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.54 HD11 HD22 ' A' ' 58' ' ' LEU . 54.8 mt -73.71 -34.63 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.188 -177.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.458 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 9.1 pt-20 -69.63 -23.65 63.53 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.423 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 44.4 mm-40 -73.59 -36.37 65.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.643 175.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -129.61 70.71 82.04 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.324 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -94.47 176.49 1.1 Allowed 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.766 2.311 . . . . 0.0 113.443 -174.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -115.95 147.85 40.08 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.73 175.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -37.23 -37.81 0.42 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.246 3.297 . . . . 0.0 115.13 -174.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.453 ' HA3' ' HB2' ' A' ' 66' ' ' GLU . . . -103.24 17.62 51.01 Favored Glycine 0 C--O 1.224 -0.486 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.025 -176.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -59.77 129.39 41.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.986 0.422 . . . . 0.0 110.62 176.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.567 HG12 ' HA ' ' A' ' 62' ' ' TYR . 39.5 mm -106.07 -57.8 4.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.526 -174.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 13.5 tp10 -164.18 157.52 18.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.681 0.277 . . . . 0.0 110.544 -172.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.4 p -150.79 118.4 6.12 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 172.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.741 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.9 pt -119.94 135.21 24.14 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -176.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 2.5 Cg_endo -80.95 120.67 3.84 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.13 2.553 . . . . 0.0 112.234 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -109.51 52.74 0.71 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.601 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.486 ' O ' HG12 ' A' ' 33' ' ' VAL . 39.5 t80 72.64 -57.79 0.62 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.263 173.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.0 t -132.5 -2.4 3.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.695 0.759 . . . . 0.0 110.14 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.6 m -122.44 140.57 52.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.211 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.54 HD22 HD11 ' A' ' 40' ' ' ILE . 50.5 tp -106.18 115.98 31.14 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.741 ' HB ' HG13 ' A' ' 52' ' ' ILE . 4.7 m -93.28 106.27 18.25 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.784 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.0 t -104.75 123.98 59.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.386 0.612 . . . . 0.0 111.292 -173.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.415 ' CE1' HG21 ' A' ' 59' ' ' THR . 87.8 m-85 -114.96 145.96 41.69 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.57 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.698 ' HH ' ' CB ' ' A' ' 17' ' ' MET . 2.4 p90 -166.54 171.29 11.92 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.125 0.488 . . . . 0.0 110.9 -175.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -99.49 111.34 23.7 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.398 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.483 ' O ' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -61.91 -21.74 65.0 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.234 -176.546 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.517 ' CE1' ' HG2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -71.39 -23.08 61.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.757 0.313 . . . . 0.0 110.981 -176.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.517 ' HG2' ' CE1' ' A' ' 65' ' ' TYR . 22.5 mm-40 -91.51 -34.41 14.79 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.196 0.522 . . . . 0.0 110.458 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 64' ' ' MET . 3.4 m -70.54 -29.86 40.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.102 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.641 ' HA ' HD23 ' A' ' 71' ' ' LEU . 2.5 m-85 -55.48 -24.96 34.22 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.704 172.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -66.69 -24.32 66.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.596 0.712 . . . . 0.0 109.824 176.749 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -102.15 -32.49 10.07 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.249 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.684 HD22 ' HA ' ' A' ' 78' ' ' PRO . 1.6 mm? -26.36 95.01 0.06 OUTLIER Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 125.514 1.526 . . . . 0.0 113.735 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.546 ' HD2' HG13 ' A' ' 75' ' ' ILE . 20.5 Cg_exo -70.4 161.04 47.45 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 123.594 2.863 . . . . 0.0 111.93 174.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -62.36 -40.34 96.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -173.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.41 -21.37 78.94 Favored Glycine 0 CA--C 1.511 -0.202 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.45 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.546 HG13 ' HD2' ' A' ' 72' ' ' PRO . 10.7 mm -81.97 100.26 5.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.057 -0.571 . . . . 0.0 109.919 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.4 m -82.52 -9.87 59.24 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.216 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.2 m -131.15 130.82 22.8 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.738 -175.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.684 ' HA ' HD22 ' A' ' 71' ' ' LEU . 83.4 Cg_exo -46.54 -48.91 12.79 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.408 2.739 . . . . 0.0 113.483 176.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.439 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 1.4 p90 -59.9 -27.4 66.7 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.485 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.657 ' HG3' ' HD2' ' A' ' 83' ' ' LYS . 8.8 tt0 -81.93 -17.83 45.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.887 0.375 . . . . 0.0 110.869 -174.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.511 ' HB2' HG22 ' A' ' 75' ' ' ILE . 48.0 t -79.26 -35.6 41.17 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.441 HG12 ' CE2' ' A' ' 62' ' ' TYR . 49.0 t -67.06 -25.32 33.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.28 178.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.657 ' HD2' ' HG3' ' A' ' 80' ' ' GLU . 94.5 mttt -51.59 -41.92 61.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.967 177.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.431 ' HA ' ' NH1' ' A' ' 84' ' ' ARG . 0.7 OUTLIER -60.9 -50.56 72.91 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.851 -177.583 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -64.88 -37.04 86.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.796 -177.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.2 m -83.36 -48.22 17.6 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 CA-C-O 118.947 -0.549 . . . . 0.0 112.023 -175.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.517 ' HG2' ' OH ' ' A' ' 7' ' ' TYR . 92.5 mt-10 . . . . . 0 N--CA 1.468 0.475 0 CA-C-N 118.25 0.477 . . . . 0.0 111.902 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.481 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 15.0 p90 . . . . . 0 CA--C 1.513 -0.465 0 CA-C-O 121.198 0.523 . . . . 0.0 111.45 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.417 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 5.6 tp60 -125.49 139.61 53.48 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.559 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 1.036 HG12 HG12 ' A' ' 19' ' ' ILE . 25.6 mt -104.36 122.35 57.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.067 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -116.22 159.99 21.05 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.862 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -86.24 124.4 32.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.53 0.681 . . . . 0.0 110.182 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.622 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -63.45 -48.22 78.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.658 -177.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -165.96 -73.17 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.652 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -128.7 -49.31 1.25 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.582 0.23 . . . . 0.0 111.522 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.08 41.35 1.66 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.639 0.733 . . . . 0.0 110.945 -172.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -143.88 152.22 40.86 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.74 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 29.0 ttp -121.28 135.42 55.12 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -174.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.622 ' HB2' HD22 ' A' ' 12' ' ' LEU . 46.8 ttm -122.22 132.4 54.42 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.145 177.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 1.036 HG12 HG12 ' A' ' 9' ' ' ILE . 5.7 mt -129.69 143.27 41.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.486 -175.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.417 ' HD2' ' O ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -125.48 126.66 45.26 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 174.11 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.8 ' HB2' HG21 ' A' ' 29' ' ' VAL . 4.9 m-85 . . . . . 0 C--N 1.325 -0.479 0 CA-C-O 121.121 0.486 . . . . 0.0 109.709 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.409 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 46.6 tt0 . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 120.702 0.287 . . . . 0.0 111.642 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.8 HG21 ' HB2' ' A' ' 21' ' ' PHE . 2.8 p -64.22 -47.98 87.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.779 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -54.92 -42.66 72.51 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.317 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.11 -39.5 10.01 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.182 -1.009 . . . . 0.0 112.537 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.409 ' HB ' ' O ' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -82.5 -21.35 9.56 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -171.459 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 55' ' ' PHE . 12.1 p -72.08 -30.3 35.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -75.46 -38.55 59.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.214 175.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.02 -20.75 51.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.977 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.505 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . . . -68.96 -28.25 66.46 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 120.873 0.368 . . . . 0.0 110.888 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.87 -42.63 99.83 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.764 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -79.13 -30.91 43.94 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.078 176.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.505 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -54.84 -44.93 74.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.433 0.635 . . . . 0.0 110.133 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 45.9 mt -79.62 -30.83 13.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.646 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.764 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 9.2 pt-20 -76.36 -25.06 54.26 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.64 -177.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -82.4 -27.99 31.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.01 0.433 . . . . 0.0 110.396 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -131.7 70.41 81.21 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.244 177.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -99.32 -178.06 0.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.395 2.73 . . . . 0.0 113.854 -173.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.434 ' CE2' HG13 ' A' ' 82' ' ' VAL . 6.0 p90 -115.93 147.41 39.1 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.92 171.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.44 ' HB2' ' CD ' ' A' ' 66' ' ' GLU . 59.0 Cg_exo -38.55 -39.35 1.12 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.987 3.125 . . . . 0.0 115.147 -174.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.66 13.76 64.96 Favored Glycine 0 C--O 1.228 -0.245 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.098 -174.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -59.07 132.75 54.97 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.052 0.453 . . . . 0.0 110.777 175.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.454 HG12 ' HA ' ' A' ' 62' ' ' TYR . 35.9 mm -106.0 -59.37 3.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.261 -175.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -163.55 158.99 21.4 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 120.66 0.267 . . . . 0.0 110.571 -173.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.3 p -150.02 118.01 6.3 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 176.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.747 HG13 ' HB ' ' A' ' 59' ' ' THR . 5.9 pt -120.97 131.58 24.44 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-O 121.106 0.479 . . . . 0.0 112.186 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 72.2 Cg_endo -86.51 141.94 6.86 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.413 2.742 . . . . 0.0 112.499 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.89 59.58 1.61 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.629 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.471 ' O ' HG13 ' A' ' 33' ' ' VAL . 52.0 t80 69.31 -54.34 0.58 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.115 0.966 . . . . 0.0 112.581 175.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.2 t -130.98 -15.74 3.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.767 0.318 . . . . 0.0 111.164 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.0 p -115.18 149.75 37.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.956 0.407 . . . . 0.0 110.936 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 38.6 tp -118.24 125.83 50.94 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.747 ' HB ' HG13 ' A' ' 52' ' ' ILE . 3.1 m -105.59 107.65 18.76 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.038 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.2 t -105.45 123.05 59.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.416 0.627 . . . . 0.0 111.473 -173.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -113.08 147.83 36.48 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.803 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.659 ' HH ' ' HB2' ' A' ' 17' ' ' MET . 2.6 p90 -165.89 171.71 12.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.757 -175.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -107.74 108.6 19.89 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 121.492 0.663 . . . . 0.0 109.851 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.575 ' O ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -55.63 -31.21 62.11 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.8 -176.681 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.8 -23.5 65.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.149 0.5 . . . . 0.0 110.742 -177.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 69' ' ' LYS . 4.0 tm-20 -92.09 -41.67 10.37 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -177.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 64' ' ' MET . 2.5 m -61.94 -28.48 44.4 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.698 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.72 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.812 ' HA ' HD12 ' A' ' 71' ' ' LEU . 4.3 m-85 -50.56 -32.51 18.77 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.407 0.683 . . . . 0.0 111.648 169.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -66.95 -30.96 71.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.203 0.525 . . . . 0.0 110.509 178.432 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -93.46 -37.71 11.8 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.144 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.812 HD12 ' HA ' ' A' ' 68' ' ' TYR . 13.4 mt -32.75 99.5 0.15 Allowed Pre-proline 0 N--CA 1.465 0.315 0 C-N-CA 125.509 1.524 . . . . 0.0 113.463 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.438 ' HD2' HG13 ' A' ' 75' ' ' ILE . 13.9 Cg_exo -74.54 154.91 45.19 Favored 'Trans proline' 0 C--N 1.332 -0.302 0 C-N-CA 124.128 3.219 . . . . 0.0 110.586 174.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -64.34 -21.25 66.55 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -171.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.3 -18.04 76.93 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.113 176.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.532 HG22 ' HB3' ' A' ' 80' ' ' GLU . 2.8 mm -101.86 105.79 18.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.97 -0.615 . . . . 0.0 110.179 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.8 t -93.0 -3.34 54.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.006 0.432 . . . . 0.0 110.506 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 80' ' ' GLU . 17.1 m -121.45 116.19 30.86 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.984 -178.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.641 ' HG3' ' CE1' ' A' ' 68' ' ' TYR . 14.4 Cg_exo -35.75 -56.6 0.58 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 124.357 3.371 . . . . 0.0 114.071 171.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.551 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -57.77 -32.74 67.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.227 -179.358 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.532 ' HB3' HG22 ' A' ' 75' ' ' ILE . 2.2 tp10 -70.19 -29.43 66.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.722 -174.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.646 ' HB2' HD22 ' A' ' 71' ' ' LEU . 46.5 t -79.37 -35.58 40.6 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.484 HG12 ' CE2' ' A' ' 62' ' ' TYR . 92.1 t -60.15 -39.95 82.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.936 177.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.74 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 17.6 mtmt -54.95 -48.31 73.34 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 21.7 mmm180 -63.01 -32.68 74.09 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.228 -174.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -69.52 -40.57 76.85 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.433 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.34 -35.59 9.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.546 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 83' ' ' LYS . 49.3 mt-10 . . . . . 0 C--O 1.223 -0.327 0 C-N-CA 122.801 0.44 . . . . 0.0 111.891 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.2 p90 . . . . . 0 N--CA 1.45 -0.439 0 CA-C-O 121.052 0.453 . . . . 0.0 111.353 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.527 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -140.04 121.75 15.35 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -178.255 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.948 HG12 HG12 ' A' ' 19' ' ' ILE . 29.3 mt -87.6 112.0 22.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.805 0.812 . . . . 0.0 110.911 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 18' ' ' MET . 4.0 pt-20 -106.87 161.48 14.66 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.489 -173.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.41 ' NE2' ' HA ' ' A' ' 11' ' ' GLN . 6.0 tp-100 -90.91 124.75 35.44 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.667 0.746 . . . . 0.0 110.686 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.567 HD22 HG21 ' A' ' 59' ' ' THR . 0.2 OUTLIER -70.69 -46.84 62.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.993 -176.527 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -157.92 -79.72 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -137.36 -36.1 0.66 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.865 0.364 . . . . 0.0 110.807 176.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.5 p -141.97 39.18 1.63 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.823 0.82 . . . . 0.0 110.201 -174.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HB2' ' HB3' ' A' ' 12' ' ' LEU . . . -143.63 151.94 40.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.277 176.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.453 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 35.4 ttp -123.16 137.89 54.79 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.063 -0.655 . . . . 0.0 112.314 -173.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.589 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 24.7 ttt -126.51 138.16 53.46 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.948 HG12 HG12 ' A' ' 9' ' ' ILE . 4.7 mt -133.13 118.79 33.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.674 -174.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.527 ' HD3' ' HB3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -102.95 125.71 49.81 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.674 177.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.496 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 176.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.7 tm0? . . . . . 0 CA--C 1.533 0.306 0 N-CA-C 111.925 0.342 . . . . 0.0 111.925 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.505 ' O ' HG12 ' A' ' 33' ' ' VAL . 11.1 p -64.1 -41.23 91.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.315 -176.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -60.1 -25.48 65.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.423 -175.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -92.57 -39.86 5.18 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.026 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -81.8 -27.24 9.71 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -173.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' A' ' 53' ' ' PRO . 11.1 p -70.54 -30.92 44.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 119.307 -0.957 . . . . 0.0 108.486 175.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -71.46 -35.17 70.77 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.695 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.64 -22.01 30.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.39 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.442 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -64.09 -21.07 66.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.351 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.93 -43.36 88.28 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.715 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -81.81 -29.9 32.45 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.802 176.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.442 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 7.8 t80 -51.59 -46.03 63.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.498 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.425 HD11 HD21 ' A' ' 58' ' ' LEU . 58.0 mt -80.4 -29.15 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.965 -175.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.715 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 10.3 pt-20 -75.81 -26.76 57.54 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.096 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 51.4 mt-10 -74.54 -35.65 63.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.061 173.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -125.19 74.94 67.88 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.244 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -95.02 -164.51 0.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.385 2.723 . . . . 0.0 113.749 -171.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -138.78 147.63 55.13 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.208 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -44.26 -22.6 0.57 Allowed 'Trans proline' 0 N--CA 1.482 0.808 0 C-N-CA 124.447 3.431 . . . . 0.0 115.881 -170.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.59 27.09 8.16 Favored Glycine 0 C--O 1.228 -0.265 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.314 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -67.91 136.0 53.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.051 0.453 . . . . 0.0 111.76 177.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.7 mm -109.33 -60.34 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.257 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -162.28 157.41 22.81 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.781 -172.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 59' ' ' THR . 2.1 p -152.05 118.23 5.56 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 173.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.535 HG13 ' HB ' ' A' ' 59' ' ' THR . 7.7 pt -126.59 142.1 42.15 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.604 -176.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.512 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 1.6 Cg_endo -84.64 139.59 7.78 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.31 2.674 . . . . 0.0 112.673 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.7 66.94 1.54 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 92.5 t80 75.91 -68.97 0.18 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.316 0.647 . . . . 0.0 111.588 171.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.1 t -134.92 2.43 3.11 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.613 0.72 . . . . 0.0 109.673 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 15.2 m -120.65 137.47 54.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.38 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.425 HD21 HD11 ' A' ' 40' ' ' ILE . 61.6 tp -102.48 126.89 49.68 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.567 HG21 HD22 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -101.42 106.8 17.98 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -177.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.1 t -109.35 119.21 58.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.459 0.647 . . . . 0.0 111.067 -174.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -112.9 146.59 38.68 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.513 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.734 ' HH ' ' HA ' ' A' ' 79' ' ' PHE . 3.6 p90 -164.78 170.32 15.63 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.873 -173.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -104.24 112.29 25.25 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.73 -177.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.42 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.4 pmm? -63.22 -26.51 68.83 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.735 -174.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.68 -27.89 66.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.201 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -90.71 -41.17 11.43 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -173.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 64' ' ' MET . 3.5 m -68.06 -30.63 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.089 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.678 ' HA ' HD21 ' A' ' 71' ' ' LEU . 3.5 m-85 -53.94 -29.45 42.41 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.495 173.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.489 ' HE2' ' HB2' ' A' ' 69' ' ' LYS . 0.3 OUTLIER -67.62 -34.96 78.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.11 0.481 . . . . 0.0 110.601 178.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 33.9 t60 -93.05 -30.82 15.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.491 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.678 HD21 ' HA ' ' A' ' 68' ' ' TYR . 0.5 OUTLIER -16.2 91.56 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 125.618 1.567 . . . . 0.0 112.672 177.124 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.481 ' HD2' HG13 ' A' ' 75' ' ' ILE . 31.8 Cg_exo -61.71 149.99 87.61 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.057 2.504 . . . . 0.0 111.352 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -63.22 -22.09 66.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.628 -172.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -83.83 -13.76 74.38 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.775 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.505 HG21 ' HB3' ' A' ' 81' ' ' SER . 4.5 mm -96.35 130.84 44.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 122.837 0.455 . . . . 0.0 109.944 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.3 t -114.34 0.07 14.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.164 0.507 . . . . 0.0 109.952 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.9 m -134.5 120.14 14.49 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.962 -177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.63 ' HA ' HD23 ' A' ' 71' ' ' LEU . 95.2 Cg_exo -46.46 -38.5 21.23 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 124.122 3.215 . . . . 0.0 113.882 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.734 ' HA ' ' HH ' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -61.9 -34.65 76.42 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.123 179.487 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.602 ' HG3' ' HD3' ' A' ' 83' ' ' LYS . 16.7 tt0 -83.46 -20.7 33.56 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.456 -174.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.505 ' HB3' HG21 ' A' ' 75' ' ' ILE . 62.5 p -75.93 -30.09 58.58 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 177.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 78' ' ' PRO . 97.7 t -67.59 -34.46 68.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.724 174.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.602 ' HD3' ' HG3' ' A' ' 80' ' ' GLU . 59.7 mtpt -51.85 -45.43 64.01 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 174.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.424 ' HE ' HD13 ' A' ' 75' ' ' ILE . 21.1 mmt180 -60.81 -35.9 77.69 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.874 -177.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -72.31 -42.4 65.51 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.047 0.451 . . . . 0.0 111.426 -177.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.6 m -87.15 -46.12 16.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.17 -177.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 83' ' ' LYS . 14.9 mm-40 . . . . . 0 C--O 1.206 -1.193 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.796 -175.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.629 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 38.9 p90 . . . . . 0 CA--C 1.517 -0.317 0 CA-C-O 121.747 0.784 . . . . 0.0 111.941 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.546 ' HB2' ' NE ' ' A' ' 20' ' ' ARG . 40.1 mt-30 -128.16 139.54 52.43 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.701 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 1.004 HG12 HG12 ' A' ' 19' ' ' ILE . 15.9 mt -101.03 120.25 50.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.764 177.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 18' ' ' MET . 11.9 pt-20 -119.85 159.17 25.12 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.846 -177.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.546 HE21 ' HA ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -88.49 129.91 35.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.971 177.492 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.65 HD21 HG22 ' A' ' 59' ' ' THR . 0.0 OUTLIER -66.4 -42.65 87.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.619 -177.653 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.83 -55.48 0.36 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.426 176.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -103.43 -74.71 0.63 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.947 0.403 . . . . 0.0 111.07 -176.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.4 p -149.58 48.15 0.95 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.686 0.755 . . . . 0.0 110.562 -177.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -142.57 155.08 44.95 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.835 176.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.481 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 37.5 ttp -128.06 124.45 37.09 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -174.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.488 ' HB2' HD23 ' A' ' 12' ' ' LEU . 51.3 ttm -109.49 139.49 44.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.131 0.491 . . . . 0.0 110.248 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 1.004 HG12 HG12 ' A' ' 9' ' ' ILE . 6.4 mt -128.21 112.67 27.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.913 -176.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.564 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -96.0 124.22 39.92 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.89 178.599 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.629 ' HA ' ' CB ' ' A' ' 7' ' ' TYR . 8.0 m-85 . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.52 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.4 tm0? . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 120.887 0.375 . . . . 0.0 111.591 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 33' ' ' VAL . 83.3 t -63.16 -41.66 93.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.395 -177.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -52.61 -32.75 43.21 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.595 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.53 -42.23 6.2 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.731 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -80.03 -22.17 11.8 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.79 0 C-N-CA 120.539 -0.464 . . . . 0.0 112.105 -173.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 29' ' ' VAL . 14.3 p -74.12 -29.5 25.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 119.593 -0.843 . . . . 0.0 108.865 174.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -70.85 -34.63 71.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.47 174.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.12 -21.44 29.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.306 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.423 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . . . -65.15 -26.54 68.22 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.031 -177.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.52 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . . . -62.0 -43.59 98.52 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.833 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -77.85 -29.66 50.59 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.846 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.423 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -55.57 -44.71 77.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.257 0.551 . . . . 0.0 109.639 177.264 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.511 HG22 ' HE2' ' A' ' 48' ' ' PHE . 41.5 mt -83.15 -37.47 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.82 -175.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.833 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 12.2 pt-20 -74.12 -20.89 60.1 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.29 -176.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.443 ' C ' ' HD3' ' A' ' 44' ' ' PRO . 38.1 mm-40 -85.72 -25.68 26.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.932 0.396 . . . . 0.0 110.684 175.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -122.76 63.36 19.99 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.443 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 50.0 Cg_endo -93.42 174.2 1.69 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.546 2.164 . . . . 0.0 114.039 -167.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -114.01 146.48 35.75 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 114.152 -1.385 . . . . 0.0 108.052 175.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.44 -15.33 3.85 Favored 'Trans proline' 0 N--CA 1.48 0.699 0 C-N-CA 123.82 3.013 . . . . 0.0 114.844 -169.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.39 20.18 28.21 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.11 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.511 ' HE2' HG22 ' A' ' 40' ' ' ILE . 4.2 t80 -62.01 132.33 52.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.986 0.422 . . . . 0.0 110.778 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.634 HG21 ' CG ' ' A' ' 50' ' ' GLU . 28.9 mm -109.48 -62.99 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.17 176.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.634 ' CG ' HG21 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -154.69 175.8 13.24 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.522 0.677 . . . . 0.0 110.393 178.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.52 ' SG ' ' HA ' ' A' ' 37' ' ' ALA . 7.5 p -161.55 119.7 2.34 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.838 162.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.76 HG13 ' HB ' ' A' ' 59' ' ' THR . 9.5 pt -114.77 134.07 22.48 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-O 120.975 0.417 . . . . 0.0 112.039 -173.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.478 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 2.0 Cg_endo -82.04 120.45 3.37 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.295 2.664 . . . . 0.0 112.342 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.52 32.95 3.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.328 178.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 71.04 -34.64 0.31 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.096 175.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -128.82 -21.35 3.39 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.85 -0.531 . . . . 0.0 111.214 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 9.5 p -124.65 141.29 52.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.139 0.495 . . . . 0.0 110.571 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.508 HD22 ' CD1' ' A' ' 40' ' ' ILE . 57.5 tp -102.44 111.98 24.5 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.76 ' HB ' HG13 ' A' ' 52' ' ' ILE . 5.2 m -90.32 105.54 17.88 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.7 t -101.25 125.36 55.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.086 0.47 . . . . 0.0 111.122 -172.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -114.73 145.87 41.58 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.613 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.716 ' HH ' ' HA ' ' A' ' 79' ' ' PHE . 2.4 p90 -165.09 169.1 16.62 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.371 0.605 . . . . 0.0 110.695 -174.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -96.61 118.95 34.17 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.616 -176.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.468 ' HA ' HG21 ' A' ' 67' ' ' VAL . 1.3 pmm? -69.34 -22.8 63.73 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.833 -172.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.42 -28.83 69.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 111.144 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -89.83 -30.98 17.58 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.769 0.795 . . . . 0.0 109.477 -173.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' A' ' 64' ' ' MET . 3.2 m -77.75 -33.81 19.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.339 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.91 ' HA ' HD23 ' A' ' 71' ' ' LEU . 59.8 t80 -68.29 -22.87 64.7 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.245 175.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -38.87 71.43 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 172.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -87.54 -74.68 0.43 Allowed 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.421 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.91 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER 32.44 66.95 1.04 Allowed Pre-proline 0 N--CA 1.471 0.593 0 O-C-N 124.186 0.929 . . . . 0.0 111.574 -178.236 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.661 ' HD2' HG13 ' A' ' 75' ' ' ILE . 33.2 Cg_exo -60.45 135.61 62.32 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.475 2.117 . . . . 0.0 111.371 -175.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -58.7 109.32 0.78 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.907 0.861 . . . . 0.0 110.964 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 136.42 -31.56 2.58 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 108.549 -1.82 . . . . 0.0 108.549 -169.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.661 HG13 ' HD2' ' A' ' 72' ' ' PRO . 14.3 mm -84.78 116.38 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 114.049 -1.076 . . . . 0.0 108.764 169.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.9 m -94.94 -4.32 47.0 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.162 0.506 . . . . 0.0 110.716 -175.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.571 ' HB2' ' HB2' ' A' ' 80' ' ' GLU . 58.0 m -141.35 134.54 14.43 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.227 -170.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.67 ' HA ' HD22 ' A' ' 71' ' ' LEU . 82.8 Cg_exo -51.92 -43.63 50.72 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.509 2.806 . . . . 0.0 113.157 173.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.716 ' HA ' ' HH ' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -67.11 -23.39 65.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.185 0.516 . . . . 0.0 110.748 176.35 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 77' ' ' SER . 39.9 tt0 -81.34 -20.73 40.03 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.159 -174.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.502 ' HB3' HG21 ' A' ' 75' ' ' ILE . 63.7 p -81.95 -37.33 26.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 78' ' ' PRO . 26.2 t -64.22 -26.02 39.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.129 177.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.55 ' HG3' ' HA ' ' A' ' 80' ' ' GLU . 93.5 mttt -50.17 -45.08 53.11 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.126 175.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -69.5 -35.14 75.24 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.042 -173.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -62.33 -41.79 98.85 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.843 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.9 m -87.41 -42.96 15.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -178.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 C--O 1.222 -0.382 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.348 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 5.9 p90 . . . . . 0 N--CA 1.447 -0.607 0 CA-C-O 121.478 0.656 . . . . 0.0 111.853 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.493 ' HB3' ' NE ' ' A' ' 20' ' ' ARG . 8.1 tp60 -146.79 115.25 6.71 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.125 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.818 HG12 HG12 ' A' ' 19' ' ' ILE . 30.5 mt -82.73 122.75 37.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.036 0.446 . . . . 0.0 110.281 176.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.413 ' OE2' ' HD2' ' A' ' 20' ' ' ARG . 12.4 pt-20 -120.7 169.68 10.16 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.209 -178.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -93.85 128.43 40.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.473 0.654 . . . . 0.0 110.56 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.599 HD23 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -69.56 -47.65 62.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.703 -177.589 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -161.61 -72.09 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -142.41 -34.42 0.45 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.223 -0.191 . . . . 0.0 111.513 177.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.1 p -144.1 42.95 1.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.795 0.807 . . . . 0.0 111.234 -176.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.46 ' HB1' ' HB3' ' A' ' 12' ' ' LEU . . . -150.45 152.75 34.76 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.204 177.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.696 ' HB2' ' HH ' ' A' ' 62' ' ' TYR . 30.8 ttp -125.4 133.12 52.62 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.751 -0.78 . . . . 0.0 112.484 -173.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.599 ' HB2' HD23 ' A' ' 12' ' ' LEU . 53.7 ttm -119.02 131.76 56.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.965 176.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.818 HG12 HG12 ' A' ' 9' ' ' ILE . 7.3 mt -123.44 109.04 22.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.65 -176.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.527 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -102.76 134.42 46.18 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.501 -179.343 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 35.3 m-85 . . . . . 0 C--N 1.323 -0.568 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.4 tm0? . . . . . 0 CA--C 1.529 0.168 0 CA-C-O 120.453 0.168 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.685 ' O ' HG22 ' A' ' 33' ' ' VAL . 4.9 p -60.31 -55.38 24.64 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.113 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -175.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -55.88 -29.48 60.03 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.389 0.431 . . . . 0.0 111.355 -176.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.68 -35.98 17.7 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.362 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -93.48 -28.55 4.37 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.872 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -170.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.685 HG22 ' O ' ' A' ' 29' ' ' VAL . 3.1 m -62.7 -35.68 71.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.744 176.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.5 t60 -71.93 -33.13 68.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.157 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.32 -32.81 24.11 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.124 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.622 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -64.9 -24.11 67.43 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 122.772 0.429 . . . . 0.0 111.203 -177.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.484 ' HB1' ' HD3' ' A' ' 53' ' ' PRO . . . -61.38 -40.3 93.82 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.739 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -85.57 -32.64 22.01 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.102 174.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.622 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 4.4 t80 -54.67 -42.53 71.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.126 0.489 . . . . 0.0 110.603 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.512 HD13 HD22 ' A' ' 58' ' ' LEU . 51.9 mt -78.06 -31.86 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.237 -177.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.739 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 10.0 pt-20 -79.5 -23.73 42.76 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.763 -177.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -78.12 -33.28 50.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.497 174.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -126.88 68.88 71.68 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.832 0.349 . . . . 0.0 110.302 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -96.03 179.17 0.57 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.109 2.539 . . . . 0.0 113.972 -171.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -111.29 146.48 34.67 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.1 171.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -43.03 -35.19 4.44 Favored 'Trans proline' 0 N--CA 1.479 0.636 0 C-N-CA 123.457 2.771 . . . . 0.0 114.992 -171.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.488 ' HA3' ' CB ' ' A' ' 66' ' ' GLU . . . -98.73 16.18 59.95 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.713 -175.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -60.68 135.99 57.93 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.08 0.466 . . . . 0.0 111.099 175.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.866 HG21 ' HG2' ' A' ' 50' ' ' GLU . 40.6 mm -110.65 -61.36 2.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.065 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.866 ' HG2' HG21 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -153.19 169.57 22.67 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.471 0.653 . . . . 0.0 111.16 -178.315 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 59' ' ' THR . 4.2 p -161.76 117.54 2.05 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.096 167.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.601 HG12 ' HB ' ' A' ' 59' ' ' THR . 0.1 OUTLIER -127.75 136.48 29.04 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.691 -175.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.484 ' HD3' ' HB1' ' A' ' 37' ' ' ALA . 71.1 Cg_endo -78.75 138.35 14.92 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.778 2.319 . . . . 0.0 112.546 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.97 58.53 1.02 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.683 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 62.9 t80 70.61 -65.53 0.33 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.695 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 t -119.11 -17.48 8.95 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.999 0.428 . . . . 0.0 111.454 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 4.3 p -112.9 144.79 41.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.204 0.526 . . . . 0.0 111.272 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.512 HD22 HD13 ' A' ' 40' ' ' ILE . 53.0 tp -102.75 118.24 36.4 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.601 ' HB ' HG12 ' A' ' 52' ' ' ILE . 0.7 OUTLIER -93.76 106.55 18.51 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.71 -177.245 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.6 t -106.2 126.12 61.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.308 0.575 . . . . 0.0 111.177 -173.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.579 ' HB2' ' HG3' ' A' ' 50' ' ' GLU . 89.5 m-85 -120.15 147.06 45.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.245 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.696 ' HH ' ' HB2' ' A' ' 17' ' ' MET . 1.9 p90 -166.11 172.39 11.37 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.292 0.567 . . . . 0.0 111.065 -172.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.417 ' OD1' ' HB3' ' A' ' 65' ' ' TYR . 10.9 t0 -99.0 113.41 25.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.662 -179.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.501 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -60.78 -20.5 61.57 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.48 -178.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.417 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -70.54 -31.79 68.98 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.94 0.4 . . . . 0.0 110.789 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.488 ' CB ' ' HA3' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -90.36 -29.56 17.98 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.503 0.668 . . . . 0.0 109.724 -173.528 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.501 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.4 m -74.9 -32.15 27.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.392 176.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.764 ' HA ' HD23 ' A' ' 71' ' ' LEU . 50.7 t80 -66.2 -24.0 66.55 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.636 175.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.82 -32.75 69.66 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.869 0.842 . . . . 0.0 108.732 174.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -91.89 -69.37 0.74 Allowed 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.197 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.764 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER 22.73 76.75 0.23 Allowed Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 124.804 1.242 . . . . 0.0 113.567 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.421 ' HD2' HG13 ' A' ' 75' ' ' ILE . 44.1 Cg_exo -58.02 153.03 47.43 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.513 2.142 . . . . 0.0 111.639 176.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -61.0 -29.19 69.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.481 -173.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.83 -30.16 56.36 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.328 -0.939 . . . . 0.0 111.025 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.587 HG23 ' HB3' ' A' ' 81' ' ' SER . 14.1 mm -76.78 108.26 9.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.947 -0.627 . . . . 0.0 110.079 177.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.2 t -89.29 -8.85 52.51 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.322 0.582 . . . . 0.0 110.464 -176.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 69.9 m -133.36 134.21 23.68 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.073 -173.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.657 ' HA ' HD22 ' A' ' 71' ' ' LEU . 84.8 Cg_exo -49.55 -49.23 16.28 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.539 2.826 . . . . 0.0 113.132 176.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.421 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -60.35 -26.88 66.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.008 0.432 . . . . 0.0 111.544 178.546 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -79.11 -21.47 46.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.075 -175.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.587 ' HB3' HG23 ' A' ' 75' ' ' ILE . 78.4 p -82.33 -37.59 25.49 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 176.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 78' ' ' PRO . 59.8 t -59.4 -29.13 41.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.823 177.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.475 ' HE2' HG22 ' A' ' 9' ' ' ILE . 95.4 mttt -52.22 -47.02 65.87 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -63.46 -33.26 75.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.654 -174.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -70.61 -38.26 73.94 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.384 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.7 m -87.3 -44.53 16.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 . . . . . 0 N--CA 1.469 0.494 0 C-N-CA 123.117 0.567 . . . . 0.0 111.994 -178.256 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.564 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . 20.0 p90 . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.423 HE21 ' HB3' ' A' ' 8' ' ' GLN . 13.6 mt-30 -139.39 133.31 30.89 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.842 176.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.872 HG12 HG12 ' A' ' 19' ' ' ILE . 26.8 mt -95.53 127.54 47.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.132 -178.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 18' ' ' MET . 11.4 pt-20 -122.57 171.43 9.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.423 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.66 137.73 32.08 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.179 0.514 . . . . 0.0 110.947 177.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.578 HD21 ' CG2' ' A' ' 59' ' ' THR . 0.0 OUTLIER -79.59 -20.33 47.19 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.01 175.322 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.2 -80.96 0.19 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.733 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -107.05 -55.44 2.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.842 0.353 . . . . 0.0 111.778 -175.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.498 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 4.6 p -149.29 42.01 0.91 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.648 0.737 . . . . 0.0 110.984 -172.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HB1' ' HB3' ' A' ' 12' ' ' LEU . . . -142.65 157.91 44.2 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.47 173.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.718 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 35.1 ttp -130.02 133.02 46.46 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.929 -174.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.562 ' HB2' HD23 ' A' ' 12' ' ' LEU . 32.8 ttp -124.06 135.38 53.53 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.109 175.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.872 HG12 HG12 ' A' ' 9' ' ' ILE . 5.0 mt -120.05 124.4 72.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.114 -176.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.523 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -104.53 118.76 37.39 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.237 178.347 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.564 ' CD2' ' HB3' ' A' ' 7' ' ' TYR . 53.3 m-85 . . . . . 0 C--N 1.318 -0.796 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.748 173.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 . . . . . 0 N--CA 1.456 -0.131 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.545 ' HB ' ' HB3' ' A' ' 21' ' ' PHE . 17.0 m -65.97 -43.82 92.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.821 0.344 . . . . 0.0 110.251 -177.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.82 -41.66 95.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.762 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.51 -37.88 29.88 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.394 -175.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.1 -29.06 13.78 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.749 0 C-N-CA 120.224 -0.591 . . . . 0.0 111.946 -175.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.433 HG22 ' HB2' ' A' ' 58' ' ' LEU . 14.1 p -71.02 -28.81 34.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -69.71 -40.27 76.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.074 173.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.09 -20.64 30.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.931 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.87 -30.44 70.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.722 0.296 . . . . 0.0 111.469 -173.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.22 98.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.719 0.771 . . . . 0.0 108.99 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.505 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -78.29 -25.67 46.73 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.73 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -66.14 -45.01 82.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.344 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.489 ' CD1' HD23 ' A' ' 58' ' ' LEU . 41.8 mt -76.25 -38.05 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.346 -175.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.505 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 14.4 pt-20 -69.6 -19.99 63.64 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.238 -175.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -91.95 -24.37 19.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.609 0.242 . . . . 0.0 110.762 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -127.1 68.84 72.88 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 175.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -95.56 -171.0 0.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.451 2.767 . . . . 0.0 113.816 -170.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -127.29 147.07 60.49 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.376 176.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -40.69 -36.74 2.0 Allowed 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.107 3.204 . . . . 0.0 115.317 -170.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -102.51 19.31 48.37 Favored Glycine 0 C--O 1.226 -0.404 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.518 -174.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -64.36 135.8 56.51 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.081 0.467 . . . . 0.0 111.211 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 62' ' ' TYR . 32.6 mm -107.67 -58.54 3.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.236 -178.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -167.17 160.86 14.15 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.197 -176.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.6 p -149.97 119.76 7.08 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 172.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.806 HG13 ' HB ' ' A' ' 59' ' ' THR . 5.3 pt -114.56 132.58 22.79 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-O 121.2 0.524 . . . . 0.0 111.845 -175.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -85.61 123.03 2.44 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.243 2.629 . . . . 0.0 112.395 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.18 27.72 7.97 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.299 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 70.92 -28.5 0.18 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.248 -0.887 . . . . 0.0 113.298 174.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -140.84 7.23 2.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.336 0.589 . . . . 0.0 110.711 171.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 47.3 m -148.18 144.36 27.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.775 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.489 HD23 ' CD1' ' A' ' 40' ' ' ILE . 54.4 tp -115.61 111.66 20.98 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.95 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.806 ' HB ' HG13 ' A' ' 52' ' ' ILE . 3.8 m -90.18 106.68 18.65 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.6 t -104.9 117.41 50.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.541 0.686 . . . . 0.0 110.88 -174.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.428 ' CE1' HG21 ' A' ' 59' ' ' THR . 80.8 m-85 -105.5 147.15 28.64 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.791 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.587 ' HH ' ' HA ' ' A' ' 79' ' ' PHE . 3.8 p90 -165.75 164.64 18.84 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.382 -176.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -99.31 114.5 27.4 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.333 -175.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.498 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 0.4 OUTLIER -65.12 -20.85 66.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.65 -169.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.647 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 0.5 OUTLIER -68.41 -29.5 68.19 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.267 -178.07 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -91.88 -35.56 13.98 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 121.445 0.641 . . . . 0.0 109.513 -175.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.49 HG21 ' HA ' ' A' ' 64' ' ' MET . 3.3 m -68.37 -29.91 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.85 177.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 1.005 ' HA ' HD22 ' A' ' 71' ' ' LEU . 30.1 t80 -69.61 -22.93 63.45 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.516 174.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.647 ' HG2' ' O ' ' A' ' 65' ' ' TYR . 27.4 mmmt -76.25 -25.42 54.97 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -89.5 -35.6 15.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.428 178.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 1.005 HD22 ' HA ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -16.89 90.21 0.04 OUTLIER Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 125.606 1.562 . . . . 0.0 112.779 178.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.633 ' HD2' HG13 ' A' ' 75' ' ' ILE . 22.8 Cg_exo -66.33 136.62 44.28 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.196 2.597 . . . . 0.0 110.941 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -65.61 100.17 0.5 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.818 0.818 . . . . 0.0 110.417 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.46 -26.02 1.83 Allowed Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -171.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.633 HG13 ' HD2' ' A' ' 72' ' ' PRO . 11.6 mm -87.75 132.9 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 114.627 -0.787 . . . . 0.0 109.636 172.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.5 t -103.44 1.11 32.07 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.159 0.504 . . . . 0.0 110.522 -176.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.592 ' HB3' ' HB3' ' A' ' 80' ' ' GLU . 21.0 t -146.57 129.41 7.98 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -170.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.702 ' HA ' HD21 ' A' ' 71' ' ' LEU . 95.8 Cg_exo -47.51 -44.42 25.44 Favored 'Trans proline' 0 C--O 1.221 -0.352 0 C-N-CA 123.577 2.851 . . . . 0.0 112.807 169.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.587 ' HA ' ' HH ' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -67.27 -36.8 82.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.034 0.445 . . . . 0.0 110.913 176.728 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.592 ' HB3' ' HB3' ' A' ' 77' ' ' SER . 39.9 tt0 -71.33 -27.09 63.13 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.595 -174.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.559 ' HB3' HG23 ' A' ' 75' ' ' ILE . 76.9 p -77.6 -37.64 49.88 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 78' ' ' PRO . 58.2 t -60.73 -34.71 59.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.102 178.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.718 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 5.3 mtmp? -53.21 -42.7 66.56 Favored 'General case' 0 C--O 1.213 -0.82 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 176.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.56 -34.24 73.91 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.483 -175.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -62.72 -41.55 99.21 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.455 176.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.7 m -84.29 -39.69 14.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.924 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.454 ' OE2' ' HB3' ' A' ' 83' ' ' LYS . 39.9 mt-10 . . . . . 0 C--O 1.218 -0.572 0 C-N-CA 123.207 0.603 . . . . 0.0 112.083 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.466 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . 27.0 p90 . . . . . 0 CA--C 1.514 -0.412 0 CA-C-O 121.8 0.809 . . . . 0.0 112.378 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.26 140.44 45.21 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.135 -1.393 . . . . 0.0 108.511 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.743 HG23 ' HD3' ' A' ' 83' ' ' LYS . 34.2 mt -113.81 131.26 66.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.9 -175.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -121.85 169.53 10.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.203 0.525 . . . . 0.0 110.432 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.555 HE21 ' HA ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -94.42 131.29 40.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.642 176.763 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.613 HD23 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -69.05 -50.11 51.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.639 -176.289 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.99 -69.96 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.703 176.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -110.57 -71.06 0.78 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.983 0.42 . . . . 0.0 111.433 -176.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.9 p -135.91 47.07 2.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.674 0.75 . . . . 0.0 110.792 -175.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.29 153.75 42.34 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.006 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.69 ' HB2' ' HH ' ' A' ' 62' ' ' TYR . 26.7 ttp -121.52 136.61 54.94 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.652 -0.419 . . . . 0.0 112.112 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.613 ' HB2' HD23 ' A' ' 12' ' ' LEU . 49.5 ttm -122.49 131.82 54.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.31 0.576 . . . . 0.0 110.049 176.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.727 HG12 HG12 ' A' ' 9' ' ' ILE . 4.0 mt -118.64 140.58 41.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.459 -178.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.4 ' N ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -123.26 117.56 25.57 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.361 0.601 . . . . 0.0 109.935 176.074 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.466 ' CD2' ' HB3' ' A' ' 7' ' ' TYR . 35.8 m-85 . . . . . 0 C--N 1.318 -0.78 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.108 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.271 0 CA-C-O 120.49 0.185 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.404 HG23 ' N ' ' A' ' 30' ' ' ASN . 35.4 m -55.19 -41.95 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 120.799 0.333 . . . . 0.0 110.931 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.404 ' N ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -66.91 -19.75 65.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.272 -177.138 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.71 -45.56 4.85 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.254 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.11 -21.35 12.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.687 -175.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 55' ' ' PHE . 14.5 p -70.76 -31.11 44.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 174.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -77.67 -36.71 51.07 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.03 177.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.79 -20.79 45.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.005 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.404 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -65.49 -26.99 68.17 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.659 0.266 . . . . 0.0 110.764 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.513 ' O ' ' HG3' ' A' ' 41' ' ' GLU . . . -62.75 -46.17 89.32 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.2 -34.94 63.88 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.607 176.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.404 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 19.3 t80 -54.98 -41.14 70.83 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.79 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.407 HD13 HD23 ' A' ' 58' ' ' LEU . 48.8 mt -76.74 -27.01 16.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.239 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' A' ' 37' ' ' ALA . 41.6 mt-10 -79.42 -41.55 27.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.957 0.408 . . . . 0.0 111.398 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -63.27 -35.35 80.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.181 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -129.55 75.93 79.26 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.897 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -95.17 177.98 0.78 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.754 2.303 . . . . 0.0 113.332 -174.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -121.46 146.47 45.17 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -45.23 -28.46 3.62 Favored 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 124.104 3.203 . . . . 0.0 115.307 -169.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.02 20.4 38.43 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.385 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -64.23 136.19 56.97 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.134 0.492 . . . . 0.0 111.375 177.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.407 HG12 ' HA ' ' A' ' 62' ' ' TYR . 39.1 mm -108.25 -58.96 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.449 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -165.94 161.16 17.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.678 0.275 . . . . 0.0 110.552 -175.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 2.4 p -152.09 119.16 5.86 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.755 HG13 ' HB ' ' A' ' 59' ' ' THR . 5.5 pt -123.81 136.12 27.02 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.834 -177.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -87.28 158.91 8.29 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.127 2.552 . . . . 0.0 112.414 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.95 48.67 1.22 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.159 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.403 ' O ' HG12 ' A' ' 33' ' ' VAL . 87.1 t80 72.54 -47.58 0.67 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.543 0.737 . . . . 0.0 112.323 174.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.1 t -133.66 -20.47 2.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.987 0.423 . . . . 0.0 110.729 177.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.4 m -108.21 152.12 25.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.011 0.434 . . . . 0.0 110.801 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.407 HD23 HD13 ' A' ' 40' ' ' ILE . 47.3 tp -126.01 122.69 36.61 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.608 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.755 ' HB ' HG13 ' A' ' 52' ' ' ILE . 5.2 m -104.16 107.18 17.97 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.188 -178.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.4 t -105.22 119.63 54.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.451 0.644 . . . . 0.0 111.241 -175.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -106.85 146.89 30.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.439 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.69 ' HH ' ' HB2' ' A' ' 17' ' ' MET . 2.4 p90 -166.32 167.85 15.57 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.046 0.451 . . . . 0.0 110.64 -175.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.41 ' OD1' ' HD1' ' A' ' 65' ' ' TYR . 5.6 t0 -98.55 117.27 32.61 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.329 -178.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.593 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -64.01 -22.67 67.03 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.835 -174.641 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.41 ' HD1' ' OD1' ' A' ' 63' ' ' ASP . 0.2 OUTLIER -69.51 -28.16 65.8 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.699 0.285 . . . . 0.0 111.142 -175.485 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -89.53 -43.38 10.85 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -171.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 m -66.93 -27.69 40.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.853 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.898 ' HA ' HD21 ' A' ' 71' ' ' LEU . 12.1 t80 -66.71 -22.35 66.07 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.049 0.54 . . . . 0.0 110.777 175.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.73 -34.33 62.53 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 173.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -76.07 -38.13 57.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.576 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.898 HD21 ' HA ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -20.33 92.21 0.04 OUTLIER Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 125.814 1.645 . . . . 0.0 113.545 178.461 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.693 ' HD2' HG13 ' A' ' 75' ' ' ILE . 20.9 Cg_exo -68.99 152.13 73.31 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 123.177 2.585 . . . . 0.0 110.264 173.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -67.77 -17.52 64.57 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -171.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.98 -19.04 70.95 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.19 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.693 HG13 ' HD2' ' A' ' 72' ' ' PRO . 11.4 mm -89.75 137.53 21.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.86 -0.67 . . . . 0.0 109.529 175.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.1 m -116.55 2.14 13.01 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.377 0.608 . . . . 0.0 110.568 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.475 ' HB3' ' HB3' ' A' ' 80' ' ' GLU . 31.2 t -141.22 130.7 12.79 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.969 -173.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.655 ' HA ' HD23 ' A' ' 71' ' ' LEU . 80.0 Cg_exo -43.95 -54.73 3.57 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.403 2.735 . . . . 0.0 112.265 169.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.47 ' HD1' ' HB2' ' A' ' 17' ' ' MET . 0.0 OUTLIER -53.35 -42.19 66.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.221 175.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.513 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 38.7 tt0 -72.39 -19.59 61.58 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.201 -173.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.446 ' HB2' HG22 ' A' ' 75' ' ' ILE . 48.2 t -81.09 -40.08 24.67 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.468 HG11 ' CD2' ' A' ' 62' ' ' TYR . 39.0 t -63.65 -30.77 50.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.987 177.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.743 ' HD3' HG23 ' A' ' 9' ' ' ILE . 7.4 mmmt -49.53 -47.61 48.81 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.208 173.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.478 ' HE ' HD12 ' A' ' 75' ' ' ILE . 19.7 mmt180 -67.9 -38.74 83.34 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.008 -172.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -63.85 -34.9 78.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.121 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.7 m -88.45 -44.69 15.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.501 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 83' ' ' LYS . 57.6 mt-10 . . . . . 0 N--CA 1.469 0.48 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.498 ' HH ' ' HG2' ' A' ' 87' ' ' GLU . 39.9 p90 . . . . . 0 CA--C 1.517 -0.318 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.504 ' O ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.11 121.6 20.55 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.858 178.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.936 HG12 HG12 ' A' ' 19' ' ' ILE . 18.6 mt -91.46 125.79 44.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.221 177.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -120.54 149.81 41.85 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.101 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -76.9 126.44 30.97 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.281 0.562 . . . . 0.0 110.21 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.623 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -67.47 -37.52 83.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.51 -177.589 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.54 -79.23 0.11 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.416 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -98.98 -68.73 0.79 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.802 0.334 . . . . 0.0 111.782 -177.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.9 p -143.46 49.79 1.41 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.975 0.893 . . . . 0.0 110.239 -174.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -142.46 152.11 42.41 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.371 177.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.496 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 34.1 ttp -124.0 130.55 52.75 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.443 -0.503 . . . . 0.0 112.016 -175.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.623 ' HB2' HD22 ' A' ' 12' ' ' LEU . 50.9 ttm -116.47 126.8 53.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.277 0.56 . . . . 0.0 110.43 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.936 HG12 HG12 ' A' ' 9' ' ' ILE . 7.9 mt -119.66 126.36 75.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.404 -176.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.504 ' HD3' ' O ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -115.06 122.51 46.37 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.89 176.128 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.665 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 28.2 m-85 . . . . . 0 C--N 1.317 -0.82 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.882 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 110.696 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.665 ' HB ' ' HB3' ' A' ' 21' ' ' PHE . 32.9 m -59.2 -33.47 50.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.083 0.468 . . . . 0.0 110.783 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -78.97 -18.59 53.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.557 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.83 -37.98 7.11 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.716 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.87 -27.57 12.4 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.994 -176.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.487 HG23 ' HB2' ' A' ' 58' ' ' LEU . 7.2 p -62.76 -32.03 54.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.177 0.513 . . . . 0.0 109.937 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -70.48 -39.11 74.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.171 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.35 -20.3 32.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.483 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.19 -23.9 67.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.432 -176.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.73 -42.32 99.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.746 0.784 . . . . 0.0 109.198 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.458 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.19 -29.67 26.4 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.699 176.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -59.21 -45.71 90.38 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.302 -178.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.419 HD12 HD23 ' A' ' 58' ' ' LEU . 58.5 mt -71.12 -37.98 69.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.503 -176.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.458 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 13.0 pt-20 -75.37 -19.69 59.43 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.31 -174.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 33.5 mt-10 -80.7 -32.14 35.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.922 0.391 . . . . 0.0 110.613 175.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -126.3 64.25 54.01 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.969 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.404 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 72.9 Cg_endo -91.96 176.34 1.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.03 2.487 . . . . 0.0 114.059 -169.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -106.41 146.61 33.34 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.134 173.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.58 -5.99 0.21 Allowed 'Trans proline' 0 N--CA 1.482 0.847 0 C-N-CA 124.085 3.19 . . . . 0.0 115.3 -172.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.23 29.23 5.35 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.943 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -71.09 135.17 47.56 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.836 0.35 . . . . 0.0 111.12 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.2 mm -110.62 -60.34 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.46 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -164.85 155.88 14.7 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.907 -172.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 59' ' ' THR . 4.6 p -152.15 119.47 5.95 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.086 0.469 . . . . 0.0 110.094 173.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.763 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.0 pt -117.67 129.62 25.23 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-O 121.285 0.564 . . . . 0.0 112.068 -178.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -85.82 139.03 6.3 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.378 2.719 . . . . 0.0 112.753 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -126.49 46.06 2.54 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.947 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.2 t80 72.1 -40.01 0.46 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.539 0.735 . . . . 0.0 112.731 174.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.1 t -136.44 -18.4 1.48 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.702 0.287 . . . . 0.0 111.25 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 p -120.3 140.59 51.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.08 0.467 . . . . 0.0 110.966 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.487 ' HB2' HG23 ' A' ' 33' ' ' VAL . 40.8 tp -108.98 119.73 40.44 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.763 ' HB ' HG13 ' A' ' 52' ' ' ILE . 2.2 m -95.01 106.11 18.07 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.5 t -105.54 125.26 60.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.505 0.669 . . . . 0.0 111.507 -173.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -116.93 146.71 42.81 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.297 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.603 ' HH ' ' HB2' ' A' ' 79' ' ' PHE . 2.1 p90 -164.96 170.71 14.91 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.011 0.434 . . . . 0.0 110.281 -174.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -101.09 107.97 19.53 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.533 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.474 ' N ' ' SD ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -62.41 -20.69 64.74 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.599 -176.422 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.29 -28.36 68.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.984 0.421 . . . . 0.0 110.207 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -90.58 -39.12 12.72 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.667 0.746 . . . . 0.0 109.151 -172.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -67.24 -30.78 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.719 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.715 ' HA ' HD23 ' A' ' 71' ' ' LEU . 48.0 t80 -58.23 -26.93 63.46 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.563 0.745 . . . . 0.0 111.801 175.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.77 -26.4 59.73 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.415 0.626 . . . . 0.0 109.862 176.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -90.25 -33.56 16.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.146 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.715 HD23 ' HA ' ' A' ' 68' ' ' TYR . 1.1 mm? -23.48 91.75 0.04 OUTLIER Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 125.764 1.626 . . . . 0.0 113.037 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.643 ' HD2' HG13 ' A' ' 75' ' ' ILE . 12.1 Cg_exo -73.49 146.81 39.99 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 123.485 2.79 . . . . 0.0 111.676 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -69.43 108.92 3.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.439 0.638 . . . . 0.0 110.089 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 133.99 -30.68 2.91 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 -170.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.643 HG13 ' HD2' ' A' ' 72' ' ' PRO . 9.1 mm -86.01 108.36 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 114.196 -1.002 . . . . 0.0 108.504 170.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.2 t -90.13 -6.67 55.15 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.125 0.488 . . . . 0.0 110.461 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 74.0 m -135.17 131.86 19.9 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.656 ' HA ' HD22 ' A' ' 71' ' ' LEU . 56.3 Cg_exo -43.42 -55.5 2.88 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.719 2.946 . . . . 0.0 113.079 173.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.603 ' HB2' ' HH ' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -57.37 -30.96 65.31 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.763 -179.244 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -73.14 -27.45 61.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.955 -176.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.517 ' HB2' HG23 ' A' ' 75' ' ' ILE . 36.9 t -73.62 -35.95 65.39 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.401 HG12 ' CE2' ' A' ' 62' ' ' TYR . 41.7 t -66.13 -30.89 51.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.651 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.73 ' HZ2' ' HB3' ' A' ' 83' ' ' LYS . 9.8 mtpm? -52.5 -46.12 66.5 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.966 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -61.07 -41.82 97.36 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.983 -175.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -70.27 -38.47 75.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.6 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.6 m -87.04 -49.32 14.9 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.617 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -175.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.498 ' HG2' ' HH ' ' A' ' 7' ' ' TYR . 50.6 mt-10 . . . . . 0 N--CA 1.464 0.267 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -174.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.539 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . 37.1 p90 . . . . . 0 CA--C 1.515 -0.37 0 CA-C-O 121.641 0.734 . . . . 0.0 112.198 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -128.46 134.82 48.83 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.488 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.491 HG22 ' HG2' ' A' ' 83' ' ' LYS . 4.5 mp -93.88 108.6 20.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.325 178.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -117.31 166.2 12.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.621 0.724 . . . . 0.0 111.214 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.66 140.87 41.09 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.643 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -84.88 -21.61 29.68 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.321 174.72 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 152.3 -68.56 0.31 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 119.903 -1.142 . . . . 0.0 113.464 176.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -119.26 -61.73 1.6 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.894 0.378 . . . . 0.0 111.393 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.1 p -141.26 39.85 1.76 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.447 0.642 . . . . 0.0 111.013 -175.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.504 ' HB2' ' HB3' ' A' ' 12' ' ' LEU . . . -141.76 160.36 40.33 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.133 175.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.658 ' HB2' ' HH ' ' A' ' 62' ' ' TYR . 34.0 ttp -129.48 136.62 50.12 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.61 -0.436 . . . . 0.0 112.115 -175.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.462 ' HB2' HD23 ' A' ' 12' ' ' LEU . 48.9 ttm -121.59 130.33 53.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.197 0.522 . . . . 0.0 110.685 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.4 mt -117.17 121.11 66.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.606 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -115.18 120.65 40.45 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.755 0.788 . . . . 0.0 110.957 -177.515 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.655 ' HD2' HG12 ' A' ' 29' ' ' VAL . 44.4 m-85 . . . . . 0 C--N 1.309 -1.19 0 CA-C-N 113.799 -1.546 . . . . 0.0 109.97 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.655 HG12 ' HD2' ' A' ' 21' ' ' PHE . 35.5 m -63.9 -45.4 97.06 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.431 ' N ' HG22 ' A' ' 29' ' ' VAL . 39.9 t30 -53.9 -42.32 68.57 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.396 -176.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.26 -47.46 6.46 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.598 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -74.25 -29.55 24.94 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.509 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -170.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.589 HG11 ' O ' ' A' ' 29' ' ' VAL . 7.3 p -63.78 -32.21 56.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.663 177.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.588 ' CE1' ' HA ' ' A' ' 55' ' ' PHE . 34.4 m80 -81.59 -32.23 32.17 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.541 179.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.61 -24.38 36.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.845 0.355 . . . . 0.0 111.121 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.502 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -67.11 -20.92 65.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.43 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.64 98.72 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.647 0.737 . . . . 0.0 109.056 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.501 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.67 -32.32 23.68 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.76 175.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.502 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 17.0 t80 -53.53 -48.94 68.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.451 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.643 HD12 HD21 ' A' ' 58' ' ' LEU . 65.2 mt -69.1 -34.78 65.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.543 -177.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.501 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 12.5 pt-20 -76.92 -22.44 53.33 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.165 -173.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 95.0 mt-10 -74.91 -34.33 62.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.755 0.312 . . . . 0.0 110.607 177.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -127.46 74.45 77.75 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -95.21 178.8 0.71 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 123.18 2.587 . . . . 0.0 113.48 -173.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.474 ' C ' ' H ' ' A' ' 47' ' ' GLY . 3.8 p90 -112.55 146.26 34.63 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.133 172.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -61.16 15.17 0.04 OUTLIER 'Trans proline' 0 N--CA 1.482 0.795 0 C-N-CA 123.992 3.128 . . . . 0.0 114.789 -174.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . -133.65 18.79 4.3 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 175.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -70.65 137.41 49.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.736 0.303 . . . . 0.0 110.608 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.1 mm -113.6 -56.88 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.39 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 9.4 tp10 -160.94 157.1 25.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.827 0.346 . . . . 0.0 110.702 -175.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 59' ' ' THR . 8.2 p -152.03 117.94 5.47 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 172.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.758 HG13 ' HB ' ' A' ' 59' ' ' THR . 7.1 pt -118.62 128.53 25.92 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-O 121.253 0.549 . . . . 0.0 112.142 -176.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.427 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 84.1 Cg_endo -86.46 120.85 1.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.497 2.798 . . . . 0.0 112.144 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.429 ' HB1' ' OG ' ' A' ' 57' ' ' SER . . . -114.41 59.86 0.68 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.686 0.279 . . . . 0.0 111.215 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.588 ' HA ' ' CE1' ' A' ' 34' ' ' HIS . 70.4 t80 74.34 -49.24 0.67 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.392 0.677 . . . . 0.0 111.817 173.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.413 ' HA ' HG12 ' A' ' 33' ' ' VAL . 14.0 t -140.05 -14.35 1.04 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.879 0.371 . . . . 0.0 111.475 176.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.429 ' OG ' ' HB1' ' A' ' 54' ' ' ALA . 18.3 p -108.66 133.75 52.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.413 0.625 . . . . 0.0 110.823 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.643 HD21 HD12 ' A' ' 40' ' ' ILE . 57.0 tp -102.58 111.77 24.23 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.758 ' HB ' HG13 ' A' ' 52' ' ' ILE . 1.8 m -95.43 107.04 19.16 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.743 -176.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.2 t -106.27 118.68 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.527 0.68 . . . . 0.0 111.243 -172.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.425 ' CE1' HG22 ' A' ' 59' ' ' THR . 88.1 m-85 -111.6 148.54 33.08 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.572 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.658 ' HH ' ' HB2' ' A' ' 17' ' ' MET . 2.1 p90 -165.82 169.62 14.78 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -175.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -102.29 113.07 26.05 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.527 -176.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.546 ' HA ' HG23 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -58.84 -19.69 43.87 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.455 -174.204 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -65.62 -28.42 69.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.637 0.256 . . . . 0.0 111.191 -177.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.536 ' O ' ' HD2' ' A' ' 70' ' ' HIS . 2.4 tm-20 -91.3 -41.32 11.0 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -176.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.546 HG23 ' HA ' ' A' ' 64' ' ' MET . 3.0 m -64.53 -30.79 51.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.996 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.923 ' HA ' HD23 ' A' ' 71' ' ' LEU . 62.6 t80 -63.93 -26.65 68.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.402 173.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.03 -27.92 66.96 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 174.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.536 ' HD2' ' O ' ' A' ' 66' ' ' GLU . 16.7 m-70 -83.78 -69.18 0.66 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.705 175.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.923 HD23 ' HA ' ' A' ' 68' ' ' TYR . 1.1 mm? 18.75 71.07 0.22 Allowed Pre-proline 0 N--CA 1.474 0.758 0 O-C-N 124.929 1.393 . . . . 0.0 112.576 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.637 ' HD2' HG13 ' A' ' 75' ' ' ILE . 64.4 Cg_exo -53.14 153.46 16.19 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.166 2.577 . . . . 0.0 112.719 -173.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -69.84 93.82 0.78 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.53 0.681 . . . . 0.0 110.724 -175.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 139.67 -27.16 2.61 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -173.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.637 HG13 ' HD2' ' A' ' 72' ' ' PRO . 8.9 mm -80.49 125.97 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.615 -0.792 . . . . 0.0 109.038 172.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.4 m -110.76 -1.86 16.46 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.227 0.536 . . . . 0.0 110.781 -177.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.539 ' OG ' ' HD1' ' A' ' 79' ' ' PHE . 22.6 t -131.57 134.37 25.45 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.791 -175.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.485 ' O ' HG23 ' A' ' 82' ' ' VAL . 96.2 Cg_exo -47.05 -53.45 6.3 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.312 2.675 . . . . 0.0 112.436 171.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.539 ' HD1' ' OG ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -60.35 -34.21 73.53 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.311 0.577 . . . . 0.0 110.551 -179.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.53 ' HA ' ' CE ' ' A' ' 83' ' ' LYS . 56.6 tt0 -69.57 -27.81 65.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.177 -177.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.523 ' HB3' HG21 ' A' ' 75' ' ' ILE . 95.7 p -79.84 -31.37 40.55 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.501 0.667 . . . . 0.0 109.539 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 78' ' ' PRO . 36.3 t -73.68 -28.82 25.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.147 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.53 ' CE ' ' HA ' ' A' ' 80' ' ' GLU . 44.6 mtmt -54.73 -41.32 70.22 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 121.374 0.607 . . . . 0.0 109.578 173.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -66.11 -32.58 74.11 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.089 -176.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -77.1 -40.79 44.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.287 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.6 m -83.5 -37.48 13.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.784 -177.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 . . . . . 0 C--O 1.219 -0.515 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.158 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 25.4 p90 . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 121.167 0.508 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.409 ' HB2' ' HE ' ' A' ' 20' ' ' ARG . 4.9 mp0 -128.34 132.43 48.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.466 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.899 HG13 HG12 ' A' ' 19' ' ' ILE . 2.9 mp -83.47 114.74 24.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 171.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -110.21 150.11 29.14 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.121 0.486 . . . . 0.0 109.69 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -81.25 127.71 33.0 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.428 0.633 . . . . 0.0 110.208 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.581 HD23 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -70.41 -40.3 73.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.427 -174.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 172.84 -66.18 0.12 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.808 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -125.75 -58.87 1.38 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.835 0.35 . . . . 0.0 111.717 -173.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.2 p -142.01 37.62 1.59 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.517 0.675 . . . . 0.0 111.29 -173.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.95 158.26 43.77 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.781 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.674 ' HB3' ' HH ' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -128.03 149.37 50.4 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.046 -179.086 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.581 ' HB2' HD23 ' A' ' 12' ' ' LEU . 53.6 ttm -132.38 135.41 46.12 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 174.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.899 HG12 HG13 ' A' ' 9' ' ' ILE . 10.5 mt -114.58 106.18 20.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.514 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -91.94 131.44 37.24 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.296 0.57 . . . . 0.0 109.879 177.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 29.0 m-85 . . . . . 0 C--N 1.308 -1.219 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.266 -178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.058 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.767 HG13 HD21 ' A' ' 30' ' ' ASN . 2.4 p -56.4 -49.0 79.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.298 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.767 HD21 HG13 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -55.67 -29.19 58.9 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.579 0.549 . . . . 0.0 111.168 -173.247 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.76 -40.6 5.25 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.73 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -87.41 -29.7 5.65 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -171.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.688 HG13 ' O ' ' A' ' 29' ' ' VAL . 9.5 p -65.74 -30.98 51.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 118.968 0.804 . . . . 0.0 109.281 178.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.4 ' HA ' ' CB ' ' A' ' 53' ' ' PRO . 22.0 t60 -81.61 -30.2 32.98 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.999 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.43 -21.72 30.62 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.015 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.459 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -65.06 -23.48 67.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.181 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.89 98.77 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.841 0.829 . . . . 0.0 109.02 177.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.736 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.96 -27.17 26.69 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.948 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.459 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 5.8 t80 -59.73 -44.48 93.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.374 179.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.427 ' CD1' HD21 ' A' ' 58' ' ' LEU . 44.6 mt -78.59 -32.03 15.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.483 -176.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.736 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 10.8 pt-20 -73.64 -20.22 60.63 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.861 -176.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -88.21 -29.89 20.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.735 0.302 . . . . 0.0 110.384 173.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -124.72 69.8 56.3 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.177 0.513 . . . . 0.0 110.091 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -99.86 -161.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.693 2.929 . . . . 0.0 114.083 -169.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.429 ' HE1' ' HB3' ' A' ' 62' ' ' TYR . 1.6 p90 -138.37 147.35 55.07 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 114.022 -1.444 . . . . 0.0 107.966 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.75 -21.26 0.86 Allowed 'Trans proline' 0 N--CA 1.482 0.842 0 C-N-CA 124.25 3.3 . . . . 0.0 115.55 -169.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.36 30.7 5.7 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.188 -0.53 . . . . 0.0 111.947 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -66.53 128.69 37.18 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.098 0.475 . . . . 0.0 110.82 175.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.4 mm -103.09 -61.71 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.108 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -164.56 155.48 15.0 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 120.767 0.317 . . . . 0.0 110.998 -174.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.9 p -144.46 118.32 9.32 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 173.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.801 HG13 ' HB ' ' A' ' 59' ' ' THR . 5.5 pt -117.43 129.26 25.46 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-O 121.042 0.449 . . . . 0.0 112.001 -175.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.58 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 17.8 Cg_endo -86.73 124.33 2.23 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.498 2.799 . . . . 0.0 112.684 -178.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -117.73 58.73 0.8 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.15 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.458 ' O ' HG11 ' A' ' 33' ' ' VAL . 56.2 t80 72.34 -49.64 0.69 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.548 0.739 . . . . 0.0 112.087 173.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.1 t -137.23 -21.07 1.2 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.747 0.308 . . . . 0.0 111.253 178.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 16.1 m -108.2 133.11 52.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.071 0.463 . . . . 0.0 110.864 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.427 HD21 ' CD1' ' A' ' 40' ' ' ILE . 44.0 tp -102.77 111.96 24.53 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.801 ' HB ' HG13 ' A' ' 52' ' ' ILE . 2.9 m -89.15 107.96 19.34 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -177.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.604 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 64.6 t -104.0 113.66 41.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.575 0.702 . . . . 0.0 111.338 -172.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -103.76 148.88 25.56 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.872 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.674 ' HH ' ' HB3' ' A' ' 17' ' ' MET . 2.3 p90 -165.13 168.53 17.13 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.164 -176.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -98.86 109.05 21.87 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.947 -175.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.608 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -61.97 -20.6 64.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.125 -177.725 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.408 ' CE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -67.47 -31.92 72.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.9 0.381 . . . . 0.0 110.281 179.481 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.457 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 10.2 tp10 -91.31 -30.69 16.44 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 122.059 0.933 . . . . 0.0 109.1 -170.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.608 HG22 ' HA ' ' A' ' 64' ' ' MET . 4.2 m -75.66 -34.12 28.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.26 176.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.849 ' HA ' HD21 ' A' ' 71' ' ' LEU . 52.4 t80 -71.28 -22.87 61.9 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.8 174.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 4.2 tppp? -59.42 -35.96 74.98 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -88.5 -65.8 0.98 Allowed 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.207 176.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.849 HD21 ' HA ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER 24.93 78.7 0.22 Allowed Pre-proline 0 N--CA 1.48 1.038 0 C-N-CA 124.858 1.263 . . . . 0.0 113.463 178.356 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.683 ' HD2' HG13 ' A' ' 75' ' ' ILE . 32.1 Cg_exo -58.52 155.06 38.26 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.321 2.014 . . . . 0.0 110.989 175.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -71.38 -17.08 62.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.675 -171.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -77.8 -28.68 56.44 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 172.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.683 HG13 ' HD2' ' A' ' 72' ' ' PRO . 20.4 mm -77.44 129.8 36.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.791 -0.705 . . . . 0.0 109.638 175.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.2 m -110.0 1.64 19.13 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.337 0.589 . . . . 0.0 110.528 -177.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.637 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 43.8 t -146.9 132.97 9.5 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.261 -172.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.638 ' HA ' HD23 ' A' ' 71' ' ' LEU . 86.3 Cg_exo -45.74 -53.47 5.6 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.349 2.699 . . . . 0.0 112.732 170.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.404 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -58.26 -31.61 67.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.93 0.395 . . . . 0.0 111.385 177.373 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.637 ' HB2' ' HB3' ' A' ' 77' ' ' SER . 23.8 tt0 -72.83 -30.07 63.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.259 -173.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.537 ' HB3' HG21 ' A' ' 75' ' ' ILE . 91.4 p -76.38 -34.55 58.89 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.517 HG13 ' CD2' ' A' ' 62' ' ' TYR . 16.6 t -63.84 -31.73 54.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.537 176.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.492 ' HE3' HG12 ' A' ' 9' ' ' ILE . 2.4 mtpt -54.93 -38.01 67.14 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-O 121.171 0.51 . . . . 0.0 109.685 175.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -67.63 -31.89 72.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.175 -176.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -78.3 -36.72 46.21 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.357 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.8 m -86.78 -40.32 13.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.649 -177.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 C--N 1.331 -0.232 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -177.626 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.481 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 42.2 p90 . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 121.319 0.58 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.491 ' NE2' ' HB3' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -130.9 116.05 17.37 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.875 -174.384 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.879 HG12 HG12 ' A' ' 19' ' ' ILE . 22.3 mt -92.62 112.52 26.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.128 175.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.491 ' HB3' ' NE2' ' A' ' 8' ' ' GLN . 11.6 pt-20 -124.25 168.46 12.92 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.499 -175.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.615 HE21 ' HA ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -87.74 128.11 35.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.46 -179.183 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.625 HD21 ' HB2' ' A' ' 18' ' ' MET . 0.3 OUTLIER -76.18 -46.41 28.6 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.127 -174.135 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -168.84 -90.62 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.629 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -110.62 -37.52 5.44 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -175.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.5 p -160.8 42.73 0.17 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.872 0.844 . . . . 0.0 110.696 -177.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.0 148.21 41.55 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.333 176.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.686 ' HB2' ' HH ' ' A' ' 62' ' ' TYR . 32.1 ttp -117.39 140.53 49.47 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 120.955 0.407 . . . . 0.0 111.504 -177.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.625 ' HB2' HD21 ' A' ' 12' ' ' LEU . 1.4 tmt? -124.69 126.05 45.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.44 0.638 . . . . 0.0 110.431 -176.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.879 HG12 HG12 ' A' ' 9' ' ' ILE . 6.6 mt -119.56 138.26 50.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.768 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.61 127.03 21.48 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.909 0.385 . . . . 0.0 110.369 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.481 ' HA ' ' CB ' ' A' ' 7' ' ' TYR . 8.1 m-85 . . . . . 0 C--N 1.317 -0.83 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.865 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.463 0.189 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.486 ' O ' HG11 ' A' ' 33' ' ' VAL . 11.9 p -65.74 -50.58 70.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.36 -174.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -53.1 -42.68 66.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.144 0.497 . . . . 0.0 110.939 -177.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.82 -5.17 90.22 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.528 -0.76 . . . . 0.0 113.614 -176.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.22 -34.25 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.605 0 CA-C-N 117.987 0.894 . . . . 0.0 113.352 -176.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.486 HG11 ' O ' ' A' ' 29' ' ' VAL . 10.8 p -62.98 -32.72 57.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 118.467 0.576 . . . . 0.0 110.681 -174.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -80.27 -23.5 40.73 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.04 -23.85 26.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.069 0.461 . . . . 0.0 110.419 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.455 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -64.28 -22.82 67.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.098 -178.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.54 97.14 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.663 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -82.98 -30.45 28.2 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.812 175.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.455 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 16.0 t80 -57.05 -44.28 82.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.377 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.651 HD12 HD23 ' A' ' 58' ' ' LEU . 49.5 mt -77.06 -38.41 27.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.587 -176.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.663 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 13.3 pt-20 -68.73 -21.11 64.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.896 0.379 . . . . 0.0 111.017 -175.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -92.56 -21.14 20.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.868 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -133.14 64.71 71.29 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.894 0.378 . . . . 0.0 110.412 178.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -97.35 -175.81 0.25 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.494 2.796 . . . . 0.0 113.077 -173.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.589 ' HZ ' ' HB2' ' A' ' 62' ' ' TYR . 14.3 p90 -116.56 148.11 41.17 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 172.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -42.22 -24.87 0.36 Allowed 'Trans proline' 0 N--CA 1.481 0.791 0 C-N-CA 124.404 3.403 . . . . 0.0 115.926 -170.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.05 19.36 32.64 Favored Glycine 0 C--O 1.229 -0.21 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.413 -176.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -69.21 134.86 49.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.007 0.432 . . . . 0.0 111.331 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 62' ' ' TYR . 40.6 mm -106.17 -60.67 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.298 -177.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -160.99 156.31 24.58 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -171.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 12.7 p -151.75 119.48 6.13 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 175.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.791 HG13 ' HB ' ' A' ' 59' ' ' THR . 9.3 pt -123.91 134.87 25.68 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.842 -175.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.405 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 78.5 Cg_endo -86.95 152.19 8.43 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.159 2.573 . . . . 0.0 112.463 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.404 ' HB1' ' OG ' ' A' ' 57' ' ' SER . . . -137.61 47.83 2.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.116 178.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.4 ' O ' HG12 ' A' ' 33' ' ' VAL . 48.7 t80 72.09 -37.52 0.39 Allowed 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 173.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.0 t -138.43 -21.3 1.04 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.183 0.516 . . . . 0.0 110.933 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.404 ' OG ' ' HB1' ' A' ' 54' ' ' ALA . 7.3 p -113.52 155.1 25.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.61 178.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.651 HD23 HD12 ' A' ' 40' ' ' ILE . 48.1 tp -124.49 114.92 20.08 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.791 ' HB ' HG13 ' A' ' 52' ' ' ILE . 4.4 m -94.91 106.92 18.93 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.885 -176.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.0 t -106.04 121.5 58.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.47 0.653 . . . . 0.0 111.647 -172.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.424 ' CE1' HG22 ' A' ' 59' ' ' THR . 90.7 m-85 -110.99 148.51 32.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.939 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.686 ' HH ' ' HB2' ' A' ' 17' ' ' MET . 3.5 p90 -167.33 170.14 11.79 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.893 -173.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -102.26 120.45 40.49 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.291 0.567 . . . . 0.0 110.692 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.17 -22.39 65.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.266 -174.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.11 -25.82 67.94 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.75 0.31 . . . . 0.0 110.784 -177.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -89.49 -33.55 16.73 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.738 0.78 . . . . 0.0 109.011 -171.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.9 m -77.67 -36.61 23.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.898 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.698 ' HA ' HD21 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -62.9 -23.11 67.19 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.973 177.598 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.484 ' HB2' ' HE2' ' A' ' 69' ' ' LYS . 3.3 tppt? -54.86 -49.17 71.79 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 121.939 0.876 . . . . 0.0 108.877 177.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -89.94 -62.89 1.37 Allowed 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.858 -177.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.698 HD21 ' HA ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER 34.5 77.3 0.38 Allowed Pre-proline 0 N--CA 1.473 0.707 0 O-C-N 124.533 1.146 . . . . 0.0 111.521 -178.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.438 ' HD2' HG13 ' A' ' 75' ' ' ILE . 50.5 Cg_exo -54.64 152.43 27.62 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.288 2.659 . . . . 0.0 112.839 -175.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -76.18 87.29 3.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.05 0.929 . . . . 0.0 110.495 -176.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 155.09 -31.19 0.65 Allowed Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 -173.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.508 HG22 ' HB2' ' A' ' 81' ' ' SER . 18.6 mm -79.77 115.7 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 114.028 -1.086 . . . . 0.0 108.808 169.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.5 m -97.76 -5.86 34.05 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.194 0.521 . . . . 0.0 110.239 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 47.6 m -138.72 132.38 16.25 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.943 -172.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.601 ' HA ' HD23 ' A' ' 71' ' ' LEU . 30.8 Cg_exo -45.23 -56.99 2.35 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.436 2.758 . . . . 0.0 113.305 173.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.586 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.8 OUTLIER -55.18 -30.82 60.67 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.203 0.525 . . . . 0.0 111.177 178.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.577 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 36.5 tt0 -73.64 -24.47 60.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.259 -176.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.508 ' HB2' HG22 ' A' ' 75' ' ' ILE . 17.4 t -76.24 -36.28 58.58 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.459 HG11 ' CD2' ' A' ' 62' ' ' TYR . 60.2 t -63.66 -30.18 49.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.248 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.585 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 14.9 mtmm -54.2 -37.85 64.98 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 176.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -64.59 -37.47 87.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.182 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -70.92 -35.48 72.28 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.916 -176.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.9 m -86.79 -42.76 15.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.149 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 . . . . . 0 C--N 1.33 -0.275 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.489 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.3 p90 . . . . . 0 N--CA 1.446 -0.636 0 CA-C-O 121.402 0.62 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.648 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . 1.8 mp0 -120.28 134.54 55.24 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.257 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.904 HG12 HG12 ' A' ' 19' ' ' ILE . 15.3 mt -101.92 114.14 40.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.291 174.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 18' ' ' MET . 10.4 pt-20 -109.12 153.1 24.19 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.691 -177.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.525 HE21 ' HA ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -76.99 126.9 31.74 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.758 0.79 . . . . 0.0 110.542 178.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.628 HD21 ' HB2' ' A' ' 18' ' ' MET . 0.3 OUTLIER -79.72 -48.67 13.25 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.019 -173.233 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.88 100.87 0.16 Allowed Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 73.2 -64.16 0.41 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 176.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.476 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 11.5 p -150.64 60.06 0.94 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.338 0.589 . . . . 0.0 111.831 -172.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.517 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -160.89 154.64 22.35 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 176.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.892 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -121.18 138.64 54.12 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.091 -177.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.628 ' HB2' HD21 ' A' ' 12' ' ' LEU . 26.4 ttt -124.04 124.06 41.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.438 0.637 . . . . 0.0 110.396 177.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.904 HG12 HG12 ' A' ' 9' ' ' ILE . 9.3 mt -116.12 144.31 24.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.191 -175.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.648 ' HD3' ' HB2' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -134.93 132.75 38.83 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 173.577 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.45 ' HB2' HG23 ' A' ' 29' ' ' VAL . 6.8 m-85 . . . . . 0 C--N 1.323 -0.545 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? . . . . . 0 CA--C 1.522 -0.126 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.57 ' O ' HG12 ' A' ' 33' ' ' VAL . 4.3 p -61.32 -46.34 96.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.757 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -53.71 -27.04 25.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.958 -177.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -97.55 -39.83 3.81 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.435 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -86.44 -22.4 7.15 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -171.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 29' ' ' VAL . 14.5 p -69.01 -28.45 39.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.371 177.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -77.79 -41.59 36.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.499 174.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.88 -26.0 60.33 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.503 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.464 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -67.12 -26.64 66.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.153 -178.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.453 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . . . -62.29 -36.82 83.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 122.013 0.911 . . . . 0.0 109.119 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.782 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.75 -36.2 21.93 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.872 174.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.464 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 2.6 t80 -54.72 -42.08 71.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.342 0.591 . . . . 0.0 110.864 -178.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.588 HD11 HD21 ' A' ' 58' ' ' LEU . 33.5 mt -78.03 -29.41 15.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.295 -178.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.782 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 6.9 pt-20 -80.67 -32.97 35.85 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.439 -177.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 54.0 mt-10 -72.72 -29.72 63.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.097 0.475 . . . . 0.0 110.139 178.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -121.42 73.56 30.05 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 172.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -96.88 -168.92 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.932 2.421 . . . . 0.0 113.773 -170.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.445 ' C ' ' H ' ' A' ' 47' ' ' GLY . 2.8 p90 -136.43 147.17 58.92 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.14 176.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.23 7.87 0.06 OUTLIER 'Trans proline' 0 N--CA 1.483 0.864 0 C-N-CA 123.653 2.902 . . . . 0.0 114.702 -174.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . -127.18 28.24 4.61 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 174.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.547 ' HE2' HG22 ' A' ' 40' ' ' ILE . 6.0 t80 -71.19 132.09 44.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.998 0.427 . . . . 0.0 110.528 177.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.499 HG22 ' HG2' ' A' ' 50' ' ' GLU . 36.9 mm -111.35 -60.74 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.469 176.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.499 ' HG2' HG22 ' A' ' 49' ' ' ILE . 2.5 mm-40 -153.28 173.01 16.13 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.889 0.852 . . . . 0.0 111.231 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 59' ' ' THR . 5.1 p -161.2 118.27 2.28 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 113.839 -1.528 . . . . 0.0 108.964 154.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.659 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.5 pt -112.93 130.46 23.5 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.251 -173.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 6.1 Cg_exo -77.83 128.06 9.05 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.454 2.769 . . . . 0.0 111.897 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.479 ' HB1' ' HB2' ' A' ' 57' ' ' SER . . . -119.25 54.29 0.99 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.629 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.44 ' O ' HG13 ' A' ' 33' ' ' VAL . 47.6 t80 72.44 -59.33 0.56 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.469 176.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -126.59 -15.34 5.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.299 0.571 . . . . 0.0 110.441 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.479 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 19.8 m -108.58 148.43 30.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.157 0.503 . . . . 0.0 110.999 -177.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.588 HD21 HD11 ' A' ' 40' ' ' ILE . 49.7 tp -117.66 111.99 19.9 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.659 ' HB ' HG13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -94.96 106.74 18.75 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.966 -177.008 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.892 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 53.7 t -107.15 109.33 27.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.252 0.549 . . . . 0.0 111.318 -171.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.454 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 74.6 m-85 -101.62 147.33 26.55 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.711 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.789 ' HH ' ' HB3' ' A' ' 17' ' ' MET . 2.7 p90 -165.22 167.85 17.63 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.172 0.51 . . . . 0.0 110.397 -176.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -98.36 111.25 23.65 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.121 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.476 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 1.0 OUTLIER -64.48 -20.3 66.11 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.546 -172.072 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -58.9 -26.02 63.92 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.571 0.224 . . . . 0.0 111.448 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.553 ' HA ' ' HE3' ' A' ' 69' ' ' LYS . 16.2 tp10 -89.76 -35.84 15.5 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.842 0.83 . . . . 0.0 109.433 -173.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.59 HG11 HG23 ' A' ' 82' ' ' VAL . 3.4 m -79.91 -31.31 13.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.912 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.998 ' HA ' HD22 ' A' ' 71' ' ' LEU . 23.2 t80 -68.98 -22.12 64.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.134 176.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.553 ' HE3' ' HA ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -53.3 -36.74 61.55 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 173.035 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.505 ' HD2' ' HB3' ' A' ' 69' ' ' LYS . 18.2 m170 -98.58 -70.53 0.72 Allowed 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.852 -177.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.998 HD22 ' HA ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER 41.34 71.95 1.19 Allowed Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 123.754 0.822 . . . . 0.0 112.265 -179.074 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.728 ' HD2' HG13 ' A' ' 75' ' ' ILE . 37.7 Cg_exo -61.74 173.95 2.59 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.134 2.556 . . . . 0.0 114.025 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.5 tp60 -62.52 -47.1 85.39 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -172.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.03 -20.74 79.11 Favored Glycine 0 CA--C 1.508 -0.37 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 -176.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.728 HG13 ' HD2' ' A' ' 72' ' ' PRO . 41.3 mm -76.95 102.96 3.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 114.51 -0.845 . . . . 0.0 109.989 175.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.3 m -84.91 -14.09 48.82 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.337 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.468 ' HB2' ' HG3' ' A' ' 80' ' ' GLU . 73.0 m -146.03 142.34 17.63 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.774 -172.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.607 ' HA ' HD21 ' A' ' 71' ' ' LEU . 79.2 Cg_exo -51.25 -36.28 56.05 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.338 2.692 . . . . 0.0 113.376 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.464 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 0.5 OUTLIER -66.11 -26.01 67.26 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.851 0.358 . . . . 0.0 111.138 178.877 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.726 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 5.0 mt-10 -72.69 -34.95 67.52 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.812 -178.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.547 ' HB3' HG23 ' A' ' 75' ' ' ILE . 18.9 p -69.38 -34.01 73.9 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -176.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.59 HG23 HG11 ' A' ' 67' ' ' VAL . 20.2 t -69.44 -36.53 72.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.565 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.726 ' HE2' ' HA ' ' A' ' 80' ' ' GLU . 54.2 mtmt -53.16 -45.57 68.51 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.55 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 23.0 mmt180 -67.75 -36.4 80.47 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.085 -172.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -62.05 -39.04 91.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.518 0.675 . . . . 0.0 110.33 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.4 m -86.96 -46.91 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.334 -177.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 83' ' ' LYS . 43.6 mt-10 . . . . . 0 C--O 1.211 -0.923 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 10.6 p90 . . . . . 0 N--CA 1.445 -0.687 0 CA-C-O 121.628 0.727 . . . . 0.0 111.349 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -130.87 143.17 50.53 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.826 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.941 HG12 HG12 ' A' ' 19' ' ' ILE . 21.3 mt -106.21 120.99 58.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.471 -177.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 18' ' ' MET . 9.0 pt-20 -113.6 163.37 15.04 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.244 -176.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -92.97 126.28 37.98 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 173.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.561 HD21 ' CG2' ' A' ' 59' ' ' THR . 0.0 OUTLIER -65.68 -43.71 88.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.766 -174.674 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.34 -67.17 0.1 Allowed Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 178.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -114.34 -70.67 0.79 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.186 0.517 . . . . 0.0 111.514 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.2 p -135.43 51.0 2.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.92 0.867 . . . . 0.0 110.119 -173.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.42 ' HB2' ' HB3' ' A' ' 12' ' ' LEU . . . -148.1 151.75 36.17 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.062 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.668 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 38.2 ttp -126.97 128.59 46.63 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.234 -176.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.567 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 33.3 ttp -118.68 138.85 52.34 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.494 177.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.941 HG12 HG12 ' A' ' 9' ' ' ILE . 6.4 mt -126.68 124.3 64.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.022 -176.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -109.9 137.26 47.94 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 177.839 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.491 ' HB2' ' CG1' ' A' ' 29' ' ' VAL . 5.3 m-85 . . . . . 0 C--N 1.324 -0.532 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.506 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 23.9 tm0? . . . . . 0 C--O 1.226 -0.171 0 CA-C-O 120.729 0.3 . . . . 0.0 110.36 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.542 ' O ' HG11 ' A' ' 33' ' ' VAL . 87.7 t -72.35 -60.8 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.18 -176.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -46.96 -33.04 4.29 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.757 0.661 . . . . 0.0 112.197 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.22 -44.04 5.44 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.35 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -80.78 -25.43 10.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -172.156 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.542 HG11 ' O ' ' A' ' 29' ' ' VAL . 13.7 p -70.23 -29.68 40.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -76.57 -31.42 57.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.699 175.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.62 -23.6 29.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.972 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.442 ' HA ' ' HB3' ' A' ' 39' ' ' TYR . . . -63.57 -24.71 67.92 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.981 -177.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.82 -42.74 99.4 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.593 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -83.56 -34.84 25.12 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.759 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.442 ' HB3' ' HA ' ' A' ' 36' ' ' ALA . 32.8 t80 -52.58 -44.52 65.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.998 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.5 mt -72.42 -33.61 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.238 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.593 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 7.8 pt-20 -80.63 -19.65 44.92 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.014 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.532 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 34.0 mt-10 -82.06 -29.78 31.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.857 0.36 . . . . 0.0 110.484 175.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -127.83 66.7 71.77 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.63 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -98.34 173.92 0.53 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.3 2.667 . . . . 0.0 114.727 -168.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -111.71 147.35 36.61 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 113.785 -1.552 . . . . 0.0 108.337 175.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.67 -8.13 0.73 Allowed 'Trans proline' 0 N--CA 1.484 0.923 0 C-N-CA 123.987 3.125 . . . . 0.0 114.957 -171.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.39 27.52 6.6 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.104 -0.569 . . . . 0.0 111.837 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -73.86 131.61 41.67 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.064 0.459 . . . . 0.0 111.552 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.3 mm -106.35 -61.21 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.242 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -161.86 162.34 29.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.711 0.291 . . . . 0.0 110.602 -172.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.599 ' HB2' HD11 ' A' ' 58' ' ' LEU . 2.6 p -158.69 118.38 3.14 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 176.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.702 HG13 ' HB ' ' A' ' 59' ' ' THR . 9.6 pt -120.68 139.46 28.97 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-O 121.007 0.432 . . . . 0.0 111.749 -175.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.464 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 4.6 Cg_endo -84.5 133.75 5.43 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.18 2.587 . . . . 0.0 112.21 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -118.1 43.52 2.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.474 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 39.0 t80 72.34 -40.55 0.48 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.448 175.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -134.18 -18.93 1.99 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.898 0.38 . . . . 0.0 111.22 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 9.1 p -121.19 142.52 49.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.776 0.322 . . . . 0.0 111.107 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.599 HD11 ' HB2' ' A' ' 51' ' ' CYS . 0.9 OUTLIER -103.17 114.42 28.69 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.637 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.702 ' HB ' HG13 ' A' ' 52' ' ' ILE . 3.0 m -87.59 106.05 17.75 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.565 HG23 HD13 ' A' ' 58' ' ' LEU . 57.7 t -101.45 124.36 55.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.397 0.617 . . . . 0.0 111.56 -174.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.418 ' CE1' HG21 ' A' ' 59' ' ' THR . 89.0 m-85 -115.79 147.27 41.15 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.419 177.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.547 ' HH ' ' CB ' ' A' ' 17' ' ' MET . 3.4 p90 -165.99 169.97 14.11 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.934 0.397 . . . . 0.0 110.149 -174.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -99.92 112.45 24.72 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.75 -176.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.646 ' HA ' HG23 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -62.37 -19.74 63.7 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.993 -176.017 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.7 -31.86 73.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 110.545 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.73 -25.64 19.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.902 0.858 . . . . 0.0 109.535 -175.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.646 HG23 ' HA ' ' A' ' 64' ' ' MET . 3.5 m -75.93 -38.83 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.459 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.906 ' HA ' HD12 ' A' ' 71' ' ' LEU . 2.5 m-85 -55.77 -30.97 62.16 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.07 0.548 . . . . 0.0 111.411 171.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -57.66 -43.75 85.21 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.989 0.899 . . . . 0.0 108.843 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -81.08 -51.12 8.82 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.934 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.906 HD12 ' HA ' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -12.16 84.63 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.469 0 O-C-N 125.549 1.781 . . . . 0.0 114.325 -173.433 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.815 ' HD2' HG13 ' A' ' 75' ' ' ILE . 32.5 Cg_exo -61.76 170.21 6.11 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 123.469 2.78 . . . . 0.0 112.172 176.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.6 -27.13 65.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.032 -172.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.98 -22.31 71.89 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.125 176.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.815 HG13 ' HD2' ' A' ' 72' ' ' PRO . 24.1 mm -86.32 114.14 25.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.615 -0.792 . . . . 0.0 110.043 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.8 m -105.59 -1.74 24.33 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.327 0.584 . . . . 0.0 110.604 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.519 ' HB2' ' HG3' ' A' ' 80' ' ' GLU . 70.6 m -141.45 141.4 22.88 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.704 -178.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.775 ' HA ' HD11 ' A' ' 71' ' ' LEU . 77.0 Cg_exo -44.45 -58.13 1.66 Allowed 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 123.18 2.587 . . . . 0.0 113.275 177.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.432 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 0.2 OUTLIER -56.06 -28.64 58.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.068 -176.818 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.602 ' HB2' HG23 ' A' ' 75' ' ' ILE . 48.6 mt-10 -67.96 -32.46 72.91 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.001 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.522 ' HB2' HG22 ' A' ' 75' ' ' ILE . 32.4 t -70.33 -33.99 72.14 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.493 HG12 ' CE2' ' A' ' 62' ' ' TYR . 26.2 t -76.95 -29.36 17.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.44 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.668 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 8.2 mtmp? -54.04 -42.09 68.81 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.463 176.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -63.88 -39.8 95.04 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.913 -176.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -61.95 -38.37 88.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.376 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.3 m -88.38 -35.21 7.72 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.86 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.43 ' OE2' ' HB3' ' A' ' 83' ' ' LYS . 40.4 mt-10 . . . . . 0 C--N 1.329 -0.318 0 C-N-CA 122.472 0.309 . . . . 0.0 111.587 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.798 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.7 m -96.13 138.21 34.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.664 0.269 . . . . 0.0 110.345 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -152.86 163.04 40.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.034 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.483 ' O ' HG21 ' A' ' 5' ' ' VAL . 12.4 t -95.78 30.43 2.36 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.478 -176.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 4' ' ' THR . 0.9 OUTLIER 62.27 151.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.422 1.089 . . . . 0.0 111.699 -175.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 6' ' ' ARG . 15.8 mmm180 -115.91 94.54 4.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.384 173.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.519 ' CE1' ' HB2' ' A' ' 95' ' ' GLU . 15.0 p90 -105.04 147.25 28.04 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.235 -176.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.613 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . 2.3 mp0 -131.95 135.9 46.93 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.799 -177.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.919 HG12 HG12 ' A' ' 19' ' ' ILE . 9.5 mt -101.94 124.83 56.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.967 178.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -121.32 165.49 15.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.09 0.472 . . . . 0.0 109.904 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -87.34 127.61 35.19 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.698 0.761 . . . . 0.0 110.358 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.602 HD21 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -68.32 -47.27 68.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.227 -174.36 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.61 -83.11 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -118.85 -44.73 2.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.673 0.273 . . . . 0.0 111.24 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.1 p -146.15 43.49 1.22 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.495 0.664 . . . . 0.0 110.83 -173.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HB1' ' HB3' ' A' ' 12' ' ' LEU . . . -144.45 156.59 44.26 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.398 178.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.655 ' CB ' ' HH ' ' A' ' 62' ' ' TYR . 35.6 ttp -128.01 134.71 49.27 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -175.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.602 ' HB2' HD21 ' A' ' 12' ' ' LEU . 39.5 ttp -125.16 130.07 51.42 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.918 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.919 HG12 HG12 ' A' ' 9' ' ' ILE . 7.3 mt -121.22 118.74 57.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.298 -173.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.613 ' HD3' ' HB2' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -103.52 139.75 38.44 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 176.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.696 ' HB2' HG12 ' A' ' 29' ' ' VAL . 15.1 m-85 -106.46 -151.54 0.46 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -97.88 179.3 32.67 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.303 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.618 ' HA ' ' HB2' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -158.88 -162.5 1.1 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 117.024 0.412 . . . . 0.0 110.46 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.535 ' HG3' ' HG2' ' A' ' 23' ' ' GLU . 38.4 mt-10 73.97 -57.9 0.61 Allowed 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 124.256 0.973 . . . . 0.0 110.654 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.5 pt -120.33 24.91 4.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.31 0.576 . . . . 0.0 110.285 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.618 ' HB2' ' HA ' ' A' ' 23' ' ' GLU . 5.6 m-20 -116.57 62.86 0.72 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.815 -174.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.411 ' HA ' ' HB3' ' A' ' 30' ' ' ASN . 3.4 mp0 -60.39 -27.02 67.1 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 173.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.482 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 25.4 tm0? -55.84 -54.12 48.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.884 173.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.696 HG12 ' HB2' ' A' ' 21' ' ' PHE . 71.0 t -66.77 -48.58 79.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.66 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.411 ' HB3' ' HA ' ' A' ' 27' ' ' GLU . 9.2 t30 -51.89 -36.71 49.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.824 -176.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.07 -34.63 8.09 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.253 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 28' ' ' GLN . 0.4 OUTLIER -79.73 -29.14 12.95 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.017 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -174.126 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.517 HG21 ' HG ' ' A' ' 58' ' ' LEU . 11.4 p -68.73 -28.71 41.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 118.879 0.763 . . . . 0.0 109.415 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -70.07 -39.65 75.51 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.517 175.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.79 -21.41 29.95 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.113 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.553 ' CB ' HD13 ' A' ' 58' ' ' LEU . . . -64.36 -27.49 69.05 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.156 -176.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.54 -44.53 96.89 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.692 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -78.88 -31.88 45.64 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.877 177.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.421 ' HE1' ' HB3' ' A' ' 89' ' ' ARG . 14.9 t80 -57.49 -44.57 85.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.23 0.538 . . . . 0.0 109.728 178.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.9 mt -71.44 -33.31 49.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.322 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.273 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.692 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 12.6 pt-20 -78.97 -18.89 52.95 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.129 -176.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.438 ' C ' ' HD3' ' A' ' 44' ' ' PRO . 42.4 mt-10 -85.16 -30.34 24.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.842 0.353 . . . . 0.0 110.749 174.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -127.11 64.46 61.06 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.937 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.438 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 80.1 Cg_endo -98.26 178.1 0.4 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 123.295 2.663 . . . . 0.0 114.033 -170.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -106.93 146.69 33.63 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.25 171.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HB2' ' HG3' ' A' ' 66' ' ' GLU . 71.5 Cg_exo -51.62 -15.31 2.66 Favored 'Trans proline' 0 N--CA 1.477 0.546 0 C-N-CA 124.019 3.146 . . . . 0.0 114.574 -173.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.8 15.22 41.11 Favored Glycine 0 C--O 1.223 -0.569 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.413 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -65.55 134.08 52.58 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.017 0.437 . . . . 0.0 110.905 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.8 mm -110.15 -59.73 3.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.437 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -161.69 157.3 24.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.719 0.295 . . . . 0.0 110.787 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.2 p -150.08 121.64 7.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.924 HG13 ' HB ' ' A' ' 59' ' ' THR . 5.7 pt -120.4 130.84 24.65 Favored Pre-proline 0 C--N 1.319 -0.746 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.498 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 5.6 Cg_exo -78.94 122.91 5.52 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.454 2.769 . . . . 0.0 111.674 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -111.11 50.08 0.84 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 -176.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.7 t80 76.58 -56.85 0.55 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.387 172.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.533 HG21 ' HB3' ' A' ' 23' ' ' GLU . 25.1 p -137.82 14.23 2.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.101 0.477 . . . . 0.0 110.741 175.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.8 t -138.7 152.57 48.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.033 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.553 HD13 ' CB ' ' A' ' 36' ' ' ALA . 5.4 mt -112.24 114.36 27.11 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.38 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.924 ' HB ' HG13 ' A' ' 52' ' ' ILE . 2.8 m -91.18 103.93 16.55 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 174.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.8 t -112.04 114.04 45.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.603 0.716 . . . . 0.0 111.188 -169.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.486 ' CE1' HG22 ' A' ' 59' ' ' THR . 84.9 m-85 -105.48 148.91 26.67 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.796 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.655 ' HH ' ' CB ' ' A' ' 17' ' ' MET . 2.8 p90 -166.54 172.94 10.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.329 0.585 . . . . 0.0 110.992 -175.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.534 ' OD1' ' HB3' ' A' ' 65' ' ' TYR . 6.7 t0 -98.49 119.55 37.4 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.841 -177.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.533 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -65.61 -20.22 66.23 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.04 -177.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.534 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -60.65 -33.6 73.05 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.102 0.477 . . . . 0.0 110.95 -178.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.56 ' HG3' ' HB2' ' A' ' 46' ' ' PRO . 0.8 OUTLIER -90.27 -22.23 21.7 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.862 0.839 . . . . 0.0 109.331 -173.813 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.533 HG22 ' HA ' ' A' ' 64' ' ' MET . 2.7 m -82.27 -37.7 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.414 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.927 ' HA ' HD22 ' A' ' 71' ' ' LEU . 32.3 m-85 -58.35 -31.65 67.8 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.093 0.473 . . . . 0.0 109.925 168.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.465 ' HB2' ' HE3' ' A' ' 69' ' ' LYS . 2.9 tppp? -60.59 -27.01 67.4 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.669 177.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -93.7 -76.13 0.48 Allowed 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.134 174.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.927 HD22 ' HA ' ' A' ' 68' ' ' TYR . 1.2 mm? 31.37 66.7 0.92 Allowed Pre-proline 0 N--CA 1.471 0.602 0 C-N-CA 124.312 1.045 . . . . 0.0 112.385 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.658 ' HD2' HG13 ' A' ' 75' ' ' ILE . 32.1 Cg_exo -59.7 153.1 58.22 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.804 2.336 . . . . 0.0 112.366 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -70.08 103.03 2.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.739 0.78 . . . . 0.0 110.541 -176.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 137.27 -34.08 2.23 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -173.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.658 HG13 ' HD2' ' A' ' 72' ' ' PRO . 18.4 mm -75.53 113.59 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 113.974 -1.113 . . . . 0.0 108.67 171.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.3 m -97.94 -3.27 38.75 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.546 -174.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.433 ' HB2' ' HB2' ' A' ' 80' ' ' GLU . 57.0 m -140.32 134.97 15.72 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.893 -172.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.603 ' HA ' HD21 ' A' ' 71' ' ' LEU . 64.9 Cg_exo -45.47 -58.35 1.66 Allowed 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 123.201 2.601 . . . . 0.0 113.33 175.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.511 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -56.48 -29.38 61.68 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.286 0.565 . . . . 0.0 111.158 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.505 ' HG3' ' HE2' ' A' ' 83' ' ' LYS . 40.2 tt0 -71.68 -25.39 62.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.519 -176.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.514 ' HB2' HG22 ' A' ' 75' ' ' ILE . 34.3 t -77.45 -38.35 49.56 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.558 HG11 ' CE2' ' A' ' 62' ' ' TYR . 46.2 t -63.28 -32.27 55.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.292 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.606 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 39.8 mtmt -51.33 -39.54 57.19 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.738 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -73.29 -39.57 65.24 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.89 -174.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -64.2 -35.08 79.63 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.718 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.474 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 18.0 m -86.34 -38.64 12.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.679 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -49.66 -52.62 29.57 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -57.19 -25.45 59.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.978 0.418 . . . . 0.0 111.39 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.421 ' HB3' ' HE1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -87.37 -48.55 7.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.631 175.342 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.57 ' O ' HG12 ' A' ' 93' ' ' ILE . 92.3 mt -65.96 -59.27 3.99 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.797 -177.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 1.034 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . . . -43.83 -40.06 4.22 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.293 -0.867 . . . . 0.0 113.087 -173.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -62.69 -9.06 7.87 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -175.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.57 HG12 ' O ' ' A' ' 90' ' ' LEU . 5.6 pt -95.77 -21.4 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.277 -176.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -179.84 -57.89 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 122.008 0.908 . . . . 0.0 110.6 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 1.034 ' HG2' ' HA ' ' A' ' 91' ' ' ALA . 4.0 pm0 -63.57 -7.39 7.02 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.92 -1.491 . . . . 0.0 114.165 -168.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.455 ' CA ' ' HB1' ' A' ' 91' ' ' ALA . 1.0 OUTLIER -57.83 -21.3 41.72 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 118.098 0.408 . . . . 0.0 110.961 174.539 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -76.3 -16.06 59.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.898 0.38 . . . . 0.0 110.686 176.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -104.95 -70.82 0.76 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.864 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 81.9 t 68.8 109.85 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.903 -177.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -75.6 -7.18 53.59 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.77 -177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.139 -0.934 . . . . 0.0 111.471 178.507 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.061 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.8 m -56.13 -46.5 79.16 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 173.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -128.41 -172.88 2.81 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.215 168.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.84 HG21 ' HB2' ' A' ' 97' ' ' TYR . 21.5 m -53.21 -80.63 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.786 0.679 . . . . 0.0 110.947 173.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.707 HG12 ' O ' ' A' ' 4' ' ' THR . 2.2 m 155.4 -177.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 C-N-CA 127.846 2.458 . . . . 0.0 106.753 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -150.53 78.91 1.33 Allowed 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.594 ' CE1' ' HB2' ' A' ' 95' ' ' GLU . 6.1 p90 -104.53 149.96 25.03 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 121.372 0.606 . . . . 0.0 110.619 -172.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -139.16 133.35 31.31 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.311 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.972 HG12 HG12 ' A' ' 19' ' ' ILE . 37.2 mt -101.57 119.77 50.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.072 177.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -114.03 165.55 12.5 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.066 -177.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -84.26 130.79 34.79 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.521 0.677 . . . . 0.0 110.461 177.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -75.89 -42.98 47.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.867 -175.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -161.78 -73.29 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -142.29 -31.63 0.53 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.5 p -144.93 40.65 1.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.4 0.619 . . . . 0.0 111.325 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.522 ' HB2' ' HB3' ' A' ' 12' ' ' LEU . . . -147.78 154.45 40.51 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.85 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -119.29 144.99 46.5 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 119.872 -0.731 . . . . 0.0 112.014 -175.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.43 ' HB2' HD21 ' A' ' 12' ' ' LEU . 26.9 ttt -130.2 129.04 42.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.488 176.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.972 HG12 HG12 ' A' ' 9' ' ' ILE . 6.4 mt -121.35 145.04 28.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.322 -175.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -136.54 139.92 42.58 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 171.143 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.729 ' HB2' HG13 ' A' ' 29' ' ' VAL . 54.2 m-85 -104.34 -146.36 0.38 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 173.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.95 167.76 25.61 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.96 -44.14 0.34 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 117.018 0.409 . . . . 0.0 111.968 -174.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -46.56 -51.35 15.73 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -174.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.6 pt -125.0 26.62 2.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.192 0.52 . . . . 0.0 110.75 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.56 ' ND2' HG13 ' A' ' 5' ' ' VAL . 2.6 m-20 -114.54 77.64 1.08 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.623 -173.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -73.29 -25.79 60.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 175.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -58.86 -52.75 64.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.583 177.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.729 HG13 ' HB2' ' A' ' 21' ' ' PHE . 99.2 t -61.29 -49.84 82.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.6 178.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -43.79 -40.92 4.67 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 124.136 0.897 . . . . 0.0 112.284 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.36 -42.75 5.13 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.491 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -72.86 -27.17 24.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -172.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 29' ' ' VAL . 11.9 p -70.94 -27.45 30.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.369 0.604 . . . . 0.0 109.433 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -70.51 -35.69 73.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.63 172.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.28 -20.06 32.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.005 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.3 -24.74 67.48 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.192 -175.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.04 -46.64 83.53 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.633 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -76.45 -27.57 56.23 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.536 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -59.51 -45.13 92.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.094 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.529 HD11 HD23 ' A' ' 58' ' ' LEU . 68.3 mt -72.15 -33.39 46.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.43 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.633 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 9.9 pt-20 -77.14 -20.25 55.8 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.94 -175.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -80.66 -32.38 36.11 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 175.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.464 ' OE1' ' HG3' ' A' ' 89' ' ' ARG . 64.2 mt-30 -126.1 72.82 71.19 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.093 0.473 . . . . 0.0 109.732 176.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -98.17 -163.13 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.886 3.057 . . . . 0.0 114.044 -169.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -137.77 145.96 50.77 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 113.965 -1.471 . . . . 0.0 107.441 174.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -53.36 -15.8 6.3 Favored 'Trans proline' 0 N--CA 1.481 0.742 0 C-N-CA 123.635 2.89 . . . . 0.0 114.906 -169.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.571 ' HA3' ' HB2' ' A' ' 66' ' ' GLU . . . -107.31 17.03 37.75 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.491 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.419 ' HZ ' ' SG ' ' A' ' 51' ' ' CYS . 45.3 t80 -63.76 130.16 43.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.044 0.449 . . . . 0.0 111.391 176.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.2 mm -104.04 -61.84 2.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.026 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -161.8 156.83 23.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.848 0.356 . . . . 0.0 110.521 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.419 ' SG ' ' HZ ' ' A' ' 48' ' ' PHE . 7.4 p -145.96 119.51 9.1 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.744 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.8 pt -124.52 131.44 24.16 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-O 121.108 0.48 . . . . 0.0 111.462 -178.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 4.7 Cg_exo -78.44 149.18 24.14 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.141 2.561 . . . . 0.0 112.493 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.682 ' HB2' ' HB2' ' A' ' 57' ' ' SER . . . -120.99 17.96 11.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.025 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 71.75 -24.47 0.18 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.654 174.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.433 ' H ' ' C ' ' A' ' 54' ' ' ALA . 7.6 t -135.98 -9.12 2.06 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.524 0.678 . . . . 0.0 109.817 169.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.682 ' HB2' ' HB2' ' A' ' 54' ' ' ALA . 16.3 m -130.73 165.53 22.7 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.549 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.529 HD23 HD11 ' A' ' 40' ' ' ILE . 45.3 tp -132.16 125.97 32.51 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.744 ' HB ' HG13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -106.16 107.05 17.86 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.816 -177.02 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.85 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 47.3 t -109.05 115.36 49.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.507 0.67 . . . . 0.0 111.295 -174.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -105.14 146.74 28.78 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.294 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.699 ' HH ' ' HB3' ' A' ' 17' ' ' MET . 3.1 p90 -164.19 171.46 14.97 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.031 0.443 . . . . 0.0 110.664 -172.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.49 ' OD1' ' HB3' ' A' ' 65' ' ' TYR . 6.2 t0 -100.92 115.49 30.55 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.347 -177.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.566 ' HA ' HG21 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -59.71 -18.77 45.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.18 -177.562 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.627 ' CE2' ' HG2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -66.7 -34.98 79.06 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -177.396 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.627 ' HG2' ' CE2' ' A' ' 65' ' ' TYR . 5.4 mm-40 -89.4 -27.37 20.47 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.872 0.844 . . . . 0.0 109.484 -174.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.613 ' CG1' HG21 ' A' ' 82' ' ' VAL . 4.1 m -83.39 -22.96 8.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.83 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.874 ' HA ' HD11 ' A' ' 71' ' ' LEU . 15.5 t80 -75.14 -28.05 60.01 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 168.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -67.97 -28.7 67.67 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.071 170.527 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.744 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 11.9 t-80 -111.52 28.33 8.84 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.492 174.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.874 HD11 ' HA ' ' A' ' 68' ' ' TYR . 2.7 mt -94.77 95.37 1.49 Allowed Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.532 176.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.744 ' HD3' ' O ' ' A' ' 70' ' ' HIS . 8.8 Cg_exo -76.48 175.2 11.66 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 124.061 3.174 . . . . 0.0 112.769 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -60.79 -42.78 98.24 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -171.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.03 -25.12 74.47 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.779 -175.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.586 HG13 ' HD2' ' A' ' 72' ' ' PRO . 5.6 mm -85.26 120.93 36.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.233 -0.483 . . . . 0.0 109.779 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.5 m -110.52 3.78 19.83 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.151 0.5 . . . . 0.0 111.17 -174.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.531 ' HB3' ' CB ' ' A' ' 80' ' ' GLU . 28.2 t -134.59 126.16 17.96 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.148 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.656 ' HA ' HD12 ' A' ' 71' ' ' LEU . 74.6 Cg_exo -42.96 -56.57 2.15 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.762 2.975 . . . . 0.0 112.626 171.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -36.44 63.38 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.359 0.6 . . . . 0.0 111.422 175.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.531 ' CB ' ' HB3' ' A' ' 77' ' ' SER . 38.5 tt0 -73.47 -30.65 63.3 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.262 -174.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.573 ' HB3' HD23 ' A' ' 71' ' ' LEU . 67.6 p -73.05 -35.18 66.67 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.655 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 78' ' ' PRO . 6.8 t -61.59 -36.32 72.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.062 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -51.86 -40.07 59.97 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -67.41 -38.09 84.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.348 -177.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -65.91 -39.75 90.85 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.804 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.556 ' O ' HD23 ' A' ' 90' ' ' LEU . 28.4 m -83.83 -46.39 18.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.35 -177.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -54.0 -42.1 68.67 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -176.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.415 ' HG3' ' HD3' ' A' ' 89' ' ' ARG . 12.1 pt-20 -59.96 -29.16 68.23 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.839 0.352 . . . . 0.0 111.237 -178.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.464 ' HG3' ' OE1' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -87.19 -49.04 7.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.104 0.478 . . . . 0.0 110.611 174.529 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.66 ' O ' HG12 ' A' ' 93' ' ' ILE . 3.3 mm? -59.7 -33.54 71.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.397 -177.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.551 ' HA ' ' HG3' ' A' ' 95' ' ' GLU . . . -49.84 -35.88 24.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.374 177.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -69.35 -5.86 26.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.54 -176.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.66 HG12 ' O ' ' A' ' 90' ' ' LEU . 3.0 pt -98.15 -36.71 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.472 -177.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 178.19 -48.13 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.29 0.567 . . . . 0.0 111.009 -178.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.594 ' HB2' ' CE1' ' A' ' 7' ' ' TYR . 1.2 pt-20 -62.31 -8.86 6.54 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.498 -0.774 . . . . 0.0 113.076 -169.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.531 ' HB2' ' HB3' ' A' ' 91' ' ' ALA . 22.0 t70 -53.68 -28.03 31.1 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 173.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.84 ' HB2' HG21 ' A' ' 4' ' ' THR . 0.3 OUTLIER -73.64 -12.56 60.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.305 0.574 . . . . 0.0 109.524 -178.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.413 ' HB2' ' HE1' ' A' ' 7' ' ' TYR . 30.1 mt-10 -119.38 -147.64 0.4 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.608 175.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.6 p 171.42 124.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 123.767 0.827 . . . . 0.0 109.061 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.687 ' OD1' ' HB ' ' A' ' 9' ' ' ILE . 8.9 t-20 -101.16 95.94 6.88 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.75 0.786 . . . . 0.0 110.904 177.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 . . . . . 0 C--N 1.301 -1.516 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.124 179.561 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.412 ' O ' ' HG2' ' A' ' 3' ' ' MET . 70.0 m -76.91 97.61 4.64 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.464 ' SD ' ' HG2' ' A' ' 6' ' ' ARG . 25.9 ptt? 49.41 -177.16 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.78 1.232 . . . . 0.0 111.902 -173.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.617 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 8.8 t -83.03 -46.26 13.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.524 0.678 . . . . 0.0 109.851 174.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.617 ' HB ' ' O ' ' A' ' 4' ' ' THR . 5.0 p 156.51 163.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 113.599 -1.637 . . . . 0.0 108.287 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.479 ' HD3' ' HA ' ' A' ' 6' ' ' ARG . 16.3 mmt180 -121.02 82.09 1.87 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.628 0.728 . . . . 0.0 109.872 175.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.558 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 18.3 p90 -104.31 148.74 26.03 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.965 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.504 ' HB2' ' NE ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -133.09 132.79 42.15 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.875 -179.157 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.751 HG12 HG12 ' A' ' 19' ' ' ILE . 14.9 mt -95.94 119.48 44.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.706 178.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -120.32 158.33 27.31 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.652 -176.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -82.89 129.34 35.0 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.453 0.644 . . . . 0.0 110.525 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.618 HD23 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -73.94 -38.67 64.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.601 -1.182 . . . . 0.0 110.98 -176.349 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.62 -87.16 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.497 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -103.47 -50.26 3.49 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -176.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.491 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 32.5 p -156.39 48.15 0.47 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 122.141 0.972 . . . . 0.0 109.966 -176.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' A' ' 12' ' ' LEU . . . -140.11 148.24 41.41 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.255 -1.339 . . . . 0.0 107.688 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.703 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 37.8 ttp -121.83 139.06 54.09 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.956 -174.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.618 ' HB2' HD23 ' A' ' 12' ' ' LEU . 49.8 ttm -124.89 132.21 53.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.054 0.454 . . . . 0.0 110.947 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.751 HG12 HG12 ' A' ' 9' ' ' ILE . 7.7 mt -124.98 120.88 59.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.654 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.504 ' NE ' ' HB2' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -114.08 134.32 54.96 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.992 177.048 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.558 ' HA ' ' CB ' ' A' ' 7' ' ' TYR . 32.1 m-85 -93.8 -147.89 0.26 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.567 0.222 . . . . 0.0 110.885 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 23' ' ' GLU . . . -70.87 -39.73 64.47 Favored Glycine 0 C--N 1.331 0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 113.313 -173.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.638 ' HB2' HG22 ' A' ' 56' ' ' THR . 41.8 tt0 76.72 -57.1 0.54 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.285 0.634 . . . . 0.0 112.4 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.615 ' HG2' HG22 ' A' ' 25' ' ' ILE . 43.2 tt0 -77.14 -72.79 0.33 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -169.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.615 HG22 ' HG2' ' A' ' 24' ' ' GLU . 38.3 pt -104.75 19.34 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.998 0.428 . . . . 0.0 111.954 -170.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.58 ' HB3' HG22 ' A' ' 29' ' ' VAL . 21.7 m120 -120.47 76.48 1.19 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.708 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.549 ' HA ' ' HB3' ' A' ' 30' ' ' ASN . 33.6 tt0 -69.29 -22.46 63.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.666 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.3 tm0? -59.4 -54.53 45.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.012 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.58 HG22 ' HB3' ' A' ' 26' ' ' ASN . 27.1 m -74.18 -25.82 20.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.686 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.549 ' HB3' ' HA ' ' A' ' 27' ' ' GLU . 8.7 t30 -59.9 -25.91 65.49 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.624 174.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -96.91 -32.86 6.29 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.417 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.467 HG23 ' HA ' ' A' ' 29' ' ' VAL . 0.5 OUTLIER -75.94 -23.59 16.27 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 C-N-CA 121.171 -0.212 . . . . 0.0 111.152 -177.058 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.465 HG23 ' HG ' ' A' ' 58' ' ' LEU . 10.5 p -65.53 -31.0 51.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.364 0.602 . . . . 0.0 109.471 176.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.415 ' HA ' ' CB ' ' A' ' 53' ' ' PRO . 53.3 t-80 -74.75 -38.0 62.35 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.708 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.58 -22.99 46.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.663 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.487 ' CB ' HD13 ' A' ' 58' ' ' LEU . . . -65.36 -25.84 67.76 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.836 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.51 -40.63 95.3 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.714 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.09 -29.61 26.65 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.859 176.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.448 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 2.7 t80 -60.34 -42.85 96.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.914 0.388 . . . . 0.0 110.401 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 51.6 mt -74.26 -38.42 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.037 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.714 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 8.4 pt-20 -71.15 -23.78 62.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.697 0.284 . . . . 0.0 110.927 -176.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -76.98 -32.54 57.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.017 177.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -134.82 68.38 71.26 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.032 0.444 . . . . 0.0 110.916 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -98.51 -176.31 0.21 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.539 2.826 . . . . 0.0 113.415 -174.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.49 ' HZ ' ' HB2' ' A' ' 62' ' ' TYR . 12.5 p90 -108.3 149.42 39.24 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -39.74 -36.35 1.19 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.003 3.135 . . . . 0.0 115.636 -172.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.414 ' HA3' ' HB3' ' A' ' 66' ' ' GLU . . . -98.37 15.41 61.27 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.97 -175.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.422 ' HZ ' ' SG ' ' A' ' 51' ' ' CYS . 32.4 t80 -62.03 132.84 54.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.264 0.554 . . . . 0.0 110.845 175.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.1 mm -106.24 -62.49 2.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.287 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -160.37 155.66 24.97 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.796 -170.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.422 ' SG ' ' HZ ' ' A' ' 48' ' ' PHE . 2.9 p -151.39 119.44 6.26 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.992 0.425 . . . . 0.0 110.024 176.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.733 HG13 ' HB ' ' A' ' 59' ' ' THR . 7.8 pt -121.43 138.6 28.44 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.436 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 11.1 Cg_endo -86.6 148.9 8.69 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.152 2.568 . . . . 0.0 112.424 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -143.5 66.68 1.3 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 69.4 t80 74.47 -60.74 0.51 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.417 0.687 . . . . 0.0 111.516 173.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.638 HG22 ' HB2' ' A' ' 23' ' ' GLU . 10.3 t -136.04 -5.75 2.12 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.287 0.565 . . . . 0.0 110.104 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 16.4 m -113.87 137.07 52.17 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.29 -174.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.487 HD13 ' CB ' ' A' ' 36' ' ' ALA . 3.8 mt -100.81 120.47 40.17 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.057 174.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.733 ' HB ' HG13 ' A' ' 52' ' ' ILE . 1.8 m -96.78 104.44 16.44 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.2 t -110.76 114.77 48.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.711 0.767 . . . . 0.0 111.064 -169.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -106.89 150.12 26.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.191 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.673 ' OH ' ' HB2' ' A' ' 17' ' ' MET . 3.1 p90 -166.62 167.77 15.08 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.371 -175.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.464 ' O ' HG13 ' A' ' 67' ' ' VAL . 1.3 t0 -100.64 115.85 31.17 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.179 0.514 . . . . 0.0 110.455 -174.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.611 ' HA ' HG23 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -61.83 -21.89 65.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.078 -174.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -69.21 -30.12 68.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.158 0.504 . . . . 0.0 109.843 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.414 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 1.2 tm-20 -92.08 -33.01 14.95 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.728 0.775 . . . . 0.0 109.131 -173.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.611 HG23 ' HA ' ' A' ' 64' ' ' MET . 3.4 m -67.21 -40.67 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.979 176.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.804 ' HA ' HD23 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -63.71 -25.82 68.38 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.519 173.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.498 ' HB2' ' HE2' ' A' ' 69' ' ' LYS . 5.3 tppt? -70.58 -21.24 62.7 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.75 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -104.87 -41.87 5.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.561 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.804 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER -7.36 84.6 0.03 OUTLIER Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 125.795 1.638 . . . . 0.0 113.703 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.426 ' HD2' HG13 ' A' ' 75' ' ' ILE . 32.3 Cg_exo -60.53 165.36 11.49 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.127 2.551 . . . . 0.0 112.921 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? -61.59 -42.29 98.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.84 0.352 . . . . 0.0 111.419 -173.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.35 -18.55 79.13 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.794 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.556 HG22 ' HB3' ' A' ' 81' ' ' SER . 6.2 mm -88.13 119.17 35.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.49 -0.355 . . . . 0.0 110.281 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -101.75 -9.31 20.94 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.93 0.395 . . . . 0.0 110.945 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.6 m -122.51 123.76 26.95 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.592 -175.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.648 ' HA ' HD22 ' A' ' 71' ' ' LEU . 46.4 Cg_exo -49.05 -46.71 24.36 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.55 2.833 . . . . 0.0 113.783 174.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.508 ' HA ' ' HH ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -60.93 -29.96 69.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.772 0.32 . . . . 0.0 111.286 175.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.401 ' O ' ' HG2' ' A' ' 84' ' ' ARG . 52.9 tt0 -75.07 -31.61 61.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.17 -175.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.556 ' HB3' HG22 ' A' ' 75' ' ' ILE . 37.3 p -72.88 -32.94 65.74 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.547 HG12 ' CD2' ' A' ' 62' ' ' TYR . 61.1 t -69.04 -37.0 76.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.161 -1.381 . . . . 0.0 111.282 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.703 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 39.4 mtmt -52.17 -43.23 64.01 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.454 0.645 . . . . 0.0 109.317 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 22.1 mmt180 -67.29 -31.42 71.71 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.866 -173.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.15 -35.28 69.03 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.005 0.431 . . . . 0.0 111.244 176.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.419 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 14.6 m -86.91 -39.18 12.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 C-N-CA 120.424 -0.511 . . . . 0.0 111.047 -177.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.418 ' HA ' ' HB2' ' A' ' 90' ' ' LEU . 50.3 mt-10 -61.33 -38.41 86.78 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 122.623 0.369 . . . . 0.0 111.923 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.21 -31.51 72.05 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.814 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.48 -41.88 17.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.087 0.47 . . . . 0.0 110.283 176.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.595 ' O ' HG12 ' A' ' 93' ' ' ILE . 92.5 mt -61.8 -48.82 78.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.252 177.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.689 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . . . -44.01 -41.85 5.68 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.978 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -59.18 -15.93 17.55 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.595 HG12 ' O ' ' A' ' 90' ' ' LEU . 2.5 pt -97.16 -31.25 3.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -174.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.421 ' HB2' ' OG1' ' A' ' 4' ' ' THR . . . -172.23 -55.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.267 0.556 . . . . 0.0 111.379 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.689 ' HG2' ' HA ' ' A' ' 91' ' ' ALA . 1.7 pm0 -61.5 -9.98 6.87 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -169.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 20.0 t70 -51.5 -22.5 3.2 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 120.874 0.369 . . . . 0.0 111.744 174.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.42 ' HD2' ' HB ' ' A' ' 4' ' ' THR . 4.4 m-30 -65.53 -12.72 55.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.43 0.633 . . . . 0.0 109.978 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -156.52 -142.9 0.11 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.925 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.6 p 179.02 128.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.129 0.49 . . . . 0.0 109.942 -173.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.22 91.63 3.21 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.492 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 . . . . . 0 C--O 1.248 1.007 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.305 -177.328 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.58 0 N-CA-C 112.009 -0.436 . . . . 0.0 112.009 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.0 m -125.55 108.56 11.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.872 0.368 . . . . 0.0 110.639 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -84.56 -171.63 3.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.896 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.4 t -131.36 119.16 21.29 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.847 0.832 . . . . 0.0 109.132 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.408 HG11 HD21 ' A' ' 26' ' ' ASN . 8.1 m -75.13 161.71 4.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.265 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.47 ' HD2' ' N ' ' A' ' 6' ' ' ARG . 1.6 mpt_? -102.76 72.03 1.2 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.687 0.756 . . . . 0.0 109.79 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.698 ' CE1' ' HB3' ' A' ' 95' ' ' GLU . 6.9 p90 -102.03 164.33 11.77 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.7 -176.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.52 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . 30.5 tt0 -141.01 133.51 28.48 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.731 0.777 . . . . 0.0 110.206 174.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.679 HG12 HG12 ' A' ' 19' ' ' ILE . 9.2 mt -92.16 109.73 21.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.557 176.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.612 ' HG2' ' O ' ' A' ' 18' ' ' MET . 9.1 pt-20 -111.34 163.14 14.3 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.692 -170.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -88.36 131.49 34.81 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.282 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.581 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -76.22 -31.48 58.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.569 -176.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.45 -72.26 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.046 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -135.99 -35.34 0.78 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.3 p -152.89 41.53 0.58 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.714 0.768 . . . . 0.0 110.976 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -143.8 155.52 44.18 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 174.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.59 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 43.8 ttp -130.09 136.57 49.49 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.441 -172.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.612 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 49.3 ttm -126.82 141.94 51.68 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.808 176.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.679 HG12 HG12 ' A' ' 9' ' ' ILE . 7.5 mt -125.4 115.3 43.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 O-C-N 122.365 -0.209 . . . . 0.0 111.296 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.52 ' HD3' ' HB3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -98.64 136.4 38.76 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 174.54 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.879 ' HB2' HG21 ' A' ' 29' ' ' VAL . 3.9 m-85 -113.66 -155.08 0.56 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.474 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -91.37 -163.36 38.53 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 176.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -172.98 -37.68 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 117.302 0.551 . . . . 0.0 111.935 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -51.07 -69.13 0.12 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.16 0.505 . . . . 0.0 111.37 -173.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.5 pt -104.36 18.04 4.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.716 0.769 . . . . 0.0 110.006 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.554 ' HB3' HG12 ' A' ' 29' ' ' VAL . 20.7 m120 -108.56 72.35 0.82 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.536 -172.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -59.8 -32.35 70.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.417 171.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -54.25 -56.39 18.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.223 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.879 HG21 ' HB2' ' A' ' 21' ' ' PHE . 9.2 p -65.17 -42.12 93.4 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.061 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -48.99 -43.48 40.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.928 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.36 -5.23 87.32 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.14 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -115.88 -31.72 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.617 0 CA-C-N 117.766 0.783 . . . . 0.0 112.372 -174.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.441 ' O ' ' HB3' ' A' ' 53' ' ' PRO . 6.7 p -60.94 -36.81 74.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 118.391 0.541 . . . . 0.0 110.419 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.41 ' HA ' ' CB ' ' A' ' 53' ' ' PRO . 11.5 p-80 -79.31 -22.59 44.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.85 0.357 . . . . 0.0 110.636 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.88 -29.96 23.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.015 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.503 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -64.23 -22.39 66.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.244 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.47 -43.08 98.34 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.57 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.36 -27.97 27.33 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.835 176.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.607 ' HE1' ' HB3' ' A' ' 89' ' ' ARG . 3.9 t80 -56.91 -48.14 78.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.066 0.46 . . . . 0.0 110.252 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.454 HD11 HD21 ' A' ' 58' ' ' LEU . 58.9 mt -72.93 -36.94 52.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.485 -174.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.57 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 13.0 pt-20 -71.17 -19.4 62.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.654 0.264 . . . . 0.0 111.349 -174.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.4 ' C ' ' HD3' ' A' ' 44' ' ' PRO . 46.0 mt-10 -79.46 -28.68 41.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.88 0.372 . . . . 0.0 110.877 174.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -129.89 64.19 71.22 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.785 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 65.2 Cg_endo -98.99 177.98 0.34 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.264 2.643 . . . . 0.0 113.389 -174.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.535 ' CE2' HG13 ' A' ' 82' ' ' VAL . 6.6 p90 -108.21 147.41 35.53 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.279 173.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.21 12.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.486 1.033 0 C-N-CA 124.293 3.329 . . . . 0.0 114.852 -173.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . -131.12 19.32 4.91 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 175.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.613 ' HZ ' ' HB3' ' A' ' 51' ' ' CYS . 30.9 t80 -79.49 142.61 35.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.013 0.435 . . . . 0.0 110.404 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.481 HG12 ' HA ' ' A' ' 62' ' ' TYR . 35.5 mm -108.38 -59.19 3.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.212 -175.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -168.93 141.6 2.73 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.351 -173.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.613 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 1.6 p -129.22 118.75 22.86 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 173.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.723 HG13 ' HB ' ' A' ' 59' ' ' THR . 4.3 pt -121.18 134.87 24.54 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.877 -175.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.441 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 86.9 Cg_endo -87.2 139.88 5.37 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.303 2.669 . . . . 0.0 112.66 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.3 59.22 1.59 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.401 ' O ' HG11 ' A' ' 33' ' ' VAL . 75.8 t80 75.02 -50.69 0.67 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.576 0.75 . . . . 0.0 112.086 172.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.27 -12.9 1.19 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.111 0.481 . . . . 0.0 110.863 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.5 m -115.39 134.14 55.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.979 0.419 . . . . 0.0 111.162 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.454 HD21 HD11 ' A' ' 40' ' ' ILE . 46.0 tp -102.86 117.23 34.17 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.789 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.723 ' HB ' HG13 ' A' ' 52' ' ' ILE . 4.8 m -97.6 114.41 26.33 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -177.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.9 t -111.41 109.58 29.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.765 0.793 . . . . 0.0 111.375 -170.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -101.25 145.61 28.61 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.009 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.659 ' HH ' ' HA ' ' A' ' 79' ' ' PHE . 2.9 p90 -166.62 166.94 15.78 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -176.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.411 ' OD1' ' HD1' ' A' ' 65' ' ' TYR . 5.4 t70 -102.58 128.55 49.19 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.339 0.59 . . . . 0.0 109.45 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.55 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -62.24 -20.56 64.35 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.799 -172.297 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.411 ' HD1' ' OD1' ' A' ' 63' ' ' ASP . 4.5 p90 -64.54 -34.93 79.39 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.847 0.356 . . . . 0.0 111.632 -174.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.461 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 1.7 tm-20 -92.52 -28.4 16.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.68 0.752 . . . . 0.0 109.598 -172.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.55 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.1 m -72.93 -34.65 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.927 ' HA ' HD21 ' A' ' 71' ' ' LEU . 58.9 t80 -72.47 -22.63 61.04 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.888 173.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.497 ' HB2' ' HE2' ' A' ' 69' ' ' LYS . 9.0 tppt? -66.27 -26.07 67.17 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 173.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -89.37 -74.64 0.47 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.786 172.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.927 HD21 ' HA ' ' A' ' 68' ' ' TYR . 0.8 OUTLIER 24.14 65.44 0.4 Allowed Pre-proline 0 N--CA 1.473 0.714 0 O-C-N 124.88 1.362 . . . . 0.0 112.88 -178.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.577 ' HD2' HG13 ' A' ' 75' ' ' ILE . 35.1 Cg_exo -60.67 143.47 99.42 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.608 2.205 . . . . 0.0 111.8 -175.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -64.0 108.39 1.5 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.499 0.666 . . . . 0.0 110.106 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 135.36 -30.1 2.83 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -171.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.577 HG13 ' HD2' ' A' ' 72' ' ' PRO . 10.9 mm -87.12 125.23 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 114.422 -0.889 . . . . 0.0 108.622 170.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.5 t -103.68 -0.15 29.86 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.353 0.597 . . . . 0.0 110.274 -174.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.534 ' OG ' ' HD1' ' A' ' 79' ' ' PHE . 38.4 t -143.89 133.83 11.85 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.127 -170.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.605 ' HA ' HD23 ' A' ' 71' ' ' LEU . 86.1 Cg_exo -50.07 -50.35 13.63 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.668 2.912 . . . . 0.0 112.863 174.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.659 ' HA ' ' HH ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -63.2 -30.24 71.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.102 0.477 . . . . 0.0 110.921 178.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.434 ' CB ' ' HB3' ' A' ' 77' ' ' SER . 40.7 tt0 -73.31 -27.1 61.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.366 -175.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.551 ' HB3' HG23 ' A' ' 75' ' ' ILE . 88.8 p -79.31 -37.75 36.92 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.56 0.695 . . . . 0.0 109.176 178.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 78' ' ' PRO . 61.0 t -63.42 -31.44 52.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.157 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.529 ' HB3' ' HZ1' ' A' ' 83' ' ' LYS . 6.3 mtmp? -52.53 -43.63 65.26 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.482 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 11.3 mmm180 -64.56 -41.83 96.07 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.429 -174.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.34 -39.36 86.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.819 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.2 m -87.24 -41.49 14.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.968 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -60.99 -41.38 96.37 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.649 ' HG3' ' HD3' ' A' ' 89' ' ' ARG . 9.3 pt-20 -59.13 -30.99 68.54 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.053 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.649 ' HD3' ' HG3' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -89.19 -56.95 3.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.464 0.649 . . . . 0.0 110.799 176.265 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.693 ' O ' HG12 ' A' ' 93' ' ' ILE . 12.0 tp -73.55 -65.61 0.8 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.869 -176.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.755 ' HA ' ' HG3' ' A' ' 95' ' ' GLU . . . -55.24 -31.96 61.92 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -172.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.677 ' HA ' ' CB ' ' A' ' 96' ' ' ASP . 4.3 tt0 -59.71 -6.58 1.23 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -171.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.693 HG12 ' O ' ' A' ' 90' ' ' LEU . 13.1 pt -88.16 -32.72 6.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.551 -174.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.643 ' N ' HG13 ' A' ' 93' ' ' ILE . . . -151.84 -30.18 0.16 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.354 0.597 . . . . 0.0 112.377 -172.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.755 ' HG3' ' HA ' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -106.42 -32.83 7.94 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.856 -164.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.677 ' CB ' ' HA ' ' A' ' 92' ' ' GLU . 28.6 t70 -51.75 -19.44 1.64 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.228 173.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -68.07 -13.43 62.19 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.729 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -134.52 -157.61 0.82 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.513 169.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.6 m -141.11 110.2 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.434 0.635 . . . . 0.0 110.9 -171.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -87.41 23.29 1.93 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.463 -178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.782 -0.628 . . . . 0.0 109.409 175.02 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.662 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t -128.17 -174.27 3.17 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.422 ' HE2' ' HB3' ' A' ' 3' ' ' MET . 15.7 ptp -126.04 150.46 48.1 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.2 t -76.49 127.65 33.26 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.29 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.613 HG13 ' CD2' ' A' ' 21' ' ' PHE . 98.8 t -82.78 141.44 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.223 0.535 . . . . 0.0 110.464 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -117.62 95.88 5.14 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.313 171.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.61 ' OH ' HD11 ' A' ' 93' ' ' ILE . 35.2 p90 -122.76 163.06 20.87 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.436 -175.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.44 120.29 18.5 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -175.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.954 HG12 HG12 ' A' ' 19' ' ' ILE . 40.7 mt -89.71 123.74 42.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.036 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.0 174.17 7.08 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.834 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -95.08 135.51 36.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.526 0.679 . . . . 0.0 110.598 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -80.87 -44.7 17.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.517 -176.587 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -172.92 -74.32 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.432 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -127.15 -50.39 1.43 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.118 0.485 . . . . 0.0 111.172 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.8 p -144.9 41.03 1.28 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.588 0.709 . . . . 0.0 110.942 -172.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.02 157.29 44.42 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.651 176.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.767 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -123.21 145.84 48.31 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.888 -176.321 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.418 ' HB2' HD22 ' A' ' 12' ' ' LEU . 51.8 ttm -127.25 131.13 50.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.749 174.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.954 HG12 HG12 ' A' ' 9' ' ' ILE . 9.9 mt -114.07 124.85 71.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.84 -177.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.7 111.75 24.03 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.618 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.613 ' CD2' HG13 ' A' ' 5' ' ' VAL . 22.9 m-85 -78.52 -174.39 3.8 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.195 0.521 . . . . 0.0 111.258 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -97.63 -164.76 31.76 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.519 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -178.65 170.9 1.56 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 76.2 -52.51 0.61 Allowed 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.286 0.634 . . . . 0.0 111.719 172.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.1 pt -107.94 10.13 9.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.799 0.809 . . . . 0.0 109.897 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.417 ' O ' HG11 ' A' ' 29' ' ' VAL . 34.3 t30 -146.29 108.92 4.51 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.409 -175.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -80.35 -30.14 38.0 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.213 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -61.45 -19.74 62.32 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -173.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.417 HG11 ' O ' ' A' ' 26' ' ' ASN . 1.5 p -62.57 -55.98 20.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.912 176.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -57.76 -29.03 64.48 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.859 -177.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.19 -15.7 58.6 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.228 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.409 ' O ' ' N ' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -115.18 -24.82 3.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.724 0 CA-C-N 117.41 0.605 . . . . 0.0 112.361 -174.351 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 55' ' ' PHE . 7.2 p -61.24 -34.57 61.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 118.785 0.72 . . . . 0.0 110.361 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -77.14 -32.09 56.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.837 0.351 . . . . 0.0 110.072 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.83 -20.8 30.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.46 -176.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 32' ' ' ILE . . . -66.46 -32.03 73.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.997 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.7 -41.07 97.1 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.892 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -73.84 -36.86 64.94 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.753 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.01 -35.43 75.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.231 0.539 . . . . 0.0 110.113 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.7 mt -81.95 -35.21 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.373 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.892 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 10.5 pt-20 -79.84 -21.77 43.75 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.751 -175.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.921 ' HG3' ' HG3' ' A' ' 43' ' ' GLN . 9.6 pt-20 -81.03 -29.89 35.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.121 0.486 . . . . 0.0 109.967 175.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.921 ' HG3' ' HG3' ' A' ' 42' ' ' GLU . 54.3 mt-30 -126.37 65.05 57.46 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.933 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.415 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 66.2 Cg_endo -93.36 -173.27 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.569 2.846 . . . . 0.0 114.017 -169.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -124.77 146.73 53.92 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.517 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -49.06 -18.63 1.92 Allowed 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 124.151 3.234 . . . . 0.0 115.265 -171.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.36 21.09 22.41 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.172 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.484 ' HZ ' ' SG ' ' A' ' 51' ' ' CYS . 45.2 t80 -66.69 130.41 43.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.993 0.425 . . . . 0.0 110.795 176.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.411 HG12 ' HA ' ' A' ' 62' ' ' TYR . 35.4 mm -102.55 -59.76 3.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.277 -177.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -162.82 154.39 17.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.738 0.304 . . . . 0.0 110.734 -174.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.484 ' SG ' ' HZ ' ' A' ' 48' ' ' PHE . 12.3 p -144.27 119.3 10.02 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 173.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.76 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.5 pt -124.95 132.83 24.39 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-O 121.127 0.489 . . . . 0.0 111.755 -178.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.55 136.9 7.68 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.02 2.48 . . . . 0.0 111.715 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -124.73 54.37 1.4 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.957 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.434 ' O ' HG13 ' A' ' 33' ' ' VAL . 57.9 m-85 74.13 -53.4 0.68 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.49 0.716 . . . . 0.0 112.285 171.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 21' ' ' PHE . 9.3 t -139.26 3.2 2.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.199 0.523 . . . . 0.0 110.477 176.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.3 m -125.7 146.3 49.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.059 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.407 ' HB3' ' HB ' ' A' ' 19' ' ' ILE . 45.8 tp -112.98 119.9 39.53 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.76 ' HB ' HG13 ' A' ' 52' ' ' ILE . 1.4 m -102.1 110.24 22.16 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.767 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 58.9 t -111.27 115.99 51.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.602 0.715 . . . . 0.0 111.185 -173.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -107.05 145.9 31.81 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.479 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.724 ' HH ' ' HA ' ' A' ' 79' ' ' PHE . 3.5 p90 -165.12 168.79 16.89 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.983 -175.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.421 ' OD1' ' HB3' ' A' ' 65' ' ' TYR . 7.2 t0 -101.97 114.35 28.38 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.495 -176.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.675 ' HA ' HG23 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -64.44 -20.82 66.41 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.075 -176.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.421 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -64.56 -27.52 69.01 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.793 0.33 . . . . 0.0 110.732 -179.203 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -90.69 -39.28 12.54 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.613 0.721 . . . . 0.0 109.271 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.675 HG23 ' HA ' ' A' ' 64' ' ' MET . 2.7 m -64.77 -34.43 70.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.235 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.674 ' HA ' HD23 ' A' ' 71' ' ' LEU . 7.3 m-85 -55.0 -28.39 51.64 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.841 0.456 . . . . 0.0 111.456 172.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -41.91 95.83 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.598 0.713 . . . . 0.0 109.415 177.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -91.0 -23.93 20.24 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.842 -174.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.675 HD22 ' HA ' ' A' ' 78' ' ' PRO . 0.6 OUTLIER -26.53 94.37 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.895 0 O-C-N 124.867 1.355 . . . . 0.0 111.546 176.106 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.489 ' HD2' HG13 ' A' ' 75' ' ' ILE . 24.1 Cg_exo -67.65 140.16 50.72 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.551 2.834 . . . . 0.0 111.603 -175.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.0 tp60 -63.01 99.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.463 0.649 . . . . 0.0 109.917 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 140.02 -24.1 2.72 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -172.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.535 HG21 ' HB3' ' A' ' 81' ' ' SER . 2.4 mm -96.29 126.94 48.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 171.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 t -112.25 -0.25 15.55 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.266 0.555 . . . . 0.0 110.109 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.6 t -118.61 111.99 37.44 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.282 -175.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.675 ' HA ' HD22 ' A' ' 71' ' ' LEU . 91.3 Cg_exo -47.98 -46.3 22.37 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.55 2.833 . . . . 0.0 113.062 173.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.724 ' HA ' ' HH ' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -61.18 -37.3 82.42 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.226 -0.19 . . . . 0.0 111.437 176.709 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 19.8 tt0 -82.07 -19.35 40.43 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.402 -174.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.535 ' HB3' HG21 ' A' ' 75' ' ' ILE . 83.3 p -74.25 -37.63 63.71 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.615 HG21 ' O ' ' A' ' 78' ' ' PRO . 26.8 t -65.67 -30.92 51.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.675 177.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.76 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 21.4 mtpt -49.94 -48.5 51.87 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 174.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.439 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 11.5 mmt180 -61.48 -38.65 88.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.494 -173.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -73.06 -33.72 65.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.137 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.502 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 22.7 m -87.01 -42.5 15.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 CA-C-O 118.911 -0.566 . . . . 0.0 112.043 -176.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.76 ' HG2' ' O ' ' A' ' 83' ' ' LYS . 8.1 pt-20 -54.01 -58.26 7.96 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.69 0.677 . . . . 0.0 111.912 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.54 ' H ' ' HG3' ' A' ' 87' ' ' GLU . 12.9 pt-20 -51.06 -26.49 6.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.289 176.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.41 ' C ' ' H ' ' A' ' 91' ' ' ALA . 0.3 OUTLIER -85.35 -47.96 9.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 122.466 1.127 . . . . 0.0 109.231 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.685 ' O ' HG23 ' A' ' 93' ' ' ILE . 87.0 mt -63.25 -6.86 4.97 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 112.987 -1.915 . . . . 0.0 111.785 175.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.41 ' H ' ' C ' ' A' ' 89' ' ' ARG . . . -39.89 -18.71 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -165.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 90' ' ' LEU . 16.0 mt-10 -65.02 -4.28 4.49 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.583 -0.698 . . . . 0.0 110.429 171.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.685 HG23 ' O ' ' A' ' 90' ' ' LEU . 2.3 pt -70.39 -16.56 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 124.313 1.045 . . . . 0.0 110.346 177.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 93' ' ' ILE . . . 77.0 -67.1 0.22 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.7 -1.136 . . . . 0.0 113.578 173.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -63.41 -23.34 67.36 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -168.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.447 ' HB2' HD12 ' A' ' 93' ' ' ILE . 12.6 t70 -49.24 -25.98 2.66 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.083 0.468 . . . . 0.0 111.994 178.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.536 ' N ' ' HD1' ' A' ' 97' ' ' TYR . 0.9 OUTLIER -68.3 -12.06 60.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.652 -175.39 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -109.81 6.96 23.9 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.601 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.9 t 74.97 121.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.864 0.866 . . . . 0.0 111.404 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -96.54 145.1 26.01 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.54 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 101' ' ' ARG . 38.5 mtt180 . . . . . 0 C--O 1.246 0.872 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.702 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.747 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.8 t -84.75 84.49 7.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.224 0.535 . . . . 0.0 109.872 -178.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.9 ptp -173.29 165.74 4.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.776 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.763 ' HB ' ' HD2' ' A' ' 97' ' ' TYR . 5.4 t -81.46 53.15 2.01 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.942 177.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.2 m 44.98 -173.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.348 1.059 . . . . 0.0 112.59 -171.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.443 ' HA ' ' HD3' ' A' ' 6' ' ' ARG . 5.5 mmt-85 -135.1 102.24 5.13 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.936 176.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.554 ' CE1' ' HB3' ' A' ' 95' ' ' GLU . 17.2 p90 -133.05 161.3 34.74 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.684 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.407 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -147.69 120.31 8.57 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 176.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.878 HG12 HG12 ' A' ' 19' ' ' ILE . 15.8 mt -76.83 117.76 22.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.839 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 18' ' ' MET . 8.7 pt-20 -116.92 162.49 17.67 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.804 -174.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.523 HE21 ' HA ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -86.05 138.06 32.23 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.596 0.712 . . . . 0.0 110.102 177.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.755 HD21 HG22 ' A' ' 59' ' ' THR . 0.4 OUTLIER -94.59 -50.29 5.26 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.711 -1.132 . . . . 0.0 110.595 -171.535 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.45 142.45 3.59 Favored Glycine 0 N--CA 1.433 -1.501 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 70.4 -73.02 0.1 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.207 0.603 . . . . 0.0 111.148 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.5 p -173.62 53.51 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.597 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.14 156.43 44.33 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.537 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.875 ' HB3' ' HH ' ' A' ' 62' ' ' TYR . 1.1 ptp -123.4 155.98 36.33 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.084 -177.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.609 ' HB2' HD23 ' A' ' 12' ' ' LEU . 48.3 ttm -136.24 137.55 40.91 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 172.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.878 HG12 HG12 ' A' ' 9' ' ' ILE . 8.3 mt -117.21 107.29 21.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.674 -177.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.569 HH21 ' CD ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -90.65 136.11 33.27 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.255 -0.578 . . . . 0.0 109.472 176.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.569 ' HB3' HG12 ' A' ' 29' ' ' VAL . 14.8 m-85 -108.15 -147.56 0.41 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 170.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -112.41 -139.95 7.77 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.657 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 173.49 -54.36 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.325 0.65 . . . . 0.0 109.329 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -41.13 -55.26 2.66 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.911 -1.041 . . . . 0.0 112.136 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.8 pt -114.5 22.19 5.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.738 0.304 . . . . 0.0 111.094 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.475 ' O ' HG23 ' A' ' 29' ' ' VAL . 91.2 m-20 -142.12 86.43 1.97 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.317 -0.401 . . . . 0.0 112.07 -174.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -68.38 -19.02 64.6 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.555 0.693 . . . . 0.0 109.291 170.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -70.4 -42.61 71.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.613 -175.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.569 HG12 ' HB3' ' A' ' 21' ' ' PHE . 31.0 m -67.4 -42.89 87.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.315 -178.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -49.14 -40.67 33.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.539 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.82 -33.31 24.66 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.101 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.511 HG13 HD11 ' A' ' 93' ' ' ILE . 0.5 OUTLIER -88.83 -26.41 5.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.463 0 O-C-N 122.422 -0.458 . . . . 0.0 112.116 -171.84 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 55' ' ' PHE . 7.8 p -63.49 -30.67 50.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.342 0.592 . . . . 0.0 109.627 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -74.98 -43.29 54.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.253 175.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.47 -22.23 57.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.132 -176.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.419 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -65.5 -27.64 68.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.527 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.61 -41.54 98.3 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.572 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.65 -21.2 30.33 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.18 176.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.419 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 10.6 t80 -66.88 -44.85 79.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.211 0.529 . . . . 0.0 110.06 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.508 HD13 HD22 ' A' ' 58' ' ' LEU . 34.0 mt -78.49 -31.49 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.696 -174.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.572 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 11.0 pt-20 -69.79 -21.96 63.37 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.777 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -85.09 -29.94 24.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.666 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -130.23 70.13 82.15 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 120.796 0.332 . . . . 0.0 111.003 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -97.39 -175.46 0.24 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.418 2.746 . . . . 0.0 113.091 -176.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.476 ' CZ ' HG13 ' A' ' 67' ' ' VAL . 9.5 p90 -116.36 148.61 42.05 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -45.25 -26.09 2.28 Favored 'Trans proline' 0 N--CA 1.482 0.836 0 C-N-CA 124.159 3.24 . . . . 0.0 115.579 -169.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.541 ' HA3' ' CB ' ' A' ' 66' ' ' GLU . . . -103.21 14.41 55.13 Favored Glycine 0 C--O 1.228 -0.268 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.743 -176.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.432 ' HZ ' ' SG ' ' A' ' 51' ' ' CYS . 31.3 t80 -68.1 139.98 56.21 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.492 0.663 . . . . 0.0 111.024 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.997 HG22 ' HG2' ' A' ' 50' ' ' GLU . 38.7 mm -112.4 -63.84 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.477 -174.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.997 ' HG2' HG22 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -152.39 169.41 22.61 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.14 0.495 . . . . 0.0 111.356 -177.445 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.432 ' SG ' ' HZ ' ' A' ' 48' ' ' PHE . 11.2 p -158.8 123.95 4.26 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 169.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.79 HG13 ' HB ' ' A' ' 59' ' ' THR . 7.9 pt -123.02 136.38 26.85 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-O 120.952 0.406 . . . . 0.0 111.724 -177.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -85.88 129.12 3.41 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.163 2.575 . . . . 0.0 112.364 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -115.09 43.92 1.9 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.887 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.413 ' O ' HG12 ' A' ' 33' ' ' VAL . 62.2 t80 72.77 -40.55 0.48 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.734 0.813 . . . . 0.0 112.742 175.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.0 t -139.22 -17.71 1.02 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.177 0.513 . . . . 0.0 110.985 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 m -113.44 134.87 54.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.177 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.508 HD22 HD13 ' A' ' 40' ' ' ILE . 52.3 tp -103.06 112.25 25.0 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 177.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.79 ' HB ' HG13 ' A' ' 52' ' ' ILE . 10.7 m -92.49 106.77 18.69 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -177.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.832 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 41.1 t -107.52 120.92 59.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.46 0.648 . . . . 0.0 111.559 -173.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.592 ' HB2' ' HG3' ' A' ' 50' ' ' GLU . 85.7 m-85 -106.39 147.34 29.38 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.185 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.875 ' HH ' ' HB3' ' A' ' 17' ' ' MET . 3.0 p90 -166.7 170.49 12.45 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.673 -176.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.5 ' O ' HG12 ' A' ' 67' ' ' VAL . 6.1 t70 -104.71 123.3 47.37 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.466 0.65 . . . . 0.0 110.773 -176.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.506 ' O ' HG21 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -61.3 -23.88 66.02 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.766 -175.71 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.492 ' HD1' ' OD1' ' A' ' 63' ' ' ASP . 0.8 OUTLIER -68.28 -28.82 67.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.383 0.611 . . . . 0.0 110.187 -176.293 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.541 ' CB ' ' HA3' ' A' ' 47' ' ' GLY . 1.0 OUTLIER -91.47 -29.76 16.83 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.65 0.738 . . . . 0.0 109.522 -175.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.506 HG21 ' O ' ' A' ' 64' ' ' MET . 2.0 m -71.24 -35.89 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 176.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.949 ' HA ' HD21 ' A' ' 71' ' ' LEU . 76.7 t80 -69.33 -22.61 63.75 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.501 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -61.27 -38.51 87.01 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 173.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -83.33 -70.25 0.57 Allowed 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 113.867 -1.515 . . . . 0.0 109.523 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.949 HD21 ' HA ' ' A' ' 68' ' ' TYR . 0.8 OUTLIER 23.43 68.08 0.36 Allowed Pre-proline 0 N--CA 1.478 0.928 0 O-C-N 124.854 1.346 . . . . 0.0 112.977 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.583 ' HD2' HG13 ' A' ' 75' ' ' ILE . 28.6 Cg_exo -62.42 153.13 72.88 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.657 2.238 . . . . 0.0 112.613 -176.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -68.21 109.26 3.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.368 0.604 . . . . 0.0 110.223 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 131.92 -31.11 3.11 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -174.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.583 HG13 ' HD2' ' A' ' 72' ' ' PRO . 17.4 mm -80.63 117.82 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 114.076 -1.062 . . . . 0.0 108.972 171.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.3 m -97.08 -1.8 44.56 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.536 -174.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.6 t -144.53 136.52 13.06 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.525 -170.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.587 ' HA ' HD23 ' A' ' 71' ' ' LEU . 98.5 Cg_exo -47.26 -57.08 2.52 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.457 2.771 . . . . 0.0 113.343 173.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.536 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -59.01 -30.73 68.21 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.171 0.51 . . . . 0.0 110.907 -179.049 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 46.2 tt0 -74.83 -26.23 59.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.191 -176.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.522 ' HB3' HG22 ' A' ' 75' ' ' ILE . 96.9 p -73.26 -36.87 66.44 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.6 t -67.87 -24.87 31.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.525 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 47.0 mtpt -55.1 -35.36 64.53 Favored 'General case' 0 C--O 1.214 -0.816 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.18 176.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -71.09 -37.18 72.41 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.067 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -69.51 -35.18 75.27 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.999 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.495 ' O ' HD21 ' A' ' 90' ' ' LEU . 31.6 m -86.02 -45.07 16.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.92 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -51.7 -44.22 63.08 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -58.63 -29.7 66.71 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.538 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.93 -43.41 13.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.127 0.489 . . . . 0.0 110.253 177.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.495 HD21 ' O ' ' A' ' 86' ' ' VAL . 4.4 mm? -60.56 -40.58 92.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.883 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.525 ' O ' ' HB2' ' A' ' 96' ' ' ASP . . . -52.06 -33.99 41.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.701 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -66.14 -6.44 13.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.394 -177.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.511 HD11 HG13 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -108.98 -38.87 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.127 -175.715 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -167.2 -51.86 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.041 0.448 . . . . 0.0 111.667 177.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.554 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 1.0 OUTLIER -57.31 -11.34 1.73 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.686 -170.314 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 32.7 t70 -43.72 -25.94 0.21 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 171.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.763 ' HD2' ' HB ' ' A' ' 4' ' ' THR . 6.3 m-85 -77.4 -16.37 58.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.837 -174.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.745 ' HG3' HG21 ' A' ' 4' ' ' THR . 61.4 mt-10 -130.42 -53.94 1.09 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.754 0.311 . . . . 0.0 111.401 177.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.7 t 69.95 114.84 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.606 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.65 98.12 0.67 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.409 0.623 . . . . 0.0 110.508 177.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 . . . . . 0 C--O 1.247 0.964 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.746 179.848 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.673 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.2 m -101.11 96.16 7.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.891 0.377 . . . . 0.0 110.098 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -75.86 155.74 35.01 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.211 0.529 . . . . 0.0 110.79 -178.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.55 ' O ' HG21 ' A' ' 5' ' ' VAL . 6.8 t -84.46 29.28 0.6 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.766 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.55 HG21 ' O ' ' A' ' 4' ' ' THR . 1.7 m 56.94 160.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.04 1.336 . . . . 0.0 112.285 -174.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.453 ' HA ' ' HD3' ' A' ' 6' ' ' ARG . 8.4 mmt180 -120.41 86.22 2.53 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.072 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.507 ' CE1' ' HB2' ' A' ' 95' ' ' GLU . 13.2 p90 -103.56 152.47 21.68 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.204 -177.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.517 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 18.7 mp0 -132.6 131.57 41.58 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.899 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 1.003 HG12 HG12 ' A' ' 19' ' ' ILE . 49.1 mt -97.7 122.94 49.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.292 173.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -119.01 164.3 15.69 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.102 0.477 . . . . 0.0 110.115 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -84.79 128.22 34.5 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.393 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.587 HD23 ' HB2' ' A' ' 18' ' ' MET . 0.2 OUTLIER -75.89 -39.64 56.02 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.773 -173.074 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -163.76 -77.98 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -138.03 -28.82 0.86 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 177.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.7 p -148.35 36.35 0.82 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.466 0.65 . . . . 0.0 111.557 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.49 ' HB1' ' HB3' ' A' ' 12' ' ' LEU . . . -143.98 156.69 44.5 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.307 176.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.698 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -125.08 147.19 49.11 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.411 -175.618 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.587 ' HB2' HD23 ' A' ' 12' ' ' LEU . 19.0 ttt -136.21 123.45 21.81 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.932 176.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 1.003 HG12 HG12 ' A' ' 9' ' ' ILE . 9.8 mt -110.66 146.35 15.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 123.014 0.526 . . . . 0.0 110.262 -175.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.517 ' HD2' ' O ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -139.56 134.49 32.24 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.45 173.131 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.619 ' HB2' HG11 ' A' ' 29' ' ' VAL . 4.7 m-85 -106.77 -156.18 0.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.17 160.04 11.43 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.967 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.414 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 9.2 tp10 -172.01 -83.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 122.681 0.392 . . . . 0.0 110.452 176.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -131.57 -73.92 0.53 Allowed 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.268 0.556 . . . . 0.0 110.688 -173.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.2 pt -117.28 46.6 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.973 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.414 ' OD1' ' HB3' ' A' ' 23' ' ' GLU . 2.0 m-20 -79.78 68.59 5.9 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.98 -171.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.493 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 11.8 tp10 -63.69 -34.61 78.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.305 173.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.66 -45.18 81.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.968 178.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.619 HG11 ' HB2' ' A' ' 21' ' ' PHE . 53.4 t -65.64 -57.95 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.763 -176.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.493 ' ND2' ' HA ' ' A' ' 27' ' ' GLU . 2.7 p30 -57.51 -23.05 47.95 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.592 0.234 . . . . 0.0 111.465 -175.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.99 -39.89 5.66 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.046 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -80.39 -26.99 11.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.768 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.465 HG11 ' O ' ' A' ' 29' ' ' VAL . 10.7 p -68.08 -29.24 43.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -73.29 -34.36 65.71 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.495 177.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.11 -22.09 27.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.598 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.85 -22.99 65.99 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.125 -174.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.406 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . . . -62.52 -44.84 95.37 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.84 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -81.05 -27.85 35.59 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.979 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -59.53 -44.68 93.12 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.516 HD12 HD21 ' A' ' 58' ' ' LEU . 47.3 mt -76.58 -44.26 34.41 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.349 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.84 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 9.5 pt-20 -65.54 -27.37 68.4 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.125 0.416 . . . . 0.0 112.125 -171.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.471 ' C ' ' HD3' ' A' ' 44' ' ' PRO . 45.9 mt-10 -92.63 -18.77 22.63 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 121.156 -0.218 . . . . 0.0 111.441 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.454 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 21.8 mt-30 -131.09 58.55 39.73 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-O 120.744 0.306 . . . . 0.0 110.25 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.471 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 43.0 Cg_endo -104.64 -167.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.988 3.126 . . . . 0.0 113.75 -171.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.667 ' HZ ' ' HB2' ' A' ' 62' ' ' TYR . 12.8 p90 -111.71 147.22 36.33 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 168.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.89 -16.4 0.82 Allowed 'Trans proline' 0 N--CA 1.481 0.747 0 C-N-CA 124.219 3.279 . . . . 0.0 115.1 -172.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.57 7.53 61.49 Favored Glycine 0 C--O 1.226 -0.357 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.769 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -61.44 136.36 58.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.32 0.581 . . . . 0.0 111.803 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.421 HG12 ' HA ' ' A' ' 62' ' ' TYR . 39.2 mm -109.19 -62.4 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.399 -177.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -163.43 157.12 19.49 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.432 -173.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.406 ' SG ' ' HA ' ' A' ' 37' ' ' ALA . 6.0 p -151.75 118.84 5.87 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 174.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.705 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.2 pt -116.13 134.25 22.81 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.826 -175.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -84.37 141.43 9.01 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.095 2.53 . . . . 0.0 112.305 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -130.87 54.11 1.93 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.734 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.2 t80 76.66 -59.4 0.5 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.492 171.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.2 p -130.64 -2.05 4.27 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.26 0.552 . . . . 0.0 110.943 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.0 t -122.24 155.36 36.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.791 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.516 HD21 HD12 ' A' ' 40' ' ' ILE . 47.6 tp -127.33 116.56 20.71 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.598 -177.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.705 ' HB ' HG13 ' A' ' 52' ' ' ILE . 1.1 m -96.22 107.39 19.72 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.698 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 44.1 t -107.44 120.58 59.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.747 0.784 . . . . 0.0 111.867 -171.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -111.44 147.07 36.05 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.675 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.729 ' HH ' ' HA ' ' A' ' 79' ' ' PHE . 3.3 p90 -165.65 172.0 12.4 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -174.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -103.53 117.34 34.2 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.431 0.634 . . . . 0.0 109.979 -177.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.511 ' HA ' HG21 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -64.77 -19.55 65.87 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.176 -176.687 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.06 -29.98 70.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.712 0.292 . . . . 0.0 111.107 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 0.6 OUTLIER -89.16 -26.88 21.05 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 122.067 0.937 . . . . 0.0 108.829 -172.113 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.54 ' CG2' ' HB3' ' A' ' 78' ' ' PRO . 3.7 m -82.62 -40.21 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.488 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.541 ' HA ' HD22 ' A' ' 71' ' ' LEU . 2.8 m-85 -58.66 -29.0 66.24 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 171.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 4.3 tppp? -53.49 -41.87 66.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.68 175.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -94.97 -71.84 0.65 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.693 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.541 HD22 ' HA ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER 38.17 68.96 1.61 Allowed Pre-proline 0 N--CA 1.468 0.459 0 O-C-N 124.146 0.904 . . . . 0.0 111.802 179.024 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -63.6 140.64 76.17 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.878 2.385 . . . . 0.0 111.775 -176.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -61.39 109.42 1.15 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.56 0.695 . . . . 0.0 110.925 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 135.49 -32.43 2.55 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 107.939 -2.064 . . . . 0.0 107.939 -169.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.9 mm -95.62 113.6 30.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 113.387 -1.406 . . . . 0.0 107.713 168.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.3 t -105.62 -4.26 21.31 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.467 0.651 . . . . 0.0 109.85 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.483 ' OG ' ' HD1' ' A' ' 79' ' ' PHE . 21.2 t -126.69 125.66 24.4 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.007 -176.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.54 ' HB3' ' CG2' ' A' ' 67' ' ' VAL . 94.8 Cg_exo -50.57 -42.8 48.26 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.644 2.896 . . . . 0.0 112.936 176.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.729 ' HA ' ' HH ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -57.13 -37.07 71.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.672 177.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.452 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 28.5 tt0 -80.29 -19.8 45.83 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.683 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.413 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 24.0 t -67.97 -31.12 70.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.519 HG23 HG12 ' A' ' 67' ' ' VAL . 12.4 t -83.41 -24.81 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.528 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.452 ' HG3' ' HA ' ' A' ' 80' ' ' GLU . 40.7 mtpt -52.66 -40.89 63.3 Favored 'General case' 0 C--O 1.213 -0.844 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 175.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.444 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 24.3 mmt180 -58.83 -41.59 87.24 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.971 177.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -66.39 -37.15 84.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.397 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.483 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 31.7 m -87.25 -48.09 15.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.688 -178.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -52.12 -43.16 63.83 Favored 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 122.877 0.471 . . . . 0.0 112.012 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 84' ' ' ARG . 12.5 pt-20 -65.4 -28.23 69.11 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.421 -177.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -85.4 -42.35 14.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.548 0.69 . . . . 0.0 110.125 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.495 ' HB3' ' OE1' ' A' ' 95' ' ' GLU . 92.4 mt -68.54 -38.36 80.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.178 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 96' ' ' ASP . . . -44.31 -37.64 3.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.81 174.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -65.2 -11.06 36.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.058 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.1 pp -95.96 -35.21 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.165 -175.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 179.63 -47.13 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.255 0.55 . . . . 0.0 111.153 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.507 ' HB2' ' CE1' ' A' ' 7' ' ' TYR . 8.8 pt-20 -67.05 -4.74 10.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.821 -168.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 14.3 t70 -38.86 -35.05 0.18 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.059 0.457 . . . . 0.0 111.569 170.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -77.51 -21.3 52.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.181 -175.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.548 ' HG2' HG23 ' A' ' 4' ' ' THR . 62.0 mm-40 -109.81 -83.04 0.57 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.105 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.421 ' HB ' ' O ' ' A' ' 98' ' ' GLU . 79.5 t 71.04 115.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.393 -172.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -41.48 -55.31 2.88 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.385 -171.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? . . . . . 0 C--O 1.244 0.78 0 CA-C-O 118.394 -0.812 . . . . 0.0 110.396 179.459 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.536 0 N-CA-C 111.952 -0.459 . . . . 0.0 111.952 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m 63.32 -177.11 0.15 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.463 0.649 . . . . 0.0 111.586 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.51 177.52 9.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.4 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.567 ' O ' HG11 ' A' ' 5' ' ' VAL . 13.5 t -113.97 35.89 3.92 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.824 0.821 . . . . 0.0 108.894 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.567 HG11 ' O ' ' A' ' 4' ' ' THR . 0.3 OUTLIER 66.34 173.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.647 -177.394 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 6' ' ' ARG . 18.8 mmm180 -138.35 123.19 18.84 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 175.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.616 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 50.2 p90 -152.67 162.3 41.43 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.707 0.765 . . . . 0.0 112.419 -175.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.726 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . 27.4 mp0 -126.79 138.47 53.36 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.247 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.824 HG12 HG12 ' A' ' 19' ' ' ILE . 29.4 mt -106.94 128.2 61.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.476 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -120.2 163.31 17.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.263 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.6 HE21 ' HA ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -92.86 124.4 36.82 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.281 0.562 . . . . 0.0 110.153 178.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.582 HD23 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -69.87 -43.14 72.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.148 -174.033 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 173.19 -89.16 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.758 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -92.62 -60.35 1.84 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.917 0.389 . . . . 0.0 111.661 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.8 p -149.73 45.77 0.94 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.569 0.7 . . . . 0.0 110.978 -175.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.82 156.94 47.4 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.149 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.698 ' CB ' ' HH ' ' A' ' 62' ' ' TYR . 28.7 ttp -126.84 134.43 50.53 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.582 ' HB2' HD23 ' A' ' 12' ' ' LEU . 50.5 ttm -118.18 132.72 56.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.049 0.452 . . . . 0.0 110.19 177.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.824 HG12 HG12 ' A' ' 9' ' ' ILE . 6.1 mt -127.24 127.66 69.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.98 -177.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.726 ' HD3' ' HB2' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -111.83 131.27 55.45 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.616 ' HA ' ' CB ' ' A' ' 7' ' ' TYR . 6.6 m-85 -98.35 -149.04 0.34 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -97.16 -152.41 28.65 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.937 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -175.79 -60.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.821 0.343 . . . . 0.0 110.807 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -43.45 -52.61 5.95 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.62 -172.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.2 pt -118.99 24.99 4.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.389 0.614 . . . . 0.0 110.146 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.413 ' O ' HG13 ' A' ' 29' ' ' VAL . 19.6 m120 -120.98 97.77 5.68 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.126 -170.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.03 -29.95 49.67 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 169.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.496 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 4.0 mm100 -60.94 -40.41 93.16 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.436 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.596 ' CG2' ' HB2' ' A' ' 21' ' ' PHE . 6.6 p -62.23 -53.43 47.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.531 -177.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -53.51 -44.06 68.78 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.666 0.604 . . . . 0.0 111.354 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.44 -38.64 17.02 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.55 -0.834 . . . . 0.0 112.88 -178.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 28' ' ' GLN . 0.3 OUTLIER -83.58 -28.51 7.58 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -172.696 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.535 HG11 ' O ' ' A' ' 29' ' ' VAL . 14.9 p -68.6 -30.35 47.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 175.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -70.59 -40.21 73.37 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.689 -1.142 . . . . 0.0 109.931 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.53 -22.02 28.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.995 -177.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.92 -28.91 70.15 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.568 0.223 . . . . 0.0 111.498 -174.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.39 -39.13 92.23 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.081 0.943 . . . . 0.0 108.706 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.458 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.85 -23.12 29.15 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.249 178.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -69.5 -41.71 75.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.15 0.5 . . . . 0.0 109.829 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.54 HD11 HD22 ' A' ' 58' ' ' LEU . 54.8 mt -73.71 -34.63 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.188 -177.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.458 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 9.1 pt-20 -69.63 -23.65 63.53 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.423 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 44.4 mm-40 -73.59 -36.37 65.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.643 175.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -129.61 70.71 82.04 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.324 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -94.47 176.49 1.1 Allowed 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.766 2.311 . . . . 0.0 113.443 -174.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -115.95 147.85 40.08 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.73 175.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -37.23 -37.81 0.42 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.246 3.297 . . . . 0.0 115.13 -174.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.453 ' HA3' ' HB2' ' A' ' 66' ' ' GLU . . . -103.24 17.62 51.01 Favored Glycine 0 C--O 1.224 -0.486 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.025 -176.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -59.77 129.39 41.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.986 0.422 . . . . 0.0 110.62 176.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.567 HG12 ' HA ' ' A' ' 62' ' ' TYR . 39.5 mm -106.07 -57.8 4.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.526 -174.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 13.5 tp10 -164.18 157.52 18.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.681 0.277 . . . . 0.0 110.544 -172.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.4 p -150.79 118.4 6.12 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 172.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.741 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.9 pt -119.94 135.21 24.14 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -176.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 2.5 Cg_endo -80.95 120.67 3.84 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.13 2.553 . . . . 0.0 112.234 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -109.51 52.74 0.71 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.601 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.486 ' O ' HG12 ' A' ' 33' ' ' VAL . 39.5 t80 72.64 -57.79 0.62 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.263 173.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.0 t -132.5 -2.4 3.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.695 0.759 . . . . 0.0 110.14 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.6 m -122.44 140.57 52.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.211 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.54 HD22 HD11 ' A' ' 40' ' ' ILE . 50.5 tp -106.18 115.98 31.14 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.741 ' HB ' HG13 ' A' ' 52' ' ' ILE . 4.7 m -93.28 106.27 18.25 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.784 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.0 t -104.75 123.98 59.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.386 0.612 . . . . 0.0 111.292 -173.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.415 ' CE1' HG21 ' A' ' 59' ' ' THR . 87.8 m-85 -114.96 145.96 41.69 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.57 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.698 ' HH ' ' CB ' ' A' ' 17' ' ' MET . 2.4 p90 -166.54 171.29 11.92 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.125 0.488 . . . . 0.0 110.9 -175.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -99.49 111.34 23.7 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.398 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.483 ' O ' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -61.91 -21.74 65.0 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.234 -176.546 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.517 ' CE1' ' HG2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -71.39 -23.08 61.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.757 0.313 . . . . 0.0 110.981 -176.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.517 ' HG2' ' CE1' ' A' ' 65' ' ' TYR . 22.5 mm-40 -91.51 -34.41 14.79 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.196 0.522 . . . . 0.0 110.458 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 64' ' ' MET . 3.4 m -70.54 -29.86 40.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.102 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.641 ' HA ' HD23 ' A' ' 71' ' ' LEU . 2.5 m-85 -55.48 -24.96 34.22 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.704 172.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -66.69 -24.32 66.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.596 0.712 . . . . 0.0 109.824 176.749 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -102.15 -32.49 10.07 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.249 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.684 HD22 ' HA ' ' A' ' 78' ' ' PRO . 1.6 mm? -26.36 95.01 0.06 OUTLIER Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 125.514 1.526 . . . . 0.0 113.735 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.546 ' HD2' HG13 ' A' ' 75' ' ' ILE . 20.5 Cg_exo -70.4 161.04 47.45 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 123.594 2.863 . . . . 0.0 111.93 174.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -62.36 -40.34 96.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -173.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.41 -21.37 78.94 Favored Glycine 0 CA--C 1.511 -0.202 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.45 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.546 HG13 ' HD2' ' A' ' 72' ' ' PRO . 10.7 mm -81.97 100.26 5.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.057 -0.571 . . . . 0.0 109.919 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.4 m -82.52 -9.87 59.24 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.216 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.2 m -131.15 130.82 22.8 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.738 -175.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.684 ' HA ' HD22 ' A' ' 71' ' ' LEU . 83.4 Cg_exo -46.54 -48.91 12.79 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.408 2.739 . . . . 0.0 113.483 176.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.439 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 1.4 p90 -59.9 -27.4 66.7 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.485 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.657 ' HG3' ' HD2' ' A' ' 83' ' ' LYS . 8.8 tt0 -81.93 -17.83 45.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.887 0.375 . . . . 0.0 110.869 -174.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.511 ' HB2' HG22 ' A' ' 75' ' ' ILE . 48.0 t -79.26 -35.6 41.17 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.441 HG12 ' CE2' ' A' ' 62' ' ' TYR . 49.0 t -67.06 -25.32 33.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.28 178.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.657 ' HD2' ' HG3' ' A' ' 80' ' ' GLU . 94.5 mttt -51.59 -41.92 61.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.967 177.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.607 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 0.7 OUTLIER -60.9 -50.56 72.91 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.851 -177.583 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -64.88 -37.04 86.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.796 -177.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.605 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 31.2 m -83.36 -48.22 17.6 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 CA-C-O 118.947 -0.549 . . . . 0.0 112.023 -175.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.517 ' HG2' ' OH ' ' A' ' 7' ' ' TYR . 92.5 mt-10 -49.27 -53.64 20.76 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 118.25 0.477 . . . . 0.0 111.902 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.739 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 11.1 pt-20 -60.35 -27.22 67.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.394 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.59 -24.36 22.86 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 175.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 86' ' ' VAL . 13.0 mt -60.95 -72.88 0.1 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -163.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -90.35 -78.11 0.38 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 118.363 -1.335 . . . . 0.0 112.213 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.404 ' O ' HG23 ' A' ' 93' ' ' ILE . 10.7 mp0 -103.38 -57.81 1.98 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.811 1.291 . . . . 0.0 109.086 164.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.739 ' HA ' ' O ' ' A' ' 88' ' ' GLU . 12.9 pt -174.33 55.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 111.309 -2.678 . . . . 0.0 104.863 -168.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.93 15.18 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.627 -171.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.464 ' H ' ' C ' ' A' ' 93' ' ' ILE . 1.2 pt-20 -59.9 -14.57 16.14 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.269 0.557 . . . . 0.0 109.743 165.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -52.34 -22.7 4.84 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.601 177.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.541 ' HE1' HG21 ' A' ' 4' ' ' THR . 2.0 m-30 -71.83 -5.91 37.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.832 -176.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.42 ' O ' ' HB ' ' A' ' 99' ' ' VAL . 57.4 mm-40 61.12 45.85 8.69 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 123.67 0.606 . . . . 0.0 109.906 -177.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.42 ' HB ' ' O ' ' A' ' 98' ' ' GLU . 95.6 t 72.18 97.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.117 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.775 -175.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -69.52 114.7 7.99 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 35.3 ttp180 . . . . . 0 C--N 1.31 -1.137 0 CA-C-O 118.593 -0.717 . . . . 0.0 109.935 -173.162 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.2 m -82.45 79.06 9.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.236 0.541 . . . . 0.0 110.444 177.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.654 ' O ' HG22 ' A' ' 4' ' ' THR . 20.4 ptm -77.43 21.19 0.27 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.979 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.654 HG22 ' O ' ' A' ' 3' ' ' MET . 0.6 OUTLIER 71.16 -3.27 2.1 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.875 0.87 . . . . 0.0 110.963 177.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.417 ' H ' ' C ' ' A' ' 3' ' ' MET . 1.0 OUTLIER 67.18 149.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.853 -178.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.483 ' HA ' ' CE1' ' A' ' 97' ' ' TYR . 29.0 mmt180 -122.23 79.09 1.56 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.387 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.481 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 15.0 p90 -104.67 146.3 29.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.45 -172.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.417 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 5.6 tp60 -125.49 139.61 53.48 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.559 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 1.036 HG12 HG12 ' A' ' 19' ' ' ILE . 25.6 mt -104.36 122.35 57.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.067 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -116.22 159.99 21.05 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.862 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -86.24 124.4 32.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.53 0.681 . . . . 0.0 110.182 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.622 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -63.45 -48.22 78.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.658 -177.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -165.96 -73.17 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.652 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -128.7 -49.31 1.25 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.582 0.23 . . . . 0.0 111.522 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.08 41.35 1.66 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.639 0.733 . . . . 0.0 110.945 -172.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -143.88 152.22 40.86 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.74 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 29.0 ttp -121.28 135.42 55.12 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -174.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.622 ' HB2' HD22 ' A' ' 12' ' ' LEU . 46.8 ttm -122.22 132.4 54.42 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.145 177.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 1.036 HG12 HG12 ' A' ' 9' ' ' ILE . 5.7 mt -129.69 143.27 41.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.486 -175.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.417 ' HD2' ' O ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -125.48 126.66 45.26 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 174.11 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.8 ' HB2' HG21 ' A' ' 29' ' ' VAL . 4.9 m-85 -102.98 -158.59 0.68 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.121 0.486 . . . . 0.0 109.709 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.09 179.36 4.81 Favored Glycine 0 N--CA 1.453 -0.188 0 CA-C-N 114.841 -1.072 . . . . 0.0 113.547 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -165.28 -76.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.949 0.404 . . . . 0.0 111.281 173.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -89.7 -78.35 0.36 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.292 0.567 . . . . 0.0 111.598 -172.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.3 pt -147.01 27.26 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.63 -174.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.517 ' O ' HG11 ' A' ' 29' ' ' VAL . 19.9 p-10 -87.24 118.74 26.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.209 0.528 . . . . 0.0 111.851 -172.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -63.24 -19.1 64.25 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.38 176.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.409 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 46.6 tt0 -46.98 -49.85 20.08 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.642 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.8 HG21 ' HB2' ' A' ' 21' ' ' PHE . 2.8 p -64.22 -47.98 87.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.779 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -54.92 -42.66 72.51 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.317 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.11 -39.5 10.01 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.182 -1.009 . . . . 0.0 112.537 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.409 ' HB ' ' O ' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -82.5 -21.35 9.56 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -171.459 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 55' ' ' PHE . 12.1 p -72.08 -30.3 35.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -75.46 -38.55 59.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.214 175.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.02 -20.75 51.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.977 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.505 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . . . -68.96 -28.25 66.46 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 120.873 0.368 . . . . 0.0 110.888 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.87 -42.63 99.83 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.764 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -79.13 -30.91 43.94 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.078 176.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.505 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -54.84 -44.93 74.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.433 0.635 . . . . 0.0 110.133 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 45.9 mt -79.62 -30.83 13.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.646 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.764 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 9.2 pt-20 -76.36 -25.06 54.26 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.64 -177.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -82.4 -27.99 31.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.01 0.433 . . . . 0.0 110.396 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.423 ' HB3' ' NH1' ' A' ' 89' ' ' ARG . 43.8 mt-30 -131.7 70.41 81.21 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.244 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -99.32 -178.06 0.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.395 2.73 . . . . 0.0 113.854 -173.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.434 ' CE2' HG13 ' A' ' 82' ' ' VAL . 6.0 p90 -115.93 147.41 39.1 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.92 171.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.44 ' HB2' ' CD ' ' A' ' 66' ' ' GLU . 59.0 Cg_exo -38.55 -39.35 1.12 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.987 3.125 . . . . 0.0 115.147 -174.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.66 13.76 64.96 Favored Glycine 0 C--O 1.228 -0.245 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.098 -174.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -59.07 132.75 54.97 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.052 0.453 . . . . 0.0 110.777 175.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.454 HG12 ' HA ' ' A' ' 62' ' ' TYR . 35.9 mm -106.0 -59.37 3.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.261 -175.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -163.55 158.99 21.4 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 120.66 0.267 . . . . 0.0 110.571 -173.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.3 p -150.02 118.01 6.3 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 176.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.747 HG13 ' HB ' ' A' ' 59' ' ' THR . 5.9 pt -120.97 131.58 24.44 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-O 121.106 0.479 . . . . 0.0 112.186 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 72.2 Cg_endo -86.51 141.94 6.86 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.413 2.742 . . . . 0.0 112.499 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.89 59.58 1.61 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.629 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.471 ' O ' HG13 ' A' ' 33' ' ' VAL . 52.0 t80 69.31 -54.34 0.58 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.115 0.966 . . . . 0.0 112.581 175.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.2 t -130.98 -15.74 3.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.767 0.318 . . . . 0.0 111.164 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.0 p -115.18 149.75 37.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.956 0.407 . . . . 0.0 110.936 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 38.6 tp -118.24 125.83 50.94 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.747 ' HB ' HG13 ' A' ' 52' ' ' ILE . 3.1 m -105.59 107.65 18.76 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.038 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.2 t -105.45 123.05 59.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.416 0.627 . . . . 0.0 111.473 -173.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -113.08 147.83 36.48 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.803 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.659 ' HH ' ' HB2' ' A' ' 17' ' ' MET . 2.6 p90 -165.89 171.71 12.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.757 -175.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -107.74 108.6 19.89 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 121.492 0.663 . . . . 0.0 109.851 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.575 ' O ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -55.63 -31.21 62.11 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.8 -176.681 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.8 -23.5 65.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.149 0.5 . . . . 0.0 110.742 -177.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 69' ' ' LYS . 4.0 tm-20 -92.09 -41.67 10.37 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -177.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 64' ' ' MET . 2.5 m -61.94 -28.48 44.4 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.698 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.72 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.812 ' HA ' HD12 ' A' ' 71' ' ' LEU . 4.3 m-85 -50.56 -32.51 18.77 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.407 0.683 . . . . 0.0 111.648 169.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -66.95 -30.96 71.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.203 0.525 . . . . 0.0 110.509 178.432 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -93.46 -37.71 11.8 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.144 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.812 HD12 ' HA ' ' A' ' 68' ' ' TYR . 13.4 mt -32.75 99.5 0.15 Allowed Pre-proline 0 N--CA 1.465 0.315 0 C-N-CA 125.509 1.524 . . . . 0.0 113.463 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.438 ' HD2' HG13 ' A' ' 75' ' ' ILE . 13.9 Cg_exo -74.54 154.91 45.19 Favored 'Trans proline' 0 C--N 1.332 -0.302 0 C-N-CA 124.128 3.219 . . . . 0.0 110.586 174.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -64.34 -21.25 66.55 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -171.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.3 -18.04 76.93 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.113 176.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.532 HG22 ' HB3' ' A' ' 80' ' ' GLU . 2.8 mm -101.86 105.79 18.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.97 -0.615 . . . . 0.0 110.179 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.8 t -93.0 -3.34 54.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.006 0.432 . . . . 0.0 110.506 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 80' ' ' GLU . 17.1 m -121.45 116.19 30.86 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.984 -178.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.641 ' HG3' ' CE1' ' A' ' 68' ' ' TYR . 14.4 Cg_exo -35.75 -56.6 0.58 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 124.357 3.371 . . . . 0.0 114.071 171.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.551 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -57.77 -32.74 67.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.227 -179.358 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.532 ' HB3' HG22 ' A' ' 75' ' ' ILE . 2.2 tp10 -70.19 -29.43 66.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.722 -174.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.646 ' HB2' HD22 ' A' ' 71' ' ' LEU . 46.5 t -79.37 -35.58 40.6 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.484 HG12 ' CE2' ' A' ' 62' ' ' TYR . 92.1 t -60.15 -39.95 82.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.936 177.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.74 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 17.6 mtmt -54.95 -48.31 73.34 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 21.7 mmm180 -63.01 -32.68 74.09 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.228 -174.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 13.8 t70 -69.52 -40.57 76.85 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.433 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.34 -35.59 9.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.546 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 83' ' ' LYS . 49.3 mt-10 -62.27 -37.2 84.56 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 122.801 0.44 . . . . 0.0 111.891 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.777 ' HG3' ' HD3' ' A' ' 89' ' ' ARG . 13.0 pt-20 -58.03 -29.1 65.08 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.227 -0.589 . . . . 0.0 109.903 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.777 ' HD3' ' HG3' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -87.5 -42.58 12.67 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.609 172.802 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 82.9 mt -84.05 -64.46 1.16 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 122.976 0.51 . . . . 0.0 112.236 -174.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.598 ' HA ' ' HB3' ' A' ' 94' ' ' ALA . . . -60.12 -17.03 37.33 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.614 0.765 . . . . 0.0 112.132 -178.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -59.77 -29.54 68.26 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.045 0.45 . . . . 0.0 109.949 172.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.422 HG13 ' N ' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -103.93 -33.97 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.598 ' HB3' ' HA ' ' A' ' 91' ' ' ALA . . . -82.39 63.9 6.78 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 165.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.412 ' HG2' ' OG1' ' A' ' 4' ' ' THR . 9.4 pt-20 -42.22 -32.68 0.51 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 112.991 -1.913 . . . . 0.0 112.424 -170.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -77.29 -27.73 53.12 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.969 -172.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.483 ' CE1' ' HA ' ' A' ' 6' ' ' ARG . 71.5 m-85 -99.51 13.73 32.37 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -167.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -59.29 -20.51 54.95 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.912 0.863 . . . . 0.0 109.567 172.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 p -114.01 79.96 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.182 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.33 -26.58 61.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.667 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.221 -0.895 . . . . 0.0 109.697 175.932 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.698 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.2 m 69.04 167.38 0.28 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.121 0.486 . . . . 0.0 110.804 -177.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.623 ' HG2' ' HB3' ' A' ' 26' ' ' ASN . 23.8 ptm -153.13 160.02 42.82 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.091 0.472 . . . . 0.0 110.317 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.771 ' HG1' ' HB1' ' A' ' 94' ' ' ALA . 4.7 t -93.37 31.53 1.49 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.657 -178.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.687 HG12 ' ND2' ' A' ' 26' ' ' ASN . 3.2 m 64.68 160.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.837 1.655 . . . . 0.0 113.828 -178.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -142.65 105.14 4.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.418 -1.719 . . . . 0.0 107.35 172.219 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -115.17 171.53 7.62 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.353 -166.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.527 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -140.04 121.75 15.35 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -178.255 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.948 HG12 HG12 ' A' ' 19' ' ' ILE . 29.3 mt -87.6 112.0 22.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.805 0.812 . . . . 0.0 110.911 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 18' ' ' MET . 4.0 pt-20 -106.87 161.48 14.66 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.489 -173.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.41 ' NE2' ' HA ' ' A' ' 11' ' ' GLN . 6.0 tp-100 -90.91 124.75 35.44 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.667 0.746 . . . . 0.0 110.686 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.567 HD22 HG21 ' A' ' 59' ' ' THR . 0.2 OUTLIER -70.69 -46.84 62.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.993 -176.527 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -157.92 -79.72 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -137.36 -36.1 0.66 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.865 0.364 . . . . 0.0 110.807 176.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.5 p -141.97 39.18 1.63 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.823 0.82 . . . . 0.0 110.201 -174.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HB2' ' HB3' ' A' ' 12' ' ' LEU . . . -143.63 151.94 40.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.277 176.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.453 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 35.4 ttp -123.16 137.89 54.79 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.063 -0.655 . . . . 0.0 112.314 -173.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.589 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 24.7 ttt -126.51 138.16 53.46 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.948 HG12 HG12 ' A' ' 9' ' ' ILE . 4.7 mt -133.13 118.79 33.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.674 -174.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.527 ' HD3' ' HB3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -102.95 125.71 49.81 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.674 177.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.496 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 0.7 OUTLIER -109.4 -159.42 0.68 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 176.347 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.775 ' HA2' HD22 ' A' ' 26' ' ' ASN . . . 68.93 107.26 0.03 OUTLIER Glycine 0 CA--C 1.51 -0.26 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.541 177.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -108.13 -79.99 0.57 Allowed 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 119.604 -0.839 . . . . 0.0 111.734 -176.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -91.13 -78.21 0.4 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.019 0.438 . . . . 0.0 111.869 -171.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.3 pp -135.24 26.36 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.079 0.466 . . . . 0.0 111.825 -171.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.775 HD22 ' HA2' ' A' ' 22' ' ' GLY . 6.0 p-10 -91.77 93.27 8.79 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.637 0.732 . . . . 0.0 111.559 -174.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -61.39 -19.04 61.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.857 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.7 tm0? -49.11 -35.84 17.35 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.925 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.505 ' O ' HG12 ' A' ' 33' ' ' VAL . 11.1 p -64.1 -41.23 91.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.315 -176.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -60.1 -25.48 65.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.423 -175.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -92.57 -39.86 5.18 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.026 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -81.8 -27.24 9.71 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -173.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' A' ' 53' ' ' PRO . 11.1 p -70.54 -30.92 44.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 119.307 -0.957 . . . . 0.0 108.486 175.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -71.46 -35.17 70.77 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.695 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.64 -22.01 30.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.39 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.442 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -64.09 -21.07 66.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.351 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.93 -43.36 88.28 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.715 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -81.81 -29.9 32.45 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.802 176.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.543 ' HE1' ' HB3' ' A' ' 89' ' ' ARG . 7.8 t80 -51.59 -46.03 63.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.498 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.425 HD11 HD21 ' A' ' 58' ' ' LEU . 58.0 mt -80.4 -29.15 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.965 -175.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.715 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 10.3 pt-20 -75.81 -26.76 57.54 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.096 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 51.4 mt-10 -74.54 -35.65 63.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.061 173.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -125.19 74.94 67.88 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.244 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -95.02 -164.51 0.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.385 2.723 . . . . 0.0 113.749 -171.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -138.78 147.63 55.13 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.208 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -44.26 -22.6 0.57 Allowed 'Trans proline' 0 N--CA 1.482 0.808 0 C-N-CA 124.447 3.431 . . . . 0.0 115.881 -170.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.59 27.09 8.16 Favored Glycine 0 C--O 1.228 -0.265 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.314 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -67.91 136.0 53.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.051 0.453 . . . . 0.0 111.76 177.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.7 mm -109.33 -60.34 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.257 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -162.28 157.41 22.81 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.781 -172.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 59' ' ' THR . 2.1 p -152.05 118.23 5.56 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 173.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.535 HG13 ' HB ' ' A' ' 59' ' ' THR . 7.7 pt -126.59 142.1 42.15 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.604 -176.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.512 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 1.6 Cg_endo -84.64 139.59 7.78 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.31 2.674 . . . . 0.0 112.673 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.7 66.94 1.54 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 92.5 t80 75.91 -68.97 0.18 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.316 0.647 . . . . 0.0 111.588 171.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.1 t -134.92 2.43 3.11 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.613 0.72 . . . . 0.0 109.673 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 15.2 m -120.65 137.47 54.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.38 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.425 HD21 HD11 ' A' ' 40' ' ' ILE . 61.6 tp -102.48 126.89 49.68 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.567 HG21 HD22 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -101.42 106.8 17.98 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -177.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.1 t -109.35 119.21 58.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.459 0.647 . . . . 0.0 111.067 -174.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -112.9 146.59 38.68 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.513 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.734 ' HH ' ' HA ' ' A' ' 79' ' ' PHE . 3.6 p90 -164.78 170.32 15.63 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.873 -173.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -104.24 112.29 25.25 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.73 -177.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.42 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.4 pmm? -63.22 -26.51 68.83 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.735 -174.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.68 -27.89 66.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.201 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -90.71 -41.17 11.43 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -173.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 64' ' ' MET . 3.5 m -68.06 -30.63 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.089 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.678 ' HA ' HD21 ' A' ' 71' ' ' LEU . 3.5 m-85 -53.94 -29.45 42.41 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.495 173.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.489 ' HE2' ' HB2' ' A' ' 69' ' ' LYS . 0.3 OUTLIER -67.62 -34.96 78.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.11 0.481 . . . . 0.0 110.601 178.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 33.9 t60 -93.05 -30.82 15.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.491 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.678 HD21 ' HA ' ' A' ' 68' ' ' TYR . 0.5 OUTLIER -16.2 91.56 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 125.618 1.567 . . . . 0.0 112.672 177.124 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.481 ' HD2' HG13 ' A' ' 75' ' ' ILE . 31.8 Cg_exo -61.71 149.99 87.61 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.057 2.504 . . . . 0.0 111.352 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -63.22 -22.09 66.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.628 -172.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -83.83 -13.76 74.38 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.775 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.505 HG21 ' HB3' ' A' ' 81' ' ' SER . 4.5 mm -96.35 130.84 44.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 122.837 0.455 . . . . 0.0 109.944 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.3 t -114.34 0.07 14.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.164 0.507 . . . . 0.0 109.952 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.9 m -134.5 120.14 14.49 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.962 -177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.63 ' HA ' HD23 ' A' ' 71' ' ' LEU . 95.2 Cg_exo -46.46 -38.5 21.23 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 124.122 3.215 . . . . 0.0 113.882 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.734 ' HA ' ' HH ' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -61.9 -34.65 76.42 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.123 179.487 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.602 ' HG3' ' HD3' ' A' ' 83' ' ' LYS . 16.7 tt0 -83.46 -20.7 33.56 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.456 -174.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.505 ' HB3' HG21 ' A' ' 75' ' ' ILE . 62.5 p -75.93 -30.09 58.58 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 177.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 78' ' ' PRO . 97.7 t -67.59 -34.46 68.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.724 174.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.602 ' HD3' ' HG3' ' A' ' 80' ' ' GLU . 59.7 mtpt -51.85 -45.43 64.01 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 174.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.424 ' HE ' HD13 ' A' ' 75' ' ' ILE . 21.1 mmt180 -60.81 -35.9 77.69 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.874 -177.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -72.31 -42.4 65.51 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.047 0.451 . . . . 0.0 111.426 -177.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.414 ' O ' HD22 ' A' ' 90' ' ' LEU . 34.6 m -87.15 -46.12 16.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.17 -177.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 83' ' ' LYS . 14.9 mm-40 -62.7 -28.47 69.97 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.796 -175.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.603 ' HG3' ' HD3' ' A' ' 89' ' ' ARG . 11.9 pt-20 -64.48 -27.9 69.3 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.88 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.603 ' HD3' ' HG3' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -85.23 -47.45 10.07 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 176.173 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 87' ' ' GLU . 4.5 mm? -60.09 -32.86 71.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.535 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.618 ' O ' ' HB2' ' A' ' 96' ' ' ASP . . . -44.17 -49.15 9.18 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.913 -178.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -62.57 -6.05 3.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.202 -174.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -98.96 -37.36 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 121.2 -0.2 . . . . 0.0 111.139 179.174 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.771 ' HB1' ' HG1' ' A' ' 4' ' ' THR . . . -164.88 -53.68 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.74 0.781 . . . . 0.0 111.258 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.585 ' HG2' ' HA ' ' A' ' 91' ' ' ALA . 1.2 pm0 -61.19 -3.41 0.86 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.806 -173.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.618 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 15.6 t70 -44.23 -23.88 0.13 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 121.29 0.567 . . . . 0.0 111.564 167.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -72.1 -2.32 18.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.857 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 62.06 42.97 9.3 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.397 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.1 m -97.07 35.97 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.385 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -89.97 85.6 6.38 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.955 -176.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 . . . . . 0 C--N 1.3 -1.551 0 CA-C-O 118.506 -0.759 . . . . 0.0 109.315 178.648 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.657 0 N-CA-C 112.194 -0.362 . . . . 0.0 112.194 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.3 t -118.53 74.91 0.99 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.534 ' HE2' ' HB3' ' A' ' 26' ' ' ASN . 1.6 pmm? -89.28 168.69 12.06 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.147 -175.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.465 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 10.0 t -125.04 16.93 8.51 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.54 -177.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.505 HG13 ' HD1' ' A' ' 7' ' ' TYR . 40.0 t 74.54 141.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 114.946 -1.025 . . . . 0.0 112.989 171.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -129.55 84.94 2.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.993 173.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.629 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 38.9 p90 -107.74 155.68 19.94 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.747 0.784 . . . . 0.0 111.941 -172.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.546 ' HB2' ' NE ' ' A' ' 20' ' ' ARG . 40.1 mt-30 -128.16 139.54 52.43 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.701 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 1.004 HG12 HG12 ' A' ' 19' ' ' ILE . 15.9 mt -101.03 120.25 50.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.764 177.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 18' ' ' MET . 11.9 pt-20 -119.85 159.17 25.12 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.846 -177.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.546 HE21 ' HA ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -88.49 129.91 35.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.971 177.492 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.65 HD21 HG22 ' A' ' 59' ' ' THR . 0.0 OUTLIER -66.4 -42.65 87.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.619 -177.653 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.83 -55.48 0.36 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.426 176.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -103.43 -74.71 0.63 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.947 0.403 . . . . 0.0 111.07 -176.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.4 p -149.58 48.15 0.95 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.686 0.755 . . . . 0.0 110.562 -177.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -142.57 155.08 44.95 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.835 176.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.481 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 37.5 ttp -128.06 124.45 37.09 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -174.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.488 ' HB2' HD23 ' A' ' 12' ' ' LEU . 51.3 ttm -109.49 139.49 44.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.131 0.491 . . . . 0.0 110.248 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 1.004 HG12 HG12 ' A' ' 9' ' ' ILE . 6.4 mt -128.21 112.67 27.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.913 -176.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.564 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -96.0 124.22 39.92 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.89 178.599 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.629 ' HA ' ' CB ' ' A' ' 7' ' ' TYR . 8.0 m-85 -97.84 -153.71 0.43 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.52 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.612 ' HA2' HG22 ' A' ' 29' ' ' VAL . . . 104.25 -175.86 23.13 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.28 176.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -149.14 -72.2 0.19 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 173.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -134.33 -69.94 0.52 Allowed 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.031 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 31.7 pt -138.96 38.24 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.402 0.62 . . . . 0.0 110.583 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.534 ' HB3' ' HE2' ' A' ' 3' ' ' MET . 15.5 p-10 -86.62 115.09 23.86 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.606 0.717 . . . . 0.0 111.873 -175.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.436 ' HA ' HD21 ' A' ' 30' ' ' ASN . 12.7 pt-20 -68.39 -19.1 64.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.129 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.4 tm0? -46.89 -45.51 20.53 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.591 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.612 HG22 ' HA2' ' A' ' 22' ' ' GLY . 83.3 t -63.16 -41.66 93.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.395 -177.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.436 HD21 ' HA ' ' A' ' 27' ' ' GLU . 43.5 m-80 -52.61 -32.75 43.21 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.595 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.53 -42.23 6.2 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.731 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -80.03 -22.17 11.8 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.79 0 C-N-CA 120.539 -0.464 . . . . 0.0 112.105 -173.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 29' ' ' VAL . 14.3 p -74.12 -29.5 25.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 119.593 -0.843 . . . . 0.0 108.865 174.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -70.85 -34.63 71.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.47 174.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.12 -21.44 29.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.306 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.423 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . . . -65.15 -26.54 68.22 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.031 -177.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.52 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . . . -62.0 -43.59 98.52 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.833 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -77.85 -29.66 50.59 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.846 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.423 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -55.57 -44.71 77.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.257 0.551 . . . . 0.0 109.639 177.264 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.511 HG22 ' HE2' ' A' ' 48' ' ' PHE . 41.5 mt -83.15 -37.47 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.82 -175.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.833 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 12.2 pt-20 -74.12 -20.89 60.1 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.29 -176.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.443 ' C ' ' HD3' ' A' ' 44' ' ' PRO . 38.1 mm-40 -85.72 -25.68 26.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.932 0.396 . . . . 0.0 110.684 175.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -122.76 63.36 19.99 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.443 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 50.0 Cg_endo -93.42 174.2 1.69 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.546 2.164 . . . . 0.0 114.039 -167.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -114.01 146.48 35.75 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 114.152 -1.385 . . . . 0.0 108.052 175.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.44 -15.33 3.85 Favored 'Trans proline' 0 N--CA 1.48 0.699 0 C-N-CA 123.82 3.013 . . . . 0.0 114.844 -169.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.39 20.18 28.21 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.11 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.511 ' HE2' HG22 ' A' ' 40' ' ' ILE . 4.2 t80 -62.01 132.33 52.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.986 0.422 . . . . 0.0 110.778 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.634 HG21 ' CG ' ' A' ' 50' ' ' GLU . 28.9 mm -109.48 -62.99 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.17 176.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.634 ' CG ' HG21 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -154.69 175.8 13.24 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.522 0.677 . . . . 0.0 110.393 178.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.52 ' SG ' ' HA ' ' A' ' 37' ' ' ALA . 7.5 p -161.55 119.7 2.34 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.838 162.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.76 HG13 ' HB ' ' A' ' 59' ' ' THR . 9.5 pt -114.77 134.07 22.48 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-O 120.975 0.417 . . . . 0.0 112.039 -173.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.478 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 2.0 Cg_endo -82.04 120.45 3.37 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.295 2.664 . . . . 0.0 112.342 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.52 32.95 3.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.328 178.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 71.04 -34.64 0.31 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.096 175.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -128.82 -21.35 3.39 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.85 -0.531 . . . . 0.0 111.214 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 9.5 p -124.65 141.29 52.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.139 0.495 . . . . 0.0 110.571 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.508 HD22 ' CD1' ' A' ' 40' ' ' ILE . 57.5 tp -102.44 111.98 24.5 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.76 ' HB ' HG13 ' A' ' 52' ' ' ILE . 5.2 m -90.32 105.54 17.88 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.7 t -101.25 125.36 55.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.086 0.47 . . . . 0.0 111.122 -172.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -114.73 145.87 41.58 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.613 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.716 ' HH ' ' HA ' ' A' ' 79' ' ' PHE . 2.4 p90 -165.09 169.1 16.62 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.371 0.605 . . . . 0.0 110.695 -174.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -96.61 118.95 34.17 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.616 -176.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.468 ' HA ' HG21 ' A' ' 67' ' ' VAL . 1.3 pmm? -69.34 -22.8 63.73 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.833 -172.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.42 -28.83 69.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 111.144 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -89.83 -30.98 17.58 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.769 0.795 . . . . 0.0 109.477 -173.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' A' ' 64' ' ' MET . 3.2 m -77.75 -33.81 19.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.339 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.91 ' HA ' HD23 ' A' ' 71' ' ' LEU . 59.8 t80 -68.29 -22.87 64.7 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.245 175.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -38.87 71.43 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 172.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -87.54 -74.68 0.43 Allowed 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.421 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.91 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER 32.44 66.95 1.04 Allowed Pre-proline 0 N--CA 1.471 0.593 0 O-C-N 124.186 0.929 . . . . 0.0 111.574 -178.236 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.661 ' HD2' HG13 ' A' ' 75' ' ' ILE . 33.2 Cg_exo -60.45 135.61 62.32 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.475 2.117 . . . . 0.0 111.371 -175.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -58.7 109.32 0.78 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.907 0.861 . . . . 0.0 110.964 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 136.42 -31.56 2.58 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 108.549 -1.82 . . . . 0.0 108.549 -169.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.661 HG13 ' HD2' ' A' ' 72' ' ' PRO . 14.3 mm -84.78 116.38 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 114.049 -1.076 . . . . 0.0 108.764 169.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.9 m -94.94 -4.32 47.0 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.162 0.506 . . . . 0.0 110.716 -175.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.571 ' HB2' ' HB2' ' A' ' 80' ' ' GLU . 58.0 m -141.35 134.54 14.43 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.227 -170.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.67 ' HA ' HD22 ' A' ' 71' ' ' LEU . 82.8 Cg_exo -51.92 -43.63 50.72 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.509 2.806 . . . . 0.0 113.157 173.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.716 ' HA ' ' HH ' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -67.11 -23.39 65.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.185 0.516 . . . . 0.0 110.748 176.35 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 77' ' ' SER . 39.9 tt0 -81.34 -20.73 40.03 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.159 -174.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.502 ' HB3' HG21 ' A' ' 75' ' ' ILE . 63.7 p -81.95 -37.33 26.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 78' ' ' PRO . 26.2 t -64.22 -26.02 39.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.129 177.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.55 ' HG3' ' HA ' ' A' ' 80' ' ' GLU . 93.5 mttt -50.17 -45.08 53.11 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.126 175.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.466 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 17.9 mmt180 -69.5 -35.14 75.24 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.042 -173.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -62.33 -41.79 98.85 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.843 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.9 m -87.41 -42.96 15.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -178.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -62.53 -33.63 75.3 Favored 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.495 ' HG3' ' HD3' ' A' ' 89' ' ' ARG . 11.0 pt-20 -59.21 -29.19 67.31 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.579 176.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.495 ' HD3' ' HG3' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -88.62 -37.88 15.28 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.738 173.642 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 88.4 mt -85.74 -67.57 0.8 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.45 0.643 . . . . 0.0 112.388 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.6 -16.47 48.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.832 -175.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.719 ' HG3' HG21 ' A' ' 93' ' ' ILE . 7.8 pt-20 -56.03 -39.89 72.61 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.99 -0.444 . . . . 0.0 110.983 176.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.719 HG21 ' HG3' ' A' ' 92' ' ' GLU . 0.5 OUTLIER -90.43 -42.36 14.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.607 -178.193 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.6 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . . . -87.29 28.0 1.0 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.784 0.802 . . . . 0.0 110.313 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.495 ' HG3' ' N ' ' A' ' 96' ' ' ASP . 10.7 pt-20 -46.41 -55.54 7.24 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.756 -1.565 . . . . 0.0 113.645 -173.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.495 ' N ' ' HG3' ' A' ' 95' ' ' GLU . 36.2 t70 -79.81 -22.26 43.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.021 0.438 . . . . 0.0 111.562 -172.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.6 ' CD2' ' HA ' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -93.62 -54.81 3.5 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.582 -170.556 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.588 ' HG3' ' H ' ' A' ' 7' ' ' TYR . 8.4 mm-40 -135.26 102.99 5.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.18 0.514 . . . . 0.0 110.892 -177.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 p -119.96 88.95 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.859 0.838 . . . . 0.0 108.934 174.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -71.56 90.11 1.0 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.088 -175.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 . . . . . 0 C--O 1.244 0.791 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.627 173.28 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.659 0 N-CA-C 112.106 -0.398 . . . . 0.0 112.106 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.1 m -84.43 166.97 16.88 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -148.65 149.91 32.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.202 0.525 . . . . 0.0 111.185 -178.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.497 ' CG2' ' HE2' ' A' ' 97' ' ' TYR . 14.9 t -82.72 -26.14 32.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 122.257 1.027 . . . . 0.0 108.296 171.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.675 HG21 HD21 ' A' ' 26' ' ' ASN . 2.3 p 178.27 159.57 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 113.291 -1.777 . . . . 0.0 109.412 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 -144.91 120.08 10.14 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 176.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 5.9 p90 -123.52 168.28 12.8 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.478 0.656 . . . . 0.0 111.853 -171.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.493 ' HB3' ' NE ' ' A' ' 20' ' ' ARG . 8.1 tp60 -146.79 115.25 6.71 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.125 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.818 HG12 HG12 ' A' ' 19' ' ' ILE . 30.5 mt -82.73 122.75 37.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.036 0.446 . . . . 0.0 110.281 176.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.413 ' OE2' ' HD2' ' A' ' 20' ' ' ARG . 12.4 pt-20 -120.7 169.68 10.16 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.209 -178.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -93.85 128.43 40.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.473 0.654 . . . . 0.0 110.56 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.599 HD23 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -69.56 -47.65 62.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.703 -177.589 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -161.61 -72.09 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -142.41 -34.42 0.45 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.223 -0.191 . . . . 0.0 111.513 177.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.1 p -144.1 42.95 1.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.795 0.807 . . . . 0.0 111.234 -176.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.46 ' HB1' ' HB3' ' A' ' 12' ' ' LEU . . . -150.45 152.75 34.76 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.204 177.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.696 ' HB2' ' HH ' ' A' ' 62' ' ' TYR . 30.8 ttp -125.4 133.12 52.62 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.751 -0.78 . . . . 0.0 112.484 -173.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.599 ' HB2' HD23 ' A' ' 12' ' ' LEU . 53.7 ttm -119.02 131.76 56.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.965 176.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.818 HG12 HG12 ' A' ' 9' ' ' ILE . 7.3 mt -123.44 109.04 22.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.65 -176.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.527 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -102.76 134.42 46.18 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.501 -179.343 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 35.3 m-85 -101.63 -144.57 0.35 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.473 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -93.43 -176.09 40.3 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 176.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.64 -45.77 0.11 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 117.414 0.607 . . . . 0.0 112.242 -175.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -59.45 -58.2 9.65 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -171.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.7 pp -120.75 20.88 5.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.123 0.487 . . . . 0.0 111.137 -175.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.675 HD21 HG21 ' A' ' 5' ' ' VAL . 1.9 m-20 -101.52 101.7 12.32 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.304 -173.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -77.62 -33.42 53.64 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.394 175.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.4 tm0? -58.07 -47.84 81.93 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.37 -177.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.685 ' O ' HG22 ' A' ' 33' ' ' VAL . 4.9 p -60.31 -55.38 24.64 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.113 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -175.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -55.88 -29.48 60.03 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.389 0.431 . . . . 0.0 111.355 -176.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.68 -35.98 17.7 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.362 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.581 HG23 HD13 ' A' ' 93' ' ' ILE . 0.4 OUTLIER -93.48 -28.55 4.37 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.872 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -170.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.685 HG22 ' O ' ' A' ' 29' ' ' VAL . 3.1 m -62.7 -35.68 71.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.744 176.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.5 t60 -71.93 -33.13 68.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.157 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.32 -32.81 24.11 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.124 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.622 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -64.9 -24.11 67.43 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 122.772 0.429 . . . . 0.0 111.203 -177.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.484 ' HB1' ' HD3' ' A' ' 53' ' ' PRO . . . -61.38 -40.3 93.82 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.739 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -85.57 -32.64 22.01 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.102 174.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.622 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 4.4 t80 -54.67 -42.53 71.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.126 0.489 . . . . 0.0 110.603 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.512 HD13 HD22 ' A' ' 58' ' ' LEU . 51.9 mt -78.06 -31.86 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.237 -177.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.739 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 10.0 pt-20 -79.5 -23.73 42.76 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.763 -177.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -78.12 -33.28 50.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.497 174.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -126.88 68.88 71.68 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.832 0.349 . . . . 0.0 110.302 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -96.03 179.17 0.57 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.109 2.539 . . . . 0.0 113.972 -171.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -111.29 146.48 34.67 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.1 171.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -43.03 -35.19 4.44 Favored 'Trans proline' 0 N--CA 1.479 0.636 0 C-N-CA 123.457 2.771 . . . . 0.0 114.992 -171.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.488 ' HA3' ' CB ' ' A' ' 66' ' ' GLU . . . -98.73 16.18 59.95 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.713 -175.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -60.68 135.99 57.93 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.08 0.466 . . . . 0.0 111.099 175.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.866 HG21 ' HG2' ' A' ' 50' ' ' GLU . 40.6 mm -110.65 -61.36 2.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.065 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.866 ' HG2' HG21 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -153.19 169.57 22.67 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.471 0.653 . . . . 0.0 111.16 -178.315 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 59' ' ' THR . 4.2 p -161.76 117.54 2.05 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.096 167.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.601 HG12 ' HB ' ' A' ' 59' ' ' THR . 0.1 OUTLIER -127.75 136.48 29.04 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.691 -175.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.484 ' HD3' ' HB1' ' A' ' 37' ' ' ALA . 71.1 Cg_endo -78.75 138.35 14.92 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.778 2.319 . . . . 0.0 112.546 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.97 58.53 1.02 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.683 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 62.9 t80 70.61 -65.53 0.33 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.695 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 t -119.11 -17.48 8.95 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.999 0.428 . . . . 0.0 111.454 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 4.3 p -112.9 144.79 41.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.204 0.526 . . . . 0.0 111.272 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.512 HD22 HD13 ' A' ' 40' ' ' ILE . 53.0 tp -102.75 118.24 36.4 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.601 ' HB ' HG12 ' A' ' 52' ' ' ILE . 0.7 OUTLIER -93.76 106.55 18.51 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.71 -177.245 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.6 t -106.2 126.12 61.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.308 0.575 . . . . 0.0 111.177 -173.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.579 ' HB2' ' HG3' ' A' ' 50' ' ' GLU . 89.5 m-85 -120.15 147.06 45.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.245 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.696 ' HH ' ' HB2' ' A' ' 17' ' ' MET . 1.9 p90 -166.11 172.39 11.37 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.292 0.567 . . . . 0.0 111.065 -172.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.417 ' OD1' ' HB3' ' A' ' 65' ' ' TYR . 10.9 t0 -99.0 113.41 25.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.662 -179.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.501 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -60.78 -20.5 61.57 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.48 -178.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.417 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -70.54 -31.79 68.98 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.94 0.4 . . . . 0.0 110.789 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.488 ' CB ' ' HA3' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -90.36 -29.56 17.98 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.503 0.668 . . . . 0.0 109.724 -173.528 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.501 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.4 m -74.9 -32.15 27.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.392 176.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.764 ' HA ' HD23 ' A' ' 71' ' ' LEU . 50.7 t80 -66.2 -24.0 66.55 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.636 175.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.82 -32.75 69.66 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.869 0.842 . . . . 0.0 108.732 174.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -91.89 -69.37 0.74 Allowed 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.197 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.764 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER 22.73 76.75 0.23 Allowed Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 124.804 1.242 . . . . 0.0 113.567 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.421 ' HD2' HG13 ' A' ' 75' ' ' ILE . 44.1 Cg_exo -58.02 153.03 47.43 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.513 2.142 . . . . 0.0 111.639 176.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -61.0 -29.19 69.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.481 -173.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.83 -30.16 56.36 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.328 -0.939 . . . . 0.0 111.025 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.587 HG23 ' HB3' ' A' ' 81' ' ' SER . 14.1 mm -76.78 108.26 9.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.947 -0.627 . . . . 0.0 110.079 177.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.2 t -89.29 -8.85 52.51 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.322 0.582 . . . . 0.0 110.464 -176.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 69.9 m -133.36 134.21 23.68 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.073 -173.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.657 ' HA ' HD22 ' A' ' 71' ' ' LEU . 84.8 Cg_exo -49.55 -49.23 16.28 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.539 2.826 . . . . 0.0 113.132 176.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.421 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -60.35 -26.88 66.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.008 0.432 . . . . 0.0 111.544 178.546 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -79.11 -21.47 46.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.075 -175.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.587 ' HB3' HG23 ' A' ' 75' ' ' ILE . 78.4 p -82.33 -37.59 25.49 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 176.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 78' ' ' PRO . 59.8 t -59.4 -29.13 41.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.823 177.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.475 ' HE2' HG22 ' A' ' 9' ' ' ILE . 95.4 mttt -52.22 -47.02 65.87 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -63.46 -33.26 75.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.654 -174.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -70.61 -38.26 73.94 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.384 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.436 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 35.7 m -87.3 -44.53 16.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -178.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -52.31 -45.19 65.46 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.117 0.567 . . . . 0.0 111.994 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.507 ' HG3' ' HD3' ' A' ' 89' ' ' ARG . 9.0 pt-20 -57.89 -31.01 66.32 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.974 0.416 . . . . 0.0 111.301 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.507 ' HD3' ' HG3' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -86.46 -38.33 17.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.295 0.569 . . . . 0.0 110.913 177.332 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.724 ' O ' HG12 ' A' ' 93' ' ' ILE . 81.9 mt -70.71 -35.5 72.78 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.453 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 96' ' ' ASP . . . -49.19 -26.58 2.95 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.776 175.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -78.78 -6.94 57.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.643 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.724 HG12 ' O ' ' A' ' 90' ' ' LEU . 5.9 pt -105.48 -41.81 6.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -174.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -179.28 -39.67 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 120.786 0.326 . . . . 0.0 111.738 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.62 ' HG2' ' HB3' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -65.16 -4.82 5.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.699 -173.088 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 9.9 t70 -38.75 -36.18 0.25 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.903 167.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.497 ' HE2' ' CG2' ' A' ' 4' ' ' THR . 3.3 m-85 -75.32 -14.79 60.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.637 -174.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -161.1 96.13 1.08 Allowed 'General case' 0 C--O 1.22 -0.461 0 CA-C-O 120.923 0.392 . . . . 0.0 111.526 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 m -82.05 87.53 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.595 ' OD1' ' HB ' ' A' ' 9' ' ' ILE . 5.2 t-20 -6.25 -88.07 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 113.123 -1.853 . . . . 0.0 114.028 -172.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.525 ' HA ' ' NE ' ' A' ' 101' ' ' ARG . 4.9 mmp_? . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.748 -0.644 . . . . 0.0 109.951 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.647 0 N-CA-C 111.511 -0.635 . . . . 0.0 111.511 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.7 p -90.12 2.65 55.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.87 0.367 . . . . 0.0 111.521 -176.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -59.37 156.01 13.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.263 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.539 ' O ' HG11 ' A' ' 5' ' ' VAL . 12.3 t -84.22 40.99 0.8 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.822 -174.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.755 HG23 HG12 ' A' ' 29' ' ' VAL . 0.3 OUTLIER 67.6 153.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.713 1.205 . . . . 0.0 112.665 -179.542 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.428 ' CG ' ' HB2' ' A' ' 23' ' ' GLU . 28.0 mmt180 -133.43 144.55 49.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.052 175.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.564 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . 20.0 p90 -164.25 161.1 21.8 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.423 HE21 ' HB3' ' A' ' 8' ' ' GLN . 13.6 mt-30 -139.39 133.31 30.89 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.842 176.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.872 HG12 HG12 ' A' ' 19' ' ' ILE . 26.8 mt -95.53 127.54 47.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.132 -178.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 18' ' ' MET . 11.4 pt-20 -122.57 171.43 9.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.423 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.66 137.73 32.08 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.179 0.514 . . . . 0.0 110.947 177.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.578 HD21 ' CG2' ' A' ' 59' ' ' THR . 0.0 OUTLIER -79.59 -20.33 47.19 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.01 175.322 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.2 -80.96 0.19 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.733 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -107.05 -55.44 2.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.842 0.353 . . . . 0.0 111.778 -175.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.498 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 4.6 p -149.29 42.01 0.91 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.648 0.737 . . . . 0.0 110.984 -172.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HB1' ' HB3' ' A' ' 12' ' ' LEU . . . -142.65 157.91 44.2 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.47 173.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.718 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 35.1 ttp -130.02 133.02 46.46 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.929 -174.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.562 ' HB2' HD23 ' A' ' 12' ' ' LEU . 32.8 ttp -124.06 135.38 53.53 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.109 175.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.872 HG12 HG12 ' A' ' 9' ' ' ILE . 5.0 mt -120.05 124.4 72.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.114 -176.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.523 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -104.53 118.76 37.39 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.237 178.347 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.564 ' CD2' ' HB3' ' A' ' 7' ' ' TYR . 53.3 m-85 -83.64 -176.74 6.44 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.748 173.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.633 ' HA2' HG23 ' A' ' 29' ' ' VAL . . . 126.89 131.34 3.5 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.403 176.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.783 ' HG2' ' HG2' ' A' ' 24' ' ' GLU . 39.1 tt0 -128.3 -84.27 0.58 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.876 0.37 . . . . 0.0 110.265 175.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.783 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 13.5 mm-40 -103.78 -77.77 0.57 Allowed 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.2 pt -149.02 31.22 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 114.435 -1.257 . . . . 0.0 107.813 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.576 ' HB2' HG22 ' A' ' 29' ' ' VAL . 1.7 m-20 -60.6 125.3 23.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.734 -1.575 . . . . 0.0 113.378 -166.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -60.13 -34.99 74.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.463 166.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -58.8 -51.93 67.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.976 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.755 HG12 HG23 ' A' ' 5' ' ' VAL . 17.0 m -65.97 -43.82 92.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.821 0.344 . . . . 0.0 110.251 -177.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.82 -41.66 95.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.762 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.51 -37.88 29.88 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.394 -175.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.451 HG13 HD12 ' A' ' 93' ' ' ILE . 0.3 OUTLIER -79.1 -29.06 13.78 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.749 0 C-N-CA 120.224 -0.591 . . . . 0.0 111.946 -175.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.433 HG22 ' HB2' ' A' ' 58' ' ' LEU . 14.1 p -71.02 -28.81 34.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -69.71 -40.27 76.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.074 173.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.09 -20.64 30.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.931 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.87 -30.44 70.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.722 0.296 . . . . 0.0 111.469 -173.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.22 98.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.719 0.771 . . . . 0.0 108.99 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.505 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -78.29 -25.67 46.73 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.73 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -66.14 -45.01 82.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.344 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.489 ' CD1' HD23 ' A' ' 58' ' ' LEU . 41.8 mt -76.25 -38.05 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.346 -175.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.505 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 14.4 pt-20 -69.6 -19.99 63.64 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.238 -175.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -91.95 -24.37 19.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.609 0.242 . . . . 0.0 110.762 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -127.1 68.84 72.88 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 175.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -95.56 -171.0 0.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.451 2.767 . . . . 0.0 113.816 -170.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -127.29 147.07 60.49 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.376 176.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -40.69 -36.74 2.0 Allowed 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.107 3.204 . . . . 0.0 115.317 -170.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -102.51 19.31 48.37 Favored Glycine 0 C--O 1.226 -0.404 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.518 -174.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -64.36 135.8 56.51 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.081 0.467 . . . . 0.0 111.211 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 62' ' ' TYR . 32.6 mm -107.67 -58.54 3.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.236 -178.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -167.17 160.86 14.15 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.197 -176.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.6 p -149.97 119.76 7.08 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 172.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.806 HG13 ' HB ' ' A' ' 59' ' ' THR . 5.3 pt -114.56 132.58 22.79 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-O 121.2 0.524 . . . . 0.0 111.845 -175.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -85.61 123.03 2.44 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.243 2.629 . . . . 0.0 112.395 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.18 27.72 7.97 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.299 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 70.92 -28.5 0.18 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.248 -0.887 . . . . 0.0 113.298 174.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -140.84 7.23 2.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.336 0.589 . . . . 0.0 110.711 171.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 47.3 m -148.18 144.36 27.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.775 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.489 HD23 ' CD1' ' A' ' 40' ' ' ILE . 54.4 tp -115.61 111.66 20.98 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.95 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.806 ' HB ' HG13 ' A' ' 52' ' ' ILE . 3.8 m -90.18 106.68 18.65 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.6 t -104.9 117.41 50.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.541 0.686 . . . . 0.0 110.88 -174.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.428 ' CE1' HG21 ' A' ' 59' ' ' THR . 80.8 m-85 -105.5 147.15 28.64 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.791 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.587 ' HH ' ' HA ' ' A' ' 79' ' ' PHE . 3.8 p90 -165.75 164.64 18.84 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.382 -176.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -99.31 114.5 27.4 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.333 -175.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.498 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 0.4 OUTLIER -65.12 -20.85 66.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.65 -169.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.647 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 0.5 OUTLIER -68.41 -29.5 68.19 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.267 -178.07 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -91.88 -35.56 13.98 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 121.445 0.641 . . . . 0.0 109.513 -175.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.49 HG21 ' HA ' ' A' ' 64' ' ' MET . 3.3 m -68.37 -29.91 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.85 177.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 1.005 ' HA ' HD22 ' A' ' 71' ' ' LEU . 30.1 t80 -69.61 -22.93 63.45 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.516 174.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.647 ' HG2' ' O ' ' A' ' 65' ' ' TYR . 27.4 mmmt -76.25 -25.42 54.97 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -89.5 -35.6 15.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.428 178.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 1.005 HD22 ' HA ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -16.89 90.21 0.04 OUTLIER Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 125.606 1.562 . . . . 0.0 112.779 178.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.633 ' HD2' HG13 ' A' ' 75' ' ' ILE . 22.8 Cg_exo -66.33 136.62 44.28 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.196 2.597 . . . . 0.0 110.941 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -65.61 100.17 0.5 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.818 0.818 . . . . 0.0 110.417 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.46 -26.02 1.83 Allowed Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -171.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.633 HG13 ' HD2' ' A' ' 72' ' ' PRO . 11.6 mm -87.75 132.9 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 114.627 -0.787 . . . . 0.0 109.636 172.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.5 t -103.44 1.11 32.07 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.159 0.504 . . . . 0.0 110.522 -176.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.592 ' HB3' ' HB3' ' A' ' 80' ' ' GLU . 21.0 t -146.57 129.41 7.98 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -170.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.702 ' HA ' HD21 ' A' ' 71' ' ' LEU . 95.8 Cg_exo -47.51 -44.42 25.44 Favored 'Trans proline' 0 C--O 1.221 -0.352 0 C-N-CA 123.577 2.851 . . . . 0.0 112.807 169.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.587 ' HA ' ' HH ' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -67.27 -36.8 82.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.034 0.445 . . . . 0.0 110.913 176.728 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.592 ' HB3' ' HB3' ' A' ' 77' ' ' SER . 39.9 tt0 -71.33 -27.09 63.13 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.595 -174.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.559 ' HB3' HG23 ' A' ' 75' ' ' ILE . 76.9 p -77.6 -37.64 49.88 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 78' ' ' PRO . 58.2 t -60.73 -34.71 59.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.102 178.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.718 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 5.3 mtmp? -53.21 -42.7 66.56 Favored 'General case' 0 C--O 1.213 -0.82 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 176.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.56 -34.24 73.91 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.483 -175.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -62.72 -41.55 99.21 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.455 176.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.478 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 32.7 m -84.29 -39.69 14.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.924 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.454 ' OE2' ' HB3' ' A' ' 83' ' ' LYS . 39.9 mt-10 -48.66 -52.42 23.37 Favored 'General case' 0 C--O 1.218 -0.572 0 C-N-CA 123.207 0.603 . . . . 0.0 112.083 178.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -63.53 -28.52 70.0 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.356 -176.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.33 -42.72 22.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.475 0.655 . . . . 0.0 110.31 176.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.709 ' O ' HG12 ' A' ' 93' ' ' ILE . 95.5 mt -64.09 -37.21 86.63 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.604 177.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.541 ' O ' ' HB2' ' A' ' 96' ' ' ASP . . . -47.19 -34.42 6.31 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.644 175.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -70.15 -7.8 44.6 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.488 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.709 HG12 ' O ' ' A' ' 90' ' ' LEU . 2.8 pt -104.59 -43.64 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 120.465 -0.494 . . . . 0.0 112.066 -173.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 179.61 -42.46 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.905 0.383 . . . . 0.0 111.674 -173.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.703 ' HG2' ' HB3' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -62.61 -16.91 58.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.11 -170.877 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 23.4 t70 -48.83 -28.48 3.75 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.591 0.557 . . . . 0.0 112.316 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.451 ' HB2' HG21 ' A' ' 4' ' ' THR . 1.3 m-30 -72.02 -23.6 61.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.367 -173.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -128.17 -59.95 1.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.86 -0.155 . . . . 0.0 111.245 -177.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.1 t 73.53 123.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.593 0.711 . . . . 0.0 111.659 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -78.14 58.9 2.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.849 175.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 . . . . . 0 C--O 1.25 1.119 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.994 -179.459 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.745 0 N-CA-C 112.314 -0.314 . . . . 0.0 112.314 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.0 m -84.54 81.24 8.93 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -151.24 176.44 11.21 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.148 0.499 . . . . 0.0 111.726 -176.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.6 t -63.4 150.22 44.07 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.007 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.671 ' HA ' HD22 ' A' ' 26' ' ' ASN . 0.7 OUTLIER -85.83 -170.86 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.977 179.038 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.401 ' H ' ' HB ' ' A' ' 5' ' ' VAL . 14.7 mmt180 -148.29 117.72 6.96 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.466 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . 27.0 p90 -143.63 162.86 34.83 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.8 0.809 . . . . 0.0 112.378 -176.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.26 140.44 45.21 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.135 -1.393 . . . . 0.0 108.511 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.743 HG23 ' HD3' ' A' ' 83' ' ' LYS . 34.2 mt -113.81 131.26 66.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.9 -175.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -121.85 169.53 10.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.203 0.525 . . . . 0.0 110.432 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.555 HE21 ' HA ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -94.42 131.29 40.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.642 176.763 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.613 HD23 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -69.05 -50.11 51.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.639 -176.289 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.99 -69.96 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.703 176.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -110.57 -71.06 0.78 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.983 0.42 . . . . 0.0 111.433 -176.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.9 p -135.91 47.07 2.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.674 0.75 . . . . 0.0 110.792 -175.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.29 153.75 42.34 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.006 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.69 ' HB2' ' HH ' ' A' ' 62' ' ' TYR . 26.7 ttp -121.52 136.61 54.94 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.652 -0.419 . . . . 0.0 112.112 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.613 ' HB2' HD23 ' A' ' 12' ' ' LEU . 49.5 ttm -122.49 131.82 54.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.31 0.576 . . . . 0.0 110.049 176.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.727 HG12 HG12 ' A' ' 9' ' ' ILE . 4.0 mt -118.64 140.58 41.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.459 -178.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.4 ' N ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -123.26 117.56 25.57 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.361 0.601 . . . . 0.0 109.935 176.074 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.466 ' CD2' ' HB3' ' A' ' 7' ' ' TYR . 35.8 m-85 -82.71 -174.63 5.34 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.108 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.453 ' C ' HG22 ' A' ' 29' ' ' VAL . . . -84.44 -138.09 3.86 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.688 178.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 170.45 -61.59 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.331 0.586 . . . . 0.0 109.548 -174.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -61.89 136.18 57.87 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.158 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.5 pt 50.36 23.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 O-C-N 124.862 1.351 . . . . 0.0 112.752 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.671 HD22 ' HA ' ' A' ' 5' ' ' VAL . 67.3 t30 -162.53 76.86 0.46 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.287 0.565 . . . . 0.0 110.549 176.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -62.69 -17.93 61.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.656 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -32.8 66.72 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.004 -179.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.504 HG21 ' O ' ' A' ' 26' ' ' ASN . 35.4 m -55.19 -41.95 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 120.799 0.333 . . . . 0.0 110.931 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.404 ' N ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -66.91 -19.75 65.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.272 -177.138 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.71 -45.56 4.85 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.254 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.11 -21.35 12.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.687 -175.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 55' ' ' PHE . 14.5 p -70.76 -31.11 44.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 174.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -77.67 -36.71 51.07 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.03 177.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.79 -20.79 45.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.005 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.404 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -65.49 -26.99 68.17 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.659 0.266 . . . . 0.0 110.764 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.513 ' O ' ' HG3' ' A' ' 41' ' ' GLU . . . -62.75 -46.17 89.32 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.2 -34.94 63.88 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.607 176.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.404 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 19.3 t80 -54.98 -41.14 70.83 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.79 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.407 HD13 HD23 ' A' ' 58' ' ' LEU . 48.8 mt -76.74 -27.01 16.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.239 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' A' ' 37' ' ' ALA . 41.6 mt-10 -79.42 -41.55 27.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.957 0.408 . . . . 0.0 111.398 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -63.27 -35.35 80.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.181 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.472 ' HB2' ' NH1' ' A' ' 89' ' ' ARG . 40.2 mt-30 -129.55 75.93 79.26 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.897 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -95.17 177.98 0.78 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.754 2.303 . . . . 0.0 113.332 -174.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -121.46 146.47 45.17 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -45.23 -28.46 3.62 Favored 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 124.104 3.203 . . . . 0.0 115.307 -169.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.02 20.4 38.43 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.385 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -64.23 136.19 56.97 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.134 0.492 . . . . 0.0 111.375 177.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.407 HG12 ' HA ' ' A' ' 62' ' ' TYR . 39.1 mm -108.25 -58.96 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.449 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -165.94 161.16 17.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.678 0.275 . . . . 0.0 110.552 -175.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 2.4 p -152.09 119.16 5.86 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.755 HG13 ' HB ' ' A' ' 59' ' ' THR . 5.5 pt -123.81 136.12 27.02 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.834 -177.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -87.28 158.91 8.29 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.127 2.552 . . . . 0.0 112.414 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.95 48.67 1.22 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.159 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.403 ' O ' HG12 ' A' ' 33' ' ' VAL . 87.1 t80 72.54 -47.58 0.67 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.543 0.737 . . . . 0.0 112.323 174.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.1 t -133.66 -20.47 2.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.987 0.423 . . . . 0.0 110.729 177.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.4 m -108.21 152.12 25.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.011 0.434 . . . . 0.0 110.801 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.407 HD23 HD13 ' A' ' 40' ' ' ILE . 47.3 tp -126.01 122.69 36.61 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.608 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.755 ' HB ' HG13 ' A' ' 52' ' ' ILE . 5.2 m -104.16 107.18 17.97 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.188 -178.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.4 t -105.22 119.63 54.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.451 0.644 . . . . 0.0 111.241 -175.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -106.85 146.89 30.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.439 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.69 ' HH ' ' HB2' ' A' ' 17' ' ' MET . 2.4 p90 -166.32 167.85 15.57 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.046 0.451 . . . . 0.0 110.64 -175.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.41 ' OD1' ' HD1' ' A' ' 65' ' ' TYR . 5.6 t0 -98.55 117.27 32.61 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.329 -178.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.593 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -64.01 -22.67 67.03 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.835 -174.641 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.41 ' HD1' ' OD1' ' A' ' 63' ' ' ASP . 0.2 OUTLIER -69.51 -28.16 65.8 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.699 0.285 . . . . 0.0 111.142 -175.485 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -89.53 -43.38 10.85 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -171.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 m -66.93 -27.69 40.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.853 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.898 ' HA ' HD21 ' A' ' 71' ' ' LEU . 12.1 t80 -66.71 -22.35 66.07 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.049 0.54 . . . . 0.0 110.777 175.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.73 -34.33 62.53 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 173.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -76.07 -38.13 57.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.576 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.898 HD21 ' HA ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -20.33 92.21 0.04 OUTLIER Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 125.814 1.645 . . . . 0.0 113.545 178.461 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.693 ' HD2' HG13 ' A' ' 75' ' ' ILE . 20.9 Cg_exo -68.99 152.13 73.31 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 123.177 2.585 . . . . 0.0 110.264 173.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -67.77 -17.52 64.57 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -171.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.98 -19.04 70.95 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.19 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.693 HG13 ' HD2' ' A' ' 72' ' ' PRO . 11.4 mm -89.75 137.53 21.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.86 -0.67 . . . . 0.0 109.529 175.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.1 m -116.55 2.14 13.01 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.377 0.608 . . . . 0.0 110.568 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.475 ' HB3' ' HB3' ' A' ' 80' ' ' GLU . 31.2 t -141.22 130.7 12.79 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.969 -173.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.655 ' HA ' HD23 ' A' ' 71' ' ' LEU . 80.0 Cg_exo -43.95 -54.73 3.57 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.403 2.735 . . . . 0.0 112.265 169.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.47 ' HD1' ' HB2' ' A' ' 17' ' ' MET . 0.0 OUTLIER -53.35 -42.19 66.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.221 175.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.513 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 38.7 tt0 -72.39 -19.59 61.58 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.201 -173.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.446 ' HB2' HG22 ' A' ' 75' ' ' ILE . 48.2 t -81.09 -40.08 24.67 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.468 HG11 ' CD2' ' A' ' 62' ' ' TYR . 39.0 t -63.65 -30.77 50.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.987 177.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.743 ' HD3' HG23 ' A' ' 9' ' ' ILE . 7.4 mmmt -49.53 -47.61 48.81 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.208 173.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.564 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 19.7 mmt180 -67.9 -38.74 83.34 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.008 -172.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -63.85 -34.9 78.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.121 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.7 m -88.45 -44.69 15.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.501 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 83' ' ' LYS . 57.6 mt-10 -57.78 -42.41 84.06 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.564 ' HG2' ' O ' ' A' ' 84' ' ' ARG . 10.6 pt-20 -64.03 -28.91 70.12 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.399 0.619 . . . . 0.0 111.056 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.472 ' NH1' ' HB2' ' A' ' 43' ' ' GLN . 47.7 mtm180 -86.05 -46.02 10.88 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.119 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.644 ' O ' HD13 ' A' ' 93' ' ' ILE . 83.9 mt -51.66 -37.88 52.41 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.327 -0.852 . . . . 0.0 108.851 170.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.476 ' HB1' ' O ' ' A' ' 88' ' ' GLU . . . -51.05 -17.78 0.68 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.593 -1.185 . . . . 0.0 113.461 173.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 89' ' ' ARG . 67.7 mt-10 -49.52 -38.7 31.64 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 118.881 0.764 . . . . 0.0 110.484 173.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.644 HD13 ' O ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -117.66 -21.93 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.655 169.541 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.532 ' HB1' ' HD2' ' A' ' 97' ' ' TYR . . . -91.49 36.63 0.94 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.9 0.857 . . . . 0.0 109.645 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -44.17 -37.21 3.02 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.395 -1.729 . . . . 0.0 111.752 175.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -80.21 -22.31 41.99 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.143 -175.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.532 ' HD2' ' HB1' ' A' ' 94' ' ' ALA . 8.4 m-85 -100.69 15.94 26.57 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.526 -167.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -50.36 -29.81 10.81 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.311 0.577 . . . . 0.0 111.804 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.0 m -100.63 49.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.156 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -69.74 140.31 53.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.724 -173.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 . . . . . 0 N--CA 1.438 -1.073 0 CA-C-O 117.718 -1.134 . . . . 0.0 108.333 167.571 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.77 0 N-CA-C 111.893 -0.483 . . . . 0.0 111.893 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.5 m -90.51 32.55 0.95 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.781 0.324 . . . . 0.0 110.305 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.7 mpp? 64.22 171.73 0.18 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.256 -175.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.599 ' O ' HG12 ' A' ' 5' ' ' VAL . 5.1 t -124.05 12.04 8.95 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.777 175.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.599 HG12 ' O ' ' A' ' 4' ' ' THR . 0.5 OUTLIER 63.86 156.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 114.044 -1.434 . . . . 0.0 113.701 173.406 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.784 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 25.1 mmm180 -131.32 139.61 49.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.669 176.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.498 ' HH ' ' HG2' ' A' ' 87' ' ' GLU . 39.9 p90 -167.76 172.75 8.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.041 -174.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.504 ' O ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.11 121.6 20.55 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.858 178.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.936 HG12 HG12 ' A' ' 19' ' ' ILE . 18.6 mt -91.46 125.79 44.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.221 177.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -120.54 149.81 41.85 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.101 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -76.9 126.44 30.97 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.281 0.562 . . . . 0.0 110.21 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.623 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -67.47 -37.52 83.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.51 -177.589 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.54 -79.23 0.11 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.416 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -98.98 -68.73 0.79 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.802 0.334 . . . . 0.0 111.782 -177.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.9 p -143.46 49.79 1.41 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.975 0.893 . . . . 0.0 110.239 -174.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -142.46 152.11 42.41 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.371 177.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.496 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 34.1 ttp -124.0 130.55 52.75 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.443 -0.503 . . . . 0.0 112.016 -175.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.623 ' HB2' HD22 ' A' ' 12' ' ' LEU . 50.9 ttm -116.47 126.8 53.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.277 0.56 . . . . 0.0 110.43 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.936 HG12 HG12 ' A' ' 9' ' ' ILE . 7.9 mt -119.66 126.36 75.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.404 -176.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.504 ' HD3' ' O ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -115.06 122.51 46.37 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.89 176.128 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.665 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 28.2 m-85 -85.97 -166.3 1.49 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.882 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.658 ' HA2' HG23 ' A' ' 29' ' ' VAL . . . 111.91 104.05 2.72 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.784 ' HB3' ' HB2' ' A' ' 6' ' ' ARG . 12.3 pt-20 -114.21 -152.81 0.51 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -176.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.417 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 3.8 mp0 -53.47 -69.84 0.11 Allowed 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -176.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.0 pp -143.02 24.97 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.19 0.519 . . . . 0.0 111.566 -172.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.416 ' O ' HG22 ' A' ' 29' ' ' VAL . 47.0 t30 -105.8 114.57 28.81 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.723 -172.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -78.63 -18.2 54.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.085 177.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.87 -29.69 60.34 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 110.696 -177.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.665 ' HB ' ' HB3' ' A' ' 21' ' ' PHE . 32.9 m -59.2 -33.47 50.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.083 0.468 . . . . 0.0 110.783 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -78.97 -18.59 53.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.557 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.83 -37.98 7.11 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.716 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.87 -27.57 12.4 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.994 -176.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.487 HG23 ' HB2' ' A' ' 58' ' ' LEU . 7.2 p -62.76 -32.03 54.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.177 0.513 . . . . 0.0 109.937 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -70.48 -39.11 74.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.171 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.35 -20.3 32.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.483 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.19 -23.9 67.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.432 -176.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.73 -42.32 99.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.746 0.784 . . . . 0.0 109.198 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.458 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.19 -29.67 26.4 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.699 176.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -59.21 -45.71 90.38 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.302 -178.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.419 HD12 HD23 ' A' ' 58' ' ' LEU . 58.5 mt -71.12 -37.98 69.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.503 -176.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.458 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 13.0 pt-20 -75.37 -19.69 59.43 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.31 -174.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 33.5 mt-10 -80.7 -32.14 35.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.922 0.391 . . . . 0.0 110.613 175.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -126.3 64.25 54.01 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.969 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.404 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 72.9 Cg_endo -91.96 176.34 1.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.03 2.487 . . . . 0.0 114.059 -169.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -106.41 146.61 33.34 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.134 173.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.58 -5.99 0.21 Allowed 'Trans proline' 0 N--CA 1.482 0.847 0 C-N-CA 124.085 3.19 . . . . 0.0 115.3 -172.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.23 29.23 5.35 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.943 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -71.09 135.17 47.56 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.836 0.35 . . . . 0.0 111.12 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.2 mm -110.62 -60.34 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.46 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -164.85 155.88 14.7 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.907 -172.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 59' ' ' THR . 4.6 p -152.15 119.47 5.95 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.086 0.469 . . . . 0.0 110.094 173.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.763 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.0 pt -117.67 129.62 25.23 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-O 121.285 0.564 . . . . 0.0 112.068 -178.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -85.82 139.03 6.3 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.378 2.719 . . . . 0.0 112.753 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -126.49 46.06 2.54 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.947 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.2 t80 72.1 -40.01 0.46 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.539 0.735 . . . . 0.0 112.731 174.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.1 t -136.44 -18.4 1.48 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.702 0.287 . . . . 0.0 111.25 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 p -120.3 140.59 51.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.08 0.467 . . . . 0.0 110.966 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.487 ' HB2' HG23 ' A' ' 33' ' ' VAL . 40.8 tp -108.98 119.73 40.44 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.763 ' HB ' HG13 ' A' ' 52' ' ' ILE . 2.2 m -95.01 106.11 18.07 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.5 t -105.54 125.26 60.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.505 0.669 . . . . 0.0 111.507 -173.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -116.93 146.71 42.81 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.297 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.603 ' HH ' ' HB2' ' A' ' 79' ' ' PHE . 2.1 p90 -164.96 170.71 14.91 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.011 0.434 . . . . 0.0 110.281 -174.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -101.09 107.97 19.53 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.533 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.474 ' N ' ' SD ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -62.41 -20.69 64.74 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.599 -176.422 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.29 -28.36 68.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.984 0.421 . . . . 0.0 110.207 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -90.58 -39.12 12.72 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.667 0.746 . . . . 0.0 109.151 -172.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -67.24 -30.78 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.719 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.715 ' HA ' HD23 ' A' ' 71' ' ' LEU . 48.0 t80 -58.23 -26.93 63.46 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.563 0.745 . . . . 0.0 111.801 175.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.77 -26.4 59.73 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.415 0.626 . . . . 0.0 109.862 176.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -90.25 -33.56 16.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.146 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.715 HD23 ' HA ' ' A' ' 68' ' ' TYR . 1.1 mm? -23.48 91.75 0.04 OUTLIER Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 125.764 1.626 . . . . 0.0 113.037 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.643 ' HD2' HG13 ' A' ' 75' ' ' ILE . 12.1 Cg_exo -73.49 146.81 39.99 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 123.485 2.79 . . . . 0.0 111.676 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -69.43 108.92 3.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.439 0.638 . . . . 0.0 110.089 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 133.99 -30.68 2.91 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 -170.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.643 HG13 ' HD2' ' A' ' 72' ' ' PRO . 9.1 mm -86.01 108.36 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 114.196 -1.002 . . . . 0.0 108.504 170.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.2 t -90.13 -6.67 55.15 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.125 0.488 . . . . 0.0 110.461 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 74.0 m -135.17 131.86 19.9 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.656 ' HA ' HD22 ' A' ' 71' ' ' LEU . 56.3 Cg_exo -43.42 -55.5 2.88 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.719 2.946 . . . . 0.0 113.079 173.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.603 ' HB2' ' HH ' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -57.37 -30.96 65.31 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.763 -179.244 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -73.14 -27.45 61.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.955 -176.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.517 ' HB2' HG23 ' A' ' 75' ' ' ILE . 36.9 t -73.62 -35.95 65.39 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.401 HG12 ' CE2' ' A' ' 62' ' ' TYR . 41.7 t -66.13 -30.89 51.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.651 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.73 ' HZ2' ' HB3' ' A' ' 83' ' ' LYS . 9.8 mtpm? -52.5 -46.12 66.5 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.966 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.421 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 20.5 mmt180 -61.07 -41.82 97.36 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.983 -175.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -70.27 -38.47 75.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.6 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.506 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 32.6 m -87.04 -49.32 14.9 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.617 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -175.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.498 ' HG2' ' HH ' ' A' ' 7' ' ' TYR . 50.6 mt-10 -52.07 -49.73 62.94 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -174.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.837 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 6.8 pt-20 -66.44 -25.04 66.55 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.836 -178.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -87.83 -19.81 26.94 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 121.947 -0.471 . . . . 0.0 112.028 174.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 86' ' ' VAL . 14.4 mt -53.21 -71.81 0.06 Allowed 'General case' 0 C--N 1.319 -0.727 0 O-C-N 123.628 0.58 . . . . 0.0 112.54 -166.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.09 -78.21 0.43 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 118.328 -1.349 . . . . 0.0 112.356 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.514 ' O ' HG21 ' A' ' 93' ' ' ILE . 45.4 mm-40 -104.26 -59.72 1.69 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.752 0.787 . . . . 0.0 111.868 170.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.837 ' HA ' ' O ' ' A' ' 88' ' ' GLU . 5.6 pt -179.51 58.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-N 113.068 -1.878 . . . . 0.0 107.118 -164.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.36 45.86 0.08 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.999 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.486 ' H ' ' C ' ' A' ' 93' ' ' ILE . 10.8 pt-20 -59.33 -35.26 73.5 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.917 176.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.33 -22.03 64.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.574 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.598 ' HE2' HH11 ' A' ' 6' ' ' ARG . 57.5 m-85 -94.3 16.22 15.54 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -170.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -47.3 -32.01 4.35 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.396 0.617 . . . . 0.0 110.241 169.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.9 m -87.35 31.25 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.133 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -73.64 -46.08 48.87 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 172.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.457 ' HD3' ' HZ ' ' A' ' 79' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.24 0 CA-C-N 114.602 -1.181 . . . . 0.0 107.922 171.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 112.006 -0.438 . . . . 0.0 112.006 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -79.21 59.4 2.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.191 0.52 . . . . 0.0 111.247 -176.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.4 ptp -93.59 164.14 13.28 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.74 178.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.3 t -79.81 45.58 0.71 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.338 0.589 . . . . 0.0 110.943 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.87 ' HA ' HD22 ' A' ' 26' ' ' ASN . 22.5 m 44.0 -175.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.547 1.139 . . . . 0.0 113.194 -174.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -151.44 72.25 1.03 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.539 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . 37.1 p90 -113.03 152.03 29.95 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.641 0.734 . . . . 0.0 112.198 -174.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -128.46 134.82 48.83 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.488 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.491 HG22 ' HG2' ' A' ' 83' ' ' LYS . 4.5 mp -93.88 108.6 20.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.325 178.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -117.31 166.2 12.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.621 0.724 . . . . 0.0 111.214 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.66 140.87 41.09 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.643 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -84.88 -21.61 29.68 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.321 174.72 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 152.3 -68.56 0.31 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 119.903 -1.142 . . . . 0.0 113.464 176.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -119.26 -61.73 1.6 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.894 0.378 . . . . 0.0 111.393 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.1 p -141.26 39.85 1.76 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.447 0.642 . . . . 0.0 111.013 -175.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.504 ' HB2' ' HB3' ' A' ' 12' ' ' LEU . . . -141.76 160.36 40.33 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.133 175.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.658 ' HB2' ' HH ' ' A' ' 62' ' ' TYR . 34.0 ttp -129.48 136.62 50.12 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.61 -0.436 . . . . 0.0 112.115 -175.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.462 ' HB2' HD23 ' A' ' 12' ' ' LEU . 48.9 ttm -121.59 130.33 53.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.197 0.522 . . . . 0.0 110.685 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.4 mt -117.17 121.11 66.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.606 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -115.18 120.65 40.45 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.755 0.788 . . . . 0.0 110.957 -177.515 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.655 ' HD2' HG12 ' A' ' 29' ' ' VAL . 44.4 m-85 -86.07 -171.85 3.78 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 113.799 -1.546 . . . . 0.0 109.97 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' A' ' 23' ' ' GLU . . . -77.65 -115.43 0.17 Allowed Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.271 177.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.58 ' HG3' ' HG3' ' A' ' 24' ' ' GLU . 11.0 pt-20 158.78 -40.51 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.848 0.859 . . . . 0.0 110.675 168.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.58 ' HG3' ' HG3' ' A' ' 23' ' ' GLU . 42.1 mt-10 -83.25 132.1 35.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.151 -174.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.6 mt 54.69 31.38 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-O 122.135 0.969 . . . . 0.0 110.03 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.87 HD22 ' HA ' ' A' ' 5' ' ' VAL . 50.7 t-20 -142.07 85.42 1.92 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.617 -174.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -69.61 -22.73 63.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.212 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.84 -46.64 81.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.789 -177.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.655 HG12 ' HD2' ' A' ' 21' ' ' PHE . 35.5 m -63.9 -45.4 97.06 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.431 ' N ' HG22 ' A' ' 29' ' ' VAL . 39.9 t30 -53.9 -42.32 68.57 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.396 -176.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.26 -47.46 6.46 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.598 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -74.25 -29.55 24.94 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.509 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -170.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.589 HG11 ' O ' ' A' ' 29' ' ' VAL . 7.3 p -63.78 -32.21 56.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.663 177.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.588 ' CE1' ' HA ' ' A' ' 55' ' ' PHE . 34.4 m80 -81.59 -32.23 32.17 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.541 179.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.61 -24.38 36.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.845 0.355 . . . . 0.0 111.121 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.502 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -67.11 -20.92 65.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.43 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.64 98.72 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.647 0.737 . . . . 0.0 109.056 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.501 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.67 -32.32 23.68 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.76 175.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.502 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 17.0 t80 -53.53 -48.94 68.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.451 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.643 HD12 HD21 ' A' ' 58' ' ' LEU . 65.2 mt -69.1 -34.78 65.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.543 -177.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.501 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 12.5 pt-20 -76.92 -22.44 53.33 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.165 -173.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 95.0 mt-10 -74.91 -34.33 62.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.755 0.312 . . . . 0.0 110.607 177.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.841 ' HB2' HH12 ' A' ' 89' ' ' ARG . 4.5 mp0 -127.46 74.45 77.75 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -95.21 178.8 0.71 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 123.18 2.587 . . . . 0.0 113.48 -173.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.474 ' C ' ' H ' ' A' ' 47' ' ' GLY . 3.8 p90 -112.55 146.26 34.63 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.133 172.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -61.16 15.17 0.04 OUTLIER 'Trans proline' 0 N--CA 1.482 0.795 0 C-N-CA 123.992 3.128 . . . . 0.0 114.789 -174.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . -133.65 18.79 4.3 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 175.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -70.65 137.41 49.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.736 0.303 . . . . 0.0 110.608 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.1 mm -113.6 -56.88 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.39 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 9.4 tp10 -160.94 157.1 25.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.827 0.346 . . . . 0.0 110.702 -175.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 59' ' ' THR . 8.2 p -152.03 117.94 5.47 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 172.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.758 HG13 ' HB ' ' A' ' 59' ' ' THR . 7.1 pt -118.62 128.53 25.92 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-O 121.253 0.549 . . . . 0.0 112.142 -176.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.427 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 84.1 Cg_endo -86.46 120.85 1.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.497 2.798 . . . . 0.0 112.144 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.429 ' HB1' ' OG ' ' A' ' 57' ' ' SER . . . -114.41 59.86 0.68 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.686 0.279 . . . . 0.0 111.215 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.588 ' HA ' ' CE1' ' A' ' 34' ' ' HIS . 70.4 t80 74.34 -49.24 0.67 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.392 0.677 . . . . 0.0 111.817 173.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.413 ' HA ' HG12 ' A' ' 33' ' ' VAL . 14.0 t -140.05 -14.35 1.04 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.879 0.371 . . . . 0.0 111.475 176.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.429 ' OG ' ' HB1' ' A' ' 54' ' ' ALA . 18.3 p -108.66 133.75 52.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.413 0.625 . . . . 0.0 110.823 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.643 HD21 HD12 ' A' ' 40' ' ' ILE . 57.0 tp -102.58 111.77 24.23 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.758 ' HB ' HG13 ' A' ' 52' ' ' ILE . 1.8 m -95.43 107.04 19.16 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.743 -176.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.2 t -106.27 118.68 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.527 0.68 . . . . 0.0 111.243 -172.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.425 ' CE1' HG22 ' A' ' 59' ' ' THR . 88.1 m-85 -111.6 148.54 33.08 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.572 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.658 ' HH ' ' HB2' ' A' ' 17' ' ' MET . 2.1 p90 -165.82 169.62 14.78 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -175.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -102.29 113.07 26.05 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.527 -176.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.546 ' HA ' HG23 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -58.84 -19.69 43.87 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.455 -174.204 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -65.62 -28.42 69.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.637 0.256 . . . . 0.0 111.191 -177.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.536 ' O ' ' HD2' ' A' ' 70' ' ' HIS . 2.4 tm-20 -91.3 -41.32 11.0 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -176.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.546 HG23 ' HA ' ' A' ' 64' ' ' MET . 3.0 m -64.53 -30.79 51.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.996 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.923 ' HA ' HD23 ' A' ' 71' ' ' LEU . 62.6 t80 -63.93 -26.65 68.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.402 173.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.03 -27.92 66.96 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 174.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.536 ' HD2' ' O ' ' A' ' 66' ' ' GLU . 16.7 m-70 -83.78 -69.18 0.66 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.705 175.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.923 HD23 ' HA ' ' A' ' 68' ' ' TYR . 1.1 mm? 18.75 71.07 0.22 Allowed Pre-proline 0 N--CA 1.474 0.758 0 O-C-N 124.929 1.393 . . . . 0.0 112.576 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.637 ' HD2' HG13 ' A' ' 75' ' ' ILE . 64.4 Cg_exo -53.14 153.46 16.19 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.166 2.577 . . . . 0.0 112.719 -173.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -69.84 93.82 0.78 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.53 0.681 . . . . 0.0 110.724 -175.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 139.67 -27.16 2.61 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -173.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.637 HG13 ' HD2' ' A' ' 72' ' ' PRO . 8.9 mm -80.49 125.97 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.615 -0.792 . . . . 0.0 109.038 172.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.4 m -110.76 -1.86 16.46 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.227 0.536 . . . . 0.0 110.781 -177.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.539 ' OG ' ' HD1' ' A' ' 79' ' ' PHE . 22.6 t -131.57 134.37 25.45 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.791 -175.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.485 ' O ' HG23 ' A' ' 82' ' ' VAL . 96.2 Cg_exo -47.05 -53.45 6.3 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.312 2.675 . . . . 0.0 112.436 171.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.539 ' HD1' ' OG ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -60.35 -34.21 73.53 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.311 0.577 . . . . 0.0 110.551 -179.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.53 ' HA ' ' CE ' ' A' ' 83' ' ' LYS . 56.6 tt0 -69.57 -27.81 65.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.177 -177.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.523 ' HB3' HG21 ' A' ' 75' ' ' ILE . 95.7 p -79.84 -31.37 40.55 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.501 0.667 . . . . 0.0 109.539 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 78' ' ' PRO . 36.3 t -73.68 -28.82 25.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.147 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.53 ' CE ' ' HA ' ' A' ' 80' ' ' GLU . 44.6 mtmt -54.73 -41.32 70.22 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 121.374 0.607 . . . . 0.0 109.578 173.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.633 ' NH1' ' HA ' ' A' ' 101' ' ' ARG . 21.4 mmm180 -66.11 -32.58 74.11 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.089 -176.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -77.1 -40.79 44.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.287 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.6 m -83.5 -37.48 13.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.784 -177.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.469 ' OE2' ' HB3' ' A' ' 91' ' ' ALA . 10.3 mm-40 -62.96 -36.21 82.73 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.852 ' HG3' ' HD3' ' A' ' 89' ' ' ARG . 9.4 pt-20 -56.83 -29.37 62.74 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.74 176.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.852 ' HD3' ' HG3' ' A' ' 88' ' ' GLU . 0.8 OUTLIER -89.26 -34.18 16.7 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.982 0.42 . . . . 0.0 111.837 173.785 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 87' ' ' GLU . 88.6 mt -85.09 -66.71 0.87 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.372 0.606 . . . . 0.0 111.502 -177.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.71 ' HB1' ' HA ' ' A' ' 99' ' ' VAL . . . -58.02 -17.85 20.32 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.265 -0.879 . . . . 0.0 113.234 -177.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.457 ' HG3' HG23 ' A' ' 93' ' ' ILE . 9.1 pt-20 -58.78 -40.33 83.67 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.373 174.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.457 HG23 ' HG3' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -95.32 -25.19 4.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.074 0.464 . . . . 0.0 110.342 179.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -100.62 35.09 2.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.933 0.873 . . . . 0.0 110.371 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -55.62 -25.71 40.25 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.328 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -48.65 -30.54 5.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.069 -0.969 . . . . 0.0 113.342 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.467 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 5.7 m-30 -74.32 -62.12 1.63 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.926 -178.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 97' ' ' TYR . 10.9 pt-20 165.38 0.17 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.286 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.71 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 55.5 t 65.72 101.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -164.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -70.43 133.46 46.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.487 0.66 . . . . 0.0 111.05 -170.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.633 ' HA ' ' NH1' ' A' ' 84' ' ' ARG . 20.1 ttt180 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.199 -0.905 . . . . 0.0 109.609 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.845 0 N-CA-C 112.128 -0.389 . . . . 0.0 112.128 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.3 t -179.66 -76.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.518 ' HB3' ' H ' ' A' ' 5' ' ' VAL . 15.9 mmt 60.13 173.9 0.09 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 122.389 1.09 . . . . 0.0 113.66 173.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.513 ' O ' HG12 ' A' ' 5' ' ' VAL . 5.1 t -120.03 15.54 12.44 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.967 -1.469 . . . . 0.0 107.628 170.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.695 HG22 HD22 ' A' ' 26' ' ' ASN . 0.3 OUTLIER 64.65 150.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 113.446 -1.706 . . . . 0.0 112.317 -174.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.984 ' HA ' ' HH ' ' A' ' 97' ' ' TYR . 2.2 mpt_? -108.73 139.11 43.99 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 113.993 -1.458 . . . . 0.0 108.133 171.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 25.4 p90 -166.26 146.82 6.34 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.167 0.508 . . . . 0.0 111.011 178.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.409 ' HB2' ' HE ' ' A' ' 20' ' ' ARG . 4.9 mp0 -128.34 132.43 48.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.466 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.899 HG13 HG12 ' A' ' 19' ' ' ILE . 2.9 mp -83.47 114.74 24.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 171.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -110.21 150.11 29.14 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.121 0.486 . . . . 0.0 109.69 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -81.25 127.71 33.0 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.428 0.633 . . . . 0.0 110.208 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.581 HD23 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -70.41 -40.3 73.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.427 -174.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 172.84 -66.18 0.12 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.808 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -125.75 -58.87 1.38 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.835 0.35 . . . . 0.0 111.717 -173.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.2 p -142.01 37.62 1.59 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.517 0.675 . . . . 0.0 111.29 -173.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.95 158.26 43.77 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.781 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.674 ' HB3' ' HH ' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -128.03 149.37 50.4 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.046 -179.086 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.581 ' HB2' HD23 ' A' ' 12' ' ' LEU . 53.6 ttm -132.38 135.41 46.12 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 174.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.899 HG12 HG13 ' A' ' 9' ' ' ILE . 10.5 mt -114.58 106.18 20.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.514 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -91.94 131.44 37.24 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.296 0.57 . . . . 0.0 109.879 177.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 29.0 m-85 -98.74 -168.0 1.57 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.266 -178.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.78 177.15 50.13 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.621 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -144.09 -66.4 0.35 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.951 0.405 . . . . 0.0 111.562 -176.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -58.48 -52.57 65.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.226 -172.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.3 pt -117.23 26.14 4.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.1 -171.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.695 HD22 HG22 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -120.93 103.82 9.35 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.684 -173.524 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.434 ' H ' ' CD ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -79.78 -45.14 19.36 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.887 176.701 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.71 -34.42 71.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.988 -171.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.767 HG13 HD21 ' A' ' 30' ' ' ASN . 2.4 p -56.4 -49.0 79.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.298 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.767 HD21 HG13 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -55.67 -29.19 58.9 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.579 0.549 . . . . 0.0 111.168 -173.247 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.76 -40.6 5.25 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.73 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -87.41 -29.7 5.65 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -171.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.688 HG13 ' O ' ' A' ' 29' ' ' VAL . 9.5 p -65.74 -30.98 51.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 118.968 0.804 . . . . 0.0 109.281 178.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.4 ' HA ' ' CB ' ' A' ' 53' ' ' PRO . 22.0 t60 -81.61 -30.2 32.98 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.999 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.43 -21.72 30.62 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.015 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.459 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -65.06 -23.48 67.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.181 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.89 98.77 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.841 0.829 . . . . 0.0 109.02 177.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.736 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.96 -27.17 26.69 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.948 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.459 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 5.8 t80 -59.73 -44.48 93.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.374 179.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.427 ' CD1' HD21 ' A' ' 58' ' ' LEU . 44.6 mt -78.59 -32.03 15.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.483 -176.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.736 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 10.8 pt-20 -73.64 -20.22 60.63 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.861 -176.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -88.21 -29.89 20.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.735 0.302 . . . . 0.0 110.384 173.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -124.72 69.8 56.3 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.177 0.513 . . . . 0.0 110.091 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -99.86 -161.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.693 2.929 . . . . 0.0 114.083 -169.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.429 ' HE1' ' HB3' ' A' ' 62' ' ' TYR . 1.6 p90 -138.37 147.35 55.07 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 114.022 -1.444 . . . . 0.0 107.966 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.75 -21.26 0.86 Allowed 'Trans proline' 0 N--CA 1.482 0.842 0 C-N-CA 124.25 3.3 . . . . 0.0 115.55 -169.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.36 30.7 5.7 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.188 -0.53 . . . . 0.0 111.947 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -66.53 128.69 37.18 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.098 0.475 . . . . 0.0 110.82 175.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.4 mm -103.09 -61.71 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.108 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -164.56 155.48 15.0 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 120.767 0.317 . . . . 0.0 110.998 -174.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.9 p -144.46 118.32 9.32 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 173.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.801 HG13 ' HB ' ' A' ' 59' ' ' THR . 5.5 pt -117.43 129.26 25.46 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-O 121.042 0.449 . . . . 0.0 112.001 -175.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.58 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 17.8 Cg_endo -86.73 124.33 2.23 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.498 2.799 . . . . 0.0 112.684 -178.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -117.73 58.73 0.8 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.15 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.458 ' O ' HG11 ' A' ' 33' ' ' VAL . 56.2 t80 72.34 -49.64 0.69 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.548 0.739 . . . . 0.0 112.087 173.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.1 t -137.23 -21.07 1.2 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.747 0.308 . . . . 0.0 111.253 178.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 16.1 m -108.2 133.11 52.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.071 0.463 . . . . 0.0 110.864 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.427 HD21 ' CD1' ' A' ' 40' ' ' ILE . 44.0 tp -102.77 111.96 24.53 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.801 ' HB ' HG13 ' A' ' 52' ' ' ILE . 2.9 m -89.15 107.96 19.34 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -177.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.604 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 64.6 t -104.0 113.66 41.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.575 0.702 . . . . 0.0 111.338 -172.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -103.76 148.88 25.56 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.872 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.674 ' HH ' ' HB3' ' A' ' 17' ' ' MET . 2.3 p90 -165.13 168.53 17.13 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.164 -176.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -98.86 109.05 21.87 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.947 -175.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.608 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -61.97 -20.6 64.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.125 -177.725 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.408 ' CE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -67.47 -31.92 72.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.9 0.381 . . . . 0.0 110.281 179.481 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.457 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 10.2 tp10 -91.31 -30.69 16.44 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 122.059 0.933 . . . . 0.0 109.1 -170.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.608 HG22 ' HA ' ' A' ' 64' ' ' MET . 4.2 m -75.66 -34.12 28.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.26 176.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.849 ' HA ' HD21 ' A' ' 71' ' ' LEU . 52.4 t80 -71.28 -22.87 61.9 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.8 174.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 4.2 tppp? -59.42 -35.96 74.98 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -88.5 -65.8 0.98 Allowed 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.207 176.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.849 HD21 ' HA ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER 24.93 78.7 0.22 Allowed Pre-proline 0 N--CA 1.48 1.038 0 C-N-CA 124.858 1.263 . . . . 0.0 113.463 178.356 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.683 ' HD2' HG13 ' A' ' 75' ' ' ILE . 32.1 Cg_exo -58.52 155.06 38.26 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.321 2.014 . . . . 0.0 110.989 175.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -71.38 -17.08 62.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.675 -171.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -77.8 -28.68 56.44 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 172.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.683 HG13 ' HD2' ' A' ' 72' ' ' PRO . 20.4 mm -77.44 129.8 36.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.791 -0.705 . . . . 0.0 109.638 175.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.2 m -110.0 1.64 19.13 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.337 0.589 . . . . 0.0 110.528 -177.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.637 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 43.8 t -146.9 132.97 9.5 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.261 -172.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.638 ' HA ' HD23 ' A' ' 71' ' ' LEU . 86.3 Cg_exo -45.74 -53.47 5.6 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.349 2.699 . . . . 0.0 112.732 170.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.404 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -58.26 -31.61 67.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.93 0.395 . . . . 0.0 111.385 177.373 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.637 ' HB2' ' HB3' ' A' ' 77' ' ' SER . 23.8 tt0 -72.83 -30.07 63.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.259 -173.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.537 ' HB3' HG21 ' A' ' 75' ' ' ILE . 91.4 p -76.38 -34.55 58.89 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.517 HG13 ' CD2' ' A' ' 62' ' ' TYR . 16.6 t -63.84 -31.73 54.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.537 176.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.492 ' HE3' HG12 ' A' ' 9' ' ' ILE . 2.4 mtpt -54.93 -38.01 67.14 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-O 121.171 0.51 . . . . 0.0 109.685 175.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -67.63 -31.89 72.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.175 -176.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -78.3 -36.72 46.21 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.357 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.8 m -86.78 -40.32 13.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.649 -177.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -69.07 -32.58 72.14 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -177.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -57.75 -26.33 61.69 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.976 175.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -88.32 -55.41 3.75 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.809 168.773 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.649 ' O ' HD12 ' A' ' 93' ' ' ILE . 90.1 mt -70.49 -67.44 0.5 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -173.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.474 ' HB1' ' HA ' ' A' ' 99' ' ' VAL . . . -56.6 -18.75 13.0 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -71.57 -47.23 56.28 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.555 -176.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.649 HD12 ' O ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -89.71 -20.23 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.455 0.645 . . . . 0.0 109.377 179.018 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -101.2 42.58 1.11 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 122.221 1.01 . . . . 0.0 108.616 174.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -57.2 -16.22 7.62 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.605 -1.634 . . . . 0.0 111.181 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -52.53 -23.79 6.95 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.389 176.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.984 ' HH ' ' HA ' ' A' ' 6' ' ' ARG . 27.9 m-85 -98.31 11.58 37.54 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.413 ' O ' ' HB ' ' A' ' 99' ' ' VAL . 8.9 pt-20 41.24 36.76 0.52 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.247 0.967 . . . . 0.0 111.39 -177.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.474 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 67.0 t 71.74 115.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.244 -171.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.43 ' HB3' ' NZ ' ' A' ' 83' ' ' LYS . 6.1 t-20 -54.86 121.17 8.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.812 -171.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.131 -171.754 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.59 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -135.01 127.16 29.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.92 0.391 . . . . 0.0 110.263 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.662 ' SD ' ' HB2' ' A' ' 28' ' ' GLN . 0.4 OUTLIER -126.19 156.64 39.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.831 177.377 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.569 ' HA ' ' CD1' ' A' ' 97' ' ' TYR . 1.8 t -79.29 100.37 7.52 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.012 0.911 . . . . 0.0 109.487 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.718 HG11 ' CD2' ' A' ' 97' ' ' TYR . 4.6 p -72.56 163.95 3.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.271 -174.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -128.72 118.94 23.71 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.512 172.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.481 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 42.2 p90 -135.57 166.84 22.29 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.319 0.58 . . . . 0.0 111.028 -175.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.491 ' NE2' ' HB3' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -130.9 116.05 17.37 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.875 -174.384 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.879 HG12 HG12 ' A' ' 19' ' ' ILE . 22.3 mt -92.62 112.52 26.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.128 175.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.491 ' HB3' ' NE2' ' A' ' 8' ' ' GLN . 11.6 pt-20 -124.25 168.46 12.92 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.499 -175.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.615 HE21 ' HA ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -87.74 128.11 35.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.46 -179.183 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.625 HD21 ' HB2' ' A' ' 18' ' ' MET . 0.3 OUTLIER -76.18 -46.41 28.6 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.127 -174.135 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -168.84 -90.62 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.629 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -110.62 -37.52 5.44 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -175.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.5 p -160.8 42.73 0.17 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.872 0.844 . . . . 0.0 110.696 -177.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.0 148.21 41.55 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.333 176.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.686 ' HB2' ' HH ' ' A' ' 62' ' ' TYR . 32.1 ttp -117.39 140.53 49.47 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 120.955 0.407 . . . . 0.0 111.504 -177.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.625 ' HB2' HD21 ' A' ' 12' ' ' LEU . 1.4 tmt? -124.69 126.05 45.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.44 0.638 . . . . 0.0 110.431 -176.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.879 HG12 HG12 ' A' ' 9' ' ' ILE . 6.6 mt -119.56 138.26 50.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.768 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.61 127.03 21.48 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.909 0.385 . . . . 0.0 110.369 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.481 ' HA ' ' CB ' ' A' ' 7' ' ' TYR . 8.1 m-85 -97.47 -152.94 0.41 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.865 -178.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.565 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -83.13 178.79 52.96 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 174.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -151.27 161.34 42.89 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 71.61 -71.51 0.13 Allowed 'General case' 0 C--N 1.332 -0.18 0 O-C-N 124.007 0.817 . . . . 0.0 111.927 176.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.5 pt -92.57 14.93 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.303 0.573 . . . . 0.0 110.864 -173.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.484 ' ND2' HG22 ' A' ' 5' ' ' VAL . 65.9 t30 -121.78 91.84 3.6 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.161 -176.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -57.86 -37.78 74.53 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.879 175.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.662 ' HB2' ' SD ' ' A' ' 3' ' ' MET . 0.5 OUTLIER -50.76 -52.02 44.77 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.577 -176.835 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 22' ' ' GLY . 11.9 p -65.74 -50.58 70.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.36 -174.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -53.1 -42.68 66.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.144 0.497 . . . . 0.0 110.939 -177.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.82 -5.17 90.22 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.528 -0.76 . . . . 0.0 113.614 -176.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.22 -34.25 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.605 0 CA-C-N 117.987 0.894 . . . . 0.0 113.352 -176.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.486 HG11 ' O ' ' A' ' 29' ' ' VAL . 10.8 p -62.98 -32.72 57.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 118.467 0.576 . . . . 0.0 110.681 -174.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -80.27 -23.5 40.73 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.04 -23.85 26.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.069 0.461 . . . . 0.0 110.419 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.455 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -64.28 -22.82 67.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.098 -178.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.54 97.14 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.663 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -82.98 -30.45 28.2 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.812 175.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.63 ' HE1' ' HB3' ' A' ' 89' ' ' ARG . 16.0 t80 -57.05 -44.28 82.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.377 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.651 HD12 HD23 ' A' ' 58' ' ' LEU . 49.5 mt -77.06 -38.41 27.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.587 -176.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.663 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 13.3 pt-20 -68.73 -21.11 64.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.896 0.379 . . . . 0.0 111.017 -175.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -92.56 -21.14 20.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.868 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -133.14 64.71 71.29 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.894 0.378 . . . . 0.0 110.412 178.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -97.35 -175.81 0.25 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.494 2.796 . . . . 0.0 113.077 -173.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.589 ' HZ ' ' HB2' ' A' ' 62' ' ' TYR . 14.3 p90 -116.56 148.11 41.17 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 172.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -42.22 -24.87 0.36 Allowed 'Trans proline' 0 N--CA 1.481 0.791 0 C-N-CA 124.404 3.403 . . . . 0.0 115.926 -170.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.05 19.36 32.64 Favored Glycine 0 C--O 1.229 -0.21 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.413 -176.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -69.21 134.86 49.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.007 0.432 . . . . 0.0 111.331 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 62' ' ' TYR . 40.6 mm -106.17 -60.67 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.298 -177.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -160.99 156.31 24.58 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -171.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 12.7 p -151.75 119.48 6.13 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 175.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.791 HG13 ' HB ' ' A' ' 59' ' ' THR . 9.3 pt -123.91 134.87 25.68 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.842 -175.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.405 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 78.5 Cg_endo -86.95 152.19 8.43 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.159 2.573 . . . . 0.0 112.463 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.404 ' HB1' ' OG ' ' A' ' 57' ' ' SER . . . -137.61 47.83 2.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.116 178.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.4 ' O ' HG12 ' A' ' 33' ' ' VAL . 48.7 t80 72.09 -37.52 0.39 Allowed 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 173.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.0 t -138.43 -21.3 1.04 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.183 0.516 . . . . 0.0 110.933 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.404 ' OG ' ' HB1' ' A' ' 54' ' ' ALA . 7.3 p -113.52 155.1 25.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.61 178.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.651 HD23 HD12 ' A' ' 40' ' ' ILE . 48.1 tp -124.49 114.92 20.08 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.791 ' HB ' HG13 ' A' ' 52' ' ' ILE . 4.4 m -94.91 106.92 18.93 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.885 -176.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.0 t -106.04 121.5 58.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.47 0.653 . . . . 0.0 111.647 -172.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.424 ' CE1' HG22 ' A' ' 59' ' ' THR . 90.7 m-85 -110.99 148.51 32.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.939 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.686 ' HH ' ' HB2' ' A' ' 17' ' ' MET . 3.5 p90 -167.33 170.14 11.79 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.893 -173.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -102.26 120.45 40.49 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.291 0.567 . . . . 0.0 110.692 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.17 -22.39 65.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.266 -174.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.11 -25.82 67.94 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.75 0.31 . . . . 0.0 110.784 -177.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -89.49 -33.55 16.73 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.738 0.78 . . . . 0.0 109.011 -171.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.9 m -77.67 -36.61 23.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.898 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.698 ' HA ' HD21 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -62.9 -23.11 67.19 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.973 177.598 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.484 ' HB2' ' HE2' ' A' ' 69' ' ' LYS . 3.3 tppt? -54.86 -49.17 71.79 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 121.939 0.876 . . . . 0.0 108.877 177.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -89.94 -62.89 1.37 Allowed 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.858 -177.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.698 HD21 ' HA ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER 34.5 77.3 0.38 Allowed Pre-proline 0 N--CA 1.473 0.707 0 O-C-N 124.533 1.146 . . . . 0.0 111.521 -178.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.438 ' HD2' HG13 ' A' ' 75' ' ' ILE . 50.5 Cg_exo -54.64 152.43 27.62 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.288 2.659 . . . . 0.0 112.839 -175.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -76.18 87.29 3.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.05 0.929 . . . . 0.0 110.495 -176.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 155.09 -31.19 0.65 Allowed Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 -173.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.508 HG22 ' HB2' ' A' ' 81' ' ' SER . 18.6 mm -79.77 115.7 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 114.028 -1.086 . . . . 0.0 108.808 169.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.5 m -97.76 -5.86 34.05 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.194 0.521 . . . . 0.0 110.239 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 47.6 m -138.72 132.38 16.25 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.943 -172.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.601 ' HA ' HD23 ' A' ' 71' ' ' LEU . 30.8 Cg_exo -45.23 -56.99 2.35 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.436 2.758 . . . . 0.0 113.305 173.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.586 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.8 OUTLIER -55.18 -30.82 60.67 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.203 0.525 . . . . 0.0 111.177 178.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.577 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 36.5 tt0 -73.64 -24.47 60.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.259 -176.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.508 ' HB2' HG22 ' A' ' 75' ' ' ILE . 17.4 t -76.24 -36.28 58.58 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.459 HG11 ' CD2' ' A' ' 62' ' ' TYR . 60.2 t -63.66 -30.18 49.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.248 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.585 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 14.9 mtmm -54.2 -37.85 64.98 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 176.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -64.59 -37.47 87.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.182 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.497 ' HA ' ' OE2' ' A' ' 88' ' ' GLU . 42.3 m-20 -70.92 -35.48 72.28 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.916 -176.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.9 m -86.79 -42.76 15.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.149 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -67.77 -33.77 75.49 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.509 ' HG3' ' HD3' ' A' ' 89' ' ' ARG . 12.2 pt-20 -57.83 -28.55 64.18 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.757 176.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.63 ' HB3' ' HE1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -87.07 -51.87 5.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.976 170.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.3 mt -73.47 -67.96 0.54 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.454 -174.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.555 ' HA ' ' HB1' ' A' ' 94' ' ' ALA . . . -56.45 -19.38 14.93 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -173.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -68.58 -36.54 78.87 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.836 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.625 HD12 ' N ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -92.49 -19.84 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.03 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.625 ' N ' HD12 ' A' ' 93' ' ' ILE . . . -90.43 33.16 0.91 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.369 177.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.436 ' H ' ' C ' ' A' ' 93' ' ' ILE . 7.9 pt-20 -39.35 -56.32 1.58 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 112.929 -1.941 . . . . 0.0 112.907 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -81.38 -21.57 38.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.107 -176.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.718 ' CD2' HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -70.03 -61.8 1.64 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.036 -168.04 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 171.46 116.83 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 O-C-N 123.93 0.769 . . . . 0.0 110.304 172.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.53 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 23.0 t -88.95 87.14 2.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.311 178.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -60.96 137.26 58.24 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.098 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 22.6 tpt180 . . . . . 0 C--O 1.249 1.044 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.896 176.843 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 p -117.87 144.88 45.02 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.493 ' HE2' HD22 ' A' ' 26' ' ' ASN . 14.6 ptt? -155.9 168.63 26.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.849 0.356 . . . . 0.0 110.839 -176.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.525 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 12.8 t -88.42 24.1 2.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.864 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.525 ' HB ' ' O ' ' A' ' 4' ' ' THR . 0.9 OUTLIER 77.12 140.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.991 -174.194 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -145.94 108.97 4.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.125 -1.398 . . . . 0.0 108.437 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.508 ' CE2' HD11 ' A' ' 93' ' ' ILE . 16.3 p90 -114.49 155.92 25.52 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.402 0.62 . . . . 0.0 111.891 -174.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.648 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . 1.8 mp0 -120.28 134.54 55.24 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.257 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.904 HG12 HG12 ' A' ' 19' ' ' ILE . 15.3 mt -101.92 114.14 40.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.291 174.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 18' ' ' MET . 10.4 pt-20 -109.12 153.1 24.19 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.691 -177.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.525 HE21 ' HA ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -76.99 126.9 31.74 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.758 0.79 . . . . 0.0 110.542 178.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.628 HD21 ' HB2' ' A' ' 18' ' ' MET . 0.3 OUTLIER -79.72 -48.67 13.25 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.019 -173.233 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.88 100.87 0.16 Allowed Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 73.2 -64.16 0.41 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 176.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.476 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 11.5 p -150.64 60.06 0.94 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.338 0.589 . . . . 0.0 111.831 -172.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.517 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -160.89 154.64 22.35 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 176.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.892 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -121.18 138.64 54.12 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.091 -177.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.628 ' HB2' HD21 ' A' ' 12' ' ' LEU . 26.4 ttt -124.04 124.06 41.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.438 0.637 . . . . 0.0 110.396 177.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.904 HG12 HG12 ' A' ' 9' ' ' ILE . 9.3 mt -116.12 144.31 24.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.191 -175.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.648 ' HD3' ' HB2' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -134.93 132.75 38.83 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 173.577 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.45 ' HB2' HG23 ' A' ' 29' ' ' VAL . 6.8 m-85 -98.52 -147.85 0.33 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.694 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -96.75 -175.84 35.28 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 174.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -139.88 -64.85 0.48 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 117.666 0.733 . . . . 0.0 111.151 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -69.85 130.76 43.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.931 -175.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.8 mm 65.87 14.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.936 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.493 HD22 ' HE2' ' A' ' 3' ' ' MET . 5.8 m-20 -120.43 83.78 2.11 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.558 -176.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -78.68 -20.2 50.73 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 174.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -54.23 -53.79 48.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.068 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 22' ' ' GLY . 4.3 p -61.32 -46.34 96.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.757 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -53.71 -27.04 25.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.958 -177.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -97.55 -39.83 3.81 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.435 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -86.44 -22.4 7.15 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -171.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 29' ' ' VAL . 14.5 p -69.01 -28.45 39.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.371 177.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -77.79 -41.59 36.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.499 174.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.88 -26.0 60.33 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.503 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.464 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -67.12 -26.64 66.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.153 -178.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.453 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . . . -62.29 -36.82 83.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 122.013 0.911 . . . . 0.0 109.119 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.782 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.75 -36.2 21.93 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.872 174.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.464 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 2.6 t80 -54.72 -42.08 71.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.342 0.591 . . . . 0.0 110.864 -178.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.588 HD11 HD21 ' A' ' 58' ' ' LEU . 33.5 mt -78.03 -29.41 15.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.295 -178.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.782 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 6.9 pt-20 -80.67 -32.97 35.85 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.439 -177.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 54.0 mt-10 -72.72 -29.72 63.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.097 0.475 . . . . 0.0 110.139 178.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -121.42 73.56 30.05 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 172.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -96.88 -168.92 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.932 2.421 . . . . 0.0 113.773 -170.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.445 ' C ' ' H ' ' A' ' 47' ' ' GLY . 2.8 p90 -136.43 147.17 58.92 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.14 176.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.23 7.87 0.06 OUTLIER 'Trans proline' 0 N--CA 1.483 0.864 0 C-N-CA 123.653 2.902 . . . . 0.0 114.702 -174.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . -127.18 28.24 4.61 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 174.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.547 ' HE2' HG22 ' A' ' 40' ' ' ILE . 6.0 t80 -71.19 132.09 44.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.998 0.427 . . . . 0.0 110.528 177.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.499 HG22 ' HG2' ' A' ' 50' ' ' GLU . 36.9 mm -111.35 -60.74 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.469 176.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.499 ' HG2' HG22 ' A' ' 49' ' ' ILE . 2.5 mm-40 -153.28 173.01 16.13 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.889 0.852 . . . . 0.0 111.231 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 59' ' ' THR . 5.1 p -161.2 118.27 2.28 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 113.839 -1.528 . . . . 0.0 108.964 154.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.659 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.5 pt -112.93 130.46 23.5 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.251 -173.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 6.1 Cg_exo -77.83 128.06 9.05 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.454 2.769 . . . . 0.0 111.897 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.479 ' HB1' ' HB2' ' A' ' 57' ' ' SER . . . -119.25 54.29 0.99 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.629 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.44 ' O ' HG13 ' A' ' 33' ' ' VAL . 47.6 t80 72.44 -59.33 0.56 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.469 176.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -126.59 -15.34 5.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.299 0.571 . . . . 0.0 110.441 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.479 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 19.8 m -108.58 148.43 30.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.157 0.503 . . . . 0.0 110.999 -177.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.588 HD21 HD11 ' A' ' 40' ' ' ILE . 49.7 tp -117.66 111.99 19.9 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.659 ' HB ' HG13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -94.96 106.74 18.75 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.966 -177.008 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.892 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 53.7 t -107.15 109.33 27.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.252 0.549 . . . . 0.0 111.318 -171.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.454 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 74.6 m-85 -101.62 147.33 26.55 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.711 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.789 ' HH ' ' HB3' ' A' ' 17' ' ' MET . 2.7 p90 -165.22 167.85 17.63 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.172 0.51 . . . . 0.0 110.397 -176.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -98.36 111.25 23.65 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.121 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.476 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 1.0 OUTLIER -64.48 -20.3 66.11 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.546 -172.072 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -58.9 -26.02 63.92 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.571 0.224 . . . . 0.0 111.448 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.553 ' HA ' ' HE3' ' A' ' 69' ' ' LYS . 16.2 tp10 -89.76 -35.84 15.5 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.842 0.83 . . . . 0.0 109.433 -173.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.59 HG11 HG23 ' A' ' 82' ' ' VAL . 3.4 m -79.91 -31.31 13.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.912 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.998 ' HA ' HD22 ' A' ' 71' ' ' LEU . 23.2 t80 -68.98 -22.12 64.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.134 176.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.553 ' HE3' ' HA ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -53.3 -36.74 61.55 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 173.035 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.505 ' HD2' ' HB3' ' A' ' 69' ' ' LYS . 18.2 m170 -98.58 -70.53 0.72 Allowed 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.852 -177.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.998 HD22 ' HA ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER 41.34 71.95 1.19 Allowed Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 123.754 0.822 . . . . 0.0 112.265 -179.074 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.728 ' HD2' HG13 ' A' ' 75' ' ' ILE . 37.7 Cg_exo -61.74 173.95 2.59 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.134 2.556 . . . . 0.0 114.025 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.5 tp60 -62.52 -47.1 85.39 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -172.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.03 -20.74 79.11 Favored Glycine 0 CA--C 1.508 -0.37 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 -176.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.728 HG13 ' HD2' ' A' ' 72' ' ' PRO . 41.3 mm -76.95 102.96 3.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 114.51 -0.845 . . . . 0.0 109.989 175.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.3 m -84.91 -14.09 48.82 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.337 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.468 ' HB2' ' HG3' ' A' ' 80' ' ' GLU . 73.0 m -146.03 142.34 17.63 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.774 -172.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.607 ' HA ' HD21 ' A' ' 71' ' ' LEU . 79.2 Cg_exo -51.25 -36.28 56.05 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.338 2.692 . . . . 0.0 113.376 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.464 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 0.5 OUTLIER -66.11 -26.01 67.26 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.851 0.358 . . . . 0.0 111.138 178.877 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.726 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 5.0 mt-10 -72.69 -34.95 67.52 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.812 -178.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.547 ' HB3' HG23 ' A' ' 75' ' ' ILE . 18.9 p -69.38 -34.01 73.9 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -176.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.59 HG23 HG11 ' A' ' 67' ' ' VAL . 20.2 t -69.44 -36.53 72.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.565 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.726 ' HE2' ' HA ' ' A' ' 80' ' ' GLU . 54.2 mtmt -53.16 -45.57 68.51 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.55 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 23.0 mmt180 -67.75 -36.4 80.47 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.085 -172.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -62.05 -39.04 91.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.518 0.675 . . . . 0.0 110.33 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.656 ' O ' ' HB3' ' A' ' 90' ' ' LEU . 14.4 m -86.96 -46.91 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.334 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 83' ' ' LYS . 43.6 mt-10 -53.89 -53.52 51.43 Favored 'General case' 0 C--O 1.211 -0.923 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -177.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.05 -26.11 68.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.06 0.457 . . . . 0.0 111.184 -172.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.607 ' NE ' ' HA ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -91.07 -36.39 14.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 122.39 1.091 . . . . 0.0 109.822 -177.961 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.656 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 0.3 OUTLIER -84.08 -7.9 59.26 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.297 -1.774 . . . . 0.0 110.261 -177.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.589 ' C ' ' H ' ' A' ' 93' ' ' ILE . . . -40.5 -18.24 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 126.652 1.981 . . . . 0.0 116.273 -173.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -56.11 -2.09 0.06 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 118.159 0.436 . . . . 0.0 111.742 172.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.638 HG23 ' O ' ' A' ' 90' ' ' LEU . 3.0 pt -64.16 -57.49 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 C-N-CA 123.64 0.776 . . . . 0.0 110.004 -176.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.448 ' N ' ' CG1' ' A' ' 93' ' ' ILE . . . 140.43 -63.98 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 O-C-N 125.413 1.696 . . . . 0.0 110.58 -170.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.679 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 1.8 pm0 -65.53 -18.1 65.06 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -170.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.421 ' HB2' HD12 ' A' ' 93' ' ' ILE . 31.4 t70 -61.22 -22.53 64.87 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.115 0.483 . . . . 0.0 111.027 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.502 ' HE1' ' O ' ' A' ' 91' ' ' ALA . 38.9 m-85 -82.57 -6.75 59.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.875 -175.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.679 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 0.9 OUTLIER -108.25 -91.08 0.44 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.867 168.334 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.4 p 177.05 120.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.39 0.614 . . . . 0.0 110.76 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -93.87 99.66 11.98 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.617 0.722 . . . . 0.0 109.552 173.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.311 -1.075 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.71 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.719 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.8 p -101.85 128.14 48.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.114 0.483 . . . . 0.0 110.711 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.445 ' C ' ' H ' ' A' ' 5' ' ' VAL . 15.5 ptp -74.95 160.83 30.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.928 175.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 5' ' ' VAL . 9.2 t -82.93 18.91 1.48 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.333 0.587 . . . . 0.0 109.843 179.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.654 HG11 HD21 ' A' ' 26' ' ' ASN . 5.0 m 53.81 170.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.698 1.599 . . . . 0.0 113.041 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.46 ' HG3' ' OH ' ' A' ' 97' ' ' TYR . 3.3 mpt_? -123.5 74.41 1.25 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.422 173.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 10.6 p90 -99.98 145.59 27.7 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.349 -173.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -130.87 143.17 50.53 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.826 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.941 HG12 HG12 ' A' ' 19' ' ' ILE . 21.3 mt -106.21 120.99 58.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.471 -177.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 18' ' ' MET . 9.0 pt-20 -113.6 163.37 15.04 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.244 -176.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -92.97 126.28 37.98 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 173.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.561 HD21 ' CG2' ' A' ' 59' ' ' THR . 0.0 OUTLIER -65.68 -43.71 88.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.766 -174.674 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.34 -67.17 0.1 Allowed Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 178.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -114.34 -70.67 0.79 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.186 0.517 . . . . 0.0 111.514 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.2 p -135.43 51.0 2.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.92 0.867 . . . . 0.0 110.119 -173.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.42 ' HB2' ' HB3' ' A' ' 12' ' ' LEU . . . -148.1 151.75 36.17 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.062 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.668 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 38.2 ttp -126.97 128.59 46.63 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.234 -176.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.567 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 33.3 ttp -118.68 138.85 52.34 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.494 177.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.941 HG12 HG12 ' A' ' 9' ' ' ILE . 6.4 mt -126.68 124.3 64.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.022 -176.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -109.9 137.26 47.94 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 177.839 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.491 ' HB2' ' CG1' ' A' ' 29' ' ' VAL . 5.3 m-85 -107.35 -150.34 0.44 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -83.22 -160.46 29.45 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 174.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -161.46 -67.75 0.06 Allowed 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.469 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -44.55 -64.33 0.71 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 124.096 0.872 . . . . 0.0 113.101 -168.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.3 pt -109.7 31.83 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.628 0.728 . . . . 0.0 110.312 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.654 HD21 HG11 ' A' ' 5' ' ' VAL . 11.2 m120 -105.77 68.98 0.8 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.173 -176.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -55.41 -39.84 70.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.164 0.506 . . . . 0.0 110.064 176.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.506 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 23.9 tm0? -52.63 -44.22 65.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.36 176.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.542 ' O ' HG11 ' A' ' 33' ' ' VAL . 87.7 t -72.35 -60.8 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.18 -176.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -46.96 -33.04 4.29 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.757 0.661 . . . . 0.0 112.197 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.22 -44.04 5.44 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.35 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -80.78 -25.43 10.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -172.156 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.542 HG11 ' O ' ' A' ' 29' ' ' VAL . 13.7 p -70.23 -29.68 40.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -76.57 -31.42 57.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.699 175.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.62 -23.6 29.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.972 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.442 ' HA ' ' HB3' ' A' ' 39' ' ' TYR . . . -63.57 -24.71 67.92 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.981 -177.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.82 -42.74 99.4 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.593 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -83.56 -34.84 25.12 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.759 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.583 ' CE1' ' HB3' ' A' ' 89' ' ' ARG . 32.8 t80 -52.58 -44.52 65.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.998 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.5 mt -72.42 -33.61 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.238 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.593 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 7.8 pt-20 -80.63 -19.65 44.92 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.014 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.532 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 34.0 mt-10 -82.06 -29.78 31.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.857 0.36 . . . . 0.0 110.484 175.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -127.83 66.7 71.77 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.63 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -98.34 173.92 0.53 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.3 2.667 . . . . 0.0 114.727 -168.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -111.71 147.35 36.61 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 113.785 -1.552 . . . . 0.0 108.337 175.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.67 -8.13 0.73 Allowed 'Trans proline' 0 N--CA 1.484 0.923 0 C-N-CA 123.987 3.125 . . . . 0.0 114.957 -171.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.39 27.52 6.6 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.104 -0.569 . . . . 0.0 111.837 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -73.86 131.61 41.67 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.064 0.459 . . . . 0.0 111.552 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.3 mm -106.35 -61.21 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.242 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -161.86 162.34 29.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.711 0.291 . . . . 0.0 110.602 -172.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.599 ' HB2' HD11 ' A' ' 58' ' ' LEU . 2.6 p -158.69 118.38 3.14 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 176.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.702 HG13 ' HB ' ' A' ' 59' ' ' THR . 9.6 pt -120.68 139.46 28.97 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-O 121.007 0.432 . . . . 0.0 111.749 -175.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.464 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 4.6 Cg_endo -84.5 133.75 5.43 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.18 2.587 . . . . 0.0 112.21 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -118.1 43.52 2.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.474 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 39.0 t80 72.34 -40.55 0.48 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.448 175.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -134.18 -18.93 1.99 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.898 0.38 . . . . 0.0 111.22 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 9.1 p -121.19 142.52 49.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.776 0.322 . . . . 0.0 111.107 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.599 HD11 ' HB2' ' A' ' 51' ' ' CYS . 0.9 OUTLIER -103.17 114.42 28.69 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.637 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.702 ' HB ' HG13 ' A' ' 52' ' ' ILE . 3.0 m -87.59 106.05 17.75 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.565 HG23 HD13 ' A' ' 58' ' ' LEU . 57.7 t -101.45 124.36 55.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.397 0.617 . . . . 0.0 111.56 -174.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.418 ' CE1' HG21 ' A' ' 59' ' ' THR . 89.0 m-85 -115.79 147.27 41.15 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.419 177.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.547 ' HH ' ' CB ' ' A' ' 17' ' ' MET . 3.4 p90 -165.99 169.97 14.11 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.934 0.397 . . . . 0.0 110.149 -174.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -99.92 112.45 24.72 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.75 -176.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.646 ' HA ' HG23 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -62.37 -19.74 63.7 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.993 -176.017 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.7 -31.86 73.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 110.545 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.73 -25.64 19.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.902 0.858 . . . . 0.0 109.535 -175.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.646 HG23 ' HA ' ' A' ' 64' ' ' MET . 3.5 m -75.93 -38.83 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.459 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.906 ' HA ' HD12 ' A' ' 71' ' ' LEU . 2.5 m-85 -55.77 -30.97 62.16 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.07 0.548 . . . . 0.0 111.411 171.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -57.66 -43.75 85.21 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.989 0.899 . . . . 0.0 108.843 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -81.08 -51.12 8.82 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.934 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.906 HD12 ' HA ' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -12.16 84.63 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.469 0 O-C-N 125.549 1.781 . . . . 0.0 114.325 -173.433 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.815 ' HD2' HG13 ' A' ' 75' ' ' ILE . 32.5 Cg_exo -61.76 170.21 6.11 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 123.469 2.78 . . . . 0.0 112.172 176.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.6 -27.13 65.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.032 -172.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.98 -22.31 71.89 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.125 176.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.815 HG13 ' HD2' ' A' ' 72' ' ' PRO . 24.1 mm -86.32 114.14 25.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.615 -0.792 . . . . 0.0 110.043 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.8 m -105.59 -1.74 24.33 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.327 0.584 . . . . 0.0 110.604 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.519 ' HB2' ' HG3' ' A' ' 80' ' ' GLU . 70.6 m -141.45 141.4 22.88 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.704 -178.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.775 ' HA ' HD11 ' A' ' 71' ' ' LEU . 77.0 Cg_exo -44.45 -58.13 1.66 Allowed 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 123.18 2.587 . . . . 0.0 113.275 177.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.432 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 0.2 OUTLIER -56.06 -28.64 58.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.068 -176.818 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.602 ' HB2' HG23 ' A' ' 75' ' ' ILE . 48.6 mt-10 -67.96 -32.46 72.91 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.001 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.522 ' HB2' HG22 ' A' ' 75' ' ' ILE . 32.4 t -70.33 -33.99 72.14 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.493 HG12 ' CE2' ' A' ' 62' ' ' TYR . 26.2 t -76.95 -29.36 17.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.44 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.668 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 8.2 mtmp? -54.04 -42.09 68.81 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.463 176.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -63.88 -39.8 95.04 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.913 -176.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -61.95 -38.37 88.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.376 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.444 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 22.3 m -88.38 -35.21 7.72 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.86 -179.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.43 ' OE2' ' HB3' ' A' ' 83' ' ' LYS . 40.4 mt-10 -62.54 -38.93 91.92 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 122.472 0.309 . . . . 0.0 111.587 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.64 -20.56 63.52 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.454 0.645 . . . . 0.0 110.505 176.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.583 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 9.8 mmt180 -88.28 -51.1 5.94 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.622 0.725 . . . . 0.0 110.022 170.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.486 ' O ' HD12 ' A' ' 93' ' ' ILE . 75.7 mt -80.76 -65.22 1.04 Allowed 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 114.715 -1.13 . . . . 0.0 112.406 -171.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.841 ' HB1' ' HA ' ' A' ' 98' ' ' GLU . . . -56.15 -17.53 7.51 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.71 -175.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -73.23 -45.5 55.72 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.92 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.486 HD12 ' O ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -90.97 -17.86 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 121.663 0.744 . . . . 0.0 109.73 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.442 ' N ' HD12 ' A' ' 93' ' ' ILE . . . -102.94 45.61 0.95 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 167.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 0.1 OUTLIER -35.4 -32.61 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 111.887 -2.415 . . . . 0.0 113.94 -179.226 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -66.77 -33.13 74.95 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.191 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.46 ' OH ' ' HG3' ' A' ' 6' ' ' ARG . 47.1 m-85 -99.22 15.4 26.2 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -170.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.841 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 4.3 pt-20 -56.33 -16.36 5.47 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.324 0.583 . . . . 0.0 111.138 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.9 m -100.44 74.06 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.861 173.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.47 ' CG ' ' HZ1' ' A' ' 83' ' ' LYS . 7.8 p30 -48.13 130.14 15.54 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.729 -178.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.5 tpp180 . . . . . 0 C--O 1.248 0.98 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.321 -178.523 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 15.0 p90 . . . . . 0 N--CA 1.44 -0.93 0 CA-C-O 121.147 0.499 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.64 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . 28.2 mp0 -131.95 135.9 46.93 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.799 -177.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.909 HG12 HG12 ' A' ' 19' ' ' ILE . 9.5 mt -101.94 124.83 56.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.967 178.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -121.32 165.49 15.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.09 0.472 . . . . 0.0 109.904 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -87.34 127.61 35.19 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.698 0.761 . . . . 0.0 110.358 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.643 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -68.32 -47.27 68.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.227 -174.36 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.61 -83.11 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -118.85 -44.73 2.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.673 0.273 . . . . 0.0 111.24 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.1 p -146.15 43.49 1.22 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.495 0.664 . . . . 0.0 110.83 -173.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -144.45 156.59 44.26 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.398 178.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.629 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 35.6 ttp -128.01 134.71 49.27 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -175.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.643 ' HB2' HD22 ' A' ' 12' ' ' LEU . 39.5 ttp -125.16 130.07 51.42 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.918 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.909 HG12 HG12 ' A' ' 9' ' ' ILE . 7.3 mt -121.22 118.74 57.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.298 -173.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.64 ' HD3' ' HB2' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -103.52 139.75 38.44 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 176.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.747 ' HB2' HG11 ' A' ' 29' ' ' VAL . 15.1 m-85 . . . . . 0 C--N 1.322 -0.622 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.496 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 25.4 tm0? . . . . . 0 N--CA 1.457 -0.077 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.747 HG11 ' HB2' ' A' ' 21' ' ' PHE . 71.0 t -66.77 -48.58 79.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.66 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -51.89 -36.71 49.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.824 -176.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.07 -34.63 8.09 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.253 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 28' ' ' GLN . 0.4 OUTLIER -79.73 -29.14 12.95 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.017 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -174.126 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.541 HG23 ' HG ' ' A' ' 58' ' ' LEU . 11.4 p -68.73 -28.71 41.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 118.879 0.763 . . . . 0.0 109.415 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -70.07 -39.65 75.51 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.517 175.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.79 -21.41 29.95 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.113 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.629 ' HB1' HD11 ' A' ' 58' ' ' LEU . . . -64.36 -27.49 69.05 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.156 -176.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.54 -44.53 96.89 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.714 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -78.88 -31.88 45.64 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.877 177.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.405 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 14.9 t80 -57.49 -44.57 85.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.23 0.538 . . . . 0.0 109.728 178.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.9 mt -71.44 -33.31 49.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.322 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.273 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.714 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 12.6 pt-20 -78.97 -18.89 52.95 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.129 -176.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.45 ' C ' ' HD3' ' A' ' 44' ' ' PRO . 42.4 mt-10 -85.16 -30.34 24.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.842 0.353 . . . . 0.0 110.749 174.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -127.11 64.46 61.06 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.937 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.45 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 80.1 Cg_endo -98.26 178.1 0.4 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 123.295 2.663 . . . . 0.0 114.033 -170.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -106.93 146.69 33.63 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.25 171.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.557 ' HB2' ' HG3' ' A' ' 66' ' ' GLU . 71.5 Cg_exo -51.62 -15.31 2.66 Favored 'Trans proline' 0 N--CA 1.477 0.546 0 C-N-CA 124.019 3.146 . . . . 0.0 114.574 -173.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.8 15.22 41.11 Favored Glycine 0 C--O 1.223 -0.569 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.413 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -65.55 134.08 52.58 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.017 0.437 . . . . 0.0 110.905 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.418 HG12 ' HA ' ' A' ' 62' ' ' TYR . 28.8 mm -110.15 -59.73 3.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.437 -176.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -161.69 157.3 24.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.719 0.295 . . . . 0.0 110.787 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.2 p -150.08 121.64 7.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.929 HG13 ' HB ' ' A' ' 59' ' ' THR . 5.7 pt -120.4 130.84 24.65 Favored Pre-proline 0 C--N 1.319 -0.746 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.498 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 5.6 Cg_exo -78.94 122.91 5.52 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.454 2.769 . . . . 0.0 111.674 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -111.11 50.08 0.84 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 -176.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.7 t80 76.58 -56.85 0.55 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.387 172.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.1 p -137.82 14.23 2.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.101 0.477 . . . . 0.0 110.741 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 15.8 t -138.7 152.57 48.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.033 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.629 HD11 ' HB1' ' A' ' 36' ' ' ALA . 5.4 mt -112.24 114.36 27.11 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.38 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.929 ' HB ' HG13 ' A' ' 52' ' ' ILE . 2.8 m -91.18 103.93 16.55 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 174.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.8 t -112.04 114.04 45.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.603 0.716 . . . . 0.0 111.188 -169.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.477 ' CE1' HG22 ' A' ' 59' ' ' THR . 84.9 m-85 -105.48 148.91 26.67 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.796 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.556 ' CE2' HG11 ' A' ' 82' ' ' VAL . 2.8 p90 -166.54 172.94 10.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.329 0.585 . . . . 0.0 110.992 -175.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.536 ' OD1' ' HB3' ' A' ' 65' ' ' TYR . 6.7 t0 -98.49 119.55 37.4 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.841 -177.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.548 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -65.61 -20.22 66.23 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.04 -177.063 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.536 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -60.65 -33.6 73.05 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.102 0.477 . . . . 0.0 110.95 -178.916 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.557 ' HG3' ' HB2' ' A' ' 46' ' ' PRO . 0.8 OUTLIER -90.27 -22.23 21.7 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.862 0.839 . . . . 0.0 109.331 -173.813 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.548 HG22 ' HA ' ' A' ' 64' ' ' MET . 2.7 m -82.27 -37.7 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.414 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.955 ' HA ' HD23 ' A' ' 71' ' ' LEU . 32.3 m-85 -58.35 -31.65 67.8 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.093 0.473 . . . . 0.0 109.925 168.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.506 ' HB2' ' HE3' ' A' ' 69' ' ' LYS . 2.9 tppp? -60.59 -27.01 67.4 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.669 177.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -93.7 -76.13 0.48 Allowed 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.134 174.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.955 HD23 ' HA ' ' A' ' 68' ' ' TYR . 1.2 mm? 31.37 66.7 0.92 Allowed Pre-proline 0 N--CA 1.471 0.602 0 C-N-CA 124.312 1.045 . . . . 0.0 112.385 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.656 ' HD2' HG13 ' A' ' 75' ' ' ILE . 32.1 Cg_exo -59.7 153.1 58.22 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.804 2.336 . . . . 0.0 112.366 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -70.08 103.03 2.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.739 0.78 . . . . 0.0 110.541 -176.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 137.27 -34.08 2.23 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -173.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.656 HG13 ' HD2' ' A' ' 72' ' ' PRO . 18.4 mm -75.53 113.59 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 113.974 -1.113 . . . . 0.0 108.67 171.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.3 m -97.94 -3.27 38.75 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.546 -174.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 80' ' ' GLU . 57.0 m -140.32 134.97 15.72 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.893 -172.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.603 ' HA ' HD21 ' A' ' 71' ' ' LEU . 64.9 Cg_exo -45.47 -58.35 1.66 Allowed 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 123.201 2.601 . . . . 0.0 113.33 175.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.53 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -56.48 -29.38 61.68 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.286 0.565 . . . . 0.0 111.158 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.526 ' HG3' ' HE2' ' A' ' 83' ' ' LYS . 40.2 tt0 -71.68 -25.39 62.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.519 -176.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.527 ' HB2' HG21 ' A' ' 75' ' ' ILE . 34.3 t -77.45 -38.35 49.56 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.556 HG11 ' CE2' ' A' ' 62' ' ' TYR . 46.2 t -63.28 -32.27 55.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.292 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.629 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 39.8 mtmt -51.33 -39.54 57.19 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.738 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -73.29 -39.57 65.24 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.89 -174.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -64.2 -35.08 79.63 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.718 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.0 m -86.34 -38.64 12.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.679 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 . . . . . 0 C--O 1.218 -0.599 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 176.65 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.565 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 6.1 p90 . . . . . 0 N--CA 1.436 -1.137 0 CA-C-O 121.372 0.606 . . . . 0.0 110.619 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.401 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 1.8 tp-100 -139.16 133.35 31.31 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.311 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.966 HG12 HG12 ' A' ' 19' ' ' ILE . 37.2 mt -101.57 119.77 50.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.072 177.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -114.03 165.55 12.5 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.066 -177.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -84.26 130.79 34.79 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.521 0.677 . . . . 0.0 110.461 177.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -75.89 -42.98 47.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.867 -175.927 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -161.78 -73.29 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -142.29 -31.63 0.53 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.5 p -144.93 40.65 1.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.4 0.619 . . . . 0.0 111.325 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -147.78 154.45 40.51 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.874 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -119.29 144.99 46.5 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 119.872 -0.731 . . . . 0.0 112.014 -175.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.477 ' HB2' HD22 ' A' ' 12' ' ' LEU . 26.9 ttt -130.2 129.04 42.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.488 176.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.966 HG12 HG12 ' A' ' 9' ' ' ILE . 6.4 mt -121.35 145.04 28.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.322 -175.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.565 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -136.54 139.92 42.58 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 171.143 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.77 ' HB2' HG11 ' A' ' 29' ' ' VAL . 54.2 m-85 . . . . . 0 C--N 1.328 -0.369 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 173.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? . . . . . 0 N--CA 1.455 -0.175 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.77 HG11 ' HB2' ' A' ' 21' ' ' PHE . 99.2 t -61.29 -49.84 82.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.6 178.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -43.79 -40.92 4.67 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 124.136 0.897 . . . . 0.0 112.284 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.36 -42.75 5.13 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.491 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -72.86 -27.17 24.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -172.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 29' ' ' VAL . 11.9 p -70.94 -27.45 30.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.369 0.604 . . . . 0.0 109.433 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -70.51 -35.69 73.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.63 172.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.28 -20.06 32.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.005 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.3 -24.74 67.48 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.192 -175.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.04 -46.64 83.53 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.655 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -76.45 -27.57 56.23 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.536 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -59.51 -45.13 92.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.094 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.534 HD11 HD21 ' A' ' 58' ' ' LEU . 68.3 mt -72.15 -33.39 46.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.43 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.655 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 9.9 pt-20 -77.14 -20.25 55.8 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.94 -175.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -80.66 -32.38 36.11 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 175.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -126.1 72.82 71.19 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.093 0.473 . . . . 0.0 109.732 176.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -98.17 -163.13 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.886 3.057 . . . . 0.0 114.044 -169.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -137.77 145.96 50.77 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 113.965 -1.471 . . . . 0.0 107.441 174.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -53.36 -15.8 6.3 Favored 'Trans proline' 0 N--CA 1.481 0.742 0 C-N-CA 123.635 2.89 . . . . 0.0 114.906 -169.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.593 ' HA3' ' HB2' ' A' ' 66' ' ' GLU . . . -107.31 17.03 37.75 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.491 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.421 ' HZ ' ' SG ' ' A' ' 51' ' ' CYS . 45.3 t80 -63.76 130.16 43.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.044 0.449 . . . . 0.0 111.391 176.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.415 HG12 ' HA ' ' A' ' 62' ' ' TYR . 35.2 mm -104.04 -61.84 2.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.026 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -161.8 156.83 23.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.848 0.356 . . . . 0.0 110.521 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.421 ' SG ' ' HZ ' ' A' ' 48' ' ' PHE . 7.4 p -145.96 119.51 9.1 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.746 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.8 pt -124.52 131.44 24.16 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-O 121.108 0.48 . . . . 0.0 111.462 -178.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 4.7 Cg_exo -78.44 149.18 24.14 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.141 2.561 . . . . 0.0 112.493 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.681 ' HB3' ' HB2' ' A' ' 57' ' ' SER . . . -120.99 17.96 11.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.025 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 71.75 -24.47 0.18 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.654 174.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.4 ' H ' ' C ' ' A' ' 54' ' ' ALA . 7.6 t -135.98 -9.12 2.06 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.524 0.678 . . . . 0.0 109.817 169.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.681 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 16.3 m -130.73 165.53 22.7 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.549 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.534 HD21 HD11 ' A' ' 40' ' ' ILE . 45.3 tp -132.16 125.97 32.51 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.746 ' HB ' HG13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -106.16 107.05 17.86 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.816 -177.02 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.874 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 47.3 t -109.05 115.36 49.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.507 0.67 . . . . 0.0 111.295 -174.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -105.14 146.74 28.78 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.294 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.544 ' CD2' HG11 ' A' ' 82' ' ' VAL . 3.1 p90 -164.19 171.46 14.97 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.031 0.443 . . . . 0.0 110.664 -172.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.503 ' OD1' ' HB3' ' A' ' 65' ' ' TYR . 6.2 t0 -100.92 115.49 30.55 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.347 -177.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.687 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -59.71 -18.77 45.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.18 -177.562 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.635 ' CE2' ' HG2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -66.7 -34.98 79.06 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -177.396 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.635 ' HG2' ' CE2' ' A' ' 65' ' ' TYR . 5.4 mm-40 -89.4 -27.37 20.47 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.872 0.844 . . . . 0.0 109.484 -174.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.722 HG11 HG22 ' A' ' 82' ' ' VAL . 4.1 m -83.39 -22.96 8.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.83 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.939 ' HA ' HD12 ' A' ' 71' ' ' LEU . 15.5 t80 -75.14 -28.05 60.01 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 168.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -67.97 -28.7 67.67 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.071 170.527 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.735 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 11.9 t-80 -111.52 28.33 8.84 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.492 174.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.939 HD12 ' HA ' ' A' ' 68' ' ' TYR . 2.7 mt -94.77 95.37 1.49 Allowed Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.532 176.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.735 ' HD3' ' O ' ' A' ' 70' ' ' HIS . 8.8 Cg_exo -76.48 175.2 11.66 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 124.061 3.174 . . . . 0.0 112.769 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -60.79 -42.78 98.24 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -171.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.03 -25.12 74.47 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.779 -175.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.613 HG13 ' HD2' ' A' ' 72' ' ' PRO . 5.6 mm -85.26 120.93 36.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.233 -0.483 . . . . 0.0 109.779 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.5 m -110.52 3.78 19.83 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.151 0.5 . . . . 0.0 111.17 -174.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.527 ' HB3' ' CB ' ' A' ' 80' ' ' GLU . 28.2 t -134.59 126.16 17.96 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.148 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.703 ' HA ' HD11 ' A' ' 71' ' ' LEU . 74.6 Cg_exo -42.96 -56.57 2.15 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.762 2.975 . . . . 0.0 112.626 171.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -36.44 63.38 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.359 0.6 . . . . 0.0 111.422 175.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.527 ' CB ' ' HB3' ' A' ' 77' ' ' SER . 38.5 tt0 -73.47 -30.65 63.3 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.262 -174.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.553 ' HB3' HG21 ' A' ' 75' ' ' ILE . 67.6 p -73.05 -35.18 66.67 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.655 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.722 HG22 HG11 ' A' ' 67' ' ' VAL . 6.8 t -61.59 -36.32 72.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.062 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -51.86 -40.07 59.97 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -67.41 -38.09 84.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.348 -177.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -65.91 -39.75 90.85 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.804 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.4 m -83.83 -46.39 18.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.35 -177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 C--O 1.219 -0.532 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -176.428 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.562 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 18.3 p90 . . . . . 0 N--CA 1.443 -0.784 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.517 ' HB2' ' NE ' ' A' ' 20' ' ' ARG . 14.7 mm-40 -133.09 132.79 42.15 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.875 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.751 HG12 HG12 ' A' ' 19' ' ' ILE . 14.9 mt -95.94 119.48 44.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.706 178.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -120.32 158.33 27.31 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.652 -176.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -82.89 129.34 35.0 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.453 0.644 . . . . 0.0 110.525 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.684 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -73.94 -38.67 64.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.601 -1.182 . . . . 0.0 110.98 -176.349 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.62 -87.16 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.497 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -103.47 -50.26 3.49 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -176.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.526 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 32.5 p -156.39 48.15 0.47 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 122.141 0.972 . . . . 0.0 109.966 -176.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -140.11 148.24 41.41 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.255 -1.339 . . . . 0.0 107.688 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.726 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 37.8 ttp -121.83 139.06 54.09 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.956 -174.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.684 ' HB2' HD22 ' A' ' 12' ' ' LEU . 49.8 ttm -124.89 132.21 53.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.054 0.454 . . . . 0.0 110.947 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.751 HG12 HG12 ' A' ' 9' ' ' ILE . 7.7 mt -124.98 120.88 59.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.654 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.517 ' NE ' ' HB2' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -114.08 134.32 54.96 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.992 177.048 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.562 ' HA ' ' CB ' ' A' ' 7' ' ' TYR . 32.1 m-85 . . . . . 0 C--N 1.327 -0.403 0 CA-C-O 120.567 0.222 . . . . 0.0 110.885 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.3 tm0? . . . . . 0 C--O 1.233 0.193 0 CA-C-O 120.912 0.387 . . . . 0.0 110.012 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.449 ' HA ' HG22 ' A' ' 32' ' ' ILE . 27.1 m -74.18 -25.82 20.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.686 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -59.9 -25.91 65.49 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.624 174.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -96.91 -32.86 6.29 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.417 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.449 HG22 ' HA ' ' A' ' 29' ' ' VAL . 0.5 OUTLIER -75.94 -23.59 16.27 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 C-N-CA 121.171 -0.212 . . . . 0.0 111.152 -177.058 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.487 HG23 ' HG ' ' A' ' 58' ' ' LEU . 10.5 p -65.53 -31.0 51.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.364 0.602 . . . . 0.0 109.471 176.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.418 ' HA ' ' CB ' ' A' ' 53' ' ' PRO . 53.3 t-80 -74.75 -38.0 62.35 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.708 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.58 -22.99 46.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.663 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.577 ' HB1' HD11 ' A' ' 58' ' ' LEU . . . -65.36 -25.84 67.76 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.836 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.51 -40.63 95.3 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.739 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.09 -29.61 26.65 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.859 176.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.487 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . 2.7 t80 -60.34 -42.85 96.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.914 0.388 . . . . 0.0 110.401 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 51.6 mt -74.26 -38.42 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.037 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.739 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 8.4 pt-20 -71.15 -23.78 62.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.697 0.284 . . . . 0.0 110.927 -176.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -76.98 -32.54 57.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.017 177.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -134.82 68.38 71.26 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.032 0.444 . . . . 0.0 110.916 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -98.51 -176.31 0.21 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.539 2.826 . . . . 0.0 113.415 -174.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.506 ' HZ ' ' HB2' ' A' ' 62' ' ' TYR . 12.5 p90 -108.3 149.42 39.24 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -39.74 -36.35 1.19 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.003 3.135 . . . . 0.0 115.636 -172.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 66' ' ' GLU . . . -98.37 15.41 61.27 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.97 -175.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.42 ' HZ ' ' SG ' ' A' ' 51' ' ' CYS . 32.4 t80 -62.03 132.84 54.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.264 0.554 . . . . 0.0 110.845 175.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.413 HG12 ' HA ' ' A' ' 62' ' ' TYR . 33.1 mm -106.24 -62.49 2.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.287 -176.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -160.37 155.66 24.97 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.796 -170.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.42 ' SG ' ' HZ ' ' A' ' 48' ' ' PHE . 2.9 p -151.39 119.44 6.26 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.992 0.425 . . . . 0.0 110.024 176.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.748 HG13 ' HB ' ' A' ' 59' ' ' THR . 7.8 pt -121.43 138.6 28.44 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.436 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 11.1 Cg_endo -86.6 148.9 8.69 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.152 2.568 . . . . 0.0 112.424 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -143.5 66.68 1.3 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 69.4 t80 74.47 -60.74 0.51 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.417 0.687 . . . . 0.0 111.516 173.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.3 t -136.04 -5.75 2.12 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.287 0.565 . . . . 0.0 110.104 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 16.4 m -113.87 137.07 52.17 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.29 -174.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.577 HD11 ' HB1' ' A' ' 36' ' ' ALA . 3.8 mt -100.81 120.47 40.17 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.057 174.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.748 ' HB ' HG13 ' A' ' 52' ' ' ILE . 1.8 m -96.78 104.44 16.44 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.2 t -110.76 114.77 48.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.711 0.767 . . . . 0.0 111.064 -169.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -106.89 150.12 26.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.191 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.689 ' OH ' ' HB2' ' A' ' 17' ' ' MET . 3.1 p90 -166.62 167.77 15.08 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.371 -175.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.477 ' O ' HG13 ' A' ' 67' ' ' VAL . 1.3 t0 -100.64 115.85 31.17 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.179 0.514 . . . . 0.0 110.455 -174.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.62 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -61.83 -21.89 65.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.078 -174.515 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -69.21 -30.12 68.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.158 0.504 . . . . 0.0 109.843 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.444 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 1.2 tm-20 -92.08 -33.01 14.95 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.728 0.775 . . . . 0.0 109.131 -173.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.62 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.4 m -67.21 -40.67 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.979 176.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.824 ' HA ' HD23 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -63.71 -25.82 68.38 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.519 173.928 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.487 ' HE2' ' HB2' ' A' ' 69' ' ' LYS . 5.3 tppt? -70.58 -21.24 62.7 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.75 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -104.87 -41.87 5.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.561 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.824 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER -7.36 84.6 0.03 OUTLIER Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 125.795 1.638 . . . . 0.0 113.703 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.427 ' HD2' HG13 ' A' ' 75' ' ' ILE . 32.3 Cg_exo -60.53 165.36 11.49 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.127 2.551 . . . . 0.0 112.921 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? -61.59 -42.29 98.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.84 0.352 . . . . 0.0 111.419 -173.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.35 -18.55 79.13 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.794 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.596 HG21 ' HB3' ' A' ' 81' ' ' SER . 6.2 mm -88.13 119.17 35.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.49 -0.355 . . . . 0.0 110.281 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -101.75 -9.31 20.94 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.93 0.395 . . . . 0.0 110.945 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.6 m -122.51 123.76 26.95 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.592 -175.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.664 ' HA ' HD21 ' A' ' 71' ' ' LEU . 46.4 Cg_exo -49.05 -46.71 24.36 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.55 2.833 . . . . 0.0 113.783 174.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.93 -29.96 69.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.772 0.32 . . . . 0.0 111.286 175.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 84' ' ' ARG . 52.9 tt0 -75.07 -31.61 61.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.17 -175.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.596 ' HB3' HG21 ' A' ' 75' ' ' ILE . 37.3 p -72.88 -32.94 65.74 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.564 HG11 ' CD2' ' A' ' 62' ' ' TYR . 61.1 t -69.04 -37.0 76.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.161 -1.381 . . . . 0.0 111.282 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.726 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 39.4 mtmt -52.17 -43.23 64.01 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.454 0.645 . . . . 0.0 109.317 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 22.1 mmt180 -67.29 -31.42 71.71 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.866 -173.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.15 -35.28 69.03 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.005 0.431 . . . . 0.0 111.244 176.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.6 m -86.91 -39.18 12.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 C-N-CA 120.424 -0.511 . . . . 0.0 111.047 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 . . . . . 0 C--O 1.214 -0.809 0 C-N-CA 122.623 0.369 . . . . 0.0 111.923 179.828 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.572 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 6.9 p90 . . . . . 0 N--CA 1.437 -1.105 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.554 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . 30.5 tt0 -141.01 133.51 28.48 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.731 0.777 . . . . 0.0 110.206 174.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.679 HG12 HG12 ' A' ' 19' ' ' ILE . 9.2 mt -92.16 109.73 21.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.557 176.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.628 ' HG2' ' O ' ' A' ' 18' ' ' MET . 9.1 pt-20 -111.34 163.14 14.3 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.692 -170.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -88.36 131.49 34.81 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.282 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.608 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -76.22 -31.48 58.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.569 -176.88 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.45 -72.26 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.046 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -135.99 -35.34 0.78 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.3 p -152.89 41.53 0.58 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.714 0.768 . . . . 0.0 110.976 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.583 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -143.8 155.52 44.18 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 174.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.611 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 43.8 ttp -130.09 136.57 49.49 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.441 -172.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.628 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 49.3 ttm -126.82 141.94 51.68 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.808 176.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.679 HG12 HG12 ' A' ' 9' ' ' ILE . 7.5 mt -125.4 115.3 43.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 O-C-N 122.365 -0.209 . . . . 0.0 111.296 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.554 ' HD3' ' HB3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -98.64 136.4 38.76 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 174.54 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.89 ' HB2' HG21 ' A' ' 29' ' ' VAL . 3.9 m-85 . . . . . 0 C--N 1.327 -0.385 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? . . . . . 0 CA--C 1.531 0.239 0 CA-C-O 120.433 0.158 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.89 HG21 ' HB2' ' A' ' 21' ' ' PHE . 9.2 p -65.17 -42.12 93.4 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.061 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -48.99 -43.48 40.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.928 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.36 -5.23 87.32 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.14 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -115.88 -31.72 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.617 0 CA-C-N 117.766 0.783 . . . . 0.0 112.372 -174.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.454 ' O ' ' HB3' ' A' ' 53' ' ' PRO . 6.7 p -60.94 -36.81 74.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 118.391 0.541 . . . . 0.0 110.419 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.415 ' HA ' ' CB ' ' A' ' 53' ' ' PRO . 11.5 p-80 -79.31 -22.59 44.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.85 0.357 . . . . 0.0 110.636 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.88 -29.96 23.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.015 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.519 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -64.23 -22.39 66.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.244 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.47 -43.08 98.34 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.59 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.36 -27.97 27.33 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.835 176.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.519 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 3.9 t80 -56.91 -48.14 78.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.066 0.46 . . . . 0.0 110.252 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.454 HD11 HD21 ' A' ' 58' ' ' LEU . 58.9 mt -72.93 -36.94 52.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.485 -174.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.59 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 13.0 pt-20 -71.17 -19.4 62.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.654 0.264 . . . . 0.0 111.349 -174.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.411 ' C ' ' HD3' ' A' ' 44' ' ' PRO . 46.0 mt-10 -79.46 -28.68 41.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.88 0.372 . . . . 0.0 110.877 174.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -129.89 64.19 71.22 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.785 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.411 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 65.2 Cg_endo -98.99 177.98 0.34 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.264 2.643 . . . . 0.0 113.389 -174.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.54 ' CE2' HG13 ' A' ' 82' ' ' VAL . 6.6 p90 -108.21 147.41 35.53 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.279 173.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.21 12.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.486 1.033 0 C-N-CA 124.293 3.329 . . . . 0.0 114.852 -173.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.491 ' HA3' ' HB2' ' A' ' 66' ' ' GLU . . . -131.12 19.32 4.91 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 175.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.594 ' HZ ' ' HB3' ' A' ' 51' ' ' CYS . 30.9 t80 -79.49 142.61 35.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.013 0.435 . . . . 0.0 110.404 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.492 HG12 ' HA ' ' A' ' 62' ' ' TYR . 35.5 mm -108.38 -59.19 3.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.212 -175.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -168.93 141.6 2.73 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.351 -173.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.594 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 1.6 p -129.22 118.75 22.86 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 173.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.734 HG13 ' HB ' ' A' ' 59' ' ' THR . 4.3 pt -121.18 134.87 24.54 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.877 -175.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.454 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 86.9 Cg_endo -87.2 139.88 5.37 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.303 2.669 . . . . 0.0 112.66 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.3 59.22 1.59 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.413 ' O ' HG11 ' A' ' 33' ' ' VAL . 75.8 t80 75.02 -50.69 0.67 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.576 0.75 . . . . 0.0 112.086 172.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.27 -12.9 1.19 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.111 0.481 . . . . 0.0 110.863 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.5 m -115.39 134.14 55.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.979 0.419 . . . . 0.0 111.162 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.454 HD21 HD11 ' A' ' 40' ' ' ILE . 46.0 tp -102.86 117.23 34.17 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.789 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.734 ' HB ' HG13 ' A' ' 52' ' ' ILE . 4.8 m -97.6 114.41 26.33 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -177.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.9 t -111.41 109.58 29.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.765 0.793 . . . . 0.0 111.375 -170.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -101.25 145.61 28.61 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.009 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.611 ' OH ' ' HB2' ' A' ' 17' ' ' MET . 2.9 p90 -166.62 166.94 15.78 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -176.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.41 ' OD1' ' HD1' ' A' ' 65' ' ' TYR . 5.4 t70 -102.58 128.55 49.19 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.339 0.59 . . . . 0.0 109.45 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.54 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -62.24 -20.56 64.35 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.799 -172.297 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.41 ' HD1' ' OD1' ' A' ' 63' ' ' ASP . 4.5 p90 -64.54 -34.93 79.39 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.847 0.356 . . . . 0.0 111.632 -174.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.491 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 1.7 tm-20 -92.52 -28.4 16.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.68 0.752 . . . . 0.0 109.598 -172.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.1 m -72.93 -34.65 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.911 ' HA ' HD23 ' A' ' 71' ' ' LEU . 58.9 t80 -72.47 -22.63 61.04 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.888 173.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.493 ' HE2' ' HB2' ' A' ' 69' ' ' LYS . 9.0 tppt? -66.27 -26.07 67.17 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 173.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -89.37 -74.64 0.47 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.786 172.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.911 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.8 OUTLIER 24.14 65.44 0.4 Allowed Pre-proline 0 N--CA 1.473 0.714 0 O-C-N 124.88 1.362 . . . . 0.0 112.88 -178.657 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.574 ' HD2' HG13 ' A' ' 75' ' ' ILE . 35.1 Cg_exo -60.67 143.47 99.42 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.608 2.205 . . . . 0.0 111.8 -175.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -64.0 108.39 1.5 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.499 0.666 . . . . 0.0 110.106 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 135.36 -30.1 2.83 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -171.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.575 HG21 ' HB3' ' A' ' 81' ' ' SER . 10.9 mm -87.12 125.23 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 114.422 -0.889 . . . . 0.0 108.622 170.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.5 t -103.68 -0.15 29.86 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.353 0.597 . . . . 0.0 110.274 -174.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.83 ' HG ' ' HD1' ' A' ' 79' ' ' PHE . 38.4 t -143.89 133.83 11.85 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.127 -170.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.59 ' HA ' HD21 ' A' ' 71' ' ' LEU . 86.1 Cg_exo -50.07 -50.35 13.63 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.668 2.912 . . . . 0.0 112.863 174.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.83 ' HD1' ' HG ' ' A' ' 77' ' ' SER . 0.1 OUTLIER -63.2 -30.24 71.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.102 0.477 . . . . 0.0 110.921 178.817 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.433 ' CB ' ' HB3' ' A' ' 77' ' ' SER . 40.7 tt0 -73.31 -27.1 61.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.366 -175.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.575 ' HB3' HG21 ' A' ' 75' ' ' ILE . 88.8 p -79.31 -37.75 36.92 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.56 0.695 . . . . 0.0 109.176 178.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 78' ' ' PRO . 61.0 t -63.42 -31.44 52.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.157 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.537 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 6.3 mtmp? -52.53 -43.63 65.26 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 84' ' ' ARG . 11.3 mmm180 -64.56 -41.83 96.07 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.429 -174.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.34 -39.36 86.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.819 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.2 m -87.24 -41.49 14.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.968 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -175.467 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.617 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 35.2 p90 . . . . . 0 N--CA 1.448 -0.567 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.44 120.29 18.5 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -175.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.943 HG12 HG12 ' A' ' 19' ' ' ILE . 40.7 mt -89.71 123.74 42.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.036 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 18' ' ' MET . 12.0 pt-20 -122.0 174.17 7.08 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.834 -176.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -95.08 135.51 36.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.526 0.679 . . . . 0.0 110.598 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.44 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -80.87 -44.7 17.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.517 -176.587 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -172.92 -74.32 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.432 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -127.15 -50.39 1.43 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.118 0.485 . . . . 0.0 111.172 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.8 p -144.9 41.03 1.28 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.588 0.709 . . . . 0.0 110.942 -172.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.02 157.29 44.42 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.651 176.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.794 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -123.21 145.84 48.31 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.888 -176.321 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.44 ' HB2' HD22 ' A' ' 12' ' ' LEU . 51.8 ttm -127.25 131.13 50.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.749 174.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.943 HG12 HG12 ' A' ' 9' ' ' ILE . 9.9 mt -114.07 124.85 71.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.84 -177.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.7 111.75 24.03 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.618 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.617 ' HA ' ' CB ' ' A' ' 7' ' ' TYR . 22.9 m-85 . . . . . 0 C--N 1.313 -1.021 0 CA-C-O 121.195 0.521 . . . . 0.0 111.258 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 . . . . . 0 N--CA 1.464 0.226 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.418 HG13 ' H ' ' A' ' 30' ' ' ASN . 1.5 p -62.57 -55.98 20.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.912 176.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.418 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -57.76 -29.03 64.48 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.859 -177.429 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.19 -15.7 58.6 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.228 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.409 ' O ' ' N ' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -115.18 -24.82 3.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.724 0 CA-C-N 117.41 0.605 . . . . 0.0 112.361 -174.351 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.446 HG11 ' O ' ' A' ' 55' ' ' PHE . 7.2 p -61.24 -34.57 61.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 118.785 0.72 . . . . 0.0 110.361 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -77.14 -32.09 56.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.837 0.351 . . . . 0.0 110.072 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.83 -20.8 30.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.46 -176.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 32' ' ' ILE . . . -66.46 -32.03 73.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.997 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.7 -41.07 97.1 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.91 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -73.84 -36.86 64.94 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.753 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.01 -35.43 75.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.231 0.539 . . . . 0.0 110.113 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.7 mt -81.95 -35.21 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.373 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.91 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 10.5 pt-20 -79.84 -21.77 43.75 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.751 -175.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.952 ' HG3' ' HG3' ' A' ' 43' ' ' GLN . 9.6 pt-20 -81.03 -29.89 35.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.121 0.486 . . . . 0.0 109.967 175.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.952 ' HG3' ' HG3' ' A' ' 42' ' ' GLU . 54.3 mt-30 -126.37 65.05 57.46 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.933 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.425 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 66.2 Cg_endo -93.36 -173.27 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.569 2.846 . . . . 0.0 114.017 -169.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -124.77 146.73 53.92 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.517 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -49.06 -18.63 1.92 Allowed 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 124.151 3.234 . . . . 0.0 115.265 -171.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.36 21.09 22.41 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.172 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.485 ' HZ ' ' SG ' ' A' ' 51' ' ' CYS . 45.2 t80 -66.69 130.41 43.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.993 0.425 . . . . 0.0 110.795 176.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.434 HG12 ' HA ' ' A' ' 62' ' ' TYR . 35.4 mm -102.55 -59.76 3.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.277 -177.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -162.82 154.39 17.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.738 0.304 . . . . 0.0 110.734 -174.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.485 ' SG ' ' HZ ' ' A' ' 48' ' ' PHE . 12.3 p -144.27 119.3 10.02 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 173.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.777 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.5 pt -124.95 132.83 24.39 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-O 121.127 0.489 . . . . 0.0 111.755 -178.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.55 136.9 7.68 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.02 2.48 . . . . 0.0 111.715 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -124.73 54.37 1.4 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.957 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.446 ' O ' HG11 ' A' ' 33' ' ' VAL . 57.9 m-85 74.13 -53.4 0.68 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.49 0.716 . . . . 0.0 112.285 171.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.417 ' O ' ' HB2' ' A' ' 21' ' ' PHE . 9.3 t -139.26 3.2 2.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.199 0.523 . . . . 0.0 110.477 176.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.3 m -125.7 146.3 49.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.059 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.43 ' HB3' ' HB ' ' A' ' 19' ' ' ILE . 45.8 tp -112.98 119.9 39.53 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.777 ' HB ' HG13 ' A' ' 52' ' ' ILE . 1.4 m -102.1 110.24 22.16 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.794 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 58.9 t -111.27 115.99 51.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.602 0.715 . . . . 0.0 111.185 -173.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -107.05 145.9 31.81 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.479 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.607 ' OH ' ' HB3' ' A' ' 17' ' ' MET . 3.5 p90 -165.12 168.79 16.89 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.983 -175.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.417 ' OD1' ' HB3' ' A' ' 65' ' ' TYR . 7.2 t0 -101.97 114.35 28.38 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.495 -176.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.706 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -64.44 -20.82 66.41 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.075 -176.848 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.417 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -64.56 -27.52 69.01 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.793 0.33 . . . . 0.0 110.732 -179.203 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -90.69 -39.28 12.54 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.613 0.721 . . . . 0.0 109.271 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.706 HG22 ' HA ' ' A' ' 64' ' ' MET . 2.7 m -64.77 -34.43 70.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.235 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.738 ' HA ' HD23 ' A' ' 71' ' ' LEU . 7.3 m-85 -55.0 -28.39 51.64 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.841 0.456 . . . . 0.0 111.456 172.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -41.91 95.83 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.598 0.713 . . . . 0.0 109.415 177.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -91.0 -23.93 20.24 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.842 -174.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.738 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -26.53 94.37 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.895 0 O-C-N 124.867 1.355 . . . . 0.0 111.546 176.106 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.478 ' HD2' HG13 ' A' ' 75' ' ' ILE . 24.1 Cg_exo -67.65 140.16 50.72 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.551 2.834 . . . . 0.0 111.603 -175.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.0 tp60 -63.01 99.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.463 0.649 . . . . 0.0 109.917 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 140.02 -24.1 2.72 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -172.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.555 HG21 ' HB3' ' A' ' 81' ' ' SER . 2.4 mm -96.29 126.94 48.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 171.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 t -112.25 -0.25 15.55 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.266 0.555 . . . . 0.0 110.109 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.42 ' HG ' ' HD2' ' A' ' 79' ' ' PHE . 34.6 t -118.61 111.99 37.44 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.282 -175.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.694 ' HA ' HD21 ' A' ' 71' ' ' LEU . 91.3 Cg_exo -47.98 -46.3 22.37 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.55 2.833 . . . . 0.0 113.062 173.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.42 ' HD2' ' HG ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -61.18 -37.3 82.42 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.226 -0.19 . . . . 0.0 111.437 176.709 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 19.8 tt0 -82.07 -19.35 40.43 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.402 -174.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.555 ' HB3' HG21 ' A' ' 75' ' ' ILE . 83.3 p -74.25 -37.63 63.71 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 78' ' ' PRO . 26.8 t -65.67 -30.92 51.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.675 177.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.763 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 21.4 mtpt -49.94 -48.5 51.87 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 174.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -61.48 -38.65 88.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.494 -173.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -73.06 -33.72 65.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.137 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.7 m -87.01 -42.5 15.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 CA-C-O 118.911 -0.566 . . . . 0.0 112.043 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.763 ' HG2' ' O ' ' A' ' 83' ' ' LYS . 8.1 pt-20 . . . . . 0 N--CA 1.451 -0.384 0 CA-C-N 118.69 0.677 . . . . 0.0 111.912 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.477 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . 17.2 p90 . . . . . 0 N--CA 1.44 -0.93 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.413 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 8.1 tm0? -147.69 120.31 8.57 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 176.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.877 HG12 HG12 ' A' ' 19' ' ' ILE . 15.8 mt -76.83 117.76 22.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.839 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.604 ' HG2' ' O ' ' A' ' 18' ' ' MET . 8.7 pt-20 -116.92 162.49 17.67 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.804 -174.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -86.05 138.06 32.23 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.596 0.712 . . . . 0.0 110.102 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.733 HD21 HG23 ' A' ' 59' ' ' THR . 0.4 OUTLIER -94.59 -50.29 5.26 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.711 -1.132 . . . . 0.0 110.595 -171.535 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.45 142.45 3.59 Favored Glycine 0 N--CA 1.433 -1.501 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 70.4 -73.02 0.1 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.207 0.603 . . . . 0.0 111.148 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.5 p -173.62 53.51 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.597 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.14 156.43 44.33 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.537 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.864 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 1.1 ptp -123.4 155.98 36.33 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.084 -177.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.707 ' HB2' HD22 ' A' ' 12' ' ' LEU . 48.3 ttm -136.24 137.55 40.91 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 172.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.877 HG12 HG12 ' A' ' 9' ' ' ILE . 8.3 mt -117.21 107.29 21.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.674 -177.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.581 HH21 ' CD ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -90.65 136.11 33.27 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.255 -0.578 . . . . 0.0 109.472 176.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.591 ' HB3' HG11 ' A' ' 29' ' ' VAL . 14.8 m-85 . . . . . 0 C--N 1.323 -0.578 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 170.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.2 tm0? . . . . . 0 CA--C 1.53 0.173 0 CA-C-O 120.739 0.304 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.591 HG11 ' HB3' ' A' ' 21' ' ' PHE . 31.0 m -67.4 -42.89 87.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.315 -178.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -49.14 -40.67 33.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.539 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.82 -33.31 24.66 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.101 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -88.83 -26.41 5.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.463 0 O-C-N 122.422 -0.458 . . . . 0.0 112.116 -171.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.425 HG11 ' O ' ' A' ' 55' ' ' PHE . 7.8 p -63.49 -30.67 50.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.342 0.592 . . . . 0.0 109.627 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -74.98 -43.29 54.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.253 175.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.47 -22.23 57.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.132 -176.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.437 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -65.5 -27.64 68.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.527 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.61 -41.54 98.3 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.592 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.65 -21.2 30.33 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.18 176.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.437 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 10.6 t80 -66.88 -44.85 79.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.211 0.529 . . . . 0.0 110.06 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.518 HD11 HD21 ' A' ' 58' ' ' LEU . 34.0 mt -78.49 -31.49 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.696 -174.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.592 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 11.0 pt-20 -69.79 -21.96 63.37 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.777 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -85.09 -29.94 24.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.666 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -130.23 70.13 82.15 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 120.796 0.332 . . . . 0.0 111.003 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -97.39 -175.46 0.24 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.418 2.746 . . . . 0.0 113.091 -176.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.487 ' CZ ' HG12 ' A' ' 67' ' ' VAL . 9.5 p90 -116.36 148.61 42.05 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -45.25 -26.09 2.28 Favored 'Trans proline' 0 N--CA 1.482 0.836 0 C-N-CA 124.159 3.24 . . . . 0.0 115.579 -169.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.553 ' HA3' ' CB ' ' A' ' 66' ' ' GLU . . . -103.21 14.41 55.13 Favored Glycine 0 C--O 1.228 -0.268 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.743 -176.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.431 ' HZ ' ' SG ' ' A' ' 51' ' ' CYS . 31.3 t80 -68.1 139.98 56.21 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.492 0.663 . . . . 0.0 111.024 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.008 HG22 ' HG2' ' A' ' 50' ' ' GLU . 38.7 mm -112.4 -63.84 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.477 -174.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 1.008 ' HG2' HG22 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -152.39 169.41 22.61 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.14 0.495 . . . . 0.0 111.356 -177.445 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.431 ' SG ' ' HZ ' ' A' ' 48' ' ' PHE . 11.2 p -158.8 123.95 4.26 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 169.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.808 HG13 ' HB ' ' A' ' 59' ' ' THR . 7.9 pt -123.02 136.38 26.85 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-O 120.952 0.406 . . . . 0.0 111.724 -177.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 61.2 Cg_endo -85.88 129.12 3.41 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.163 2.575 . . . . 0.0 112.364 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -115.09 43.92 1.9 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.887 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.425 ' O ' HG11 ' A' ' 33' ' ' VAL . 62.2 t80 72.77 -40.55 0.48 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.734 0.813 . . . . 0.0 112.742 175.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.0 t -139.22 -17.71 1.02 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.177 0.513 . . . . 0.0 110.985 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 m -113.44 134.87 54.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.177 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.518 HD21 HD11 ' A' ' 40' ' ' ILE . 52.3 tp -103.06 112.25 25.0 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 177.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.808 ' HB ' HG13 ' A' ' 52' ' ' ILE . 10.7 m -92.49 106.77 18.69 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -177.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.864 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 41.1 t -107.52 120.92 59.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.46 0.648 . . . . 0.0 111.559 -173.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.605 ' HB2' ' HG3' ' A' ' 50' ' ' GLU . 85.7 m-85 -106.39 147.34 29.38 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.185 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.63 ' OH ' ' HB3' ' A' ' 17' ' ' MET . 3.0 p90 -166.7 170.49 12.45 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.673 -176.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.512 ' O ' HG13 ' A' ' 67' ' ' VAL . 6.1 t70 -104.71 123.3 47.37 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.466 0.65 . . . . 0.0 110.773 -176.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.513 ' O ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -61.3 -23.88 66.02 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.766 -175.71 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.49 ' HD1' ' OD1' ' A' ' 63' ' ' ASP . 0.8 OUTLIER -68.28 -28.82 67.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.383 0.611 . . . . 0.0 110.187 -176.293 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.553 ' CB ' ' HA3' ' A' ' 47' ' ' GLY . 1.0 OUTLIER -91.47 -29.76 16.83 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.65 0.738 . . . . 0.0 109.522 -175.396 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 64' ' ' MET . 2.0 m -71.24 -35.89 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 176.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.98 ' HA ' HD23 ' A' ' 71' ' ' LEU . 76.7 t80 -69.33 -22.61 63.75 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.501 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -61.27 -38.51 87.01 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 173.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -83.33 -70.25 0.57 Allowed 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 113.867 -1.515 . . . . 0.0 109.523 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.98 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.8 OUTLIER 23.43 68.08 0.36 Allowed Pre-proline 0 N--CA 1.478 0.928 0 O-C-N 124.854 1.346 . . . . 0.0 112.977 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.593 ' HD2' HG13 ' A' ' 75' ' ' ILE . 28.6 Cg_exo -62.42 153.13 72.88 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.657 2.238 . . . . 0.0 112.613 -176.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -68.21 109.26 3.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.368 0.604 . . . . 0.0 110.223 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 131.92 -31.11 3.11 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -174.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.593 HG13 ' HD2' ' A' ' 72' ' ' PRO . 17.4 mm -80.63 117.82 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 114.076 -1.062 . . . . 0.0 108.972 171.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.3 m -97.08 -1.8 44.56 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.536 -174.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.6 t -144.53 136.52 13.06 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.525 -170.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.593 ' HA ' HD21 ' A' ' 71' ' ' LEU . 98.5 Cg_exo -47.26 -57.08 2.52 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.457 2.771 . . . . 0.0 113.343 173.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.551 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -59.01 -30.73 68.21 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.171 0.51 . . . . 0.0 110.907 -179.049 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 46.2 tt0 -74.83 -26.23 59.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.191 -176.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.562 ' HB3' HG21 ' A' ' 75' ' ' ILE . 96.9 p -73.26 -36.87 66.44 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.6 t -67.87 -24.87 31.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.525 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.5 ' HG2' HG21 ' A' ' 9' ' ' ILE . 47.0 mtpt -55.1 -35.36 64.53 Favored 'General case' 0 C--O 1.214 -0.816 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.18 176.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -71.09 -37.18 72.41 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.067 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -69.51 -35.18 75.27 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.999 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.6 m -86.02 -45.07 16.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.92 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 . . . . . 0 C--O 1.221 -0.427 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 179.865 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.2 p90 . . . . . 0 N--CA 1.446 -0.674 0 CA-C-O 120.934 0.397 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.522 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 18.7 mp0 -132.6 131.57 41.58 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.899 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.973 HG12 HG12 ' A' ' 19' ' ' ILE . 49.1 mt -97.7 122.94 49.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.292 173.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -119.01 164.3 15.69 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.102 0.477 . . . . 0.0 110.115 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -84.79 128.22 34.5 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.393 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.614 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.2 OUTLIER -75.89 -39.64 56.02 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.773 -173.074 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -163.76 -77.98 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -138.03 -28.82 0.86 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 177.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.7 p -148.35 36.35 0.82 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.466 0.65 . . . . 0.0 111.557 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.495 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -143.98 156.69 44.5 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.307 176.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.721 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -125.08 147.19 49.11 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.411 -175.618 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.614 ' HB2' HD22 ' A' ' 12' ' ' LEU . 19.0 ttt -136.21 123.45 21.81 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.932 176.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.973 HG12 HG12 ' A' ' 9' ' ' ILE . 9.8 mt -110.66 146.35 15.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 123.014 0.526 . . . . 0.0 110.262 -175.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.522 ' HD2' ' O ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -139.56 134.49 32.24 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.45 173.131 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.608 ' HB2' HG11 ' A' ' 29' ' ' VAL . 4.7 m-85 . . . . . 0 C--N 1.328 -0.338 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.401 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.225 -0.194 0 CA-C-O 120.956 0.408 . . . . 0.0 109.968 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.608 HG11 ' HB2' ' A' ' 21' ' ' PHE . 53.4 t -65.64 -57.95 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.763 -176.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -57.51 -23.05 47.95 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.592 0.234 . . . . 0.0 111.465 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.99 -39.89 5.66 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.046 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.401 ' HB ' ' O ' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -80.39 -26.99 11.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.768 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -175.812 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 29' ' ' VAL . 10.7 p -68.08 -29.24 43.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -73.29 -34.36 65.71 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.495 177.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.11 -22.09 27.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.598 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.85 -22.99 65.99 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.125 -174.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.427 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . . . -62.52 -44.84 95.37 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.865 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -81.05 -27.85 35.59 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.979 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -59.53 -44.68 93.12 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.498 HD11 HD21 ' A' ' 58' ' ' LEU . 47.3 mt -76.58 -44.26 34.41 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.349 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.865 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 9.5 pt-20 -65.54 -27.37 68.4 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.125 0.416 . . . . 0.0 112.125 -171.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.477 ' C ' ' HD3' ' A' ' 44' ' ' PRO . 45.9 mt-10 -92.63 -18.77 22.63 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 121.156 -0.218 . . . . 0.0 111.441 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.445 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 67.3 mt-30 -131.09 58.55 39.73 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-O 120.744 0.306 . . . . 0.0 110.25 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.477 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 43.0 Cg_endo -104.64 -167.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.988 3.126 . . . . 0.0 113.75 -171.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.678 ' HZ ' ' HB2' ' A' ' 62' ' ' TYR . 12.8 p90 -111.71 147.22 36.33 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 168.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.89 -16.4 0.82 Allowed 'Trans proline' 0 N--CA 1.481 0.747 0 C-N-CA 124.219 3.279 . . . . 0.0 115.1 -172.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.57 7.53 61.49 Favored Glycine 0 C--O 1.226 -0.357 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.769 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -61.44 136.36 58.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.32 0.581 . . . . 0.0 111.803 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 62' ' ' TYR . 39.2 mm -109.19 -62.4 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.399 -177.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -163.43 157.12 19.49 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.432 -173.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.427 ' SG ' ' HA ' ' A' ' 37' ' ' ALA . 6.0 p -151.75 118.84 5.87 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 174.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.704 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.2 pt -116.13 134.25 22.81 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.826 -175.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 62.8 Cg_endo -84.37 141.43 9.01 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.095 2.53 . . . . 0.0 112.305 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -130.87 54.11 1.93 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.734 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.2 t80 76.66 -59.4 0.5 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.492 171.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.2 p -130.64 -2.05 4.27 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.26 0.552 . . . . 0.0 110.943 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 34.0 t -122.24 155.36 36.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.791 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.498 HD21 HD11 ' A' ' 40' ' ' ILE . 47.6 tp -127.33 116.56 20.71 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.598 -177.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.704 ' HB ' HG13 ' A' ' 52' ' ' ILE . 1.1 m -96.22 107.39 19.72 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.721 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 44.1 t -107.44 120.58 59.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.747 0.784 . . . . 0.0 111.867 -171.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -111.44 147.07 36.05 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.675 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.678 ' HB2' ' HZ ' ' A' ' 45' ' ' PHE . 3.3 p90 -165.65 172.0 12.4 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -174.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -103.53 117.34 34.2 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.431 0.634 . . . . 0.0 109.979 -177.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.523 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -64.77 -19.55 65.87 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.176 -176.687 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.06 -29.98 70.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.712 0.292 . . . . 0.0 111.107 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 0.6 OUTLIER -89.16 -26.88 21.05 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 122.067 0.937 . . . . 0.0 108.829 -172.113 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.641 HG11 HG22 ' A' ' 82' ' ' VAL . 3.7 m -82.62 -40.21 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.488 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.558 ' HA ' HD23 ' A' ' 71' ' ' LEU . 2.8 m-85 -58.66 -29.0 66.24 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 171.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.502 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 4.3 tppp? -53.49 -41.87 66.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.68 175.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -94.97 -71.84 0.65 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.693 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER 38.17 68.96 1.61 Allowed Pre-proline 0 N--CA 1.468 0.459 0 O-C-N 124.146 0.904 . . . . 0.0 111.802 179.024 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -63.6 140.64 76.17 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.878 2.385 . . . . 0.0 111.775 -176.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -61.39 109.42 1.15 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.56 0.695 . . . . 0.0 110.925 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 135.49 -32.43 2.55 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 107.939 -2.064 . . . . 0.0 107.939 -169.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.9 mm -95.62 113.6 30.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 113.387 -1.406 . . . . 0.0 107.713 168.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.3 t -105.62 -4.26 21.31 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.467 0.651 . . . . 0.0 109.85 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.484 ' OG ' ' HD1' ' A' ' 79' ' ' PHE . 21.2 t -126.69 125.66 24.4 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.007 -176.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.539 ' O ' HG23 ' A' ' 82' ' ' VAL . 94.8 Cg_exo -50.57 -42.8 48.26 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.644 2.896 . . . . 0.0 112.936 176.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.484 ' HD1' ' OG ' ' A' ' 77' ' ' SER . 0.1 OUTLIER -57.13 -37.07 71.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.672 177.934 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.446 ' HA ' ' CG ' ' A' ' 83' ' ' LYS . 28.5 tt0 -80.29 -19.8 45.83 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.683 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.422 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 24.0 t -67.97 -31.12 70.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.641 HG22 HG11 ' A' ' 67' ' ' VAL . 12.4 t -83.41 -24.81 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.528 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.447 ' HE2' ' HB3' ' A' ' 83' ' ' LYS . 40.7 mtpt -52.66 -40.89 63.3 Favored 'General case' 0 C--O 1.213 -0.844 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 175.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -58.83 -41.59 87.24 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.971 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -66.39 -37.15 84.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.397 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.7 m -87.25 -48.09 15.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.688 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 . . . . . 0 C--O 1.219 -0.511 0 C-N-CA 122.877 0.471 . . . . 0.0 112.012 -177.509 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.63 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 50.2 p90 . . . . . 0 CA--C 1.514 -0.416 0 CA-C-O 121.707 0.765 . . . . 0.0 112.419 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.758 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . 27.4 mp0 -126.79 138.47 53.36 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.247 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.829 HG12 HG12 ' A' ' 19' ' ' ILE . 29.4 mt -106.94 128.2 61.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.476 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 18' ' ' MET . 12.0 pt-20 -120.2 163.31 17.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.263 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -92.86 124.4 36.82 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.281 0.562 . . . . 0.0 110.153 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.627 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -69.87 -43.14 72.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.148 -174.033 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 173.19 -89.16 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.758 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -92.62 -60.35 1.84 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.917 0.389 . . . . 0.0 111.661 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.8 p -149.73 45.77 0.94 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.569 0.7 . . . . 0.0 110.978 -175.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.82 156.94 47.4 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.149 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.401 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 28.7 ttp -126.84 134.43 50.53 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.627 ' HB2' HD22 ' A' ' 12' ' ' LEU . 50.5 ttm -118.18 132.72 56.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.049 0.452 . . . . 0.0 110.19 177.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.829 HG12 HG12 ' A' ' 9' ' ' ILE . 6.1 mt -127.24 127.66 69.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.98 -177.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.758 ' HD3' ' HB2' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -111.83 131.27 55.45 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.63 ' HA ' ' CB ' ' A' ' 7' ' ' TYR . 6.6 m-85 . . . . . 0 C--N 1.323 -0.565 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.514 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 4.0 mm100 . . . . . 0 C--O 1.223 -0.299 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.608 ' CG2' ' HB2' ' A' ' 21' ' ' PHE . 6.6 p -62.23 -53.43 47.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.531 -177.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.443 ' N ' HG13 ' A' ' 29' ' ' VAL . 32.5 m-80 -53.51 -44.06 68.78 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.666 0.604 . . . . 0.0 111.354 -177.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.44 -38.64 17.02 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.55 -0.834 . . . . 0.0 112.88 -178.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 28' ' ' GLN . 0.3 OUTLIER -83.58 -28.51 7.58 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -172.696 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 29' ' ' VAL . 14.9 p -68.6 -30.35 47.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 175.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -70.59 -40.21 73.37 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.689 -1.142 . . . . 0.0 109.931 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.53 -22.02 28.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.995 -177.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.404 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . . . -63.92 -28.91 70.15 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.568 0.223 . . . . 0.0 111.498 -174.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.39 -39.13 92.23 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.081 0.943 . . . . 0.0 108.706 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.489 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.85 -23.12 29.15 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.249 178.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.404 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . 1.1 t80 -69.5 -41.71 75.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.15 0.5 . . . . 0.0 109.829 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.569 HD11 HD21 ' A' ' 58' ' ' LEU . 54.8 mt -73.71 -34.63 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.188 -177.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.489 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 9.1 pt-20 -69.63 -23.65 63.53 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.423 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 44.4 mm-40 -73.59 -36.37 65.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.643 175.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -129.61 70.71 82.04 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.324 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -94.47 176.49 1.1 Allowed 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.766 2.311 . . . . 0.0 113.443 -174.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -115.95 147.85 40.08 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.73 175.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -37.23 -37.81 0.42 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.246 3.297 . . . . 0.0 115.13 -174.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.459 ' HA3' ' HB2' ' A' ' 66' ' ' GLU . . . -103.24 17.62 51.01 Favored Glycine 0 C--O 1.224 -0.486 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.025 -176.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -59.77 129.39 41.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.986 0.422 . . . . 0.0 110.62 176.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.59 HG12 ' HA ' ' A' ' 62' ' ' TYR . 39.5 mm -106.07 -57.8 4.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.526 -174.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 13.5 tp10 -164.18 157.52 18.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.681 0.277 . . . . 0.0 110.544 -172.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.4 p -150.79 118.4 6.12 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 172.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.748 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.9 pt -119.94 135.21 24.14 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -176.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 2.5 Cg_endo -80.95 120.67 3.84 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.13 2.553 . . . . 0.0 112.234 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -109.51 52.74 0.71 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.601 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.505 ' O ' HG11 ' A' ' 33' ' ' VAL . 39.5 t80 72.64 -57.79 0.62 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.263 173.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.0 t -132.5 -2.4 3.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.695 0.759 . . . . 0.0 110.14 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.6 m -122.44 140.57 52.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.211 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.569 HD21 HD11 ' A' ' 40' ' ' ILE . 50.5 tp -106.18 115.98 31.14 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.748 ' HB ' HG13 ' A' ' 52' ' ' ILE . 4.7 m -93.28 106.27 18.25 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.784 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.0 t -104.75 123.98 59.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.386 0.612 . . . . 0.0 111.292 -173.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.427 ' CE1' HG22 ' A' ' 59' ' ' THR . 87.8 m-85 -114.96 145.96 41.69 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.57 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.59 ' HA ' HG12 ' A' ' 49' ' ' ILE . 2.4 p90 -166.54 171.29 11.92 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.125 0.488 . . . . 0.0 110.9 -175.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -99.49 111.34 23.7 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.398 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.547 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -61.91 -21.74 65.0 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.234 -176.546 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.52 ' CE1' ' HG2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -71.39 -23.08 61.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.757 0.313 . . . . 0.0 110.981 -176.9 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.52 ' HG2' ' CE1' ' A' ' 65' ' ' TYR . 22.5 mm-40 -91.51 -34.41 14.79 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.196 0.522 . . . . 0.0 110.458 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.547 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.4 m -70.54 -29.86 40.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.102 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.76 ' HA ' HD23 ' A' ' 71' ' ' LEU . 2.5 m-85 -55.48 -24.96 34.22 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.704 172.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -66.69 -24.32 66.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.596 0.712 . . . . 0.0 109.824 176.749 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -102.15 -32.49 10.07 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.249 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.824 HD21 ' HA ' ' A' ' 78' ' ' PRO . 1.6 mm? -26.36 95.01 0.06 OUTLIER Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 125.514 1.526 . . . . 0.0 113.735 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.547 ' HD2' HG13 ' A' ' 75' ' ' ILE . 20.5 Cg_exo -70.4 161.04 47.45 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 123.594 2.863 . . . . 0.0 111.93 174.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -62.36 -40.34 96.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -173.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.41 -21.37 78.94 Favored Glycine 0 CA--C 1.511 -0.202 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.45 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.548 HG21 ' HB2' ' A' ' 81' ' ' SER . 10.7 mm -81.97 100.26 5.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.057 -0.571 . . . . 0.0 109.919 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.4 m -82.52 -9.87 59.24 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.216 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.2 m -131.15 130.82 22.8 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.738 -175.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.824 ' HA ' HD21 ' A' ' 71' ' ' LEU . 83.4 Cg_exo -46.54 -48.91 12.79 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.408 2.739 . . . . 0.0 113.483 176.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.457 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 1.4 p90 -59.9 -27.4 66.7 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.485 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.667 ' HG3' ' HD2' ' A' ' 83' ' ' LYS . 8.8 tt0 -81.93 -17.83 45.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.887 0.375 . . . . 0.0 110.869 -174.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.548 ' HB2' HG21 ' A' ' 75' ' ' ILE . 48.0 t -79.26 -35.6 41.17 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.459 HG11 ' CE2' ' A' ' 62' ' ' TYR . 49.0 t -67.06 -25.32 33.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.28 178.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.667 ' HD2' ' HG3' ' A' ' 80' ' ' GLU . 94.5 mttt -51.59 -41.92 61.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.967 177.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.444 ' NH1' ' HA ' ' A' ' 84' ' ' ARG . 0.7 OUTLIER -60.9 -50.56 72.91 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.851 -177.583 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -64.88 -37.04 86.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.796 -177.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.2 m -83.36 -48.22 17.6 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 CA-C-O 118.947 -0.549 . . . . 0.0 112.023 -175.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.521 ' HG2' ' OH ' ' A' ' 7' ' ' TYR . 92.5 mt-10 . . . . . 0 N--CA 1.468 0.475 0 CA-C-N 118.25 0.477 . . . . 0.0 111.902 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.507 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 15.0 p90 . . . . . 0 CA--C 1.513 -0.465 0 CA-C-O 121.198 0.523 . . . . 0.0 111.45 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.431 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 5.6 tp60 -125.49 139.61 53.48 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.559 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 1.057 HG12 HG12 ' A' ' 19' ' ' ILE . 25.6 mt -104.36 122.35 57.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.067 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -116.22 159.99 21.05 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.862 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -86.24 124.4 32.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.53 0.681 . . . . 0.0 110.182 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.703 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -63.45 -48.22 78.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.658 -177.721 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -165.96 -73.17 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.652 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -128.7 -49.31 1.25 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.582 0.23 . . . . 0.0 111.522 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.08 41.35 1.66 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.639 0.733 . . . . 0.0 110.945 -172.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -143.88 152.22 40.86 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.759 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 29.0 ttp -121.28 135.42 55.12 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -174.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.703 ' HB2' HD22 ' A' ' 12' ' ' LEU . 46.8 ttm -122.22 132.4 54.42 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.145 177.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.057 HG12 HG12 ' A' ' 9' ' ' ILE . 5.7 mt -129.69 143.27 41.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.486 -175.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -125.48 126.66 45.26 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 174.11 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.837 ' HB2' HG23 ' A' ' 29' ' ' VAL . 4.9 m-85 . . . . . 0 C--N 1.325 -0.479 0 CA-C-O 121.121 0.486 . . . . 0.0 109.709 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.423 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 46.6 tt0 . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 120.702 0.287 . . . . 0.0 111.642 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.837 HG23 ' HB2' ' A' ' 21' ' ' PHE . 2.8 p -64.22 -47.98 87.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.779 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -54.92 -42.66 72.51 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.317 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.11 -39.5 10.01 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.182 -1.009 . . . . 0.0 112.537 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.423 ' HB ' ' O ' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -82.5 -21.35 9.56 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -171.459 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.454 HG11 ' O ' ' A' ' 55' ' ' PHE . 12.1 p -72.08 -30.3 35.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -75.46 -38.55 59.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.214 175.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.02 -20.75 51.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.977 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.542 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . . . -68.96 -28.25 66.46 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 120.873 0.368 . . . . 0.0 110.888 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.87 -42.63 99.83 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.793 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -79.13 -30.91 43.94 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.078 176.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.542 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -54.84 -44.93 74.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.433 0.635 . . . . 0.0 110.133 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 45.9 mt -79.62 -30.83 13.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.646 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.793 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 9.2 pt-20 -76.36 -25.06 54.26 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.64 -177.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -82.4 -27.99 31.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.01 0.433 . . . . 0.0 110.396 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -131.7 70.41 81.21 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.244 177.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -99.32 -178.06 0.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.395 2.73 . . . . 0.0 113.854 -173.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.437 ' CE2' HG13 ' A' ' 82' ' ' VAL . 6.0 p90 -115.93 147.41 39.1 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.92 171.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.449 ' HB2' ' CD ' ' A' ' 66' ' ' GLU . 59.0 Cg_exo -38.55 -39.35 1.12 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.987 3.125 . . . . 0.0 115.147 -174.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 66' ' ' GLU . . . -96.66 13.76 64.96 Favored Glycine 0 C--O 1.228 -0.245 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.098 -174.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -59.07 132.75 54.97 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.052 0.453 . . . . 0.0 110.777 175.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.47 HG12 ' HA ' ' A' ' 62' ' ' TYR . 35.9 mm -106.0 -59.37 3.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.261 -175.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -163.55 158.99 21.4 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 120.66 0.267 . . . . 0.0 110.571 -173.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.3 p -150.02 118.01 6.3 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 176.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.754 HG13 ' HB ' ' A' ' 59' ' ' THR . 5.9 pt -120.97 131.58 24.44 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-O 121.106 0.479 . . . . 0.0 112.186 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 72.2 Cg_endo -86.51 141.94 6.86 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.413 2.742 . . . . 0.0 112.499 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.89 59.58 1.61 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.629 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.454 ' O ' HG11 ' A' ' 33' ' ' VAL . 52.0 t80 69.31 -54.34 0.58 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.115 0.966 . . . . 0.0 112.581 175.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.2 t -130.98 -15.74 3.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.767 0.318 . . . . 0.0 111.164 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.0 p -115.18 149.75 37.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.956 0.407 . . . . 0.0 110.936 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 38.6 tp -118.24 125.83 50.94 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.754 ' HB ' HG13 ' A' ' 52' ' ' ILE . 3.1 m -105.59 107.65 18.76 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.038 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.2 t -105.45 123.05 59.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.416 0.627 . . . . 0.0 111.473 -173.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -113.08 147.83 36.48 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.803 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.568 ' OH ' ' HB2' ' A' ' 79' ' ' PHE . 2.6 p90 -165.89 171.71 12.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.757 -175.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -107.74 108.6 19.89 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 121.492 0.663 . . . . 0.0 109.851 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.551 ' O ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -55.63 -31.21 62.11 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.8 -176.681 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.8 -23.5 65.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.149 0.5 . . . . 0.0 110.742 -177.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' A' ' 69' ' ' LYS . 4.0 tm-20 -92.09 -41.67 10.37 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -177.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 64' ' ' MET . 2.5 m -61.94 -28.48 44.4 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.698 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.72 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.82 ' HA ' HD12 ' A' ' 71' ' ' LEU . 4.3 m-85 -50.56 -32.51 18.77 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.407 0.683 . . . . 0.0 111.648 169.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -66.95 -30.96 71.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.203 0.525 . . . . 0.0 110.509 178.432 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -93.46 -37.71 11.8 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.144 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.82 HD12 ' HA ' ' A' ' 68' ' ' TYR . 13.4 mt -32.75 99.5 0.15 Allowed Pre-proline 0 N--CA 1.465 0.315 0 C-N-CA 125.509 1.524 . . . . 0.0 113.463 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.44 ' HD2' HG13 ' A' ' 75' ' ' ILE . 13.9 Cg_exo -74.54 154.91 45.19 Favored 'Trans proline' 0 C--N 1.332 -0.302 0 C-N-CA 124.128 3.219 . . . . 0.0 110.586 174.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -64.34 -21.25 66.55 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -171.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.3 -18.04 76.93 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.113 176.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.539 HG23 ' HB3' ' A' ' 80' ' ' GLU . 2.8 mm -101.86 105.79 18.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.97 -0.615 . . . . 0.0 110.179 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.8 t -93.0 -3.34 54.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.006 0.432 . . . . 0.0 110.506 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' ' 80' ' ' GLU . 17.1 m -121.45 116.19 30.86 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.984 -178.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.665 ' HG3' ' CE1' ' A' ' 68' ' ' TYR . 14.4 Cg_exo -35.75 -56.6 0.58 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 124.357 3.371 . . . . 0.0 114.071 171.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.568 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -57.77 -32.74 67.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.227 -179.358 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.539 ' HB3' HG23 ' A' ' 75' ' ' ILE . 2.2 tp10 -70.19 -29.43 66.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.722 -174.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.64 ' HB2' HD23 ' A' ' 71' ' ' LEU . 46.5 t -79.37 -35.58 40.6 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.478 HG11 ' CE2' ' A' ' 62' ' ' TYR . 92.1 t -60.15 -39.95 82.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.936 177.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.759 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 17.6 mtmt -54.95 -48.31 73.34 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 21.7 mmm180 -63.01 -32.68 74.09 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.228 -174.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -69.52 -40.57 76.85 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.433 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.34 -35.59 9.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.546 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 . . . . . 0 C--O 1.223 -0.327 0 C-N-CA 122.801 0.44 . . . . 0.0 111.891 179.724 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.2 p90 . . . . . 0 N--CA 1.45 -0.439 0 CA-C-O 121.052 0.453 . . . . 0.0 111.353 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.563 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -140.04 121.75 15.35 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -178.255 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.946 HG12 HG12 ' A' ' 19' ' ' ILE . 29.3 mt -87.6 112.0 22.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.805 0.812 . . . . 0.0 110.911 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 18' ' ' MET . 4.0 pt-20 -106.87 161.48 14.66 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.489 -173.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.432 ' HA ' ' NE2' ' A' ' 11' ' ' GLN . 6.0 tp-100 -90.91 124.75 35.44 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.667 0.746 . . . . 0.0 110.686 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.561 HD21 HG22 ' A' ' 59' ' ' THR . 0.2 OUTLIER -70.69 -46.84 62.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.993 -176.527 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -157.92 -79.72 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -137.36 -36.1 0.66 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.865 0.364 . . . . 0.0 110.807 176.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.5 p -141.97 39.18 1.63 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.823 0.82 . . . . 0.0 110.201 -174.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -143.63 151.94 40.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.277 176.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.473 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 35.4 ttp -123.16 137.89 54.79 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.063 -0.655 . . . . 0.0 112.314 -173.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.596 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 24.7 ttt -126.51 138.16 53.46 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.946 HG12 HG12 ' A' ' 9' ' ' ILE . 4.7 mt -133.13 118.79 33.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.674 -174.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.563 ' HD3' ' HB3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -102.95 125.71 49.81 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.674 177.816 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.511 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 176.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.7 tm0? . . . . . 0 CA--C 1.533 0.306 0 N-CA-C 111.925 0.342 . . . . 0.0 111.925 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.537 ' O ' HG12 ' A' ' 33' ' ' VAL . 11.1 p -64.1 -41.23 91.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.315 -176.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -60.1 -25.48 65.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.423 -175.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -92.57 -39.86 5.18 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.026 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -81.8 -27.24 9.71 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -173.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 29' ' ' VAL . 11.1 p -70.54 -30.92 44.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 119.307 -0.957 . . . . 0.0 108.486 175.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -71.46 -35.17 70.77 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.695 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.64 -22.01 30.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.39 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.479 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . . . -64.09 -21.07 66.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.351 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.93 -43.36 88.28 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.737 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -81.81 -29.9 32.45 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.802 176.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.479 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . 7.8 t80 -51.59 -46.03 63.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.498 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.437 HD11 HD21 ' A' ' 58' ' ' LEU . 58.0 mt -80.4 -29.15 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.965 -175.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.737 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 10.3 pt-20 -75.81 -26.76 57.54 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.096 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 51.4 mt-10 -74.54 -35.65 63.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.061 173.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -125.19 74.94 67.88 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.244 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -95.02 -164.51 0.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.385 2.723 . . . . 0.0 113.749 -171.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -138.78 147.63 55.13 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.208 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -44.26 -22.6 0.57 Allowed 'Trans proline' 0 N--CA 1.482 0.808 0 C-N-CA 124.447 3.431 . . . . 0.0 115.881 -170.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.405 ' HA3' ' HB3' ' A' ' 66' ' ' GLU . . . -116.59 27.09 8.16 Favored Glycine 0 C--O 1.228 -0.265 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.314 -177.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -67.91 136.0 53.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.051 0.453 . . . . 0.0 111.76 177.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.7 mm -109.33 -60.34 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.257 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 40.6 tt0 -162.28 157.41 22.81 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.781 -172.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 59' ' ' THR . 2.1 p -152.05 118.23 5.56 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 173.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.537 HG13 ' HB ' ' A' ' 59' ' ' THR . 7.7 pt -126.59 142.1 42.15 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.604 -176.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.516 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 1.6 Cg_endo -84.64 139.59 7.78 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.31 2.674 . . . . 0.0 112.673 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.7 66.94 1.54 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 92.5 t80 75.91 -68.97 0.18 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.316 0.647 . . . . 0.0 111.588 171.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.1 t -134.92 2.43 3.11 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.613 0.72 . . . . 0.0 109.673 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 15.2 m -120.65 137.47 54.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.38 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.437 HD21 HD11 ' A' ' 40' ' ' ILE . 61.6 tp -102.48 126.89 49.68 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.561 HG22 HD21 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -101.42 106.8 17.98 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -177.947 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.1 t -109.35 119.21 58.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.459 0.647 . . . . 0.0 111.067 -174.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 85.1 m-85 -112.9 146.59 38.68 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.513 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.563 ' CE2' HG11 ' A' ' 82' ' ' VAL . 3.6 p90 -164.78 170.32 15.63 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.873 -173.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -104.24 112.29 25.25 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.73 -177.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.469 ' HA ' HG22 ' A' ' 67' ' ' VAL . 1.4 pmm? -63.22 -26.51 68.83 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.735 -174.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.68 -27.89 66.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.201 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.405 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 4.0 tp10 -90.71 -41.17 11.43 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -173.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.469 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.5 m -68.06 -30.63 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.089 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.712 ' HA ' HD23 ' A' ' 71' ' ' LEU . 3.5 m-85 -53.94 -29.45 42.41 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.495 173.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.479 ' HE2' ' HB2' ' A' ' 69' ' ' LYS . 0.3 OUTLIER -67.62 -34.96 78.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.11 0.481 . . . . 0.0 110.601 178.911 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 33.9 t60 -93.05 -30.82 15.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.491 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.712 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.5 OUTLIER -16.2 91.56 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 125.618 1.567 . . . . 0.0 112.672 177.124 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.473 ' HD2' HG13 ' A' ' 75' ' ' ILE . 31.8 Cg_exo -61.71 149.99 87.61 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.057 2.504 . . . . 0.0 111.352 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -63.22 -22.09 66.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.628 -172.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -83.83 -13.76 74.38 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.775 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.502 HG21 ' HB3' ' A' ' 81' ' ' SER . 4.5 mm -96.35 130.84 44.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 122.837 0.455 . . . . 0.0 109.944 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.3 t -114.34 0.07 14.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.164 0.507 . . . . 0.0 109.952 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.9 m -134.5 120.14 14.49 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.962 -177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.619 ' HA ' HD21 ' A' ' 71' ' ' LEU . 95.2 Cg_exo -46.46 -38.5 21.23 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 124.122 3.215 . . . . 0.0 113.882 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.9 -34.65 76.42 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.123 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.627 ' HA ' ' HD3' ' A' ' 83' ' ' LYS . 16.7 tt0 -83.46 -20.7 33.56 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.456 -174.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.502 ' HB3' HG21 ' A' ' 75' ' ' ILE . 62.5 p -75.93 -30.09 58.58 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 177.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 78' ' ' PRO . 97.7 t -67.59 -34.46 68.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.724 174.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.627 ' HD3' ' HA ' ' A' ' 80' ' ' GLU . 59.7 mtpt -51.85 -45.43 64.01 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 174.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.496 ' HE ' HD11 ' A' ' 75' ' ' ILE . 21.1 mmt180 -60.81 -35.9 77.69 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.874 -177.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -72.31 -42.4 65.51 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.047 0.451 . . . . 0.0 111.426 -177.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.6 m -87.15 -46.12 16.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.17 -177.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 83' ' ' LYS . 14.9 mm-40 . . . . . 0 C--O 1.206 -1.193 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.796 -175.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.649 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 38.9 p90 . . . . . 0 CA--C 1.517 -0.317 0 CA-C-O 121.747 0.784 . . . . 0.0 111.941 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.562 ' HB2' ' NE ' ' A' ' 20' ' ' ARG . 40.1 mt-30 -128.16 139.54 52.43 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.701 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 1.001 HG12 HG12 ' A' ' 19' ' ' ILE . 15.9 mt -101.03 120.25 50.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.764 177.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 18' ' ' MET . 11.9 pt-20 -119.85 159.17 25.12 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.846 -177.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -88.49 129.91 35.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.971 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.675 HD21 HG23 ' A' ' 59' ' ' THR . 0.0 OUTLIER -66.4 -42.65 87.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.619 -177.653 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.83 -55.48 0.36 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.426 176.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -103.43 -74.71 0.63 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.947 0.403 . . . . 0.0 111.07 -176.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.4 p -149.58 48.15 0.95 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.686 0.755 . . . . 0.0 110.562 -177.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.555 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -142.57 155.08 44.95 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.835 176.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.502 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 37.5 ttp -128.06 124.45 37.09 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -174.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.477 ' HB2' HD22 ' A' ' 12' ' ' LEU . 51.3 ttm -109.49 139.49 44.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.131 0.491 . . . . 0.0 110.248 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.001 HG12 HG12 ' A' ' 9' ' ' ILE . 6.4 mt -128.21 112.67 27.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.913 -176.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.576 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -96.0 124.22 39.92 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.89 178.599 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.649 ' HA ' ' CB ' ' A' ' 7' ' ' TYR . 8.0 m-85 . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.52 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.4 tm0? . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 120.887 0.375 . . . . 0.0 111.591 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 33' ' ' VAL . 83.3 t -63.16 -41.66 93.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.395 -177.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -52.61 -32.75 43.21 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.595 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.53 -42.23 6.2 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.731 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -80.03 -22.17 11.8 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.79 0 C-N-CA 120.539 -0.464 . . . . 0.0 112.105 -173.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 29' ' ' VAL . 14.3 p -74.12 -29.5 25.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 119.593 -0.843 . . . . 0.0 108.865 174.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -70.85 -34.63 71.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.47 174.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.12 -21.44 29.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.306 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.461 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . . . -65.15 -26.54 68.22 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.031 -177.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.54 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . . . -62.0 -43.59 98.52 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.86 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -77.85 -29.66 50.59 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.846 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.461 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -55.57 -44.71 77.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.257 0.551 . . . . 0.0 109.639 177.264 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.522 ' CD1' HD21 ' A' ' 58' ' ' LEU . 41.5 mt -83.15 -37.47 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.82 -175.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.86 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 12.2 pt-20 -74.12 -20.89 60.1 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.29 -176.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.454 ' C ' ' HD3' ' A' ' 44' ' ' PRO . 38.1 mm-40 -85.72 -25.68 26.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.932 0.396 . . . . 0.0 110.684 175.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -122.76 63.36 19.99 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.454 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 50.0 Cg_endo -93.42 174.2 1.69 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.546 2.164 . . . . 0.0 114.039 -167.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -114.01 146.48 35.75 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 114.152 -1.385 . . . . 0.0 108.052 175.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.44 -15.33 3.85 Favored 'Trans proline' 0 N--CA 1.48 0.699 0 C-N-CA 123.82 3.013 . . . . 0.0 114.844 -169.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 66' ' ' GLU . . . -109.39 20.18 28.21 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.11 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.516 ' HE2' HG22 ' A' ' 40' ' ' ILE . 4.2 t80 -62.01 132.33 52.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.986 0.422 . . . . 0.0 110.778 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.646 HG22 ' CG ' ' A' ' 50' ' ' GLU . 28.9 mm -109.48 -62.99 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.17 176.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.646 ' CG ' HG22 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -154.69 175.8 13.24 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.522 0.677 . . . . 0.0 110.393 178.893 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' A' ' 37' ' ' ALA . 7.5 p -161.55 119.7 2.34 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.838 162.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.767 HG13 ' HB ' ' A' ' 59' ' ' THR . 9.5 pt -114.77 134.07 22.48 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-O 120.975 0.417 . . . . 0.0 112.039 -173.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.482 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 2.0 Cg_endo -82.04 120.45 3.37 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.295 2.664 . . . . 0.0 112.342 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.52 32.95 3.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.328 178.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 71.04 -34.64 0.31 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.096 175.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -128.82 -21.35 3.39 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.85 -0.531 . . . . 0.0 111.214 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 9.5 p -124.65 141.29 52.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.139 0.495 . . . . 0.0 110.571 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.522 HD21 ' CD1' ' A' ' 40' ' ' ILE . 57.5 tp -102.44 111.98 24.5 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.767 ' HB ' HG13 ' A' ' 52' ' ' ILE . 5.2 m -90.32 105.54 17.88 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.7 t -101.25 125.36 55.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.086 0.47 . . . . 0.0 111.122 -172.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -114.73 145.87 41.58 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.613 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.502 ' OH ' ' HB2' ' A' ' 17' ' ' MET . 2.4 p90 -165.09 169.1 16.62 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.371 0.605 . . . . 0.0 110.695 -174.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -96.61 118.95 34.17 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.616 -176.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.478 ' HA ' HG22 ' A' ' 67' ' ' VAL . 1.3 pmm? -69.34 -22.8 63.73 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.833 -172.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.42 -28.83 69.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 111.144 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.401 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 13.8 tp10 -89.83 -30.98 17.58 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.769 0.795 . . . . 0.0 109.477 -173.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.478 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.2 m -77.75 -33.81 19.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.339 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.907 ' HA ' HD23 ' A' ' 71' ' ' LEU . 59.8 t80 -68.29 -22.87 64.7 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.245 175.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -38.87 71.43 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 172.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -87.54 -74.68 0.43 Allowed 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.421 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.907 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER 32.44 66.95 1.04 Allowed Pre-proline 0 N--CA 1.471 0.593 0 O-C-N 124.186 0.929 . . . . 0.0 111.574 -178.236 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.669 ' HD2' HG13 ' A' ' 75' ' ' ILE . 33.2 Cg_exo -60.45 135.61 62.32 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.475 2.117 . . . . 0.0 111.371 -175.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -58.7 109.32 0.78 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.907 0.861 . . . . 0.0 110.964 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 136.42 -31.56 2.58 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 108.549 -1.82 . . . . 0.0 108.549 -169.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.669 HG13 ' HD2' ' A' ' 72' ' ' PRO . 14.3 mm -84.78 116.38 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 114.049 -1.076 . . . . 0.0 108.764 169.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.9 m -94.94 -4.32 47.0 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.162 0.506 . . . . 0.0 110.716 -175.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.607 ' HB2' ' HB2' ' A' ' 80' ' ' GLU . 58.0 m -141.35 134.54 14.43 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.227 -170.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.649 ' HA ' HD21 ' A' ' 71' ' ' LEU . 82.8 Cg_exo -51.92 -43.63 50.72 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.509 2.806 . . . . 0.0 113.157 173.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -67.11 -23.39 65.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.185 0.516 . . . . 0.0 110.748 176.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 77' ' ' SER . 39.9 tt0 -81.34 -20.73 40.03 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.159 -174.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.538 ' HB3' HG21 ' A' ' 75' ' ' ILE . 63.7 p -81.95 -37.33 26.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 78' ' ' PRO . 26.2 t -64.22 -26.02 39.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.129 177.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.564 ' HG3' ' HA ' ' A' ' 80' ' ' GLU . 93.5 mttt -50.17 -45.08 53.11 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.126 175.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -69.5 -35.14 75.24 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.042 -173.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -62.33 -41.79 98.85 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.843 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.9 m -87.41 -42.96 15.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -178.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 C--O 1.222 -0.382 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.348 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 5.9 p90 . . . . . 0 N--CA 1.447 -0.607 0 CA-C-O 121.478 0.656 . . . . 0.0 111.853 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.508 ' HB3' ' NE ' ' A' ' 20' ' ' ARG . 8.1 tp60 -146.79 115.25 6.71 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.125 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.82 HG12 HG12 ' A' ' 19' ' ' ILE . 30.5 mt -82.73 122.75 37.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.036 0.446 . . . . 0.0 110.281 176.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.428 ' OE2' ' HD2' ' A' ' 20' ' ' ARG . 12.4 pt-20 -120.7 169.68 10.16 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.209 -178.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -93.85 128.43 40.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.473 0.654 . . . . 0.0 110.56 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.64 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -69.56 -47.65 62.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.703 -177.589 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -161.61 -72.09 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -142.41 -34.42 0.45 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.223 -0.191 . . . . 0.0 111.513 177.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.1 p -144.1 42.95 1.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.795 0.807 . . . . 0.0 111.234 -176.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -150.45 152.75 34.76 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.204 177.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.499 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 30.8 ttp -125.4 133.12 52.62 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.751 -0.78 . . . . 0.0 112.484 -173.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.64 ' HB2' HD22 ' A' ' 12' ' ' LEU . 53.7 ttm -119.02 131.76 56.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.965 176.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.82 HG12 HG12 ' A' ' 9' ' ' ILE . 7.3 mt -123.44 109.04 22.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.65 -176.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -102.76 134.42 46.18 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.501 -179.343 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 35.3 m-85 . . . . . 0 C--N 1.323 -0.568 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.4 tm0? . . . . . 0 CA--C 1.529 0.168 0 CA-C-O 120.453 0.168 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.694 ' O ' HG22 ' A' ' 33' ' ' VAL . 4.9 p -60.31 -55.38 24.64 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.113 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -175.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.451 ' N ' HG13 ' A' ' 29' ' ' VAL . 51.9 m-80 -55.88 -29.48 60.03 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.389 0.431 . . . . 0.0 111.355 -176.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.68 -35.98 17.7 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.362 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -93.48 -28.55 4.37 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.872 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -170.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 29' ' ' VAL . 3.1 m -62.7 -35.68 71.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.744 176.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.5 t60 -71.93 -33.13 68.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.157 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.32 -32.81 24.11 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.124 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.635 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -64.9 -24.11 67.43 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 122.772 0.429 . . . . 0.0 111.203 -177.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.485 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . . . -61.38 -40.3 93.82 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.765 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -85.57 -32.64 22.01 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.102 174.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.635 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 4.4 t80 -54.67 -42.53 71.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.126 0.489 . . . . 0.0 110.603 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.531 HD11 HD21 ' A' ' 58' ' ' LEU . 51.9 mt -78.06 -31.86 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.237 -177.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.765 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 10.0 pt-20 -79.5 -23.73 42.76 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.763 -177.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -78.12 -33.28 50.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.497 174.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -126.88 68.88 71.68 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.832 0.349 . . . . 0.0 110.302 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -96.03 179.17 0.57 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.109 2.539 . . . . 0.0 113.972 -171.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -111.29 146.48 34.67 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.1 171.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -43.03 -35.19 4.44 Favored 'Trans proline' 0 N--CA 1.479 0.636 0 C-N-CA 123.457 2.771 . . . . 0.0 114.992 -171.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.499 ' HA3' ' CB ' ' A' ' 66' ' ' GLU . . . -98.73 16.18 59.95 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.713 -175.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -60.68 135.99 57.93 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.08 0.466 . . . . 0.0 111.099 175.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.88 HG22 ' HG2' ' A' ' 50' ' ' GLU . 40.6 mm -110.65 -61.36 2.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.065 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.88 ' HG2' HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -153.19 169.57 22.67 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.471 0.653 . . . . 0.0 111.16 -178.315 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 59' ' ' THR . 4.2 p -161.76 117.54 2.05 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.096 167.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.607 HG12 ' HB ' ' A' ' 59' ' ' THR . 0.1 OUTLIER -127.75 136.48 29.04 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.691 -175.943 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 37' ' ' ALA . 71.1 Cg_endo -78.75 138.35 14.92 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.778 2.319 . . . . 0.0 112.546 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.97 58.53 1.02 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.683 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 62.9 t80 70.61 -65.53 0.33 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.695 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 t -119.11 -17.48 8.95 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.999 0.428 . . . . 0.0 111.454 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 4.3 p -112.9 144.79 41.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.204 0.526 . . . . 0.0 111.272 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.531 HD21 HD11 ' A' ' 40' ' ' ILE . 53.0 tp -102.75 118.24 36.4 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.607 ' HB ' HG12 ' A' ' 52' ' ' ILE . 0.7 OUTLIER -93.76 106.55 18.51 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.71 -177.245 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.6 t -106.2 126.12 61.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.308 0.575 . . . . 0.0 111.177 -173.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.589 ' HB2' ' HG3' ' A' ' 50' ' ' GLU . 89.5 m-85 -120.15 147.06 45.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.245 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.499 ' OH ' ' HB2' ' A' ' 17' ' ' MET . 1.9 p90 -166.11 172.39 11.37 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.292 0.567 . . . . 0.0 111.065 -172.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.412 ' OD1' ' HB3' ' A' ' 65' ' ' TYR . 10.9 t0 -99.0 113.41 25.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.662 -179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.535 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -60.78 -20.5 61.57 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.48 -178.956 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.412 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -70.54 -31.79 68.98 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.94 0.4 . . . . 0.0 110.789 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.499 ' CB ' ' HA3' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -90.36 -29.56 17.98 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.503 0.668 . . . . 0.0 109.724 -173.528 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.535 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.4 m -74.9 -32.15 27.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.392 176.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.774 ' HA ' HD23 ' A' ' 71' ' ' LEU . 50.7 t80 -66.2 -24.0 66.55 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.636 175.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.82 -32.75 69.66 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.869 0.842 . . . . 0.0 108.732 174.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -91.89 -69.37 0.74 Allowed 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.197 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.774 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER 22.73 76.75 0.23 Allowed Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 124.804 1.242 . . . . 0.0 113.567 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.426 ' HD2' HG13 ' A' ' 75' ' ' ILE . 44.1 Cg_exo -58.02 153.03 47.43 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.513 2.142 . . . . 0.0 111.639 176.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -61.0 -29.19 69.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.481 -173.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.83 -30.16 56.36 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.328 -0.939 . . . . 0.0 111.025 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.615 HG21 ' HB3' ' A' ' 81' ' ' SER . 14.1 mm -76.78 108.26 9.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.947 -0.627 . . . . 0.0 110.079 177.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.2 t -89.29 -8.85 52.51 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.322 0.582 . . . . 0.0 110.464 -176.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 69.9 m -133.36 134.21 23.68 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.073 -173.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.713 ' HA ' HD21 ' A' ' 71' ' ' LEU . 84.8 Cg_exo -49.55 -49.23 16.28 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.539 2.826 . . . . 0.0 113.132 176.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.446 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -60.35 -26.88 66.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.008 0.432 . . . . 0.0 111.544 178.546 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -79.11 -21.47 46.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.075 -175.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.615 ' HB3' HG21 ' A' ' 75' ' ' ILE . 78.4 p -82.33 -37.59 25.49 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 176.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 78' ' ' PRO . 59.8 t -59.4 -29.13 41.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.823 177.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.472 ' HE2' HG21 ' A' ' 9' ' ' ILE . 95.4 mttt -52.22 -47.02 65.87 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -63.46 -33.26 75.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.654 -174.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -70.61 -38.26 73.94 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.384 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.7 m -87.3 -44.53 16.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 . . . . . 0 N--CA 1.469 0.494 0 C-N-CA 123.117 0.567 . . . . 0.0 111.994 -178.256 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.575 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . 20.0 p90 . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -139.39 133.31 30.89 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.842 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.876 HG12 HG12 ' A' ' 19' ' ' ILE . 26.8 mt -95.53 127.54 47.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.132 -178.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 18' ' ' MET . 11.4 pt-20 -122.57 171.43 9.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.423 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -89.66 137.73 32.08 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.179 0.514 . . . . 0.0 110.947 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.587 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -79.59 -20.33 47.19 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.01 175.322 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.2 -80.96 0.19 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.733 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -107.05 -55.44 2.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.842 0.353 . . . . 0.0 111.778 -175.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.539 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 4.6 p -149.29 42.01 0.91 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.648 0.737 . . . . 0.0 110.984 -172.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.522 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -142.65 157.91 44.2 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.47 173.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.733 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 35.1 ttp -130.02 133.02 46.46 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.929 -174.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.587 ' HB2' HD22 ' A' ' 12' ' ' LEU . 32.8 ttp -124.06 135.38 53.53 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.109 175.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.876 HG12 HG12 ' A' ' 9' ' ' ILE . 5.0 mt -120.05 124.4 72.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.114 -176.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.518 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -104.53 118.76 37.39 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.237 178.347 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.575 ' CD2' ' HB3' ' A' ' 7' ' ' TYR . 53.3 m-85 . . . . . 0 C--N 1.318 -0.796 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.748 173.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 . . . . . 0 N--CA 1.456 -0.131 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.572 ' HB ' ' HB3' ' A' ' 21' ' ' PHE . 17.0 m -65.97 -43.82 92.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.821 0.344 . . . . 0.0 110.251 -177.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.82 -41.66 95.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.762 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.51 -37.88 29.88 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.394 -175.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.1 -29.06 13.78 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.749 0 C-N-CA 120.224 -0.591 . . . . 0.0 111.946 -175.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.45 HG23 ' HB2' ' A' ' 58' ' ' LEU . 14.1 p -71.02 -28.81 34.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -69.71 -40.27 76.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.074 173.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.09 -20.64 30.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.931 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.87 -30.44 70.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.722 0.296 . . . . 0.0 111.469 -173.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.22 98.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.719 0.771 . . . . 0.0 108.99 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.528 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -78.29 -25.67 46.73 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.73 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -66.14 -45.01 82.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.344 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.497 ' CD1' HD21 ' A' ' 58' ' ' LEU . 41.8 mt -76.25 -38.05 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.346 -175.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 14.4 pt-20 -69.6 -19.99 63.64 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.238 -175.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -91.95 -24.37 19.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.609 0.242 . . . . 0.0 110.762 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -127.1 68.84 72.88 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 175.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -95.56 -171.0 0.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.451 2.767 . . . . 0.0 113.816 -170.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -127.29 147.07 60.49 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.376 176.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -40.69 -36.74 2.0 Allowed 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.107 3.204 . . . . 0.0 115.317 -170.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -102.51 19.31 48.37 Favored Glycine 0 C--O 1.226 -0.404 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.518 -174.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -64.36 135.8 56.51 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.081 0.467 . . . . 0.0 111.211 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.447 HG12 ' HA ' ' A' ' 62' ' ' TYR . 32.6 mm -107.67 -58.54 3.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.236 -178.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -167.17 160.86 14.15 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.197 -176.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 59' ' ' THR . 5.6 p -149.97 119.76 7.08 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 172.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.807 HG13 ' HB ' ' A' ' 59' ' ' THR . 5.3 pt -114.56 132.58 22.79 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-O 121.2 0.524 . . . . 0.0 111.845 -175.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -85.61 123.03 2.44 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.243 2.629 . . . . 0.0 112.395 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.18 27.72 7.97 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.299 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 70.92 -28.5 0.18 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.248 -0.887 . . . . 0.0 113.298 174.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -140.84 7.23 2.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.336 0.589 . . . . 0.0 110.711 171.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 47.3 m -148.18 144.36 27.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.775 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.497 HD21 ' CD1' ' A' ' 40' ' ' ILE . 54.4 tp -115.61 111.66 20.98 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.95 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.807 ' HB ' HG13 ' A' ' 52' ' ' ILE . 3.8 m -90.18 106.68 18.65 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.6 t -104.9 117.41 50.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.541 0.686 . . . . 0.0 110.88 -174.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.422 ' CE1' HG22 ' A' ' 59' ' ' THR . 80.8 m-85 -105.5 147.15 28.64 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.791 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.573 ' CE2' HG11 ' A' ' 82' ' ' VAL . 3.8 p90 -165.75 164.64 18.84 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.382 -176.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -99.31 114.5 27.4 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.333 -175.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.58 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -65.12 -20.85 66.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.65 -169.976 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.659 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 0.5 OUTLIER -68.41 -29.5 68.19 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.267 -178.07 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -91.88 -35.56 13.98 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 121.445 0.641 . . . . 0.0 109.513 -175.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.58 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.3 m -68.37 -29.91 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.85 177.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 1.029 ' HA ' HD23 ' A' ' 71' ' ' LEU . 30.1 t80 -69.61 -22.93 63.45 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.516 174.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' A' ' 65' ' ' TYR . 27.4 mmmt -76.25 -25.42 54.97 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -89.5 -35.6 15.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.428 178.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.029 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -16.89 90.21 0.04 OUTLIER Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 125.606 1.562 . . . . 0.0 112.779 178.935 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.635 ' HD2' HG13 ' A' ' 75' ' ' ILE . 22.8 Cg_exo -66.33 136.62 44.28 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.196 2.597 . . . . 0.0 110.941 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -65.61 100.17 0.5 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.818 0.818 . . . . 0.0 110.417 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.46 -26.02 1.83 Allowed Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -171.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.65 HG22 ' H ' ' A' ' 77' ' ' SER . 11.6 mm -87.75 132.9 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 114.627 -0.787 . . . . 0.0 109.636 172.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.5 t -103.44 1.11 32.07 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.159 0.504 . . . . 0.0 110.522 -176.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.65 ' H ' HG22 ' A' ' 75' ' ' ILE . 21.0 t -146.57 129.41 7.98 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -170.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.694 ' HA ' HD21 ' A' ' 71' ' ' LEU . 95.8 Cg_exo -47.51 -44.42 25.44 Favored 'Trans proline' 0 C--O 1.221 -0.352 0 C-N-CA 123.577 2.851 . . . . 0.0 112.807 169.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -36.8 82.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.034 0.445 . . . . 0.0 110.913 176.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 77' ' ' SER . 39.9 tt0 -71.33 -27.09 63.13 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.595 -174.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.597 ' HB3' HG21 ' A' ' 75' ' ' ILE . 76.9 p -77.6 -37.64 49.88 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 78' ' ' PRO . 58.2 t -60.73 -34.71 59.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.102 178.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.733 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 5.3 mtmp? -53.21 -42.7 66.56 Favored 'General case' 0 C--O 1.213 -0.82 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 176.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.56 -34.24 73.91 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.483 -175.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -62.72 -41.55 99.21 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.455 176.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.7 m -84.29 -39.69 14.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.924 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.465 ' OE2' ' HB3' ' A' ' 83' ' ' LYS . 39.9 mt-10 . . . . . 0 C--O 1.218 -0.572 0 C-N-CA 123.207 0.603 . . . . 0.0 112.083 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.478 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . 27.0 p90 . . . . . 0 CA--C 1.514 -0.412 0 CA-C-O 121.8 0.809 . . . . 0.0 112.378 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -135.26 140.44 45.21 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.135 -1.393 . . . . 0.0 108.511 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.754 HG21 ' HD3' ' A' ' 83' ' ' LYS . 34.2 mt -113.81 131.26 66.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.9 -175.15 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -121.85 169.53 10.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.203 0.525 . . . . 0.0 110.432 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -94.42 131.29 40.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.642 176.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.682 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -69.05 -50.11 51.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.639 -176.289 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.99 -69.96 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.703 176.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -110.57 -71.06 0.78 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.983 0.42 . . . . 0.0 111.433 -176.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.9 p -135.91 47.07 2.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.674 0.75 . . . . 0.0 110.792 -175.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.29 153.75 42.34 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.006 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.475 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 26.7 ttp -121.52 136.61 54.94 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.652 -0.419 . . . . 0.0 112.112 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.682 ' HB2' HD22 ' A' ' 12' ' ' LEU . 49.5 ttm -122.49 131.82 54.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.31 0.576 . . . . 0.0 110.049 176.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.743 HG12 HG12 ' A' ' 9' ' ' ILE . 4.0 mt -118.64 140.58 41.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.459 -178.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.408 ' N ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -123.26 117.56 25.57 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.361 0.601 . . . . 0.0 109.935 176.074 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.478 ' CD2' ' HB3' ' A' ' 7' ' ' TYR . 35.8 m-85 . . . . . 0 C--N 1.318 -0.78 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.108 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.271 0 CA-C-O 120.49 0.185 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 21' ' ' PHE . 35.4 m -55.19 -41.95 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 120.799 0.333 . . . . 0.0 110.931 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.401 ' N ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -66.91 -19.75 65.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.272 -177.138 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.71 -45.56 4.85 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.254 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.11 -21.35 12.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.687 -175.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.5 p -70.76 -31.11 44.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 174.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -77.67 -36.71 51.07 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.03 177.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.79 -20.79 45.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.005 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.409 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -65.49 -26.99 68.17 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.659 0.266 . . . . 0.0 110.764 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.511 ' O ' ' HG3' ' A' ' 41' ' ' GLU . . . -62.75 -46.17 89.32 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.2 -34.94 63.88 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.607 176.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.409 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 19.3 t80 -54.98 -41.14 70.83 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.79 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.416 HD11 HD21 ' A' ' 58' ' ' LEU . 48.8 mt -76.74 -27.01 16.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.239 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 37' ' ' ALA . 41.6 mt-10 -79.42 -41.55 27.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.957 0.408 . . . . 0.0 111.398 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -63.27 -35.35 80.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.181 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -129.55 75.93 79.26 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.897 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -95.17 177.98 0.78 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.754 2.303 . . . . 0.0 113.332 -174.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -121.46 146.47 45.17 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -45.23 -28.46 3.62 Favored 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 124.104 3.203 . . . . 0.0 115.307 -169.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.02 20.4 38.43 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.385 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -64.23 136.19 56.97 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.134 0.492 . . . . 0.0 111.375 177.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.432 HG12 ' HA ' ' A' ' 62' ' ' TYR . 39.1 mm -108.25 -58.96 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.449 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -165.94 161.16 17.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.678 0.275 . . . . 0.0 110.552 -175.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 2.4 p -152.09 119.16 5.86 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.769 HG13 ' HB ' ' A' ' 59' ' ' THR . 5.5 pt -123.81 136.12 27.02 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.834 -177.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 72.0 Cg_endo -87.28 158.91 8.29 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.127 2.552 . . . . 0.0 112.414 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.95 48.67 1.22 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.159 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 87.1 t80 72.54 -47.58 0.67 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.543 0.737 . . . . 0.0 112.323 174.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.1 t -133.66 -20.47 2.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.987 0.423 . . . . 0.0 110.729 177.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.4 m -108.21 152.12 25.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.011 0.434 . . . . 0.0 110.801 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.416 HD21 HD11 ' A' ' 40' ' ' ILE . 47.3 tp -126.01 122.69 36.61 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.608 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.769 ' HB ' HG13 ' A' ' 52' ' ' ILE . 5.2 m -104.16 107.18 17.97 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.188 -178.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.4 t -105.22 119.63 54.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.451 0.644 . . . . 0.0 111.241 -175.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -106.85 146.89 30.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.439 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.481 ' CD2' HG11 ' A' ' 82' ' ' VAL . 2.4 p90 -166.32 167.85 15.57 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.046 0.451 . . . . 0.0 110.64 -175.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.407 ' OD1' ' HD1' ' A' ' 65' ' ' TYR . 5.6 t0 -98.55 117.27 32.61 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.329 -178.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.618 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -64.01 -22.67 67.03 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.835 -174.641 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.407 ' HD1' ' OD1' ' A' ' 63' ' ' ASP . 0.2 OUTLIER -69.51 -28.16 65.8 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.699 0.285 . . . . 0.0 111.142 -175.485 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -89.53 -43.38 10.85 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -171.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 m -66.93 -27.69 40.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.853 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.883 ' HA ' HD23 ' A' ' 71' ' ' LEU . 12.1 t80 -66.71 -22.35 66.07 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.049 0.54 . . . . 0.0 110.777 175.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.73 -34.33 62.53 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 173.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -76.07 -38.13 57.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.576 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.883 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -20.33 92.21 0.04 OUTLIER Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 125.814 1.645 . . . . 0.0 113.545 178.461 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.706 ' HD2' HG13 ' A' ' 75' ' ' ILE . 20.9 Cg_exo -68.99 152.13 73.31 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 123.177 2.585 . . . . 0.0 110.264 173.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -67.77 -17.52 64.57 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -171.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.98 -19.04 70.95 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.19 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.706 HG13 ' HD2' ' A' ' 72' ' ' PRO . 11.4 mm -89.75 137.53 21.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.86 -0.67 . . . . 0.0 109.529 175.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.1 m -116.55 2.14 13.01 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.377 0.608 . . . . 0.0 110.568 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.485 ' HB3' ' HB3' ' A' ' 80' ' ' GLU . 31.2 t -141.22 130.7 12.79 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.969 -173.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.67 ' HA ' HD21 ' A' ' 71' ' ' LEU . 80.0 Cg_exo -43.95 -54.73 3.57 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.403 2.735 . . . . 0.0 112.265 169.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.467 ' HD1' ' HB2' ' A' ' 17' ' ' MET . 0.0 OUTLIER -53.35 -42.19 66.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.221 175.821 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 38.7 tt0 -72.39 -19.59 61.58 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.201 -173.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.461 ' HB2' HG21 ' A' ' 75' ' ' ILE . 48.2 t -81.09 -40.08 24.67 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.481 HG11 ' CD2' ' A' ' 62' ' ' TYR . 39.0 t -63.65 -30.77 50.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.987 177.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.754 ' HD3' HG21 ' A' ' 9' ' ' ILE . 7.4 mmmt -49.53 -47.61 48.81 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.208 173.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.504 ' HE ' HD11 ' A' ' 75' ' ' ILE . 19.7 mmt180 -67.9 -38.74 83.34 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.008 -172.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -63.85 -34.9 78.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.121 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.7 m -88.45 -44.69 15.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.501 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 83' ' ' LYS . 57.6 mt-10 . . . . . 0 N--CA 1.469 0.48 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.407 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 39.9 p90 . . . . . 0 CA--C 1.517 -0.318 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.507 ' O ' ' HD3' ' A' ' 20' ' ' ARG . 18.3 mp0 -135.11 121.6 20.55 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.858 178.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.924 HG12 HG12 ' A' ' 19' ' ' ILE . 18.6 mt -91.46 125.79 44.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.221 177.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -120.54 149.81 41.85 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.101 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -76.9 126.44 30.97 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.281 0.562 . . . . 0.0 110.21 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.684 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -67.47 -37.52 83.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.51 -177.589 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.54 -79.23 0.11 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.416 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -98.98 -68.73 0.79 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.802 0.334 . . . . 0.0 111.782 -177.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.9 p -143.46 49.79 1.41 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.975 0.893 . . . . 0.0 110.239 -174.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -142.46 152.11 42.41 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.371 177.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.516 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 34.1 ttp -124.0 130.55 52.75 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.443 -0.503 . . . . 0.0 112.016 -175.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.684 ' HB2' HD22 ' A' ' 12' ' ' LEU . 50.9 ttm -116.47 126.8 53.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.277 0.56 . . . . 0.0 110.43 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.924 HG12 HG12 ' A' ' 9' ' ' ILE . 7.9 mt -119.66 126.36 75.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.404 -176.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.507 ' HD3' ' O ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -115.06 122.51 46.37 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.89 176.128 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.684 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 28.2 m-85 . . . . . 0 C--N 1.317 -0.82 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.882 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 110.696 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.684 ' HB ' ' HB3' ' A' ' 21' ' ' PHE . 32.9 m -59.2 -33.47 50.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.083 0.468 . . . . 0.0 110.783 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -78.97 -18.59 53.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.557 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.83 -37.98 7.11 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.716 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.87 -27.57 12.4 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.994 -176.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.522 HG23 ' HB2' ' A' ' 58' ' ' LEU . 7.2 p -62.76 -32.03 54.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.177 0.513 . . . . 0.0 109.937 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -70.48 -39.11 74.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.171 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.35 -20.3 32.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.483 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.411 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -63.19 -23.9 67.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.432 -176.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.73 -42.32 99.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.746 0.784 . . . . 0.0 109.198 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.481 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.19 -29.67 26.4 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.699 176.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.411 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 1.5 t80 -59.21 -45.71 90.38 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.302 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.435 HD11 HD21 ' A' ' 58' ' ' LEU . 58.5 mt -71.12 -37.98 69.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.503 -176.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.481 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 13.0 pt-20 -75.37 -19.69 59.43 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.31 -174.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 33.5 mt-10 -80.7 -32.14 35.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.922 0.391 . . . . 0.0 110.613 175.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -126.3 64.25 54.01 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.969 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.419 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 72.9 Cg_endo -91.96 176.34 1.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.03 2.487 . . . . 0.0 114.059 -169.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.41 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 2.8 p90 -106.41 146.61 33.34 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.134 173.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 45' ' ' PHE . 73.7 Cg_exo -52.58 -5.99 0.21 Allowed 'Trans proline' 0 N--CA 1.482 0.847 0 C-N-CA 124.085 3.19 . . . . 0.0 115.3 -172.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.41 ' HA3' ' HB3' ' A' ' 66' ' ' GLU . . . -123.23 29.23 5.35 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.943 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -71.09 135.17 47.56 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.836 0.35 . . . . 0.0 111.12 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.2 mm -110.62 -60.34 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.46 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -164.85 155.88 14.7 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.907 -172.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 59' ' ' THR . 4.6 p -152.15 119.47 5.95 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.086 0.469 . . . . 0.0 110.094 173.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.768 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.0 pt -117.67 129.62 25.23 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-O 121.285 0.564 . . . . 0.0 112.068 -178.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 92.9 Cg_endo -85.82 139.03 6.3 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.378 2.719 . . . . 0.0 112.753 -177.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -126.49 46.06 2.54 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.947 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.2 t80 72.1 -40.01 0.46 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.539 0.735 . . . . 0.0 112.731 174.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.1 t -136.44 -18.4 1.48 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.702 0.287 . . . . 0.0 111.25 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 5.4 p -120.3 140.59 51.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.08 0.467 . . . . 0.0 110.966 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.522 ' HB2' HG23 ' A' ' 33' ' ' VAL . 40.8 tp -108.98 119.73 40.44 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.768 ' HB ' HG13 ' A' ' 52' ' ' ILE . 2.2 m -95.01 106.11 18.07 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.5 t -105.54 125.26 60.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.505 0.669 . . . . 0.0 111.507 -173.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -116.93 146.71 42.81 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.297 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.516 ' OH ' ' HB2' ' A' ' 17' ' ' MET . 2.1 p90 -164.96 170.71 14.91 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.011 0.434 . . . . 0.0 110.281 -174.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -101.09 107.97 19.53 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.533 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.474 ' SD ' ' N ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -62.41 -20.69 64.74 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.599 -176.422 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.29 -28.36 68.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.984 0.421 . . . . 0.0 110.207 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.41 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 4.6 tp10 -90.58 -39.12 12.72 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.667 0.746 . . . . 0.0 109.151 -172.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.469 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.4 m -67.24 -30.78 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.719 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.727 ' HA ' HD23 ' A' ' 71' ' ' LEU . 48.0 t80 -58.23 -26.93 63.46 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.563 0.745 . . . . 0.0 111.801 175.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.77 -26.4 59.73 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.415 0.626 . . . . 0.0 109.862 176.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -90.25 -33.56 16.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.146 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.727 HD23 ' HA ' ' A' ' 68' ' ' TYR . 1.1 mm? -23.48 91.75 0.04 OUTLIER Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 125.764 1.626 . . . . 0.0 113.037 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.643 ' HD2' HG13 ' A' ' 75' ' ' ILE . 12.1 Cg_exo -73.49 146.81 39.99 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 123.485 2.79 . . . . 0.0 111.676 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -69.43 108.92 3.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.439 0.638 . . . . 0.0 110.089 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 133.99 -30.68 2.91 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 -170.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.643 HG13 ' HD2' ' A' ' 72' ' ' PRO . 9.1 mm -86.01 108.36 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 114.196 -1.002 . . . . 0.0 108.504 170.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.2 t -90.13 -6.67 55.15 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.125 0.488 . . . . 0.0 110.461 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 74.0 m -135.17 131.86 19.9 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.682 ' HA ' HD21 ' A' ' 71' ' ' LEU . 56.3 Cg_exo -43.42 -55.5 2.88 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.719 2.946 . . . . 0.0 113.079 173.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.471 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -57.37 -30.96 65.31 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.763 -179.244 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -73.14 -27.45 61.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.955 -176.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.532 ' HB2' HG21 ' A' ' 75' ' ' ILE . 36.9 t -73.62 -35.95 65.39 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.429 HG11 ' CD2' ' A' ' 62' ' ' TYR . 41.7 t -66.13 -30.89 51.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.651 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.69 ' HB3' ' HZ3' ' A' ' 83' ' ' LYS . 9.8 mtpm? -52.5 -46.12 66.5 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.966 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.404 ' HE ' HD11 ' A' ' 75' ' ' ILE . 20.5 mmt180 -61.07 -41.82 97.36 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.983 -175.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -70.27 -38.47 75.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.6 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.6 m -87.04 -49.32 14.9 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.617 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -175.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.47 ' OE1' ' HB3' ' A' ' 83' ' ' LYS . 50.6 mt-10 . . . . . 0 N--CA 1.464 0.267 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -174.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.59 ' HE1' HD11 ' A' ' 9' ' ' ILE . 37.1 p90 . . . . . 0 CA--C 1.515 -0.37 0 CA-C-O 121.641 0.734 . . . . 0.0 112.198 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -128.46 134.82 48.83 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.488 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.59 HD11 ' HE1' ' A' ' 7' ' ' TYR . 4.5 mp -93.88 108.6 20.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.325 178.109 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -117.31 166.2 12.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.621 0.724 . . . . 0.0 111.214 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.66 140.87 41.09 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.643 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.517 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -84.88 -21.61 29.68 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.321 174.72 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 152.3 -68.56 0.31 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 119.903 -1.142 . . . . 0.0 113.464 176.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -119.26 -61.73 1.6 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.894 0.378 . . . . 0.0 111.393 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.1 p -141.26 39.85 1.76 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.447 0.642 . . . . 0.0 111.013 -175.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.509 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -141.76 160.36 40.33 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.133 175.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.435 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 34.0 ttp -129.48 136.62 50.12 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.61 -0.436 . . . . 0.0 112.115 -175.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.517 ' HB2' HD22 ' A' ' 12' ' ' LEU . 48.9 ttm -121.59 130.33 53.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.197 0.522 . . . . 0.0 110.685 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.4 mt -117.17 121.11 66.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.606 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -115.18 120.65 40.45 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.755 0.788 . . . . 0.0 110.957 -177.515 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.648 ' HD2' HG12 ' A' ' 29' ' ' VAL . 44.4 m-85 . . . . . 0 C--N 1.309 -1.19 0 CA-C-N 113.799 -1.546 . . . . 0.0 109.97 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.648 HG12 ' HD2' ' A' ' 21' ' ' PHE . 35.5 m -63.9 -45.4 97.06 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.421 ' N ' HG23 ' A' ' 29' ' ' VAL . 39.9 t30 -53.9 -42.32 68.57 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.396 -176.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.26 -47.46 6.46 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.598 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -74.25 -29.55 24.94 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.509 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -170.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 29' ' ' VAL . 7.3 p -63.78 -32.21 56.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.663 177.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.597 ' CE1' ' HA ' ' A' ' 55' ' ' PHE . 34.4 m80 -81.59 -32.23 32.17 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.541 179.005 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.61 -24.38 36.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.845 0.355 . . . . 0.0 111.121 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.518 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -67.11 -20.92 65.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.43 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.64 98.72 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.647 0.737 . . . . 0.0 109.056 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.521 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.67 -32.32 23.68 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.76 175.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.518 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 17.0 t80 -53.53 -48.94 68.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.451 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.681 HD11 HD21 ' A' ' 58' ' ' LEU . 65.2 mt -69.1 -34.78 65.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.543 -177.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.521 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 12.5 pt-20 -76.92 -22.44 53.33 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.165 -173.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 95.0 mt-10 -74.91 -34.33 62.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.755 0.312 . . . . 0.0 110.607 177.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -127.46 74.45 77.75 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -95.21 178.8 0.71 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 123.18 2.587 . . . . 0.0 113.48 -173.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 3.8 p90 -112.55 146.26 34.63 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.133 172.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 45' ' ' PHE . 42.5 Cg_exo -61.16 15.17 0.04 OUTLIER 'Trans proline' 0 N--CA 1.482 0.795 0 C-N-CA 123.992 3.128 . . . . 0.0 114.789 -174.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . -133.65 18.79 4.3 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 175.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -70.65 137.41 49.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.736 0.303 . . . . 0.0 110.608 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.1 mm -113.6 -56.88 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.39 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.431 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 9.4 tp10 -160.94 157.1 25.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.827 0.346 . . . . 0.0 110.702 -175.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 59' ' ' THR . 8.2 p -152.03 117.94 5.47 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 172.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.759 HG13 ' HB ' ' A' ' 59' ' ' THR . 7.1 pt -118.62 128.53 25.92 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-O 121.253 0.549 . . . . 0.0 112.142 -176.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.443 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 84.1 Cg_endo -86.46 120.85 1.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.497 2.798 . . . . 0.0 112.144 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.417 ' HB3' ' OG ' ' A' ' 57' ' ' SER . . . -114.41 59.86 0.68 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.686 0.279 . . . . 0.0 111.215 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.597 ' HA ' ' CE1' ' A' ' 34' ' ' HIS . 70.4 t80 74.34 -49.24 0.67 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.392 0.677 . . . . 0.0 111.817 173.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.411 ' HA ' HG11 ' A' ' 33' ' ' VAL . 14.0 t -140.05 -14.35 1.04 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.879 0.371 . . . . 0.0 111.475 176.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.417 ' OG ' ' HB3' ' A' ' 54' ' ' ALA . 18.3 p -108.66 133.75 52.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.413 0.625 . . . . 0.0 110.823 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.681 HD21 HD11 ' A' ' 40' ' ' ILE . 57.0 tp -102.58 111.77 24.23 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.759 ' HB ' HG13 ' A' ' 52' ' ' ILE . 1.8 m -95.43 107.04 19.16 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.743 -176.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.2 t -106.27 118.68 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.527 0.68 . . . . 0.0 111.243 -172.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.431 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 88.1 m-85 -111.6 148.54 33.08 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.572 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.448 ' OH ' ' HA ' ' A' ' 79' ' ' PHE . 2.1 p90 -165.82 169.62 14.78 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -175.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -102.29 113.07 26.05 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.527 -176.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.631 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -58.84 -19.69 43.87 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.455 -174.204 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -65.62 -28.42 69.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.637 0.256 . . . . 0.0 111.191 -177.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.536 ' O ' ' HD2' ' A' ' 70' ' ' HIS . 2.4 tm-20 -91.3 -41.32 11.0 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -176.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.631 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.0 m -64.53 -30.79 51.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.996 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.933 ' HA ' HD23 ' A' ' 71' ' ' LEU . 62.6 t80 -63.93 -26.65 68.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.402 173.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.03 -27.92 66.96 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 174.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.536 ' HD2' ' O ' ' A' ' 66' ' ' GLU . 16.7 m-70 -83.78 -69.18 0.66 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.705 175.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.933 HD23 ' HA ' ' A' ' 68' ' ' TYR . 1.1 mm? 18.75 71.07 0.22 Allowed Pre-proline 0 N--CA 1.474 0.758 0 O-C-N 124.929 1.393 . . . . 0.0 112.576 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.612 ' HD2' HG13 ' A' ' 75' ' ' ILE . 64.4 Cg_exo -53.14 153.46 16.19 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.166 2.577 . . . . 0.0 112.719 -173.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -69.84 93.82 0.78 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.53 0.681 . . . . 0.0 110.724 -175.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 139.67 -27.16 2.61 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -173.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.612 HG13 ' HD2' ' A' ' 72' ' ' PRO . 8.9 mm -80.49 125.97 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.615 -0.792 . . . . 0.0 109.038 172.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.4 m -110.76 -1.86 16.46 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.227 0.536 . . . . 0.0 110.781 -177.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.538 ' OG ' ' HD1' ' A' ' 79' ' ' PHE . 22.6 t -131.57 134.37 25.45 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.791 -175.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.497 ' O ' HG23 ' A' ' 82' ' ' VAL . 96.2 Cg_exo -47.05 -53.45 6.3 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.312 2.675 . . . . 0.0 112.436 171.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.538 ' HD1' ' OG ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -60.35 -34.21 73.53 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.311 0.577 . . . . 0.0 110.551 -179.636 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.544 ' HA ' ' CE ' ' A' ' 83' ' ' LYS . 56.6 tt0 -69.57 -27.81 65.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.177 -177.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.539 ' HB3' HG21 ' A' ' 75' ' ' ILE . 95.7 p -79.84 -31.37 40.55 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.501 0.667 . . . . 0.0 109.539 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 78' ' ' PRO . 36.3 t -73.68 -28.82 25.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.147 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.544 ' CE ' ' HA ' ' A' ' 80' ' ' GLU . 44.6 mtmt -54.73 -41.32 70.22 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 121.374 0.607 . . . . 0.0 109.578 173.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -66.11 -32.58 74.11 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.089 -176.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -77.1 -40.79 44.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.287 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.6 m -83.5 -37.48 13.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.784 -177.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 . . . . . 0 C--O 1.219 -0.515 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.158 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 25.4 p90 . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 121.167 0.508 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.431 ' HB2' ' HE ' ' A' ' 20' ' ' ARG . 4.9 mp0 -128.34 132.43 48.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.466 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.93 HG13 HG12 ' A' ' 19' ' ' ILE . 2.9 mp -83.47 114.74 24.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 171.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 18' ' ' MET . 12.4 pt-20 -110.21 150.11 29.14 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.121 0.486 . . . . 0.0 109.69 177.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -81.25 127.71 33.0 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.428 0.633 . . . . 0.0 110.208 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.649 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -70.41 -40.3 73.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.427 -174.777 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 172.84 -66.18 0.12 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.808 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -125.75 -58.87 1.38 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.835 0.35 . . . . 0.0 111.717 -173.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.2 p -142.01 37.62 1.59 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.517 0.675 . . . . 0.0 111.29 -173.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.95 158.26 43.77 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.781 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.626 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -128.03 149.37 50.4 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.046 -179.086 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.649 ' HB2' HD22 ' A' ' 12' ' ' LEU . 53.6 ttm -132.38 135.41 46.12 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 174.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.93 HG12 HG13 ' A' ' 9' ' ' ILE . 10.5 mt -114.58 106.18 20.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.514 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -91.94 131.44 37.24 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.296 0.57 . . . . 0.0 109.879 177.905 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 29.0 m-85 . . . . . 0 C--N 1.308 -1.219 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.266 -178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.058 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.727 ' O ' HG12 ' A' ' 33' ' ' VAL . 2.4 p -56.4 -49.0 79.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.298 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -55.67 -29.19 58.9 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.579 0.549 . . . . 0.0 111.168 -173.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.76 -40.6 5.25 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.73 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -87.41 -29.7 5.65 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -171.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 29' ' ' VAL . 9.5 p -65.74 -30.98 51.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 118.968 0.804 . . . . 0.0 109.281 178.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.401 ' HA ' ' CB ' ' A' ' 53' ' ' PRO . 22.0 t60 -81.61 -30.2 32.98 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.999 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.43 -21.72 30.62 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.015 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.475 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -65.06 -23.48 67.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.181 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.89 98.77 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.841 0.829 . . . . 0.0 109.02 177.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.763 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.96 -27.17 26.69 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.948 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.475 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 5.8 t80 -59.73 -44.48 93.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.374 179.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.463 HD11 HD21 ' A' ' 58' ' ' LEU . 44.6 mt -78.59 -32.03 15.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.483 -176.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.763 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 10.8 pt-20 -73.64 -20.22 60.63 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.861 -176.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -88.21 -29.89 20.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.735 0.302 . . . . 0.0 110.384 173.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -124.72 69.8 56.3 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.177 0.513 . . . . 0.0 110.091 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -99.86 -161.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.693 2.929 . . . . 0.0 114.083 -169.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.45 ' HE1' ' HB3' ' A' ' 62' ' ' TYR . 1.6 p90 -138.37 147.35 55.07 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 114.022 -1.444 . . . . 0.0 107.966 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.75 -21.26 0.86 Allowed 'Trans proline' 0 N--CA 1.482 0.842 0 C-N-CA 124.25 3.3 . . . . 0.0 115.55 -169.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.419 ' HA3' ' HB3' ' A' ' 66' ' ' GLU . . . -119.36 30.7 5.7 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.188 -0.53 . . . . 0.0 111.947 -179.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.505 ' HZ ' ' HG ' ' A' ' 51' ' ' CYS . 47.2 t80 -66.53 128.69 37.18 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.098 0.475 . . . . 0.0 110.82 175.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.4 mm -103.09 -61.71 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.108 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -164.56 155.48 15.0 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 120.767 0.317 . . . . 0.0 110.998 -174.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.505 ' HG ' ' HZ ' ' A' ' 48' ' ' PHE . 5.9 p -144.46 118.32 9.32 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 173.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.806 HG13 ' HB ' ' A' ' 59' ' ' THR . 5.5 pt -117.43 129.26 25.46 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-O 121.042 0.449 . . . . 0.0 112.001 -175.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.592 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 17.8 Cg_endo -86.73 124.33 2.23 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.498 2.799 . . . . 0.0 112.684 -178.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -117.73 58.73 0.8 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.15 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.458 ' O ' HG11 ' A' ' 33' ' ' VAL . 56.2 t80 72.34 -49.64 0.69 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.548 0.739 . . . . 0.0 112.087 173.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.1 t -137.23 -21.07 1.2 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.747 0.308 . . . . 0.0 111.253 178.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 16.1 m -108.2 133.11 52.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.071 0.463 . . . . 0.0 110.864 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.463 HD21 HD11 ' A' ' 40' ' ' ILE . 44.0 tp -102.77 111.96 24.53 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.806 ' HB ' HG13 ' A' ' 52' ' ' ILE . 2.9 m -89.15 107.96 19.34 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -177.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.626 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 64.6 t -104.0 113.66 41.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.575 0.702 . . . . 0.0 111.338 -172.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -103.76 148.88 25.56 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.872 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.53 ' CD2' HG11 ' A' ' 82' ' ' VAL . 2.3 p90 -165.13 168.53 17.13 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.164 -176.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -98.86 109.05 21.87 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.947 -175.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.653 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -61.97 -20.6 64.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.125 -177.725 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.41 ' CE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -67.47 -31.92 72.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.9 0.381 . . . . 0.0 110.281 179.481 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 10.2 tp10 -91.31 -30.69 16.44 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 122.059 0.933 . . . . 0.0 109.1 -170.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.653 HG22 ' HA ' ' A' ' 64' ' ' MET . 4.2 m -75.66 -34.12 28.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.26 176.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.855 ' HA ' HD23 ' A' ' 71' ' ' LEU . 52.4 t80 -71.28 -22.87 61.9 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.8 174.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 4.2 tppp? -59.42 -35.96 74.98 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -88.5 -65.8 0.98 Allowed 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.207 176.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.855 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER 24.93 78.7 0.22 Allowed Pre-proline 0 N--CA 1.48 1.038 0 C-N-CA 124.858 1.263 . . . . 0.0 113.463 178.356 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.686 ' HD2' HG13 ' A' ' 75' ' ' ILE . 32.1 Cg_exo -58.52 155.06 38.26 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.321 2.014 . . . . 0.0 110.989 175.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -71.38 -17.08 62.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.675 -171.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -77.8 -28.68 56.44 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 172.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.686 HG13 ' HD2' ' A' ' 72' ' ' PRO . 20.4 mm -77.44 129.8 36.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.791 -0.705 . . . . 0.0 109.638 175.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.2 m -110.0 1.64 19.13 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.337 0.589 . . . . 0.0 110.528 -177.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.658 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 43.8 t -146.9 132.97 9.5 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.261 -172.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.628 ' HA ' HD21 ' A' ' 71' ' ' LEU . 86.3 Cg_exo -45.74 -53.47 5.6 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.349 2.699 . . . . 0.0 112.732 170.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.407 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -58.26 -31.61 67.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.93 0.395 . . . . 0.0 111.385 177.373 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.658 ' HB2' ' HB3' ' A' ' 77' ' ' SER . 23.8 tt0 -72.83 -30.07 63.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.259 -173.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.558 ' HB3' HG21 ' A' ' 75' ' ' ILE . 91.4 p -76.38 -34.55 58.89 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.53 HG11 ' CD2' ' A' ' 62' ' ' TYR . 16.6 t -63.84 -31.73 54.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.537 176.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.495 ' HE3' HG12 ' A' ' 9' ' ' ILE . 2.4 mtpt -54.93 -38.01 67.14 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-O 121.171 0.51 . . . . 0.0 109.685 175.127 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -67.63 -31.89 72.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.175 -176.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -78.3 -36.72 46.21 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.357 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.8 m -86.78 -40.32 13.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.649 -177.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 C--N 1.331 -0.232 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -177.626 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.506 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 42.2 p90 . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 121.319 0.58 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -130.9 116.05 17.37 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.875 -174.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.884 HG12 HG12 ' A' ' 19' ' ' ILE . 22.3 mt -92.62 112.52 26.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.128 175.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -124.25 168.46 12.92 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.499 -175.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -87.74 128.11 35.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.46 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.679 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.3 OUTLIER -76.18 -46.41 28.6 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.127 -174.135 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -168.84 -90.62 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.629 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -110.62 -37.52 5.44 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -175.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.5 p -160.8 42.73 0.17 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.872 0.844 . . . . 0.0 110.696 -177.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.0 148.21 41.55 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.333 176.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.598 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 32.1 ttp -117.39 140.53 49.47 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 120.955 0.407 . . . . 0.0 111.504 -177.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.679 ' HB2' HD22 ' A' ' 12' ' ' LEU . 1.4 tmt? -124.69 126.05 45.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.44 0.638 . . . . 0.0 110.431 -176.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.884 HG12 HG12 ' A' ' 9' ' ' ILE . 6.6 mt -119.56 138.26 50.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.768 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.61 127.03 21.48 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.909 0.385 . . . . 0.0 110.369 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.506 ' HA ' ' CB ' ' A' ' 7' ' ' TYR . 8.1 m-85 . . . . . 0 C--N 1.317 -0.83 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.865 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.463 0.189 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.514 ' O ' HG12 ' A' ' 33' ' ' VAL . 11.9 p -65.74 -50.58 70.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.36 -174.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.439 ' N ' HG13 ' A' ' 29' ' ' VAL . 70.9 m-20 -53.1 -42.68 66.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.144 0.497 . . . . 0.0 110.939 -177.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.82 -5.17 90.22 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.528 -0.76 . . . . 0.0 113.614 -176.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.22 -34.25 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.605 0 CA-C-N 117.987 0.894 . . . . 0.0 113.352 -176.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 29' ' ' VAL . 10.8 p -62.98 -32.72 57.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 118.467 0.576 . . . . 0.0 110.681 -174.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -80.27 -23.5 40.73 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.04 -23.85 26.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.069 0.461 . . . . 0.0 110.419 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.472 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -64.28 -22.82 67.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.098 -178.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.54 97.14 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.688 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -82.98 -30.45 28.2 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.812 175.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.472 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 16.0 t80 -57.05 -44.28 82.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.377 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.695 HD11 HD21 ' A' ' 58' ' ' LEU . 49.5 mt -77.06 -38.41 27.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.587 -176.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.688 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 13.3 pt-20 -68.73 -21.11 64.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.896 0.379 . . . . 0.0 111.017 -175.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -92.56 -21.14 20.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.868 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -133.14 64.71 71.29 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.894 0.378 . . . . 0.0 110.412 178.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -97.35 -175.81 0.25 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.494 2.796 . . . . 0.0 113.077 -173.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.606 ' HZ ' ' HB2' ' A' ' 62' ' ' TYR . 14.3 p90 -116.56 148.11 41.17 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 172.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -42.22 -24.87 0.36 Allowed 'Trans proline' 0 N--CA 1.481 0.791 0 C-N-CA 124.404 3.403 . . . . 0.0 115.926 -170.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.05 19.36 32.64 Favored Glycine 0 C--O 1.229 -0.21 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.413 -176.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.464 ' HZ ' ' HG ' ' A' ' 51' ' ' CYS . 37.1 t80 -69.21 134.86 49.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.007 0.432 . . . . 0.0 111.331 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.472 HG12 ' HA ' ' A' ' 62' ' ' TYR . 40.6 mm -106.17 -60.67 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.298 -177.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -160.99 156.31 24.58 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -171.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.464 ' HG ' ' HZ ' ' A' ' 48' ' ' PHE . 12.7 p -151.75 119.48 6.13 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 175.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.794 HG13 ' HB ' ' A' ' 59' ' ' THR . 9.3 pt -123.91 134.87 25.68 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.842 -175.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.427 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 78.5 Cg_endo -86.95 152.19 8.43 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.159 2.573 . . . . 0.0 112.463 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -137.61 47.83 2.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.116 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.408 ' O ' HG11 ' A' ' 33' ' ' VAL . 48.7 t80 72.09 -37.52 0.39 Allowed 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 173.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.0 t -138.43 -21.3 1.04 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.183 0.516 . . . . 0.0 110.933 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.3 p -113.52 155.1 25.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.61 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.695 HD21 HD11 ' A' ' 40' ' ' ILE . 48.1 tp -124.49 114.92 20.08 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.794 ' HB ' HG13 ' A' ' 52' ' ' ILE . 4.4 m -94.91 106.92 18.93 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.885 -176.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.0 t -106.04 121.5 58.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.47 0.653 . . . . 0.0 111.647 -172.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.408 ' CE1' HG22 ' A' ' 59' ' ' THR . 90.7 m-85 -110.99 148.51 32.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.939 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.606 ' HB2' ' HZ ' ' A' ' 45' ' ' PHE . 3.5 p90 -167.33 170.14 11.79 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.893 -173.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -102.26 120.45 40.49 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.291 0.567 . . . . 0.0 110.692 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.17 -22.39 65.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.266 -174.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.11 -25.82 67.94 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.75 0.31 . . . . 0.0 110.784 -177.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -89.49 -33.55 16.73 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.738 0.78 . . . . 0.0 109.011 -171.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.9 m -77.67 -36.61 23.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.898 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.763 ' HA ' HD23 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -62.9 -23.11 67.19 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.973 177.598 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.507 ' HE2' ' HB2' ' A' ' 69' ' ' LYS . 3.3 tppt? -54.86 -49.17 71.79 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 121.939 0.876 . . . . 0.0 108.877 177.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -89.94 -62.89 1.37 Allowed 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.858 -177.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.763 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER 34.5 77.3 0.38 Allowed Pre-proline 0 N--CA 1.473 0.707 0 O-C-N 124.533 1.146 . . . . 0.0 111.521 -178.959 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.444 ' HD2' HG13 ' A' ' 75' ' ' ILE . 50.5 Cg_exo -54.64 152.43 27.62 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.288 2.659 . . . . 0.0 112.839 -175.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -76.18 87.29 3.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.05 0.929 . . . . 0.0 110.495 -176.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 155.09 -31.19 0.65 Allowed Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 -173.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.514 HG21 ' HB2' ' A' ' 81' ' ' SER . 18.6 mm -79.77 115.7 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 114.028 -1.086 . . . . 0.0 108.808 169.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.5 m -97.76 -5.86 34.05 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.194 0.521 . . . . 0.0 110.239 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 47.6 m -138.72 132.38 16.25 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.943 -172.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.609 ' HA ' HD21 ' A' ' 71' ' ' LEU . 30.8 Cg_exo -45.23 -56.99 2.35 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.436 2.758 . . . . 0.0 113.305 173.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.606 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.8 OUTLIER -55.18 -30.82 60.67 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.203 0.525 . . . . 0.0 111.177 178.98 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.604 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 36.5 tt0 -73.64 -24.47 60.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.259 -176.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.514 ' HB2' HG21 ' A' ' 75' ' ' ILE . 17.4 t -76.24 -36.28 58.58 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.466 HG11 ' CD2' ' A' ' 62' ' ' TYR . 60.2 t -63.66 -30.18 49.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.248 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.604 ' HG3' ' HA ' ' A' ' 80' ' ' GLU . 14.9 mtmm -54.2 -37.85 64.98 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 176.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -64.59 -37.47 87.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.182 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -70.92 -35.48 72.28 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.916 -176.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.9 m -86.79 -42.76 15.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.149 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 . . . . . 0 C--N 1.33 -0.275 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.489 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.3 p90 . . . . . 0 N--CA 1.446 -0.636 0 CA-C-O 121.402 0.62 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.666 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . 1.8 mp0 -120.28 134.54 55.24 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.257 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.928 HG12 HG12 ' A' ' 19' ' ' ILE . 15.3 mt -101.92 114.14 40.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.291 174.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 18' ' ' MET . 10.4 pt-20 -109.12 153.1 24.19 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.691 -177.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -76.99 126.9 31.74 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.758 0.79 . . . . 0.0 110.542 178.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.693 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.3 OUTLIER -79.72 -48.67 13.25 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.019 -173.233 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.88 100.87 0.16 Allowed Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 73.2 -64.16 0.41 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 176.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.515 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 11.5 p -150.64 60.06 0.94 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.338 0.589 . . . . 0.0 111.831 -172.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -160.89 154.64 22.35 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 176.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.917 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -121.18 138.64 54.12 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.091 -177.944 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.693 ' HB2' HD22 ' A' ' 12' ' ' LEU . 26.4 ttt -124.04 124.06 41.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.438 0.637 . . . . 0.0 110.396 177.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.928 HG12 HG12 ' A' ' 9' ' ' ILE . 9.3 mt -116.12 144.31 24.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.191 -175.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.666 ' HD3' ' HB2' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -134.93 132.75 38.83 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 173.577 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.477 ' HB2' HG21 ' A' ' 29' ' ' VAL . 6.8 m-85 . . . . . 0 C--N 1.323 -0.545 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? . . . . . 0 CA--C 1.522 -0.126 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.6 ' O ' HG12 ' A' ' 33' ' ' VAL . 4.3 p -61.32 -46.34 96.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.757 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -53.71 -27.04 25.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.958 -177.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -97.55 -39.83 3.81 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.435 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -86.44 -22.4 7.15 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -171.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.6 HG12 ' O ' ' A' ' 29' ' ' VAL . 14.5 p -69.01 -28.45 39.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.371 177.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -77.79 -41.59 36.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.499 174.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.88 -26.0 60.33 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.503 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.478 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -67.12 -26.64 66.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.153 -178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.471 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . . . -62.29 -36.82 83.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 122.013 0.911 . . . . 0.0 109.119 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.81 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.75 -36.2 21.93 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.872 174.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.478 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 2.6 t80 -54.72 -42.08 71.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.342 0.591 . . . . 0.0 110.864 -178.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.598 HD11 HD21 ' A' ' 58' ' ' LEU . 33.5 mt -78.03 -29.41 15.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.295 -178.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.81 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 6.9 pt-20 -80.67 -32.97 35.85 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.439 -177.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 54.0 mt-10 -72.72 -29.72 63.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.097 0.475 . . . . 0.0 110.139 178.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -121.42 73.56 30.05 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 172.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -96.88 -168.92 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.932 2.421 . . . . 0.0 113.773 -170.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.416 ' C ' ' H ' ' A' ' 47' ' ' GLY . 2.8 p90 -136.43 147.17 58.92 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.14 176.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 45' ' ' PHE . 52.1 Cg_exo -58.23 7.87 0.06 OUTLIER 'Trans proline' 0 N--CA 1.483 0.864 0 C-N-CA 123.653 2.902 . . . . 0.0 114.702 -174.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . -127.18 28.24 4.61 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 174.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.559 ' HE2' HG22 ' A' ' 40' ' ' ILE . 6.0 t80 -71.19 132.09 44.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.998 0.427 . . . . 0.0 110.528 177.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.544 HG22 ' HG2' ' A' ' 50' ' ' GLU . 36.9 mm -111.35 -60.74 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.469 176.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.544 ' HG2' HG22 ' A' ' 49' ' ' ILE . 2.5 mm-40 -153.28 173.01 16.13 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.889 0.852 . . . . 0.0 111.231 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 59' ' ' THR . 5.1 p -161.2 118.27 2.28 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 113.839 -1.528 . . . . 0.0 108.964 154.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.668 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.5 pt -112.93 130.46 23.5 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.251 -173.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 6.1 Cg_exo -77.83 128.06 9.05 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.454 2.769 . . . . 0.0 111.897 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.491 ' HB3' ' HB2' ' A' ' 57' ' ' SER . . . -119.25 54.29 0.99 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.629 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.446 ' O ' HG11 ' A' ' 33' ' ' VAL . 47.6 t80 72.44 -59.33 0.56 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.469 176.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -126.59 -15.34 5.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.299 0.571 . . . . 0.0 110.441 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.491 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 19.8 m -108.58 148.43 30.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.157 0.503 . . . . 0.0 110.999 -177.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.598 HD21 HD11 ' A' ' 40' ' ' ILE . 49.7 tp -117.66 111.99 19.9 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.668 ' HB ' HG13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -94.96 106.74 18.75 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.966 -177.008 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.917 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 53.7 t -107.15 109.33 27.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.252 0.549 . . . . 0.0 111.318 -171.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.439 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 74.6 m-85 -101.62 147.33 26.55 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.711 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.48 ' OH ' ' HB3' ' A' ' 17' ' ' MET . 2.7 p90 -165.22 167.85 17.63 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.172 0.51 . . . . 0.0 110.397 -176.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -98.36 111.25 23.65 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.121 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.515 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 1.0 OUTLIER -64.48 -20.3 66.11 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.546 -172.072 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -58.9 -26.02 63.92 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.571 0.224 . . . . 0.0 111.448 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.575 ' HA ' ' HE3' ' A' ' 69' ' ' LYS . 16.2 tp10 -89.76 -35.84 15.5 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.842 0.83 . . . . 0.0 109.433 -173.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.696 HG11 HG22 ' A' ' 82' ' ' VAL . 3.4 m -79.91 -31.31 13.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.912 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.967 ' HA ' HD23 ' A' ' 71' ' ' LEU . 23.2 t80 -68.98 -22.12 64.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.134 176.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.575 ' HE3' ' HA ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -53.3 -36.74 61.55 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 173.035 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.58 -70.53 0.72 Allowed 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.852 -177.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.967 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER 41.34 71.95 1.19 Allowed Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 123.754 0.822 . . . . 0.0 112.265 -179.074 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.729 ' HD2' HG13 ' A' ' 75' ' ' ILE . 37.7 Cg_exo -61.74 173.95 2.59 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.134 2.556 . . . . 0.0 114.025 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.5 tp60 -62.52 -47.1 85.39 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -172.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.03 -20.74 79.11 Favored Glycine 0 CA--C 1.508 -0.37 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 -176.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.729 HG13 ' HD2' ' A' ' 72' ' ' PRO . 41.3 mm -76.95 102.96 3.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 114.51 -0.845 . . . . 0.0 109.989 175.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.3 m -84.91 -14.09 48.82 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.337 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.481 ' HB2' ' HG3' ' A' ' 80' ' ' GLU . 73.0 m -146.03 142.34 17.63 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.774 -172.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.606 ' HA ' HD21 ' A' ' 71' ' ' LEU . 79.2 Cg_exo -51.25 -36.28 56.05 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.338 2.692 . . . . 0.0 113.376 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.481 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 0.5 OUTLIER -66.11 -26.01 67.26 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.851 0.358 . . . . 0.0 111.138 178.877 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.744 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 5.0 mt-10 -72.69 -34.95 67.52 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.812 -178.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.574 ' HB3' HG21 ' A' ' 75' ' ' ILE . 18.9 p -69.38 -34.01 73.9 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -176.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.696 HG22 HG11 ' A' ' 67' ' ' VAL . 20.2 t -69.44 -36.53 72.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.565 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.744 ' HE2' ' HA ' ' A' ' 80' ' ' GLU . 54.2 mtmt -53.16 -45.57 68.51 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 23.0 mmt180 -67.75 -36.4 80.47 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.085 -172.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -62.05 -39.04 91.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.518 0.675 . . . . 0.0 110.33 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.4 m -86.96 -46.91 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.334 -177.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.471 ' OE1' ' HD3' ' A' ' 84' ' ' ARG . 43.6 mt-10 . . . . . 0 C--O 1.211 -0.923 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 10.6 p90 . . . . . 0 N--CA 1.445 -0.687 0 CA-C-O 121.628 0.727 . . . . 0.0 111.349 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -130.87 143.17 50.53 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.826 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.923 HG12 HG12 ' A' ' 19' ' ' ILE . 21.3 mt -106.21 120.99 58.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.471 -177.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 18' ' ' MET . 9.0 pt-20 -113.6 163.37 15.04 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.244 -176.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -92.97 126.28 37.98 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 173.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.582 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -65.68 -43.71 88.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.766 -174.674 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.34 -67.17 0.1 Allowed Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 178.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -114.34 -70.67 0.79 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.186 0.517 . . . . 0.0 111.514 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.2 p -135.43 51.0 2.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.92 0.867 . . . . 0.0 110.119 -173.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -148.1 151.75 36.17 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.062 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.688 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 38.2 ttp -126.97 128.59 46.63 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.234 -176.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.582 ' HB2' HD22 ' A' ' 12' ' ' LEU . 33.3 ttp -118.68 138.85 52.34 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.494 177.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.923 HG12 HG12 ' A' ' 9' ' ' ILE . 6.4 mt -126.68 124.3 64.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.022 -176.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -109.9 137.26 47.94 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 177.839 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.501 ' HB2' ' CG1' ' A' ' 29' ' ' VAL . 5.3 m-85 . . . . . 0 C--N 1.324 -0.532 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.519 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 23.9 tm0? . . . . . 0 C--O 1.226 -0.171 0 CA-C-O 120.729 0.3 . . . . 0.0 110.36 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.563 ' O ' HG12 ' A' ' 33' ' ' VAL . 87.7 t -72.35 -60.8 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.18 -176.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -46.96 -33.04 4.29 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.757 0.661 . . . . 0.0 112.197 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.22 -44.04 5.44 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.35 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.519 ' HB ' ' O ' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -80.78 -25.43 10.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -172.156 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 29' ' ' VAL . 13.7 p -70.23 -29.68 40.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -76.57 -31.42 57.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.699 175.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.62 -23.6 29.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.972 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.476 ' HA ' ' HB3' ' A' ' 39' ' ' TYR . . . -63.57 -24.71 67.92 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.981 -177.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.82 -42.74 99.4 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.627 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -83.56 -34.84 25.12 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.759 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.476 ' HB3' ' HA ' ' A' ' 36' ' ' ALA . 32.8 t80 -52.58 -44.52 65.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.998 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.5 mt -72.42 -33.61 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.238 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.627 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 7.8 pt-20 -80.63 -19.65 44.92 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.014 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.539 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 34.0 mt-10 -82.06 -29.78 31.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.857 0.36 . . . . 0.0 110.484 175.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -127.83 66.7 71.77 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.63 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -98.34 173.92 0.53 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.3 2.667 . . . . 0.0 114.727 -168.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -111.71 147.35 36.61 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 113.785 -1.552 . . . . 0.0 108.337 175.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.67 -8.13 0.73 Allowed 'Trans proline' 0 N--CA 1.484 0.923 0 C-N-CA 123.987 3.125 . . . . 0.0 114.957 -171.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.39 27.52 6.6 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.104 -0.569 . . . . 0.0 111.837 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -73.86 131.61 41.67 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.064 0.459 . . . . 0.0 111.552 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.3 mm -106.35 -61.21 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.242 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 42.5 tt0 -161.86 162.34 29.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.711 0.291 . . . . 0.0 110.602 -172.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.615 ' HB2' HD11 ' A' ' 58' ' ' LEU . 2.6 p -158.69 118.38 3.14 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 176.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.702 HG13 ' HB ' ' A' ' 59' ' ' THR . 9.6 pt -120.68 139.46 28.97 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-O 121.007 0.432 . . . . 0.0 111.749 -175.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.47 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 4.6 Cg_endo -84.5 133.75 5.43 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.18 2.587 . . . . 0.0 112.21 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -118.1 43.52 2.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.474 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 39.0 t80 72.34 -40.55 0.48 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.448 175.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -134.18 -18.93 1.99 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.898 0.38 . . . . 0.0 111.22 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 9.1 p -121.19 142.52 49.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.776 0.322 . . . . 0.0 111.107 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' A' ' 51' ' ' CYS . 0.9 OUTLIER -103.17 114.42 28.69 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.637 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.702 ' HB ' HG13 ' A' ' 52' ' ' ILE . 3.0 m -87.59 106.05 17.75 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.539 HG22 HD12 ' A' ' 58' ' ' LEU . 57.7 t -101.45 124.36 55.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.397 0.617 . . . . 0.0 111.56 -174.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.424 ' CE1' HG22 ' A' ' 59' ' ' THR . 89.0 m-85 -115.79 147.27 41.15 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.419 177.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.5 ' CE2' HG11 ' A' ' 82' ' ' VAL . 3.4 p90 -165.99 169.97 14.11 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.934 0.397 . . . . 0.0 110.149 -174.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -99.92 112.45 24.72 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.75 -176.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.659 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -62.37 -19.74 63.7 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.993 -176.017 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.7 -31.86 73.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 110.545 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.73 -25.64 19.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.902 0.858 . . . . 0.0 109.535 -175.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.659 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.5 m -75.93 -38.83 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.459 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.835 ' HA ' HD13 ' A' ' 71' ' ' LEU . 2.5 m-85 -55.77 -30.97 62.16 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.07 0.548 . . . . 0.0 111.411 171.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -57.66 -43.75 85.21 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.989 0.899 . . . . 0.0 108.843 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -81.08 -51.12 8.82 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.934 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.847 HD11 ' HA ' ' A' ' 78' ' ' PRO . 0.1 OUTLIER -12.16 84.63 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.469 0 O-C-N 125.549 1.781 . . . . 0.0 114.325 -173.433 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.816 ' HD2' HG13 ' A' ' 75' ' ' ILE . 32.5 Cg_exo -61.76 170.21 6.11 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 123.469 2.78 . . . . 0.0 112.172 176.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.6 -27.13 65.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.032 -172.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.98 -22.31 71.89 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.125 176.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.816 HG13 ' HD2' ' A' ' 72' ' ' PRO . 24.1 mm -86.32 114.14 25.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.615 -0.792 . . . . 0.0 110.043 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.8 m -105.59 -1.74 24.33 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.327 0.584 . . . . 0.0 110.604 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.532 ' HB2' ' HG3' ' A' ' 80' ' ' GLU . 70.6 m -141.45 141.4 22.88 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.704 -178.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.847 ' HA ' HD11 ' A' ' 71' ' ' LEU . 77.0 Cg_exo -44.45 -58.13 1.66 Allowed 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 123.18 2.587 . . . . 0.0 113.275 177.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.45 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 0.2 OUTLIER -56.06 -28.64 58.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.068 -176.818 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.662 ' HB2' HG23 ' A' ' 75' ' ' ILE . 48.6 mt-10 -67.96 -32.46 72.91 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.001 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.551 ' HB2' HG21 ' A' ' 75' ' ' ILE . 32.4 t -70.33 -33.99 72.14 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' A' ' 62' ' ' TYR . 26.2 t -76.95 -29.36 17.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.44 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.688 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 8.2 mtmp? -54.04 -42.09 68.81 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.463 176.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -63.88 -39.8 95.04 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.913 -176.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -61.95 -38.37 88.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.376 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.3 m -88.38 -35.21 7.72 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.86 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.439 ' OE2' ' HB3' ' A' ' 83' ' ' LYS . 40.4 mt-10 . . . . . 0 C--N 1.329 -0.318 0 C-N-CA 122.472 0.309 . . . . 0.0 111.587 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.798 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.7 m -96.13 138.21 34.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.664 0.269 . . . . 0.0 110.345 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -152.86 163.04 40.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.034 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.506 ' O ' HG22 ' A' ' 5' ' ' VAL . 12.4 t -95.78 30.43 2.36 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.478 -176.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 4' ' ' THR . 0.9 OUTLIER 62.27 151.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.422 1.089 . . . . 0.0 111.699 -175.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.429 ' HD2' ' HA ' ' A' ' 6' ' ' ARG . 15.8 mmm180 -115.91 94.54 4.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.384 173.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.543 ' CE1' ' HB2' ' A' ' 95' ' ' GLU . 15.0 p90 -105.04 147.25 28.04 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.235 -176.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.64 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . 2.3 mp0 -131.95 135.9 46.93 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.799 -177.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.909 HG12 HG12 ' A' ' 19' ' ' ILE . 9.5 mt -101.94 124.83 56.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.967 178.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -121.32 165.49 15.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.09 0.472 . . . . 0.0 109.904 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -87.34 127.61 35.19 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.698 0.761 . . . . 0.0 110.358 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.643 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -68.32 -47.27 68.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.227 -174.36 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.61 -83.11 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -118.85 -44.73 2.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.673 0.273 . . . . 0.0 111.24 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.1 p -146.15 43.49 1.22 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.495 0.664 . . . . 0.0 110.83 -173.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -144.45 156.59 44.26 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.398 178.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.629 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 35.6 ttp -128.01 134.71 49.27 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -175.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.643 ' HB2' HD22 ' A' ' 12' ' ' LEU . 39.5 ttp -125.16 130.07 51.42 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.918 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.909 HG12 HG12 ' A' ' 9' ' ' ILE . 7.3 mt -121.22 118.74 57.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.298 -173.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.64 ' HD3' ' HB2' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -103.52 139.75 38.44 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 176.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.747 ' HB2' HG11 ' A' ' 29' ' ' VAL . 15.1 m-85 -106.46 -151.54 0.46 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -97.88 179.3 32.67 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.303 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.628 ' HA ' ' HB2' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -158.88 -162.5 1.1 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 117.024 0.412 . . . . 0.0 110.46 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.558 ' HG3' ' HG2' ' A' ' 23' ' ' GLU . 38.4 mt-10 73.97 -57.9 0.61 Allowed 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 124.256 0.973 . . . . 0.0 110.654 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.5 pt -120.33 24.91 4.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.31 0.576 . . . . 0.0 110.285 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.628 ' HB2' ' HA ' ' A' ' 23' ' ' GLU . 5.6 m-20 -116.57 62.86 0.72 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.815 -174.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 30' ' ' ASN . 3.4 mp0 -60.39 -27.02 67.1 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 173.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.496 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 25.4 tm0? -55.84 -54.12 48.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.884 173.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.747 HG11 ' HB2' ' A' ' 21' ' ' PHE . 71.0 t -66.77 -48.58 79.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.66 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.417 ' HB3' ' HA ' ' A' ' 27' ' ' GLU . 9.2 t30 -51.89 -36.71 49.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.824 -176.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.07 -34.63 8.09 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.253 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 28' ' ' GLN . 0.4 OUTLIER -79.73 -29.14 12.95 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.017 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -174.126 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.541 HG23 ' HG ' ' A' ' 58' ' ' LEU . 11.4 p -68.73 -28.71 41.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 118.879 0.763 . . . . 0.0 109.415 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -70.07 -39.65 75.51 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.517 175.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.79 -21.41 29.95 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.113 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.629 ' HB1' HD11 ' A' ' 58' ' ' LEU . . . -64.36 -27.49 69.05 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.156 -176.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.54 -44.53 96.89 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.714 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -78.88 -31.88 45.64 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.877 177.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.405 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 14.9 t80 -57.49 -44.57 85.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.23 0.538 . . . . 0.0 109.728 178.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.9 mt -71.44 -33.31 49.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.322 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.273 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.714 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 12.6 pt-20 -78.97 -18.89 52.95 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.129 -176.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.45 ' C ' ' HD3' ' A' ' 44' ' ' PRO . 42.4 mt-10 -85.16 -30.34 24.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.842 0.353 . . . . 0.0 110.749 174.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -127.11 64.46 61.06 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.937 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.45 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 80.1 Cg_endo -98.26 178.1 0.4 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 123.295 2.663 . . . . 0.0 114.033 -170.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -106.93 146.69 33.63 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.25 171.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.557 ' HB2' ' HG3' ' A' ' 66' ' ' GLU . 71.5 Cg_exo -51.62 -15.31 2.66 Favored 'Trans proline' 0 N--CA 1.477 0.546 0 C-N-CA 124.019 3.146 . . . . 0.0 114.574 -173.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.8 15.22 41.11 Favored Glycine 0 C--O 1.223 -0.569 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.413 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -65.55 134.08 52.58 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.017 0.437 . . . . 0.0 110.905 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.418 HG12 ' HA ' ' A' ' 62' ' ' TYR . 28.8 mm -110.15 -59.73 3.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.437 -176.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -161.69 157.3 24.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.719 0.295 . . . . 0.0 110.787 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.2 p -150.08 121.64 7.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.929 HG13 ' HB ' ' A' ' 59' ' ' THR . 5.7 pt -120.4 130.84 24.65 Favored Pre-proline 0 C--N 1.319 -0.746 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.498 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 5.6 Cg_exo -78.94 122.91 5.52 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.454 2.769 . . . . 0.0 111.674 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -111.11 50.08 0.84 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 -176.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.7 t80 76.58 -56.85 0.55 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.387 172.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.561 HG21 ' HB3' ' A' ' 23' ' ' GLU . 25.1 p -137.82 14.23 2.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.101 0.477 . . . . 0.0 110.741 175.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 15.8 t -138.7 152.57 48.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.033 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.629 HD11 ' HB1' ' A' ' 36' ' ' ALA . 5.4 mt -112.24 114.36 27.11 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.38 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.929 ' HB ' HG13 ' A' ' 52' ' ' ILE . 2.8 m -91.18 103.93 16.55 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 174.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.8 t -112.04 114.04 45.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.603 0.716 . . . . 0.0 111.188 -169.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.477 ' CE1' HG22 ' A' ' 59' ' ' THR . 84.9 m-85 -105.48 148.91 26.67 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.796 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.556 ' CE2' HG11 ' A' ' 82' ' ' VAL . 2.8 p90 -166.54 172.94 10.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.329 0.585 . . . . 0.0 110.992 -175.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.536 ' OD1' ' HB3' ' A' ' 65' ' ' TYR . 6.7 t0 -98.49 119.55 37.4 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.841 -177.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.548 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -65.61 -20.22 66.23 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.04 -177.063 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.536 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -60.65 -33.6 73.05 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.102 0.477 . . . . 0.0 110.95 -178.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.557 ' HG3' ' HB2' ' A' ' 46' ' ' PRO . 0.8 OUTLIER -90.27 -22.23 21.7 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.862 0.839 . . . . 0.0 109.331 -173.813 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.548 HG22 ' HA ' ' A' ' 64' ' ' MET . 2.7 m -82.27 -37.7 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.414 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.955 ' HA ' HD23 ' A' ' 71' ' ' LEU . 32.3 m-85 -58.35 -31.65 67.8 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.093 0.473 . . . . 0.0 109.925 168.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.506 ' HB2' ' HE3' ' A' ' 69' ' ' LYS . 2.9 tppp? -60.59 -27.01 67.4 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.669 177.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -93.7 -76.13 0.48 Allowed 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.134 174.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.955 HD23 ' HA ' ' A' ' 68' ' ' TYR . 1.2 mm? 31.37 66.7 0.92 Allowed Pre-proline 0 N--CA 1.471 0.602 0 C-N-CA 124.312 1.045 . . . . 0.0 112.385 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.656 ' HD2' HG13 ' A' ' 75' ' ' ILE . 32.1 Cg_exo -59.7 153.1 58.22 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.804 2.336 . . . . 0.0 112.366 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -70.08 103.03 2.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.739 0.78 . . . . 0.0 110.541 -176.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 137.27 -34.08 2.23 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -173.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.656 HG13 ' HD2' ' A' ' 72' ' ' PRO . 18.4 mm -75.53 113.59 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 113.974 -1.113 . . . . 0.0 108.67 171.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.3 m -97.94 -3.27 38.75 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.546 -174.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 80' ' ' GLU . 57.0 m -140.32 134.97 15.72 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.893 -172.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.603 ' HA ' HD21 ' A' ' 71' ' ' LEU . 64.9 Cg_exo -45.47 -58.35 1.66 Allowed 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 123.201 2.601 . . . . 0.0 113.33 175.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.53 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -56.48 -29.38 61.68 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.286 0.565 . . . . 0.0 111.158 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.526 ' HG3' ' HE2' ' A' ' 83' ' ' LYS . 40.2 tt0 -71.68 -25.39 62.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.519 -176.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.527 ' HB2' HG21 ' A' ' 75' ' ' ILE . 34.3 t -77.45 -38.35 49.56 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.556 HG11 ' CE2' ' A' ' 62' ' ' TYR . 46.2 t -63.28 -32.27 55.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.292 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.629 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 39.8 mtmt -51.33 -39.54 57.19 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.738 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -73.29 -39.57 65.24 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.89 -174.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -64.2 -35.08 79.63 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.718 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.479 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 18.0 m -86.34 -38.64 12.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.679 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -49.66 -52.62 29.57 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -57.19 -25.45 59.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.978 0.418 . . . . 0.0 111.39 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -87.37 -48.55 7.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.631 175.342 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.568 ' O ' HG12 ' A' ' 93' ' ' ILE . 92.3 mt -65.96 -59.27 3.99 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.797 -177.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 1.105 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . . . -43.83 -40.06 4.22 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.293 -0.867 . . . . 0.0 113.087 -173.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -62.69 -9.06 7.87 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -175.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.568 HG12 ' O ' ' A' ' 90' ' ' LEU . 5.6 pt -95.77 -21.4 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.277 -176.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -179.84 -57.89 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 122.008 0.908 . . . . 0.0 110.6 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 1.105 ' HG2' ' HA ' ' A' ' 91' ' ' ALA . 4.0 pm0 -63.57 -7.39 7.02 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.92 -1.491 . . . . 0.0 114.165 -168.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.447 ' CA ' ' HB1' ' A' ' 91' ' ' ALA . 1.0 OUTLIER -57.83 -21.3 41.72 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 118.098 0.408 . . . . 0.0 110.961 174.539 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -76.3 -16.06 59.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.898 0.38 . . . . 0.0 110.686 176.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -104.95 -70.82 0.76 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.864 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 81.9 t 68.8 109.85 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.903 -177.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -75.6 -7.18 53.59 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.77 -177.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.139 -0.934 . . . . 0.0 111.471 178.507 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.061 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.8 m -56.13 -46.5 79.16 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 173.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -128.41 -172.88 2.81 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.215 168.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.845 HG23 ' HB2' ' A' ' 97' ' ' TYR . 21.5 m -53.21 -80.63 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.786 0.679 . . . . 0.0 110.947 173.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.71 HG13 ' O ' ' A' ' 4' ' ' THR . 2.2 m 155.4 -177.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 C-N-CA 127.846 2.458 . . . . 0.0 106.753 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.418 ' HD2' ' HA ' ' A' ' 6' ' ' ARG . 13.8 mmm180 -150.53 78.91 1.33 Allowed 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.614 ' CE1' ' HB2' ' A' ' 95' ' ' GLU . 6.1 p90 -104.53 149.96 25.03 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 121.372 0.606 . . . . 0.0 110.619 -172.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.401 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 1.8 tp-100 -139.16 133.35 31.31 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.311 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.966 HG12 HG12 ' A' ' 19' ' ' ILE . 37.2 mt -101.57 119.77 50.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.072 177.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -114.03 165.55 12.5 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.066 -177.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -84.26 130.79 34.79 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.521 0.677 . . . . 0.0 110.461 177.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -75.89 -42.98 47.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.867 -175.927 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -161.78 -73.29 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -142.29 -31.63 0.53 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.5 p -144.93 40.65 1.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.4 0.619 . . . . 0.0 111.325 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -147.78 154.45 40.51 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.874 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -119.29 144.99 46.5 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 119.872 -0.731 . . . . 0.0 112.014 -175.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.477 ' HB2' HD22 ' A' ' 12' ' ' LEU . 26.9 ttt -130.2 129.04 42.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.488 176.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.966 HG12 HG12 ' A' ' 9' ' ' ILE . 6.4 mt -121.35 145.04 28.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.322 -175.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.565 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -136.54 139.92 42.58 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 171.143 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.77 ' HB2' HG11 ' A' ' 29' ' ' VAL . 54.2 m-85 -104.34 -146.36 0.38 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 173.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.95 167.76 25.61 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.96 -44.14 0.34 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 117.018 0.409 . . . . 0.0 111.968 -174.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -46.56 -51.35 15.73 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -174.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.6 pt -125.0 26.62 2.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.192 0.52 . . . . 0.0 110.75 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.57 ' ND2' HG12 ' A' ' 5' ' ' VAL . 2.6 m-20 -114.54 77.64 1.08 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.623 -173.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -73.29 -25.79 60.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 175.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -58.86 -52.75 64.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.583 177.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.77 HG11 ' HB2' ' A' ' 21' ' ' PHE . 99.2 t -61.29 -49.84 82.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.6 178.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -43.79 -40.92 4.67 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 124.136 0.897 . . . . 0.0 112.284 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.36 -42.75 5.13 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.491 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -72.86 -27.17 24.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -172.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 29' ' ' VAL . 11.9 p -70.94 -27.45 30.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.369 0.604 . . . . 0.0 109.433 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -70.51 -35.69 73.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.63 172.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.28 -20.06 32.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.005 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.3 -24.74 67.48 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.192 -175.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.04 -46.64 83.53 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.655 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -76.45 -27.57 56.23 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.536 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -59.51 -45.13 92.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.094 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.534 HD11 HD21 ' A' ' 58' ' ' LEU . 68.3 mt -72.15 -33.39 46.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.43 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.655 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 9.9 pt-20 -77.14 -20.25 55.8 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.94 -175.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -80.66 -32.38 36.11 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 175.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.484 ' OE1' ' HG3' ' A' ' 89' ' ' ARG . 64.2 mt-30 -126.1 72.82 71.19 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.093 0.473 . . . . 0.0 109.732 176.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -98.17 -163.13 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.886 3.057 . . . . 0.0 114.044 -169.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -137.77 145.96 50.77 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 113.965 -1.471 . . . . 0.0 107.441 174.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -53.36 -15.8 6.3 Favored 'Trans proline' 0 N--CA 1.481 0.742 0 C-N-CA 123.635 2.89 . . . . 0.0 114.906 -169.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.593 ' HA3' ' HB2' ' A' ' 66' ' ' GLU . . . -107.31 17.03 37.75 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.491 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.421 ' HZ ' ' SG ' ' A' ' 51' ' ' CYS . 45.3 t80 -63.76 130.16 43.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.044 0.449 . . . . 0.0 111.391 176.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.415 HG12 ' HA ' ' A' ' 62' ' ' TYR . 35.2 mm -104.04 -61.84 2.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.026 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -161.8 156.83 23.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.848 0.356 . . . . 0.0 110.521 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.421 ' SG ' ' HZ ' ' A' ' 48' ' ' PHE . 7.4 p -145.96 119.51 9.1 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.746 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.8 pt -124.52 131.44 24.16 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-O 121.108 0.48 . . . . 0.0 111.462 -178.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 4.7 Cg_exo -78.44 149.18 24.14 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.141 2.561 . . . . 0.0 112.493 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.681 ' HB3' ' HB2' ' A' ' 57' ' ' SER . . . -120.99 17.96 11.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.025 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 71.75 -24.47 0.18 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.654 174.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.4 ' H ' ' C ' ' A' ' 54' ' ' ALA . 7.6 t -135.98 -9.12 2.06 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.524 0.678 . . . . 0.0 109.817 169.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.681 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 16.3 m -130.73 165.53 22.7 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.549 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.534 HD21 HD11 ' A' ' 40' ' ' ILE . 45.3 tp -132.16 125.97 32.51 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.746 ' HB ' HG13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -106.16 107.05 17.86 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.816 -177.02 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.874 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 47.3 t -109.05 115.36 49.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.507 0.67 . . . . 0.0 111.295 -174.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -105.14 146.74 28.78 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.294 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.544 ' CD2' HG11 ' A' ' 82' ' ' VAL . 3.1 p90 -164.19 171.46 14.97 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.031 0.443 . . . . 0.0 110.664 -172.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.503 ' OD1' ' HB3' ' A' ' 65' ' ' TYR . 6.2 t0 -100.92 115.49 30.55 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.347 -177.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.687 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -59.71 -18.77 45.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.18 -177.562 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.635 ' CE2' ' HG2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -66.7 -34.98 79.06 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -177.396 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.635 ' HG2' ' CE2' ' A' ' 65' ' ' TYR . 5.4 mm-40 -89.4 -27.37 20.47 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.872 0.844 . . . . 0.0 109.484 -174.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.722 HG11 HG22 ' A' ' 82' ' ' VAL . 4.1 m -83.39 -22.96 8.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.83 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.939 ' HA ' HD12 ' A' ' 71' ' ' LEU . 15.5 t80 -75.14 -28.05 60.01 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 168.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -67.97 -28.7 67.67 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.071 170.527 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.735 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 11.9 t-80 -111.52 28.33 8.84 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.492 174.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.939 HD12 ' HA ' ' A' ' 68' ' ' TYR . 2.7 mt -94.77 95.37 1.49 Allowed Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.532 176.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.735 ' HD3' ' O ' ' A' ' 70' ' ' HIS . 8.8 Cg_exo -76.48 175.2 11.66 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 124.061 3.174 . . . . 0.0 112.769 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -60.79 -42.78 98.24 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -171.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.03 -25.12 74.47 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.779 -175.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.613 HG13 ' HD2' ' A' ' 72' ' ' PRO . 5.6 mm -85.26 120.93 36.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.233 -0.483 . . . . 0.0 109.779 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.5 m -110.52 3.78 19.83 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.151 0.5 . . . . 0.0 111.17 -174.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.527 ' HB3' ' CB ' ' A' ' 80' ' ' GLU . 28.2 t -134.59 126.16 17.96 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.148 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.703 ' HA ' HD11 ' A' ' 71' ' ' LEU . 74.6 Cg_exo -42.96 -56.57 2.15 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.762 2.975 . . . . 0.0 112.626 171.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -36.44 63.38 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.359 0.6 . . . . 0.0 111.422 175.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.527 ' CB ' ' HB3' ' A' ' 77' ' ' SER . 38.5 tt0 -73.47 -30.65 63.3 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.262 -174.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.553 ' HB3' HG21 ' A' ' 75' ' ' ILE . 67.6 p -73.05 -35.18 66.67 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.655 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.722 HG22 HG11 ' A' ' 67' ' ' VAL . 6.8 t -61.59 -36.32 72.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.062 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -51.86 -40.07 59.97 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -67.41 -38.09 84.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.348 -177.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -65.91 -39.75 90.85 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.804 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.581 ' O ' HD23 ' A' ' 90' ' ' LEU . 28.4 m -83.83 -46.39 18.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.35 -177.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -54.0 -42.1 68.67 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -176.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.42 ' HG3' ' HD3' ' A' ' 89' ' ' ARG . 12.1 pt-20 -59.96 -29.16 68.23 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.839 0.352 . . . . 0.0 111.237 -178.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.484 ' HG3' ' OE1' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -87.19 -49.04 7.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.104 0.478 . . . . 0.0 110.611 174.529 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.665 ' O ' HG12 ' A' ' 93' ' ' ILE . 3.3 mm? -59.7 -33.54 71.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.397 -177.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.57 ' HA ' ' HG3' ' A' ' 95' ' ' GLU . . . -49.84 -35.88 24.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.374 177.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -69.35 -5.86 26.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.54 -176.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.665 HG12 ' O ' ' A' ' 90' ' ' LEU . 3.0 pt -98.15 -36.71 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.472 -177.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 178.19 -48.13 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.29 0.567 . . . . 0.0 111.009 -178.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.614 ' HB2' ' CE1' ' A' ' 7' ' ' TYR . 1.2 pt-20 -62.31 -8.86 6.54 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.498 -0.774 . . . . 0.0 113.076 -169.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.557 ' HB2' ' HB1' ' A' ' 91' ' ' ALA . 22.0 t70 -53.68 -28.03 31.1 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 173.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.845 ' HB2' HG23 ' A' ' 4' ' ' THR . 0.3 OUTLIER -73.64 -12.56 60.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.305 0.574 . . . . 0.0 109.524 -178.628 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.432 ' HB2' ' HE1' ' A' ' 7' ' ' TYR . 30.1 mt-10 -119.38 -147.64 0.4 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.608 175.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.6 p 171.42 124.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 123.767 0.827 . . . . 0.0 109.061 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.7 ' OD1' ' HB ' ' A' ' 9' ' ' ILE . 8.9 t-20 -101.16 95.94 6.88 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.75 0.786 . . . . 0.0 110.904 177.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 . . . . . 0 C--N 1.301 -1.516 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.124 179.561 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.431 ' O ' ' HG2' ' A' ' 3' ' ' MET . 70.0 m -76.91 97.61 4.64 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.483 ' SD ' ' HG2' ' A' ' 6' ' ' ARG . 25.9 ptt? 49.41 -177.16 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.78 1.232 . . . . 0.0 111.902 -173.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.629 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 8.8 t -83.03 -46.26 13.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.524 0.678 . . . . 0.0 109.851 174.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.629 ' HB ' ' O ' ' A' ' 4' ' ' THR . 5.0 p 156.51 163.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 113.599 -1.637 . . . . 0.0 108.287 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.483 ' HG2' ' SD ' ' A' ' 3' ' ' MET . 16.3 mmt180 -121.02 82.09 1.87 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.628 0.728 . . . . 0.0 109.872 175.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.562 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 18.3 p90 -104.31 148.74 26.03 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.965 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.517 ' HB2' ' NE ' ' A' ' 20' ' ' ARG . 14.7 mm-40 -133.09 132.79 42.15 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.875 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.751 HG12 HG12 ' A' ' 19' ' ' ILE . 14.9 mt -95.94 119.48 44.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.706 178.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -120.32 158.33 27.31 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.652 -176.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -82.89 129.34 35.0 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.453 0.644 . . . . 0.0 110.525 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.684 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -73.94 -38.67 64.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.601 -1.182 . . . . 0.0 110.98 -176.349 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.62 -87.16 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.497 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -103.47 -50.26 3.49 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -176.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.526 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 32.5 p -156.39 48.15 0.47 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 122.141 0.972 . . . . 0.0 109.966 -176.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -140.11 148.24 41.41 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.255 -1.339 . . . . 0.0 107.688 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.726 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 37.8 ttp -121.83 139.06 54.09 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.956 -174.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.684 ' HB2' HD22 ' A' ' 12' ' ' LEU . 49.8 ttm -124.89 132.21 53.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.054 0.454 . . . . 0.0 110.947 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.751 HG12 HG12 ' A' ' 9' ' ' ILE . 7.7 mt -124.98 120.88 59.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.654 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.517 ' NE ' ' HB2' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -114.08 134.32 54.96 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.992 177.048 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.562 ' HA ' ' CB ' ' A' ' 7' ' ' TYR . 32.1 m-85 -93.8 -147.89 0.26 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.567 0.222 . . . . 0.0 110.885 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 23' ' ' GLU . . . -70.87 -39.73 64.47 Favored Glycine 0 C--N 1.331 0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 113.313 -173.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.637 ' HB2' HG21 ' A' ' 56' ' ' THR . 41.8 tt0 76.72 -57.1 0.54 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.285 0.634 . . . . 0.0 112.4 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.631 ' HG2' HG23 ' A' ' 25' ' ' ILE . 43.2 tt0 -77.14 -72.79 0.33 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -169.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.631 HG23 ' HG2' ' A' ' 24' ' ' GLU . 38.3 pt -104.75 19.34 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.998 0.428 . . . . 0.0 111.954 -170.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.615 ' HB3' HG22 ' A' ' 29' ' ' VAL . 21.7 m120 -120.47 76.48 1.19 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.708 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.581 ' HA ' ' HB3' ' A' ' 30' ' ' ASN . 33.6 tt0 -69.29 -22.46 63.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.666 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.3 tm0? -59.4 -54.53 45.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.012 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.615 HG22 ' HB3' ' A' ' 26' ' ' ASN . 27.1 m -74.18 -25.82 20.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.686 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.581 ' HB3' ' HA ' ' A' ' 27' ' ' GLU . 8.7 t30 -59.9 -25.91 65.49 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.624 174.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -96.91 -32.86 6.29 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.417 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.449 HG22 ' HA ' ' A' ' 29' ' ' VAL . 0.5 OUTLIER -75.94 -23.59 16.27 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 C-N-CA 121.171 -0.212 . . . . 0.0 111.152 -177.058 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.487 HG23 ' HG ' ' A' ' 58' ' ' LEU . 10.5 p -65.53 -31.0 51.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.364 0.602 . . . . 0.0 109.471 176.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.418 ' HA ' ' CB ' ' A' ' 53' ' ' PRO . 53.3 t-80 -74.75 -38.0 62.35 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.708 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.58 -22.99 46.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.663 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.577 ' HB1' HD11 ' A' ' 58' ' ' LEU . . . -65.36 -25.84 67.76 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.836 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.51 -40.63 95.3 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.739 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.09 -29.61 26.65 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.859 176.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.487 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . 2.7 t80 -60.34 -42.85 96.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.914 0.388 . . . . 0.0 110.401 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 51.6 mt -74.26 -38.42 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.037 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.739 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 8.4 pt-20 -71.15 -23.78 62.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.697 0.284 . . . . 0.0 110.927 -176.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -76.98 -32.54 57.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.017 177.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -134.82 68.38 71.26 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.032 0.444 . . . . 0.0 110.916 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -98.51 -176.31 0.21 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.539 2.826 . . . . 0.0 113.415 -174.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.506 ' HZ ' ' HB2' ' A' ' 62' ' ' TYR . 12.5 p90 -108.3 149.42 39.24 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -39.74 -36.35 1.19 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.003 3.135 . . . . 0.0 115.636 -172.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 66' ' ' GLU . . . -98.37 15.41 61.27 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.97 -175.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.42 ' HZ ' ' SG ' ' A' ' 51' ' ' CYS . 32.4 t80 -62.03 132.84 54.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.264 0.554 . . . . 0.0 110.845 175.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.413 HG12 ' HA ' ' A' ' 62' ' ' TYR . 33.1 mm -106.24 -62.49 2.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.287 -176.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -160.37 155.66 24.97 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.796 -170.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.42 ' SG ' ' HZ ' ' A' ' 48' ' ' PHE . 2.9 p -151.39 119.44 6.26 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.992 0.425 . . . . 0.0 110.024 176.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.748 HG13 ' HB ' ' A' ' 59' ' ' THR . 7.8 pt -121.43 138.6 28.44 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.436 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 11.1 Cg_endo -86.6 148.9 8.69 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.152 2.568 . . . . 0.0 112.424 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -143.5 66.68 1.3 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 69.4 t80 74.47 -60.74 0.51 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.417 0.687 . . . . 0.0 111.516 173.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.637 HG21 ' HB2' ' A' ' 23' ' ' GLU . 10.3 t -136.04 -5.75 2.12 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.287 0.565 . . . . 0.0 110.104 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 16.4 m -113.87 137.07 52.17 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.29 -174.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.577 HD11 ' HB1' ' A' ' 36' ' ' ALA . 3.8 mt -100.81 120.47 40.17 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.057 174.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.748 ' HB ' HG13 ' A' ' 52' ' ' ILE . 1.8 m -96.78 104.44 16.44 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.2 t -110.76 114.77 48.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.711 0.767 . . . . 0.0 111.064 -169.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -106.89 150.12 26.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.191 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.689 ' OH ' ' HB2' ' A' ' 17' ' ' MET . 3.1 p90 -166.62 167.77 15.08 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.371 -175.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.477 ' O ' HG13 ' A' ' 67' ' ' VAL . 1.3 t0 -100.64 115.85 31.17 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.179 0.514 . . . . 0.0 110.455 -174.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.62 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -61.83 -21.89 65.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.078 -174.515 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -69.21 -30.12 68.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.158 0.504 . . . . 0.0 109.843 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.444 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 1.2 tm-20 -92.08 -33.01 14.95 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.728 0.775 . . . . 0.0 109.131 -173.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.62 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.4 m -67.21 -40.67 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.979 176.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.824 ' HA ' HD23 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -63.71 -25.82 68.38 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.519 173.928 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.487 ' HE2' ' HB2' ' A' ' 69' ' ' LYS . 5.3 tppt? -70.58 -21.24 62.7 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.75 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -104.87 -41.87 5.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.561 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.824 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER -7.36 84.6 0.03 OUTLIER Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 125.795 1.638 . . . . 0.0 113.703 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.427 ' HD2' HG13 ' A' ' 75' ' ' ILE . 32.3 Cg_exo -60.53 165.36 11.49 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.127 2.551 . . . . 0.0 112.921 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? -61.59 -42.29 98.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.84 0.352 . . . . 0.0 111.419 -173.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.35 -18.55 79.13 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.794 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.596 HG21 ' HB3' ' A' ' 81' ' ' SER . 6.2 mm -88.13 119.17 35.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.49 -0.355 . . . . 0.0 110.281 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -101.75 -9.31 20.94 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.93 0.395 . . . . 0.0 110.945 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.6 m -122.51 123.76 26.95 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.592 -175.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.664 ' HA ' HD21 ' A' ' 71' ' ' LEU . 46.4 Cg_exo -49.05 -46.71 24.36 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.55 2.833 . . . . 0.0 113.783 174.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.93 -29.96 69.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.772 0.32 . . . . 0.0 111.286 175.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 84' ' ' ARG . 52.9 tt0 -75.07 -31.61 61.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.17 -175.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.596 ' HB3' HG21 ' A' ' 75' ' ' ILE . 37.3 p -72.88 -32.94 65.74 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.564 HG11 ' CD2' ' A' ' 62' ' ' TYR . 61.1 t -69.04 -37.0 76.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.161 -1.381 . . . . 0.0 111.282 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.726 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 39.4 mtmt -52.17 -43.23 64.01 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.454 0.645 . . . . 0.0 109.317 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 22.1 mmt180 -67.29 -31.42 71.71 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.866 -173.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.15 -35.28 69.03 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.005 0.431 . . . . 0.0 111.244 176.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.418 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 14.6 m -86.91 -39.18 12.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 C-N-CA 120.424 -0.511 . . . . 0.0 111.047 -177.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.439 ' HA ' ' HB2' ' A' ' 90' ' ' LEU . 50.3 mt-10 -61.33 -38.41 86.78 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 122.623 0.369 . . . . 0.0 111.923 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.21 -31.51 72.05 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.814 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.48 -41.88 17.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.087 0.47 . . . . 0.0 110.283 176.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.601 ' O ' HG12 ' A' ' 93' ' ' ILE . 92.5 mt -61.8 -48.82 78.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.252 177.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.72 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . . . -44.01 -41.85 5.68 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.978 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -59.18 -15.93 17.55 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 90' ' ' LEU . 2.5 pt -97.16 -31.25 3.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -174.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.475 ' HB1' ' OG1' ' A' ' 4' ' ' THR . . . -172.23 -55.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.267 0.556 . . . . 0.0 111.379 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.72 ' HG2' ' HA ' ' A' ' 91' ' ' ALA . 1.7 pm0 -61.5 -9.98 6.87 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -169.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 20.0 t70 -51.5 -22.5 3.2 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 120.874 0.369 . . . . 0.0 111.744 174.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.423 ' HD2' ' HB ' ' A' ' 4' ' ' THR . 4.4 m-30 -65.53 -12.72 55.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.43 0.633 . . . . 0.0 109.978 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.413 ' HB2' ' H ' ' A' ' 99' ' ' VAL . 5.6 pt-20 -156.52 -142.9 0.11 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.925 175.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.413 ' H ' ' HB2' ' A' ' 98' ' ' GLU . 7.6 p 179.02 128.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.129 0.49 . . . . 0.0 109.942 -173.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.22 91.63 3.21 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.492 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 . . . . . 0 C--O 1.248 1.007 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.305 -177.328 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.58 0 N-CA-C 112.009 -0.436 . . . . 0.0 112.009 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.0 m -125.55 108.56 11.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.872 0.368 . . . . 0.0 110.639 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -84.56 -171.63 3.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.896 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.4 t -131.36 119.16 21.29 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.847 0.832 . . . . 0.0 109.132 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.1 m -75.13 161.71 4.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.265 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.48 ' HD2' ' N ' ' A' ' 6' ' ' ARG . 1.6 mpt_? -102.76 72.03 1.2 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.687 0.756 . . . . 0.0 109.79 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.721 ' CE1' ' HB3' ' A' ' 95' ' ' GLU . 6.9 p90 -102.03 164.33 11.77 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.7 -176.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.554 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . 30.5 tt0 -141.01 133.51 28.48 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.731 0.777 . . . . 0.0 110.206 174.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.679 HG12 HG12 ' A' ' 19' ' ' ILE . 9.2 mt -92.16 109.73 21.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.557 176.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.628 ' HG2' ' O ' ' A' ' 18' ' ' MET . 9.1 pt-20 -111.34 163.14 14.3 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.692 -170.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -88.36 131.49 34.81 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.282 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.608 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -76.22 -31.48 58.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.569 -176.88 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.45 -72.26 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.046 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -135.99 -35.34 0.78 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.3 p -152.89 41.53 0.58 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.714 0.768 . . . . 0.0 110.976 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.583 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -143.8 155.52 44.18 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 174.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.611 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 43.8 ttp -130.09 136.57 49.49 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.441 -172.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.628 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 49.3 ttm -126.82 141.94 51.68 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.808 176.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.679 HG12 HG12 ' A' ' 9' ' ' ILE . 7.5 mt -125.4 115.3 43.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 O-C-N 122.365 -0.209 . . . . 0.0 111.296 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.554 ' HD3' ' HB3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -98.64 136.4 38.76 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 174.54 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.89 ' HB2' HG21 ' A' ' 29' ' ' VAL . 3.9 m-85 -113.66 -155.08 0.56 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.485 ' O ' HG11 ' A' ' 29' ' ' VAL . . . -91.37 -163.36 38.53 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 176.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -172.98 -37.68 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 117.302 0.551 . . . . 0.0 111.935 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -51.07 -69.13 0.12 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.16 0.505 . . . . 0.0 111.37 -173.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.5 pt -104.36 18.04 4.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.716 0.769 . . . . 0.0 110.006 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.59 ' HB3' HG12 ' A' ' 29' ' ' VAL . 45.4 m-80 -108.56 72.35 0.82 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.536 -172.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -59.8 -32.35 70.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.417 171.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -54.25 -56.39 18.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.223 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.89 HG21 ' HB2' ' A' ' 21' ' ' PHE . 9.2 p -65.17 -42.12 93.4 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.061 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -48.99 -43.48 40.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.928 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.36 -5.23 87.32 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.14 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -115.88 -31.72 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.617 0 CA-C-N 117.766 0.783 . . . . 0.0 112.372 -174.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.454 ' O ' ' HB3' ' A' ' 53' ' ' PRO . 6.7 p -60.94 -36.81 74.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 118.391 0.541 . . . . 0.0 110.419 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.415 ' HA ' ' CB ' ' A' ' 53' ' ' PRO . 11.5 p-80 -79.31 -22.59 44.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.85 0.357 . . . . 0.0 110.636 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.88 -29.96 23.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.015 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.519 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -64.23 -22.39 66.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.244 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.47 -43.08 98.34 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.59 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.36 -27.97 27.33 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.835 176.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.609 ' HE1' ' HB3' ' A' ' 89' ' ' ARG . 3.9 t80 -56.91 -48.14 78.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.066 0.46 . . . . 0.0 110.252 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.454 HD11 HD21 ' A' ' 58' ' ' LEU . 58.9 mt -72.93 -36.94 52.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.485 -174.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.59 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 13.0 pt-20 -71.17 -19.4 62.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.654 0.264 . . . . 0.0 111.349 -174.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.411 ' C ' ' HD3' ' A' ' 44' ' ' PRO . 46.0 mt-10 -79.46 -28.68 41.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.88 0.372 . . . . 0.0 110.877 174.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -129.89 64.19 71.22 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.785 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.411 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 65.2 Cg_endo -98.99 177.98 0.34 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.264 2.643 . . . . 0.0 113.389 -174.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.54 ' CE2' HG13 ' A' ' 82' ' ' VAL . 6.6 p90 -108.21 147.41 35.53 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.279 173.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.21 12.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.486 1.033 0 C-N-CA 124.293 3.329 . . . . 0.0 114.852 -173.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.491 ' HA3' ' HB2' ' A' ' 66' ' ' GLU . . . -131.12 19.32 4.91 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 175.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.594 ' HZ ' ' HB3' ' A' ' 51' ' ' CYS . 30.9 t80 -79.49 142.61 35.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.013 0.435 . . . . 0.0 110.404 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.492 HG12 ' HA ' ' A' ' 62' ' ' TYR . 35.5 mm -108.38 -59.19 3.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.212 -175.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -168.93 141.6 2.73 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.351 -173.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.594 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 1.6 p -129.22 118.75 22.86 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 173.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.734 HG13 ' HB ' ' A' ' 59' ' ' THR . 4.3 pt -121.18 134.87 24.54 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.877 -175.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.454 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 86.9 Cg_endo -87.2 139.88 5.37 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.303 2.669 . . . . 0.0 112.66 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.3 59.22 1.59 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.413 ' O ' HG11 ' A' ' 33' ' ' VAL . 75.8 t80 75.02 -50.69 0.67 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.576 0.75 . . . . 0.0 112.086 172.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.27 -12.9 1.19 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.111 0.481 . . . . 0.0 110.863 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.5 m -115.39 134.14 55.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.979 0.419 . . . . 0.0 111.162 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.454 HD21 HD11 ' A' ' 40' ' ' ILE . 46.0 tp -102.86 117.23 34.17 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.789 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.734 ' HB ' HG13 ' A' ' 52' ' ' ILE . 4.8 m -97.6 114.41 26.33 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -177.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.9 t -111.41 109.58 29.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.765 0.793 . . . . 0.0 111.375 -170.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -101.25 145.61 28.61 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.009 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.611 ' OH ' ' HB2' ' A' ' 17' ' ' MET . 2.9 p90 -166.62 166.94 15.78 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -176.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.41 ' OD1' ' HD1' ' A' ' 65' ' ' TYR . 5.4 t70 -102.58 128.55 49.19 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.339 0.59 . . . . 0.0 109.45 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.54 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -62.24 -20.56 64.35 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.799 -172.297 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.41 ' HD1' ' OD1' ' A' ' 63' ' ' ASP . 4.5 p90 -64.54 -34.93 79.39 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.847 0.356 . . . . 0.0 111.632 -174.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.491 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 1.7 tm-20 -92.52 -28.4 16.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.68 0.752 . . . . 0.0 109.598 -172.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.1 m -72.93 -34.65 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.911 ' HA ' HD23 ' A' ' 71' ' ' LEU . 58.9 t80 -72.47 -22.63 61.04 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.888 173.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.493 ' HE2' ' HB2' ' A' ' 69' ' ' LYS . 9.0 tppt? -66.27 -26.07 67.17 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 173.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -89.37 -74.64 0.47 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.786 172.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.911 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.8 OUTLIER 24.14 65.44 0.4 Allowed Pre-proline 0 N--CA 1.473 0.714 0 O-C-N 124.88 1.362 . . . . 0.0 112.88 -178.657 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.574 ' HD2' HG13 ' A' ' 75' ' ' ILE . 35.1 Cg_exo -60.67 143.47 99.42 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.608 2.205 . . . . 0.0 111.8 -175.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -64.0 108.39 1.5 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.499 0.666 . . . . 0.0 110.106 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 135.36 -30.1 2.83 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -171.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.575 HG21 ' HB3' ' A' ' 81' ' ' SER . 10.9 mm -87.12 125.23 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 114.422 -0.889 . . . . 0.0 108.622 170.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.5 t -103.68 -0.15 29.86 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.353 0.597 . . . . 0.0 110.274 -174.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.83 ' HG ' ' HD1' ' A' ' 79' ' ' PHE . 38.4 t -143.89 133.83 11.85 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.127 -170.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.59 ' HA ' HD21 ' A' ' 71' ' ' LEU . 86.1 Cg_exo -50.07 -50.35 13.63 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.668 2.912 . . . . 0.0 112.863 174.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.83 ' HD1' ' HG ' ' A' ' 77' ' ' SER . 0.1 OUTLIER -63.2 -30.24 71.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.102 0.477 . . . . 0.0 110.921 178.817 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.433 ' CB ' ' HB3' ' A' ' 77' ' ' SER . 40.7 tt0 -73.31 -27.1 61.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.366 -175.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.575 ' HB3' HG21 ' A' ' 75' ' ' ILE . 88.8 p -79.31 -37.75 36.92 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.56 0.695 . . . . 0.0 109.176 178.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 78' ' ' PRO . 61.0 t -63.42 -31.44 52.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.157 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.537 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 6.3 mtmp? -52.53 -43.63 65.26 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.48 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 11.3 mmm180 -64.56 -41.83 96.07 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.429 -174.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.34 -39.36 86.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.819 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.2 m -87.24 -41.49 14.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.968 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -60.99 -41.38 96.37 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.648 ' HG3' ' HD3' ' A' ' 89' ' ' ARG . 9.3 pt-20 -59.13 -30.99 68.54 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.053 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.648 ' HD3' ' HG3' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -89.19 -56.95 3.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.464 0.649 . . . . 0.0 110.799 176.265 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.697 ' O ' HG12 ' A' ' 93' ' ' ILE . 12.0 tp -73.55 -65.61 0.8 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.869 -176.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.754 ' HA ' ' HG3' ' A' ' 95' ' ' GLU . . . -55.24 -31.96 61.92 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -172.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.698 ' HA ' ' CB ' ' A' ' 96' ' ' ASP . 4.3 tt0 -59.71 -6.58 1.23 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -171.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.697 HG12 ' O ' ' A' ' 90' ' ' LEU . 13.1 pt -88.16 -32.72 6.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.551 -174.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.641 ' N ' HG13 ' A' ' 93' ' ' ILE . . . -151.84 -30.18 0.16 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.354 0.597 . . . . 0.0 112.377 -172.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.754 ' HG3' ' HA ' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -106.42 -32.83 7.94 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.856 -164.486 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.698 ' CB ' ' HA ' ' A' ' 92' ' ' GLU . 28.6 t70 -51.75 -19.44 1.64 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.228 173.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -68.07 -13.43 62.19 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.729 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -134.52 -157.61 0.82 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.513 169.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.6 m -141.11 110.2 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.434 0.635 . . . . 0.0 110.9 -171.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -87.41 23.29 1.93 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.463 -178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.782 -0.628 . . . . 0.0 109.409 175.02 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.662 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t -128.17 -174.27 3.17 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.7 ptp -126.04 150.46 48.1 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.2 t -76.49 127.65 33.26 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.29 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.623 HG11 ' CD2' ' A' ' 21' ' ' PHE . 98.8 t -82.78 141.44 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.223 0.535 . . . . 0.0 110.464 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -117.62 95.88 5.14 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.313 171.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.627 ' OH ' HD12 ' A' ' 93' ' ' ILE . 35.2 p90 -122.76 163.06 20.87 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.436 -175.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.44 120.29 18.5 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -175.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.943 HG12 HG12 ' A' ' 19' ' ' ILE . 40.7 mt -89.71 123.74 42.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.036 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 18' ' ' MET . 12.0 pt-20 -122.0 174.17 7.08 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.834 -176.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -95.08 135.51 36.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.526 0.679 . . . . 0.0 110.598 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.44 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -80.87 -44.7 17.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.517 -176.587 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -172.92 -74.32 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.432 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -127.15 -50.39 1.43 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.118 0.485 . . . . 0.0 111.172 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.8 p -144.9 41.03 1.28 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.588 0.709 . . . . 0.0 110.942 -172.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.02 157.29 44.42 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.651 176.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.794 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -123.21 145.84 48.31 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.888 -176.321 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.44 ' HB2' HD22 ' A' ' 12' ' ' LEU . 51.8 ttm -127.25 131.13 50.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.749 174.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.943 HG12 HG12 ' A' ' 9' ' ' ILE . 9.9 mt -114.07 124.85 71.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.84 -177.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.7 111.75 24.03 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.618 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.623 ' CD2' HG11 ' A' ' 5' ' ' VAL . 22.9 m-85 -78.52 -174.39 3.8 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.195 0.521 . . . . 0.0 111.258 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.439 ' O ' HG11 ' A' ' 29' ' ' VAL . . . -97.63 -164.76 31.76 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.519 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -178.65 170.9 1.56 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 76.2 -52.51 0.61 Allowed 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.286 0.634 . . . . 0.0 111.719 172.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.1 pt -107.94 10.13 9.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.799 0.809 . . . . 0.0 109.897 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.477 ' O ' HG12 ' A' ' 29' ' ' VAL . 34.3 t30 -146.29 108.92 4.51 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.409 -175.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -80.35 -30.14 38.0 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.213 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -61.45 -19.74 62.32 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -173.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 26' ' ' ASN . 1.5 p -62.57 -55.98 20.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.912 176.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.418 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -57.76 -29.03 64.48 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.859 -177.429 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.19 -15.7 58.6 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.228 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.409 ' O ' ' N ' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -115.18 -24.82 3.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.724 0 CA-C-N 117.41 0.605 . . . . 0.0 112.361 -174.351 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.446 HG11 ' O ' ' A' ' 55' ' ' PHE . 7.2 p -61.24 -34.57 61.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 118.785 0.72 . . . . 0.0 110.361 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -77.14 -32.09 56.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.837 0.351 . . . . 0.0 110.072 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.83 -20.8 30.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.46 -176.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 32' ' ' ILE . . . -66.46 -32.03 73.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.997 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.7 -41.07 97.1 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.91 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -73.84 -36.86 64.94 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.753 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.01 -35.43 75.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.231 0.539 . . . . 0.0 110.113 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.7 mt -81.95 -35.21 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.373 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.91 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 10.5 pt-20 -79.84 -21.77 43.75 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.751 -175.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.952 ' HG3' ' HG3' ' A' ' 43' ' ' GLN . 9.6 pt-20 -81.03 -29.89 35.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.121 0.486 . . . . 0.0 109.967 175.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.952 ' HG3' ' HG3' ' A' ' 42' ' ' GLU . 54.3 mt-30 -126.37 65.05 57.46 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.933 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.425 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 66.2 Cg_endo -93.36 -173.27 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.569 2.846 . . . . 0.0 114.017 -169.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -124.77 146.73 53.92 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.517 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -49.06 -18.63 1.92 Allowed 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 124.151 3.234 . . . . 0.0 115.265 -171.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.36 21.09 22.41 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.172 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.485 ' HZ ' ' SG ' ' A' ' 51' ' ' CYS . 45.2 t80 -66.69 130.41 43.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.993 0.425 . . . . 0.0 110.795 176.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.434 HG12 ' HA ' ' A' ' 62' ' ' TYR . 35.4 mm -102.55 -59.76 3.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.277 -177.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -162.82 154.39 17.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.738 0.304 . . . . 0.0 110.734 -174.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.485 ' SG ' ' HZ ' ' A' ' 48' ' ' PHE . 12.3 p -144.27 119.3 10.02 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 173.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.777 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.5 pt -124.95 132.83 24.39 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-O 121.127 0.489 . . . . 0.0 111.755 -178.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.55 136.9 7.68 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.02 2.48 . . . . 0.0 111.715 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -124.73 54.37 1.4 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.957 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.446 ' O ' HG11 ' A' ' 33' ' ' VAL . 57.9 m-85 74.13 -53.4 0.68 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.49 0.716 . . . . 0.0 112.285 171.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.417 ' O ' ' HB2' ' A' ' 21' ' ' PHE . 9.3 t -139.26 3.2 2.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.199 0.523 . . . . 0.0 110.477 176.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.3 m -125.7 146.3 49.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.059 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.43 ' HB3' ' HB ' ' A' ' 19' ' ' ILE . 45.8 tp -112.98 119.9 39.53 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.777 ' HB ' HG13 ' A' ' 52' ' ' ILE . 1.4 m -102.1 110.24 22.16 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.794 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 58.9 t -111.27 115.99 51.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.602 0.715 . . . . 0.0 111.185 -173.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -107.05 145.9 31.81 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.479 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.607 ' OH ' ' HB3' ' A' ' 17' ' ' MET . 3.5 p90 -165.12 168.79 16.89 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.983 -175.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.417 ' OD1' ' HB3' ' A' ' 65' ' ' TYR . 7.2 t0 -101.97 114.35 28.38 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.495 -176.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.706 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -64.44 -20.82 66.41 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.075 -176.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.417 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -64.56 -27.52 69.01 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.793 0.33 . . . . 0.0 110.732 -179.203 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -90.69 -39.28 12.54 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.613 0.721 . . . . 0.0 109.271 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.706 HG22 ' HA ' ' A' ' 64' ' ' MET . 2.7 m -64.77 -34.43 70.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.235 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.738 ' HA ' HD23 ' A' ' 71' ' ' LEU . 7.3 m-85 -55.0 -28.39 51.64 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.841 0.456 . . . . 0.0 111.456 172.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -41.91 95.83 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.598 0.713 . . . . 0.0 109.415 177.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -91.0 -23.93 20.24 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.842 -174.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.738 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -26.53 94.37 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.895 0 O-C-N 124.867 1.355 . . . . 0.0 111.546 176.106 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.478 ' HD2' HG13 ' A' ' 75' ' ' ILE . 24.1 Cg_exo -67.65 140.16 50.72 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.551 2.834 . . . . 0.0 111.603 -175.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.0 tp60 -63.01 99.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.463 0.649 . . . . 0.0 109.917 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 140.02 -24.1 2.72 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -172.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.555 HG21 ' HB3' ' A' ' 81' ' ' SER . 2.4 mm -96.29 126.94 48.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 171.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 t -112.25 -0.25 15.55 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.266 0.555 . . . . 0.0 110.109 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.42 ' HG ' ' HD2' ' A' ' 79' ' ' PHE . 34.6 t -118.61 111.99 37.44 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.282 -175.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.694 ' HA ' HD21 ' A' ' 71' ' ' LEU . 91.3 Cg_exo -47.98 -46.3 22.37 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.55 2.833 . . . . 0.0 113.062 173.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.42 ' HD2' ' HG ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -61.18 -37.3 82.42 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.226 -0.19 . . . . 0.0 111.437 176.709 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 19.8 tt0 -82.07 -19.35 40.43 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.402 -174.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.555 ' HB3' HG21 ' A' ' 75' ' ' ILE . 83.3 p -74.25 -37.63 63.71 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 78' ' ' PRO . 26.8 t -65.67 -30.92 51.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.675 177.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.763 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 21.4 mtpt -49.94 -48.5 51.87 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 174.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 11.5 mmt180 -61.48 -38.65 88.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.494 -173.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -73.06 -33.72 65.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.137 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.507 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 22.7 m -87.01 -42.5 15.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 CA-C-O 118.911 -0.566 . . . . 0.0 112.043 -176.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.763 ' HG2' ' O ' ' A' ' 83' ' ' LYS . 8.1 pt-20 -54.01 -58.26 7.96 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.69 0.677 . . . . 0.0 111.912 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.494 ' H ' ' HG3' ' A' ' 87' ' ' GLU . 12.9 pt-20 -51.06 -26.49 6.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.289 176.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -85.35 -47.96 9.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 122.466 1.127 . . . . 0.0 109.231 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.682 ' O ' HG23 ' A' ' 93' ' ' ILE . 87.0 mt -63.25 -6.86 4.97 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 112.987 -1.915 . . . . 0.0 111.785 175.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -39.89 -18.71 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -165.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 90' ' ' LEU . 16.0 mt-10 -65.02 -4.28 4.49 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.583 -0.698 . . . . 0.0 110.429 171.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.682 HG23 ' O ' ' A' ' 90' ' ' LEU . 2.3 pt -70.39 -16.56 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 124.313 1.045 . . . . 0.0 110.346 177.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 93' ' ' ILE . . . 77.0 -67.1 0.22 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.7 -1.136 . . . . 0.0 113.578 173.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -63.41 -23.34 67.36 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -168.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.445 ' HB2' HD11 ' A' ' 93' ' ' ILE . 12.6 t70 -49.24 -25.98 2.66 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.083 0.468 . . . . 0.0 111.994 178.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.536 ' N ' ' HD1' ' A' ' 97' ' ' TYR . 0.9 OUTLIER -68.3 -12.06 60.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.652 -175.39 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -109.81 6.96 23.9 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.601 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.9 t 74.97 121.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.864 0.866 . . . . 0.0 111.404 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -96.54 145.1 26.01 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.54 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 101' ' ' ARG . 38.5 mtt180 . . . . . 0 C--O 1.246 0.872 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.702 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.747 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.8 t -84.75 84.49 7.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.224 0.535 . . . . 0.0 109.872 -178.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.9 ptp -173.29 165.74 4.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.776 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.77 ' HB ' ' HD2' ' A' ' 97' ' ' TYR . 5.4 t -81.46 53.15 2.01 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.942 177.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.2 m 44.98 -173.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.348 1.059 . . . . 0.0 112.59 -171.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.457 ' HD3' ' HA ' ' A' ' 6' ' ' ARG . 5.5 mmt-85 -135.1 102.24 5.13 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.936 176.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.569 ' CE1' ' HB3' ' A' ' 95' ' ' GLU . 17.2 p90 -133.05 161.3 34.74 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.684 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.413 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 8.1 tm0? -147.69 120.31 8.57 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 176.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.877 HG12 HG12 ' A' ' 19' ' ' ILE . 15.8 mt -76.83 117.76 22.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.839 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.604 ' HG2' ' O ' ' A' ' 18' ' ' MET . 8.7 pt-20 -116.92 162.49 17.67 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.804 -174.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -86.05 138.06 32.23 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.596 0.712 . . . . 0.0 110.102 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.733 HD21 HG23 ' A' ' 59' ' ' THR . 0.4 OUTLIER -94.59 -50.29 5.26 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.711 -1.132 . . . . 0.0 110.595 -171.535 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.45 142.45 3.59 Favored Glycine 0 N--CA 1.433 -1.501 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 70.4 -73.02 0.1 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.207 0.603 . . . . 0.0 111.148 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.5 p -173.62 53.51 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.597 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.14 156.43 44.33 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.537 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.864 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 1.1 ptp -123.4 155.98 36.33 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.084 -177.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.707 ' HB2' HD22 ' A' ' 12' ' ' LEU . 48.3 ttm -136.24 137.55 40.91 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 172.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.877 HG12 HG12 ' A' ' 9' ' ' ILE . 8.3 mt -117.21 107.29 21.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.674 -177.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.581 HH21 ' CD ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -90.65 136.11 33.27 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.255 -0.578 . . . . 0.0 109.472 176.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.591 ' HB3' HG11 ' A' ' 29' ' ' VAL . 14.8 m-85 -108.15 -147.56 0.41 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 170.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -112.41 -139.95 7.77 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.657 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 173.49 -54.36 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.325 0.65 . . . . 0.0 109.329 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -41.13 -55.26 2.66 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.911 -1.041 . . . . 0.0 112.136 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.8 pt -114.5 22.19 5.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.738 0.304 . . . . 0.0 111.094 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.472 ' O ' HG22 ' A' ' 29' ' ' VAL . 91.2 m-20 -142.12 86.43 1.97 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.317 -0.401 . . . . 0.0 112.07 -174.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -68.38 -19.02 64.6 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.555 0.693 . . . . 0.0 109.291 170.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.2 tm0? -70.4 -42.61 71.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.613 -175.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.591 HG11 ' HB3' ' A' ' 21' ' ' PHE . 31.0 m -67.4 -42.89 87.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.315 -178.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -49.14 -40.67 33.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.539 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.82 -33.31 24.66 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.101 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.529 HG13 HD13 ' A' ' 93' ' ' ILE . 0.5 OUTLIER -88.83 -26.41 5.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.463 0 O-C-N 122.422 -0.458 . . . . 0.0 112.116 -171.84 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.425 HG11 ' O ' ' A' ' 55' ' ' PHE . 7.8 p -63.49 -30.67 50.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.342 0.592 . . . . 0.0 109.627 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -74.98 -43.29 54.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.253 175.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.47 -22.23 57.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.132 -176.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.437 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -65.5 -27.64 68.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.527 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.61 -41.54 98.3 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.592 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.65 -21.2 30.33 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.18 176.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.437 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 10.6 t80 -66.88 -44.85 79.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.211 0.529 . . . . 0.0 110.06 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.518 HD11 HD21 ' A' ' 58' ' ' LEU . 34.0 mt -78.49 -31.49 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.696 -174.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.592 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 11.0 pt-20 -69.79 -21.96 63.37 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.777 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -85.09 -29.94 24.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.666 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -130.23 70.13 82.15 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 120.796 0.332 . . . . 0.0 111.003 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -97.39 -175.46 0.24 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.418 2.746 . . . . 0.0 113.091 -176.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.487 ' CZ ' HG12 ' A' ' 67' ' ' VAL . 9.5 p90 -116.36 148.61 42.05 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -45.25 -26.09 2.28 Favored 'Trans proline' 0 N--CA 1.482 0.836 0 C-N-CA 124.159 3.24 . . . . 0.0 115.579 -169.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.553 ' HA3' ' CB ' ' A' ' 66' ' ' GLU . . . -103.21 14.41 55.13 Favored Glycine 0 C--O 1.228 -0.268 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.743 -176.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.431 ' HZ ' ' SG ' ' A' ' 51' ' ' CYS . 31.3 t80 -68.1 139.98 56.21 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.492 0.663 . . . . 0.0 111.024 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.008 HG22 ' HG2' ' A' ' 50' ' ' GLU . 38.7 mm -112.4 -63.84 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.477 -174.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 1.008 ' HG2' HG22 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -152.39 169.41 22.61 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.14 0.495 . . . . 0.0 111.356 -177.445 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.431 ' SG ' ' HZ ' ' A' ' 48' ' ' PHE . 11.2 p -158.8 123.95 4.26 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 169.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.808 HG13 ' HB ' ' A' ' 59' ' ' THR . 7.9 pt -123.02 136.38 26.85 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-O 120.952 0.406 . . . . 0.0 111.724 -177.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 61.2 Cg_endo -85.88 129.12 3.41 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.163 2.575 . . . . 0.0 112.364 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -115.09 43.92 1.9 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.887 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.425 ' O ' HG11 ' A' ' 33' ' ' VAL . 62.2 t80 72.77 -40.55 0.48 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.734 0.813 . . . . 0.0 112.742 175.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.0 t -139.22 -17.71 1.02 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.177 0.513 . . . . 0.0 110.985 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 m -113.44 134.87 54.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.177 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.518 HD21 HD11 ' A' ' 40' ' ' ILE . 52.3 tp -103.06 112.25 25.0 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 177.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.808 ' HB ' HG13 ' A' ' 52' ' ' ILE . 10.7 m -92.49 106.77 18.69 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -177.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.864 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 41.1 t -107.52 120.92 59.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.46 0.648 . . . . 0.0 111.559 -173.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.605 ' HB2' ' HG3' ' A' ' 50' ' ' GLU . 85.7 m-85 -106.39 147.34 29.38 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.185 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.63 ' OH ' ' HB3' ' A' ' 17' ' ' MET . 3.0 p90 -166.7 170.49 12.45 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.673 -176.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.512 ' O ' HG13 ' A' ' 67' ' ' VAL . 6.1 t70 -104.71 123.3 47.37 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.466 0.65 . . . . 0.0 110.773 -176.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.513 ' O ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -61.3 -23.88 66.02 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.766 -175.71 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.49 ' HD1' ' OD1' ' A' ' 63' ' ' ASP . 0.8 OUTLIER -68.28 -28.82 67.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.383 0.611 . . . . 0.0 110.187 -176.293 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.553 ' CB ' ' HA3' ' A' ' 47' ' ' GLY . 1.0 OUTLIER -91.47 -29.76 16.83 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.65 0.738 . . . . 0.0 109.522 -175.396 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 64' ' ' MET . 2.0 m -71.24 -35.89 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 176.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.98 ' HA ' HD23 ' A' ' 71' ' ' LEU . 76.7 t80 -69.33 -22.61 63.75 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.501 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -61.27 -38.51 87.01 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 173.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -83.33 -70.25 0.57 Allowed 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 113.867 -1.515 . . . . 0.0 109.523 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.98 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.8 OUTLIER 23.43 68.08 0.36 Allowed Pre-proline 0 N--CA 1.478 0.928 0 O-C-N 124.854 1.346 . . . . 0.0 112.977 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.593 ' HD2' HG13 ' A' ' 75' ' ' ILE . 28.6 Cg_exo -62.42 153.13 72.88 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.657 2.238 . . . . 0.0 112.613 -176.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -68.21 109.26 3.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.368 0.604 . . . . 0.0 110.223 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 131.92 -31.11 3.11 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -174.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.593 HG13 ' HD2' ' A' ' 72' ' ' PRO . 17.4 mm -80.63 117.82 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 114.076 -1.062 . . . . 0.0 108.972 171.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.3 m -97.08 -1.8 44.56 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.536 -174.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.6 t -144.53 136.52 13.06 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.525 -170.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.593 ' HA ' HD21 ' A' ' 71' ' ' LEU . 98.5 Cg_exo -47.26 -57.08 2.52 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.457 2.771 . . . . 0.0 113.343 173.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.551 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -59.01 -30.73 68.21 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.171 0.51 . . . . 0.0 110.907 -179.049 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 46.2 tt0 -74.83 -26.23 59.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.191 -176.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.562 ' HB3' HG21 ' A' ' 75' ' ' ILE . 96.9 p -73.26 -36.87 66.44 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.6 t -67.87 -24.87 31.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.525 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.5 ' HG2' HG21 ' A' ' 9' ' ' ILE . 47.0 mtpt -55.1 -35.36 64.53 Favored 'General case' 0 C--O 1.214 -0.816 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.18 176.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -71.09 -37.18 72.41 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.067 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -69.51 -35.18 75.27 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.999 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.508 ' O ' HD23 ' A' ' 90' ' ' LEU . 31.6 m -86.02 -45.07 16.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.92 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -51.7 -44.22 63.08 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -58.63 -29.7 66.71 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.538 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.93 -43.41 13.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.127 0.489 . . . . 0.0 110.253 177.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 86' ' ' VAL . 4.4 mm? -60.56 -40.58 92.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.883 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.545 ' O ' ' HB2' ' A' ' 96' ' ' ASP . . . -52.06 -33.99 41.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.701 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -66.14 -6.44 13.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.394 -177.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.529 HD13 HG13 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -108.98 -38.87 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.127 -175.715 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -167.2 -51.86 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.041 0.448 . . . . 0.0 111.667 177.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.569 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 1.0 OUTLIER -57.31 -11.34 1.73 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.686 -170.314 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.545 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 32.7 t70 -43.72 -25.94 0.21 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 171.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.77 ' HD2' ' HB ' ' A' ' 4' ' ' THR . 6.3 m-85 -77.4 -16.37 58.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.837 -174.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.76 ' HG3' HG21 ' A' ' 4' ' ' THR . 61.4 mt-10 -130.42 -53.94 1.09 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.754 0.311 . . . . 0.0 111.401 177.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.7 t 69.95 114.84 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.606 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.65 98.12 0.67 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.409 0.623 . . . . 0.0 110.508 177.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 . . . . . 0 C--O 1.247 0.964 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.746 179.848 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.673 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.2 m -101.11 96.16 7.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.891 0.377 . . . . 0.0 110.098 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -75.86 155.74 35.01 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.211 0.529 . . . . 0.0 110.79 -178.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.56 ' O ' HG22 ' A' ' 5' ' ' VAL . 6.8 t -84.46 29.28 0.6 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.766 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 4' ' ' THR . 1.7 m 56.94 160.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.04 1.336 . . . . 0.0 112.285 -174.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.428 ' HA ' ' HD3' ' A' ' 6' ' ' ARG . 8.4 mmt180 -120.41 86.22 2.53 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.072 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.527 ' CE1' ' HB2' ' A' ' 95' ' ' GLU . 13.2 p90 -103.56 152.47 21.68 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.204 -177.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.522 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 18.7 mp0 -132.6 131.57 41.58 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.899 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.973 HG12 HG12 ' A' ' 19' ' ' ILE . 49.1 mt -97.7 122.94 49.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.292 173.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -119.01 164.3 15.69 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.102 0.477 . . . . 0.0 110.115 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -84.79 128.22 34.5 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.393 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.614 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.2 OUTLIER -75.89 -39.64 56.02 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.773 -173.074 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -163.76 -77.98 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -138.03 -28.82 0.86 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 177.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.7 p -148.35 36.35 0.82 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.466 0.65 . . . . 0.0 111.557 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.495 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -143.98 156.69 44.5 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.307 176.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.721 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -125.08 147.19 49.11 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.411 -175.618 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.614 ' HB2' HD22 ' A' ' 12' ' ' LEU . 19.0 ttt -136.21 123.45 21.81 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.932 176.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.973 HG12 HG12 ' A' ' 9' ' ' ILE . 9.8 mt -110.66 146.35 15.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 123.014 0.526 . . . . 0.0 110.262 -175.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.522 ' HD2' ' O ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -139.56 134.49 32.24 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.45 173.131 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.608 ' HB2' HG11 ' A' ' 29' ' ' VAL . 4.7 m-85 -106.77 -156.18 0.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.17 160.04 11.43 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.967 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.422 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 9.2 tp10 -172.01 -83.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 122.681 0.392 . . . . 0.0 110.452 176.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -131.57 -73.92 0.53 Allowed 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.268 0.556 . . . . 0.0 110.688 -173.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.2 pt -117.28 46.6 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.973 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.422 ' OD1' ' HB3' ' A' ' 23' ' ' GLU . 2.0 m-20 -79.78 68.59 5.9 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.98 -171.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.504 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 11.8 tp10 -63.69 -34.61 78.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.305 173.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.401 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -56.66 -45.18 81.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.968 178.139 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.608 HG11 ' HB2' ' A' ' 21' ' ' PHE . 53.4 t -65.64 -57.95 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.763 -176.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.504 ' ND2' ' HA ' ' A' ' 27' ' ' GLU . 2.7 p30 -57.51 -23.05 47.95 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.592 0.234 . . . . 0.0 111.465 -175.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.99 -39.89 5.66 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.046 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.401 ' HB ' ' O ' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -80.39 -26.99 11.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.768 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -175.812 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 29' ' ' VAL . 10.7 p -68.08 -29.24 43.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -73.29 -34.36 65.71 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.495 177.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.11 -22.09 27.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.598 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.85 -22.99 65.99 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.125 -174.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.427 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . . . -62.52 -44.84 95.37 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.865 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -81.05 -27.85 35.59 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.979 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -59.53 -44.68 93.12 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.498 HD11 HD21 ' A' ' 58' ' ' LEU . 47.3 mt -76.58 -44.26 34.41 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.349 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.865 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 9.5 pt-20 -65.54 -27.37 68.4 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.125 0.416 . . . . 0.0 112.125 -171.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.477 ' C ' ' HD3' ' A' ' 44' ' ' PRO . 45.9 mt-10 -92.63 -18.77 22.63 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 121.156 -0.218 . . . . 0.0 111.441 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.445 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 67.3 mt-30 -131.09 58.55 39.73 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-O 120.744 0.306 . . . . 0.0 110.25 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.477 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 43.0 Cg_endo -104.64 -167.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.988 3.126 . . . . 0.0 113.75 -171.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.678 ' HZ ' ' HB2' ' A' ' 62' ' ' TYR . 12.8 p90 -111.71 147.22 36.33 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 168.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.89 -16.4 0.82 Allowed 'Trans proline' 0 N--CA 1.481 0.747 0 C-N-CA 124.219 3.279 . . . . 0.0 115.1 -172.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.57 7.53 61.49 Favored Glycine 0 C--O 1.226 -0.357 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.769 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -61.44 136.36 58.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.32 0.581 . . . . 0.0 111.803 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 62' ' ' TYR . 39.2 mm -109.19 -62.4 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.399 -177.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -163.43 157.12 19.49 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.432 -173.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.427 ' SG ' ' HA ' ' A' ' 37' ' ' ALA . 6.0 p -151.75 118.84 5.87 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 174.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.704 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.2 pt -116.13 134.25 22.81 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.826 -175.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 62.8 Cg_endo -84.37 141.43 9.01 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.095 2.53 . . . . 0.0 112.305 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -130.87 54.11 1.93 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.734 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.2 t80 76.66 -59.4 0.5 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.492 171.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.2 p -130.64 -2.05 4.27 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.26 0.552 . . . . 0.0 110.943 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 34.0 t -122.24 155.36 36.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.791 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.498 HD21 HD11 ' A' ' 40' ' ' ILE . 47.6 tp -127.33 116.56 20.71 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.598 -177.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.704 ' HB ' HG13 ' A' ' 52' ' ' ILE . 1.1 m -96.22 107.39 19.72 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.721 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 44.1 t -107.44 120.58 59.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.747 0.784 . . . . 0.0 111.867 -171.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -111.44 147.07 36.05 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.675 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.678 ' HB2' ' HZ ' ' A' ' 45' ' ' PHE . 3.3 p90 -165.65 172.0 12.4 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -174.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -103.53 117.34 34.2 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.431 0.634 . . . . 0.0 109.979 -177.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.523 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -64.77 -19.55 65.87 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.176 -176.687 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.06 -29.98 70.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.712 0.292 . . . . 0.0 111.107 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 0.6 OUTLIER -89.16 -26.88 21.05 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 122.067 0.937 . . . . 0.0 108.829 -172.113 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.641 HG11 HG22 ' A' ' 82' ' ' VAL . 3.7 m -82.62 -40.21 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.488 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.558 ' HA ' HD23 ' A' ' 71' ' ' LEU . 2.8 m-85 -58.66 -29.0 66.24 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 171.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.502 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 4.3 tppp? -53.49 -41.87 66.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.68 175.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -94.97 -71.84 0.65 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.693 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER 38.17 68.96 1.61 Allowed Pre-proline 0 N--CA 1.468 0.459 0 O-C-N 124.146 0.904 . . . . 0.0 111.802 179.024 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -63.6 140.64 76.17 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.878 2.385 . . . . 0.0 111.775 -176.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -61.39 109.42 1.15 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.56 0.695 . . . . 0.0 110.925 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 135.49 -32.43 2.55 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 107.939 -2.064 . . . . 0.0 107.939 -169.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.9 mm -95.62 113.6 30.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 113.387 -1.406 . . . . 0.0 107.713 168.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.3 t -105.62 -4.26 21.31 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.467 0.651 . . . . 0.0 109.85 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.484 ' OG ' ' HD1' ' A' ' 79' ' ' PHE . 21.2 t -126.69 125.66 24.4 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.007 -176.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.539 ' O ' HG23 ' A' ' 82' ' ' VAL . 94.8 Cg_exo -50.57 -42.8 48.26 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.644 2.896 . . . . 0.0 112.936 176.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.484 ' HD1' ' OG ' ' A' ' 77' ' ' SER . 0.1 OUTLIER -57.13 -37.07 71.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.672 177.934 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.446 ' HA ' ' CG ' ' A' ' 83' ' ' LYS . 28.5 tt0 -80.29 -19.8 45.83 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.683 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.422 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 24.0 t -67.97 -31.12 70.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.641 HG22 HG11 ' A' ' 67' ' ' VAL . 12.4 t -83.41 -24.81 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.528 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.447 ' HE2' ' HB3' ' A' ' 83' ' ' LYS . 40.7 mtpt -52.66 -40.89 63.3 Favored 'General case' 0 C--O 1.213 -0.844 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 175.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.44 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 24.3 mmt180 -58.83 -41.59 87.24 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.971 177.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -66.39 -37.15 84.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.397 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.477 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 31.7 m -87.25 -48.09 15.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.688 -178.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -52.12 -43.16 63.83 Favored 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 122.877 0.471 . . . . 0.0 112.012 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 84' ' ' ARG . 12.5 pt-20 -65.4 -28.23 69.11 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.421 -177.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -85.4 -42.35 14.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.548 0.69 . . . . 0.0 110.125 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.507 ' HB3' ' OE1' ' A' ' 95' ' ' GLU . 92.4 mt -68.54 -38.36 80.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.178 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.566 ' O ' ' HB2' ' A' ' 96' ' ' ASP . . . -44.31 -37.64 3.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.81 174.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -65.2 -11.06 36.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.058 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.1 pp -95.96 -35.21 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.165 -175.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 179.63 -47.13 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.255 0.55 . . . . 0.0 111.153 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.527 ' HB2' ' CE1' ' A' ' 7' ' ' TYR . 8.8 pt-20 -67.05 -4.74 10.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.821 -168.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.566 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 14.3 t70 -38.86 -35.05 0.18 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.059 0.457 . . . . 0.0 111.569 170.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -77.51 -21.3 52.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.181 -175.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.455 ' HG2' HG21 ' A' ' 4' ' ' THR . 62.0 mm-40 -109.81 -83.04 0.57 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.105 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 98' ' ' GLU . 79.5 t 71.04 115.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.393 -172.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -41.48 -55.31 2.88 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.385 -171.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? . . . . . 0 C--O 1.244 0.78 0 CA-C-O 118.394 -0.812 . . . . 0.0 110.396 179.459 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.536 0 N-CA-C 111.952 -0.459 . . . . 0.0 111.952 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m 63.32 -177.11 0.15 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.463 0.649 . . . . 0.0 111.586 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.51 177.52 9.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.4 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.582 ' O ' HG12 ' A' ' 5' ' ' VAL . 13.5 t -113.97 35.89 3.92 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.824 0.821 . . . . 0.0 108.894 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.582 HG12 ' O ' ' A' ' 4' ' ' THR . 0.3 OUTLIER 66.34 173.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.647 -177.394 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 6' ' ' ARG . 18.8 mmm180 -138.35 123.19 18.84 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 175.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.63 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 50.2 p90 -152.67 162.3 41.43 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.707 0.765 . . . . 0.0 112.419 -175.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.758 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . 27.4 mp0 -126.79 138.47 53.36 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.247 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.829 HG12 HG12 ' A' ' 19' ' ' ILE . 29.4 mt -106.94 128.2 61.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.476 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 18' ' ' MET . 12.0 pt-20 -120.2 163.31 17.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.263 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -92.86 124.4 36.82 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.281 0.562 . . . . 0.0 110.153 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.627 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -69.87 -43.14 72.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.148 -174.033 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 173.19 -89.16 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.758 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -92.62 -60.35 1.84 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.917 0.389 . . . . 0.0 111.661 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.8 p -149.73 45.77 0.94 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.569 0.7 . . . . 0.0 110.978 -175.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.82 156.94 47.4 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.149 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.401 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 28.7 ttp -126.84 134.43 50.53 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.627 ' HB2' HD22 ' A' ' 12' ' ' LEU . 50.5 ttm -118.18 132.72 56.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.049 0.452 . . . . 0.0 110.19 177.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.829 HG12 HG12 ' A' ' 9' ' ' ILE . 6.1 mt -127.24 127.66 69.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.98 -177.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.758 ' HD3' ' HB2' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -111.83 131.27 55.45 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.63 ' HA ' ' CB ' ' A' ' 7' ' ' TYR . 6.6 m-85 -98.35 -149.04 0.34 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -97.16 -152.41 28.65 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.937 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -175.79 -60.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.821 0.343 . . . . 0.0 110.807 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -43.45 -52.61 5.95 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.62 -172.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.2 pt -118.99 24.99 4.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.389 0.614 . . . . 0.0 110.146 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.471 ' HB3' HG12 ' A' ' 29' ' ' VAL . 19.6 m120 -120.98 97.77 5.68 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.126 -170.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.437 ' CD ' ' H ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -78.03 -29.95 49.67 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 169.775 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.514 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 4.0 mm100 -60.94 -40.41 93.16 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.436 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.608 ' CG2' ' HB2' ' A' ' 21' ' ' PHE . 6.6 p -62.23 -53.43 47.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.531 -177.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.443 ' N ' HG13 ' A' ' 29' ' ' VAL . 32.5 m-80 -53.51 -44.06 68.78 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.666 0.604 . . . . 0.0 111.354 -177.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.44 -38.64 17.02 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.55 -0.834 . . . . 0.0 112.88 -178.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 28' ' ' GLN . 0.3 OUTLIER -83.58 -28.51 7.58 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -172.696 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 29' ' ' VAL . 14.9 p -68.6 -30.35 47.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 175.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -70.59 -40.21 73.37 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.689 -1.142 . . . . 0.0 109.931 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.53 -22.02 28.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.995 -177.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.404 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . . . -63.92 -28.91 70.15 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.568 0.223 . . . . 0.0 111.498 -174.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.39 -39.13 92.23 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.081 0.943 . . . . 0.0 108.706 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.489 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.85 -23.12 29.15 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.249 178.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.404 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . 1.1 t80 -69.5 -41.71 75.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.15 0.5 . . . . 0.0 109.829 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.569 HD11 HD21 ' A' ' 58' ' ' LEU . 54.8 mt -73.71 -34.63 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.188 -177.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.489 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 9.1 pt-20 -69.63 -23.65 63.53 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.423 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 44.4 mm-40 -73.59 -36.37 65.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.643 175.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -129.61 70.71 82.04 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.324 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -94.47 176.49 1.1 Allowed 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.766 2.311 . . . . 0.0 113.443 -174.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -115.95 147.85 40.08 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.73 175.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -37.23 -37.81 0.42 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.246 3.297 . . . . 0.0 115.13 -174.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.459 ' HA3' ' HB2' ' A' ' 66' ' ' GLU . . . -103.24 17.62 51.01 Favored Glycine 0 C--O 1.224 -0.486 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.025 -176.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -59.77 129.39 41.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.986 0.422 . . . . 0.0 110.62 176.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.59 HG12 ' HA ' ' A' ' 62' ' ' TYR . 39.5 mm -106.07 -57.8 4.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.526 -174.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 13.5 tp10 -164.18 157.52 18.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.681 0.277 . . . . 0.0 110.544 -172.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.4 p -150.79 118.4 6.12 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 172.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.748 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.9 pt -119.94 135.21 24.14 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -176.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 2.5 Cg_endo -80.95 120.67 3.84 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.13 2.553 . . . . 0.0 112.234 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -109.51 52.74 0.71 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.601 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.505 ' O ' HG11 ' A' ' 33' ' ' VAL . 39.5 t80 72.64 -57.79 0.62 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.263 173.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.0 t -132.5 -2.4 3.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.695 0.759 . . . . 0.0 110.14 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.6 m -122.44 140.57 52.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.211 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.569 HD21 HD11 ' A' ' 40' ' ' ILE . 50.5 tp -106.18 115.98 31.14 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.748 ' HB ' HG13 ' A' ' 52' ' ' ILE . 4.7 m -93.28 106.27 18.25 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.784 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.0 t -104.75 123.98 59.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.386 0.612 . . . . 0.0 111.292 -173.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.427 ' CE1' HG22 ' A' ' 59' ' ' THR . 87.8 m-85 -114.96 145.96 41.69 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.57 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.59 ' HA ' HG12 ' A' ' 49' ' ' ILE . 2.4 p90 -166.54 171.29 11.92 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.125 0.488 . . . . 0.0 110.9 -175.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -99.49 111.34 23.7 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.398 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.547 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -61.91 -21.74 65.0 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.234 -176.546 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.52 ' CE1' ' HG2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -71.39 -23.08 61.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.757 0.313 . . . . 0.0 110.981 -176.9 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.52 ' HG2' ' CE1' ' A' ' 65' ' ' TYR . 22.5 mm-40 -91.51 -34.41 14.79 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.196 0.522 . . . . 0.0 110.458 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.547 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.4 m -70.54 -29.86 40.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.102 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.76 ' HA ' HD23 ' A' ' 71' ' ' LEU . 2.5 m-85 -55.48 -24.96 34.22 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.704 172.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -66.69 -24.32 66.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.596 0.712 . . . . 0.0 109.824 176.749 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -102.15 -32.49 10.07 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.249 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.824 HD21 ' HA ' ' A' ' 78' ' ' PRO . 1.6 mm? -26.36 95.01 0.06 OUTLIER Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 125.514 1.526 . . . . 0.0 113.735 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.547 ' HD2' HG13 ' A' ' 75' ' ' ILE . 20.5 Cg_exo -70.4 161.04 47.45 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 123.594 2.863 . . . . 0.0 111.93 174.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -62.36 -40.34 96.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -173.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.41 -21.37 78.94 Favored Glycine 0 CA--C 1.511 -0.202 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.45 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.548 HG21 ' HB2' ' A' ' 81' ' ' SER . 10.7 mm -81.97 100.26 5.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.057 -0.571 . . . . 0.0 109.919 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.4 m -82.52 -9.87 59.24 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.216 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.2 m -131.15 130.82 22.8 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.738 -175.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.824 ' HA ' HD21 ' A' ' 71' ' ' LEU . 83.4 Cg_exo -46.54 -48.91 12.79 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.408 2.739 . . . . 0.0 113.483 176.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.457 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 1.4 p90 -59.9 -27.4 66.7 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.485 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.667 ' HG3' ' HD2' ' A' ' 83' ' ' LYS . 8.8 tt0 -81.93 -17.83 45.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.887 0.375 . . . . 0.0 110.869 -174.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.548 ' HB2' HG21 ' A' ' 75' ' ' ILE . 48.0 t -79.26 -35.6 41.17 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.459 HG11 ' CE2' ' A' ' 62' ' ' TYR . 49.0 t -67.06 -25.32 33.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.28 178.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.667 ' HD2' ' HG3' ' A' ' 80' ' ' GLU . 94.5 mttt -51.59 -41.92 61.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.967 177.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.604 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 0.7 OUTLIER -60.9 -50.56 72.91 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.851 -177.583 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -64.88 -37.04 86.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.796 -177.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.62 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 31.2 m -83.36 -48.22 17.6 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 CA-C-O 118.947 -0.549 . . . . 0.0 112.023 -175.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.521 ' HG2' ' OH ' ' A' ' 7' ' ' TYR . 92.5 mt-10 -49.27 -53.64 20.76 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 118.25 0.477 . . . . 0.0 111.902 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.758 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 11.1 pt-20 -60.35 -27.22 67.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.394 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.59 -24.36 22.86 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 175.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 86' ' ' VAL . 13.0 mt -60.95 -72.88 0.1 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -163.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -90.35 -78.11 0.38 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 118.363 -1.335 . . . . 0.0 112.213 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.42 ' O ' HG23 ' A' ' 93' ' ' ILE . 10.7 mp0 -103.38 -57.81 1.98 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.811 1.291 . . . . 0.0 109.086 164.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.758 ' HA ' ' O ' ' A' ' 88' ' ' GLU . 12.9 pt -174.33 55.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 111.309 -2.678 . . . . 0.0 104.863 -168.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.93 15.18 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.627 -171.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.428 ' H ' ' C ' ' A' ' 93' ' ' ILE . 1.2 pt-20 -59.9 -14.57 16.14 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.269 0.557 . . . . 0.0 109.743 165.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -52.34 -22.7 4.84 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.601 177.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.498 ' HE1' HG23 ' A' ' 4' ' ' THR . 2.0 m-30 -71.83 -5.91 37.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.832 -176.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.426 ' O ' ' HB ' ' A' ' 99' ' ' VAL . 57.4 mm-40 61.12 45.85 8.69 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 123.67 0.606 . . . . 0.0 109.906 -177.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.426 ' HB ' ' O ' ' A' ' 98' ' ' GLU . 95.6 t 72.18 97.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.117 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.775 -175.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -69.52 114.7 7.99 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 35.3 ttp180 . . . . . 0 C--N 1.31 -1.137 0 CA-C-O 118.593 -0.717 . . . . 0.0 109.935 -173.162 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.2 m -82.45 79.06 9.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.236 0.541 . . . . 0.0 110.444 177.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.652 ' O ' HG22 ' A' ' 4' ' ' THR . 20.4 ptm -77.43 21.19 0.27 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.979 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.652 HG22 ' O ' ' A' ' 3' ' ' MET . 0.6 OUTLIER 71.16 -3.27 2.1 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.875 0.87 . . . . 0.0 110.963 177.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 67.18 149.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.853 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.492 ' HA ' ' CE1' ' A' ' 97' ' ' TYR . 29.0 mmt180 -122.23 79.09 1.56 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.387 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.507 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 15.0 p90 -104.67 146.3 29.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.45 -172.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.431 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 5.6 tp60 -125.49 139.61 53.48 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.559 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 1.057 HG12 HG12 ' A' ' 19' ' ' ILE . 25.6 mt -104.36 122.35 57.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.067 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -116.22 159.99 21.05 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.862 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -86.24 124.4 32.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.53 0.681 . . . . 0.0 110.182 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.703 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -63.45 -48.22 78.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.658 -177.721 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -165.96 -73.17 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.652 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -128.7 -49.31 1.25 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.582 0.23 . . . . 0.0 111.522 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.08 41.35 1.66 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.639 0.733 . . . . 0.0 110.945 -172.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -143.88 152.22 40.86 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.759 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 29.0 ttp -121.28 135.42 55.12 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -174.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.703 ' HB2' HD22 ' A' ' 12' ' ' LEU . 46.8 ttm -122.22 132.4 54.42 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.145 177.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.057 HG12 HG12 ' A' ' 9' ' ' ILE . 5.7 mt -129.69 143.27 41.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.486 -175.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -125.48 126.66 45.26 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 174.11 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.837 ' HB2' HG23 ' A' ' 29' ' ' VAL . 4.9 m-85 -102.98 -158.59 0.68 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.121 0.486 . . . . 0.0 109.709 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.09 179.36 4.81 Favored Glycine 0 N--CA 1.453 -0.188 0 CA-C-N 114.841 -1.072 . . . . 0.0 113.547 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -165.28 -76.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.949 0.404 . . . . 0.0 111.281 173.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -89.7 -78.35 0.36 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.292 0.567 . . . . 0.0 111.598 -172.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.3 pt -147.01 27.26 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.63 -174.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.505 ' O ' HG12 ' A' ' 29' ' ' VAL . 19.9 p-10 -87.24 118.74 26.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.209 0.528 . . . . 0.0 111.851 -172.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -63.24 -19.1 64.25 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.38 176.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.423 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 46.6 tt0 -46.98 -49.85 20.08 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.642 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.837 HG23 ' HB2' ' A' ' 21' ' ' PHE . 2.8 p -64.22 -47.98 87.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.779 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -54.92 -42.66 72.51 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.317 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.11 -39.5 10.01 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.182 -1.009 . . . . 0.0 112.537 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.423 ' HB ' ' O ' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -82.5 -21.35 9.56 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -171.459 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.454 HG11 ' O ' ' A' ' 55' ' ' PHE . 12.1 p -72.08 -30.3 35.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -75.46 -38.55 59.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.214 175.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.02 -20.75 51.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.977 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.542 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . . . -68.96 -28.25 66.46 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 120.873 0.368 . . . . 0.0 110.888 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.87 -42.63 99.83 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.793 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -79.13 -30.91 43.94 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.078 176.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.542 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -54.84 -44.93 74.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.433 0.635 . . . . 0.0 110.133 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 45.9 mt -79.62 -30.83 13.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.646 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.793 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 9.2 pt-20 -76.36 -25.06 54.26 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.64 -177.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -82.4 -27.99 31.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.01 0.433 . . . . 0.0 110.396 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.435 ' HB3' ' NH1' ' A' ' 89' ' ' ARG . 43.8 mt-30 -131.7 70.41 81.21 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.244 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -99.32 -178.06 0.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.395 2.73 . . . . 0.0 113.854 -173.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.437 ' CE2' HG13 ' A' ' 82' ' ' VAL . 6.0 p90 -115.93 147.41 39.1 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.92 171.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.449 ' HB2' ' CD ' ' A' ' 66' ' ' GLU . 59.0 Cg_exo -38.55 -39.35 1.12 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.987 3.125 . . . . 0.0 115.147 -174.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 66' ' ' GLU . . . -96.66 13.76 64.96 Favored Glycine 0 C--O 1.228 -0.245 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.098 -174.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -59.07 132.75 54.97 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.052 0.453 . . . . 0.0 110.777 175.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.47 HG12 ' HA ' ' A' ' 62' ' ' TYR . 35.9 mm -106.0 -59.37 3.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.261 -175.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -163.55 158.99 21.4 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 120.66 0.267 . . . . 0.0 110.571 -173.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.3 p -150.02 118.01 6.3 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 176.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.754 HG13 ' HB ' ' A' ' 59' ' ' THR . 5.9 pt -120.97 131.58 24.44 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-O 121.106 0.479 . . . . 0.0 112.186 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 72.2 Cg_endo -86.51 141.94 6.86 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.413 2.742 . . . . 0.0 112.499 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.89 59.58 1.61 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.629 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.454 ' O ' HG11 ' A' ' 33' ' ' VAL . 52.0 t80 69.31 -54.34 0.58 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.115 0.966 . . . . 0.0 112.581 175.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.2 t -130.98 -15.74 3.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.767 0.318 . . . . 0.0 111.164 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.0 p -115.18 149.75 37.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.956 0.407 . . . . 0.0 110.936 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 38.6 tp -118.24 125.83 50.94 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.754 ' HB ' HG13 ' A' ' 52' ' ' ILE . 3.1 m -105.59 107.65 18.76 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.038 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.2 t -105.45 123.05 59.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.416 0.627 . . . . 0.0 111.473 -173.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -113.08 147.83 36.48 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.803 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.568 ' OH ' ' HB2' ' A' ' 79' ' ' PHE . 2.6 p90 -165.89 171.71 12.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.757 -175.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -107.74 108.6 19.89 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 121.492 0.663 . . . . 0.0 109.851 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.551 ' O ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -55.63 -31.21 62.11 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.8 -176.681 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.8 -23.5 65.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.149 0.5 . . . . 0.0 110.742 -177.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' A' ' 69' ' ' LYS . 4.0 tm-20 -92.09 -41.67 10.37 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -177.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 64' ' ' MET . 2.5 m -61.94 -28.48 44.4 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.698 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.72 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.82 ' HA ' HD12 ' A' ' 71' ' ' LEU . 4.3 m-85 -50.56 -32.51 18.77 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.407 0.683 . . . . 0.0 111.648 169.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -66.95 -30.96 71.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.203 0.525 . . . . 0.0 110.509 178.432 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -93.46 -37.71 11.8 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.144 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.82 HD12 ' HA ' ' A' ' 68' ' ' TYR . 13.4 mt -32.75 99.5 0.15 Allowed Pre-proline 0 N--CA 1.465 0.315 0 C-N-CA 125.509 1.524 . . . . 0.0 113.463 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.44 ' HD2' HG13 ' A' ' 75' ' ' ILE . 13.9 Cg_exo -74.54 154.91 45.19 Favored 'Trans proline' 0 C--N 1.332 -0.302 0 C-N-CA 124.128 3.219 . . . . 0.0 110.586 174.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -64.34 -21.25 66.55 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -171.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.3 -18.04 76.93 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.113 176.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.539 HG23 ' HB3' ' A' ' 80' ' ' GLU . 2.8 mm -101.86 105.79 18.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.97 -0.615 . . . . 0.0 110.179 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.8 t -93.0 -3.34 54.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.006 0.432 . . . . 0.0 110.506 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' ' 80' ' ' GLU . 17.1 m -121.45 116.19 30.86 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.984 -178.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.665 ' HG3' ' CE1' ' A' ' 68' ' ' TYR . 14.4 Cg_exo -35.75 -56.6 0.58 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 124.357 3.371 . . . . 0.0 114.071 171.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.568 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -57.77 -32.74 67.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.227 -179.358 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.539 ' HB3' HG23 ' A' ' 75' ' ' ILE . 2.2 tp10 -70.19 -29.43 66.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.722 -174.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.64 ' HB2' HD23 ' A' ' 71' ' ' LEU . 46.5 t -79.37 -35.58 40.6 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.478 HG11 ' CE2' ' A' ' 62' ' ' TYR . 92.1 t -60.15 -39.95 82.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.936 177.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.759 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 17.6 mtmt -54.95 -48.31 73.34 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 21.7 mmm180 -63.01 -32.68 74.09 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.228 -174.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 13.8 t70 -69.52 -40.57 76.85 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.433 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.408 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 34.1 m -86.34 -35.59 9.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.546 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -62.27 -37.2 84.56 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 122.801 0.44 . . . . 0.0 111.891 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.802 ' HG3' ' HD3' ' A' ' 89' ' ' ARG . 13.0 pt-20 -58.03 -29.1 65.08 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.227 -0.589 . . . . 0.0 109.903 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.802 ' HD3' ' HG3' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -87.5 -42.58 12.67 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.609 172.802 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 86' ' ' VAL . 82.9 mt -84.05 -64.46 1.16 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 122.976 0.51 . . . . 0.0 112.236 -174.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.611 ' HA ' ' HB3' ' A' ' 94' ' ' ALA . . . -60.12 -17.03 37.33 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.614 0.765 . . . . 0.0 112.132 -178.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -59.77 -29.54 68.26 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.045 0.45 . . . . 0.0 109.949 172.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.408 HG13 ' N ' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -103.93 -33.97 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.472 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.611 ' HB3' ' HA ' ' A' ' 91' ' ' ALA . . . -82.39 63.9 6.78 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 165.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.41 ' HG2' ' OG1' ' A' ' 4' ' ' THR . 9.4 pt-20 -42.22 -32.68 0.51 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 112.991 -1.913 . . . . 0.0 112.424 -170.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -77.29 -27.73 53.12 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.969 -172.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.492 ' CE1' ' HA ' ' A' ' 6' ' ' ARG . 71.5 m-85 -99.51 13.73 32.37 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -167.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -59.29 -20.51 54.95 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.912 0.863 . . . . 0.0 109.567 172.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 p -114.01 79.96 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.182 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.33 -26.58 61.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.667 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.221 -0.895 . . . . 0.0 109.697 175.932 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.698 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.2 m 69.04 167.38 0.28 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.121 0.486 . . . . 0.0 110.804 -177.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.654 ' HG2' ' HB3' ' A' ' 26' ' ' ASN . 23.8 ptm -153.13 160.02 42.82 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.091 0.472 . . . . 0.0 110.317 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.667 ' O ' HG22 ' A' ' 5' ' ' VAL . 4.7 t -93.37 31.53 1.49 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.657 -178.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.693 HG12 ' ND2' ' A' ' 26' ' ' ASN . 3.2 m 64.68 160.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.837 1.655 . . . . 0.0 113.828 -178.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -142.65 105.14 4.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.418 -1.719 . . . . 0.0 107.35 172.219 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -115.17 171.53 7.62 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.353 -166.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.563 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -140.04 121.75 15.35 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -178.255 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.946 HG12 HG12 ' A' ' 19' ' ' ILE . 29.3 mt -87.6 112.0 22.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.805 0.812 . . . . 0.0 110.911 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 18' ' ' MET . 4.0 pt-20 -106.87 161.48 14.66 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.489 -173.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.432 ' HA ' ' NE2' ' A' ' 11' ' ' GLN . 6.0 tp-100 -90.91 124.75 35.44 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.667 0.746 . . . . 0.0 110.686 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.561 HD21 HG22 ' A' ' 59' ' ' THR . 0.2 OUTLIER -70.69 -46.84 62.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.993 -176.527 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -157.92 -79.72 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -137.36 -36.1 0.66 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.865 0.364 . . . . 0.0 110.807 176.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.5 p -141.97 39.18 1.63 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.823 0.82 . . . . 0.0 110.201 -174.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -143.63 151.94 40.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.277 176.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.473 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 35.4 ttp -123.16 137.89 54.79 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.063 -0.655 . . . . 0.0 112.314 -173.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.596 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 24.7 ttt -126.51 138.16 53.46 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.946 HG12 HG12 ' A' ' 9' ' ' ILE . 4.7 mt -133.13 118.79 33.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.674 -174.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.563 ' HD3' ' HB3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -102.95 125.71 49.81 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.674 177.816 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.511 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 0.7 OUTLIER -109.4 -159.42 0.68 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 176.347 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.778 ' HA2' HD21 ' A' ' 26' ' ' ASN . . . 68.93 107.26 0.03 OUTLIER Glycine 0 CA--C 1.51 -0.26 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.541 177.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -108.13 -79.99 0.57 Allowed 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 119.604 -0.839 . . . . 0.0 111.734 -176.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -91.13 -78.21 0.4 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.019 0.438 . . . . 0.0 111.869 -171.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.3 pp -135.24 26.36 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.079 0.466 . . . . 0.0 111.825 -171.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.778 HD21 ' HA2' ' A' ' 22' ' ' GLY . 6.0 p-10 -91.77 93.27 8.79 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.637 0.732 . . . . 0.0 111.559 -174.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -61.39 -19.04 61.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.857 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.7 tm0? -49.11 -35.84 17.35 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.925 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.537 ' O ' HG12 ' A' ' 33' ' ' VAL . 11.1 p -64.1 -41.23 91.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.315 -176.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -60.1 -25.48 65.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.423 -175.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -92.57 -39.86 5.18 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.026 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -81.8 -27.24 9.71 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -173.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 29' ' ' VAL . 11.1 p -70.54 -30.92 44.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 119.307 -0.957 . . . . 0.0 108.486 175.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -71.46 -35.17 70.77 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.695 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.64 -22.01 30.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.39 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.479 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . . . -64.09 -21.07 66.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.351 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.93 -43.36 88.28 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.737 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -81.81 -29.9 32.45 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.802 176.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.558 ' HE1' ' HB3' ' A' ' 89' ' ' ARG . 7.8 t80 -51.59 -46.03 63.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.498 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.437 HD11 HD21 ' A' ' 58' ' ' LEU . 58.0 mt -80.4 -29.15 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.965 -175.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.737 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 10.3 pt-20 -75.81 -26.76 57.54 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.096 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 51.4 mt-10 -74.54 -35.65 63.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.061 173.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -125.19 74.94 67.88 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.244 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -95.02 -164.51 0.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.385 2.723 . . . . 0.0 113.749 -171.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -138.78 147.63 55.13 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.208 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -44.26 -22.6 0.57 Allowed 'Trans proline' 0 N--CA 1.482 0.808 0 C-N-CA 124.447 3.431 . . . . 0.0 115.881 -170.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.405 ' HA3' ' HB3' ' A' ' 66' ' ' GLU . . . -116.59 27.09 8.16 Favored Glycine 0 C--O 1.228 -0.265 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.314 -177.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -67.91 136.0 53.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.051 0.453 . . . . 0.0 111.76 177.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.7 mm -109.33 -60.34 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.257 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 40.6 tt0 -162.28 157.41 22.81 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.781 -172.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 59' ' ' THR . 2.1 p -152.05 118.23 5.56 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 173.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.537 HG13 ' HB ' ' A' ' 59' ' ' THR . 7.7 pt -126.59 142.1 42.15 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.604 -176.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.516 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 1.6 Cg_endo -84.64 139.59 7.78 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.31 2.674 . . . . 0.0 112.673 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.7 66.94 1.54 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 92.5 t80 75.91 -68.97 0.18 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.316 0.647 . . . . 0.0 111.588 171.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.1 t -134.92 2.43 3.11 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.613 0.72 . . . . 0.0 109.673 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 15.2 m -120.65 137.47 54.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.38 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.437 HD21 HD11 ' A' ' 40' ' ' ILE . 61.6 tp -102.48 126.89 49.68 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.561 HG22 HD21 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -101.42 106.8 17.98 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -177.947 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.1 t -109.35 119.21 58.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.459 0.647 . . . . 0.0 111.067 -174.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 85.1 m-85 -112.9 146.59 38.68 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.513 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.563 ' CE2' HG11 ' A' ' 82' ' ' VAL . 3.6 p90 -164.78 170.32 15.63 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.873 -173.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -104.24 112.29 25.25 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.73 -177.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.469 ' HA ' HG22 ' A' ' 67' ' ' VAL . 1.4 pmm? -63.22 -26.51 68.83 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.735 -174.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.68 -27.89 66.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.201 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.405 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 4.0 tp10 -90.71 -41.17 11.43 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -173.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.469 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.5 m -68.06 -30.63 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.089 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.712 ' HA ' HD23 ' A' ' 71' ' ' LEU . 3.5 m-85 -53.94 -29.45 42.41 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.495 173.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.479 ' HE2' ' HB2' ' A' ' 69' ' ' LYS . 0.3 OUTLIER -67.62 -34.96 78.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.11 0.481 . . . . 0.0 110.601 178.911 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 33.9 t60 -93.05 -30.82 15.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.491 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.712 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.5 OUTLIER -16.2 91.56 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 125.618 1.567 . . . . 0.0 112.672 177.124 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.473 ' HD2' HG13 ' A' ' 75' ' ' ILE . 31.8 Cg_exo -61.71 149.99 87.61 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.057 2.504 . . . . 0.0 111.352 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -63.22 -22.09 66.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.628 -172.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -83.83 -13.76 74.38 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.775 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.502 HG21 ' HB3' ' A' ' 81' ' ' SER . 4.5 mm -96.35 130.84 44.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 122.837 0.455 . . . . 0.0 109.944 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.3 t -114.34 0.07 14.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.164 0.507 . . . . 0.0 109.952 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.9 m -134.5 120.14 14.49 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.962 -177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.619 ' HA ' HD21 ' A' ' 71' ' ' LEU . 95.2 Cg_exo -46.46 -38.5 21.23 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 124.122 3.215 . . . . 0.0 113.882 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.9 -34.65 76.42 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.123 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.627 ' HA ' ' HD3' ' A' ' 83' ' ' LYS . 16.7 tt0 -83.46 -20.7 33.56 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.456 -174.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.502 ' HB3' HG21 ' A' ' 75' ' ' ILE . 62.5 p -75.93 -30.09 58.58 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 177.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 78' ' ' PRO . 97.7 t -67.59 -34.46 68.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.724 174.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.627 ' HD3' ' HA ' ' A' ' 80' ' ' GLU . 59.7 mtpt -51.85 -45.43 64.01 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 174.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.496 ' HE ' HD11 ' A' ' 75' ' ' ILE . 21.1 mmt180 -60.81 -35.9 77.69 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.874 -177.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -72.31 -42.4 65.51 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.047 0.451 . . . . 0.0 111.426 -177.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.425 ' O ' HD23 ' A' ' 90' ' ' LEU . 34.6 m -87.15 -46.12 16.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.17 -177.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 83' ' ' LYS . 14.9 mm-40 -62.7 -28.47 69.97 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.796 -175.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.654 ' HG3' ' HD3' ' A' ' 89' ' ' ARG . 11.9 pt-20 -64.48 -27.9 69.3 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.88 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.654 ' HD3' ' HG3' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -85.23 -47.45 10.07 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 176.173 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 87' ' ' GLU . 4.5 mm? -60.09 -32.86 71.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.535 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.631 ' O ' ' HB2' ' A' ' 96' ' ' ASP . . . -44.17 -49.15 9.18 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.913 -178.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -62.57 -6.05 3.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.202 -174.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.455 HG23 ' O ' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -98.96 -37.36 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 121.2 -0.2 . . . . 0.0 111.139 179.174 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.45 ' HB2' ' OG1' ' A' ' 4' ' ' THR . . . -164.88 -53.68 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.74 0.781 . . . . 0.0 111.258 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.627 ' HG2' ' HA ' ' A' ' 91' ' ' ALA . 1.2 pm0 -61.19 -3.41 0.86 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.806 -173.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.631 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 15.6 t70 -44.23 -23.88 0.13 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 121.29 0.567 . . . . 0.0 111.564 167.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -72.1 -2.32 18.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.857 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 62.06 42.97 9.3 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.397 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.1 m -97.07 35.97 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.385 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.97 85.6 6.38 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.955 -176.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 . . . . . 0 C--N 1.3 -1.551 0 CA-C-O 118.506 -0.759 . . . . 0.0 109.315 178.648 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.657 0 N-CA-C 112.194 -0.362 . . . . 0.0 112.194 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.3 t -118.53 74.91 0.99 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -89.28 168.69 12.06 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.147 -175.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.48 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 10.0 t -125.04 16.93 8.51 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.54 -177.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 4' ' ' THR . 40.0 t 74.54 141.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 114.946 -1.025 . . . . 0.0 112.989 171.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -129.55 84.94 2.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.993 173.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.649 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 38.9 p90 -107.74 155.68 19.94 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.747 0.784 . . . . 0.0 111.941 -172.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.562 ' HB2' ' NE ' ' A' ' 20' ' ' ARG . 40.1 mt-30 -128.16 139.54 52.43 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.701 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 1.001 HG12 HG12 ' A' ' 19' ' ' ILE . 15.9 mt -101.03 120.25 50.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.764 177.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 18' ' ' MET . 11.9 pt-20 -119.85 159.17 25.12 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.846 -177.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -88.49 129.91 35.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.971 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.675 HD21 HG23 ' A' ' 59' ' ' THR . 0.0 OUTLIER -66.4 -42.65 87.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.619 -177.653 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.83 -55.48 0.36 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.426 176.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -103.43 -74.71 0.63 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.947 0.403 . . . . 0.0 111.07 -176.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.4 p -149.58 48.15 0.95 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.686 0.755 . . . . 0.0 110.562 -177.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.555 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -142.57 155.08 44.95 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.835 176.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.502 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 37.5 ttp -128.06 124.45 37.09 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -174.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.477 ' HB2' HD22 ' A' ' 12' ' ' LEU . 51.3 ttm -109.49 139.49 44.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.131 0.491 . . . . 0.0 110.248 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.001 HG12 HG12 ' A' ' 9' ' ' ILE . 6.4 mt -128.21 112.67 27.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.913 -176.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.576 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -96.0 124.22 39.92 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.89 178.599 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.649 ' HA ' ' CB ' ' A' ' 7' ' ' TYR . 8.0 m-85 -97.84 -153.71 0.43 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.52 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.615 ' HA2' HG21 ' A' ' 29' ' ' VAL . . . 104.25 -175.86 23.13 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.28 176.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -149.14 -72.2 0.19 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 173.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -134.33 -69.94 0.52 Allowed 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.031 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 31.7 pt -138.96 38.24 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.402 0.62 . . . . 0.0 110.583 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.404 ' ND2' HG23 ' A' ' 29' ' ' VAL . 15.5 p-10 -86.62 115.09 23.86 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.606 0.717 . . . . 0.0 111.873 -175.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.39 -19.1 64.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.129 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.4 tm0? -46.89 -45.51 20.53 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.591 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.615 HG21 ' HA2' ' A' ' 22' ' ' GLY . 83.3 t -63.16 -41.66 93.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.395 -177.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -52.61 -32.75 43.21 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.595 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.53 -42.23 6.2 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.731 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -80.03 -22.17 11.8 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.79 0 C-N-CA 120.539 -0.464 . . . . 0.0 112.105 -173.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 29' ' ' VAL . 14.3 p -74.12 -29.5 25.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 119.593 -0.843 . . . . 0.0 108.865 174.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -70.85 -34.63 71.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.47 174.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.12 -21.44 29.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.306 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.461 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . . . -65.15 -26.54 68.22 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.031 -177.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.54 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . . . -62.0 -43.59 98.52 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.86 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -77.85 -29.66 50.59 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.846 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.461 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -55.57 -44.71 77.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.257 0.551 . . . . 0.0 109.639 177.264 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.522 ' CD1' HD21 ' A' ' 58' ' ' LEU . 41.5 mt -83.15 -37.47 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.82 -175.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.86 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 12.2 pt-20 -74.12 -20.89 60.1 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.29 -176.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.454 ' C ' ' HD3' ' A' ' 44' ' ' PRO . 38.1 mm-40 -85.72 -25.68 26.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.932 0.396 . . . . 0.0 110.684 175.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -122.76 63.36 19.99 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.454 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 50.0 Cg_endo -93.42 174.2 1.69 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.546 2.164 . . . . 0.0 114.039 -167.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -114.01 146.48 35.75 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 114.152 -1.385 . . . . 0.0 108.052 175.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.44 -15.33 3.85 Favored 'Trans proline' 0 N--CA 1.48 0.699 0 C-N-CA 123.82 3.013 . . . . 0.0 114.844 -169.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 66' ' ' GLU . . . -109.39 20.18 28.21 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.11 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.516 ' HE2' HG22 ' A' ' 40' ' ' ILE . 4.2 t80 -62.01 132.33 52.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.986 0.422 . . . . 0.0 110.778 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.646 HG22 ' CG ' ' A' ' 50' ' ' GLU . 28.9 mm -109.48 -62.99 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.17 176.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.646 ' CG ' HG22 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -154.69 175.8 13.24 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.522 0.677 . . . . 0.0 110.393 178.893 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' A' ' 37' ' ' ALA . 7.5 p -161.55 119.7 2.34 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.838 162.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.767 HG13 ' HB ' ' A' ' 59' ' ' THR . 9.5 pt -114.77 134.07 22.48 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-O 120.975 0.417 . . . . 0.0 112.039 -173.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.482 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 2.0 Cg_endo -82.04 120.45 3.37 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.295 2.664 . . . . 0.0 112.342 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.52 32.95 3.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.328 178.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 71.04 -34.64 0.31 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.096 175.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -128.82 -21.35 3.39 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.85 -0.531 . . . . 0.0 111.214 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 9.5 p -124.65 141.29 52.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.139 0.495 . . . . 0.0 110.571 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.522 HD21 ' CD1' ' A' ' 40' ' ' ILE . 57.5 tp -102.44 111.98 24.5 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.767 ' HB ' HG13 ' A' ' 52' ' ' ILE . 5.2 m -90.32 105.54 17.88 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.7 t -101.25 125.36 55.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.086 0.47 . . . . 0.0 111.122 -172.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -114.73 145.87 41.58 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.613 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.502 ' OH ' ' HB2' ' A' ' 17' ' ' MET . 2.4 p90 -165.09 169.1 16.62 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.371 0.605 . . . . 0.0 110.695 -174.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -96.61 118.95 34.17 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.616 -176.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.478 ' HA ' HG22 ' A' ' 67' ' ' VAL . 1.3 pmm? -69.34 -22.8 63.73 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.833 -172.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.42 -28.83 69.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 111.144 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.401 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 13.8 tp10 -89.83 -30.98 17.58 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.769 0.795 . . . . 0.0 109.477 -173.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.478 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.2 m -77.75 -33.81 19.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.339 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.907 ' HA ' HD23 ' A' ' 71' ' ' LEU . 59.8 t80 -68.29 -22.87 64.7 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.245 175.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -38.87 71.43 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 172.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -87.54 -74.68 0.43 Allowed 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.421 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.907 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER 32.44 66.95 1.04 Allowed Pre-proline 0 N--CA 1.471 0.593 0 O-C-N 124.186 0.929 . . . . 0.0 111.574 -178.236 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.669 ' HD2' HG13 ' A' ' 75' ' ' ILE . 33.2 Cg_exo -60.45 135.61 62.32 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.475 2.117 . . . . 0.0 111.371 -175.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -58.7 109.32 0.78 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.907 0.861 . . . . 0.0 110.964 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 136.42 -31.56 2.58 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 108.549 -1.82 . . . . 0.0 108.549 -169.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.669 HG13 ' HD2' ' A' ' 72' ' ' PRO . 14.3 mm -84.78 116.38 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 114.049 -1.076 . . . . 0.0 108.764 169.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.9 m -94.94 -4.32 47.0 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.162 0.506 . . . . 0.0 110.716 -175.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.607 ' HB2' ' HB2' ' A' ' 80' ' ' GLU . 58.0 m -141.35 134.54 14.43 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.227 -170.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.649 ' HA ' HD21 ' A' ' 71' ' ' LEU . 82.8 Cg_exo -51.92 -43.63 50.72 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.509 2.806 . . . . 0.0 113.157 173.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -67.11 -23.39 65.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.185 0.516 . . . . 0.0 110.748 176.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 77' ' ' SER . 39.9 tt0 -81.34 -20.73 40.03 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.159 -174.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.538 ' HB3' HG21 ' A' ' 75' ' ' ILE . 63.7 p -81.95 -37.33 26.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 78' ' ' PRO . 26.2 t -64.22 -26.02 39.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.129 177.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.564 ' HG3' ' HA ' ' A' ' 80' ' ' GLU . 93.5 mttt -50.17 -45.08 53.11 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.126 175.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.458 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 17.9 mmt180 -69.5 -35.14 75.24 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.042 -173.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -62.33 -41.79 98.85 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.843 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.9 m -87.41 -42.96 15.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -178.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -62.53 -33.63 75.3 Favored 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.5 ' HG3' ' HD3' ' A' ' 89' ' ' ARG . 11.0 pt-20 -59.21 -29.19 67.31 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.579 176.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.5 ' HD3' ' HG3' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -88.62 -37.88 15.28 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.738 173.642 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 93' ' ' ILE . 88.4 mt -85.74 -67.57 0.8 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.45 0.643 . . . . 0.0 112.388 -176.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.6 -16.47 48.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.832 -175.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.666 ' HG3' HG22 ' A' ' 93' ' ' ILE . 7.8 pt-20 -56.03 -39.89 72.61 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.99 -0.444 . . . . 0.0 110.983 176.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.666 HG22 ' HG3' ' A' ' 92' ' ' GLU . 0.5 OUTLIER -90.43 -42.36 14.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.607 -178.193 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.614 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . . . -87.29 28.0 1.0 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.784 0.802 . . . . 0.0 110.313 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' A' ' 96' ' ' ASP . 10.7 pt-20 -46.41 -55.54 7.24 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.756 -1.565 . . . . 0.0 113.645 -173.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.506 ' N ' ' HG3' ' A' ' 95' ' ' GLU . 36.2 t70 -79.81 -22.26 43.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.021 0.438 . . . . 0.0 111.562 -172.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.614 ' CD2' ' HA ' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -93.62 -54.81 3.5 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.582 -170.556 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.564 ' HG3' ' H ' ' A' ' 7' ' ' TYR . 8.4 mm-40 -135.26 102.99 5.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.18 0.514 . . . . 0.0 110.892 -177.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 p -119.96 88.95 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.859 0.838 . . . . 0.0 108.934 174.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -71.56 90.11 1.0 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.088 -175.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 . . . . . 0 C--O 1.244 0.791 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.627 173.28 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.659 0 N-CA-C 112.106 -0.398 . . . . 0.0 112.106 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.1 m -84.43 166.97 16.88 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.4 ' HG3' ' HG2' ' A' ' 6' ' ' ARG . 1.8 pmm? -148.65 149.91 32.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.202 0.525 . . . . 0.0 111.185 -178.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.494 ' CG2' ' HE2' ' A' ' 97' ' ' TYR . 14.9 t -82.72 -26.14 32.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 122.257 1.027 . . . . 0.0 108.296 171.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 p 178.27 159.57 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 113.291 -1.777 . . . . 0.0 109.412 -178.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.4 ' HG2' ' HG3' ' A' ' 3' ' ' MET . 40.5 mmt180 -144.91 120.08 10.14 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 176.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 5.9 p90 -123.52 168.28 12.8 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.478 0.656 . . . . 0.0 111.853 -171.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.508 ' HB3' ' NE ' ' A' ' 20' ' ' ARG . 8.1 tp60 -146.79 115.25 6.71 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.125 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.82 HG12 HG12 ' A' ' 19' ' ' ILE . 30.5 mt -82.73 122.75 37.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.036 0.446 . . . . 0.0 110.281 176.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.428 ' OE2' ' HD2' ' A' ' 20' ' ' ARG . 12.4 pt-20 -120.7 169.68 10.16 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.209 -178.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -93.85 128.43 40.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.473 0.654 . . . . 0.0 110.56 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.64 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -69.56 -47.65 62.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.703 -177.589 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -161.61 -72.09 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -142.41 -34.42 0.45 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.223 -0.191 . . . . 0.0 111.513 177.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.1 p -144.1 42.95 1.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.795 0.807 . . . . 0.0 111.234 -176.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -150.45 152.75 34.76 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.204 177.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.499 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 30.8 ttp -125.4 133.12 52.62 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.751 -0.78 . . . . 0.0 112.484 -173.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.64 ' HB2' HD22 ' A' ' 12' ' ' LEU . 53.7 ttm -119.02 131.76 56.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.965 176.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.82 HG12 HG12 ' A' ' 9' ' ' ILE . 7.3 mt -123.44 109.04 22.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.65 -176.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -102.76 134.42 46.18 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.501 -179.343 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 35.3 m-85 -101.63 -144.57 0.35 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.532 ' O ' HG11 ' A' ' 29' ' ' VAL . . . -93.43 -176.09 40.3 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 176.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.64 -45.77 0.11 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 117.414 0.607 . . . . 0.0 112.242 -175.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -59.45 -58.2 9.65 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -171.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.7 pp -120.75 20.88 5.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.123 0.487 . . . . 0.0 111.137 -175.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.552 ' N ' HD21 ' A' ' 26' ' ' ASN . 0.6 OUTLIER -101.52 101.7 12.32 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.304 -173.4 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -77.62 -33.42 53.64 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.394 175.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.4 tm0? -58.07 -47.84 81.93 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.37 -177.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.694 ' O ' HG22 ' A' ' 33' ' ' VAL . 4.9 p -60.31 -55.38 24.64 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.113 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -175.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.451 ' N ' HG13 ' A' ' 29' ' ' VAL . 51.9 m-80 -55.88 -29.48 60.03 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.389 0.431 . . . . 0.0 111.355 -176.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.68 -35.98 17.7 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.362 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.591 HG21 HD12 ' A' ' 93' ' ' ILE . 0.4 OUTLIER -93.48 -28.55 4.37 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.872 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -170.947 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 29' ' ' VAL . 3.1 m -62.7 -35.68 71.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.744 176.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.5 t60 -71.93 -33.13 68.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.157 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.32 -32.81 24.11 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.124 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.635 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -64.9 -24.11 67.43 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 122.772 0.429 . . . . 0.0 111.203 -177.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.485 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . . . -61.38 -40.3 93.82 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.765 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -85.57 -32.64 22.01 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.102 174.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.635 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 4.4 t80 -54.67 -42.53 71.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.126 0.489 . . . . 0.0 110.603 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.531 HD11 HD21 ' A' ' 58' ' ' LEU . 51.9 mt -78.06 -31.86 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.237 -177.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.765 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 10.0 pt-20 -79.5 -23.73 42.76 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.763 -177.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -78.12 -33.28 50.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.497 174.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -126.88 68.88 71.68 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.832 0.349 . . . . 0.0 110.302 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -96.03 179.17 0.57 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.109 2.539 . . . . 0.0 113.972 -171.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -111.29 146.48 34.67 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.1 171.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -43.03 -35.19 4.44 Favored 'Trans proline' 0 N--CA 1.479 0.636 0 C-N-CA 123.457 2.771 . . . . 0.0 114.992 -171.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.499 ' HA3' ' CB ' ' A' ' 66' ' ' GLU . . . -98.73 16.18 59.95 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.713 -175.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -60.68 135.99 57.93 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.08 0.466 . . . . 0.0 111.099 175.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.88 HG22 ' HG2' ' A' ' 50' ' ' GLU . 40.6 mm -110.65 -61.36 2.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.065 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.88 ' HG2' HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -153.19 169.57 22.67 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.471 0.653 . . . . 0.0 111.16 -178.315 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 59' ' ' THR . 4.2 p -161.76 117.54 2.05 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.096 167.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.607 HG12 ' HB ' ' A' ' 59' ' ' THR . 0.1 OUTLIER -127.75 136.48 29.04 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.691 -175.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 37' ' ' ALA . 71.1 Cg_endo -78.75 138.35 14.92 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.778 2.319 . . . . 0.0 112.546 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.97 58.53 1.02 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.683 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 62.9 t80 70.61 -65.53 0.33 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.695 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 t -119.11 -17.48 8.95 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.999 0.428 . . . . 0.0 111.454 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 4.3 p -112.9 144.79 41.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.204 0.526 . . . . 0.0 111.272 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.531 HD21 HD11 ' A' ' 40' ' ' ILE . 53.0 tp -102.75 118.24 36.4 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.607 ' HB ' HG12 ' A' ' 52' ' ' ILE . 0.7 OUTLIER -93.76 106.55 18.51 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.71 -177.245 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.6 t -106.2 126.12 61.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.308 0.575 . . . . 0.0 111.177 -173.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.589 ' HB2' ' HG3' ' A' ' 50' ' ' GLU . 89.5 m-85 -120.15 147.06 45.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.245 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.499 ' OH ' ' HB2' ' A' ' 17' ' ' MET . 1.9 p90 -166.11 172.39 11.37 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.292 0.567 . . . . 0.0 111.065 -172.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.412 ' OD1' ' HB3' ' A' ' 65' ' ' TYR . 10.9 t0 -99.0 113.41 25.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.662 -179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.535 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -60.78 -20.5 61.57 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.48 -178.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.412 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -70.54 -31.79 68.98 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.94 0.4 . . . . 0.0 110.789 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.499 ' CB ' ' HA3' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -90.36 -29.56 17.98 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.503 0.668 . . . . 0.0 109.724 -173.528 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.535 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.4 m -74.9 -32.15 27.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.392 176.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.774 ' HA ' HD23 ' A' ' 71' ' ' LEU . 50.7 t80 -66.2 -24.0 66.55 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.636 175.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.82 -32.75 69.66 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.869 0.842 . . . . 0.0 108.732 174.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -91.89 -69.37 0.74 Allowed 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.197 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.774 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER 22.73 76.75 0.23 Allowed Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 124.804 1.242 . . . . 0.0 113.567 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.426 ' HD2' HG13 ' A' ' 75' ' ' ILE . 44.1 Cg_exo -58.02 153.03 47.43 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.513 2.142 . . . . 0.0 111.639 176.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -61.0 -29.19 69.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.481 -173.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.83 -30.16 56.36 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.328 -0.939 . . . . 0.0 111.025 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.615 HG21 ' HB3' ' A' ' 81' ' ' SER . 14.1 mm -76.78 108.26 9.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.947 -0.627 . . . . 0.0 110.079 177.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.2 t -89.29 -8.85 52.51 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.322 0.582 . . . . 0.0 110.464 -176.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 69.9 m -133.36 134.21 23.68 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.073 -173.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.713 ' HA ' HD21 ' A' ' 71' ' ' LEU . 84.8 Cg_exo -49.55 -49.23 16.28 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.539 2.826 . . . . 0.0 113.132 176.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.446 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -60.35 -26.88 66.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.008 0.432 . . . . 0.0 111.544 178.546 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -79.11 -21.47 46.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.075 -175.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.615 ' HB3' HG21 ' A' ' 75' ' ' ILE . 78.4 p -82.33 -37.59 25.49 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 176.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 78' ' ' PRO . 59.8 t -59.4 -29.13 41.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.823 177.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.472 ' HE2' HG21 ' A' ' 9' ' ' ILE . 95.4 mttt -52.22 -47.02 65.87 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -63.46 -33.26 75.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.654 -174.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -70.61 -38.26 73.94 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.384 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.431 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 35.7 m -87.3 -44.53 16.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -52.31 -45.19 65.46 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.117 0.567 . . . . 0.0 111.994 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.506 ' HG3' ' HD3' ' A' ' 89' ' ' ARG . 9.0 pt-20 -57.89 -31.01 66.32 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.974 0.416 . . . . 0.0 111.301 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.506 ' HD3' ' HG3' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -86.46 -38.33 17.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.295 0.569 . . . . 0.0 110.913 177.332 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.737 ' O ' HG12 ' A' ' 93' ' ' ILE . 81.9 mt -70.71 -35.5 72.78 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.453 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 96' ' ' ASP . . . -49.19 -26.58 2.95 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.776 175.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -78.78 -6.94 57.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.643 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.737 HG12 ' O ' ' A' ' 90' ' ' LEU . 5.9 pt -105.48 -41.81 6.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -174.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -179.28 -39.67 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 120.786 0.326 . . . . 0.0 111.738 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.65 ' HG2' ' HB3' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -65.16 -4.82 5.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.699 -173.088 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 9.9 t70 -38.75 -36.18 0.25 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.903 167.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.494 ' HE2' ' CG2' ' A' ' 4' ' ' THR . 3.3 m-85 -75.32 -14.79 60.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.637 -174.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -161.1 96.13 1.08 Allowed 'General case' 0 C--O 1.22 -0.461 0 CA-C-O 120.923 0.392 . . . . 0.0 111.526 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 m -82.05 87.53 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.607 ' OD1' ' HB ' ' A' ' 9' ' ' ILE . 5.2 t-20 -6.25 -88.07 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 113.123 -1.853 . . . . 0.0 114.028 -172.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.546 ' NE ' ' HA ' ' A' ' 101' ' ' ARG . 4.9 mmp_? . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.748 -0.644 . . . . 0.0 109.951 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.647 0 N-CA-C 111.511 -0.635 . . . . 0.0 111.511 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.7 p -90.12 2.65 55.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.87 0.367 . . . . 0.0 111.521 -176.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -59.37 156.01 13.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.263 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.562 ' O ' HG12 ' A' ' 5' ' ' VAL . 12.3 t -84.22 40.99 0.8 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.822 -174.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.668 HG22 HG12 ' A' ' 29' ' ' VAL . 0.3 OUTLIER 67.6 153.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.713 1.205 . . . . 0.0 112.665 -179.542 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.422 ' CG ' ' HB2' ' A' ' 23' ' ' GLU . 28.0 mmt180 -133.43 144.55 49.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.052 175.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.575 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . 20.0 p90 -164.25 161.1 21.8 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -139.39 133.31 30.89 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.842 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.876 HG12 HG12 ' A' ' 19' ' ' ILE . 26.8 mt -95.53 127.54 47.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.132 -178.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 18' ' ' MET . 11.4 pt-20 -122.57 171.43 9.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.423 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -89.66 137.73 32.08 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.179 0.514 . . . . 0.0 110.947 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.587 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -79.59 -20.33 47.19 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.01 175.322 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.2 -80.96 0.19 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.733 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -107.05 -55.44 2.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.842 0.353 . . . . 0.0 111.778 -175.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.539 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 4.6 p -149.29 42.01 0.91 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.648 0.737 . . . . 0.0 110.984 -172.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.522 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -142.65 157.91 44.2 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.47 173.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.733 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 35.1 ttp -130.02 133.02 46.46 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.929 -174.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.587 ' HB2' HD22 ' A' ' 12' ' ' LEU . 32.8 ttp -124.06 135.38 53.53 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.109 175.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.876 HG12 HG12 ' A' ' 9' ' ' ILE . 5.0 mt -120.05 124.4 72.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.114 -176.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.518 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -104.53 118.76 37.39 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.237 178.347 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.575 ' CD2' ' HB3' ' A' ' 7' ' ' TYR . 53.3 m-85 -83.64 -176.74 6.44 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.748 173.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.645 ' HA2' HG21 ' A' ' 29' ' ' VAL . . . 126.89 131.34 3.5 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.403 176.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.798 ' HG2' ' HG2' ' A' ' 24' ' ' GLU . 39.1 tt0 -128.3 -84.27 0.58 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.876 0.37 . . . . 0.0 110.265 175.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.798 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 13.5 mm-40 -103.78 -77.77 0.57 Allowed 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.2 pt -149.02 31.22 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 114.435 -1.257 . . . . 0.0 107.813 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.591 ' HB2' HG22 ' A' ' 29' ' ' VAL . 1.7 m-20 -60.6 125.3 23.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.734 -1.575 . . . . 0.0 113.378 -166.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -60.13 -34.99 74.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.463 166.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -58.8 -51.93 67.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.976 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.668 HG12 HG22 ' A' ' 5' ' ' VAL . 17.0 m -65.97 -43.82 92.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.821 0.344 . . . . 0.0 110.251 -177.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.82 -41.66 95.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.762 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.51 -37.88 29.88 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.394 -175.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.451 HG13 HD12 ' A' ' 93' ' ' ILE . 0.3 OUTLIER -79.1 -29.06 13.78 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.749 0 C-N-CA 120.224 -0.591 . . . . 0.0 111.946 -175.654 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.45 HG23 ' HB2' ' A' ' 58' ' ' LEU . 14.1 p -71.02 -28.81 34.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -69.71 -40.27 76.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.074 173.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.09 -20.64 30.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.931 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.87 -30.44 70.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.722 0.296 . . . . 0.0 111.469 -173.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.22 98.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.719 0.771 . . . . 0.0 108.99 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.528 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -78.29 -25.67 46.73 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.73 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -66.14 -45.01 82.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.344 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.497 ' CD1' HD21 ' A' ' 58' ' ' LEU . 41.8 mt -76.25 -38.05 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.346 -175.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 14.4 pt-20 -69.6 -19.99 63.64 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.238 -175.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -91.95 -24.37 19.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.609 0.242 . . . . 0.0 110.762 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -127.1 68.84 72.88 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 175.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -95.56 -171.0 0.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.451 2.767 . . . . 0.0 113.816 -170.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -127.29 147.07 60.49 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.376 176.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -40.69 -36.74 2.0 Allowed 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.107 3.204 . . . . 0.0 115.317 -170.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -102.51 19.31 48.37 Favored Glycine 0 C--O 1.226 -0.404 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.518 -174.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -64.36 135.8 56.51 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.081 0.467 . . . . 0.0 111.211 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.447 HG12 ' HA ' ' A' ' 62' ' ' TYR . 32.6 mm -107.67 -58.54 3.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.236 -178.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -167.17 160.86 14.15 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.197 -176.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 59' ' ' THR . 5.6 p -149.97 119.76 7.08 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 172.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.807 HG13 ' HB ' ' A' ' 59' ' ' THR . 5.3 pt -114.56 132.58 22.79 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-O 121.2 0.524 . . . . 0.0 111.845 -175.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -85.61 123.03 2.44 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.243 2.629 . . . . 0.0 112.395 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.18 27.72 7.97 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.299 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 70.92 -28.5 0.18 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.248 -0.887 . . . . 0.0 113.298 174.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -140.84 7.23 2.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.336 0.589 . . . . 0.0 110.711 171.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 47.3 m -148.18 144.36 27.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.775 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.497 HD21 ' CD1' ' A' ' 40' ' ' ILE . 54.4 tp -115.61 111.66 20.98 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.95 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.807 ' HB ' HG13 ' A' ' 52' ' ' ILE . 3.8 m -90.18 106.68 18.65 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.6 t -104.9 117.41 50.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.541 0.686 . . . . 0.0 110.88 -174.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.422 ' CE1' HG22 ' A' ' 59' ' ' THR . 80.8 m-85 -105.5 147.15 28.64 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.791 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.573 ' CE2' HG11 ' A' ' 82' ' ' VAL . 3.8 p90 -165.75 164.64 18.84 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.382 -176.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -99.31 114.5 27.4 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.333 -175.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.58 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -65.12 -20.85 66.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.65 -169.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.659 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 0.5 OUTLIER -68.41 -29.5 68.19 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.267 -178.07 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -91.88 -35.56 13.98 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 121.445 0.641 . . . . 0.0 109.513 -175.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.58 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.3 m -68.37 -29.91 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.85 177.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 1.029 ' HA ' HD23 ' A' ' 71' ' ' LEU . 30.1 t80 -69.61 -22.93 63.45 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.516 174.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' A' ' 65' ' ' TYR . 27.4 mmmt -76.25 -25.42 54.97 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -89.5 -35.6 15.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.428 178.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.029 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -16.89 90.21 0.04 OUTLIER Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 125.606 1.562 . . . . 0.0 112.779 178.935 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.635 ' HD2' HG13 ' A' ' 75' ' ' ILE . 22.8 Cg_exo -66.33 136.62 44.28 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.196 2.597 . . . . 0.0 110.941 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -65.61 100.17 0.5 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.818 0.818 . . . . 0.0 110.417 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.46 -26.02 1.83 Allowed Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -171.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.65 HG22 ' H ' ' A' ' 77' ' ' SER . 11.6 mm -87.75 132.9 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 114.627 -0.787 . . . . 0.0 109.636 172.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.5 t -103.44 1.11 32.07 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.159 0.504 . . . . 0.0 110.522 -176.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.65 ' H ' HG22 ' A' ' 75' ' ' ILE . 21.0 t -146.57 129.41 7.98 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -170.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.694 ' HA ' HD21 ' A' ' 71' ' ' LEU . 95.8 Cg_exo -47.51 -44.42 25.44 Favored 'Trans proline' 0 C--O 1.221 -0.352 0 C-N-CA 123.577 2.851 . . . . 0.0 112.807 169.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -36.8 82.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.034 0.445 . . . . 0.0 110.913 176.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 77' ' ' SER . 39.9 tt0 -71.33 -27.09 63.13 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.595 -174.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.597 ' HB3' HG21 ' A' ' 75' ' ' ILE . 76.9 p -77.6 -37.64 49.88 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 78' ' ' PRO . 58.2 t -60.73 -34.71 59.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.102 178.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.733 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 5.3 mtmp? -53.21 -42.7 66.56 Favored 'General case' 0 C--O 1.213 -0.82 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 176.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.56 -34.24 73.91 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.483 -175.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -62.72 -41.55 99.21 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.455 176.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.473 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 32.7 m -84.29 -39.69 14.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.924 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.465 ' OE2' ' HB3' ' A' ' 83' ' ' LYS . 39.9 mt-10 -48.66 -52.42 23.37 Favored 'General case' 0 C--O 1.218 -0.572 0 C-N-CA 123.207 0.603 . . . . 0.0 112.083 178.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -63.53 -28.52 70.0 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.356 -176.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.33 -42.72 22.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.475 0.655 . . . . 0.0 110.31 176.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.725 ' HB3' ' HG2' ' A' ' 95' ' ' GLU . 95.5 mt -64.09 -37.21 86.63 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.604 177.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.563 ' O ' ' HB2' ' A' ' 96' ' ' ASP . . . -47.19 -34.42 6.31 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.644 175.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -70.15 -7.8 44.6 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.488 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.717 HG12 ' O ' ' A' ' 90' ' ' LEU . 2.8 pt -104.59 -43.64 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 120.465 -0.494 . . . . 0.0 112.066 -173.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 179.61 -42.46 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.905 0.383 . . . . 0.0 111.674 -173.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.725 ' HG2' ' HB3' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -62.61 -16.91 58.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.11 -170.877 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.563 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 23.4 t70 -48.83 -28.48 3.75 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.591 0.557 . . . . 0.0 112.316 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.494 ' HB2' HG21 ' A' ' 4' ' ' THR . 1.3 m-30 -72.02 -23.6 61.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.367 -173.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -128.17 -59.95 1.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.86 -0.155 . . . . 0.0 111.245 -177.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.1 t 73.53 123.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.593 0.711 . . . . 0.0 111.659 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -78.14 58.9 2.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.849 175.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 . . . . . 0 C--O 1.25 1.119 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.994 -179.459 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.745 0 N-CA-C 112.314 -0.314 . . . . 0.0 112.314 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.0 m -84.54 81.24 8.93 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -151.24 176.44 11.21 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.148 0.499 . . . . 0.0 111.726 -176.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.6 t -63.4 150.22 44.07 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.007 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.514 ' HA ' ' OD1' ' A' ' 26' ' ' ASN . 0.7 OUTLIER -85.83 -170.86 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.977 179.038 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -148.29 117.72 6.96 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.478 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . 27.0 p90 -143.63 162.86 34.83 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.8 0.809 . . . . 0.0 112.378 -176.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.411 ' HA ' HD21 ' A' ' 100' ' ' ASN . 15.3 mp0 -135.26 140.44 45.21 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.135 -1.393 . . . . 0.0 108.511 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.754 HG21 ' HD3' ' A' ' 83' ' ' LYS . 34.2 mt -113.81 131.26 66.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.9 -175.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -121.85 169.53 10.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.203 0.525 . . . . 0.0 110.432 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -94.42 131.29 40.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.642 176.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.682 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -69.05 -50.11 51.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.639 -176.289 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.99 -69.96 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.703 176.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -110.57 -71.06 0.78 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.983 0.42 . . . . 0.0 111.433 -176.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.9 p -135.91 47.07 2.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.674 0.75 . . . . 0.0 110.792 -175.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.29 153.75 42.34 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.006 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.475 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 26.7 ttp -121.52 136.61 54.94 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.652 -0.419 . . . . 0.0 112.112 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.682 ' HB2' HD22 ' A' ' 12' ' ' LEU . 49.5 ttm -122.49 131.82 54.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.31 0.576 . . . . 0.0 110.049 176.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.743 HG12 HG12 ' A' ' 9' ' ' ILE . 4.0 mt -118.64 140.58 41.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.459 -178.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.408 ' N ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -123.26 117.56 25.57 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.361 0.601 . . . . 0.0 109.935 176.074 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.478 ' CD2' ' HB3' ' A' ' 7' ' ' TYR . 35.8 m-85 -82.71 -174.63 5.34 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.108 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.463 ' C ' HG21 ' A' ' 29' ' ' VAL . . . -84.44 -138.09 3.86 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.688 178.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 170.45 -61.59 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.331 0.586 . . . . 0.0 109.548 -174.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -61.89 136.18 57.87 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.158 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.5 pt 50.36 23.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 O-C-N 124.862 1.351 . . . . 0.0 112.752 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.514 ' OD1' ' HA ' ' A' ' 5' ' ' VAL . 3.2 t-20 -162.53 76.86 0.46 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.287 0.565 . . . . 0.0 110.549 176.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -62.69 -17.93 61.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.656 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -32.8 66.72 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.004 -179.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 26' ' ' ASN . 35.4 m -55.19 -41.95 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 120.799 0.333 . . . . 0.0 110.931 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.401 ' N ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -66.91 -19.75 65.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.272 -177.138 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.71 -45.56 4.85 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.254 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.11 -21.35 12.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.687 -175.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.5 p -70.76 -31.11 44.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 174.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -77.67 -36.71 51.07 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.03 177.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.79 -20.79 45.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.005 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.409 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -65.49 -26.99 68.17 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.659 0.266 . . . . 0.0 110.764 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.511 ' O ' ' HG3' ' A' ' 41' ' ' GLU . . . -62.75 -46.17 89.32 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.2 -34.94 63.88 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.607 176.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.409 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 19.3 t80 -54.98 -41.14 70.83 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.79 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.416 HD11 HD21 ' A' ' 58' ' ' LEU . 48.8 mt -76.74 -27.01 16.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.239 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 37' ' ' ALA . 41.6 mt-10 -79.42 -41.55 27.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.957 0.408 . . . . 0.0 111.398 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -63.27 -35.35 80.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.181 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.49 ' HB2' ' NH1' ' A' ' 89' ' ' ARG . 40.2 mt-30 -129.55 75.93 79.26 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.897 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -95.17 177.98 0.78 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.754 2.303 . . . . 0.0 113.332 -174.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -121.46 146.47 45.17 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -45.23 -28.46 3.62 Favored 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 124.104 3.203 . . . . 0.0 115.307 -169.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.02 20.4 38.43 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.385 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -64.23 136.19 56.97 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.134 0.492 . . . . 0.0 111.375 177.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.432 HG12 ' HA ' ' A' ' 62' ' ' TYR . 39.1 mm -108.25 -58.96 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.449 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -165.94 161.16 17.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.678 0.275 . . . . 0.0 110.552 -175.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 2.4 p -152.09 119.16 5.86 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.769 HG13 ' HB ' ' A' ' 59' ' ' THR . 5.5 pt -123.81 136.12 27.02 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.834 -177.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 72.0 Cg_endo -87.28 158.91 8.29 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.127 2.552 . . . . 0.0 112.414 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.95 48.67 1.22 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.159 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 87.1 t80 72.54 -47.58 0.67 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.543 0.737 . . . . 0.0 112.323 174.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.1 t -133.66 -20.47 2.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.987 0.423 . . . . 0.0 110.729 177.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.4 m -108.21 152.12 25.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.011 0.434 . . . . 0.0 110.801 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.416 HD21 HD11 ' A' ' 40' ' ' ILE . 47.3 tp -126.01 122.69 36.61 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.608 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.769 ' HB ' HG13 ' A' ' 52' ' ' ILE . 5.2 m -104.16 107.18 17.97 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.188 -178.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.4 t -105.22 119.63 54.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.451 0.644 . . . . 0.0 111.241 -175.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -106.85 146.89 30.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.439 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.481 ' CD2' HG11 ' A' ' 82' ' ' VAL . 2.4 p90 -166.32 167.85 15.57 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.046 0.451 . . . . 0.0 110.64 -175.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.407 ' OD1' ' HD1' ' A' ' 65' ' ' TYR . 5.6 t0 -98.55 117.27 32.61 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.329 -178.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.618 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -64.01 -22.67 67.03 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.835 -174.641 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.407 ' HD1' ' OD1' ' A' ' 63' ' ' ASP . 0.2 OUTLIER -69.51 -28.16 65.8 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.699 0.285 . . . . 0.0 111.142 -175.485 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -89.53 -43.38 10.85 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -171.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 m -66.93 -27.69 40.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.853 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.883 ' HA ' HD23 ' A' ' 71' ' ' LEU . 12.1 t80 -66.71 -22.35 66.07 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.049 0.54 . . . . 0.0 110.777 175.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.73 -34.33 62.53 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 173.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -76.07 -38.13 57.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.576 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.883 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -20.33 92.21 0.04 OUTLIER Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 125.814 1.645 . . . . 0.0 113.545 178.461 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.706 ' HD2' HG13 ' A' ' 75' ' ' ILE . 20.9 Cg_exo -68.99 152.13 73.31 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 123.177 2.585 . . . . 0.0 110.264 173.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -67.77 -17.52 64.57 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -171.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.98 -19.04 70.95 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.19 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.706 HG13 ' HD2' ' A' ' 72' ' ' PRO . 11.4 mm -89.75 137.53 21.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.86 -0.67 . . . . 0.0 109.529 175.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.1 m -116.55 2.14 13.01 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.377 0.608 . . . . 0.0 110.568 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.485 ' HB3' ' HB3' ' A' ' 80' ' ' GLU . 31.2 t -141.22 130.7 12.79 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.969 -173.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.67 ' HA ' HD21 ' A' ' 71' ' ' LEU . 80.0 Cg_exo -43.95 -54.73 3.57 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.403 2.735 . . . . 0.0 112.265 169.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.467 ' HD1' ' HB2' ' A' ' 17' ' ' MET . 0.0 OUTLIER -53.35 -42.19 66.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.221 175.821 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 38.7 tt0 -72.39 -19.59 61.58 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.201 -173.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.461 ' HB2' HG21 ' A' ' 75' ' ' ILE . 48.2 t -81.09 -40.08 24.67 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.481 HG11 ' CD2' ' A' ' 62' ' ' TYR . 39.0 t -63.65 -30.77 50.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.987 177.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.754 ' HD3' HG21 ' A' ' 9' ' ' ILE . 7.4 mmmt -49.53 -47.61 48.81 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.208 173.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.562 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 19.7 mmt180 -67.9 -38.74 83.34 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.008 -172.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -63.85 -34.9 78.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.121 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.7 m -88.45 -44.69 15.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.501 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 83' ' ' LYS . 57.6 mt-10 -57.78 -42.41 84.06 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.562 ' HG2' ' O ' ' A' ' 84' ' ' ARG . 10.6 pt-20 -64.03 -28.91 70.12 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.399 0.619 . . . . 0.0 111.056 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.49 ' NH1' ' HB2' ' A' ' 43' ' ' GLN . 47.7 mtm180 -86.05 -46.02 10.88 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.119 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.653 ' O ' HD13 ' A' ' 93' ' ' ILE . 83.9 mt -51.66 -37.88 52.41 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.327 -0.852 . . . . 0.0 108.851 170.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 88' ' ' GLU . . . -51.05 -17.78 0.68 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.593 -1.185 . . . . 0.0 113.461 173.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 89' ' ' ARG . 67.7 mt-10 -49.52 -38.7 31.64 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 118.881 0.764 . . . . 0.0 110.484 173.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.653 HD13 ' O ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -117.66 -21.93 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.655 169.541 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.555 ' HB1' ' HD2' ' A' ' 97' ' ' TYR . . . -91.49 36.63 0.94 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.9 0.857 . . . . 0.0 109.645 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -44.17 -37.21 3.02 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.395 -1.729 . . . . 0.0 111.752 175.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -80.21 -22.31 41.99 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.143 -175.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.555 ' HD2' ' HB1' ' A' ' 94' ' ' ALA . 8.4 m-85 -100.69 15.94 26.57 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.526 -167.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -50.36 -29.81 10.81 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.311 0.577 . . . . 0.0 111.804 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.0 m -100.63 49.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.156 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.411 HD21 ' HA ' ' A' ' 8' ' ' GLN . 2.1 t30 -69.74 140.31 53.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.724 -173.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 . . . . . 0 N--CA 1.438 -1.073 0 CA-C-O 117.718 -1.134 . . . . 0.0 108.333 167.571 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.77 0 N-CA-C 111.893 -0.483 . . . . 0.0 111.893 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.5 m -90.51 32.55 0.95 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.781 0.324 . . . . 0.0 110.305 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.7 mpp? 64.22 171.73 0.18 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.256 -175.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.597 ' O ' HG12 ' A' ' 5' ' ' VAL . 5.1 t -124.05 12.04 8.95 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.777 175.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.597 HG12 ' O ' ' A' ' 4' ' ' THR . 0.5 OUTLIER 63.86 156.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 114.044 -1.434 . . . . 0.0 113.701 173.406 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.812 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 25.1 mmm180 -131.32 139.61 49.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.669 176.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.446 ' HD1' HG13 ' A' ' 5' ' ' VAL . 39.9 p90 -167.76 172.75 8.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.041 -174.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.507 ' O ' ' HD3' ' A' ' 20' ' ' ARG . 18.3 mp0 -135.11 121.6 20.55 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.858 178.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.924 HG12 HG12 ' A' ' 19' ' ' ILE . 18.6 mt -91.46 125.79 44.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.221 177.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -120.54 149.81 41.85 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.101 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -76.9 126.44 30.97 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.281 0.562 . . . . 0.0 110.21 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.684 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -67.47 -37.52 83.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.51 -177.589 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.54 -79.23 0.11 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.416 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -98.98 -68.73 0.79 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.802 0.334 . . . . 0.0 111.782 -177.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.9 p -143.46 49.79 1.41 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.975 0.893 . . . . 0.0 110.239 -174.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -142.46 152.11 42.41 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.371 177.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.516 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 34.1 ttp -124.0 130.55 52.75 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.443 -0.503 . . . . 0.0 112.016 -175.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.684 ' HB2' HD22 ' A' ' 12' ' ' LEU . 50.9 ttm -116.47 126.8 53.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.277 0.56 . . . . 0.0 110.43 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.924 HG12 HG12 ' A' ' 9' ' ' ILE . 7.9 mt -119.66 126.36 75.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.404 -176.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.507 ' HD3' ' O ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -115.06 122.51 46.37 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.89 176.128 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.684 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 28.2 m-85 -85.97 -166.3 1.49 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.882 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.666 ' HA2' HG21 ' A' ' 29' ' ' VAL . . . 111.91 104.05 2.72 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.812 ' HB3' ' HB2' ' A' ' 6' ' ' ARG . 12.3 pt-20 -114.21 -152.81 0.51 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -176.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.401 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 3.8 mp0 -53.47 -69.84 0.11 Allowed 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -176.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.0 pp -143.02 24.97 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.19 0.519 . . . . 0.0 111.566 -172.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.434 ' HB3' ' CG ' ' A' ' 23' ' ' GLU . 47.0 t30 -105.8 114.57 28.81 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.723 -172.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -78.63 -18.2 54.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.085 177.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.87 -29.69 60.34 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 110.696 -177.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.684 ' HB ' ' HB3' ' A' ' 21' ' ' PHE . 32.9 m -59.2 -33.47 50.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.083 0.468 . . . . 0.0 110.783 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -78.97 -18.59 53.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.557 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.83 -37.98 7.11 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.716 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.87 -27.57 12.4 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.994 -176.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.522 HG23 ' HB2' ' A' ' 58' ' ' LEU . 7.2 p -62.76 -32.03 54.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.177 0.513 . . . . 0.0 109.937 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -70.48 -39.11 74.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.171 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.35 -20.3 32.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.483 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.411 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -63.19 -23.9 67.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.432 -176.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.73 -42.32 99.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.746 0.784 . . . . 0.0 109.198 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.481 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.19 -29.67 26.4 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.699 176.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.411 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 1.5 t80 -59.21 -45.71 90.38 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.302 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.435 HD11 HD21 ' A' ' 58' ' ' LEU . 58.5 mt -71.12 -37.98 69.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.503 -176.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.481 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 13.0 pt-20 -75.37 -19.69 59.43 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.31 -174.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 33.5 mt-10 -80.7 -32.14 35.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.922 0.391 . . . . 0.0 110.613 175.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -126.3 64.25 54.01 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.969 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.419 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 72.9 Cg_endo -91.96 176.34 1.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.03 2.487 . . . . 0.0 114.059 -169.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.41 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 2.8 p90 -106.41 146.61 33.34 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.134 173.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 45' ' ' PHE . 73.7 Cg_exo -52.58 -5.99 0.21 Allowed 'Trans proline' 0 N--CA 1.482 0.847 0 C-N-CA 124.085 3.19 . . . . 0.0 115.3 -172.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.41 ' HA3' ' HB3' ' A' ' 66' ' ' GLU . . . -123.23 29.23 5.35 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.943 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -71.09 135.17 47.56 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.836 0.35 . . . . 0.0 111.12 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.2 mm -110.62 -60.34 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.46 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -164.85 155.88 14.7 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.907 -172.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 59' ' ' THR . 4.6 p -152.15 119.47 5.95 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.086 0.469 . . . . 0.0 110.094 173.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.768 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.0 pt -117.67 129.62 25.23 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-O 121.285 0.564 . . . . 0.0 112.068 -178.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 92.9 Cg_endo -85.82 139.03 6.3 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.378 2.719 . . . . 0.0 112.753 -177.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -126.49 46.06 2.54 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.947 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.2 t80 72.1 -40.01 0.46 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.539 0.735 . . . . 0.0 112.731 174.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.1 t -136.44 -18.4 1.48 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.702 0.287 . . . . 0.0 111.25 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 5.4 p -120.3 140.59 51.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.08 0.467 . . . . 0.0 110.966 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.522 ' HB2' HG23 ' A' ' 33' ' ' VAL . 40.8 tp -108.98 119.73 40.44 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.768 ' HB ' HG13 ' A' ' 52' ' ' ILE . 2.2 m -95.01 106.11 18.07 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.5 t -105.54 125.26 60.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.505 0.669 . . . . 0.0 111.507 -173.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -116.93 146.71 42.81 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.297 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.516 ' OH ' ' HB2' ' A' ' 17' ' ' MET . 2.1 p90 -164.96 170.71 14.91 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.011 0.434 . . . . 0.0 110.281 -174.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -101.09 107.97 19.53 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.533 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.474 ' SD ' ' N ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -62.41 -20.69 64.74 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.599 -176.422 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.29 -28.36 68.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.984 0.421 . . . . 0.0 110.207 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.41 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 4.6 tp10 -90.58 -39.12 12.72 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.667 0.746 . . . . 0.0 109.151 -172.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.469 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.4 m -67.24 -30.78 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.719 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.727 ' HA ' HD23 ' A' ' 71' ' ' LEU . 48.0 t80 -58.23 -26.93 63.46 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.563 0.745 . . . . 0.0 111.801 175.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.77 -26.4 59.73 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.415 0.626 . . . . 0.0 109.862 176.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -90.25 -33.56 16.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.146 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.727 HD23 ' HA ' ' A' ' 68' ' ' TYR . 1.1 mm? -23.48 91.75 0.04 OUTLIER Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 125.764 1.626 . . . . 0.0 113.037 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.643 ' HD2' HG13 ' A' ' 75' ' ' ILE . 12.1 Cg_exo -73.49 146.81 39.99 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 123.485 2.79 . . . . 0.0 111.676 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -69.43 108.92 3.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.439 0.638 . . . . 0.0 110.089 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 133.99 -30.68 2.91 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 -170.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.643 HG13 ' HD2' ' A' ' 72' ' ' PRO . 9.1 mm -86.01 108.36 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 114.196 -1.002 . . . . 0.0 108.504 170.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.2 t -90.13 -6.67 55.15 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.125 0.488 . . . . 0.0 110.461 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 74.0 m -135.17 131.86 19.9 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.682 ' HA ' HD21 ' A' ' 71' ' ' LEU . 56.3 Cg_exo -43.42 -55.5 2.88 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.719 2.946 . . . . 0.0 113.079 173.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.476 ' HZ ' ' HD3' ' A' ' 101' ' ' ARG . 0.4 OUTLIER -57.37 -30.96 65.31 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.763 -179.244 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -73.14 -27.45 61.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.955 -176.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.532 ' HB2' HG21 ' A' ' 75' ' ' ILE . 36.9 t -73.62 -35.95 65.39 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.429 HG11 ' CD2' ' A' ' 62' ' ' TYR . 41.7 t -66.13 -30.89 51.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.651 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.69 ' HB3' ' HZ3' ' A' ' 83' ' ' LYS . 9.8 mtpm? -52.5 -46.12 66.5 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.966 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.424 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 20.5 mmt180 -61.07 -41.82 97.36 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.983 -175.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -70.27 -38.47 75.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.6 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.523 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 32.6 m -87.04 -49.32 14.9 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.617 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -175.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.47 ' OE1' ' HB3' ' A' ' 83' ' ' LYS . 50.6 mt-10 -52.07 -49.73 62.94 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -174.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.833 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 6.8 pt-20 -66.44 -25.04 66.55 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.836 -178.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -87.83 -19.81 26.94 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 121.947 -0.471 . . . . 0.0 112.028 174.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 86' ' ' VAL . 14.4 mt -53.21 -71.81 0.06 Allowed 'General case' 0 C--N 1.319 -0.727 0 O-C-N 123.628 0.58 . . . . 0.0 112.54 -166.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.09 -78.21 0.43 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 118.328 -1.349 . . . . 0.0 112.356 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.527 ' O ' HG23 ' A' ' 93' ' ' ILE . 45.4 mm-40 -104.26 -59.72 1.69 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.752 0.787 . . . . 0.0 111.868 170.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.833 ' HA ' ' O ' ' A' ' 88' ' ' GLU . 5.6 pt -179.51 58.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-N 113.068 -1.878 . . . . 0.0 107.118 -164.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 87' ' ' GLU . . . -70.36 45.86 0.08 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.999 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.422 ' H ' ' C ' ' A' ' 93' ' ' ILE . 10.8 pt-20 -59.33 -35.26 73.5 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.917 176.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.33 -22.03 64.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.574 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.617 ' HE2' HH11 ' A' ' 6' ' ' ARG . 57.5 m-85 -94.3 16.22 15.54 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -170.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -47.3 -32.01 4.35 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.396 0.617 . . . . 0.0 110.241 169.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.9 m -87.35 31.25 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.133 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -73.64 -46.08 48.87 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 172.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.476 ' HD3' ' HZ ' ' A' ' 79' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.24 0 CA-C-N 114.602 -1.181 . . . . 0.0 107.922 171.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 112.006 -0.438 . . . . 0.0 112.006 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -79.21 59.4 2.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.191 0.52 . . . . 0.0 111.247 -176.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.4 ptp -93.59 164.14 13.28 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.74 178.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.3 t -79.81 45.58 0.71 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.338 0.589 . . . . 0.0 110.943 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.898 ' HA ' HD21 ' A' ' 26' ' ' ASN . 22.5 m 44.0 -175.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.547 1.139 . . . . 0.0 113.194 -174.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -151.44 72.25 1.03 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.59 ' HE1' HD11 ' A' ' 9' ' ' ILE . 37.1 p90 -113.03 152.03 29.95 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.641 0.734 . . . . 0.0 112.198 -174.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -128.46 134.82 48.83 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.488 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.59 HD11 ' HE1' ' A' ' 7' ' ' TYR . 4.5 mp -93.88 108.6 20.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.325 178.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -117.31 166.2 12.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.621 0.724 . . . . 0.0 111.214 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.66 140.87 41.09 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.643 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.517 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -84.88 -21.61 29.68 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.321 174.72 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 152.3 -68.56 0.31 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 119.903 -1.142 . . . . 0.0 113.464 176.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -119.26 -61.73 1.6 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.894 0.378 . . . . 0.0 111.393 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.1 p -141.26 39.85 1.76 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.447 0.642 . . . . 0.0 111.013 -175.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.509 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -141.76 160.36 40.33 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.133 175.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.435 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 34.0 ttp -129.48 136.62 50.12 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.61 -0.436 . . . . 0.0 112.115 -175.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.517 ' HB2' HD22 ' A' ' 12' ' ' LEU . 48.9 ttm -121.59 130.33 53.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.197 0.522 . . . . 0.0 110.685 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.4 mt -117.17 121.11 66.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.606 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -115.18 120.65 40.45 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.755 0.788 . . . . 0.0 110.957 -177.515 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.648 ' HD2' HG12 ' A' ' 29' ' ' VAL . 44.4 m-85 -86.07 -171.85 3.78 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 113.799 -1.546 . . . . 0.0 109.97 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' A' ' 23' ' ' GLU . . . -77.65 -115.43 0.17 Allowed Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.271 177.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.616 ' HG3' ' HG3' ' A' ' 24' ' ' GLU . 11.0 pt-20 158.78 -40.51 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.848 0.859 . . . . 0.0 110.675 168.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.616 ' HG3' ' HG3' ' A' ' 23' ' ' GLU . 42.1 mt-10 -83.25 132.1 35.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.151 -174.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.6 mt 54.69 31.38 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-O 122.135 0.969 . . . . 0.0 110.03 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.898 HD21 ' HA ' ' A' ' 5' ' ' VAL . 50.7 t-20 -142.07 85.42 1.92 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.617 -174.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -69.61 -22.73 63.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.212 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.84 -46.64 81.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.789 -177.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.648 HG12 ' HD2' ' A' ' 21' ' ' PHE . 35.5 m -63.9 -45.4 97.06 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.421 ' N ' HG23 ' A' ' 29' ' ' VAL . 39.9 t30 -53.9 -42.32 68.57 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.396 -176.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.26 -47.46 6.46 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.598 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -74.25 -29.55 24.94 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.509 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -170.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 29' ' ' VAL . 7.3 p -63.78 -32.21 56.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.663 177.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.597 ' CE1' ' HA ' ' A' ' 55' ' ' PHE . 34.4 m80 -81.59 -32.23 32.17 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.541 179.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.61 -24.38 36.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.845 0.355 . . . . 0.0 111.121 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.518 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -67.11 -20.92 65.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.43 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.64 98.72 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.647 0.737 . . . . 0.0 109.056 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.521 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.67 -32.32 23.68 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.76 175.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.518 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 17.0 t80 -53.53 -48.94 68.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.451 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.681 HD11 HD21 ' A' ' 58' ' ' LEU . 65.2 mt -69.1 -34.78 65.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.543 -177.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.521 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 12.5 pt-20 -76.92 -22.44 53.33 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.165 -173.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 95.0 mt-10 -74.91 -34.33 62.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.755 0.312 . . . . 0.0 110.607 177.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.854 ' HB2' HH12 ' A' ' 89' ' ' ARG . 4.5 mp0 -127.46 74.45 77.75 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -95.21 178.8 0.71 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 123.18 2.587 . . . . 0.0 113.48 -173.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 3.8 p90 -112.55 146.26 34.63 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.133 172.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 45' ' ' PHE . 42.5 Cg_exo -61.16 15.17 0.04 OUTLIER 'Trans proline' 0 N--CA 1.482 0.795 0 C-N-CA 123.992 3.128 . . . . 0.0 114.789 -174.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . -133.65 18.79 4.3 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 175.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -70.65 137.41 49.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.736 0.303 . . . . 0.0 110.608 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.1 mm -113.6 -56.88 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.39 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.431 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 9.4 tp10 -160.94 157.1 25.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.827 0.346 . . . . 0.0 110.702 -175.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 59' ' ' THR . 8.2 p -152.03 117.94 5.47 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 172.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.759 HG13 ' HB ' ' A' ' 59' ' ' THR . 7.1 pt -118.62 128.53 25.92 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-O 121.253 0.549 . . . . 0.0 112.142 -176.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.443 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 84.1 Cg_endo -86.46 120.85 1.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.497 2.798 . . . . 0.0 112.144 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.417 ' HB3' ' OG ' ' A' ' 57' ' ' SER . . . -114.41 59.86 0.68 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.686 0.279 . . . . 0.0 111.215 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.597 ' HA ' ' CE1' ' A' ' 34' ' ' HIS . 70.4 t80 74.34 -49.24 0.67 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.392 0.677 . . . . 0.0 111.817 173.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.411 ' HA ' HG11 ' A' ' 33' ' ' VAL . 14.0 t -140.05 -14.35 1.04 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.879 0.371 . . . . 0.0 111.475 176.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.417 ' OG ' ' HB3' ' A' ' 54' ' ' ALA . 18.3 p -108.66 133.75 52.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.413 0.625 . . . . 0.0 110.823 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.681 HD21 HD11 ' A' ' 40' ' ' ILE . 57.0 tp -102.58 111.77 24.23 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.759 ' HB ' HG13 ' A' ' 52' ' ' ILE . 1.8 m -95.43 107.04 19.16 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.743 -176.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.2 t -106.27 118.68 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.527 0.68 . . . . 0.0 111.243 -172.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.431 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 88.1 m-85 -111.6 148.54 33.08 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.572 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.448 ' OH ' ' HA ' ' A' ' 79' ' ' PHE . 2.1 p90 -165.82 169.62 14.78 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -175.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -102.29 113.07 26.05 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.527 -176.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.631 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -58.84 -19.69 43.87 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.455 -174.204 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -65.62 -28.42 69.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.637 0.256 . . . . 0.0 111.191 -177.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.536 ' O ' ' HD2' ' A' ' 70' ' ' HIS . 2.4 tm-20 -91.3 -41.32 11.0 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -176.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.631 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.0 m -64.53 -30.79 51.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.996 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.933 ' HA ' HD23 ' A' ' 71' ' ' LEU . 62.6 t80 -63.93 -26.65 68.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.402 173.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.03 -27.92 66.96 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 174.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.536 ' HD2' ' O ' ' A' ' 66' ' ' GLU . 16.7 m-70 -83.78 -69.18 0.66 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.705 175.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.933 HD23 ' HA ' ' A' ' 68' ' ' TYR . 1.1 mm? 18.75 71.07 0.22 Allowed Pre-proline 0 N--CA 1.474 0.758 0 O-C-N 124.929 1.393 . . . . 0.0 112.576 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.612 ' HD2' HG13 ' A' ' 75' ' ' ILE . 64.4 Cg_exo -53.14 153.46 16.19 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.166 2.577 . . . . 0.0 112.719 -173.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -69.84 93.82 0.78 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.53 0.681 . . . . 0.0 110.724 -175.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 139.67 -27.16 2.61 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -173.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.612 HG13 ' HD2' ' A' ' 72' ' ' PRO . 8.9 mm -80.49 125.97 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.615 -0.792 . . . . 0.0 109.038 172.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.4 m -110.76 -1.86 16.46 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.227 0.536 . . . . 0.0 110.781 -177.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.538 ' OG ' ' HD1' ' A' ' 79' ' ' PHE . 22.6 t -131.57 134.37 25.45 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.791 -175.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.497 ' O ' HG23 ' A' ' 82' ' ' VAL . 96.2 Cg_exo -47.05 -53.45 6.3 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.312 2.675 . . . . 0.0 112.436 171.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.538 ' HD1' ' OG ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -60.35 -34.21 73.53 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.311 0.577 . . . . 0.0 110.551 -179.636 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.544 ' HA ' ' CE ' ' A' ' 83' ' ' LYS . 56.6 tt0 -69.57 -27.81 65.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.177 -177.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.539 ' HB3' HG21 ' A' ' 75' ' ' ILE . 95.7 p -79.84 -31.37 40.55 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.501 0.667 . . . . 0.0 109.539 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 78' ' ' PRO . 36.3 t -73.68 -28.82 25.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.147 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.544 ' CE ' ' HA ' ' A' ' 80' ' ' GLU . 44.6 mtmt -54.73 -41.32 70.22 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 121.374 0.607 . . . . 0.0 109.578 173.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.649 ' NH1' ' HA ' ' A' ' 101' ' ' ARG . 21.4 mmm180 -66.11 -32.58 74.11 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.089 -176.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 14.6 t70 -77.1 -40.79 44.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.287 -178.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.6 m -83.5 -37.48 13.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.784 -177.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.475 ' OE2' ' HB2' ' A' ' 91' ' ' ALA . 10.3 mm-40 -62.96 -36.21 82.73 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.89 ' HG3' ' HD3' ' A' ' 89' ' ' ARG . 9.4 pt-20 -56.83 -29.37 62.74 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.74 176.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.89 ' HD3' ' HG3' ' A' ' 88' ' ' GLU . 0.8 OUTLIER -89.26 -34.18 16.7 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.982 0.42 . . . . 0.0 111.837 173.785 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 87' ' ' GLU . 88.6 mt -85.09 -66.71 0.87 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.372 0.606 . . . . 0.0 111.502 -177.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.704 ' HB1' ' HA ' ' A' ' 99' ' ' VAL . . . -58.02 -17.85 20.32 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.265 -0.879 . . . . 0.0 113.234 -177.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -58.78 -40.33 83.67 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.373 174.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.457 HD13 ' O ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -95.32 -25.19 4.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.074 0.464 . . . . 0.0 110.342 179.741 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -100.62 35.09 2.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.933 0.873 . . . . 0.0 110.371 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -55.62 -25.71 40.25 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.328 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -48.65 -30.54 5.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.069 -0.969 . . . . 0.0 113.342 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.46 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 5.7 m-30 -74.32 -62.12 1.63 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.926 -178.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 97' ' ' TYR . 10.9 pt-20 165.38 0.17 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.286 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.704 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 55.5 t 65.72 101.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -164.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -70.43 133.46 46.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.487 0.66 . . . . 0.0 111.05 -170.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.649 ' HA ' ' NH1' ' A' ' 84' ' ' ARG . 20.1 ttt180 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.199 -0.905 . . . . 0.0 109.609 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.845 0 N-CA-C 112.128 -0.389 . . . . 0.0 112.128 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.3 t -179.66 -76.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.581 ' HB3' ' H ' ' A' ' 5' ' ' VAL . 15.9 mmt 60.13 173.9 0.09 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 122.389 1.09 . . . . 0.0 113.66 173.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.541 ' O ' HG12 ' A' ' 5' ' ' VAL . 5.1 t -120.03 15.54 12.44 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.967 -1.469 . . . . 0.0 107.628 170.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.773 HG23 HD21 ' A' ' 26' ' ' ASN . 0.3 OUTLIER 64.65 150.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 113.446 -1.706 . . . . 0.0 112.317 -174.806 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.57 ' HA ' ' OH ' ' A' ' 97' ' ' TYR . 2.2 mpt_? -108.73 139.11 43.99 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 113.993 -1.458 . . . . 0.0 108.133 171.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 25.4 p90 -166.26 146.82 6.34 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.167 0.508 . . . . 0.0 111.011 178.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.431 ' HB2' ' HE ' ' A' ' 20' ' ' ARG . 4.9 mp0 -128.34 132.43 48.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.466 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.93 HG13 HG12 ' A' ' 19' ' ' ILE . 2.9 mp -83.47 114.74 24.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 171.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 18' ' ' MET . 12.4 pt-20 -110.21 150.11 29.14 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.121 0.486 . . . . 0.0 109.69 177.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -81.25 127.71 33.0 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.428 0.633 . . . . 0.0 110.208 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.649 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -70.41 -40.3 73.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.427 -174.777 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 172.84 -66.18 0.12 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.808 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -125.75 -58.87 1.38 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.835 0.35 . . . . 0.0 111.717 -173.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.2 p -142.01 37.62 1.59 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.517 0.675 . . . . 0.0 111.29 -173.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.95 158.26 43.77 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.781 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.626 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -128.03 149.37 50.4 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.046 -179.086 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.649 ' HB2' HD22 ' A' ' 12' ' ' LEU . 53.6 ttm -132.38 135.41 46.12 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 174.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.93 HG12 HG13 ' A' ' 9' ' ' ILE . 10.5 mt -114.58 106.18 20.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.514 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -91.94 131.44 37.24 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.296 0.57 . . . . 0.0 109.879 177.905 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 29.0 m-85 -98.74 -168.0 1.57 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.266 -178.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.78 177.15 50.13 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.621 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -144.09 -66.4 0.35 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.951 0.405 . . . . 0.0 111.562 -176.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -58.48 -52.57 65.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.226 -172.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.3 pt -117.23 26.14 4.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.1 -171.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.773 HD21 HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -120.93 103.82 9.35 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.684 -173.524 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.521 ' CD ' ' H ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -79.78 -45.14 19.36 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.887 176.701 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.71 -34.42 71.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.988 -171.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.727 ' O ' HG12 ' A' ' 33' ' ' VAL . 2.4 p -56.4 -49.0 79.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.298 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -55.67 -29.19 58.9 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.579 0.549 . . . . 0.0 111.168 -173.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.76 -40.6 5.25 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.73 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -87.41 -29.7 5.65 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -171.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 29' ' ' VAL . 9.5 p -65.74 -30.98 51.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 118.968 0.804 . . . . 0.0 109.281 178.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.401 ' HA ' ' CB ' ' A' ' 53' ' ' PRO . 22.0 t60 -81.61 -30.2 32.98 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.999 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.43 -21.72 30.62 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.015 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.475 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -65.06 -23.48 67.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.181 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.89 98.77 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.841 0.829 . . . . 0.0 109.02 177.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.763 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.96 -27.17 26.69 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.948 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.475 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 5.8 t80 -59.73 -44.48 93.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.374 179.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.463 HD11 HD21 ' A' ' 58' ' ' LEU . 44.6 mt -78.59 -32.03 15.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.483 -176.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.763 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 10.8 pt-20 -73.64 -20.22 60.63 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.861 -176.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -88.21 -29.89 20.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.735 0.302 . . . . 0.0 110.384 173.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -124.72 69.8 56.3 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.177 0.513 . . . . 0.0 110.091 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -99.86 -161.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.693 2.929 . . . . 0.0 114.083 -169.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.45 ' HE1' ' HB3' ' A' ' 62' ' ' TYR . 1.6 p90 -138.37 147.35 55.07 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 114.022 -1.444 . . . . 0.0 107.966 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.75 -21.26 0.86 Allowed 'Trans proline' 0 N--CA 1.482 0.842 0 C-N-CA 124.25 3.3 . . . . 0.0 115.55 -169.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.419 ' HA3' ' HB3' ' A' ' 66' ' ' GLU . . . -119.36 30.7 5.7 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.188 -0.53 . . . . 0.0 111.947 -179.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.505 ' HZ ' ' HG ' ' A' ' 51' ' ' CYS . 47.2 t80 -66.53 128.69 37.18 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.098 0.475 . . . . 0.0 110.82 175.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.4 mm -103.09 -61.71 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.108 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -164.56 155.48 15.0 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 120.767 0.317 . . . . 0.0 110.998 -174.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.505 ' HG ' ' HZ ' ' A' ' 48' ' ' PHE . 5.9 p -144.46 118.32 9.32 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 173.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.806 HG13 ' HB ' ' A' ' 59' ' ' THR . 5.5 pt -117.43 129.26 25.46 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-O 121.042 0.449 . . . . 0.0 112.001 -175.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.592 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 17.8 Cg_endo -86.73 124.33 2.23 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.498 2.799 . . . . 0.0 112.684 -178.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -117.73 58.73 0.8 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.15 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.458 ' O ' HG11 ' A' ' 33' ' ' VAL . 56.2 t80 72.34 -49.64 0.69 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.548 0.739 . . . . 0.0 112.087 173.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.1 t -137.23 -21.07 1.2 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.747 0.308 . . . . 0.0 111.253 178.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 16.1 m -108.2 133.11 52.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.071 0.463 . . . . 0.0 110.864 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.463 HD21 HD11 ' A' ' 40' ' ' ILE . 44.0 tp -102.77 111.96 24.53 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.806 ' HB ' HG13 ' A' ' 52' ' ' ILE . 2.9 m -89.15 107.96 19.34 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -177.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.626 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 64.6 t -104.0 113.66 41.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.575 0.702 . . . . 0.0 111.338 -172.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -103.76 148.88 25.56 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.872 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.53 ' CD2' HG11 ' A' ' 82' ' ' VAL . 2.3 p90 -165.13 168.53 17.13 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.164 -176.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -98.86 109.05 21.87 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.947 -175.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.653 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -61.97 -20.6 64.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.125 -177.725 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.41 ' CE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -67.47 -31.92 72.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.9 0.381 . . . . 0.0 110.281 179.481 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 10.2 tp10 -91.31 -30.69 16.44 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 122.059 0.933 . . . . 0.0 109.1 -170.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.653 HG22 ' HA ' ' A' ' 64' ' ' MET . 4.2 m -75.66 -34.12 28.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.26 176.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.855 ' HA ' HD23 ' A' ' 71' ' ' LEU . 52.4 t80 -71.28 -22.87 61.9 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.8 174.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 4.2 tppp? -59.42 -35.96 74.98 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -88.5 -65.8 0.98 Allowed 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.207 176.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.855 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER 24.93 78.7 0.22 Allowed Pre-proline 0 N--CA 1.48 1.038 0 C-N-CA 124.858 1.263 . . . . 0.0 113.463 178.356 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.686 ' HD2' HG13 ' A' ' 75' ' ' ILE . 32.1 Cg_exo -58.52 155.06 38.26 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.321 2.014 . . . . 0.0 110.989 175.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -71.38 -17.08 62.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.675 -171.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -77.8 -28.68 56.44 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 172.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.686 HG13 ' HD2' ' A' ' 72' ' ' PRO . 20.4 mm -77.44 129.8 36.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.791 -0.705 . . . . 0.0 109.638 175.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.2 m -110.0 1.64 19.13 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.337 0.589 . . . . 0.0 110.528 -177.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.658 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 43.8 t -146.9 132.97 9.5 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.261 -172.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.628 ' HA ' HD21 ' A' ' 71' ' ' LEU . 86.3 Cg_exo -45.74 -53.47 5.6 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.349 2.699 . . . . 0.0 112.732 170.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.407 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -58.26 -31.61 67.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.93 0.395 . . . . 0.0 111.385 177.373 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.658 ' HB2' ' HB3' ' A' ' 77' ' ' SER . 23.8 tt0 -72.83 -30.07 63.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.259 -173.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.558 ' HB3' HG21 ' A' ' 75' ' ' ILE . 91.4 p -76.38 -34.55 58.89 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.53 HG11 ' CD2' ' A' ' 62' ' ' TYR . 16.6 t -63.84 -31.73 54.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.537 176.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.495 ' HE3' HG12 ' A' ' 9' ' ' ILE . 2.4 mtpt -54.93 -38.01 67.14 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-O 121.171 0.51 . . . . 0.0 109.685 175.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -67.63 -31.89 72.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.175 -176.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -78.3 -36.72 46.21 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.357 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.8 m -86.78 -40.32 13.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.649 -177.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.403 ' HA ' ' HB2' ' A' ' 90' ' ' LEU . 6.1 mm-40 -69.07 -32.58 72.14 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -177.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -57.75 -26.33 61.69 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.976 175.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -88.32 -55.41 3.75 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.809 168.773 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.659 ' O ' HD13 ' A' ' 93' ' ' ILE . 90.1 mt -70.49 -67.44 0.5 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -173.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.411 ' HB1' ' HA ' ' A' ' 99' ' ' VAL . . . -56.6 -18.75 13.0 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -71.57 -47.23 56.28 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.555 -176.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.659 HD13 ' O ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -89.71 -20.23 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.455 0.645 . . . . 0.0 109.377 179.018 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -101.2 42.58 1.11 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 122.221 1.01 . . . . 0.0 108.616 174.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -57.2 -16.22 7.62 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.605 -1.634 . . . . 0.0 111.181 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -52.53 -23.79 6.95 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.389 176.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.57 ' OH ' ' HA ' ' A' ' 6' ' ' ARG . 27.9 m-85 -98.31 11.58 37.54 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.417 ' O ' ' HB ' ' A' ' 99' ' ' VAL . 8.9 pt-20 41.24 36.76 0.52 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.247 0.967 . . . . 0.0 111.39 -177.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 98' ' ' GLU . 67.0 t 71.74 115.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.244 -171.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.439 ' HB3' ' NZ ' ' A' ' 83' ' ' LYS . 6.1 t-20 -54.86 121.17 8.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.812 -171.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.131 -171.754 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.59 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -135.01 127.16 29.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.92 0.391 . . . . 0.0 110.263 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.67 ' SD ' ' HB2' ' A' ' 28' ' ' GLN . 0.4 OUTLIER -126.19 156.64 39.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.831 177.377 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.595 ' HA ' ' CD1' ' A' ' 97' ' ' TYR . 1.8 t -79.29 100.37 7.52 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.012 0.911 . . . . 0.0 109.487 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.739 HG12 ' CD2' ' A' ' 97' ' ' TYR . 4.6 p -72.56 163.95 3.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.271 -174.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -128.72 118.94 23.71 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.512 172.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.506 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 42.2 p90 -135.57 166.84 22.29 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.319 0.58 . . . . 0.0 111.028 -175.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -130.9 116.05 17.37 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.875 -174.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.884 HG12 HG12 ' A' ' 19' ' ' ILE . 22.3 mt -92.62 112.52 26.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.128 175.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -124.25 168.46 12.92 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.499 -175.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -87.74 128.11 35.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.46 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.679 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.3 OUTLIER -76.18 -46.41 28.6 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.127 -174.135 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -168.84 -90.62 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.629 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -110.62 -37.52 5.44 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -175.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.5 p -160.8 42.73 0.17 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.872 0.844 . . . . 0.0 110.696 -177.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.0 148.21 41.55 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.333 176.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.598 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 32.1 ttp -117.39 140.53 49.47 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 120.955 0.407 . . . . 0.0 111.504 -177.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.679 ' HB2' HD22 ' A' ' 12' ' ' LEU . 1.4 tmt? -124.69 126.05 45.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.44 0.638 . . . . 0.0 110.431 -176.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.884 HG12 HG12 ' A' ' 9' ' ' ILE . 6.6 mt -119.56 138.26 50.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.768 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.61 127.03 21.48 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.909 0.385 . . . . 0.0 110.369 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.506 ' HA ' ' CB ' ' A' ' 7' ' ' TYR . 8.1 m-85 -97.47 -152.94 0.41 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.865 -178.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.564 ' O ' HG11 ' A' ' 29' ' ' VAL . . . -83.13 178.79 52.96 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 174.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -151.27 161.34 42.89 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 71.61 -71.51 0.13 Allowed 'General case' 0 C--N 1.332 -0.18 0 O-C-N 124.007 0.817 . . . . 0.0 111.927 176.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.5 pt -92.57 14.93 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.303 0.573 . . . . 0.0 110.864 -173.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.402 ' O ' HG12 ' A' ' 29' ' ' VAL . 3.5 t-20 -121.78 91.84 3.6 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.161 -176.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -57.86 -37.78 74.53 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.879 175.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.67 ' HB2' ' SD ' ' A' ' 3' ' ' MET . 0.5 OUTLIER -50.76 -52.02 44.77 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.577 -176.835 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.564 HG11 ' O ' ' A' ' 22' ' ' GLY . 11.9 p -65.74 -50.58 70.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.36 -174.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.439 ' N ' HG13 ' A' ' 29' ' ' VAL . 70.9 m-20 -53.1 -42.68 66.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.144 0.497 . . . . 0.0 110.939 -177.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.82 -5.17 90.22 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.528 -0.76 . . . . 0.0 113.614 -176.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.22 -34.25 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.605 0 CA-C-N 117.987 0.894 . . . . 0.0 113.352 -176.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 29' ' ' VAL . 10.8 p -62.98 -32.72 57.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 118.467 0.576 . . . . 0.0 110.681 -174.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -80.27 -23.5 40.73 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.04 -23.85 26.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.069 0.461 . . . . 0.0 110.419 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.472 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -64.28 -22.82 67.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.098 -178.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.54 97.14 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.688 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -82.98 -30.45 28.2 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.812 175.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.622 ' HE1' ' HB3' ' A' ' 89' ' ' ARG . 16.0 t80 -57.05 -44.28 82.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.377 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.695 HD11 HD21 ' A' ' 58' ' ' LEU . 49.5 mt -77.06 -38.41 27.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.587 -176.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.688 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 13.3 pt-20 -68.73 -21.11 64.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.896 0.379 . . . . 0.0 111.017 -175.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -92.56 -21.14 20.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.868 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -133.14 64.71 71.29 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.894 0.378 . . . . 0.0 110.412 178.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -97.35 -175.81 0.25 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.494 2.796 . . . . 0.0 113.077 -173.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.606 ' HZ ' ' HB2' ' A' ' 62' ' ' TYR . 14.3 p90 -116.56 148.11 41.17 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 172.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -42.22 -24.87 0.36 Allowed 'Trans proline' 0 N--CA 1.481 0.791 0 C-N-CA 124.404 3.403 . . . . 0.0 115.926 -170.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.05 19.36 32.64 Favored Glycine 0 C--O 1.229 -0.21 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.413 -176.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.464 ' HZ ' ' HG ' ' A' ' 51' ' ' CYS . 37.1 t80 -69.21 134.86 49.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.007 0.432 . . . . 0.0 111.331 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.472 HG12 ' HA ' ' A' ' 62' ' ' TYR . 40.6 mm -106.17 -60.67 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.298 -177.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -160.99 156.31 24.58 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -171.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.464 ' HG ' ' HZ ' ' A' ' 48' ' ' PHE . 12.7 p -151.75 119.48 6.13 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 175.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.794 HG13 ' HB ' ' A' ' 59' ' ' THR . 9.3 pt -123.91 134.87 25.68 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.842 -175.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.427 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 78.5 Cg_endo -86.95 152.19 8.43 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.159 2.573 . . . . 0.0 112.463 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -137.61 47.83 2.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.116 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.408 ' O ' HG11 ' A' ' 33' ' ' VAL . 48.7 t80 72.09 -37.52 0.39 Allowed 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 173.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.0 t -138.43 -21.3 1.04 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.183 0.516 . . . . 0.0 110.933 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.3 p -113.52 155.1 25.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.61 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.695 HD21 HD11 ' A' ' 40' ' ' ILE . 48.1 tp -124.49 114.92 20.08 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.794 ' HB ' HG13 ' A' ' 52' ' ' ILE . 4.4 m -94.91 106.92 18.93 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.885 -176.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.0 t -106.04 121.5 58.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.47 0.653 . . . . 0.0 111.647 -172.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.408 ' CE1' HG22 ' A' ' 59' ' ' THR . 90.7 m-85 -110.99 148.51 32.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.939 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.606 ' HB2' ' HZ ' ' A' ' 45' ' ' PHE . 3.5 p90 -167.33 170.14 11.79 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.893 -173.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -102.26 120.45 40.49 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.291 0.567 . . . . 0.0 110.692 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.17 -22.39 65.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.266 -174.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.11 -25.82 67.94 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.75 0.31 . . . . 0.0 110.784 -177.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -89.49 -33.55 16.73 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.738 0.78 . . . . 0.0 109.011 -171.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.9 m -77.67 -36.61 23.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.898 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.763 ' HA ' HD23 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -62.9 -23.11 67.19 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.973 177.598 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.507 ' HE2' ' HB2' ' A' ' 69' ' ' LYS . 3.3 tppt? -54.86 -49.17 71.79 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 121.939 0.876 . . . . 0.0 108.877 177.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -89.94 -62.89 1.37 Allowed 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.858 -177.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.763 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER 34.5 77.3 0.38 Allowed Pre-proline 0 N--CA 1.473 0.707 0 O-C-N 124.533 1.146 . . . . 0.0 111.521 -178.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.444 ' HD2' HG13 ' A' ' 75' ' ' ILE . 50.5 Cg_exo -54.64 152.43 27.62 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.288 2.659 . . . . 0.0 112.839 -175.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -76.18 87.29 3.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.05 0.929 . . . . 0.0 110.495 -176.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 155.09 -31.19 0.65 Allowed Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 -173.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.514 HG21 ' HB2' ' A' ' 81' ' ' SER . 18.6 mm -79.77 115.7 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 114.028 -1.086 . . . . 0.0 108.808 169.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.5 m -97.76 -5.86 34.05 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.194 0.521 . . . . 0.0 110.239 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 47.6 m -138.72 132.38 16.25 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.943 -172.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.609 ' HA ' HD21 ' A' ' 71' ' ' LEU . 30.8 Cg_exo -45.23 -56.99 2.35 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.436 2.758 . . . . 0.0 113.305 173.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.606 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.8 OUTLIER -55.18 -30.82 60.67 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.203 0.525 . . . . 0.0 111.177 178.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.604 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 36.5 tt0 -73.64 -24.47 60.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.259 -176.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.514 ' HB2' HG21 ' A' ' 75' ' ' ILE . 17.4 t -76.24 -36.28 58.58 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.466 HG11 ' CD2' ' A' ' 62' ' ' TYR . 60.2 t -63.66 -30.18 49.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.248 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.604 ' HG3' ' HA ' ' A' ' 80' ' ' GLU . 14.9 mtmm -54.2 -37.85 64.98 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 176.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -64.59 -37.47 87.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.182 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.513 ' HA ' ' OE2' ' A' ' 88' ' ' GLU . 42.3 m-20 -70.92 -35.48 72.28 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.916 -176.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.9 m -86.79 -42.76 15.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.149 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -67.77 -33.77 75.49 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.536 ' HG3' ' HD3' ' A' ' 89' ' ' ARG . 12.2 pt-20 -57.83 -28.55 64.18 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.757 176.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.622 ' HB3' ' HE1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -87.07 -51.87 5.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.976 170.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.3 mt -73.47 -67.96 0.54 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.454 -174.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.653 ' HA ' ' HB3' ' A' ' 94' ' ' ALA . . . -56.45 -19.38 14.93 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -173.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -68.58 -36.54 78.87 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.836 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.626 HD13 ' N ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -92.49 -19.84 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.03 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.653 ' HB3' ' HA ' ' A' ' 91' ' ' ALA . . . -90.43 33.16 0.91 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.369 177.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -39.35 -56.32 1.58 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 112.929 -1.941 . . . . 0.0 112.907 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -81.38 -21.57 38.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.107 -176.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.739 ' CD2' HG12 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -70.03 -61.8 1.64 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.036 -168.04 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 171.46 116.83 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 O-C-N 123.93 0.769 . . . . 0.0 110.304 172.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.502 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 23.0 t -88.95 87.14 2.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.311 178.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -60.96 137.26 58.24 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.098 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 22.6 tpt180 . . . . . 0 C--O 1.249 1.044 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.896 176.843 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 p -117.87 144.88 45.02 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.6 ptt? -155.9 168.63 26.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.849 0.356 . . . . 0.0 110.839 -176.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.548 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 12.8 t -88.42 24.1 2.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.864 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.548 ' HB ' ' O ' ' A' ' 4' ' ' THR . 0.9 OUTLIER 77.12 140.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.991 -174.194 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -145.94 108.97 4.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.125 -1.398 . . . . 0.0 108.437 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.519 ' CE2' HD12 ' A' ' 93' ' ' ILE . 16.3 p90 -114.49 155.92 25.52 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.402 0.62 . . . . 0.0 111.891 -174.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.666 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . 1.8 mp0 -120.28 134.54 55.24 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.257 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.928 HG12 HG12 ' A' ' 19' ' ' ILE . 15.3 mt -101.92 114.14 40.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.291 174.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 18' ' ' MET . 10.4 pt-20 -109.12 153.1 24.19 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.691 -177.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -76.99 126.9 31.74 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.758 0.79 . . . . 0.0 110.542 178.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.693 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.3 OUTLIER -79.72 -48.67 13.25 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.019 -173.233 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.88 100.87 0.16 Allowed Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 73.2 -64.16 0.41 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 176.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.515 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 11.5 p -150.64 60.06 0.94 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.338 0.589 . . . . 0.0 111.831 -172.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -160.89 154.64 22.35 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 176.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.917 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -121.18 138.64 54.12 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.091 -177.944 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.693 ' HB2' HD22 ' A' ' 12' ' ' LEU . 26.4 ttt -124.04 124.06 41.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.438 0.637 . . . . 0.0 110.396 177.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.928 HG12 HG12 ' A' ' 9' ' ' ILE . 9.3 mt -116.12 144.31 24.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.191 -175.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.666 ' HD3' ' HB2' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -134.93 132.75 38.83 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 173.577 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.477 ' HB2' HG21 ' A' ' 29' ' ' VAL . 6.8 m-85 -98.52 -147.85 0.33 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.707 ' O ' HG11 ' A' ' 29' ' ' VAL . . . -96.75 -175.84 35.28 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 174.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -139.88 -64.85 0.48 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 117.666 0.733 . . . . 0.0 111.151 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -69.85 130.76 43.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.931 -175.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.8 mm 65.87 14.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.936 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.489 ' HB3' HG12 ' A' ' 29' ' ' VAL . 5.8 m-20 -120.43 83.78 2.11 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.558 -176.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -78.68 -20.2 50.73 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 174.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -54.23 -53.79 48.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.068 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.707 HG11 ' O ' ' A' ' 22' ' ' GLY . 4.3 p -61.32 -46.34 96.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.757 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -53.71 -27.04 25.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.958 -177.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -97.55 -39.83 3.81 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.435 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -86.44 -22.4 7.15 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -171.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.6 HG12 ' O ' ' A' ' 29' ' ' VAL . 14.5 p -69.01 -28.45 39.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.371 177.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -77.79 -41.59 36.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.499 174.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.88 -26.0 60.33 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.503 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.478 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -67.12 -26.64 66.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.153 -178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.471 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . . . -62.29 -36.82 83.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 122.013 0.911 . . . . 0.0 109.119 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.81 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.75 -36.2 21.93 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.872 174.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.478 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 2.6 t80 -54.72 -42.08 71.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.342 0.591 . . . . 0.0 110.864 -178.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.598 HD11 HD21 ' A' ' 58' ' ' LEU . 33.5 mt -78.03 -29.41 15.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.295 -178.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.81 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 6.9 pt-20 -80.67 -32.97 35.85 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.439 -177.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 54.0 mt-10 -72.72 -29.72 63.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.097 0.475 . . . . 0.0 110.139 178.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -121.42 73.56 30.05 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 172.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -96.88 -168.92 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.932 2.421 . . . . 0.0 113.773 -170.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.416 ' C ' ' H ' ' A' ' 47' ' ' GLY . 2.8 p90 -136.43 147.17 58.92 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.14 176.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 45' ' ' PHE . 52.1 Cg_exo -58.23 7.87 0.06 OUTLIER 'Trans proline' 0 N--CA 1.483 0.864 0 C-N-CA 123.653 2.902 . . . . 0.0 114.702 -174.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . -127.18 28.24 4.61 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 174.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.559 ' HE2' HG22 ' A' ' 40' ' ' ILE . 6.0 t80 -71.19 132.09 44.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.998 0.427 . . . . 0.0 110.528 177.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.544 HG22 ' HG2' ' A' ' 50' ' ' GLU . 36.9 mm -111.35 -60.74 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.469 176.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.544 ' HG2' HG22 ' A' ' 49' ' ' ILE . 2.5 mm-40 -153.28 173.01 16.13 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.889 0.852 . . . . 0.0 111.231 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 59' ' ' THR . 5.1 p -161.2 118.27 2.28 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 113.839 -1.528 . . . . 0.0 108.964 154.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.668 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.5 pt -112.93 130.46 23.5 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.251 -173.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 6.1 Cg_exo -77.83 128.06 9.05 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.454 2.769 . . . . 0.0 111.897 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.491 ' HB3' ' HB2' ' A' ' 57' ' ' SER . . . -119.25 54.29 0.99 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.629 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.446 ' O ' HG11 ' A' ' 33' ' ' VAL . 47.6 t80 72.44 -59.33 0.56 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.469 176.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -126.59 -15.34 5.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.299 0.571 . . . . 0.0 110.441 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.491 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 19.8 m -108.58 148.43 30.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.157 0.503 . . . . 0.0 110.999 -177.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.598 HD21 HD11 ' A' ' 40' ' ' ILE . 49.7 tp -117.66 111.99 19.9 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.668 ' HB ' HG13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -94.96 106.74 18.75 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.966 -177.008 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.917 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 53.7 t -107.15 109.33 27.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.252 0.549 . . . . 0.0 111.318 -171.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.439 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 74.6 m-85 -101.62 147.33 26.55 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.711 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.48 ' OH ' ' HB3' ' A' ' 17' ' ' MET . 2.7 p90 -165.22 167.85 17.63 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.172 0.51 . . . . 0.0 110.397 -176.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -98.36 111.25 23.65 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.121 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.515 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 1.0 OUTLIER -64.48 -20.3 66.11 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.546 -172.072 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -58.9 -26.02 63.92 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.571 0.224 . . . . 0.0 111.448 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.575 ' HA ' ' HE3' ' A' ' 69' ' ' LYS . 16.2 tp10 -89.76 -35.84 15.5 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.842 0.83 . . . . 0.0 109.433 -173.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.696 HG11 HG22 ' A' ' 82' ' ' VAL . 3.4 m -79.91 -31.31 13.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.912 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.967 ' HA ' HD23 ' A' ' 71' ' ' LEU . 23.2 t80 -68.98 -22.12 64.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.134 176.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.575 ' HE3' ' HA ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -53.3 -36.74 61.55 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 173.035 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.58 -70.53 0.72 Allowed 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.852 -177.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.967 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER 41.34 71.95 1.19 Allowed Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 123.754 0.822 . . . . 0.0 112.265 -179.074 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.729 ' HD2' HG13 ' A' ' 75' ' ' ILE . 37.7 Cg_exo -61.74 173.95 2.59 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.134 2.556 . . . . 0.0 114.025 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.5 tp60 -62.52 -47.1 85.39 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -172.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.03 -20.74 79.11 Favored Glycine 0 CA--C 1.508 -0.37 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 -176.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.729 HG13 ' HD2' ' A' ' 72' ' ' PRO . 41.3 mm -76.95 102.96 3.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 114.51 -0.845 . . . . 0.0 109.989 175.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.3 m -84.91 -14.09 48.82 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.337 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.481 ' HB2' ' HG3' ' A' ' 80' ' ' GLU . 73.0 m -146.03 142.34 17.63 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.774 -172.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.606 ' HA ' HD21 ' A' ' 71' ' ' LEU . 79.2 Cg_exo -51.25 -36.28 56.05 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.338 2.692 . . . . 0.0 113.376 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.481 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 0.5 OUTLIER -66.11 -26.01 67.26 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.851 0.358 . . . . 0.0 111.138 178.877 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.744 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 5.0 mt-10 -72.69 -34.95 67.52 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.812 -178.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.574 ' HB3' HG21 ' A' ' 75' ' ' ILE . 18.9 p -69.38 -34.01 73.9 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -176.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.696 HG22 HG11 ' A' ' 67' ' ' VAL . 20.2 t -69.44 -36.53 72.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.565 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.744 ' HE2' ' HA ' ' A' ' 80' ' ' GLU . 54.2 mtmt -53.16 -45.57 68.51 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 23.0 mmt180 -67.75 -36.4 80.47 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.085 -172.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -62.05 -39.04 91.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.518 0.675 . . . . 0.0 110.33 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.663 ' O ' ' HB3' ' A' ' 90' ' ' LEU . 14.4 m -86.96 -46.91 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.334 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.471 ' OE1' ' HD3' ' A' ' 84' ' ' ARG . 43.6 mt-10 -53.89 -53.52 51.43 Favored 'General case' 0 C--O 1.211 -0.923 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -177.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.05 -26.11 68.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.06 0.457 . . . . 0.0 111.184 -172.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.614 ' NE ' ' HA ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -91.07 -36.39 14.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 122.39 1.091 . . . . 0.0 109.822 -177.961 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.679 ' O ' HG23 ' A' ' 93' ' ' ILE . 0.3 OUTLIER -84.08 -7.9 59.26 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.297 -1.774 . . . . 0.0 110.261 -177.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.533 ' C ' ' H ' ' A' ' 93' ' ' ILE . . . -40.5 -18.24 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 126.652 1.981 . . . . 0.0 116.273 -173.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -56.11 -2.09 0.06 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 118.159 0.436 . . . . 0.0 111.742 172.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.679 HG23 ' O ' ' A' ' 90' ' ' LEU . 3.0 pt -64.16 -57.49 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 C-N-CA 123.64 0.776 . . . . 0.0 110.004 -176.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.448 ' N ' ' CG1' ' A' ' 93' ' ' ILE . . . 140.43 -63.98 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 O-C-N 125.413 1.696 . . . . 0.0 110.58 -170.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.687 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 1.8 pm0 -65.53 -18.1 65.06 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -170.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.446 ' HB2' HD11 ' A' ' 93' ' ' ILE . 31.4 t70 -61.22 -22.53 64.87 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.115 0.483 . . . . 0.0 111.027 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.506 ' HE1' ' O ' ' A' ' 91' ' ' ALA . 38.9 m-85 -82.57 -6.75 59.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.875 -175.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.687 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 0.9 OUTLIER -108.25 -91.08 0.44 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.867 168.334 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.4 p 177.05 120.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.39 0.614 . . . . 0.0 110.76 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -93.87 99.66 11.98 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.617 0.722 . . . . 0.0 109.552 173.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.311 -1.075 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.71 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.719 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.8 p -101.85 128.14 48.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.114 0.483 . . . . 0.0 110.711 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.417 ' C ' ' H ' ' A' ' 5' ' ' VAL . 15.5 ptp -74.95 160.83 30.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.928 175.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.514 ' O ' HG22 ' A' ' 5' ' ' VAL . 9.2 t -82.93 18.91 1.48 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.333 0.587 . . . . 0.0 109.843 179.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 4' ' ' THR . 5.0 m 53.81 170.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.698 1.599 . . . . 0.0 113.041 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.465 ' HD2' ' C ' ' A' ' 5' ' ' VAL . 3.3 mpt_? -123.5 74.41 1.25 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.422 173.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 10.6 p90 -99.98 145.59 27.7 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.349 -173.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -130.87 143.17 50.53 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.826 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.923 HG12 HG12 ' A' ' 19' ' ' ILE . 21.3 mt -106.21 120.99 58.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.471 -177.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 18' ' ' MET . 9.0 pt-20 -113.6 163.37 15.04 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.244 -176.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -92.97 126.28 37.98 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 173.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.582 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -65.68 -43.71 88.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.766 -174.674 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.34 -67.17 0.1 Allowed Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 178.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -114.34 -70.67 0.79 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.186 0.517 . . . . 0.0 111.514 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.2 p -135.43 51.0 2.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.92 0.867 . . . . 0.0 110.119 -173.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -148.1 151.75 36.17 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.062 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.688 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 38.2 ttp -126.97 128.59 46.63 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.234 -176.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.582 ' HB2' HD22 ' A' ' 12' ' ' LEU . 33.3 ttp -118.68 138.85 52.34 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.494 177.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.923 HG12 HG12 ' A' ' 9' ' ' ILE . 6.4 mt -126.68 124.3 64.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.022 -176.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -109.9 137.26 47.94 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 177.839 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.501 ' HB2' ' CG1' ' A' ' 29' ' ' VAL . 5.3 m-85 -107.35 -150.34 0.44 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -83.22 -160.46 29.45 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 174.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -161.46 -67.75 0.06 Allowed 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.469 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -44.55 -64.33 0.71 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 124.096 0.872 . . . . 0.0 113.101 -168.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.3 pt -109.7 31.83 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.628 0.728 . . . . 0.0 110.312 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.443 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 9.8 m-80 -105.77 68.98 0.8 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.173 -176.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -55.41 -39.84 70.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.164 0.506 . . . . 0.0 110.064 176.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.519 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 23.9 tm0? -52.63 -44.22 65.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.36 176.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.563 ' O ' HG12 ' A' ' 33' ' ' VAL . 87.7 t -72.35 -60.8 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.18 -176.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -46.96 -33.04 4.29 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.757 0.661 . . . . 0.0 112.197 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.22 -44.04 5.44 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.35 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.519 ' HB ' ' O ' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -80.78 -25.43 10.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -172.156 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 29' ' ' VAL . 13.7 p -70.23 -29.68 40.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -76.57 -31.42 57.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.699 175.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.62 -23.6 29.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.972 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.476 ' HA ' ' HB3' ' A' ' 39' ' ' TYR . . . -63.57 -24.71 67.92 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.981 -177.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.82 -42.74 99.4 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.627 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -83.56 -34.84 25.12 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.759 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.588 ' CE1' ' HB3' ' A' ' 89' ' ' ARG . 32.8 t80 -52.58 -44.52 65.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.998 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.5 mt -72.42 -33.61 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.238 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.627 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 7.8 pt-20 -80.63 -19.65 44.92 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.014 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.539 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 34.0 mt-10 -82.06 -29.78 31.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.857 0.36 . . . . 0.0 110.484 175.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -127.83 66.7 71.77 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.63 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -98.34 173.92 0.53 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.3 2.667 . . . . 0.0 114.727 -168.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -111.71 147.35 36.61 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 113.785 -1.552 . . . . 0.0 108.337 175.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.67 -8.13 0.73 Allowed 'Trans proline' 0 N--CA 1.484 0.923 0 C-N-CA 123.987 3.125 . . . . 0.0 114.957 -171.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.39 27.52 6.6 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.104 -0.569 . . . . 0.0 111.837 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -73.86 131.61 41.67 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.064 0.459 . . . . 0.0 111.552 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.3 mm -106.35 -61.21 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.242 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 42.5 tt0 -161.86 162.34 29.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.711 0.291 . . . . 0.0 110.602 -172.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.615 ' HB2' HD11 ' A' ' 58' ' ' LEU . 2.6 p -158.69 118.38 3.14 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 176.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.702 HG13 ' HB ' ' A' ' 59' ' ' THR . 9.6 pt -120.68 139.46 28.97 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-O 121.007 0.432 . . . . 0.0 111.749 -175.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.47 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 4.6 Cg_endo -84.5 133.75 5.43 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.18 2.587 . . . . 0.0 112.21 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -118.1 43.52 2.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.474 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 39.0 t80 72.34 -40.55 0.48 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.448 175.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -134.18 -18.93 1.99 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.898 0.38 . . . . 0.0 111.22 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 9.1 p -121.19 142.52 49.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.776 0.322 . . . . 0.0 111.107 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' A' ' 51' ' ' CYS . 0.9 OUTLIER -103.17 114.42 28.69 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.637 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.702 ' HB ' HG13 ' A' ' 52' ' ' ILE . 3.0 m -87.59 106.05 17.75 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.539 HG22 HD12 ' A' ' 58' ' ' LEU . 57.7 t -101.45 124.36 55.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.397 0.617 . . . . 0.0 111.56 -174.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.424 ' CE1' HG22 ' A' ' 59' ' ' THR . 89.0 m-85 -115.79 147.27 41.15 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.419 177.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.5 ' CE2' HG11 ' A' ' 82' ' ' VAL . 3.4 p90 -165.99 169.97 14.11 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.934 0.397 . . . . 0.0 110.149 -174.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -99.92 112.45 24.72 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.75 -176.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.659 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -62.37 -19.74 63.7 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.993 -176.017 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.7 -31.86 73.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 110.545 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.73 -25.64 19.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.902 0.858 . . . . 0.0 109.535 -175.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.659 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.5 m -75.93 -38.83 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.459 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.835 ' HA ' HD13 ' A' ' 71' ' ' LEU . 2.5 m-85 -55.77 -30.97 62.16 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.07 0.548 . . . . 0.0 111.411 171.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -57.66 -43.75 85.21 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.989 0.899 . . . . 0.0 108.843 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -81.08 -51.12 8.82 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.934 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.847 HD11 ' HA ' ' A' ' 78' ' ' PRO . 0.1 OUTLIER -12.16 84.63 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.469 0 O-C-N 125.549 1.781 . . . . 0.0 114.325 -173.433 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.816 ' HD2' HG13 ' A' ' 75' ' ' ILE . 32.5 Cg_exo -61.76 170.21 6.11 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 123.469 2.78 . . . . 0.0 112.172 176.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.6 -27.13 65.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.032 -172.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.98 -22.31 71.89 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.125 176.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.816 HG13 ' HD2' ' A' ' 72' ' ' PRO . 24.1 mm -86.32 114.14 25.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.615 -0.792 . . . . 0.0 110.043 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.8 m -105.59 -1.74 24.33 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.327 0.584 . . . . 0.0 110.604 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.532 ' HB2' ' HG3' ' A' ' 80' ' ' GLU . 70.6 m -141.45 141.4 22.88 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.704 -178.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.847 ' HA ' HD11 ' A' ' 71' ' ' LEU . 77.0 Cg_exo -44.45 -58.13 1.66 Allowed 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 123.18 2.587 . . . . 0.0 113.275 177.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.45 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 0.2 OUTLIER -56.06 -28.64 58.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.068 -176.818 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.662 ' HB2' HG23 ' A' ' 75' ' ' ILE . 48.6 mt-10 -67.96 -32.46 72.91 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.001 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.551 ' HB2' HG21 ' A' ' 75' ' ' ILE . 32.4 t -70.33 -33.99 72.14 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' A' ' 62' ' ' TYR . 26.2 t -76.95 -29.36 17.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.44 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.688 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 8.2 mtmp? -54.04 -42.09 68.81 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.463 176.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -63.88 -39.8 95.04 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.913 -176.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -61.95 -38.37 88.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.376 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.457 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 22.3 m -88.38 -35.21 7.72 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.86 -179.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.439 ' OE2' ' HB3' ' A' ' 83' ' ' LYS . 40.4 mt-10 -62.54 -38.93 91.92 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 122.472 0.309 . . . . 0.0 111.587 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.64 -20.56 63.52 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.454 0.645 . . . . 0.0 110.505 176.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.588 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 9.8 mmt180 -88.28 -51.1 5.94 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.622 0.725 . . . . 0.0 110.022 170.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.587 ' O ' HD13 ' A' ' 93' ' ' ILE . 75.7 mt -80.76 -65.22 1.04 Allowed 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 114.715 -1.13 . . . . 0.0 112.406 -171.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.861 ' HB1' ' HA ' ' A' ' 98' ' ' GLU . . . -56.15 -17.53 7.51 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.71 -175.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -73.23 -45.5 55.72 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.92 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.587 HD13 ' O ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -90.97 -17.86 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 121.663 0.744 . . . . 0.0 109.73 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.434 ' N ' HD13 ' A' ' 93' ' ' ILE . . . -102.94 45.61 0.95 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 167.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 0.1 OUTLIER -35.4 -32.61 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 111.887 -2.415 . . . . 0.0 113.94 -179.226 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -66.77 -33.13 74.95 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.191 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.442 ' OH ' ' HG3' ' A' ' 6' ' ' ARG . 47.1 m-85 -99.22 15.4 26.2 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -170.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.861 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 4.3 pt-20 -56.33 -16.36 5.47 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.324 0.583 . . . . 0.0 111.138 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.9 m -100.44 74.06 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.861 173.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -48.13 130.14 15.54 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.729 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.5 tpp180 . . . . . 0 C--O 1.248 0.98 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.321 -178.523 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 15.0 p90 . . . . . 0 N--CA 1.44 -0.93 0 CA-C-O 121.147 0.499 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.64 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . 2.3 mp0 -131.95 135.9 46.93 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.799 -177.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.909 HG12 HG12 ' A' ' 19' ' ' ILE . 9.5 mt -101.94 124.83 56.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.967 178.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -121.32 165.49 15.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.09 0.472 . . . . 0.0 109.904 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -87.34 127.61 35.19 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.698 0.761 . . . . 0.0 110.358 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.643 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -68.32 -47.27 68.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.227 -174.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.61 -83.11 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -118.85 -44.73 2.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.673 0.273 . . . . 0.0 111.24 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.1 p -146.15 43.49 1.22 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.495 0.664 . . . . 0.0 110.83 -173.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -144.45 156.59 44.26 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.398 178.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.629 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 35.6 ttp -128.01 134.71 49.27 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -175.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.643 ' HB2' HD22 ' A' ' 12' ' ' LEU . 39.5 ttp -125.16 130.07 51.42 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.918 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.909 HG12 HG12 ' A' ' 9' ' ' ILE . 7.3 mt -121.22 118.74 57.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.298 -173.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.64 ' HD3' ' HB2' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -103.52 139.75 38.44 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 176.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.747 ' HB2' HG11 ' A' ' 29' ' ' VAL . 15.1 m-85 . . . . . 0 C--N 1.322 -0.622 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.496 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 25.4 tm0? . . . . . 0 N--CA 1.457 -0.077 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.747 HG11 ' HB2' ' A' ' 21' ' ' PHE . 71.0 t -66.77 -48.58 79.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.66 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -51.89 -36.71 49.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.824 -176.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.07 -34.63 8.09 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.253 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 28' ' ' GLN . 0.4 OUTLIER -79.73 -29.14 12.95 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.017 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -174.126 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.541 HG23 ' HG ' ' A' ' 58' ' ' LEU . 11.4 p -68.73 -28.71 41.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 118.879 0.763 . . . . 0.0 109.415 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -70.07 -39.65 75.51 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.517 175.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.79 -21.41 29.95 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.113 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.629 ' HB1' HD11 ' A' ' 58' ' ' LEU . . . -64.36 -27.49 69.05 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.156 -176.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.54 -44.53 96.89 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.714 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -78.88 -31.88 45.64 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.877 177.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.405 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 14.9 t80 -57.49 -44.57 85.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.23 0.538 . . . . 0.0 109.728 178.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.9 mt -71.44 -33.31 49.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.322 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.273 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.714 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 12.6 pt-20 -78.97 -18.89 52.95 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.129 -176.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.45 ' C ' ' HD3' ' A' ' 44' ' ' PRO . 42.4 mt-10 -85.16 -30.34 24.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.842 0.353 . . . . 0.0 110.749 174.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -127.11 64.46 61.06 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.937 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.45 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 80.1 Cg_endo -98.26 178.1 0.4 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 123.295 2.663 . . . . 0.0 114.033 -170.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -106.93 146.69 33.63 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.25 171.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.557 ' HB2' ' HG3' ' A' ' 66' ' ' GLU . 71.5 Cg_exo -51.62 -15.31 2.66 Favored 'Trans proline' 0 N--CA 1.477 0.546 0 C-N-CA 124.019 3.146 . . . . 0.0 114.574 -173.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.8 15.22 41.11 Favored Glycine 0 C--O 1.223 -0.569 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.413 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -65.55 134.08 52.58 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.017 0.437 . . . . 0.0 110.905 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.418 HG12 ' HA ' ' A' ' 62' ' ' TYR . 28.8 mm -110.15 -59.73 3.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.437 -176.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -161.69 157.3 24.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.719 0.295 . . . . 0.0 110.787 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.2 p -150.08 121.64 7.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.929 HG13 ' HB ' ' A' ' 59' ' ' THR . 5.7 pt -120.4 130.84 24.65 Favored Pre-proline 0 C--N 1.319 -0.746 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.498 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 5.6 Cg_exo -78.94 122.91 5.52 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.454 2.769 . . . . 0.0 111.674 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -111.11 50.08 0.84 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 -176.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.7 t80 76.58 -56.85 0.55 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.387 172.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.1 p -137.82 14.23 2.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.101 0.477 . . . . 0.0 110.741 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 15.8 t -138.7 152.57 48.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.033 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.629 HD11 ' HB1' ' A' ' 36' ' ' ALA . 5.4 mt -112.24 114.36 27.11 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.38 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.929 ' HB ' HG13 ' A' ' 52' ' ' ILE . 2.8 m -91.18 103.93 16.55 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 174.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.8 t -112.04 114.04 45.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.603 0.716 . . . . 0.0 111.188 -169.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.477 ' CE1' HG22 ' A' ' 59' ' ' THR . 84.9 m-85 -105.48 148.91 26.67 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.796 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.556 ' CE2' HG11 ' A' ' 82' ' ' VAL . 2.8 p90 -166.54 172.94 10.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.329 0.585 . . . . 0.0 110.992 -175.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.536 ' OD1' ' HB3' ' A' ' 65' ' ' TYR . 6.7 t0 -98.49 119.55 37.4 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.841 -177.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.548 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -65.61 -20.22 66.23 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.04 -177.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.536 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -60.65 -33.6 73.05 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.102 0.477 . . . . 0.0 110.95 -178.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.557 ' HG3' ' HB2' ' A' ' 46' ' ' PRO . 0.8 OUTLIER -90.27 -22.23 21.7 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.862 0.839 . . . . 0.0 109.331 -173.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.548 HG22 ' HA ' ' A' ' 64' ' ' MET . 2.7 m -82.27 -37.7 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.414 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.955 ' HA ' HD23 ' A' ' 71' ' ' LEU . 32.3 m-85 -58.35 -31.65 67.8 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.093 0.473 . . . . 0.0 109.925 168.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.506 ' HB2' ' HE3' ' A' ' 69' ' ' LYS . 2.9 tppp? -60.59 -27.01 67.4 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.669 177.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -93.7 -76.13 0.48 Allowed 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.134 174.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.955 HD23 ' HA ' ' A' ' 68' ' ' TYR . 1.2 mm? 31.37 66.7 0.92 Allowed Pre-proline 0 N--CA 1.471 0.602 0 C-N-CA 124.312 1.045 . . . . 0.0 112.385 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.656 ' HD2' HG13 ' A' ' 75' ' ' ILE . 32.1 Cg_exo -59.7 153.1 58.22 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.804 2.336 . . . . 0.0 112.366 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -70.08 103.03 2.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.739 0.78 . . . . 0.0 110.541 -176.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 137.27 -34.08 2.23 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -173.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.656 HG13 ' HD2' ' A' ' 72' ' ' PRO . 18.4 mm -75.53 113.59 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 113.974 -1.113 . . . . 0.0 108.67 171.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.3 m -97.94 -3.27 38.75 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.546 -174.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 80' ' ' GLU . 57.0 m -140.32 134.97 15.72 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.893 -172.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.603 ' HA ' HD21 ' A' ' 71' ' ' LEU . 64.9 Cg_exo -45.47 -58.35 1.66 Allowed 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 123.201 2.601 . . . . 0.0 113.33 175.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.53 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -56.48 -29.38 61.68 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.286 0.565 . . . . 0.0 111.158 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.526 ' HG3' ' HE2' ' A' ' 83' ' ' LYS . 40.2 tt0 -71.68 -25.39 62.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.519 -176.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.527 ' HB2' HG21 ' A' ' 75' ' ' ILE . 34.3 t -77.45 -38.35 49.56 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.556 HG11 ' CE2' ' A' ' 62' ' ' TYR . 46.2 t -63.28 -32.27 55.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.292 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.629 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 39.8 mtmt -51.33 -39.54 57.19 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.738 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -73.29 -39.57 65.24 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.89 -174.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -64.2 -35.08 79.63 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.718 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.0 m -86.34 -38.64 12.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.679 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 . . . . . 0 C--O 1.218 -0.599 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 176.65 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.565 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 6.1 p90 . . . . . 0 N--CA 1.436 -1.137 0 CA-C-O 121.372 0.606 . . . . 0.0 110.619 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.401 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 1.8 tp-100 -139.16 133.35 31.31 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.311 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.966 HG12 HG12 ' A' ' 19' ' ' ILE . 37.2 mt -101.57 119.77 50.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.072 177.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -114.03 165.55 12.5 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.066 -177.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -84.26 130.79 34.79 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.521 0.677 . . . . 0.0 110.461 177.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -75.89 -42.98 47.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.867 -175.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -161.78 -73.29 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -142.29 -31.63 0.53 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.5 p -144.93 40.65 1.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.4 0.619 . . . . 0.0 111.325 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -147.78 154.45 40.51 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.874 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -119.29 144.99 46.5 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 119.872 -0.731 . . . . 0.0 112.014 -175.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.477 ' HB2' HD22 ' A' ' 12' ' ' LEU . 26.9 ttt -130.2 129.04 42.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.488 176.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.966 HG12 HG12 ' A' ' 9' ' ' ILE . 6.4 mt -121.35 145.04 28.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.322 -175.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.565 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -136.54 139.92 42.58 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 171.143 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.77 ' HB2' HG11 ' A' ' 29' ' ' VAL . 54.2 m-85 . . . . . 0 C--N 1.328 -0.369 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 173.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? . . . . . 0 N--CA 1.455 -0.175 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.77 HG11 ' HB2' ' A' ' 21' ' ' PHE . 99.2 t -61.29 -49.84 82.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.6 178.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -43.79 -40.92 4.67 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 124.136 0.897 . . . . 0.0 112.284 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.36 -42.75 5.13 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.491 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -72.86 -27.17 24.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -172.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 29' ' ' VAL . 11.9 p -70.94 -27.45 30.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.369 0.604 . . . . 0.0 109.433 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -70.51 -35.69 73.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.63 172.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.28 -20.06 32.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.005 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.3 -24.74 67.48 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.192 -175.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.04 -46.64 83.53 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.655 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -76.45 -27.57 56.23 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.536 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -59.51 -45.13 92.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.094 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.534 HD11 HD21 ' A' ' 58' ' ' LEU . 68.3 mt -72.15 -33.39 46.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.43 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.655 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 9.9 pt-20 -77.14 -20.25 55.8 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.94 -175.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -80.66 -32.38 36.11 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 175.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -126.1 72.82 71.19 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.093 0.473 . . . . 0.0 109.732 176.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -98.17 -163.13 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.886 3.057 . . . . 0.0 114.044 -169.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -137.77 145.96 50.77 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 113.965 -1.471 . . . . 0.0 107.441 174.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -53.36 -15.8 6.3 Favored 'Trans proline' 0 N--CA 1.481 0.742 0 C-N-CA 123.635 2.89 . . . . 0.0 114.906 -169.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.593 ' HA3' ' HB2' ' A' ' 66' ' ' GLU . . . -107.31 17.03 37.75 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.491 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.421 ' HZ ' ' SG ' ' A' ' 51' ' ' CYS . 45.3 t80 -63.76 130.16 43.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.044 0.449 . . . . 0.0 111.391 176.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.415 HG12 ' HA ' ' A' ' 62' ' ' TYR . 35.2 mm -104.04 -61.84 2.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.026 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -161.8 156.83 23.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.848 0.356 . . . . 0.0 110.521 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.421 ' SG ' ' HZ ' ' A' ' 48' ' ' PHE . 7.4 p -145.96 119.51 9.1 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.746 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.8 pt -124.52 131.44 24.16 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-O 121.108 0.48 . . . . 0.0 111.462 -178.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 4.7 Cg_exo -78.44 149.18 24.14 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.141 2.561 . . . . 0.0 112.493 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.681 ' HB3' ' HB2' ' A' ' 57' ' ' SER . . . -120.99 17.96 11.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.025 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 71.75 -24.47 0.18 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.654 174.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.4 ' H ' ' C ' ' A' ' 54' ' ' ALA . 7.6 t -135.98 -9.12 2.06 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.524 0.678 . . . . 0.0 109.817 169.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.681 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 16.3 m -130.73 165.53 22.7 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.549 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.534 HD21 HD11 ' A' ' 40' ' ' ILE . 45.3 tp -132.16 125.97 32.51 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.746 ' HB ' HG13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -106.16 107.05 17.86 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.816 -177.02 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.874 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 47.3 t -109.05 115.36 49.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.507 0.67 . . . . 0.0 111.295 -174.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -105.14 146.74 28.78 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.294 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.544 ' CD2' HG11 ' A' ' 82' ' ' VAL . 3.1 p90 -164.19 171.46 14.97 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.031 0.443 . . . . 0.0 110.664 -172.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.503 ' OD1' ' HB3' ' A' ' 65' ' ' TYR . 6.2 t0 -100.92 115.49 30.55 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.347 -177.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.687 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -59.71 -18.77 45.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.18 -177.562 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.635 ' CE2' ' HG2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -66.7 -34.98 79.06 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -177.396 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.635 ' HG2' ' CE2' ' A' ' 65' ' ' TYR . 5.4 mm-40 -89.4 -27.37 20.47 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.872 0.844 . . . . 0.0 109.484 -174.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.722 HG11 HG22 ' A' ' 82' ' ' VAL . 4.1 m -83.39 -22.96 8.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.83 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.939 ' HA ' HD12 ' A' ' 71' ' ' LEU . 15.5 t80 -75.14 -28.05 60.01 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 168.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -67.97 -28.7 67.67 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.071 170.527 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.735 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 11.9 t-80 -111.52 28.33 8.84 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.492 174.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.939 HD12 ' HA ' ' A' ' 68' ' ' TYR . 2.7 mt -94.77 95.37 1.49 Allowed Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.532 176.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.735 ' HD3' ' O ' ' A' ' 70' ' ' HIS . 8.8 Cg_exo -76.48 175.2 11.66 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 124.061 3.174 . . . . 0.0 112.769 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -60.79 -42.78 98.24 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -171.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.03 -25.12 74.47 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.779 -175.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.613 HG13 ' HD2' ' A' ' 72' ' ' PRO . 5.6 mm -85.26 120.93 36.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.233 -0.483 . . . . 0.0 109.779 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.5 m -110.52 3.78 19.83 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.151 0.5 . . . . 0.0 111.17 -174.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.527 ' HB3' ' CB ' ' A' ' 80' ' ' GLU . 28.2 t -134.59 126.16 17.96 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.148 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.703 ' HA ' HD11 ' A' ' 71' ' ' LEU . 74.6 Cg_exo -42.96 -56.57 2.15 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.762 2.975 . . . . 0.0 112.626 171.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -36.44 63.38 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.359 0.6 . . . . 0.0 111.422 175.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.527 ' CB ' ' HB3' ' A' ' 77' ' ' SER . 38.5 tt0 -73.47 -30.65 63.3 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.262 -174.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.553 ' HB3' HG21 ' A' ' 75' ' ' ILE . 67.6 p -73.05 -35.18 66.67 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.655 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.722 HG22 HG11 ' A' ' 67' ' ' VAL . 6.8 t -61.59 -36.32 72.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.062 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -51.86 -40.07 59.97 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -67.41 -38.09 84.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.348 -177.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -65.91 -39.75 90.85 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.804 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.4 m -83.83 -46.39 18.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.35 -177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 C--O 1.219 -0.532 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -176.428 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.562 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 18.3 p90 . . . . . 0 N--CA 1.443 -0.784 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.517 ' HB2' ' NE ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -133.09 132.79 42.15 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.875 -179.157 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.751 HG12 HG12 ' A' ' 19' ' ' ILE . 14.9 mt -95.94 119.48 44.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.706 178.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -120.32 158.33 27.31 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.652 -176.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -82.89 129.34 35.0 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.453 0.644 . . . . 0.0 110.525 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.684 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -73.94 -38.67 64.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.601 -1.182 . . . . 0.0 110.98 -176.349 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.62 -87.16 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.497 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -103.47 -50.26 3.49 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -176.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.526 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 32.5 p -156.39 48.15 0.47 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 122.141 0.972 . . . . 0.0 109.966 -176.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -140.11 148.24 41.41 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.255 -1.339 . . . . 0.0 107.688 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.726 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 37.8 ttp -121.83 139.06 54.09 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.956 -174.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.684 ' HB2' HD22 ' A' ' 12' ' ' LEU . 49.8 ttm -124.89 132.21 53.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.054 0.454 . . . . 0.0 110.947 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.751 HG12 HG12 ' A' ' 9' ' ' ILE . 7.7 mt -124.98 120.88 59.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.654 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.517 ' NE ' ' HB2' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -114.08 134.32 54.96 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.992 177.048 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.562 ' HA ' ' CB ' ' A' ' 7' ' ' TYR . 32.1 m-85 . . . . . 0 C--N 1.327 -0.403 0 CA-C-O 120.567 0.222 . . . . 0.0 110.885 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.3 tm0? . . . . . 0 C--O 1.233 0.193 0 CA-C-O 120.912 0.387 . . . . 0.0 110.012 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.449 ' HA ' HG22 ' A' ' 32' ' ' ILE . 27.1 m -74.18 -25.82 20.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.686 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -59.9 -25.91 65.49 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.624 174.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -96.91 -32.86 6.29 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.417 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.449 HG22 ' HA ' ' A' ' 29' ' ' VAL . 0.5 OUTLIER -75.94 -23.59 16.27 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 C-N-CA 121.171 -0.212 . . . . 0.0 111.152 -177.058 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.487 HG23 ' HG ' ' A' ' 58' ' ' LEU . 10.5 p -65.53 -31.0 51.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.364 0.602 . . . . 0.0 109.471 176.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.418 ' HA ' ' CB ' ' A' ' 53' ' ' PRO . 53.3 t-80 -74.75 -38.0 62.35 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.708 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.58 -22.99 46.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.663 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.577 ' HB1' HD11 ' A' ' 58' ' ' LEU . . . -65.36 -25.84 67.76 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.836 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.51 -40.63 95.3 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.739 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.09 -29.61 26.65 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.859 176.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.487 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . 2.7 t80 -60.34 -42.85 96.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.914 0.388 . . . . 0.0 110.401 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 51.6 mt -74.26 -38.42 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.037 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.739 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 8.4 pt-20 -71.15 -23.78 62.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.697 0.284 . . . . 0.0 110.927 -176.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -76.98 -32.54 57.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.017 177.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -134.82 68.38 71.26 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.032 0.444 . . . . 0.0 110.916 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -98.51 -176.31 0.21 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.539 2.826 . . . . 0.0 113.415 -174.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.506 ' HZ ' ' HB2' ' A' ' 62' ' ' TYR . 12.5 p90 -108.3 149.42 39.24 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -39.74 -36.35 1.19 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.003 3.135 . . . . 0.0 115.636 -172.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 66' ' ' GLU . . . -98.37 15.41 61.27 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.97 -175.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.42 ' HZ ' ' SG ' ' A' ' 51' ' ' CYS . 32.4 t80 -62.03 132.84 54.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.264 0.554 . . . . 0.0 110.845 175.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.413 HG12 ' HA ' ' A' ' 62' ' ' TYR . 33.1 mm -106.24 -62.49 2.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.287 -176.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -160.37 155.66 24.97 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.796 -170.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.42 ' SG ' ' HZ ' ' A' ' 48' ' ' PHE . 2.9 p -151.39 119.44 6.26 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.992 0.425 . . . . 0.0 110.024 176.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.748 HG13 ' HB ' ' A' ' 59' ' ' THR . 7.8 pt -121.43 138.6 28.44 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.436 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 11.1 Cg_endo -86.6 148.9 8.69 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.152 2.568 . . . . 0.0 112.424 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -143.5 66.68 1.3 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 69.4 t80 74.47 -60.74 0.51 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.417 0.687 . . . . 0.0 111.516 173.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.3 t -136.04 -5.75 2.12 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.287 0.565 . . . . 0.0 110.104 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 16.4 m -113.87 137.07 52.17 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.29 -174.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.577 HD11 ' HB1' ' A' ' 36' ' ' ALA . 3.8 mt -100.81 120.47 40.17 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.057 174.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.748 ' HB ' HG13 ' A' ' 52' ' ' ILE . 1.8 m -96.78 104.44 16.44 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.2 t -110.76 114.77 48.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.711 0.767 . . . . 0.0 111.064 -169.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -106.89 150.12 26.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.191 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.689 ' OH ' ' HB2' ' A' ' 17' ' ' MET . 3.1 p90 -166.62 167.77 15.08 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.371 -175.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.477 ' O ' HG13 ' A' ' 67' ' ' VAL . 1.3 t0 -100.64 115.85 31.17 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.179 0.514 . . . . 0.0 110.455 -174.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.62 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -61.83 -21.89 65.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.078 -174.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -69.21 -30.12 68.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.158 0.504 . . . . 0.0 109.843 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.444 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 1.2 tm-20 -92.08 -33.01 14.95 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.728 0.775 . . . . 0.0 109.131 -173.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.62 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.4 m -67.21 -40.67 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.979 176.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.824 ' HA ' HD23 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -63.71 -25.82 68.38 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.519 173.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.487 ' HE2' ' HB2' ' A' ' 69' ' ' LYS . 5.3 tppt? -70.58 -21.24 62.7 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.75 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -104.87 -41.87 5.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.561 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.824 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER -7.36 84.6 0.03 OUTLIER Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 125.795 1.638 . . . . 0.0 113.703 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.427 ' HD2' HG13 ' A' ' 75' ' ' ILE . 32.3 Cg_exo -60.53 165.36 11.49 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.127 2.551 . . . . 0.0 112.921 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? -61.59 -42.29 98.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.84 0.352 . . . . 0.0 111.419 -173.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.35 -18.55 79.13 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.794 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.596 HG21 ' HB3' ' A' ' 81' ' ' SER . 6.2 mm -88.13 119.17 35.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.49 -0.355 . . . . 0.0 110.281 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -101.75 -9.31 20.94 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.93 0.395 . . . . 0.0 110.945 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.6 m -122.51 123.76 26.95 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.592 -175.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.664 ' HA ' HD21 ' A' ' 71' ' ' LEU . 46.4 Cg_exo -49.05 -46.71 24.36 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.55 2.833 . . . . 0.0 113.783 174.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.93 -29.96 69.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.772 0.32 . . . . 0.0 111.286 175.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 84' ' ' ARG . 52.9 tt0 -75.07 -31.61 61.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.17 -175.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.596 ' HB3' HG21 ' A' ' 75' ' ' ILE . 37.3 p -72.88 -32.94 65.74 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.564 HG11 ' CD2' ' A' ' 62' ' ' TYR . 61.1 t -69.04 -37.0 76.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.161 -1.381 . . . . 0.0 111.282 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.726 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 39.4 mtmt -52.17 -43.23 64.01 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.454 0.645 . . . . 0.0 109.317 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 22.1 mmt180 -67.29 -31.42 71.71 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.866 -173.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.15 -35.28 69.03 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.005 0.431 . . . . 0.0 111.244 176.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.6 m -86.91 -39.18 12.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 C-N-CA 120.424 -0.511 . . . . 0.0 111.047 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 . . . . . 0 C--O 1.214 -0.809 0 C-N-CA 122.623 0.369 . . . . 0.0 111.923 179.828 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.572 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 6.9 p90 . . . . . 0 N--CA 1.437 -1.105 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.554 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . 30.5 tt0 -141.01 133.51 28.48 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.731 0.777 . . . . 0.0 110.206 174.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.679 HG12 HG12 ' A' ' 19' ' ' ILE . 9.2 mt -92.16 109.73 21.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.557 176.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.628 ' HG2' ' O ' ' A' ' 18' ' ' MET . 9.1 pt-20 -111.34 163.14 14.3 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.692 -170.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -88.36 131.49 34.81 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.282 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.608 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -76.22 -31.48 58.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.569 -176.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.45 -72.26 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.046 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -135.99 -35.34 0.78 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.3 p -152.89 41.53 0.58 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.714 0.768 . . . . 0.0 110.976 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.583 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -143.8 155.52 44.18 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 174.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.611 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 43.8 ttp -130.09 136.57 49.49 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.441 -172.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.628 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 49.3 ttm -126.82 141.94 51.68 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.808 176.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.679 HG12 HG12 ' A' ' 9' ' ' ILE . 7.5 mt -125.4 115.3 43.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 O-C-N 122.365 -0.209 . . . . 0.0 111.296 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.554 ' HD3' ' HB3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -98.64 136.4 38.76 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 174.54 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.89 ' HB2' HG21 ' A' ' 29' ' ' VAL . 3.9 m-85 . . . . . 0 C--N 1.327 -0.385 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? . . . . . 0 CA--C 1.531 0.239 0 CA-C-O 120.433 0.158 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.89 HG21 ' HB2' ' A' ' 21' ' ' PHE . 9.2 p -65.17 -42.12 93.4 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.061 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -48.99 -43.48 40.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.928 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.36 -5.23 87.32 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.14 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -115.88 -31.72 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.617 0 CA-C-N 117.766 0.783 . . . . 0.0 112.372 -174.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.454 ' O ' ' HB3' ' A' ' 53' ' ' PRO . 6.7 p -60.94 -36.81 74.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 118.391 0.541 . . . . 0.0 110.419 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.415 ' HA ' ' CB ' ' A' ' 53' ' ' PRO . 11.5 p-80 -79.31 -22.59 44.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.85 0.357 . . . . 0.0 110.636 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.88 -29.96 23.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.015 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.519 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -64.23 -22.39 66.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.244 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.47 -43.08 98.34 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.59 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.36 -27.97 27.33 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.835 176.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.519 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 3.9 t80 -56.91 -48.14 78.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.066 0.46 . . . . 0.0 110.252 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.454 HD11 HD21 ' A' ' 58' ' ' LEU . 58.9 mt -72.93 -36.94 52.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.485 -174.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.59 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 13.0 pt-20 -71.17 -19.4 62.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.654 0.264 . . . . 0.0 111.349 -174.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.411 ' C ' ' HD3' ' A' ' 44' ' ' PRO . 46.0 mt-10 -79.46 -28.68 41.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.88 0.372 . . . . 0.0 110.877 174.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -129.89 64.19 71.22 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.785 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.411 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 65.2 Cg_endo -98.99 177.98 0.34 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.264 2.643 . . . . 0.0 113.389 -174.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.54 ' CE2' HG13 ' A' ' 82' ' ' VAL . 6.6 p90 -108.21 147.41 35.53 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.279 173.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.21 12.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.486 1.033 0 C-N-CA 124.293 3.329 . . . . 0.0 114.852 -173.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.491 ' HA3' ' HB2' ' A' ' 66' ' ' GLU . . . -131.12 19.32 4.91 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 175.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.594 ' HZ ' ' HB3' ' A' ' 51' ' ' CYS . 30.9 t80 -79.49 142.61 35.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.013 0.435 . . . . 0.0 110.404 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.492 HG12 ' HA ' ' A' ' 62' ' ' TYR . 35.5 mm -108.38 -59.19 3.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.212 -175.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -168.93 141.6 2.73 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.351 -173.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.594 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 1.6 p -129.22 118.75 22.86 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 173.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.734 HG13 ' HB ' ' A' ' 59' ' ' THR . 4.3 pt -121.18 134.87 24.54 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.877 -175.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.454 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 86.9 Cg_endo -87.2 139.88 5.37 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.303 2.669 . . . . 0.0 112.66 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.3 59.22 1.59 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.413 ' O ' HG11 ' A' ' 33' ' ' VAL . 75.8 t80 75.02 -50.69 0.67 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.576 0.75 . . . . 0.0 112.086 172.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.27 -12.9 1.19 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.111 0.481 . . . . 0.0 110.863 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.5 m -115.39 134.14 55.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.979 0.419 . . . . 0.0 111.162 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.454 HD21 HD11 ' A' ' 40' ' ' ILE . 46.0 tp -102.86 117.23 34.17 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.789 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.734 ' HB ' HG13 ' A' ' 52' ' ' ILE . 4.8 m -97.6 114.41 26.33 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -177.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.9 t -111.41 109.58 29.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.765 0.793 . . . . 0.0 111.375 -170.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -101.25 145.61 28.61 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.009 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.611 ' OH ' ' HB2' ' A' ' 17' ' ' MET . 2.9 p90 -166.62 166.94 15.78 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -176.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.41 ' OD1' ' HD1' ' A' ' 65' ' ' TYR . 5.4 t70 -102.58 128.55 49.19 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.339 0.59 . . . . 0.0 109.45 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.54 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -62.24 -20.56 64.35 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.799 -172.297 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.41 ' HD1' ' OD1' ' A' ' 63' ' ' ASP . 4.5 p90 -64.54 -34.93 79.39 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.847 0.356 . . . . 0.0 111.632 -174.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.491 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 1.7 tm-20 -92.52 -28.4 16.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.68 0.752 . . . . 0.0 109.598 -172.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.1 m -72.93 -34.65 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.911 ' HA ' HD23 ' A' ' 71' ' ' LEU . 58.9 t80 -72.47 -22.63 61.04 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.888 173.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.493 ' HE2' ' HB2' ' A' ' 69' ' ' LYS . 9.0 tppt? -66.27 -26.07 67.17 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 173.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -89.37 -74.64 0.47 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.786 172.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.911 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.8 OUTLIER 24.14 65.44 0.4 Allowed Pre-proline 0 N--CA 1.473 0.714 0 O-C-N 124.88 1.362 . . . . 0.0 112.88 -178.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.574 ' HD2' HG13 ' A' ' 75' ' ' ILE . 35.1 Cg_exo -60.67 143.47 99.42 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.608 2.205 . . . . 0.0 111.8 -175.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -64.0 108.39 1.5 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.499 0.666 . . . . 0.0 110.106 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 135.36 -30.1 2.83 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -171.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.575 HG21 ' HB3' ' A' ' 81' ' ' SER . 10.9 mm -87.12 125.23 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 114.422 -0.889 . . . . 0.0 108.622 170.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.5 t -103.68 -0.15 29.86 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.353 0.597 . . . . 0.0 110.274 -174.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.83 ' HG ' ' HD1' ' A' ' 79' ' ' PHE . 38.4 t -143.89 133.83 11.85 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.127 -170.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.59 ' HA ' HD21 ' A' ' 71' ' ' LEU . 86.1 Cg_exo -50.07 -50.35 13.63 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.668 2.912 . . . . 0.0 112.863 174.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.83 ' HD1' ' HG ' ' A' ' 77' ' ' SER . 0.1 OUTLIER -63.2 -30.24 71.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.102 0.477 . . . . 0.0 110.921 178.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.433 ' CB ' ' HB3' ' A' ' 77' ' ' SER . 40.7 tt0 -73.31 -27.1 61.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.366 -175.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.575 ' HB3' HG21 ' A' ' 75' ' ' ILE . 88.8 p -79.31 -37.75 36.92 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.56 0.695 . . . . 0.0 109.176 178.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 78' ' ' PRO . 61.0 t -63.42 -31.44 52.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.157 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.537 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 6.3 mtmp? -52.53 -43.63 65.26 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 84' ' ' ARG . 11.3 mmm180 -64.56 -41.83 96.07 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.429 -174.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.34 -39.36 86.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.819 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.2 m -87.24 -41.49 14.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.968 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -175.467 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.617 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 35.2 p90 . . . . . 0 N--CA 1.448 -0.567 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.44 120.29 18.5 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -175.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.943 HG12 HG12 ' A' ' 19' ' ' ILE . 40.7 mt -89.71 123.74 42.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.036 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 18' ' ' MET . 12.0 pt-20 -122.0 174.17 7.08 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.834 -176.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -95.08 135.51 36.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.526 0.679 . . . . 0.0 110.598 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.44 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -80.87 -44.7 17.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.517 -176.587 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -172.92 -74.32 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.432 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -127.15 -50.39 1.43 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.118 0.485 . . . . 0.0 111.172 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.8 p -144.9 41.03 1.28 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.588 0.709 . . . . 0.0 110.942 -172.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.02 157.29 44.42 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.651 176.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.794 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -123.21 145.84 48.31 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.888 -176.321 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.44 ' HB2' HD22 ' A' ' 12' ' ' LEU . 51.8 ttm -127.25 131.13 50.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.749 174.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.943 HG12 HG12 ' A' ' 9' ' ' ILE . 9.9 mt -114.07 124.85 71.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.84 -177.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.7 111.75 24.03 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.618 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.617 ' HA ' ' CB ' ' A' ' 7' ' ' TYR . 22.9 m-85 . . . . . 0 C--N 1.313 -1.021 0 CA-C-O 121.195 0.521 . . . . 0.0 111.258 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 . . . . . 0 N--CA 1.464 0.226 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.418 HG13 ' H ' ' A' ' 30' ' ' ASN . 1.5 p -62.57 -55.98 20.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.912 176.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.418 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -57.76 -29.03 64.48 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.859 -177.429 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.19 -15.7 58.6 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.228 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.409 ' O ' ' N ' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -115.18 -24.82 3.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.724 0 CA-C-N 117.41 0.605 . . . . 0.0 112.361 -174.351 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.446 HG11 ' O ' ' A' ' 55' ' ' PHE . 7.2 p -61.24 -34.57 61.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 118.785 0.72 . . . . 0.0 110.361 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -77.14 -32.09 56.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.837 0.351 . . . . 0.0 110.072 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.83 -20.8 30.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.46 -176.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 32' ' ' ILE . . . -66.46 -32.03 73.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.997 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.7 -41.07 97.1 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.91 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -73.84 -36.86 64.94 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.753 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.01 -35.43 75.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.231 0.539 . . . . 0.0 110.113 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.7 mt -81.95 -35.21 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.373 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.91 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 10.5 pt-20 -79.84 -21.77 43.75 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.751 -175.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.952 ' HG3' ' HG3' ' A' ' 43' ' ' GLN . 9.6 pt-20 -81.03 -29.89 35.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.121 0.486 . . . . 0.0 109.967 175.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.952 ' HG3' ' HG3' ' A' ' 42' ' ' GLU . 54.3 mt-30 -126.37 65.05 57.46 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.933 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.425 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 66.2 Cg_endo -93.36 -173.27 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.569 2.846 . . . . 0.0 114.017 -169.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -124.77 146.73 53.92 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.517 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -49.06 -18.63 1.92 Allowed 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 124.151 3.234 . . . . 0.0 115.265 -171.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.36 21.09 22.41 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.172 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.485 ' HZ ' ' SG ' ' A' ' 51' ' ' CYS . 45.2 t80 -66.69 130.41 43.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.993 0.425 . . . . 0.0 110.795 176.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.434 HG12 ' HA ' ' A' ' 62' ' ' TYR . 35.4 mm -102.55 -59.76 3.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.277 -177.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -162.82 154.39 17.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.738 0.304 . . . . 0.0 110.734 -174.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.485 ' SG ' ' HZ ' ' A' ' 48' ' ' PHE . 12.3 p -144.27 119.3 10.02 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 173.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.777 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.5 pt -124.95 132.83 24.39 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-O 121.127 0.489 . . . . 0.0 111.755 -178.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.55 136.9 7.68 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.02 2.48 . . . . 0.0 111.715 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -124.73 54.37 1.4 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.957 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.446 ' O ' HG11 ' A' ' 33' ' ' VAL . 57.9 m-85 74.13 -53.4 0.68 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.49 0.716 . . . . 0.0 112.285 171.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.417 ' O ' ' HB2' ' A' ' 21' ' ' PHE . 9.3 t -139.26 3.2 2.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.199 0.523 . . . . 0.0 110.477 176.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.3 m -125.7 146.3 49.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.059 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.43 ' HB3' ' HB ' ' A' ' 19' ' ' ILE . 45.8 tp -112.98 119.9 39.53 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.777 ' HB ' HG13 ' A' ' 52' ' ' ILE . 1.4 m -102.1 110.24 22.16 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.794 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 58.9 t -111.27 115.99 51.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.602 0.715 . . . . 0.0 111.185 -173.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -107.05 145.9 31.81 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.479 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.607 ' OH ' ' HB3' ' A' ' 17' ' ' MET . 3.5 p90 -165.12 168.79 16.89 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.983 -175.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.417 ' OD1' ' HB3' ' A' ' 65' ' ' TYR . 7.2 t0 -101.97 114.35 28.38 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.495 -176.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.706 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -64.44 -20.82 66.41 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.075 -176.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.417 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -64.56 -27.52 69.01 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.793 0.33 . . . . 0.0 110.732 -179.203 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -90.69 -39.28 12.54 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.613 0.721 . . . . 0.0 109.271 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.706 HG22 ' HA ' ' A' ' 64' ' ' MET . 2.7 m -64.77 -34.43 70.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.235 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.738 ' HA ' HD23 ' A' ' 71' ' ' LEU . 7.3 m-85 -55.0 -28.39 51.64 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.841 0.456 . . . . 0.0 111.456 172.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -41.91 95.83 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.598 0.713 . . . . 0.0 109.415 177.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -91.0 -23.93 20.24 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.842 -174.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.738 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -26.53 94.37 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.895 0 O-C-N 124.867 1.355 . . . . 0.0 111.546 176.106 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.478 ' HD2' HG13 ' A' ' 75' ' ' ILE . 24.1 Cg_exo -67.65 140.16 50.72 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.551 2.834 . . . . 0.0 111.603 -175.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.0 tp60 -63.01 99.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.463 0.649 . . . . 0.0 109.917 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 140.02 -24.1 2.72 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -172.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.555 HG21 ' HB3' ' A' ' 81' ' ' SER . 2.4 mm -96.29 126.94 48.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 171.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 t -112.25 -0.25 15.55 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.266 0.555 . . . . 0.0 110.109 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.42 ' HG ' ' HD2' ' A' ' 79' ' ' PHE . 34.6 t -118.61 111.99 37.44 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.282 -175.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.694 ' HA ' HD21 ' A' ' 71' ' ' LEU . 91.3 Cg_exo -47.98 -46.3 22.37 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.55 2.833 . . . . 0.0 113.062 173.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.42 ' HD2' ' HG ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -61.18 -37.3 82.42 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.226 -0.19 . . . . 0.0 111.437 176.709 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 19.8 tt0 -82.07 -19.35 40.43 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.402 -174.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.555 ' HB3' HG21 ' A' ' 75' ' ' ILE . 83.3 p -74.25 -37.63 63.71 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 78' ' ' PRO . 26.8 t -65.67 -30.92 51.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.675 177.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.763 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 21.4 mtpt -49.94 -48.5 51.87 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 174.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -61.48 -38.65 88.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.494 -173.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -73.06 -33.72 65.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.137 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.7 m -87.01 -42.5 15.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 CA-C-O 118.911 -0.566 . . . . 0.0 112.043 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.763 ' HG2' ' O ' ' A' ' 83' ' ' LYS . 8.1 pt-20 . . . . . 0 N--CA 1.451 -0.384 0 CA-C-N 118.69 0.677 . . . . 0.0 111.912 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.477 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . 17.2 p90 . . . . . 0 N--CA 1.44 -0.93 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.413 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -147.69 120.31 8.57 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 176.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.877 HG12 HG12 ' A' ' 19' ' ' ILE . 15.8 mt -76.83 117.76 22.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.839 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.604 ' HG2' ' O ' ' A' ' 18' ' ' MET . 8.7 pt-20 -116.92 162.49 17.67 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.804 -174.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.591 HE21 ' HA ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -86.05 138.06 32.23 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.596 0.712 . . . . 0.0 110.102 177.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.733 HD21 HG23 ' A' ' 59' ' ' THR . 0.4 OUTLIER -94.59 -50.29 5.26 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.711 -1.132 . . . . 0.0 110.595 -171.535 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.45 142.45 3.59 Favored Glycine 0 N--CA 1.433 -1.501 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 70.4 -73.02 0.1 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.207 0.603 . . . . 0.0 111.148 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.5 p -173.62 53.51 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.597 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.14 156.43 44.33 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.537 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.864 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 1.1 ptp -123.4 155.98 36.33 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.084 -177.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.707 ' HB2' HD22 ' A' ' 12' ' ' LEU . 48.3 ttm -136.24 137.55 40.91 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 172.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.877 HG12 HG12 ' A' ' 9' ' ' ILE . 8.3 mt -117.21 107.29 21.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.674 -177.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.581 HH21 ' CD ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -90.65 136.11 33.27 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.255 -0.578 . . . . 0.0 109.472 176.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.591 ' HB3' HG11 ' A' ' 29' ' ' VAL . 14.8 m-85 . . . . . 0 C--N 1.323 -0.578 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 170.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.173 0 CA-C-O 120.739 0.304 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.591 HG11 ' HB3' ' A' ' 21' ' ' PHE . 31.0 m -67.4 -42.89 87.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.315 -178.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -49.14 -40.67 33.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.539 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.82 -33.31 24.66 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.101 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -88.83 -26.41 5.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.463 0 O-C-N 122.422 -0.458 . . . . 0.0 112.116 -171.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.425 HG11 ' O ' ' A' ' 55' ' ' PHE . 7.8 p -63.49 -30.67 50.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.342 0.592 . . . . 0.0 109.627 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -74.98 -43.29 54.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.253 175.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.47 -22.23 57.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.132 -176.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.437 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -65.5 -27.64 68.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.527 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.61 -41.54 98.3 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.592 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.65 -21.2 30.33 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.18 176.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.437 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 10.6 t80 -66.88 -44.85 79.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.211 0.529 . . . . 0.0 110.06 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.518 HD11 HD21 ' A' ' 58' ' ' LEU . 34.0 mt -78.49 -31.49 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.696 -174.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.592 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 11.0 pt-20 -69.79 -21.96 63.37 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.777 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -85.09 -29.94 24.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.666 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -130.23 70.13 82.15 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 120.796 0.332 . . . . 0.0 111.003 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -97.39 -175.46 0.24 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.418 2.746 . . . . 0.0 113.091 -176.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.487 ' CZ ' HG12 ' A' ' 67' ' ' VAL . 9.5 p90 -116.36 148.61 42.05 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -45.25 -26.09 2.28 Favored 'Trans proline' 0 N--CA 1.482 0.836 0 C-N-CA 124.159 3.24 . . . . 0.0 115.579 -169.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.553 ' HA3' ' CB ' ' A' ' 66' ' ' GLU . . . -103.21 14.41 55.13 Favored Glycine 0 C--O 1.228 -0.268 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.743 -176.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.431 ' HZ ' ' SG ' ' A' ' 51' ' ' CYS . 31.3 t80 -68.1 139.98 56.21 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.492 0.663 . . . . 0.0 111.024 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.008 HG22 ' HG2' ' A' ' 50' ' ' GLU . 38.7 mm -112.4 -63.84 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.477 -174.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 1.008 ' HG2' HG22 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -152.39 169.41 22.61 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.14 0.495 . . . . 0.0 111.356 -177.445 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.431 ' SG ' ' HZ ' ' A' ' 48' ' ' PHE . 11.2 p -158.8 123.95 4.26 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 169.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.808 HG13 ' HB ' ' A' ' 59' ' ' THR . 7.9 pt -123.02 136.38 26.85 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-O 120.952 0.406 . . . . 0.0 111.724 -177.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 61.2 Cg_endo -85.88 129.12 3.41 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.163 2.575 . . . . 0.0 112.364 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -115.09 43.92 1.9 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.887 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.425 ' O ' HG11 ' A' ' 33' ' ' VAL . 62.2 t80 72.77 -40.55 0.48 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.734 0.813 . . . . 0.0 112.742 175.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.0 t -139.22 -17.71 1.02 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.177 0.513 . . . . 0.0 110.985 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 m -113.44 134.87 54.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.177 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.518 HD21 HD11 ' A' ' 40' ' ' ILE . 52.3 tp -103.06 112.25 25.0 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 177.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.808 ' HB ' HG13 ' A' ' 52' ' ' ILE . 10.7 m -92.49 106.77 18.69 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -177.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.864 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 41.1 t -107.52 120.92 59.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.46 0.648 . . . . 0.0 111.559 -173.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.605 ' HB2' ' HG3' ' A' ' 50' ' ' GLU . 85.7 m-85 -106.39 147.34 29.38 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.185 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.63 ' OH ' ' HB3' ' A' ' 17' ' ' MET . 3.0 p90 -166.7 170.49 12.45 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.673 -176.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.512 ' O ' HG13 ' A' ' 67' ' ' VAL . 6.1 t70 -104.71 123.3 47.37 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.466 0.65 . . . . 0.0 110.773 -176.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.513 ' O ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -61.3 -23.88 66.02 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.766 -175.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.49 ' HD1' ' OD1' ' A' ' 63' ' ' ASP . 0.8 OUTLIER -68.28 -28.82 67.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.383 0.611 . . . . 0.0 110.187 -176.293 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.553 ' CB ' ' HA3' ' A' ' 47' ' ' GLY . 1.0 OUTLIER -91.47 -29.76 16.83 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.65 0.738 . . . . 0.0 109.522 -175.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 64' ' ' MET . 2.0 m -71.24 -35.89 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 176.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.98 ' HA ' HD23 ' A' ' 71' ' ' LEU . 76.7 t80 -69.33 -22.61 63.75 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.501 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -61.27 -38.51 87.01 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 173.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -83.33 -70.25 0.57 Allowed 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 113.867 -1.515 . . . . 0.0 109.523 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.98 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.8 OUTLIER 23.43 68.08 0.36 Allowed Pre-proline 0 N--CA 1.478 0.928 0 O-C-N 124.854 1.346 . . . . 0.0 112.977 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.593 ' HD2' HG13 ' A' ' 75' ' ' ILE . 28.6 Cg_exo -62.42 153.13 72.88 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.657 2.238 . . . . 0.0 112.613 -176.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -68.21 109.26 3.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.368 0.604 . . . . 0.0 110.223 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 131.92 -31.11 3.11 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -174.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.593 HG13 ' HD2' ' A' ' 72' ' ' PRO . 17.4 mm -80.63 117.82 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 114.076 -1.062 . . . . 0.0 108.972 171.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.3 m -97.08 -1.8 44.56 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.536 -174.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.6 t -144.53 136.52 13.06 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.525 -170.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.593 ' HA ' HD21 ' A' ' 71' ' ' LEU . 98.5 Cg_exo -47.26 -57.08 2.52 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.457 2.771 . . . . 0.0 113.343 173.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.551 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -59.01 -30.73 68.21 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.171 0.51 . . . . 0.0 110.907 -179.049 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 46.2 tt0 -74.83 -26.23 59.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.191 -176.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.562 ' HB3' HG21 ' A' ' 75' ' ' ILE . 96.9 p -73.26 -36.87 66.44 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.6 t -67.87 -24.87 31.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.525 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.5 ' HG2' HG21 ' A' ' 9' ' ' ILE . 47.0 mtpt -55.1 -35.36 64.53 Favored 'General case' 0 C--O 1.214 -0.816 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.18 176.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -71.09 -37.18 72.41 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.067 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -69.51 -35.18 75.27 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.999 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.6 m -86.02 -45.07 16.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.92 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 . . . . . 0 C--O 1.221 -0.427 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 179.865 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.2 p90 . . . . . 0 N--CA 1.446 -0.674 0 CA-C-O 120.934 0.397 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.522 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 18.7 mp0 -132.6 131.57 41.58 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.899 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.973 HG12 HG12 ' A' ' 19' ' ' ILE . 49.1 mt -97.7 122.94 49.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.292 173.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -119.01 164.3 15.69 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.102 0.477 . . . . 0.0 110.115 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -84.79 128.22 34.5 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.393 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.614 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.2 OUTLIER -75.89 -39.64 56.02 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.773 -173.074 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -163.76 -77.98 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -138.03 -28.82 0.86 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 177.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.7 p -148.35 36.35 0.82 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.466 0.65 . . . . 0.0 111.557 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.495 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -143.98 156.69 44.5 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.307 176.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.721 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -125.08 147.19 49.11 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.411 -175.618 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.614 ' HB2' HD22 ' A' ' 12' ' ' LEU . 19.0 ttt -136.21 123.45 21.81 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.932 176.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.973 HG12 HG12 ' A' ' 9' ' ' ILE . 9.8 mt -110.66 146.35 15.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 123.014 0.526 . . . . 0.0 110.262 -175.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.522 ' HD2' ' O ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -139.56 134.49 32.24 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.45 173.131 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.608 ' HB2' HG11 ' A' ' 29' ' ' VAL . 4.7 m-85 . . . . . 0 C--N 1.328 -0.338 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.401 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.225 -0.194 0 CA-C-O 120.956 0.408 . . . . 0.0 109.968 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.608 HG11 ' HB2' ' A' ' 21' ' ' PHE . 53.4 t -65.64 -57.95 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.763 -176.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -57.51 -23.05 47.95 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.592 0.234 . . . . 0.0 111.465 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.99 -39.89 5.66 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.046 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.401 ' HB ' ' O ' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -80.39 -26.99 11.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.768 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -175.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 29' ' ' VAL . 10.7 p -68.08 -29.24 43.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -73.29 -34.36 65.71 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.495 177.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.11 -22.09 27.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.598 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.85 -22.99 65.99 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.125 -174.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.427 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . . . -62.52 -44.84 95.37 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.865 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -81.05 -27.85 35.59 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.979 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -59.53 -44.68 93.12 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.498 HD11 HD21 ' A' ' 58' ' ' LEU . 47.3 mt -76.58 -44.26 34.41 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.349 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.865 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 9.5 pt-20 -65.54 -27.37 68.4 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.125 0.416 . . . . 0.0 112.125 -171.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.477 ' C ' ' HD3' ' A' ' 44' ' ' PRO . 45.9 mt-10 -92.63 -18.77 22.63 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 121.156 -0.218 . . . . 0.0 111.441 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.445 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 21.8 mt-30 -131.09 58.55 39.73 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-O 120.744 0.306 . . . . 0.0 110.25 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.477 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 43.0 Cg_endo -104.64 -167.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.988 3.126 . . . . 0.0 113.75 -171.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.678 ' HZ ' ' HB2' ' A' ' 62' ' ' TYR . 12.8 p90 -111.71 147.22 36.33 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 168.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.89 -16.4 0.82 Allowed 'Trans proline' 0 N--CA 1.481 0.747 0 C-N-CA 124.219 3.279 . . . . 0.0 115.1 -172.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.57 7.53 61.49 Favored Glycine 0 C--O 1.226 -0.357 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.769 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -61.44 136.36 58.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.32 0.581 . . . . 0.0 111.803 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 62' ' ' TYR . 39.2 mm -109.19 -62.4 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.399 -177.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -163.43 157.12 19.49 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.432 -173.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.427 ' SG ' ' HA ' ' A' ' 37' ' ' ALA . 6.0 p -151.75 118.84 5.87 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 174.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.704 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.2 pt -116.13 134.25 22.81 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.826 -175.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 62.8 Cg_endo -84.37 141.43 9.01 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.095 2.53 . . . . 0.0 112.305 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -130.87 54.11 1.93 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.734 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.2 t80 76.66 -59.4 0.5 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.492 171.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.2 p -130.64 -2.05 4.27 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.26 0.552 . . . . 0.0 110.943 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 34.0 t -122.24 155.36 36.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.791 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.498 HD21 HD11 ' A' ' 40' ' ' ILE . 47.6 tp -127.33 116.56 20.71 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.598 -177.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.704 ' HB ' HG13 ' A' ' 52' ' ' ILE . 1.1 m -96.22 107.39 19.72 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.721 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 44.1 t -107.44 120.58 59.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.747 0.784 . . . . 0.0 111.867 -171.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -111.44 147.07 36.05 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.675 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.678 ' HB2' ' HZ ' ' A' ' 45' ' ' PHE . 3.3 p90 -165.65 172.0 12.4 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -174.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -103.53 117.34 34.2 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.431 0.634 . . . . 0.0 109.979 -177.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.523 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -64.77 -19.55 65.87 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.176 -176.687 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.06 -29.98 70.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.712 0.292 . . . . 0.0 111.107 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 0.6 OUTLIER -89.16 -26.88 21.05 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 122.067 0.937 . . . . 0.0 108.829 -172.113 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.641 HG11 HG22 ' A' ' 82' ' ' VAL . 3.7 m -82.62 -40.21 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.488 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.558 ' HA ' HD23 ' A' ' 71' ' ' LEU . 2.8 m-85 -58.66 -29.0 66.24 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 171.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.502 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 4.3 tppp? -53.49 -41.87 66.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.68 175.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -94.97 -71.84 0.65 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.693 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER 38.17 68.96 1.61 Allowed Pre-proline 0 N--CA 1.468 0.459 0 O-C-N 124.146 0.904 . . . . 0.0 111.802 179.024 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -63.6 140.64 76.17 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.878 2.385 . . . . 0.0 111.775 -176.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -61.39 109.42 1.15 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.56 0.695 . . . . 0.0 110.925 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 135.49 -32.43 2.55 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 107.939 -2.064 . . . . 0.0 107.939 -169.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.9 mm -95.62 113.6 30.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 113.387 -1.406 . . . . 0.0 107.713 168.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.3 t -105.62 -4.26 21.31 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.467 0.651 . . . . 0.0 109.85 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.484 ' OG ' ' HD1' ' A' ' 79' ' ' PHE . 21.2 t -126.69 125.66 24.4 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.007 -176.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.539 ' O ' HG23 ' A' ' 82' ' ' VAL . 94.8 Cg_exo -50.57 -42.8 48.26 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.644 2.896 . . . . 0.0 112.936 176.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.484 ' HD1' ' OG ' ' A' ' 77' ' ' SER . 0.1 OUTLIER -57.13 -37.07 71.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.672 177.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.446 ' HA ' ' CG ' ' A' ' 83' ' ' LYS . 28.5 tt0 -80.29 -19.8 45.83 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.683 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.422 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 24.0 t -67.97 -31.12 70.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.641 HG22 HG11 ' A' ' 67' ' ' VAL . 12.4 t -83.41 -24.81 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.528 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.447 ' HE2' ' HB3' ' A' ' 83' ' ' LYS . 40.7 mtpt -52.66 -40.89 63.3 Favored 'General case' 0 C--O 1.213 -0.844 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 175.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -58.83 -41.59 87.24 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.971 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -66.39 -37.15 84.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.397 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.7 m -87.25 -48.09 15.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.688 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 . . . . . 0 C--O 1.219 -0.511 0 C-N-CA 122.877 0.471 . . . . 0.0 112.012 -177.509 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.63 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 50.2 p90 . . . . . 0 CA--C 1.514 -0.416 0 CA-C-O 121.707 0.765 . . . . 0.0 112.419 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.758 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . 27.4 mp0 -126.79 138.47 53.36 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.247 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.829 HG12 HG12 ' A' ' 19' ' ' ILE . 29.4 mt -106.94 128.2 61.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.476 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 18' ' ' MET . 12.0 pt-20 -120.2 163.31 17.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.263 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.688 HE21 ' HA ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -92.86 124.4 36.82 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.281 0.562 . . . . 0.0 110.153 178.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.627 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -69.87 -43.14 72.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.148 -174.033 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 173.19 -89.16 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.758 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -92.62 -60.35 1.84 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.917 0.389 . . . . 0.0 111.661 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.8 p -149.73 45.77 0.94 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.569 0.7 . . . . 0.0 110.978 -175.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.82 156.94 47.4 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.149 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.401 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 28.7 ttp -126.84 134.43 50.53 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.627 ' HB2' HD22 ' A' ' 12' ' ' LEU . 50.5 ttm -118.18 132.72 56.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.049 0.452 . . . . 0.0 110.19 177.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.829 HG12 HG12 ' A' ' 9' ' ' ILE . 6.1 mt -127.24 127.66 69.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.98 -177.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.758 ' HD3' ' HB2' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -111.83 131.27 55.45 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.63 ' HA ' ' CB ' ' A' ' 7' ' ' TYR . 6.6 m-85 . . . . . 0 C--N 1.323 -0.565 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.514 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 4.0 mm100 . . . . . 0 C--O 1.223 -0.299 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.608 ' CG2' ' HB2' ' A' ' 21' ' ' PHE . 6.6 p -62.23 -53.43 47.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.531 -177.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.443 ' N ' HG13 ' A' ' 29' ' ' VAL . 32.5 m-80 -53.51 -44.06 68.78 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.666 0.604 . . . . 0.0 111.354 -177.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.44 -38.64 17.02 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.55 -0.834 . . . . 0.0 112.88 -178.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 28' ' ' GLN . 0.3 OUTLIER -83.58 -28.51 7.58 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -172.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 29' ' ' VAL . 14.9 p -68.6 -30.35 47.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 175.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -70.59 -40.21 73.37 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.689 -1.142 . . . . 0.0 109.931 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.53 -22.02 28.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.995 -177.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.404 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . . . -63.92 -28.91 70.15 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.568 0.223 . . . . 0.0 111.498 -174.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.39 -39.13 92.23 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.081 0.943 . . . . 0.0 108.706 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.489 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.85 -23.12 29.15 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.249 178.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.404 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . 1.1 t80 -69.5 -41.71 75.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.15 0.5 . . . . 0.0 109.829 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.569 HD11 HD21 ' A' ' 58' ' ' LEU . 54.8 mt -73.71 -34.63 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.188 -177.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.489 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 9.1 pt-20 -69.63 -23.65 63.53 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.423 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 44.4 mm-40 -73.59 -36.37 65.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.643 175.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -129.61 70.71 82.04 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.324 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -94.47 176.49 1.1 Allowed 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.766 2.311 . . . . 0.0 113.443 -174.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -115.95 147.85 40.08 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.73 175.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -37.23 -37.81 0.42 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.246 3.297 . . . . 0.0 115.13 -174.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.459 ' HA3' ' HB2' ' A' ' 66' ' ' GLU . . . -103.24 17.62 51.01 Favored Glycine 0 C--O 1.224 -0.486 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.025 -176.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -59.77 129.39 41.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.986 0.422 . . . . 0.0 110.62 176.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.59 HG12 ' HA ' ' A' ' 62' ' ' TYR . 39.5 mm -106.07 -57.8 4.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.526 -174.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 13.5 tp10 -164.18 157.52 18.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.681 0.277 . . . . 0.0 110.544 -172.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.4 p -150.79 118.4 6.12 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 172.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.748 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.9 pt -119.94 135.21 24.14 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -176.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 2.5 Cg_endo -80.95 120.67 3.84 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.13 2.553 . . . . 0.0 112.234 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -109.51 52.74 0.71 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.601 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.505 ' O ' HG11 ' A' ' 33' ' ' VAL . 39.5 t80 72.64 -57.79 0.62 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.263 173.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.0 t -132.5 -2.4 3.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.695 0.759 . . . . 0.0 110.14 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.6 m -122.44 140.57 52.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.211 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.569 HD21 HD11 ' A' ' 40' ' ' ILE . 50.5 tp -106.18 115.98 31.14 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.748 ' HB ' HG13 ' A' ' 52' ' ' ILE . 4.7 m -93.28 106.27 18.25 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.784 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.0 t -104.75 123.98 59.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.386 0.612 . . . . 0.0 111.292 -173.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.427 ' CE1' HG22 ' A' ' 59' ' ' THR . 87.8 m-85 -114.96 145.96 41.69 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.57 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.59 ' HA ' HG12 ' A' ' 49' ' ' ILE . 2.4 p90 -166.54 171.29 11.92 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.125 0.488 . . . . 0.0 110.9 -175.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -99.49 111.34 23.7 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.398 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.547 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -61.91 -21.74 65.0 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.234 -176.546 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.52 ' CE1' ' HG2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -71.39 -23.08 61.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.757 0.313 . . . . 0.0 110.981 -176.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.52 ' HG2' ' CE1' ' A' ' 65' ' ' TYR . 22.5 mm-40 -91.51 -34.41 14.79 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.196 0.522 . . . . 0.0 110.458 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.547 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.4 m -70.54 -29.86 40.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.102 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.76 ' HA ' HD23 ' A' ' 71' ' ' LEU . 2.5 m-85 -55.48 -24.96 34.22 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.704 172.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -66.69 -24.32 66.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.596 0.712 . . . . 0.0 109.824 176.749 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -102.15 -32.49 10.07 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.249 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.824 HD21 ' HA ' ' A' ' 78' ' ' PRO . 1.6 mm? -26.36 95.01 0.06 OUTLIER Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 125.514 1.526 . . . . 0.0 113.735 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.547 ' HD2' HG13 ' A' ' 75' ' ' ILE . 20.5 Cg_exo -70.4 161.04 47.45 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 123.594 2.863 . . . . 0.0 111.93 174.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -62.36 -40.34 96.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -173.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.41 -21.37 78.94 Favored Glycine 0 CA--C 1.511 -0.202 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.45 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.548 HG21 ' HB2' ' A' ' 81' ' ' SER . 10.7 mm -81.97 100.26 5.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.057 -0.571 . . . . 0.0 109.919 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.4 m -82.52 -9.87 59.24 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.216 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.2 m -131.15 130.82 22.8 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.738 -175.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.824 ' HA ' HD21 ' A' ' 71' ' ' LEU . 83.4 Cg_exo -46.54 -48.91 12.79 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.408 2.739 . . . . 0.0 113.483 176.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.457 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 1.4 p90 -59.9 -27.4 66.7 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.485 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.667 ' HG3' ' HD2' ' A' ' 83' ' ' LYS . 8.8 tt0 -81.93 -17.83 45.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.887 0.375 . . . . 0.0 110.869 -174.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.548 ' HB2' HG21 ' A' ' 75' ' ' ILE . 48.0 t -79.26 -35.6 41.17 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.459 HG11 ' CE2' ' A' ' 62' ' ' TYR . 49.0 t -67.06 -25.32 33.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.28 178.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.667 ' HD2' ' HG3' ' A' ' 80' ' ' GLU . 94.5 mttt -51.59 -41.92 61.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.967 177.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.444 ' NH1' ' HA ' ' A' ' 84' ' ' ARG . 0.7 OUTLIER -60.9 -50.56 72.91 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.851 -177.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -64.88 -37.04 86.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.796 -177.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.2 m -83.36 -48.22 17.6 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 CA-C-O 118.947 -0.549 . . . . 0.0 112.023 -175.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.521 ' HG2' ' OH ' ' A' ' 7' ' ' TYR . 92.5 mt-10 . . . . . 0 N--CA 1.468 0.475 0 CA-C-N 118.25 0.477 . . . . 0.0 111.902 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.507 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 15.0 p90 . . . . . 0 CA--C 1.513 -0.465 0 CA-C-O 121.198 0.523 . . . . 0.0 111.45 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.431 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 5.6 tp60 -125.49 139.61 53.48 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.559 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 1.057 HG12 HG12 ' A' ' 19' ' ' ILE . 25.6 mt -104.36 122.35 57.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.067 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -116.22 159.99 21.05 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.862 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -86.24 124.4 32.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.53 0.681 . . . . 0.0 110.182 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.703 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -63.45 -48.22 78.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.658 -177.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -165.96 -73.17 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.652 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -128.7 -49.31 1.25 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.582 0.23 . . . . 0.0 111.522 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.08 41.35 1.66 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.639 0.733 . . . . 0.0 110.945 -172.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -143.88 152.22 40.86 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.759 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 29.0 ttp -121.28 135.42 55.12 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -174.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.703 ' HB2' HD22 ' A' ' 12' ' ' LEU . 46.8 ttm -122.22 132.4 54.42 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.145 177.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.057 HG12 HG12 ' A' ' 9' ' ' ILE . 5.7 mt -129.69 143.27 41.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.486 -175.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -125.48 126.66 45.26 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 174.11 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.837 ' HB2' HG23 ' A' ' 29' ' ' VAL . 4.9 m-85 . . . . . 0 C--N 1.325 -0.479 0 CA-C-O 121.121 0.486 . . . . 0.0 109.709 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.423 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 46.6 tt0 . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 120.702 0.287 . . . . 0.0 111.642 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.837 HG23 ' HB2' ' A' ' 21' ' ' PHE . 2.8 p -64.22 -47.98 87.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.779 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -54.92 -42.66 72.51 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.317 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.11 -39.5 10.01 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.182 -1.009 . . . . 0.0 112.537 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.423 ' HB ' ' O ' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -82.5 -21.35 9.56 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -171.459 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.454 HG11 ' O ' ' A' ' 55' ' ' PHE . 12.1 p -72.08 -30.3 35.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -75.46 -38.55 59.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.214 175.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.02 -20.75 51.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.977 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.542 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . . . -68.96 -28.25 66.46 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 120.873 0.368 . . . . 0.0 110.888 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.87 -42.63 99.83 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.793 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -79.13 -30.91 43.94 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.078 176.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.542 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -54.84 -44.93 74.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.433 0.635 . . . . 0.0 110.133 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 45.9 mt -79.62 -30.83 13.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.646 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.793 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 9.2 pt-20 -76.36 -25.06 54.26 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.64 -177.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -82.4 -27.99 31.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.01 0.433 . . . . 0.0 110.396 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -131.7 70.41 81.21 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.244 177.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -99.32 -178.06 0.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.395 2.73 . . . . 0.0 113.854 -173.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.437 ' CE2' HG13 ' A' ' 82' ' ' VAL . 6.0 p90 -115.93 147.41 39.1 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.92 171.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.449 ' HB2' ' CD ' ' A' ' 66' ' ' GLU . 59.0 Cg_exo -38.55 -39.35 1.12 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.987 3.125 . . . . 0.0 115.147 -174.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 66' ' ' GLU . . . -96.66 13.76 64.96 Favored Glycine 0 C--O 1.228 -0.245 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.098 -174.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -59.07 132.75 54.97 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.052 0.453 . . . . 0.0 110.777 175.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.47 HG12 ' HA ' ' A' ' 62' ' ' TYR . 35.9 mm -106.0 -59.37 3.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.261 -175.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -163.55 158.99 21.4 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 120.66 0.267 . . . . 0.0 110.571 -173.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.3 p -150.02 118.01 6.3 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 176.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.754 HG13 ' HB ' ' A' ' 59' ' ' THR . 5.9 pt -120.97 131.58 24.44 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-O 121.106 0.479 . . . . 0.0 112.186 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 72.2 Cg_endo -86.51 141.94 6.86 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.413 2.742 . . . . 0.0 112.499 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.89 59.58 1.61 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.629 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.454 ' O ' HG11 ' A' ' 33' ' ' VAL . 52.0 t80 69.31 -54.34 0.58 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.115 0.966 . . . . 0.0 112.581 175.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.2 t -130.98 -15.74 3.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.767 0.318 . . . . 0.0 111.164 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.0 p -115.18 149.75 37.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.956 0.407 . . . . 0.0 110.936 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 38.6 tp -118.24 125.83 50.94 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.754 ' HB ' HG13 ' A' ' 52' ' ' ILE . 3.1 m -105.59 107.65 18.76 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.038 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.2 t -105.45 123.05 59.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.416 0.627 . . . . 0.0 111.473 -173.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -113.08 147.83 36.48 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.803 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.568 ' OH ' ' HB2' ' A' ' 79' ' ' PHE . 2.6 p90 -165.89 171.71 12.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.757 -175.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -107.74 108.6 19.89 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 121.492 0.663 . . . . 0.0 109.851 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.551 ' O ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -55.63 -31.21 62.11 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.8 -176.681 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.8 -23.5 65.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.149 0.5 . . . . 0.0 110.742 -177.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' A' ' 69' ' ' LYS . 4.0 tm-20 -92.09 -41.67 10.37 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -177.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 64' ' ' MET . 2.5 m -61.94 -28.48 44.4 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.698 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.72 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.82 ' HA ' HD12 ' A' ' 71' ' ' LEU . 4.3 m-85 -50.56 -32.51 18.77 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.407 0.683 . . . . 0.0 111.648 169.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -66.95 -30.96 71.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.203 0.525 . . . . 0.0 110.509 178.432 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -93.46 -37.71 11.8 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.144 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.82 HD12 ' HA ' ' A' ' 68' ' ' TYR . 13.4 mt -32.75 99.5 0.15 Allowed Pre-proline 0 N--CA 1.465 0.315 0 C-N-CA 125.509 1.524 . . . . 0.0 113.463 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.44 ' HD2' HG13 ' A' ' 75' ' ' ILE . 13.9 Cg_exo -74.54 154.91 45.19 Favored 'Trans proline' 0 C--N 1.332 -0.302 0 C-N-CA 124.128 3.219 . . . . 0.0 110.586 174.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -64.34 -21.25 66.55 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -171.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.3 -18.04 76.93 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.113 176.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.539 HG23 ' HB3' ' A' ' 80' ' ' GLU . 2.8 mm -101.86 105.79 18.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.97 -0.615 . . . . 0.0 110.179 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.8 t -93.0 -3.34 54.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.006 0.432 . . . . 0.0 110.506 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' ' 80' ' ' GLU . 17.1 m -121.45 116.19 30.86 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.984 -178.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.665 ' HG3' ' CE1' ' A' ' 68' ' ' TYR . 14.4 Cg_exo -35.75 -56.6 0.58 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 124.357 3.371 . . . . 0.0 114.071 171.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.568 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -57.77 -32.74 67.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.227 -179.358 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.539 ' HB3' HG23 ' A' ' 75' ' ' ILE . 2.2 tp10 -70.19 -29.43 66.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.722 -174.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.64 ' HB2' HD23 ' A' ' 71' ' ' LEU . 46.5 t -79.37 -35.58 40.6 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.478 HG11 ' CE2' ' A' ' 62' ' ' TYR . 92.1 t -60.15 -39.95 82.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.936 177.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.759 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 17.6 mtmt -54.95 -48.31 73.34 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 21.7 mmm180 -63.01 -32.68 74.09 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.228 -174.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -69.52 -40.57 76.85 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.433 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.34 -35.59 9.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.546 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 . . . . . 0 C--O 1.223 -0.327 0 C-N-CA 122.801 0.44 . . . . 0.0 111.891 179.724 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.2 p90 . . . . . 0 N--CA 1.45 -0.439 0 CA-C-O 121.052 0.453 . . . . 0.0 111.353 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.563 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -140.04 121.75 15.35 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -178.255 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.946 HG12 HG12 ' A' ' 19' ' ' ILE . 29.3 mt -87.6 112.0 22.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.805 0.812 . . . . 0.0 110.911 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 18' ' ' MET . 4.0 pt-20 -106.87 161.48 14.66 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.489 -173.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.432 ' HA ' ' NE2' ' A' ' 11' ' ' GLN . 6.0 tp-100 -90.91 124.75 35.44 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.667 0.746 . . . . 0.0 110.686 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.561 HD21 HG22 ' A' ' 59' ' ' THR . 0.2 OUTLIER -70.69 -46.84 62.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.993 -176.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -157.92 -79.72 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -137.36 -36.1 0.66 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.865 0.364 . . . . 0.0 110.807 176.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.5 p -141.97 39.18 1.63 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.823 0.82 . . . . 0.0 110.201 -174.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -143.63 151.94 40.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.277 176.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.473 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 35.4 ttp -123.16 137.89 54.79 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.063 -0.655 . . . . 0.0 112.314 -173.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.596 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 24.7 ttt -126.51 138.16 53.46 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.946 HG12 HG12 ' A' ' 9' ' ' ILE . 4.7 mt -133.13 118.79 33.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.674 -174.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.563 ' HD3' ' HB3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -102.95 125.71 49.81 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.674 177.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.511 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 176.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.7 tm0? . . . . . 0 CA--C 1.533 0.306 0 N-CA-C 111.925 0.342 . . . . 0.0 111.925 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.537 ' O ' HG12 ' A' ' 33' ' ' VAL . 11.1 p -64.1 -41.23 91.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.315 -176.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -60.1 -25.48 65.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.423 -175.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -92.57 -39.86 5.18 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.026 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -81.8 -27.24 9.71 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -173.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 29' ' ' VAL . 11.1 p -70.54 -30.92 44.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 119.307 -0.957 . . . . 0.0 108.486 175.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -71.46 -35.17 70.77 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.695 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.64 -22.01 30.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.39 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.479 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . . . -64.09 -21.07 66.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.351 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.93 -43.36 88.28 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.737 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -81.81 -29.9 32.45 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.802 176.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.479 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . 7.8 t80 -51.59 -46.03 63.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.498 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.437 HD11 HD21 ' A' ' 58' ' ' LEU . 58.0 mt -80.4 -29.15 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.965 -175.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.737 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 10.3 pt-20 -75.81 -26.76 57.54 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.096 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 51.4 mt-10 -74.54 -35.65 63.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.061 173.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -125.19 74.94 67.88 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.244 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -95.02 -164.51 0.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.385 2.723 . . . . 0.0 113.749 -171.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -138.78 147.63 55.13 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.208 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -44.26 -22.6 0.57 Allowed 'Trans proline' 0 N--CA 1.482 0.808 0 C-N-CA 124.447 3.431 . . . . 0.0 115.881 -170.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.405 ' HA3' ' HB3' ' A' ' 66' ' ' GLU . . . -116.59 27.09 8.16 Favored Glycine 0 C--O 1.228 -0.265 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.314 -177.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -67.91 136.0 53.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.051 0.453 . . . . 0.0 111.76 177.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.7 mm -109.33 -60.34 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.257 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 40.6 tt0 -162.28 157.41 22.81 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.781 -172.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 59' ' ' THR . 2.1 p -152.05 118.23 5.56 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 173.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.537 HG13 ' HB ' ' A' ' 59' ' ' THR . 7.7 pt -126.59 142.1 42.15 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.604 -176.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.516 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 1.6 Cg_endo -84.64 139.59 7.78 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.31 2.674 . . . . 0.0 112.673 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.7 66.94 1.54 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 92.5 t80 75.91 -68.97 0.18 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.316 0.647 . . . . 0.0 111.588 171.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.1 t -134.92 2.43 3.11 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.613 0.72 . . . . 0.0 109.673 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 15.2 m -120.65 137.47 54.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.38 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.437 HD21 HD11 ' A' ' 40' ' ' ILE . 61.6 tp -102.48 126.89 49.68 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.561 HG22 HD21 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -101.42 106.8 17.98 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -177.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.1 t -109.35 119.21 58.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.459 0.647 . . . . 0.0 111.067 -174.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 85.1 m-85 -112.9 146.59 38.68 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.513 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.563 ' CE2' HG11 ' A' ' 82' ' ' VAL . 3.6 p90 -164.78 170.32 15.63 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.873 -173.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -104.24 112.29 25.25 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.73 -177.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.469 ' HA ' HG22 ' A' ' 67' ' ' VAL . 1.4 pmm? -63.22 -26.51 68.83 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.735 -174.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.68 -27.89 66.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.201 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.405 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 4.0 tp10 -90.71 -41.17 11.43 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -173.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.469 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.5 m -68.06 -30.63 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.089 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.712 ' HA ' HD23 ' A' ' 71' ' ' LEU . 3.5 m-85 -53.94 -29.45 42.41 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.495 173.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.479 ' HE2' ' HB2' ' A' ' 69' ' ' LYS . 0.3 OUTLIER -67.62 -34.96 78.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.11 0.481 . . . . 0.0 110.601 178.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 33.9 t60 -93.05 -30.82 15.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.491 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.712 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.5 OUTLIER -16.2 91.56 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 125.618 1.567 . . . . 0.0 112.672 177.124 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.473 ' HD2' HG13 ' A' ' 75' ' ' ILE . 31.8 Cg_exo -61.71 149.99 87.61 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.057 2.504 . . . . 0.0 111.352 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -63.22 -22.09 66.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.628 -172.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -83.83 -13.76 74.38 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.775 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.502 HG21 ' HB3' ' A' ' 81' ' ' SER . 4.5 mm -96.35 130.84 44.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 122.837 0.455 . . . . 0.0 109.944 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.3 t -114.34 0.07 14.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.164 0.507 . . . . 0.0 109.952 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.9 m -134.5 120.14 14.49 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.962 -177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.619 ' HA ' HD21 ' A' ' 71' ' ' LEU . 95.2 Cg_exo -46.46 -38.5 21.23 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 124.122 3.215 . . . . 0.0 113.882 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.9 -34.65 76.42 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.123 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.627 ' HA ' ' HD3' ' A' ' 83' ' ' LYS . 16.7 tt0 -83.46 -20.7 33.56 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.456 -174.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.502 ' HB3' HG21 ' A' ' 75' ' ' ILE . 62.5 p -75.93 -30.09 58.58 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 177.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 78' ' ' PRO . 97.7 t -67.59 -34.46 68.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.724 174.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.627 ' HD3' ' HA ' ' A' ' 80' ' ' GLU . 59.7 mtpt -51.85 -45.43 64.01 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 174.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.496 ' HE ' HD11 ' A' ' 75' ' ' ILE . 21.1 mmt180 -60.81 -35.9 77.69 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.874 -177.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -72.31 -42.4 65.51 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.047 0.451 . . . . 0.0 111.426 -177.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.6 m -87.15 -46.12 16.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.17 -177.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 83' ' ' LYS . 14.9 mm-40 . . . . . 0 C--O 1.206 -1.193 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.796 -175.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.649 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 38.9 p90 . . . . . 0 CA--C 1.517 -0.317 0 CA-C-O 121.747 0.784 . . . . 0.0 111.941 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.562 ' HB2' ' NE ' ' A' ' 20' ' ' ARG . 40.1 mt-30 -128.16 139.54 52.43 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.701 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 1.001 HG12 HG12 ' A' ' 19' ' ' ILE . 15.9 mt -101.03 120.25 50.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.764 177.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 18' ' ' MET . 11.9 pt-20 -119.85 159.17 25.12 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.846 -177.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.627 HE21 ' HA ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -88.49 129.91 35.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.971 177.492 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.675 HD21 HG23 ' A' ' 59' ' ' THR . 0.0 OUTLIER -66.4 -42.65 87.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.619 -177.653 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.83 -55.48 0.36 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.426 176.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -103.43 -74.71 0.63 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.947 0.403 . . . . 0.0 111.07 -176.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.4 p -149.58 48.15 0.95 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.686 0.755 . . . . 0.0 110.562 -177.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.555 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -142.57 155.08 44.95 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.835 176.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.502 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 37.5 ttp -128.06 124.45 37.09 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -174.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.477 ' HB2' HD22 ' A' ' 12' ' ' LEU . 51.3 ttm -109.49 139.49 44.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.131 0.491 . . . . 0.0 110.248 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.001 HG12 HG12 ' A' ' 9' ' ' ILE . 6.4 mt -128.21 112.67 27.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.913 -176.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.576 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -96.0 124.22 39.92 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.89 178.599 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.649 ' HA ' ' CB ' ' A' ' 7' ' ' TYR . 8.0 m-85 . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.52 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.4 tm0? . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 120.887 0.375 . . . . 0.0 111.591 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 33' ' ' VAL . 83.3 t -63.16 -41.66 93.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.395 -177.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -52.61 -32.75 43.21 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.595 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.53 -42.23 6.2 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.731 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -80.03 -22.17 11.8 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.79 0 C-N-CA 120.539 -0.464 . . . . 0.0 112.105 -173.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 29' ' ' VAL . 14.3 p -74.12 -29.5 25.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 119.593 -0.843 . . . . 0.0 108.865 174.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -70.85 -34.63 71.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.47 174.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.12 -21.44 29.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.306 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.461 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . . . -65.15 -26.54 68.22 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.031 -177.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.54 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . . . -62.0 -43.59 98.52 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.86 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -77.85 -29.66 50.59 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.846 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.461 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -55.57 -44.71 77.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.257 0.551 . . . . 0.0 109.639 177.264 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.522 ' CD1' HD21 ' A' ' 58' ' ' LEU . 41.5 mt -83.15 -37.47 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.82 -175.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.86 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 12.2 pt-20 -74.12 -20.89 60.1 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.29 -176.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.454 ' C ' ' HD3' ' A' ' 44' ' ' PRO . 38.1 mm-40 -85.72 -25.68 26.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.932 0.396 . . . . 0.0 110.684 175.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -122.76 63.36 19.99 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.454 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 50.0 Cg_endo -93.42 174.2 1.69 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.546 2.164 . . . . 0.0 114.039 -167.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -114.01 146.48 35.75 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 114.152 -1.385 . . . . 0.0 108.052 175.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.44 -15.33 3.85 Favored 'Trans proline' 0 N--CA 1.48 0.699 0 C-N-CA 123.82 3.013 . . . . 0.0 114.844 -169.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 66' ' ' GLU . . . -109.39 20.18 28.21 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.11 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.516 ' HE2' HG22 ' A' ' 40' ' ' ILE . 4.2 t80 -62.01 132.33 52.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.986 0.422 . . . . 0.0 110.778 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.646 HG22 ' CG ' ' A' ' 50' ' ' GLU . 28.9 mm -109.48 -62.99 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.17 176.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.646 ' CG ' HG22 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -154.69 175.8 13.24 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.522 0.677 . . . . 0.0 110.393 178.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' A' ' 37' ' ' ALA . 7.5 p -161.55 119.7 2.34 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.838 162.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.767 HG13 ' HB ' ' A' ' 59' ' ' THR . 9.5 pt -114.77 134.07 22.48 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-O 120.975 0.417 . . . . 0.0 112.039 -173.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.482 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 2.0 Cg_endo -82.04 120.45 3.37 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.295 2.664 . . . . 0.0 112.342 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.52 32.95 3.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.328 178.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 71.04 -34.64 0.31 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.096 175.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -128.82 -21.35 3.39 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.85 -0.531 . . . . 0.0 111.214 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 9.5 p -124.65 141.29 52.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.139 0.495 . . . . 0.0 110.571 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.522 HD21 ' CD1' ' A' ' 40' ' ' ILE . 57.5 tp -102.44 111.98 24.5 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.767 ' HB ' HG13 ' A' ' 52' ' ' ILE . 5.2 m -90.32 105.54 17.88 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.7 t -101.25 125.36 55.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.086 0.47 . . . . 0.0 111.122 -172.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -114.73 145.87 41.58 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.613 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.502 ' OH ' ' HB2' ' A' ' 17' ' ' MET . 2.4 p90 -165.09 169.1 16.62 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.371 0.605 . . . . 0.0 110.695 -174.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -96.61 118.95 34.17 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.616 -176.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.478 ' HA ' HG22 ' A' ' 67' ' ' VAL . 1.3 pmm? -69.34 -22.8 63.73 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.833 -172.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.42 -28.83 69.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 111.144 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.401 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 13.8 tp10 -89.83 -30.98 17.58 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.769 0.795 . . . . 0.0 109.477 -173.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.478 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.2 m -77.75 -33.81 19.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.339 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.907 ' HA ' HD23 ' A' ' 71' ' ' LEU . 59.8 t80 -68.29 -22.87 64.7 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.245 175.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -38.87 71.43 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 172.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -87.54 -74.68 0.43 Allowed 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.421 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.907 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER 32.44 66.95 1.04 Allowed Pre-proline 0 N--CA 1.471 0.593 0 O-C-N 124.186 0.929 . . . . 0.0 111.574 -178.236 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.669 ' HD2' HG13 ' A' ' 75' ' ' ILE . 33.2 Cg_exo -60.45 135.61 62.32 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.475 2.117 . . . . 0.0 111.371 -175.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -58.7 109.32 0.78 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.907 0.861 . . . . 0.0 110.964 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 136.42 -31.56 2.58 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 108.549 -1.82 . . . . 0.0 108.549 -169.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.669 HG13 ' HD2' ' A' ' 72' ' ' PRO . 14.3 mm -84.78 116.38 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 114.049 -1.076 . . . . 0.0 108.764 169.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.9 m -94.94 -4.32 47.0 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.162 0.506 . . . . 0.0 110.716 -175.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.607 ' HB2' ' HB2' ' A' ' 80' ' ' GLU . 58.0 m -141.35 134.54 14.43 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.227 -170.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.649 ' HA ' HD21 ' A' ' 71' ' ' LEU . 82.8 Cg_exo -51.92 -43.63 50.72 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.509 2.806 . . . . 0.0 113.157 173.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -67.11 -23.39 65.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.185 0.516 . . . . 0.0 110.748 176.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 77' ' ' SER . 39.9 tt0 -81.34 -20.73 40.03 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.159 -174.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.538 ' HB3' HG21 ' A' ' 75' ' ' ILE . 63.7 p -81.95 -37.33 26.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 78' ' ' PRO . 26.2 t -64.22 -26.02 39.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.129 177.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.564 ' HG3' ' HA ' ' A' ' 80' ' ' GLU . 93.5 mttt -50.17 -45.08 53.11 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.126 175.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -69.5 -35.14 75.24 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.042 -173.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -62.33 -41.79 98.85 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.843 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.9 m -87.41 -42.96 15.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -178.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 C--O 1.222 -0.382 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.348 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 5.9 p90 . . . . . 0 N--CA 1.447 -0.607 0 CA-C-O 121.478 0.656 . . . . 0.0 111.853 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.508 ' HB3' ' NE ' ' A' ' 20' ' ' ARG . 8.1 tp60 -146.79 115.25 6.71 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.125 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.82 HG12 HG12 ' A' ' 19' ' ' ILE . 30.5 mt -82.73 122.75 37.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.036 0.446 . . . . 0.0 110.281 176.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.428 ' OE2' ' HD2' ' A' ' 20' ' ' ARG . 12.4 pt-20 -120.7 169.68 10.16 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.209 -178.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -93.85 128.43 40.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.473 0.654 . . . . 0.0 110.56 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.64 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -69.56 -47.65 62.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.703 -177.589 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -161.61 -72.09 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -142.41 -34.42 0.45 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.223 -0.191 . . . . 0.0 111.513 177.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.1 p -144.1 42.95 1.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.795 0.807 . . . . 0.0 111.234 -176.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -150.45 152.75 34.76 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.204 177.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.499 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 30.8 ttp -125.4 133.12 52.62 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.751 -0.78 . . . . 0.0 112.484 -173.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.64 ' HB2' HD22 ' A' ' 12' ' ' LEU . 53.7 ttm -119.02 131.76 56.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.965 176.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.82 HG12 HG12 ' A' ' 9' ' ' ILE . 7.3 mt -123.44 109.04 22.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.65 -176.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -102.76 134.42 46.18 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.501 -179.343 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 35.3 m-85 . . . . . 0 C--N 1.323 -0.568 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.4 tm0? . . . . . 0 CA--C 1.529 0.168 0 CA-C-O 120.453 0.168 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.694 ' O ' HG22 ' A' ' 33' ' ' VAL . 4.9 p -60.31 -55.38 24.64 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.113 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -175.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.451 ' N ' HG13 ' A' ' 29' ' ' VAL . 51.9 m-80 -55.88 -29.48 60.03 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.389 0.431 . . . . 0.0 111.355 -176.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.68 -35.98 17.7 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.362 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -93.48 -28.55 4.37 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.872 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -170.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 29' ' ' VAL . 3.1 m -62.7 -35.68 71.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.744 176.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.5 t60 -71.93 -33.13 68.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.157 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.32 -32.81 24.11 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.124 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.635 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -64.9 -24.11 67.43 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 122.772 0.429 . . . . 0.0 111.203 -177.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.485 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . . . -61.38 -40.3 93.82 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.765 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -85.57 -32.64 22.01 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.102 174.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.635 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 4.4 t80 -54.67 -42.53 71.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.126 0.489 . . . . 0.0 110.603 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.531 HD11 HD21 ' A' ' 58' ' ' LEU . 51.9 mt -78.06 -31.86 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.237 -177.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.765 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 10.0 pt-20 -79.5 -23.73 42.76 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.763 -177.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -78.12 -33.28 50.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.497 174.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -126.88 68.88 71.68 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.832 0.349 . . . . 0.0 110.302 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -96.03 179.17 0.57 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.109 2.539 . . . . 0.0 113.972 -171.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -111.29 146.48 34.67 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.1 171.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -43.03 -35.19 4.44 Favored 'Trans proline' 0 N--CA 1.479 0.636 0 C-N-CA 123.457 2.771 . . . . 0.0 114.992 -171.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.499 ' HA3' ' CB ' ' A' ' 66' ' ' GLU . . . -98.73 16.18 59.95 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.713 -175.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -60.68 135.99 57.93 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.08 0.466 . . . . 0.0 111.099 175.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.88 HG22 ' HG2' ' A' ' 50' ' ' GLU . 40.6 mm -110.65 -61.36 2.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.065 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.88 ' HG2' HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -153.19 169.57 22.67 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.471 0.653 . . . . 0.0 111.16 -178.315 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 59' ' ' THR . 4.2 p -161.76 117.54 2.05 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.096 167.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.607 HG12 ' HB ' ' A' ' 59' ' ' THR . 0.1 OUTLIER -127.75 136.48 29.04 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.691 -175.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 37' ' ' ALA . 71.1 Cg_endo -78.75 138.35 14.92 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.778 2.319 . . . . 0.0 112.546 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.97 58.53 1.02 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.683 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 62.9 t80 70.61 -65.53 0.33 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.695 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 t -119.11 -17.48 8.95 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.999 0.428 . . . . 0.0 111.454 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 4.3 p -112.9 144.79 41.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.204 0.526 . . . . 0.0 111.272 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.531 HD21 HD11 ' A' ' 40' ' ' ILE . 53.0 tp -102.75 118.24 36.4 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.607 ' HB ' HG12 ' A' ' 52' ' ' ILE . 0.7 OUTLIER -93.76 106.55 18.51 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.71 -177.245 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.6 t -106.2 126.12 61.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.308 0.575 . . . . 0.0 111.177 -173.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.589 ' HB2' ' HG3' ' A' ' 50' ' ' GLU . 89.5 m-85 -120.15 147.06 45.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.245 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.499 ' OH ' ' HB2' ' A' ' 17' ' ' MET . 1.9 p90 -166.11 172.39 11.37 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.292 0.567 . . . . 0.0 111.065 -172.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.412 ' OD1' ' HB3' ' A' ' 65' ' ' TYR . 10.9 t0 -99.0 113.41 25.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.662 -179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.535 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -60.78 -20.5 61.57 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.48 -178.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.412 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -70.54 -31.79 68.98 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.94 0.4 . . . . 0.0 110.789 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.499 ' CB ' ' HA3' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -90.36 -29.56 17.98 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.503 0.668 . . . . 0.0 109.724 -173.528 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.535 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.4 m -74.9 -32.15 27.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.392 176.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.774 ' HA ' HD23 ' A' ' 71' ' ' LEU . 50.7 t80 -66.2 -24.0 66.55 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.636 175.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.82 -32.75 69.66 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.869 0.842 . . . . 0.0 108.732 174.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -91.89 -69.37 0.74 Allowed 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.197 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.774 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER 22.73 76.75 0.23 Allowed Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 124.804 1.242 . . . . 0.0 113.567 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.426 ' HD2' HG13 ' A' ' 75' ' ' ILE . 44.1 Cg_exo -58.02 153.03 47.43 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.513 2.142 . . . . 0.0 111.639 176.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -61.0 -29.19 69.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.481 -173.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.83 -30.16 56.36 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.328 -0.939 . . . . 0.0 111.025 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.615 HG21 ' HB3' ' A' ' 81' ' ' SER . 14.1 mm -76.78 108.26 9.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.947 -0.627 . . . . 0.0 110.079 177.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.2 t -89.29 -8.85 52.51 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.322 0.582 . . . . 0.0 110.464 -176.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 69.9 m -133.36 134.21 23.68 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.073 -173.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.713 ' HA ' HD21 ' A' ' 71' ' ' LEU . 84.8 Cg_exo -49.55 -49.23 16.28 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.539 2.826 . . . . 0.0 113.132 176.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.446 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -60.35 -26.88 66.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.008 0.432 . . . . 0.0 111.544 178.546 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -79.11 -21.47 46.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.075 -175.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.615 ' HB3' HG21 ' A' ' 75' ' ' ILE . 78.4 p -82.33 -37.59 25.49 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 176.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 78' ' ' PRO . 59.8 t -59.4 -29.13 41.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.823 177.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.472 ' HE2' HG21 ' A' ' 9' ' ' ILE . 95.4 mttt -52.22 -47.02 65.87 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -63.46 -33.26 75.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.654 -174.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -70.61 -38.26 73.94 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.384 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.7 m -87.3 -44.53 16.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 . . . . . 0 N--CA 1.469 0.494 0 C-N-CA 123.117 0.567 . . . . 0.0 111.994 -178.256 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.575 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . 20.0 p90 . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.417 HE21 ' HB3' ' A' ' 8' ' ' GLN . 13.6 mt-30 -139.39 133.31 30.89 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.842 176.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.876 HG12 HG12 ' A' ' 19' ' ' ILE . 26.8 mt -95.53 127.54 47.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.132 -178.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 18' ' ' MET . 11.4 pt-20 -122.57 171.43 9.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.423 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.66 137.73 32.08 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.179 0.514 . . . . 0.0 110.947 177.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.587 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -79.59 -20.33 47.19 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.01 175.322 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.2 -80.96 0.19 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.733 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -107.05 -55.44 2.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.842 0.353 . . . . 0.0 111.778 -175.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.539 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 4.6 p -149.29 42.01 0.91 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.648 0.737 . . . . 0.0 110.984 -172.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.522 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -142.65 157.91 44.2 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.47 173.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.733 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 35.1 ttp -130.02 133.02 46.46 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.929 -174.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.587 ' HB2' HD22 ' A' ' 12' ' ' LEU . 32.8 ttp -124.06 135.38 53.53 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.109 175.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.876 HG12 HG12 ' A' ' 9' ' ' ILE . 5.0 mt -120.05 124.4 72.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.114 -176.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.518 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -104.53 118.76 37.39 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.237 178.347 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.575 ' CD2' ' HB3' ' A' ' 7' ' ' TYR . 53.3 m-85 . . . . . 0 C--N 1.318 -0.796 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.748 173.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 . . . . . 0 N--CA 1.456 -0.131 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.572 ' HB ' ' HB3' ' A' ' 21' ' ' PHE . 17.0 m -65.97 -43.82 92.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.821 0.344 . . . . 0.0 110.251 -177.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.82 -41.66 95.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.762 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.51 -37.88 29.88 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.394 -175.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.1 -29.06 13.78 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.749 0 C-N-CA 120.224 -0.591 . . . . 0.0 111.946 -175.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.45 HG23 ' HB2' ' A' ' 58' ' ' LEU . 14.1 p -71.02 -28.81 34.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -69.71 -40.27 76.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.074 173.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.09 -20.64 30.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.931 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.87 -30.44 70.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.722 0.296 . . . . 0.0 111.469 -173.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.22 98.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.719 0.771 . . . . 0.0 108.99 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.528 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -78.29 -25.67 46.73 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.73 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -66.14 -45.01 82.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.344 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.497 ' CD1' HD21 ' A' ' 58' ' ' LEU . 41.8 mt -76.25 -38.05 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.346 -175.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 14.4 pt-20 -69.6 -19.99 63.64 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.238 -175.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -91.95 -24.37 19.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.609 0.242 . . . . 0.0 110.762 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -127.1 68.84 72.88 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 175.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -95.56 -171.0 0.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.451 2.767 . . . . 0.0 113.816 -170.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -127.29 147.07 60.49 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.376 176.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -40.69 -36.74 2.0 Allowed 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.107 3.204 . . . . 0.0 115.317 -170.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -102.51 19.31 48.37 Favored Glycine 0 C--O 1.226 -0.404 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.518 -174.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -64.36 135.8 56.51 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.081 0.467 . . . . 0.0 111.211 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.447 HG12 ' HA ' ' A' ' 62' ' ' TYR . 32.6 mm -107.67 -58.54 3.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.236 -178.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -167.17 160.86 14.15 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.197 -176.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 59' ' ' THR . 5.6 p -149.97 119.76 7.08 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 172.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.807 HG13 ' HB ' ' A' ' 59' ' ' THR . 5.3 pt -114.56 132.58 22.79 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-O 121.2 0.524 . . . . 0.0 111.845 -175.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -85.61 123.03 2.44 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.243 2.629 . . . . 0.0 112.395 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.18 27.72 7.97 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.299 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 70.92 -28.5 0.18 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.248 -0.887 . . . . 0.0 113.298 174.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -140.84 7.23 2.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.336 0.589 . . . . 0.0 110.711 171.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 47.3 m -148.18 144.36 27.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.775 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.497 HD21 ' CD1' ' A' ' 40' ' ' ILE . 54.4 tp -115.61 111.66 20.98 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.95 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.807 ' HB ' HG13 ' A' ' 52' ' ' ILE . 3.8 m -90.18 106.68 18.65 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.6 t -104.9 117.41 50.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.541 0.686 . . . . 0.0 110.88 -174.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.422 ' CE1' HG22 ' A' ' 59' ' ' THR . 80.8 m-85 -105.5 147.15 28.64 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.791 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.573 ' CE2' HG11 ' A' ' 82' ' ' VAL . 3.8 p90 -165.75 164.64 18.84 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.382 -176.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -99.31 114.5 27.4 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.333 -175.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.58 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -65.12 -20.85 66.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.65 -169.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.659 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 0.5 OUTLIER -68.41 -29.5 68.19 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.267 -178.07 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -91.88 -35.56 13.98 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 121.445 0.641 . . . . 0.0 109.513 -175.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.58 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.3 m -68.37 -29.91 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.85 177.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 1.029 ' HA ' HD23 ' A' ' 71' ' ' LEU . 30.1 t80 -69.61 -22.93 63.45 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.516 174.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' A' ' 65' ' ' TYR . 27.4 mmmt -76.25 -25.42 54.97 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -89.5 -35.6 15.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.428 178.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.029 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -16.89 90.21 0.04 OUTLIER Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 125.606 1.562 . . . . 0.0 112.779 178.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.635 ' HD2' HG13 ' A' ' 75' ' ' ILE . 22.8 Cg_exo -66.33 136.62 44.28 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.196 2.597 . . . . 0.0 110.941 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -65.61 100.17 0.5 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.818 0.818 . . . . 0.0 110.417 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.46 -26.02 1.83 Allowed Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -171.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.65 HG22 ' H ' ' A' ' 77' ' ' SER . 11.6 mm -87.75 132.9 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 114.627 -0.787 . . . . 0.0 109.636 172.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.5 t -103.44 1.11 32.07 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.159 0.504 . . . . 0.0 110.522 -176.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.65 ' H ' HG22 ' A' ' 75' ' ' ILE . 21.0 t -146.57 129.41 7.98 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -170.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.694 ' HA ' HD21 ' A' ' 71' ' ' LEU . 95.8 Cg_exo -47.51 -44.42 25.44 Favored 'Trans proline' 0 C--O 1.221 -0.352 0 C-N-CA 123.577 2.851 . . . . 0.0 112.807 169.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -36.8 82.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.034 0.445 . . . . 0.0 110.913 176.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 77' ' ' SER . 39.9 tt0 -71.33 -27.09 63.13 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.595 -174.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.597 ' HB3' HG21 ' A' ' 75' ' ' ILE . 76.9 p -77.6 -37.64 49.88 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 78' ' ' PRO . 58.2 t -60.73 -34.71 59.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.102 178.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.733 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 5.3 mtmp? -53.21 -42.7 66.56 Favored 'General case' 0 C--O 1.213 -0.82 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 176.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.56 -34.24 73.91 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.483 -175.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -62.72 -41.55 99.21 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.455 176.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.7 m -84.29 -39.69 14.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.924 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.465 ' OE2' ' HB3' ' A' ' 83' ' ' LYS . 39.9 mt-10 . . . . . 0 C--O 1.218 -0.572 0 C-N-CA 123.207 0.603 . . . . 0.0 112.083 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.478 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . 27.0 p90 . . . . . 0 CA--C 1.514 -0.412 0 CA-C-O 121.8 0.809 . . . . 0.0 112.378 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.26 140.44 45.21 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.135 -1.393 . . . . 0.0 108.511 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.754 HG21 ' HD3' ' A' ' 83' ' ' LYS . 34.2 mt -113.81 131.26 66.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.9 -175.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -121.85 169.53 10.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.203 0.525 . . . . 0.0 110.432 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.64 HE21 ' HA ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -94.42 131.29 40.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.642 176.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.682 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -69.05 -50.11 51.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.639 -176.289 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.99 -69.96 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.703 176.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -110.57 -71.06 0.78 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.983 0.42 . . . . 0.0 111.433 -176.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.9 p -135.91 47.07 2.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.674 0.75 . . . . 0.0 110.792 -175.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.29 153.75 42.34 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.006 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.475 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 26.7 ttp -121.52 136.61 54.94 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.652 -0.419 . . . . 0.0 112.112 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.682 ' HB2' HD22 ' A' ' 12' ' ' LEU . 49.5 ttm -122.49 131.82 54.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.31 0.576 . . . . 0.0 110.049 176.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.743 HG12 HG12 ' A' ' 9' ' ' ILE . 4.0 mt -118.64 140.58 41.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.459 -178.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.408 ' N ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -123.26 117.56 25.57 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.361 0.601 . . . . 0.0 109.935 176.074 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.478 ' CD2' ' HB3' ' A' ' 7' ' ' TYR . 35.8 m-85 . . . . . 0 C--N 1.318 -0.78 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.108 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.271 0 CA-C-O 120.49 0.185 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 21' ' ' PHE . 35.4 m -55.19 -41.95 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 120.799 0.333 . . . . 0.0 110.931 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.401 ' N ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -66.91 -19.75 65.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.272 -177.138 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.71 -45.56 4.85 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.254 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.11 -21.35 12.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.687 -175.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.5 p -70.76 -31.11 44.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 174.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -77.67 -36.71 51.07 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.03 177.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.79 -20.79 45.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.005 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.409 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -65.49 -26.99 68.17 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.659 0.266 . . . . 0.0 110.764 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.511 ' O ' ' HG3' ' A' ' 41' ' ' GLU . . . -62.75 -46.17 89.32 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.2 -34.94 63.88 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.607 176.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.409 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 19.3 t80 -54.98 -41.14 70.83 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.79 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.416 HD11 HD21 ' A' ' 58' ' ' LEU . 48.8 mt -76.74 -27.01 16.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.239 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 37' ' ' ALA . 41.6 mt-10 -79.42 -41.55 27.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.957 0.408 . . . . 0.0 111.398 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -63.27 -35.35 80.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.181 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -129.55 75.93 79.26 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.897 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -95.17 177.98 0.78 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.754 2.303 . . . . 0.0 113.332 -174.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -121.46 146.47 45.17 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -45.23 -28.46 3.62 Favored 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 124.104 3.203 . . . . 0.0 115.307 -169.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.02 20.4 38.43 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.385 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -64.23 136.19 56.97 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.134 0.492 . . . . 0.0 111.375 177.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.432 HG12 ' HA ' ' A' ' 62' ' ' TYR . 39.1 mm -108.25 -58.96 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.449 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -165.94 161.16 17.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.678 0.275 . . . . 0.0 110.552 -175.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 2.4 p -152.09 119.16 5.86 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.769 HG13 ' HB ' ' A' ' 59' ' ' THR . 5.5 pt -123.81 136.12 27.02 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.834 -177.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 72.0 Cg_endo -87.28 158.91 8.29 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.127 2.552 . . . . 0.0 112.414 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.95 48.67 1.22 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.159 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 87.1 t80 72.54 -47.58 0.67 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.543 0.737 . . . . 0.0 112.323 174.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.1 t -133.66 -20.47 2.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.987 0.423 . . . . 0.0 110.729 177.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.4 m -108.21 152.12 25.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.011 0.434 . . . . 0.0 110.801 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.416 HD21 HD11 ' A' ' 40' ' ' ILE . 47.3 tp -126.01 122.69 36.61 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.608 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.769 ' HB ' HG13 ' A' ' 52' ' ' ILE . 5.2 m -104.16 107.18 17.97 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.188 -178.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.4 t -105.22 119.63 54.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.451 0.644 . . . . 0.0 111.241 -175.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -106.85 146.89 30.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.439 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.481 ' CD2' HG11 ' A' ' 82' ' ' VAL . 2.4 p90 -166.32 167.85 15.57 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.046 0.451 . . . . 0.0 110.64 -175.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.407 ' OD1' ' HD1' ' A' ' 65' ' ' TYR . 5.6 t0 -98.55 117.27 32.61 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.329 -178.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.618 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -64.01 -22.67 67.03 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.835 -174.641 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.407 ' HD1' ' OD1' ' A' ' 63' ' ' ASP . 0.2 OUTLIER -69.51 -28.16 65.8 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.699 0.285 . . . . 0.0 111.142 -175.485 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -89.53 -43.38 10.85 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -171.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 m -66.93 -27.69 40.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.853 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.883 ' HA ' HD23 ' A' ' 71' ' ' LEU . 12.1 t80 -66.71 -22.35 66.07 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.049 0.54 . . . . 0.0 110.777 175.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.73 -34.33 62.53 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 173.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -76.07 -38.13 57.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.576 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.883 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -20.33 92.21 0.04 OUTLIER Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 125.814 1.645 . . . . 0.0 113.545 178.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.706 ' HD2' HG13 ' A' ' 75' ' ' ILE . 20.9 Cg_exo -68.99 152.13 73.31 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 123.177 2.585 . . . . 0.0 110.264 173.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -67.77 -17.52 64.57 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -171.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.98 -19.04 70.95 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.19 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.706 HG13 ' HD2' ' A' ' 72' ' ' PRO . 11.4 mm -89.75 137.53 21.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.86 -0.67 . . . . 0.0 109.529 175.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.1 m -116.55 2.14 13.01 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.377 0.608 . . . . 0.0 110.568 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.485 ' HB3' ' HB3' ' A' ' 80' ' ' GLU . 31.2 t -141.22 130.7 12.79 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.969 -173.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.67 ' HA ' HD21 ' A' ' 71' ' ' LEU . 80.0 Cg_exo -43.95 -54.73 3.57 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.403 2.735 . . . . 0.0 112.265 169.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.467 ' HD1' ' HB2' ' A' ' 17' ' ' MET . 0.0 OUTLIER -53.35 -42.19 66.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.221 175.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 38.7 tt0 -72.39 -19.59 61.58 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.201 -173.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.461 ' HB2' HG21 ' A' ' 75' ' ' ILE . 48.2 t -81.09 -40.08 24.67 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.481 HG11 ' CD2' ' A' ' 62' ' ' TYR . 39.0 t -63.65 -30.77 50.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.987 177.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.754 ' HD3' HG21 ' A' ' 9' ' ' ILE . 7.4 mmmt -49.53 -47.61 48.81 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.208 173.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.504 ' HE ' HD11 ' A' ' 75' ' ' ILE . 19.7 mmt180 -67.9 -38.74 83.34 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.008 -172.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -63.85 -34.9 78.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.121 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.7 m -88.45 -44.69 15.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.501 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 83' ' ' LYS . 57.6 mt-10 . . . . . 0 N--CA 1.469 0.48 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.407 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 39.9 p90 . . . . . 0 CA--C 1.517 -0.318 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.507 ' O ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.11 121.6 20.55 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.858 178.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.924 HG12 HG12 ' A' ' 19' ' ' ILE . 18.6 mt -91.46 125.79 44.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.221 177.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -120.54 149.81 41.85 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.101 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -76.9 126.44 30.97 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.281 0.562 . . . . 0.0 110.21 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.684 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -67.47 -37.52 83.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.51 -177.589 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.54 -79.23 0.11 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.416 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -98.98 -68.73 0.79 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.802 0.334 . . . . 0.0 111.782 -177.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.9 p -143.46 49.79 1.41 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.975 0.893 . . . . 0.0 110.239 -174.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -142.46 152.11 42.41 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.371 177.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.516 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 34.1 ttp -124.0 130.55 52.75 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.443 -0.503 . . . . 0.0 112.016 -175.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.684 ' HB2' HD22 ' A' ' 12' ' ' LEU . 50.9 ttm -116.47 126.8 53.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.277 0.56 . . . . 0.0 110.43 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.924 HG12 HG12 ' A' ' 9' ' ' ILE . 7.9 mt -119.66 126.36 75.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.404 -176.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.507 ' HD3' ' O ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -115.06 122.51 46.37 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.89 176.128 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.684 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 28.2 m-85 . . . . . 0 C--N 1.317 -0.82 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.882 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 110.696 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.684 ' HB ' ' HB3' ' A' ' 21' ' ' PHE . 32.9 m -59.2 -33.47 50.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.083 0.468 . . . . 0.0 110.783 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -78.97 -18.59 53.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.557 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.83 -37.98 7.11 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.716 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.87 -27.57 12.4 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.994 -176.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.522 HG23 ' HB2' ' A' ' 58' ' ' LEU . 7.2 p -62.76 -32.03 54.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.177 0.513 . . . . 0.0 109.937 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -70.48 -39.11 74.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.171 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.35 -20.3 32.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.483 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.411 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -63.19 -23.9 67.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.432 -176.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.73 -42.32 99.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.746 0.784 . . . . 0.0 109.198 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.481 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.19 -29.67 26.4 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.699 176.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.411 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 1.5 t80 -59.21 -45.71 90.38 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.302 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.435 HD11 HD21 ' A' ' 58' ' ' LEU . 58.5 mt -71.12 -37.98 69.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.503 -176.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.481 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 13.0 pt-20 -75.37 -19.69 59.43 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.31 -174.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 33.5 mt-10 -80.7 -32.14 35.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.922 0.391 . . . . 0.0 110.613 175.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -126.3 64.25 54.01 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.969 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.419 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 72.9 Cg_endo -91.96 176.34 1.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.03 2.487 . . . . 0.0 114.059 -169.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.41 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 2.8 p90 -106.41 146.61 33.34 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.134 173.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 45' ' ' PHE . 73.7 Cg_exo -52.58 -5.99 0.21 Allowed 'Trans proline' 0 N--CA 1.482 0.847 0 C-N-CA 124.085 3.19 . . . . 0.0 115.3 -172.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.41 ' HA3' ' HB3' ' A' ' 66' ' ' GLU . . . -123.23 29.23 5.35 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.943 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -71.09 135.17 47.56 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.836 0.35 . . . . 0.0 111.12 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.2 mm -110.62 -60.34 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.46 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -164.85 155.88 14.7 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.907 -172.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 59' ' ' THR . 4.6 p -152.15 119.47 5.95 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.086 0.469 . . . . 0.0 110.094 173.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.768 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.0 pt -117.67 129.62 25.23 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-O 121.285 0.564 . . . . 0.0 112.068 -178.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 92.9 Cg_endo -85.82 139.03 6.3 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.378 2.719 . . . . 0.0 112.753 -177.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -126.49 46.06 2.54 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.947 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.2 t80 72.1 -40.01 0.46 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.539 0.735 . . . . 0.0 112.731 174.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.1 t -136.44 -18.4 1.48 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.702 0.287 . . . . 0.0 111.25 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 5.4 p -120.3 140.59 51.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.08 0.467 . . . . 0.0 110.966 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.522 ' HB2' HG23 ' A' ' 33' ' ' VAL . 40.8 tp -108.98 119.73 40.44 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.768 ' HB ' HG13 ' A' ' 52' ' ' ILE . 2.2 m -95.01 106.11 18.07 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.5 t -105.54 125.26 60.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.505 0.669 . . . . 0.0 111.507 -173.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -116.93 146.71 42.81 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.297 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.516 ' OH ' ' HB2' ' A' ' 17' ' ' MET . 2.1 p90 -164.96 170.71 14.91 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.011 0.434 . . . . 0.0 110.281 -174.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -101.09 107.97 19.53 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.533 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.474 ' SD ' ' N ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -62.41 -20.69 64.74 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.599 -176.422 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.29 -28.36 68.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.984 0.421 . . . . 0.0 110.207 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.41 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 4.6 tp10 -90.58 -39.12 12.72 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.667 0.746 . . . . 0.0 109.151 -172.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.469 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.4 m -67.24 -30.78 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.719 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.727 ' HA ' HD23 ' A' ' 71' ' ' LEU . 48.0 t80 -58.23 -26.93 63.46 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.563 0.745 . . . . 0.0 111.801 175.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.77 -26.4 59.73 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.415 0.626 . . . . 0.0 109.862 176.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -90.25 -33.56 16.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.146 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.727 HD23 ' HA ' ' A' ' 68' ' ' TYR . 1.1 mm? -23.48 91.75 0.04 OUTLIER Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 125.764 1.626 . . . . 0.0 113.037 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.643 ' HD2' HG13 ' A' ' 75' ' ' ILE . 12.1 Cg_exo -73.49 146.81 39.99 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 123.485 2.79 . . . . 0.0 111.676 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -69.43 108.92 3.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.439 0.638 . . . . 0.0 110.089 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 133.99 -30.68 2.91 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 -170.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.643 HG13 ' HD2' ' A' ' 72' ' ' PRO . 9.1 mm -86.01 108.36 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 114.196 -1.002 . . . . 0.0 108.504 170.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.2 t -90.13 -6.67 55.15 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.125 0.488 . . . . 0.0 110.461 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 74.0 m -135.17 131.86 19.9 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.682 ' HA ' HD21 ' A' ' 71' ' ' LEU . 56.3 Cg_exo -43.42 -55.5 2.88 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.719 2.946 . . . . 0.0 113.079 173.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.471 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -57.37 -30.96 65.31 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.763 -179.244 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -73.14 -27.45 61.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.955 -176.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.532 ' HB2' HG21 ' A' ' 75' ' ' ILE . 36.9 t -73.62 -35.95 65.39 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.429 HG11 ' CD2' ' A' ' 62' ' ' TYR . 41.7 t -66.13 -30.89 51.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.651 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.69 ' HB3' ' HZ3' ' A' ' 83' ' ' LYS . 9.8 mtpm? -52.5 -46.12 66.5 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.966 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.404 ' HE ' HD11 ' A' ' 75' ' ' ILE . 20.5 mmt180 -61.07 -41.82 97.36 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.983 -175.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -70.27 -38.47 75.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.6 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.6 m -87.04 -49.32 14.9 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.617 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -175.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.47 ' OE1' ' HB3' ' A' ' 83' ' ' LYS . 50.6 mt-10 . . . . . 0 N--CA 1.464 0.267 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -174.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.59 ' HE1' HD11 ' A' ' 9' ' ' ILE . 37.1 p90 . . . . . 0 CA--C 1.515 -0.37 0 CA-C-O 121.641 0.734 . . . . 0.0 112.198 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -128.46 134.82 48.83 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.488 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.59 HD11 ' HE1' ' A' ' 7' ' ' TYR . 4.5 mp -93.88 108.6 20.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.325 178.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -117.31 166.2 12.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.621 0.724 . . . . 0.0 111.214 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.66 140.87 41.09 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.643 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.517 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -84.88 -21.61 29.68 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.321 174.72 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 152.3 -68.56 0.31 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 119.903 -1.142 . . . . 0.0 113.464 176.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -119.26 -61.73 1.6 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.894 0.378 . . . . 0.0 111.393 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.1 p -141.26 39.85 1.76 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.447 0.642 . . . . 0.0 111.013 -175.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.509 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -141.76 160.36 40.33 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.133 175.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.435 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 34.0 ttp -129.48 136.62 50.12 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.61 -0.436 . . . . 0.0 112.115 -175.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.517 ' HB2' HD22 ' A' ' 12' ' ' LEU . 48.9 ttm -121.59 130.33 53.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.197 0.522 . . . . 0.0 110.685 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.4 mt -117.17 121.11 66.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.606 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -115.18 120.65 40.45 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.755 0.788 . . . . 0.0 110.957 -177.515 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.648 ' HD2' HG12 ' A' ' 29' ' ' VAL . 44.4 m-85 . . . . . 0 C--N 1.309 -1.19 0 CA-C-N 113.799 -1.546 . . . . 0.0 109.97 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.648 HG12 ' HD2' ' A' ' 21' ' ' PHE . 35.5 m -63.9 -45.4 97.06 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.421 ' N ' HG23 ' A' ' 29' ' ' VAL . 39.9 t30 -53.9 -42.32 68.57 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.396 -176.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.26 -47.46 6.46 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.598 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -74.25 -29.55 24.94 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.509 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -170.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 29' ' ' VAL . 7.3 p -63.78 -32.21 56.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.663 177.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.597 ' CE1' ' HA ' ' A' ' 55' ' ' PHE . 34.4 m80 -81.59 -32.23 32.17 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.541 179.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.61 -24.38 36.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.845 0.355 . . . . 0.0 111.121 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.518 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -67.11 -20.92 65.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.43 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.64 98.72 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.647 0.737 . . . . 0.0 109.056 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.521 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.67 -32.32 23.68 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.76 175.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.518 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 17.0 t80 -53.53 -48.94 68.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.451 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.681 HD11 HD21 ' A' ' 58' ' ' LEU . 65.2 mt -69.1 -34.78 65.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.543 -177.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.521 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 12.5 pt-20 -76.92 -22.44 53.33 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.165 -173.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 95.0 mt-10 -74.91 -34.33 62.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.755 0.312 . . . . 0.0 110.607 177.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -127.46 74.45 77.75 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -95.21 178.8 0.71 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 123.18 2.587 . . . . 0.0 113.48 -173.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 3.8 p90 -112.55 146.26 34.63 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.133 172.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 45' ' ' PHE . 42.5 Cg_exo -61.16 15.17 0.04 OUTLIER 'Trans proline' 0 N--CA 1.482 0.795 0 C-N-CA 123.992 3.128 . . . . 0.0 114.789 -174.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . -133.65 18.79 4.3 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 175.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -70.65 137.41 49.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.736 0.303 . . . . 0.0 110.608 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.1 mm -113.6 -56.88 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.39 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.431 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 9.4 tp10 -160.94 157.1 25.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.827 0.346 . . . . 0.0 110.702 -175.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 59' ' ' THR . 8.2 p -152.03 117.94 5.47 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 172.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.759 HG13 ' HB ' ' A' ' 59' ' ' THR . 7.1 pt -118.62 128.53 25.92 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-O 121.253 0.549 . . . . 0.0 112.142 -176.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.443 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 84.1 Cg_endo -86.46 120.85 1.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.497 2.798 . . . . 0.0 112.144 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.417 ' HB3' ' OG ' ' A' ' 57' ' ' SER . . . -114.41 59.86 0.68 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.686 0.279 . . . . 0.0 111.215 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.597 ' HA ' ' CE1' ' A' ' 34' ' ' HIS . 70.4 t80 74.34 -49.24 0.67 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.392 0.677 . . . . 0.0 111.817 173.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.411 ' HA ' HG11 ' A' ' 33' ' ' VAL . 14.0 t -140.05 -14.35 1.04 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.879 0.371 . . . . 0.0 111.475 176.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.417 ' OG ' ' HB3' ' A' ' 54' ' ' ALA . 18.3 p -108.66 133.75 52.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.413 0.625 . . . . 0.0 110.823 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.681 HD21 HD11 ' A' ' 40' ' ' ILE . 57.0 tp -102.58 111.77 24.23 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.759 ' HB ' HG13 ' A' ' 52' ' ' ILE . 1.8 m -95.43 107.04 19.16 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.743 -176.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.2 t -106.27 118.68 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.527 0.68 . . . . 0.0 111.243 -172.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.431 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 88.1 m-85 -111.6 148.54 33.08 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.572 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.448 ' OH ' ' HA ' ' A' ' 79' ' ' PHE . 2.1 p90 -165.82 169.62 14.78 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -175.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -102.29 113.07 26.05 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.527 -176.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.631 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -58.84 -19.69 43.87 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.455 -174.204 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -65.62 -28.42 69.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.637 0.256 . . . . 0.0 111.191 -177.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.536 ' O ' ' HD2' ' A' ' 70' ' ' HIS . 2.4 tm-20 -91.3 -41.32 11.0 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -176.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.631 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.0 m -64.53 -30.79 51.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.996 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.933 ' HA ' HD23 ' A' ' 71' ' ' LEU . 62.6 t80 -63.93 -26.65 68.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.402 173.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.03 -27.92 66.96 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 174.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.536 ' HD2' ' O ' ' A' ' 66' ' ' GLU . 16.7 m-70 -83.78 -69.18 0.66 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.705 175.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.933 HD23 ' HA ' ' A' ' 68' ' ' TYR . 1.1 mm? 18.75 71.07 0.22 Allowed Pre-proline 0 N--CA 1.474 0.758 0 O-C-N 124.929 1.393 . . . . 0.0 112.576 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.612 ' HD2' HG13 ' A' ' 75' ' ' ILE . 64.4 Cg_exo -53.14 153.46 16.19 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.166 2.577 . . . . 0.0 112.719 -173.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -69.84 93.82 0.78 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.53 0.681 . . . . 0.0 110.724 -175.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 139.67 -27.16 2.61 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -173.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.612 HG13 ' HD2' ' A' ' 72' ' ' PRO . 8.9 mm -80.49 125.97 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.615 -0.792 . . . . 0.0 109.038 172.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.4 m -110.76 -1.86 16.46 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.227 0.536 . . . . 0.0 110.781 -177.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.538 ' OG ' ' HD1' ' A' ' 79' ' ' PHE . 22.6 t -131.57 134.37 25.45 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.791 -175.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.497 ' O ' HG23 ' A' ' 82' ' ' VAL . 96.2 Cg_exo -47.05 -53.45 6.3 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.312 2.675 . . . . 0.0 112.436 171.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.538 ' HD1' ' OG ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -60.35 -34.21 73.53 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.311 0.577 . . . . 0.0 110.551 -179.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.544 ' HA ' ' CE ' ' A' ' 83' ' ' LYS . 56.6 tt0 -69.57 -27.81 65.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.177 -177.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.539 ' HB3' HG21 ' A' ' 75' ' ' ILE . 95.7 p -79.84 -31.37 40.55 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.501 0.667 . . . . 0.0 109.539 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 78' ' ' PRO . 36.3 t -73.68 -28.82 25.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.147 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.544 ' CE ' ' HA ' ' A' ' 80' ' ' GLU . 44.6 mtmt -54.73 -41.32 70.22 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 121.374 0.607 . . . . 0.0 109.578 173.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -66.11 -32.58 74.11 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.089 -176.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -77.1 -40.79 44.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.287 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.6 m -83.5 -37.48 13.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.784 -177.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 . . . . . 0 C--O 1.219 -0.515 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.158 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 25.4 p90 . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 121.167 0.508 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.431 ' HB2' ' HE ' ' A' ' 20' ' ' ARG . 4.9 mp0 -128.34 132.43 48.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.466 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.93 HG13 HG12 ' A' ' 19' ' ' ILE . 2.9 mp -83.47 114.74 24.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 171.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 18' ' ' MET . 12.4 pt-20 -110.21 150.11 29.14 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.121 0.486 . . . . 0.0 109.69 177.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -81.25 127.71 33.0 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.428 0.633 . . . . 0.0 110.208 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.649 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -70.41 -40.3 73.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.427 -174.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 172.84 -66.18 0.12 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.808 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -125.75 -58.87 1.38 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.835 0.35 . . . . 0.0 111.717 -173.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.2 p -142.01 37.62 1.59 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.517 0.675 . . . . 0.0 111.29 -173.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.95 158.26 43.77 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.781 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.626 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -128.03 149.37 50.4 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.046 -179.086 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.649 ' HB2' HD22 ' A' ' 12' ' ' LEU . 53.6 ttm -132.38 135.41 46.12 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 174.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.93 HG12 HG13 ' A' ' 9' ' ' ILE . 10.5 mt -114.58 106.18 20.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.514 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -91.94 131.44 37.24 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.296 0.57 . . . . 0.0 109.879 177.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 29.0 m-85 . . . . . 0 C--N 1.308 -1.219 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.266 -178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.058 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.819 HG13 HD22 ' A' ' 30' ' ' ASN . 2.4 p -56.4 -49.0 79.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.298 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.819 HD22 HG13 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -55.67 -29.19 58.9 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.579 0.549 . . . . 0.0 111.168 -173.247 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.76 -40.6 5.25 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.73 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -87.41 -29.7 5.65 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -171.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 29' ' ' VAL . 9.5 p -65.74 -30.98 51.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 118.968 0.804 . . . . 0.0 109.281 178.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.401 ' HA ' ' CB ' ' A' ' 53' ' ' PRO . 22.0 t60 -81.61 -30.2 32.98 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.999 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.43 -21.72 30.62 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.015 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.475 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -65.06 -23.48 67.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.181 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.89 98.77 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.841 0.829 . . . . 0.0 109.02 177.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.763 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.96 -27.17 26.69 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.948 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.475 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 5.8 t80 -59.73 -44.48 93.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.374 179.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.463 HD11 HD21 ' A' ' 58' ' ' LEU . 44.6 mt -78.59 -32.03 15.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.483 -176.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.763 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 10.8 pt-20 -73.64 -20.22 60.63 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.861 -176.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -88.21 -29.89 20.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.735 0.302 . . . . 0.0 110.384 173.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -124.72 69.8 56.3 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.177 0.513 . . . . 0.0 110.091 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -99.86 -161.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.693 2.929 . . . . 0.0 114.083 -169.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.45 ' HE1' ' HB3' ' A' ' 62' ' ' TYR . 1.6 p90 -138.37 147.35 55.07 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 114.022 -1.444 . . . . 0.0 107.966 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.75 -21.26 0.86 Allowed 'Trans proline' 0 N--CA 1.482 0.842 0 C-N-CA 124.25 3.3 . . . . 0.0 115.55 -169.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.419 ' HA3' ' HB3' ' A' ' 66' ' ' GLU . . . -119.36 30.7 5.7 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.188 -0.53 . . . . 0.0 111.947 -179.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.505 ' HZ ' ' HG ' ' A' ' 51' ' ' CYS . 47.2 t80 -66.53 128.69 37.18 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.098 0.475 . . . . 0.0 110.82 175.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.4 mm -103.09 -61.71 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.108 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -164.56 155.48 15.0 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 120.767 0.317 . . . . 0.0 110.998 -174.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.505 ' HG ' ' HZ ' ' A' ' 48' ' ' PHE . 5.9 p -144.46 118.32 9.32 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 173.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.806 HG13 ' HB ' ' A' ' 59' ' ' THR . 5.5 pt -117.43 129.26 25.46 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-O 121.042 0.449 . . . . 0.0 112.001 -175.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.592 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 17.8 Cg_endo -86.73 124.33 2.23 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.498 2.799 . . . . 0.0 112.684 -178.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -117.73 58.73 0.8 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.15 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.458 ' O ' HG11 ' A' ' 33' ' ' VAL . 56.2 t80 72.34 -49.64 0.69 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.548 0.739 . . . . 0.0 112.087 173.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.1 t -137.23 -21.07 1.2 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.747 0.308 . . . . 0.0 111.253 178.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 16.1 m -108.2 133.11 52.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.071 0.463 . . . . 0.0 110.864 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.463 HD21 HD11 ' A' ' 40' ' ' ILE . 44.0 tp -102.77 111.96 24.53 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.806 ' HB ' HG13 ' A' ' 52' ' ' ILE . 2.9 m -89.15 107.96 19.34 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -177.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.626 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 64.6 t -104.0 113.66 41.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.575 0.702 . . . . 0.0 111.338 -172.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -103.76 148.88 25.56 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.872 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.53 ' CD2' HG11 ' A' ' 82' ' ' VAL . 2.3 p90 -165.13 168.53 17.13 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.164 -176.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -98.86 109.05 21.87 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.947 -175.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.653 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -61.97 -20.6 64.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.125 -177.725 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.41 ' CE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -67.47 -31.92 72.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.9 0.381 . . . . 0.0 110.281 179.481 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 10.2 tp10 -91.31 -30.69 16.44 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 122.059 0.933 . . . . 0.0 109.1 -170.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.653 HG22 ' HA ' ' A' ' 64' ' ' MET . 4.2 m -75.66 -34.12 28.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.26 176.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.855 ' HA ' HD23 ' A' ' 71' ' ' LEU . 52.4 t80 -71.28 -22.87 61.9 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.8 174.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 4.2 tppp? -59.42 -35.96 74.98 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -88.5 -65.8 0.98 Allowed 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.207 176.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.855 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER 24.93 78.7 0.22 Allowed Pre-proline 0 N--CA 1.48 1.038 0 C-N-CA 124.858 1.263 . . . . 0.0 113.463 178.356 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.686 ' HD2' HG13 ' A' ' 75' ' ' ILE . 32.1 Cg_exo -58.52 155.06 38.26 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.321 2.014 . . . . 0.0 110.989 175.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -71.38 -17.08 62.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.675 -171.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -77.8 -28.68 56.44 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 172.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.686 HG13 ' HD2' ' A' ' 72' ' ' PRO . 20.4 mm -77.44 129.8 36.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.791 -0.705 . . . . 0.0 109.638 175.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.2 m -110.0 1.64 19.13 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.337 0.589 . . . . 0.0 110.528 -177.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.658 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 43.8 t -146.9 132.97 9.5 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.261 -172.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.628 ' HA ' HD21 ' A' ' 71' ' ' LEU . 86.3 Cg_exo -45.74 -53.47 5.6 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.349 2.699 . . . . 0.0 112.732 170.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.407 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -58.26 -31.61 67.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.93 0.395 . . . . 0.0 111.385 177.373 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.658 ' HB2' ' HB3' ' A' ' 77' ' ' SER . 23.8 tt0 -72.83 -30.07 63.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.259 -173.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.558 ' HB3' HG21 ' A' ' 75' ' ' ILE . 91.4 p -76.38 -34.55 58.89 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.53 HG11 ' CD2' ' A' ' 62' ' ' TYR . 16.6 t -63.84 -31.73 54.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.537 176.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.495 ' HE3' HG12 ' A' ' 9' ' ' ILE . 2.4 mtpt -54.93 -38.01 67.14 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-O 121.171 0.51 . . . . 0.0 109.685 175.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -67.63 -31.89 72.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.175 -176.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -78.3 -36.72 46.21 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.357 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.8 m -86.78 -40.32 13.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.649 -177.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 C--N 1.331 -0.232 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -177.626 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.506 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 42.2 p90 . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 121.319 0.58 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.534 HE22 ' HB3' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -130.9 116.05 17.37 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.875 -174.384 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.884 HG12 HG12 ' A' ' 19' ' ' ILE . 22.3 mt -92.62 112.52 26.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.128 175.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.534 ' HB3' HE22 ' A' ' 8' ' ' GLN . 11.6 pt-20 -124.25 168.46 12.92 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.499 -175.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.694 HE21 ' HA ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -87.74 128.11 35.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.46 -179.183 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.679 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.3 OUTLIER -76.18 -46.41 28.6 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.127 -174.135 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -168.84 -90.62 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.629 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -110.62 -37.52 5.44 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -175.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.5 p -160.8 42.73 0.17 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.872 0.844 . . . . 0.0 110.696 -177.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.0 148.21 41.55 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.333 176.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.598 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 32.1 ttp -117.39 140.53 49.47 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 120.955 0.407 . . . . 0.0 111.504 -177.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.679 ' HB2' HD22 ' A' ' 12' ' ' LEU . 1.4 tmt? -124.69 126.05 45.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.44 0.638 . . . . 0.0 110.431 -176.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.884 HG12 HG12 ' A' ' 9' ' ' ILE . 6.6 mt -119.56 138.26 50.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.768 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.61 127.03 21.48 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.909 0.385 . . . . 0.0 110.369 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.506 ' HA ' ' CB ' ' A' ' 7' ' ' TYR . 8.1 m-85 . . . . . 0 C--N 1.317 -0.83 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.865 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.463 0.189 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.514 ' O ' HG12 ' A' ' 33' ' ' VAL . 11.9 p -65.74 -50.58 70.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.36 -174.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.439 ' N ' HG13 ' A' ' 29' ' ' VAL . 70.9 m-20 -53.1 -42.68 66.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.144 0.497 . . . . 0.0 110.939 -177.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.82 -5.17 90.22 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.528 -0.76 . . . . 0.0 113.614 -176.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.22 -34.25 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.605 0 CA-C-N 117.987 0.894 . . . . 0.0 113.352 -176.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 29' ' ' VAL . 10.8 p -62.98 -32.72 57.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 118.467 0.576 . . . . 0.0 110.681 -174.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -80.27 -23.5 40.73 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.04 -23.85 26.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.069 0.461 . . . . 0.0 110.419 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.472 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -64.28 -22.82 67.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.098 -178.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.54 97.14 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.688 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -82.98 -30.45 28.2 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.812 175.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.472 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 16.0 t80 -57.05 -44.28 82.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.377 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.695 HD11 HD21 ' A' ' 58' ' ' LEU . 49.5 mt -77.06 -38.41 27.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.587 -176.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.688 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 13.3 pt-20 -68.73 -21.11 64.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.896 0.379 . . . . 0.0 111.017 -175.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -92.56 -21.14 20.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.868 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -133.14 64.71 71.29 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.894 0.378 . . . . 0.0 110.412 178.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -97.35 -175.81 0.25 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.494 2.796 . . . . 0.0 113.077 -173.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.606 ' HZ ' ' HB2' ' A' ' 62' ' ' TYR . 14.3 p90 -116.56 148.11 41.17 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 172.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -42.22 -24.87 0.36 Allowed 'Trans proline' 0 N--CA 1.481 0.791 0 C-N-CA 124.404 3.403 . . . . 0.0 115.926 -170.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.05 19.36 32.64 Favored Glycine 0 C--O 1.229 -0.21 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.413 -176.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.464 ' HZ ' ' HG ' ' A' ' 51' ' ' CYS . 37.1 t80 -69.21 134.86 49.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.007 0.432 . . . . 0.0 111.331 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.472 HG12 ' HA ' ' A' ' 62' ' ' TYR . 40.6 mm -106.17 -60.67 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.298 -177.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -160.99 156.31 24.58 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -171.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.464 ' HG ' ' HZ ' ' A' ' 48' ' ' PHE . 12.7 p -151.75 119.48 6.13 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 175.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.794 HG13 ' HB ' ' A' ' 59' ' ' THR . 9.3 pt -123.91 134.87 25.68 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.842 -175.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.427 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 78.5 Cg_endo -86.95 152.19 8.43 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.159 2.573 . . . . 0.0 112.463 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -137.61 47.83 2.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.116 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.408 ' O ' HG11 ' A' ' 33' ' ' VAL . 48.7 t80 72.09 -37.52 0.39 Allowed 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 173.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.0 t -138.43 -21.3 1.04 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.183 0.516 . . . . 0.0 110.933 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.3 p -113.52 155.1 25.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.61 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.695 HD21 HD11 ' A' ' 40' ' ' ILE . 48.1 tp -124.49 114.92 20.08 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.794 ' HB ' HG13 ' A' ' 52' ' ' ILE . 4.4 m -94.91 106.92 18.93 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.885 -176.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.0 t -106.04 121.5 58.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.47 0.653 . . . . 0.0 111.647 -172.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.408 ' CE1' HG22 ' A' ' 59' ' ' THR . 90.7 m-85 -110.99 148.51 32.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.939 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.606 ' HB2' ' HZ ' ' A' ' 45' ' ' PHE . 3.5 p90 -167.33 170.14 11.79 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.893 -173.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -102.26 120.45 40.49 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.291 0.567 . . . . 0.0 110.692 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.17 -22.39 65.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.266 -174.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.11 -25.82 67.94 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.75 0.31 . . . . 0.0 110.784 -177.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -89.49 -33.55 16.73 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.738 0.78 . . . . 0.0 109.011 -171.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.9 m -77.67 -36.61 23.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.898 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.763 ' HA ' HD23 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -62.9 -23.11 67.19 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.973 177.598 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.507 ' HE2' ' HB2' ' A' ' 69' ' ' LYS . 3.3 tppt? -54.86 -49.17 71.79 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 121.939 0.876 . . . . 0.0 108.877 177.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -89.94 -62.89 1.37 Allowed 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.858 -177.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.763 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER 34.5 77.3 0.38 Allowed Pre-proline 0 N--CA 1.473 0.707 0 O-C-N 124.533 1.146 . . . . 0.0 111.521 -178.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.444 ' HD2' HG13 ' A' ' 75' ' ' ILE . 50.5 Cg_exo -54.64 152.43 27.62 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.288 2.659 . . . . 0.0 112.839 -175.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -76.18 87.29 3.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.05 0.929 . . . . 0.0 110.495 -176.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 155.09 -31.19 0.65 Allowed Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 -173.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.514 HG21 ' HB2' ' A' ' 81' ' ' SER . 18.6 mm -79.77 115.7 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 114.028 -1.086 . . . . 0.0 108.808 169.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.5 m -97.76 -5.86 34.05 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.194 0.521 . . . . 0.0 110.239 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 47.6 m -138.72 132.38 16.25 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.943 -172.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.609 ' HA ' HD21 ' A' ' 71' ' ' LEU . 30.8 Cg_exo -45.23 -56.99 2.35 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.436 2.758 . . . . 0.0 113.305 173.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.606 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.8 OUTLIER -55.18 -30.82 60.67 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.203 0.525 . . . . 0.0 111.177 178.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.604 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 36.5 tt0 -73.64 -24.47 60.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.259 -176.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.514 ' HB2' HG21 ' A' ' 75' ' ' ILE . 17.4 t -76.24 -36.28 58.58 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.466 HG11 ' CD2' ' A' ' 62' ' ' TYR . 60.2 t -63.66 -30.18 49.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.248 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.604 ' HG3' ' HA ' ' A' ' 80' ' ' GLU . 14.9 mtmm -54.2 -37.85 64.98 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 176.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -64.59 -37.47 87.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.182 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -70.92 -35.48 72.28 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.916 -176.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.9 m -86.79 -42.76 15.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.149 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 . . . . . 0 C--N 1.33 -0.275 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.489 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.3 p90 . . . . . 0 N--CA 1.446 -0.636 0 CA-C-O 121.402 0.62 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.666 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . 1.8 mp0 -120.28 134.54 55.24 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.257 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.928 HG12 HG12 ' A' ' 19' ' ' ILE . 15.3 mt -101.92 114.14 40.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.291 174.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 18' ' ' MET . 10.4 pt-20 -109.12 153.1 24.19 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.691 -177.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.599 HE21 ' HA ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -76.99 126.9 31.74 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.758 0.79 . . . . 0.0 110.542 178.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.693 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.3 OUTLIER -79.72 -48.67 13.25 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.019 -173.233 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.88 100.87 0.16 Allowed Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 73.2 -64.16 0.41 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 176.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.515 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 11.5 p -150.64 60.06 0.94 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.338 0.589 . . . . 0.0 111.831 -172.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -160.89 154.64 22.35 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 176.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.917 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -121.18 138.64 54.12 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.091 -177.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.693 ' HB2' HD22 ' A' ' 12' ' ' LEU . 26.4 ttt -124.04 124.06 41.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.438 0.637 . . . . 0.0 110.396 177.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.928 HG12 HG12 ' A' ' 9' ' ' ILE . 9.3 mt -116.12 144.31 24.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.191 -175.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.666 ' HD3' ' HB2' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -134.93 132.75 38.83 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 173.577 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.477 ' HB2' HG21 ' A' ' 29' ' ' VAL . 6.8 m-85 . . . . . 0 C--N 1.323 -0.545 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? . . . . . 0 CA--C 1.522 -0.126 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.6 ' O ' HG12 ' A' ' 33' ' ' VAL . 4.3 p -61.32 -46.34 96.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.757 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -53.71 -27.04 25.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.958 -177.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -97.55 -39.83 3.81 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.435 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -86.44 -22.4 7.15 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -171.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.6 HG12 ' O ' ' A' ' 29' ' ' VAL . 14.5 p -69.01 -28.45 39.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.371 177.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -77.79 -41.59 36.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.499 174.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.88 -26.0 60.33 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.503 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.478 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -67.12 -26.64 66.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.153 -178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.471 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . . . -62.29 -36.82 83.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 122.013 0.911 . . . . 0.0 109.119 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.81 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.75 -36.2 21.93 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.872 174.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.478 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 2.6 t80 -54.72 -42.08 71.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.342 0.591 . . . . 0.0 110.864 -178.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.598 HD11 HD21 ' A' ' 58' ' ' LEU . 33.5 mt -78.03 -29.41 15.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.295 -178.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.81 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 6.9 pt-20 -80.67 -32.97 35.85 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.439 -177.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 54.0 mt-10 -72.72 -29.72 63.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.097 0.475 . . . . 0.0 110.139 178.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -121.42 73.56 30.05 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 172.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -96.88 -168.92 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.932 2.421 . . . . 0.0 113.773 -170.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.416 ' C ' ' H ' ' A' ' 47' ' ' GLY . 2.8 p90 -136.43 147.17 58.92 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.14 176.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 45' ' ' PHE . 52.1 Cg_exo -58.23 7.87 0.06 OUTLIER 'Trans proline' 0 N--CA 1.483 0.864 0 C-N-CA 123.653 2.902 . . . . 0.0 114.702 -174.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . -127.18 28.24 4.61 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 174.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.559 ' HE2' HG22 ' A' ' 40' ' ' ILE . 6.0 t80 -71.19 132.09 44.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.998 0.427 . . . . 0.0 110.528 177.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.544 HG22 ' HG2' ' A' ' 50' ' ' GLU . 36.9 mm -111.35 -60.74 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.469 176.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.544 ' HG2' HG22 ' A' ' 49' ' ' ILE . 2.5 mm-40 -153.28 173.01 16.13 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.889 0.852 . . . . 0.0 111.231 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 59' ' ' THR . 5.1 p -161.2 118.27 2.28 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 113.839 -1.528 . . . . 0.0 108.964 154.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.668 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.5 pt -112.93 130.46 23.5 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.251 -173.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 6.1 Cg_exo -77.83 128.06 9.05 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.454 2.769 . . . . 0.0 111.897 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.491 ' HB3' ' HB2' ' A' ' 57' ' ' SER . . . -119.25 54.29 0.99 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.629 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.446 ' O ' HG11 ' A' ' 33' ' ' VAL . 47.6 t80 72.44 -59.33 0.56 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.469 176.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -126.59 -15.34 5.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.299 0.571 . . . . 0.0 110.441 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.491 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 19.8 m -108.58 148.43 30.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.157 0.503 . . . . 0.0 110.999 -177.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.598 HD21 HD11 ' A' ' 40' ' ' ILE . 49.7 tp -117.66 111.99 19.9 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.668 ' HB ' HG13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -94.96 106.74 18.75 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.966 -177.008 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.917 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 53.7 t -107.15 109.33 27.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.252 0.549 . . . . 0.0 111.318 -171.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.439 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 74.6 m-85 -101.62 147.33 26.55 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.711 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.48 ' OH ' ' HB3' ' A' ' 17' ' ' MET . 2.7 p90 -165.22 167.85 17.63 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.172 0.51 . . . . 0.0 110.397 -176.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -98.36 111.25 23.65 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.121 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.515 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 1.0 OUTLIER -64.48 -20.3 66.11 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.546 -172.072 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -58.9 -26.02 63.92 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.571 0.224 . . . . 0.0 111.448 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.575 ' HA ' ' HE3' ' A' ' 69' ' ' LYS . 16.2 tp10 -89.76 -35.84 15.5 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.842 0.83 . . . . 0.0 109.433 -173.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.696 HG11 HG22 ' A' ' 82' ' ' VAL . 3.4 m -79.91 -31.31 13.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.912 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.967 ' HA ' HD23 ' A' ' 71' ' ' LEU . 23.2 t80 -68.98 -22.12 64.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.134 176.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.575 ' HE3' ' HA ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -53.3 -36.74 61.55 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 173.035 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.51 ' HD2' ' HB3' ' A' ' 69' ' ' LYS . 18.2 m170 -98.58 -70.53 0.72 Allowed 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.852 -177.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.967 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER 41.34 71.95 1.19 Allowed Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 123.754 0.822 . . . . 0.0 112.265 -179.074 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.729 ' HD2' HG13 ' A' ' 75' ' ' ILE . 37.7 Cg_exo -61.74 173.95 2.59 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.134 2.556 . . . . 0.0 114.025 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.5 tp60 -62.52 -47.1 85.39 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -172.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.03 -20.74 79.11 Favored Glycine 0 CA--C 1.508 -0.37 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 -176.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.729 HG13 ' HD2' ' A' ' 72' ' ' PRO . 41.3 mm -76.95 102.96 3.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 114.51 -0.845 . . . . 0.0 109.989 175.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.3 m -84.91 -14.09 48.82 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.337 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.481 ' HB2' ' HG3' ' A' ' 80' ' ' GLU . 73.0 m -146.03 142.34 17.63 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.774 -172.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.606 ' HA ' HD21 ' A' ' 71' ' ' LEU . 79.2 Cg_exo -51.25 -36.28 56.05 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.338 2.692 . . . . 0.0 113.376 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.481 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 0.5 OUTLIER -66.11 -26.01 67.26 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.851 0.358 . . . . 0.0 111.138 178.877 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.744 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 5.0 mt-10 -72.69 -34.95 67.52 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.812 -178.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.574 ' HB3' HG21 ' A' ' 75' ' ' ILE . 18.9 p -69.38 -34.01 73.9 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -176.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.696 HG22 HG11 ' A' ' 67' ' ' VAL . 20.2 t -69.44 -36.53 72.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.565 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.744 ' HE2' ' HA ' ' A' ' 80' ' ' GLU . 54.2 mtmt -53.16 -45.57 68.51 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 23.0 mmt180 -67.75 -36.4 80.47 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.085 -172.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -62.05 -39.04 91.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.518 0.675 . . . . 0.0 110.33 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.4 m -86.96 -46.91 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.334 -177.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.471 ' OE1' ' HD3' ' A' ' 84' ' ' ARG . 43.6 mt-10 . . . . . 0 C--O 1.211 -0.923 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 10.6 p90 . . . . . 0 N--CA 1.445 -0.687 0 CA-C-O 121.628 0.727 . . . . 0.0 111.349 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -130.87 143.17 50.53 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.826 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.923 HG12 HG12 ' A' ' 19' ' ' ILE . 21.3 mt -106.21 120.99 58.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.471 -177.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 18' ' ' MET . 9.0 pt-20 -113.6 163.37 15.04 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.244 -176.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -92.97 126.28 37.98 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 173.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.582 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -65.68 -43.71 88.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.766 -174.674 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.34 -67.17 0.1 Allowed Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 178.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -114.34 -70.67 0.79 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.186 0.517 . . . . 0.0 111.514 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.2 p -135.43 51.0 2.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.92 0.867 . . . . 0.0 110.119 -173.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -148.1 151.75 36.17 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.062 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.688 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 38.2 ttp -126.97 128.59 46.63 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.234 -176.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.582 ' HB2' HD22 ' A' ' 12' ' ' LEU . 33.3 ttp -118.68 138.85 52.34 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.494 177.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.923 HG12 HG12 ' A' ' 9' ' ' ILE . 6.4 mt -126.68 124.3 64.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.022 -176.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -109.9 137.26 47.94 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 177.839 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.501 ' HB2' ' CG1' ' A' ' 29' ' ' VAL . 5.3 m-85 . . . . . 0 C--N 1.324 -0.532 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.519 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 23.9 tm0? . . . . . 0 C--O 1.226 -0.171 0 CA-C-O 120.729 0.3 . . . . 0.0 110.36 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.563 ' O ' HG12 ' A' ' 33' ' ' VAL . 87.7 t -72.35 -60.8 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.18 -176.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -46.96 -33.04 4.29 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.757 0.661 . . . . 0.0 112.197 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.22 -44.04 5.44 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.35 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.519 ' HB ' ' O ' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -80.78 -25.43 10.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -172.156 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 29' ' ' VAL . 13.7 p -70.23 -29.68 40.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -76.57 -31.42 57.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.699 175.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.62 -23.6 29.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.972 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.476 ' HA ' ' HB3' ' A' ' 39' ' ' TYR . . . -63.57 -24.71 67.92 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.981 -177.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.82 -42.74 99.4 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.627 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -83.56 -34.84 25.12 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.759 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.476 ' HB3' ' HA ' ' A' ' 36' ' ' ALA . 32.8 t80 -52.58 -44.52 65.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.998 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.5 mt -72.42 -33.61 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.238 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.627 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 7.8 pt-20 -80.63 -19.65 44.92 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.014 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.539 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 34.0 mt-10 -82.06 -29.78 31.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.857 0.36 . . . . 0.0 110.484 175.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -127.83 66.7 71.77 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.63 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -98.34 173.92 0.53 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.3 2.667 . . . . 0.0 114.727 -168.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -111.71 147.35 36.61 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 113.785 -1.552 . . . . 0.0 108.337 175.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.67 -8.13 0.73 Allowed 'Trans proline' 0 N--CA 1.484 0.923 0 C-N-CA 123.987 3.125 . . . . 0.0 114.957 -171.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.39 27.52 6.6 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.104 -0.569 . . . . 0.0 111.837 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -73.86 131.61 41.67 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.064 0.459 . . . . 0.0 111.552 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.3 mm -106.35 -61.21 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.242 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 42.5 tt0 -161.86 162.34 29.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.711 0.291 . . . . 0.0 110.602 -172.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.615 ' HB2' HD11 ' A' ' 58' ' ' LEU . 2.6 p -158.69 118.38 3.14 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 176.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.702 HG13 ' HB ' ' A' ' 59' ' ' THR . 9.6 pt -120.68 139.46 28.97 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-O 121.007 0.432 . . . . 0.0 111.749 -175.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.47 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 4.6 Cg_endo -84.5 133.75 5.43 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.18 2.587 . . . . 0.0 112.21 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -118.1 43.52 2.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.474 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 39.0 t80 72.34 -40.55 0.48 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.448 175.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -134.18 -18.93 1.99 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.898 0.38 . . . . 0.0 111.22 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 9.1 p -121.19 142.52 49.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.776 0.322 . . . . 0.0 111.107 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' A' ' 51' ' ' CYS . 0.9 OUTLIER -103.17 114.42 28.69 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.637 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.702 ' HB ' HG13 ' A' ' 52' ' ' ILE . 3.0 m -87.59 106.05 17.75 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.539 HG22 HD12 ' A' ' 58' ' ' LEU . 57.7 t -101.45 124.36 55.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.397 0.617 . . . . 0.0 111.56 -174.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.424 ' CE1' HG22 ' A' ' 59' ' ' THR . 89.0 m-85 -115.79 147.27 41.15 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.419 177.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.5 ' CE2' HG11 ' A' ' 82' ' ' VAL . 3.4 p90 -165.99 169.97 14.11 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.934 0.397 . . . . 0.0 110.149 -174.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -99.92 112.45 24.72 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.75 -176.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.659 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -62.37 -19.74 63.7 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.993 -176.017 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.7 -31.86 73.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 110.545 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.73 -25.64 19.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.902 0.858 . . . . 0.0 109.535 -175.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.659 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.5 m -75.93 -38.83 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.459 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.835 ' HA ' HD13 ' A' ' 71' ' ' LEU . 2.5 m-85 -55.77 -30.97 62.16 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.07 0.548 . . . . 0.0 111.411 171.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -57.66 -43.75 85.21 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.989 0.899 . . . . 0.0 108.843 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -81.08 -51.12 8.82 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.934 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.847 HD11 ' HA ' ' A' ' 78' ' ' PRO . 0.1 OUTLIER -12.16 84.63 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.469 0 O-C-N 125.549 1.781 . . . . 0.0 114.325 -173.433 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.816 ' HD2' HG13 ' A' ' 75' ' ' ILE . 32.5 Cg_exo -61.76 170.21 6.11 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 123.469 2.78 . . . . 0.0 112.172 176.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.6 -27.13 65.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.032 -172.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.98 -22.31 71.89 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.125 176.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.816 HG13 ' HD2' ' A' ' 72' ' ' PRO . 24.1 mm -86.32 114.14 25.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.615 -0.792 . . . . 0.0 110.043 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.8 m -105.59 -1.74 24.33 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.327 0.584 . . . . 0.0 110.604 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.532 ' HB2' ' HG3' ' A' ' 80' ' ' GLU . 70.6 m -141.45 141.4 22.88 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.704 -178.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.847 ' HA ' HD11 ' A' ' 71' ' ' LEU . 77.0 Cg_exo -44.45 -58.13 1.66 Allowed 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 123.18 2.587 . . . . 0.0 113.275 177.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.45 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 0.2 OUTLIER -56.06 -28.64 58.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.068 -176.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.662 ' HB2' HG23 ' A' ' 75' ' ' ILE . 48.6 mt-10 -67.96 -32.46 72.91 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.001 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.551 ' HB2' HG21 ' A' ' 75' ' ' ILE . 32.4 t -70.33 -33.99 72.14 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' A' ' 62' ' ' TYR . 26.2 t -76.95 -29.36 17.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.44 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.688 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 8.2 mtmp? -54.04 -42.09 68.81 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.463 176.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -63.88 -39.8 95.04 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.913 -176.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -61.95 -38.37 88.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.376 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.3 m -88.38 -35.21 7.72 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.86 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.439 ' OE2' ' HB3' ' A' ' 83' ' ' LYS . 40.4 mt-10 . . . . . 0 C--N 1.329 -0.318 0 C-N-CA 122.472 0.309 . . . . 0.0 111.587 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.798 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.7 m -96.13 138.21 34.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.664 0.269 . . . . 0.0 110.345 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -152.86 163.04 40.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.034 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.506 ' O ' HG22 ' A' ' 5' ' ' VAL . 12.4 t -95.78 30.43 2.36 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.478 -176.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 4' ' ' THR . 0.9 OUTLIER 62.27 151.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.422 1.089 . . . . 0.0 111.699 -175.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.429 ' HD2' ' HA ' ' A' ' 6' ' ' ARG . 15.8 mmm180 -115.91 94.54 4.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.384 173.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.543 ' CE1' ' HB2' ' A' ' 95' ' ' GLU . 15.0 p90 -105.04 147.25 28.04 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.235 -176.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.64 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . 2.3 mp0 -131.95 135.9 46.93 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.799 -177.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.909 HG12 HG12 ' A' ' 19' ' ' ILE . 9.5 mt -101.94 124.83 56.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.967 178.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -121.32 165.49 15.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.09 0.472 . . . . 0.0 109.904 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -87.34 127.61 35.19 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.698 0.761 . . . . 0.0 110.358 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.643 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -68.32 -47.27 68.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.227 -174.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.61 -83.11 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -118.85 -44.73 2.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.673 0.273 . . . . 0.0 111.24 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.1 p -146.15 43.49 1.22 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.495 0.664 . . . . 0.0 110.83 -173.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -144.45 156.59 44.26 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.398 178.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.629 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 35.6 ttp -128.01 134.71 49.27 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -175.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.643 ' HB2' HD22 ' A' ' 12' ' ' LEU . 39.5 ttp -125.16 130.07 51.42 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.918 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.909 HG12 HG12 ' A' ' 9' ' ' ILE . 7.3 mt -121.22 118.74 57.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.298 -173.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.64 ' HD3' ' HB2' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -103.52 139.75 38.44 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 176.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.747 ' HB2' HG11 ' A' ' 29' ' ' VAL . 15.1 m-85 -106.46 -151.54 0.46 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -97.88 179.3 32.67 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.303 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.628 ' HA ' ' HB2' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -158.88 -162.5 1.1 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 117.024 0.412 . . . . 0.0 110.46 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.558 ' HG3' ' HG2' ' A' ' 23' ' ' GLU . 38.4 mt-10 73.97 -57.9 0.61 Allowed 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 124.256 0.973 . . . . 0.0 110.654 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.5 pt -120.33 24.91 4.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.31 0.576 . . . . 0.0 110.285 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.628 ' HB2' ' HA ' ' A' ' 23' ' ' GLU . 5.6 m-20 -116.57 62.86 0.72 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.815 -174.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 30' ' ' ASN . 3.4 mp0 -60.39 -27.02 67.1 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 173.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.496 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 25.4 tm0? -55.84 -54.12 48.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.884 173.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.747 HG11 ' HB2' ' A' ' 21' ' ' PHE . 71.0 t -66.77 -48.58 79.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.66 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.417 ' HB3' ' HA ' ' A' ' 27' ' ' GLU . 9.2 t30 -51.89 -36.71 49.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.824 -176.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.07 -34.63 8.09 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.253 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 28' ' ' GLN . 0.4 OUTLIER -79.73 -29.14 12.95 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.017 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -174.126 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.541 HG23 ' HG ' ' A' ' 58' ' ' LEU . 11.4 p -68.73 -28.71 41.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 118.879 0.763 . . . . 0.0 109.415 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -70.07 -39.65 75.51 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.517 175.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.79 -21.41 29.95 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.113 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.629 ' HB1' HD11 ' A' ' 58' ' ' LEU . . . -64.36 -27.49 69.05 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.156 -176.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.54 -44.53 96.89 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.714 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -78.88 -31.88 45.64 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.877 177.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.405 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 14.9 t80 -57.49 -44.57 85.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.23 0.538 . . . . 0.0 109.728 178.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.9 mt -71.44 -33.31 49.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.322 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.273 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.714 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 12.6 pt-20 -78.97 -18.89 52.95 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.129 -176.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.45 ' C ' ' HD3' ' A' ' 44' ' ' PRO . 42.4 mt-10 -85.16 -30.34 24.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.842 0.353 . . . . 0.0 110.749 174.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -127.11 64.46 61.06 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.937 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.45 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 80.1 Cg_endo -98.26 178.1 0.4 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 123.295 2.663 . . . . 0.0 114.033 -170.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -106.93 146.69 33.63 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.25 171.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.557 ' HB2' ' HG3' ' A' ' 66' ' ' GLU . 71.5 Cg_exo -51.62 -15.31 2.66 Favored 'Trans proline' 0 N--CA 1.477 0.546 0 C-N-CA 124.019 3.146 . . . . 0.0 114.574 -173.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.8 15.22 41.11 Favored Glycine 0 C--O 1.223 -0.569 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.413 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -65.55 134.08 52.58 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.017 0.437 . . . . 0.0 110.905 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.418 HG12 ' HA ' ' A' ' 62' ' ' TYR . 28.8 mm -110.15 -59.73 3.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.437 -176.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -161.69 157.3 24.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.719 0.295 . . . . 0.0 110.787 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.2 p -150.08 121.64 7.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.929 HG13 ' HB ' ' A' ' 59' ' ' THR . 5.7 pt -120.4 130.84 24.65 Favored Pre-proline 0 C--N 1.319 -0.746 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.498 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 5.6 Cg_exo -78.94 122.91 5.52 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.454 2.769 . . . . 0.0 111.674 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -111.11 50.08 0.84 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 -176.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.7 t80 76.58 -56.85 0.55 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.387 172.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.561 HG21 ' HB3' ' A' ' 23' ' ' GLU . 25.1 p -137.82 14.23 2.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.101 0.477 . . . . 0.0 110.741 175.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 15.8 t -138.7 152.57 48.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.033 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.629 HD11 ' HB1' ' A' ' 36' ' ' ALA . 5.4 mt -112.24 114.36 27.11 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.38 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.929 ' HB ' HG13 ' A' ' 52' ' ' ILE . 2.8 m -91.18 103.93 16.55 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 174.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.8 t -112.04 114.04 45.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.603 0.716 . . . . 0.0 111.188 -169.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.477 ' CE1' HG22 ' A' ' 59' ' ' THR . 84.9 m-85 -105.48 148.91 26.67 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.796 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.556 ' CE2' HG11 ' A' ' 82' ' ' VAL . 2.8 p90 -166.54 172.94 10.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.329 0.585 . . . . 0.0 110.992 -175.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.536 ' OD1' ' HB3' ' A' ' 65' ' ' TYR . 6.7 t0 -98.49 119.55 37.4 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.841 -177.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.548 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -65.61 -20.22 66.23 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.04 -177.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.536 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -60.65 -33.6 73.05 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.102 0.477 . . . . 0.0 110.95 -178.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.557 ' HG3' ' HB2' ' A' ' 46' ' ' PRO . 0.8 OUTLIER -90.27 -22.23 21.7 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.862 0.839 . . . . 0.0 109.331 -173.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.548 HG22 ' HA ' ' A' ' 64' ' ' MET . 2.7 m -82.27 -37.7 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.414 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.955 ' HA ' HD23 ' A' ' 71' ' ' LEU . 32.3 m-85 -58.35 -31.65 67.8 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.093 0.473 . . . . 0.0 109.925 168.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.506 ' HB2' ' HE3' ' A' ' 69' ' ' LYS . 2.9 tppp? -60.59 -27.01 67.4 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.669 177.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -93.7 -76.13 0.48 Allowed 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.134 174.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.955 HD23 ' HA ' ' A' ' 68' ' ' TYR . 1.2 mm? 31.37 66.7 0.92 Allowed Pre-proline 0 N--CA 1.471 0.602 0 C-N-CA 124.312 1.045 . . . . 0.0 112.385 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.656 ' HD2' HG13 ' A' ' 75' ' ' ILE . 32.1 Cg_exo -59.7 153.1 58.22 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.804 2.336 . . . . 0.0 112.366 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -70.08 103.03 2.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.739 0.78 . . . . 0.0 110.541 -176.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 137.27 -34.08 2.23 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -173.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.656 HG13 ' HD2' ' A' ' 72' ' ' PRO . 18.4 mm -75.53 113.59 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 113.974 -1.113 . . . . 0.0 108.67 171.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.3 m -97.94 -3.27 38.75 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.546 -174.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 80' ' ' GLU . 57.0 m -140.32 134.97 15.72 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.893 -172.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.603 ' HA ' HD21 ' A' ' 71' ' ' LEU . 64.9 Cg_exo -45.47 -58.35 1.66 Allowed 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 123.201 2.601 . . . . 0.0 113.33 175.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.53 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -56.48 -29.38 61.68 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.286 0.565 . . . . 0.0 111.158 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.526 ' HG3' ' HE2' ' A' ' 83' ' ' LYS . 40.2 tt0 -71.68 -25.39 62.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.519 -176.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.527 ' HB2' HG21 ' A' ' 75' ' ' ILE . 34.3 t -77.45 -38.35 49.56 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.556 HG11 ' CE2' ' A' ' 62' ' ' TYR . 46.2 t -63.28 -32.27 55.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.292 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.629 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 39.8 mtmt -51.33 -39.54 57.19 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.738 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -73.29 -39.57 65.24 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.89 -174.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -64.2 -35.08 79.63 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.718 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.479 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 18.0 m -86.34 -38.64 12.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.679 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -49.66 -52.62 29.57 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -57.19 -25.45 59.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.978 0.418 . . . . 0.0 111.39 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -87.37 -48.55 7.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.631 175.342 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.568 ' O ' HG12 ' A' ' 93' ' ' ILE . 92.3 mt -65.96 -59.27 3.99 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.797 -177.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 1.105 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . . . -43.83 -40.06 4.22 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.293 -0.867 . . . . 0.0 113.087 -173.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -62.69 -9.06 7.87 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -175.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.568 HG12 ' O ' ' A' ' 90' ' ' LEU . 5.6 pt -95.77 -21.4 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.277 -176.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -179.84 -57.89 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 122.008 0.908 . . . . 0.0 110.6 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 1.105 ' HG2' ' HA ' ' A' ' 91' ' ' ALA . 4.0 pm0 -63.57 -7.39 7.02 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.92 -1.491 . . . . 0.0 114.165 -168.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.447 ' CA ' ' HB1' ' A' ' 91' ' ' ALA . 1.0 OUTLIER -57.83 -21.3 41.72 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 118.098 0.408 . . . . 0.0 110.961 174.539 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -76.3 -16.06 59.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.898 0.38 . . . . 0.0 110.686 176.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -104.95 -70.82 0.76 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.864 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 81.9 t 68.8 109.85 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.903 -177.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -75.6 -7.18 53.59 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.77 -177.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.139 -0.934 . . . . 0.0 111.471 178.507 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.061 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.8 m -56.13 -46.5 79.16 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 173.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -128.41 -172.88 2.81 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.215 168.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.845 HG23 ' HB2' ' A' ' 97' ' ' TYR . 21.5 m -53.21 -80.63 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.786 0.679 . . . . 0.0 110.947 173.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.71 HG13 ' O ' ' A' ' 4' ' ' THR . 2.2 m 155.4 -177.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 C-N-CA 127.846 2.458 . . . . 0.0 106.753 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.418 ' HD2' ' HA ' ' A' ' 6' ' ' ARG . 13.8 mmm180 -150.53 78.91 1.33 Allowed 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.614 ' CE1' ' HB2' ' A' ' 95' ' ' GLU . 6.1 p90 -104.53 149.96 25.03 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 121.372 0.606 . . . . 0.0 110.619 -172.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.401 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 1.8 tp-100 -139.16 133.35 31.31 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.311 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.966 HG12 HG12 ' A' ' 19' ' ' ILE . 37.2 mt -101.57 119.77 50.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.072 177.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -114.03 165.55 12.5 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.066 -177.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -84.26 130.79 34.79 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.521 0.677 . . . . 0.0 110.461 177.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -75.89 -42.98 47.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.867 -175.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -161.78 -73.29 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -142.29 -31.63 0.53 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.5 p -144.93 40.65 1.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.4 0.619 . . . . 0.0 111.325 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -147.78 154.45 40.51 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.874 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -119.29 144.99 46.5 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 119.872 -0.731 . . . . 0.0 112.014 -175.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.477 ' HB2' HD22 ' A' ' 12' ' ' LEU . 26.9 ttt -130.2 129.04 42.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.488 176.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.966 HG12 HG12 ' A' ' 9' ' ' ILE . 6.4 mt -121.35 145.04 28.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.322 -175.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.565 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -136.54 139.92 42.58 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 171.143 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.77 ' HB2' HG11 ' A' ' 29' ' ' VAL . 54.2 m-85 -104.34 -146.36 0.38 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 173.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.95 167.76 25.61 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.96 -44.14 0.34 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 117.018 0.409 . . . . 0.0 111.968 -174.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -46.56 -51.35 15.73 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -174.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.6 pt -125.0 26.62 2.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.192 0.52 . . . . 0.0 110.75 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.57 ' ND2' HG12 ' A' ' 5' ' ' VAL . 2.6 m-20 -114.54 77.64 1.08 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.623 -173.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -73.29 -25.79 60.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 175.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -58.86 -52.75 64.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.583 177.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.77 HG11 ' HB2' ' A' ' 21' ' ' PHE . 99.2 t -61.29 -49.84 82.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.6 178.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -43.79 -40.92 4.67 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 124.136 0.897 . . . . 0.0 112.284 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.36 -42.75 5.13 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.491 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -72.86 -27.17 24.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -172.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 29' ' ' VAL . 11.9 p -70.94 -27.45 30.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.369 0.604 . . . . 0.0 109.433 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -70.51 -35.69 73.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.63 172.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.28 -20.06 32.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.005 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.3 -24.74 67.48 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.192 -175.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.04 -46.64 83.53 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.655 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -76.45 -27.57 56.23 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.536 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -59.51 -45.13 92.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.094 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.534 HD11 HD21 ' A' ' 58' ' ' LEU . 68.3 mt -72.15 -33.39 46.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.43 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.655 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 9.9 pt-20 -77.14 -20.25 55.8 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.94 -175.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -80.66 -32.38 36.11 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 175.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.484 ' OE1' ' HG3' ' A' ' 89' ' ' ARG . 64.2 mt-30 -126.1 72.82 71.19 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.093 0.473 . . . . 0.0 109.732 176.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -98.17 -163.13 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.886 3.057 . . . . 0.0 114.044 -169.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -137.77 145.96 50.77 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 113.965 -1.471 . . . . 0.0 107.441 174.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -53.36 -15.8 6.3 Favored 'Trans proline' 0 N--CA 1.481 0.742 0 C-N-CA 123.635 2.89 . . . . 0.0 114.906 -169.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.593 ' HA3' ' HB2' ' A' ' 66' ' ' GLU . . . -107.31 17.03 37.75 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.491 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.421 ' HZ ' ' SG ' ' A' ' 51' ' ' CYS . 45.3 t80 -63.76 130.16 43.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.044 0.449 . . . . 0.0 111.391 176.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.415 HG12 ' HA ' ' A' ' 62' ' ' TYR . 35.2 mm -104.04 -61.84 2.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.026 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -161.8 156.83 23.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.848 0.356 . . . . 0.0 110.521 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.421 ' SG ' ' HZ ' ' A' ' 48' ' ' PHE . 7.4 p -145.96 119.51 9.1 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.746 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.8 pt -124.52 131.44 24.16 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-O 121.108 0.48 . . . . 0.0 111.462 -178.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 4.7 Cg_exo -78.44 149.18 24.14 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.141 2.561 . . . . 0.0 112.493 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.681 ' HB3' ' HB2' ' A' ' 57' ' ' SER . . . -120.99 17.96 11.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.025 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 71.75 -24.47 0.18 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.654 174.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.4 ' H ' ' C ' ' A' ' 54' ' ' ALA . 7.6 t -135.98 -9.12 2.06 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.524 0.678 . . . . 0.0 109.817 169.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.681 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 16.3 m -130.73 165.53 22.7 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.549 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.534 HD21 HD11 ' A' ' 40' ' ' ILE . 45.3 tp -132.16 125.97 32.51 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.746 ' HB ' HG13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -106.16 107.05 17.86 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.816 -177.02 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.874 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 47.3 t -109.05 115.36 49.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.507 0.67 . . . . 0.0 111.295 -174.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -105.14 146.74 28.78 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.294 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.544 ' CD2' HG11 ' A' ' 82' ' ' VAL . 3.1 p90 -164.19 171.46 14.97 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.031 0.443 . . . . 0.0 110.664 -172.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.503 ' OD1' ' HB3' ' A' ' 65' ' ' TYR . 6.2 t0 -100.92 115.49 30.55 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.347 -177.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.687 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -59.71 -18.77 45.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.18 -177.562 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.635 ' CE2' ' HG2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -66.7 -34.98 79.06 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -177.396 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.635 ' HG2' ' CE2' ' A' ' 65' ' ' TYR . 5.4 mm-40 -89.4 -27.37 20.47 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.872 0.844 . . . . 0.0 109.484 -174.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.722 HG11 HG22 ' A' ' 82' ' ' VAL . 4.1 m -83.39 -22.96 8.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.83 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.939 ' HA ' HD12 ' A' ' 71' ' ' LEU . 15.5 t80 -75.14 -28.05 60.01 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 168.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -67.97 -28.7 67.67 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.071 170.527 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.735 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 11.9 t-80 -111.52 28.33 8.84 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.492 174.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.939 HD12 ' HA ' ' A' ' 68' ' ' TYR . 2.7 mt -94.77 95.37 1.49 Allowed Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.532 176.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.735 ' HD3' ' O ' ' A' ' 70' ' ' HIS . 8.8 Cg_exo -76.48 175.2 11.66 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 124.061 3.174 . . . . 0.0 112.769 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -60.79 -42.78 98.24 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -171.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.03 -25.12 74.47 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.779 -175.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.613 HG13 ' HD2' ' A' ' 72' ' ' PRO . 5.6 mm -85.26 120.93 36.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.233 -0.483 . . . . 0.0 109.779 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.5 m -110.52 3.78 19.83 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.151 0.5 . . . . 0.0 111.17 -174.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.527 ' HB3' ' CB ' ' A' ' 80' ' ' GLU . 28.2 t -134.59 126.16 17.96 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.148 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.703 ' HA ' HD11 ' A' ' 71' ' ' LEU . 74.6 Cg_exo -42.96 -56.57 2.15 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.762 2.975 . . . . 0.0 112.626 171.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -36.44 63.38 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.359 0.6 . . . . 0.0 111.422 175.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.527 ' CB ' ' HB3' ' A' ' 77' ' ' SER . 38.5 tt0 -73.47 -30.65 63.3 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.262 -174.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.553 ' HB3' HG21 ' A' ' 75' ' ' ILE . 67.6 p -73.05 -35.18 66.67 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.655 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.722 HG22 HG11 ' A' ' 67' ' ' VAL . 6.8 t -61.59 -36.32 72.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.062 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -51.86 -40.07 59.97 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -67.41 -38.09 84.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.348 -177.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -65.91 -39.75 90.85 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.804 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.581 ' O ' HD23 ' A' ' 90' ' ' LEU . 28.4 m -83.83 -46.39 18.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.35 -177.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -54.0 -42.1 68.67 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -176.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.42 ' HG3' ' HD3' ' A' ' 89' ' ' ARG . 12.1 pt-20 -59.96 -29.16 68.23 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.839 0.352 . . . . 0.0 111.237 -178.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.484 ' HG3' ' OE1' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -87.19 -49.04 7.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.104 0.478 . . . . 0.0 110.611 174.529 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.665 ' O ' HG12 ' A' ' 93' ' ' ILE . 3.3 mm? -59.7 -33.54 71.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.397 -177.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.57 ' HA ' ' HG3' ' A' ' 95' ' ' GLU . . . -49.84 -35.88 24.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.374 177.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -69.35 -5.86 26.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.54 -176.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.665 HG12 ' O ' ' A' ' 90' ' ' LEU . 3.0 pt -98.15 -36.71 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.472 -177.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 178.19 -48.13 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.29 0.567 . . . . 0.0 111.009 -178.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.614 ' HB2' ' CE1' ' A' ' 7' ' ' TYR . 1.2 pt-20 -62.31 -8.86 6.54 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.498 -0.774 . . . . 0.0 113.076 -169.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.557 ' HB2' ' HB1' ' A' ' 91' ' ' ALA . 22.0 t70 -53.68 -28.03 31.1 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 173.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.845 ' HB2' HG23 ' A' ' 4' ' ' THR . 0.3 OUTLIER -73.64 -12.56 60.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.305 0.574 . . . . 0.0 109.524 -178.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.432 ' HB2' ' HE1' ' A' ' 7' ' ' TYR . 30.1 mt-10 -119.38 -147.64 0.4 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.608 175.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.6 p 171.42 124.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 123.767 0.827 . . . . 0.0 109.061 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.7 ' OD1' ' HB ' ' A' ' 9' ' ' ILE . 8.9 t-20 -101.16 95.94 6.88 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.75 0.786 . . . . 0.0 110.904 177.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 . . . . . 0 C--N 1.301 -1.516 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.124 179.561 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.431 ' O ' ' HG2' ' A' ' 3' ' ' MET . 70.0 m -76.91 97.61 4.64 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.483 ' SD ' ' HG2' ' A' ' 6' ' ' ARG . 25.9 ptt? 49.41 -177.16 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.78 1.232 . . . . 0.0 111.902 -173.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.629 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 8.8 t -83.03 -46.26 13.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.524 0.678 . . . . 0.0 109.851 174.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.629 ' HB ' ' O ' ' A' ' 4' ' ' THR . 5.0 p 156.51 163.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 113.599 -1.637 . . . . 0.0 108.287 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.483 ' HG2' ' SD ' ' A' ' 3' ' ' MET . 16.3 mmt180 -121.02 82.09 1.87 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.628 0.728 . . . . 0.0 109.872 175.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.562 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 18.3 p90 -104.31 148.74 26.03 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.965 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.517 ' HB2' ' NE ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -133.09 132.79 42.15 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.875 -179.157 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.751 HG12 HG12 ' A' ' 19' ' ' ILE . 14.9 mt -95.94 119.48 44.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.706 178.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -120.32 158.33 27.31 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.652 -176.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -82.89 129.34 35.0 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.453 0.644 . . . . 0.0 110.525 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.684 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -73.94 -38.67 64.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.601 -1.182 . . . . 0.0 110.98 -176.349 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.62 -87.16 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.497 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -103.47 -50.26 3.49 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -176.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.526 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 32.5 p -156.39 48.15 0.47 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 122.141 0.972 . . . . 0.0 109.966 -176.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -140.11 148.24 41.41 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.255 -1.339 . . . . 0.0 107.688 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.726 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 37.8 ttp -121.83 139.06 54.09 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.956 -174.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.684 ' HB2' HD22 ' A' ' 12' ' ' LEU . 49.8 ttm -124.89 132.21 53.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.054 0.454 . . . . 0.0 110.947 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.751 HG12 HG12 ' A' ' 9' ' ' ILE . 7.7 mt -124.98 120.88 59.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.654 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.517 ' NE ' ' HB2' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -114.08 134.32 54.96 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.992 177.048 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.562 ' HA ' ' CB ' ' A' ' 7' ' ' TYR . 32.1 m-85 -93.8 -147.89 0.26 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.567 0.222 . . . . 0.0 110.885 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 23' ' ' GLU . . . -70.87 -39.73 64.47 Favored Glycine 0 C--N 1.331 0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 113.313 -173.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.637 ' HB2' HG21 ' A' ' 56' ' ' THR . 41.8 tt0 76.72 -57.1 0.54 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.285 0.634 . . . . 0.0 112.4 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.631 ' HG2' HG23 ' A' ' 25' ' ' ILE . 43.2 tt0 -77.14 -72.79 0.33 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -169.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.631 HG23 ' HG2' ' A' ' 24' ' ' GLU . 38.3 pt -104.75 19.34 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.998 0.428 . . . . 0.0 111.954 -170.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.615 ' HB3' HG22 ' A' ' 29' ' ' VAL . 21.7 m120 -120.47 76.48 1.19 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.708 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.581 ' HA ' ' HB3' ' A' ' 30' ' ' ASN . 33.6 tt0 -69.29 -22.46 63.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.666 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.3 tm0? -59.4 -54.53 45.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.012 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.615 HG22 ' HB3' ' A' ' 26' ' ' ASN . 27.1 m -74.18 -25.82 20.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.686 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.581 ' HB3' ' HA ' ' A' ' 27' ' ' GLU . 8.7 t30 -59.9 -25.91 65.49 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.624 174.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -96.91 -32.86 6.29 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.417 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.449 HG22 ' HA ' ' A' ' 29' ' ' VAL . 0.5 OUTLIER -75.94 -23.59 16.27 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 C-N-CA 121.171 -0.212 . . . . 0.0 111.152 -177.058 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.487 HG23 ' HG ' ' A' ' 58' ' ' LEU . 10.5 p -65.53 -31.0 51.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.364 0.602 . . . . 0.0 109.471 176.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.418 ' HA ' ' CB ' ' A' ' 53' ' ' PRO . 53.3 t-80 -74.75 -38.0 62.35 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.708 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.58 -22.99 46.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.663 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.577 ' HB1' HD11 ' A' ' 58' ' ' LEU . . . -65.36 -25.84 67.76 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.836 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.51 -40.63 95.3 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.739 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.09 -29.61 26.65 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.859 176.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.487 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . 2.7 t80 -60.34 -42.85 96.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.914 0.388 . . . . 0.0 110.401 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 51.6 mt -74.26 -38.42 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.037 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.739 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 8.4 pt-20 -71.15 -23.78 62.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.697 0.284 . . . . 0.0 110.927 -176.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -76.98 -32.54 57.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.017 177.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -134.82 68.38 71.26 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.032 0.444 . . . . 0.0 110.916 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -98.51 -176.31 0.21 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.539 2.826 . . . . 0.0 113.415 -174.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.506 ' HZ ' ' HB2' ' A' ' 62' ' ' TYR . 12.5 p90 -108.3 149.42 39.24 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -39.74 -36.35 1.19 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.003 3.135 . . . . 0.0 115.636 -172.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 66' ' ' GLU . . . -98.37 15.41 61.27 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.97 -175.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.42 ' HZ ' ' SG ' ' A' ' 51' ' ' CYS . 32.4 t80 -62.03 132.84 54.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.264 0.554 . . . . 0.0 110.845 175.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.413 HG12 ' HA ' ' A' ' 62' ' ' TYR . 33.1 mm -106.24 -62.49 2.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.287 -176.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -160.37 155.66 24.97 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.796 -170.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.42 ' SG ' ' HZ ' ' A' ' 48' ' ' PHE . 2.9 p -151.39 119.44 6.26 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.992 0.425 . . . . 0.0 110.024 176.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.748 HG13 ' HB ' ' A' ' 59' ' ' THR . 7.8 pt -121.43 138.6 28.44 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.436 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 11.1 Cg_endo -86.6 148.9 8.69 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.152 2.568 . . . . 0.0 112.424 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -143.5 66.68 1.3 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 69.4 t80 74.47 -60.74 0.51 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.417 0.687 . . . . 0.0 111.516 173.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.637 HG21 ' HB2' ' A' ' 23' ' ' GLU . 10.3 t -136.04 -5.75 2.12 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.287 0.565 . . . . 0.0 110.104 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 16.4 m -113.87 137.07 52.17 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.29 -174.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.577 HD11 ' HB1' ' A' ' 36' ' ' ALA . 3.8 mt -100.81 120.47 40.17 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.057 174.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.748 ' HB ' HG13 ' A' ' 52' ' ' ILE . 1.8 m -96.78 104.44 16.44 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.2 t -110.76 114.77 48.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.711 0.767 . . . . 0.0 111.064 -169.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -106.89 150.12 26.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.191 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.689 ' OH ' ' HB2' ' A' ' 17' ' ' MET . 3.1 p90 -166.62 167.77 15.08 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.371 -175.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.477 ' O ' HG13 ' A' ' 67' ' ' VAL . 1.3 t0 -100.64 115.85 31.17 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.179 0.514 . . . . 0.0 110.455 -174.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.62 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -61.83 -21.89 65.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.078 -174.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -69.21 -30.12 68.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.158 0.504 . . . . 0.0 109.843 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.444 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 1.2 tm-20 -92.08 -33.01 14.95 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.728 0.775 . . . . 0.0 109.131 -173.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.62 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.4 m -67.21 -40.67 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.979 176.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.824 ' HA ' HD23 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -63.71 -25.82 68.38 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.519 173.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.487 ' HE2' ' HB2' ' A' ' 69' ' ' LYS . 5.3 tppt? -70.58 -21.24 62.7 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.75 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -104.87 -41.87 5.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.561 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.824 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER -7.36 84.6 0.03 OUTLIER Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 125.795 1.638 . . . . 0.0 113.703 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.427 ' HD2' HG13 ' A' ' 75' ' ' ILE . 32.3 Cg_exo -60.53 165.36 11.49 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.127 2.551 . . . . 0.0 112.921 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? -61.59 -42.29 98.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.84 0.352 . . . . 0.0 111.419 -173.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.35 -18.55 79.13 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.794 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.596 HG21 ' HB3' ' A' ' 81' ' ' SER . 6.2 mm -88.13 119.17 35.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.49 -0.355 . . . . 0.0 110.281 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -101.75 -9.31 20.94 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.93 0.395 . . . . 0.0 110.945 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.6 m -122.51 123.76 26.95 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.592 -175.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.664 ' HA ' HD21 ' A' ' 71' ' ' LEU . 46.4 Cg_exo -49.05 -46.71 24.36 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.55 2.833 . . . . 0.0 113.783 174.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.93 -29.96 69.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.772 0.32 . . . . 0.0 111.286 175.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 84' ' ' ARG . 52.9 tt0 -75.07 -31.61 61.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.17 -175.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.596 ' HB3' HG21 ' A' ' 75' ' ' ILE . 37.3 p -72.88 -32.94 65.74 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.564 HG11 ' CD2' ' A' ' 62' ' ' TYR . 61.1 t -69.04 -37.0 76.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.161 -1.381 . . . . 0.0 111.282 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.726 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 39.4 mtmt -52.17 -43.23 64.01 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.454 0.645 . . . . 0.0 109.317 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 22.1 mmt180 -67.29 -31.42 71.71 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.866 -173.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.15 -35.28 69.03 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.005 0.431 . . . . 0.0 111.244 176.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.418 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 14.6 m -86.91 -39.18 12.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 C-N-CA 120.424 -0.511 . . . . 0.0 111.047 -177.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.439 ' HA ' ' HB2' ' A' ' 90' ' ' LEU . 50.3 mt-10 -61.33 -38.41 86.78 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 122.623 0.369 . . . . 0.0 111.923 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.21 -31.51 72.05 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.814 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.48 -41.88 17.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.087 0.47 . . . . 0.0 110.283 176.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.601 ' O ' HG12 ' A' ' 93' ' ' ILE . 92.5 mt -61.8 -48.82 78.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.252 177.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.72 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . . . -44.01 -41.85 5.68 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.978 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -59.18 -15.93 17.55 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 90' ' ' LEU . 2.5 pt -97.16 -31.25 3.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -174.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.475 ' HB1' ' OG1' ' A' ' 4' ' ' THR . . . -172.23 -55.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.267 0.556 . . . . 0.0 111.379 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.72 ' HG2' ' HA ' ' A' ' 91' ' ' ALA . 1.7 pm0 -61.5 -9.98 6.87 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -169.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 20.0 t70 -51.5 -22.5 3.2 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 120.874 0.369 . . . . 0.0 111.744 174.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.423 ' HD2' ' HB ' ' A' ' 4' ' ' THR . 4.4 m-30 -65.53 -12.72 55.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.43 0.633 . . . . 0.0 109.978 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.413 ' HB2' ' H ' ' A' ' 99' ' ' VAL . 5.6 pt-20 -156.52 -142.9 0.11 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.925 175.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.413 ' H ' ' HB2' ' A' ' 98' ' ' GLU . 7.6 p 179.02 128.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.129 0.49 . . . . 0.0 109.942 -173.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.22 91.63 3.21 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.492 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 . . . . . 0 C--O 1.248 1.007 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.305 -177.328 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.58 0 N-CA-C 112.009 -0.436 . . . . 0.0 112.009 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.0 m -125.55 108.56 11.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.872 0.368 . . . . 0.0 110.639 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -84.56 -171.63 3.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.896 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.4 t -131.36 119.16 21.29 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.847 0.832 . . . . 0.0 109.132 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.432 HG12 HD22 ' A' ' 26' ' ' ASN . 8.1 m -75.13 161.71 4.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.265 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.48 ' HD2' ' N ' ' A' ' 6' ' ' ARG . 1.6 mpt_? -102.76 72.03 1.2 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.687 0.756 . . . . 0.0 109.79 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.721 ' CE1' ' HB3' ' A' ' 95' ' ' GLU . 6.9 p90 -102.03 164.33 11.77 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.7 -176.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.554 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . 30.5 tt0 -141.01 133.51 28.48 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.731 0.777 . . . . 0.0 110.206 174.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.679 HG12 HG12 ' A' ' 19' ' ' ILE . 9.2 mt -92.16 109.73 21.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.557 176.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.628 ' HG2' ' O ' ' A' ' 18' ' ' MET . 9.1 pt-20 -111.34 163.14 14.3 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.692 -170.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -88.36 131.49 34.81 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.282 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.608 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -76.22 -31.48 58.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.569 -176.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.45 -72.26 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.046 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -135.99 -35.34 0.78 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.3 p -152.89 41.53 0.58 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.714 0.768 . . . . 0.0 110.976 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.583 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -143.8 155.52 44.18 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 174.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.611 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 43.8 ttp -130.09 136.57 49.49 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.441 -172.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.628 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 49.3 ttm -126.82 141.94 51.68 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.808 176.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.679 HG12 HG12 ' A' ' 9' ' ' ILE . 7.5 mt -125.4 115.3 43.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 O-C-N 122.365 -0.209 . . . . 0.0 111.296 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.554 ' HD3' ' HB3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -98.64 136.4 38.76 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 174.54 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.89 ' HB2' HG21 ' A' ' 29' ' ' VAL . 3.9 m-85 -113.66 -155.08 0.56 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.485 ' O ' HG11 ' A' ' 29' ' ' VAL . . . -91.37 -163.36 38.53 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 176.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -172.98 -37.68 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 117.302 0.551 . . . . 0.0 111.935 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -51.07 -69.13 0.12 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.16 0.505 . . . . 0.0 111.37 -173.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.5 pt -104.36 18.04 4.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.716 0.769 . . . . 0.0 110.006 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.59 ' HB3' HG12 ' A' ' 29' ' ' VAL . 20.7 m120 -108.56 72.35 0.82 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.536 -172.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -59.8 -32.35 70.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.417 171.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -54.25 -56.39 18.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.223 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.89 HG21 ' HB2' ' A' ' 21' ' ' PHE . 9.2 p -65.17 -42.12 93.4 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.061 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -48.99 -43.48 40.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.928 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.36 -5.23 87.32 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.14 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -115.88 -31.72 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.617 0 CA-C-N 117.766 0.783 . . . . 0.0 112.372 -174.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.454 ' O ' ' HB3' ' A' ' 53' ' ' PRO . 6.7 p -60.94 -36.81 74.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 118.391 0.541 . . . . 0.0 110.419 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.415 ' HA ' ' CB ' ' A' ' 53' ' ' PRO . 11.5 p-80 -79.31 -22.59 44.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.85 0.357 . . . . 0.0 110.636 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.88 -29.96 23.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.015 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.519 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -64.23 -22.39 66.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.244 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.47 -43.08 98.34 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.59 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.36 -27.97 27.33 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.835 176.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.609 ' HE1' ' HB3' ' A' ' 89' ' ' ARG . 3.9 t80 -56.91 -48.14 78.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.066 0.46 . . . . 0.0 110.252 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.454 HD11 HD21 ' A' ' 58' ' ' LEU . 58.9 mt -72.93 -36.94 52.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.485 -174.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.59 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 13.0 pt-20 -71.17 -19.4 62.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.654 0.264 . . . . 0.0 111.349 -174.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.411 ' C ' ' HD3' ' A' ' 44' ' ' PRO . 46.0 mt-10 -79.46 -28.68 41.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.88 0.372 . . . . 0.0 110.877 174.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -129.89 64.19 71.22 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.785 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.411 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 65.2 Cg_endo -98.99 177.98 0.34 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.264 2.643 . . . . 0.0 113.389 -174.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.54 ' CE2' HG13 ' A' ' 82' ' ' VAL . 6.6 p90 -108.21 147.41 35.53 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.279 173.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.21 12.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.486 1.033 0 C-N-CA 124.293 3.329 . . . . 0.0 114.852 -173.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.491 ' HA3' ' HB2' ' A' ' 66' ' ' GLU . . . -131.12 19.32 4.91 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 175.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.594 ' HZ ' ' HB3' ' A' ' 51' ' ' CYS . 30.9 t80 -79.49 142.61 35.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.013 0.435 . . . . 0.0 110.404 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.492 HG12 ' HA ' ' A' ' 62' ' ' TYR . 35.5 mm -108.38 -59.19 3.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.212 -175.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -168.93 141.6 2.73 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.351 -173.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.594 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 1.6 p -129.22 118.75 22.86 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 173.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.734 HG13 ' HB ' ' A' ' 59' ' ' THR . 4.3 pt -121.18 134.87 24.54 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.877 -175.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.454 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 86.9 Cg_endo -87.2 139.88 5.37 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.303 2.669 . . . . 0.0 112.66 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.3 59.22 1.59 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.413 ' O ' HG11 ' A' ' 33' ' ' VAL . 75.8 t80 75.02 -50.69 0.67 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.576 0.75 . . . . 0.0 112.086 172.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.27 -12.9 1.19 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.111 0.481 . . . . 0.0 110.863 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.5 m -115.39 134.14 55.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.979 0.419 . . . . 0.0 111.162 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.454 HD21 HD11 ' A' ' 40' ' ' ILE . 46.0 tp -102.86 117.23 34.17 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.789 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.734 ' HB ' HG13 ' A' ' 52' ' ' ILE . 4.8 m -97.6 114.41 26.33 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -177.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.9 t -111.41 109.58 29.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.765 0.793 . . . . 0.0 111.375 -170.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -101.25 145.61 28.61 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.009 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.611 ' OH ' ' HB2' ' A' ' 17' ' ' MET . 2.9 p90 -166.62 166.94 15.78 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -176.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.41 ' OD1' ' HD1' ' A' ' 65' ' ' TYR . 5.4 t70 -102.58 128.55 49.19 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.339 0.59 . . . . 0.0 109.45 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.54 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -62.24 -20.56 64.35 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.799 -172.297 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.41 ' HD1' ' OD1' ' A' ' 63' ' ' ASP . 4.5 p90 -64.54 -34.93 79.39 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.847 0.356 . . . . 0.0 111.632 -174.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.491 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 1.7 tm-20 -92.52 -28.4 16.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.68 0.752 . . . . 0.0 109.598 -172.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.1 m -72.93 -34.65 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.911 ' HA ' HD23 ' A' ' 71' ' ' LEU . 58.9 t80 -72.47 -22.63 61.04 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.888 173.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.493 ' HE2' ' HB2' ' A' ' 69' ' ' LYS . 9.0 tppt? -66.27 -26.07 67.17 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 173.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -89.37 -74.64 0.47 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.786 172.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.911 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.8 OUTLIER 24.14 65.44 0.4 Allowed Pre-proline 0 N--CA 1.473 0.714 0 O-C-N 124.88 1.362 . . . . 0.0 112.88 -178.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.574 ' HD2' HG13 ' A' ' 75' ' ' ILE . 35.1 Cg_exo -60.67 143.47 99.42 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.608 2.205 . . . . 0.0 111.8 -175.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -64.0 108.39 1.5 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.499 0.666 . . . . 0.0 110.106 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 135.36 -30.1 2.83 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -171.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.575 HG21 ' HB3' ' A' ' 81' ' ' SER . 10.9 mm -87.12 125.23 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 114.422 -0.889 . . . . 0.0 108.622 170.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.5 t -103.68 -0.15 29.86 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.353 0.597 . . . . 0.0 110.274 -174.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.83 ' HG ' ' HD1' ' A' ' 79' ' ' PHE . 38.4 t -143.89 133.83 11.85 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.127 -170.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.59 ' HA ' HD21 ' A' ' 71' ' ' LEU . 86.1 Cg_exo -50.07 -50.35 13.63 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.668 2.912 . . . . 0.0 112.863 174.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.83 ' HD1' ' HG ' ' A' ' 77' ' ' SER . 0.1 OUTLIER -63.2 -30.24 71.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.102 0.477 . . . . 0.0 110.921 178.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.433 ' CB ' ' HB3' ' A' ' 77' ' ' SER . 40.7 tt0 -73.31 -27.1 61.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.366 -175.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.575 ' HB3' HG21 ' A' ' 75' ' ' ILE . 88.8 p -79.31 -37.75 36.92 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.56 0.695 . . . . 0.0 109.176 178.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 78' ' ' PRO . 61.0 t -63.42 -31.44 52.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.157 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.537 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 6.3 mtmp? -52.53 -43.63 65.26 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.48 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 11.3 mmm180 -64.56 -41.83 96.07 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.429 -174.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.34 -39.36 86.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.819 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.2 m -87.24 -41.49 14.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.968 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -60.99 -41.38 96.37 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.648 ' HG3' ' HD3' ' A' ' 89' ' ' ARG . 9.3 pt-20 -59.13 -30.99 68.54 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.053 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.648 ' HD3' ' HG3' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -89.19 -56.95 3.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.464 0.649 . . . . 0.0 110.799 176.265 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.697 ' O ' HG12 ' A' ' 93' ' ' ILE . 12.0 tp -73.55 -65.61 0.8 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.869 -176.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.754 ' HA ' ' HG3' ' A' ' 95' ' ' GLU . . . -55.24 -31.96 61.92 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -172.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.698 ' HA ' ' CB ' ' A' ' 96' ' ' ASP . 4.3 tt0 -59.71 -6.58 1.23 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -171.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.697 HG12 ' O ' ' A' ' 90' ' ' LEU . 13.1 pt -88.16 -32.72 6.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.551 -174.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.641 ' N ' HG13 ' A' ' 93' ' ' ILE . . . -151.84 -30.18 0.16 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.354 0.597 . . . . 0.0 112.377 -172.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.754 ' HG3' ' HA ' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -106.42 -32.83 7.94 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.856 -164.486 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.698 ' CB ' ' HA ' ' A' ' 92' ' ' GLU . 28.6 t70 -51.75 -19.44 1.64 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.228 173.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -68.07 -13.43 62.19 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.729 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -134.52 -157.61 0.82 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.513 169.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.6 m -141.11 110.2 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.434 0.635 . . . . 0.0 110.9 -171.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -87.41 23.29 1.93 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.463 -178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.782 -0.628 . . . . 0.0 109.409 175.02 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.662 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t -128.17 -174.27 3.17 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.7 ptp -126.04 150.46 48.1 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.2 t -76.49 127.65 33.26 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.29 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.623 HG11 ' CD2' ' A' ' 21' ' ' PHE . 98.8 t -82.78 141.44 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.223 0.535 . . . . 0.0 110.464 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -117.62 95.88 5.14 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.313 171.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.627 ' OH ' HD12 ' A' ' 93' ' ' ILE . 35.2 p90 -122.76 163.06 20.87 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.436 -175.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.44 120.29 18.5 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -175.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.943 HG12 HG12 ' A' ' 19' ' ' ILE . 40.7 mt -89.71 123.74 42.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.036 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 18' ' ' MET . 12.0 pt-20 -122.0 174.17 7.08 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.834 -176.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -95.08 135.51 36.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.526 0.679 . . . . 0.0 110.598 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.44 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -80.87 -44.7 17.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.517 -176.587 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -172.92 -74.32 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.432 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -127.15 -50.39 1.43 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.118 0.485 . . . . 0.0 111.172 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.8 p -144.9 41.03 1.28 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.588 0.709 . . . . 0.0 110.942 -172.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.02 157.29 44.42 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.651 176.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.794 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -123.21 145.84 48.31 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.888 -176.321 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.44 ' HB2' HD22 ' A' ' 12' ' ' LEU . 51.8 ttm -127.25 131.13 50.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.749 174.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.943 HG12 HG12 ' A' ' 9' ' ' ILE . 9.9 mt -114.07 124.85 71.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.84 -177.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.7 111.75 24.03 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.618 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.623 ' CD2' HG11 ' A' ' 5' ' ' VAL . 22.9 m-85 -78.52 -174.39 3.8 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.195 0.521 . . . . 0.0 111.258 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.439 ' O ' HG11 ' A' ' 29' ' ' VAL . . . -97.63 -164.76 31.76 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.519 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -178.65 170.9 1.56 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 76.2 -52.51 0.61 Allowed 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.286 0.634 . . . . 0.0 111.719 172.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.1 pt -107.94 10.13 9.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.799 0.809 . . . . 0.0 109.897 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.477 ' O ' HG12 ' A' ' 29' ' ' VAL . 34.3 t30 -146.29 108.92 4.51 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.409 -175.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -80.35 -30.14 38.0 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.213 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -61.45 -19.74 62.32 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -173.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 26' ' ' ASN . 1.5 p -62.57 -55.98 20.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.912 176.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.418 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -57.76 -29.03 64.48 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.859 -177.429 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.19 -15.7 58.6 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.228 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.409 ' O ' ' N ' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -115.18 -24.82 3.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.724 0 CA-C-N 117.41 0.605 . . . . 0.0 112.361 -174.351 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.446 HG11 ' O ' ' A' ' 55' ' ' PHE . 7.2 p -61.24 -34.57 61.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 118.785 0.72 . . . . 0.0 110.361 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -77.14 -32.09 56.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.837 0.351 . . . . 0.0 110.072 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.83 -20.8 30.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.46 -176.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 32' ' ' ILE . . . -66.46 -32.03 73.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.997 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.7 -41.07 97.1 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.91 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -73.84 -36.86 64.94 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.753 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.01 -35.43 75.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.231 0.539 . . . . 0.0 110.113 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.7 mt -81.95 -35.21 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.373 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.91 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 10.5 pt-20 -79.84 -21.77 43.75 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.751 -175.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.952 ' HG3' ' HG3' ' A' ' 43' ' ' GLN . 9.6 pt-20 -81.03 -29.89 35.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.121 0.486 . . . . 0.0 109.967 175.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.952 ' HG3' ' HG3' ' A' ' 42' ' ' GLU . 54.3 mt-30 -126.37 65.05 57.46 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.933 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.425 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 66.2 Cg_endo -93.36 -173.27 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.569 2.846 . . . . 0.0 114.017 -169.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -124.77 146.73 53.92 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.517 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -49.06 -18.63 1.92 Allowed 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 124.151 3.234 . . . . 0.0 115.265 -171.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.36 21.09 22.41 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.172 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.485 ' HZ ' ' SG ' ' A' ' 51' ' ' CYS . 45.2 t80 -66.69 130.41 43.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.993 0.425 . . . . 0.0 110.795 176.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.434 HG12 ' HA ' ' A' ' 62' ' ' TYR . 35.4 mm -102.55 -59.76 3.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.277 -177.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -162.82 154.39 17.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.738 0.304 . . . . 0.0 110.734 -174.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.485 ' SG ' ' HZ ' ' A' ' 48' ' ' PHE . 12.3 p -144.27 119.3 10.02 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 173.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.777 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.5 pt -124.95 132.83 24.39 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-O 121.127 0.489 . . . . 0.0 111.755 -178.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.55 136.9 7.68 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.02 2.48 . . . . 0.0 111.715 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -124.73 54.37 1.4 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.957 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.446 ' O ' HG11 ' A' ' 33' ' ' VAL . 57.9 m-85 74.13 -53.4 0.68 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.49 0.716 . . . . 0.0 112.285 171.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.417 ' O ' ' HB2' ' A' ' 21' ' ' PHE . 9.3 t -139.26 3.2 2.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.199 0.523 . . . . 0.0 110.477 176.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.3 m -125.7 146.3 49.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.059 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.43 ' HB3' ' HB ' ' A' ' 19' ' ' ILE . 45.8 tp -112.98 119.9 39.53 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.777 ' HB ' HG13 ' A' ' 52' ' ' ILE . 1.4 m -102.1 110.24 22.16 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.794 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 58.9 t -111.27 115.99 51.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.602 0.715 . . . . 0.0 111.185 -173.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -107.05 145.9 31.81 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.479 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.607 ' OH ' ' HB3' ' A' ' 17' ' ' MET . 3.5 p90 -165.12 168.79 16.89 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.983 -175.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.417 ' OD1' ' HB3' ' A' ' 65' ' ' TYR . 7.2 t0 -101.97 114.35 28.38 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.495 -176.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.706 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -64.44 -20.82 66.41 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.075 -176.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.417 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -64.56 -27.52 69.01 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.793 0.33 . . . . 0.0 110.732 -179.203 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -90.69 -39.28 12.54 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.613 0.721 . . . . 0.0 109.271 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.706 HG22 ' HA ' ' A' ' 64' ' ' MET . 2.7 m -64.77 -34.43 70.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.235 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.738 ' HA ' HD23 ' A' ' 71' ' ' LEU . 7.3 m-85 -55.0 -28.39 51.64 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.841 0.456 . . . . 0.0 111.456 172.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -41.91 95.83 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.598 0.713 . . . . 0.0 109.415 177.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -91.0 -23.93 20.24 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.842 -174.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.738 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -26.53 94.37 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.895 0 O-C-N 124.867 1.355 . . . . 0.0 111.546 176.106 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.478 ' HD2' HG13 ' A' ' 75' ' ' ILE . 24.1 Cg_exo -67.65 140.16 50.72 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.551 2.834 . . . . 0.0 111.603 -175.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.0 tp60 -63.01 99.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.463 0.649 . . . . 0.0 109.917 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 140.02 -24.1 2.72 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -172.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.555 HG21 ' HB3' ' A' ' 81' ' ' SER . 2.4 mm -96.29 126.94 48.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 171.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 t -112.25 -0.25 15.55 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.266 0.555 . . . . 0.0 110.109 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.42 ' HG ' ' HD2' ' A' ' 79' ' ' PHE . 34.6 t -118.61 111.99 37.44 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.282 -175.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.694 ' HA ' HD21 ' A' ' 71' ' ' LEU . 91.3 Cg_exo -47.98 -46.3 22.37 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.55 2.833 . . . . 0.0 113.062 173.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.42 ' HD2' ' HG ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -61.18 -37.3 82.42 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.226 -0.19 . . . . 0.0 111.437 176.709 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 19.8 tt0 -82.07 -19.35 40.43 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.402 -174.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.555 ' HB3' HG21 ' A' ' 75' ' ' ILE . 83.3 p -74.25 -37.63 63.71 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 78' ' ' PRO . 26.8 t -65.67 -30.92 51.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.675 177.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.763 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 21.4 mtpt -49.94 -48.5 51.87 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 174.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 11.5 mmt180 -61.48 -38.65 88.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.494 -173.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -73.06 -33.72 65.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.137 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.507 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 22.7 m -87.01 -42.5 15.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 CA-C-O 118.911 -0.566 . . . . 0.0 112.043 -176.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.763 ' HG2' ' O ' ' A' ' 83' ' ' LYS . 8.1 pt-20 -54.01 -58.26 7.96 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.69 0.677 . . . . 0.0 111.912 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.494 ' H ' ' HG3' ' A' ' 87' ' ' GLU . 12.9 pt-20 -51.06 -26.49 6.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.289 176.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -85.35 -47.96 9.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 122.466 1.127 . . . . 0.0 109.231 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.682 ' O ' HG23 ' A' ' 93' ' ' ILE . 87.0 mt -63.25 -6.86 4.97 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 112.987 -1.915 . . . . 0.0 111.785 175.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -39.89 -18.71 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -165.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 90' ' ' LEU . 16.0 mt-10 -65.02 -4.28 4.49 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.583 -0.698 . . . . 0.0 110.429 171.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.682 HG23 ' O ' ' A' ' 90' ' ' LEU . 2.3 pt -70.39 -16.56 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 124.313 1.045 . . . . 0.0 110.346 177.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 93' ' ' ILE . . . 77.0 -67.1 0.22 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.7 -1.136 . . . . 0.0 113.578 173.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -63.41 -23.34 67.36 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -168.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.445 ' HB2' HD11 ' A' ' 93' ' ' ILE . 12.6 t70 -49.24 -25.98 2.66 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.083 0.468 . . . . 0.0 111.994 178.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.536 ' N ' ' HD1' ' A' ' 97' ' ' TYR . 0.9 OUTLIER -68.3 -12.06 60.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.652 -175.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -109.81 6.96 23.9 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.601 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.9 t 74.97 121.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.864 0.866 . . . . 0.0 111.404 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -96.54 145.1 26.01 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.54 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 101' ' ' ARG . 38.5 mtt180 . . . . . 0 C--O 1.246 0.872 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.702 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.747 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.8 t -84.75 84.49 7.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.224 0.535 . . . . 0.0 109.872 -178.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.9 ptp -173.29 165.74 4.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.776 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.77 ' HB ' ' HD2' ' A' ' 97' ' ' TYR . 5.4 t -81.46 53.15 2.01 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.942 177.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.2 m 44.98 -173.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.348 1.059 . . . . 0.0 112.59 -171.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.457 ' HD3' ' HA ' ' A' ' 6' ' ' ARG . 5.5 mmt-85 -135.1 102.24 5.13 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.936 176.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.569 ' CE1' ' HB3' ' A' ' 95' ' ' GLU . 17.2 p90 -133.05 161.3 34.74 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.684 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.413 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -147.69 120.31 8.57 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 176.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.877 HG12 HG12 ' A' ' 19' ' ' ILE . 15.8 mt -76.83 117.76 22.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.839 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.604 ' HG2' ' O ' ' A' ' 18' ' ' MET . 8.7 pt-20 -116.92 162.49 17.67 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.804 -174.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.591 HE21 ' HA ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -86.05 138.06 32.23 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.596 0.712 . . . . 0.0 110.102 177.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.733 HD21 HG23 ' A' ' 59' ' ' THR . 0.4 OUTLIER -94.59 -50.29 5.26 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.711 -1.132 . . . . 0.0 110.595 -171.535 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.45 142.45 3.59 Favored Glycine 0 N--CA 1.433 -1.501 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 70.4 -73.02 0.1 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.207 0.603 . . . . 0.0 111.148 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.5 p -173.62 53.51 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.597 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.14 156.43 44.33 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.537 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.864 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 1.1 ptp -123.4 155.98 36.33 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.084 -177.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.707 ' HB2' HD22 ' A' ' 12' ' ' LEU . 48.3 ttm -136.24 137.55 40.91 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 172.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.877 HG12 HG12 ' A' ' 9' ' ' ILE . 8.3 mt -117.21 107.29 21.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.674 -177.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.581 HH21 ' CD ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -90.65 136.11 33.27 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.255 -0.578 . . . . 0.0 109.472 176.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.591 ' HB3' HG11 ' A' ' 29' ' ' VAL . 14.8 m-85 -108.15 -147.56 0.41 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 170.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -112.41 -139.95 7.77 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.657 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 173.49 -54.36 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.325 0.65 . . . . 0.0 109.329 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -41.13 -55.26 2.66 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.911 -1.041 . . . . 0.0 112.136 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.8 pt -114.5 22.19 5.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.738 0.304 . . . . 0.0 111.094 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.472 ' O ' HG22 ' A' ' 29' ' ' VAL . 91.2 m-20 -142.12 86.43 1.97 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.317 -0.401 . . . . 0.0 112.07 -174.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -68.38 -19.02 64.6 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.555 0.693 . . . . 0.0 109.291 170.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -70.4 -42.61 71.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.613 -175.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.591 HG11 ' HB3' ' A' ' 21' ' ' PHE . 31.0 m -67.4 -42.89 87.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.315 -178.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -49.14 -40.67 33.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.539 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.82 -33.31 24.66 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.101 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.529 HG13 HD13 ' A' ' 93' ' ' ILE . 0.5 OUTLIER -88.83 -26.41 5.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.463 0 O-C-N 122.422 -0.458 . . . . 0.0 112.116 -171.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.425 HG11 ' O ' ' A' ' 55' ' ' PHE . 7.8 p -63.49 -30.67 50.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.342 0.592 . . . . 0.0 109.627 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -74.98 -43.29 54.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.253 175.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.47 -22.23 57.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.132 -176.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.437 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -65.5 -27.64 68.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.527 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.61 -41.54 98.3 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.592 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.65 -21.2 30.33 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.18 176.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.437 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 10.6 t80 -66.88 -44.85 79.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.211 0.529 . . . . 0.0 110.06 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.518 HD11 HD21 ' A' ' 58' ' ' LEU . 34.0 mt -78.49 -31.49 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.696 -174.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.592 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 11.0 pt-20 -69.79 -21.96 63.37 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.777 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -85.09 -29.94 24.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.666 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -130.23 70.13 82.15 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 120.796 0.332 . . . . 0.0 111.003 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -97.39 -175.46 0.24 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.418 2.746 . . . . 0.0 113.091 -176.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.487 ' CZ ' HG12 ' A' ' 67' ' ' VAL . 9.5 p90 -116.36 148.61 42.05 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -45.25 -26.09 2.28 Favored 'Trans proline' 0 N--CA 1.482 0.836 0 C-N-CA 124.159 3.24 . . . . 0.0 115.579 -169.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.553 ' HA3' ' CB ' ' A' ' 66' ' ' GLU . . . -103.21 14.41 55.13 Favored Glycine 0 C--O 1.228 -0.268 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.743 -176.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.431 ' HZ ' ' SG ' ' A' ' 51' ' ' CYS . 31.3 t80 -68.1 139.98 56.21 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.492 0.663 . . . . 0.0 111.024 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.008 HG22 ' HG2' ' A' ' 50' ' ' GLU . 38.7 mm -112.4 -63.84 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.477 -174.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 1.008 ' HG2' HG22 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -152.39 169.41 22.61 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.14 0.495 . . . . 0.0 111.356 -177.445 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.431 ' SG ' ' HZ ' ' A' ' 48' ' ' PHE . 11.2 p -158.8 123.95 4.26 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 169.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.808 HG13 ' HB ' ' A' ' 59' ' ' THR . 7.9 pt -123.02 136.38 26.85 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-O 120.952 0.406 . . . . 0.0 111.724 -177.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 61.2 Cg_endo -85.88 129.12 3.41 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.163 2.575 . . . . 0.0 112.364 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -115.09 43.92 1.9 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.887 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.425 ' O ' HG11 ' A' ' 33' ' ' VAL . 62.2 t80 72.77 -40.55 0.48 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.734 0.813 . . . . 0.0 112.742 175.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.0 t -139.22 -17.71 1.02 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.177 0.513 . . . . 0.0 110.985 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 m -113.44 134.87 54.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.177 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.518 HD21 HD11 ' A' ' 40' ' ' ILE . 52.3 tp -103.06 112.25 25.0 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 177.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.808 ' HB ' HG13 ' A' ' 52' ' ' ILE . 10.7 m -92.49 106.77 18.69 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -177.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.864 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 41.1 t -107.52 120.92 59.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.46 0.648 . . . . 0.0 111.559 -173.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.605 ' HB2' ' HG3' ' A' ' 50' ' ' GLU . 85.7 m-85 -106.39 147.34 29.38 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.185 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.63 ' OH ' ' HB3' ' A' ' 17' ' ' MET . 3.0 p90 -166.7 170.49 12.45 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.673 -176.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.512 ' O ' HG13 ' A' ' 67' ' ' VAL . 6.1 t70 -104.71 123.3 47.37 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.466 0.65 . . . . 0.0 110.773 -176.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.513 ' O ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -61.3 -23.88 66.02 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.766 -175.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.49 ' HD1' ' OD1' ' A' ' 63' ' ' ASP . 0.8 OUTLIER -68.28 -28.82 67.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.383 0.611 . . . . 0.0 110.187 -176.293 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.553 ' CB ' ' HA3' ' A' ' 47' ' ' GLY . 1.0 OUTLIER -91.47 -29.76 16.83 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.65 0.738 . . . . 0.0 109.522 -175.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 64' ' ' MET . 2.0 m -71.24 -35.89 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 176.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.98 ' HA ' HD23 ' A' ' 71' ' ' LEU . 76.7 t80 -69.33 -22.61 63.75 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.501 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -61.27 -38.51 87.01 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 173.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -83.33 -70.25 0.57 Allowed 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 113.867 -1.515 . . . . 0.0 109.523 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.98 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.8 OUTLIER 23.43 68.08 0.36 Allowed Pre-proline 0 N--CA 1.478 0.928 0 O-C-N 124.854 1.346 . . . . 0.0 112.977 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.593 ' HD2' HG13 ' A' ' 75' ' ' ILE . 28.6 Cg_exo -62.42 153.13 72.88 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.657 2.238 . . . . 0.0 112.613 -176.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -68.21 109.26 3.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.368 0.604 . . . . 0.0 110.223 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 131.92 -31.11 3.11 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -174.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.593 HG13 ' HD2' ' A' ' 72' ' ' PRO . 17.4 mm -80.63 117.82 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 114.076 -1.062 . . . . 0.0 108.972 171.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.3 m -97.08 -1.8 44.56 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.536 -174.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.6 t -144.53 136.52 13.06 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.525 -170.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.593 ' HA ' HD21 ' A' ' 71' ' ' LEU . 98.5 Cg_exo -47.26 -57.08 2.52 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.457 2.771 . . . . 0.0 113.343 173.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.551 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -59.01 -30.73 68.21 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.171 0.51 . . . . 0.0 110.907 -179.049 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 46.2 tt0 -74.83 -26.23 59.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.191 -176.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.562 ' HB3' HG21 ' A' ' 75' ' ' ILE . 96.9 p -73.26 -36.87 66.44 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.6 t -67.87 -24.87 31.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.525 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.5 ' HG2' HG21 ' A' ' 9' ' ' ILE . 47.0 mtpt -55.1 -35.36 64.53 Favored 'General case' 0 C--O 1.214 -0.816 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.18 176.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -71.09 -37.18 72.41 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.067 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -69.51 -35.18 75.27 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.999 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.508 ' O ' HD23 ' A' ' 90' ' ' LEU . 31.6 m -86.02 -45.07 16.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.92 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -51.7 -44.22 63.08 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -58.63 -29.7 66.71 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.538 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.93 -43.41 13.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.127 0.489 . . . . 0.0 110.253 177.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 86' ' ' VAL . 4.4 mm? -60.56 -40.58 92.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.883 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.545 ' O ' ' HB2' ' A' ' 96' ' ' ASP . . . -52.06 -33.99 41.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.701 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -66.14 -6.44 13.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.394 -177.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.529 HD13 HG13 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -108.98 -38.87 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.127 -175.715 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -167.2 -51.86 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.041 0.448 . . . . 0.0 111.667 177.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.569 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 1.0 OUTLIER -57.31 -11.34 1.73 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.686 -170.314 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.545 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 32.7 t70 -43.72 -25.94 0.21 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 171.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.77 ' HD2' ' HB ' ' A' ' 4' ' ' THR . 6.3 m-85 -77.4 -16.37 58.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.837 -174.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.76 ' HG3' HG21 ' A' ' 4' ' ' THR . 61.4 mt-10 -130.42 -53.94 1.09 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.754 0.311 . . . . 0.0 111.401 177.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.7 t 69.95 114.84 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.606 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.65 98.12 0.67 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.409 0.623 . . . . 0.0 110.508 177.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 . . . . . 0 C--O 1.247 0.964 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.746 179.848 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.673 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.2 m -101.11 96.16 7.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.891 0.377 . . . . 0.0 110.098 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -75.86 155.74 35.01 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.211 0.529 . . . . 0.0 110.79 -178.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.56 ' O ' HG22 ' A' ' 5' ' ' VAL . 6.8 t -84.46 29.28 0.6 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.766 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 4' ' ' THR . 1.7 m 56.94 160.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.04 1.336 . . . . 0.0 112.285 -174.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.428 ' HA ' ' HD3' ' A' ' 6' ' ' ARG . 8.4 mmt180 -120.41 86.22 2.53 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.072 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.527 ' CE1' ' HB2' ' A' ' 95' ' ' GLU . 13.2 p90 -103.56 152.47 21.68 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.204 -177.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.522 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 18.7 mp0 -132.6 131.57 41.58 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.899 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.973 HG12 HG12 ' A' ' 19' ' ' ILE . 49.1 mt -97.7 122.94 49.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.292 173.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -119.01 164.3 15.69 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.102 0.477 . . . . 0.0 110.115 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -84.79 128.22 34.5 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.393 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.614 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.2 OUTLIER -75.89 -39.64 56.02 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.773 -173.074 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -163.76 -77.98 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -138.03 -28.82 0.86 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 177.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.7 p -148.35 36.35 0.82 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.466 0.65 . . . . 0.0 111.557 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.495 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -143.98 156.69 44.5 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.307 176.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.721 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -125.08 147.19 49.11 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.411 -175.618 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.614 ' HB2' HD22 ' A' ' 12' ' ' LEU . 19.0 ttt -136.21 123.45 21.81 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.932 176.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.973 HG12 HG12 ' A' ' 9' ' ' ILE . 9.8 mt -110.66 146.35 15.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 123.014 0.526 . . . . 0.0 110.262 -175.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.522 ' HD2' ' O ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -139.56 134.49 32.24 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.45 173.131 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.608 ' HB2' HG11 ' A' ' 29' ' ' VAL . 4.7 m-85 -106.77 -156.18 0.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.17 160.04 11.43 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.967 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.422 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 9.2 tp10 -172.01 -83.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 122.681 0.392 . . . . 0.0 110.452 176.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -131.57 -73.92 0.53 Allowed 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.268 0.556 . . . . 0.0 110.688 -173.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.2 pt -117.28 46.6 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.973 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.422 ' OD1' ' HB3' ' A' ' 23' ' ' GLU . 2.0 m-20 -79.78 68.59 5.9 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.98 -171.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.504 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 11.8 tp10 -63.69 -34.61 78.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.305 173.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.401 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -56.66 -45.18 81.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.968 178.139 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.608 HG11 ' HB2' ' A' ' 21' ' ' PHE . 53.4 t -65.64 -57.95 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.763 -176.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.504 ' ND2' ' HA ' ' A' ' 27' ' ' GLU . 2.7 p30 -57.51 -23.05 47.95 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.592 0.234 . . . . 0.0 111.465 -175.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.99 -39.89 5.66 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.046 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.401 ' HB ' ' O ' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -80.39 -26.99 11.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.768 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -175.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 29' ' ' VAL . 10.7 p -68.08 -29.24 43.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -73.29 -34.36 65.71 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.495 177.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.11 -22.09 27.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.598 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.85 -22.99 65.99 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.125 -174.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.427 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . . . -62.52 -44.84 95.37 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.865 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -81.05 -27.85 35.59 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.979 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -59.53 -44.68 93.12 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.498 HD11 HD21 ' A' ' 58' ' ' LEU . 47.3 mt -76.58 -44.26 34.41 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.349 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.865 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 9.5 pt-20 -65.54 -27.37 68.4 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.125 0.416 . . . . 0.0 112.125 -171.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.477 ' C ' ' HD3' ' A' ' 44' ' ' PRO . 45.9 mt-10 -92.63 -18.77 22.63 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 121.156 -0.218 . . . . 0.0 111.441 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.445 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 21.8 mt-30 -131.09 58.55 39.73 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-O 120.744 0.306 . . . . 0.0 110.25 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.477 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 43.0 Cg_endo -104.64 -167.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.988 3.126 . . . . 0.0 113.75 -171.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.678 ' HZ ' ' HB2' ' A' ' 62' ' ' TYR . 12.8 p90 -111.71 147.22 36.33 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 168.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.89 -16.4 0.82 Allowed 'Trans proline' 0 N--CA 1.481 0.747 0 C-N-CA 124.219 3.279 . . . . 0.0 115.1 -172.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.57 7.53 61.49 Favored Glycine 0 C--O 1.226 -0.357 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.769 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -61.44 136.36 58.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.32 0.581 . . . . 0.0 111.803 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 62' ' ' TYR . 39.2 mm -109.19 -62.4 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.399 -177.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -163.43 157.12 19.49 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.432 -173.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.427 ' SG ' ' HA ' ' A' ' 37' ' ' ALA . 6.0 p -151.75 118.84 5.87 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 174.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.704 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.2 pt -116.13 134.25 22.81 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.826 -175.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 62.8 Cg_endo -84.37 141.43 9.01 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.095 2.53 . . . . 0.0 112.305 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -130.87 54.11 1.93 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.734 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.2 t80 76.66 -59.4 0.5 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.492 171.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.2 p -130.64 -2.05 4.27 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.26 0.552 . . . . 0.0 110.943 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 34.0 t -122.24 155.36 36.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.791 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.498 HD21 HD11 ' A' ' 40' ' ' ILE . 47.6 tp -127.33 116.56 20.71 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.598 -177.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.704 ' HB ' HG13 ' A' ' 52' ' ' ILE . 1.1 m -96.22 107.39 19.72 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.721 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 44.1 t -107.44 120.58 59.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.747 0.784 . . . . 0.0 111.867 -171.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -111.44 147.07 36.05 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.675 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.678 ' HB2' ' HZ ' ' A' ' 45' ' ' PHE . 3.3 p90 -165.65 172.0 12.4 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -174.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -103.53 117.34 34.2 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.431 0.634 . . . . 0.0 109.979 -177.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.523 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -64.77 -19.55 65.87 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.176 -176.687 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.06 -29.98 70.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.712 0.292 . . . . 0.0 111.107 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 0.6 OUTLIER -89.16 -26.88 21.05 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 122.067 0.937 . . . . 0.0 108.829 -172.113 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.641 HG11 HG22 ' A' ' 82' ' ' VAL . 3.7 m -82.62 -40.21 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.488 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.558 ' HA ' HD23 ' A' ' 71' ' ' LEU . 2.8 m-85 -58.66 -29.0 66.24 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 171.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.502 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 4.3 tppp? -53.49 -41.87 66.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.68 175.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -94.97 -71.84 0.65 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.693 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER 38.17 68.96 1.61 Allowed Pre-proline 0 N--CA 1.468 0.459 0 O-C-N 124.146 0.904 . . . . 0.0 111.802 179.024 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -63.6 140.64 76.17 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.878 2.385 . . . . 0.0 111.775 -176.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -61.39 109.42 1.15 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.56 0.695 . . . . 0.0 110.925 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 135.49 -32.43 2.55 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 107.939 -2.064 . . . . 0.0 107.939 -169.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.9 mm -95.62 113.6 30.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 113.387 -1.406 . . . . 0.0 107.713 168.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.3 t -105.62 -4.26 21.31 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.467 0.651 . . . . 0.0 109.85 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.484 ' OG ' ' HD1' ' A' ' 79' ' ' PHE . 21.2 t -126.69 125.66 24.4 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.007 -176.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.539 ' O ' HG23 ' A' ' 82' ' ' VAL . 94.8 Cg_exo -50.57 -42.8 48.26 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.644 2.896 . . . . 0.0 112.936 176.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.484 ' HD1' ' OG ' ' A' ' 77' ' ' SER . 0.1 OUTLIER -57.13 -37.07 71.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.672 177.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.446 ' HA ' ' CG ' ' A' ' 83' ' ' LYS . 28.5 tt0 -80.29 -19.8 45.83 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.683 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.422 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 24.0 t -67.97 -31.12 70.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.641 HG22 HG11 ' A' ' 67' ' ' VAL . 12.4 t -83.41 -24.81 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.528 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.447 ' HE2' ' HB3' ' A' ' 83' ' ' LYS . 40.7 mtpt -52.66 -40.89 63.3 Favored 'General case' 0 C--O 1.213 -0.844 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 175.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.44 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 24.3 mmt180 -58.83 -41.59 87.24 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.971 177.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -66.39 -37.15 84.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.397 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.477 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 31.7 m -87.25 -48.09 15.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.688 -178.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -52.12 -43.16 63.83 Favored 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 122.877 0.471 . . . . 0.0 112.012 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 84' ' ' ARG . 12.5 pt-20 -65.4 -28.23 69.11 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.421 -177.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -85.4 -42.35 14.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.548 0.69 . . . . 0.0 110.125 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.507 ' HB3' ' OE1' ' A' ' 95' ' ' GLU . 92.4 mt -68.54 -38.36 80.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.178 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.566 ' O ' ' HB2' ' A' ' 96' ' ' ASP . . . -44.31 -37.64 3.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.81 174.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -65.2 -11.06 36.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.058 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.1 pp -95.96 -35.21 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.165 -175.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 179.63 -47.13 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.255 0.55 . . . . 0.0 111.153 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.527 ' HB2' ' CE1' ' A' ' 7' ' ' TYR . 8.8 pt-20 -67.05 -4.74 10.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.821 -168.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.566 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 14.3 t70 -38.86 -35.05 0.18 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.059 0.457 . . . . 0.0 111.569 170.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -77.51 -21.3 52.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.181 -175.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.455 ' HG2' HG21 ' A' ' 4' ' ' THR . 62.0 mm-40 -109.81 -83.04 0.57 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.105 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 98' ' ' GLU . 79.5 t 71.04 115.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.393 -172.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -41.48 -55.31 2.88 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.385 -171.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? . . . . . 0 C--O 1.244 0.78 0 CA-C-O 118.394 -0.812 . . . . 0.0 110.396 179.459 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.536 0 N-CA-C 111.952 -0.459 . . . . 0.0 111.952 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m 63.32 -177.11 0.15 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.463 0.649 . . . . 0.0 111.586 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.51 177.52 9.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.4 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.582 ' O ' HG12 ' A' ' 5' ' ' VAL . 13.5 t -113.97 35.89 3.92 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.824 0.821 . . . . 0.0 108.894 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.582 HG12 ' O ' ' A' ' 4' ' ' THR . 0.3 OUTLIER 66.34 173.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.647 -177.394 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 6' ' ' ARG . 18.8 mmm180 -138.35 123.19 18.84 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 175.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.63 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 50.2 p90 -152.67 162.3 41.43 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.707 0.765 . . . . 0.0 112.419 -175.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.758 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . 27.4 mp0 -126.79 138.47 53.36 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.247 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.829 HG12 HG12 ' A' ' 19' ' ' ILE . 29.4 mt -106.94 128.2 61.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.476 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 18' ' ' MET . 12.0 pt-20 -120.2 163.31 17.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.263 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.688 HE21 ' HA ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -92.86 124.4 36.82 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.281 0.562 . . . . 0.0 110.153 178.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.627 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -69.87 -43.14 72.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.148 -174.033 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 173.19 -89.16 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.758 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -92.62 -60.35 1.84 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.917 0.389 . . . . 0.0 111.661 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.8 p -149.73 45.77 0.94 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.569 0.7 . . . . 0.0 110.978 -175.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.82 156.94 47.4 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.149 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.401 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 28.7 ttp -126.84 134.43 50.53 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.627 ' HB2' HD22 ' A' ' 12' ' ' LEU . 50.5 ttm -118.18 132.72 56.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.049 0.452 . . . . 0.0 110.19 177.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.829 HG12 HG12 ' A' ' 9' ' ' ILE . 6.1 mt -127.24 127.66 69.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.98 -177.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.758 ' HD3' ' HB2' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -111.83 131.27 55.45 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.63 ' HA ' ' CB ' ' A' ' 7' ' ' TYR . 6.6 m-85 -98.35 -149.04 0.34 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -97.16 -152.41 28.65 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.937 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -175.79 -60.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.821 0.343 . . . . 0.0 110.807 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -43.45 -52.61 5.95 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.62 -172.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.2 pt -118.99 24.99 4.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.389 0.614 . . . . 0.0 110.146 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.471 ' HB3' HG12 ' A' ' 29' ' ' VAL . 19.6 m120 -120.98 97.77 5.68 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.126 -170.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.437 ' CD ' ' H ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -78.03 -29.95 49.67 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 169.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.514 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 4.0 mm100 -60.94 -40.41 93.16 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.436 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.608 ' CG2' ' HB2' ' A' ' 21' ' ' PHE . 6.6 p -62.23 -53.43 47.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.531 -177.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.443 ' N ' HG13 ' A' ' 29' ' ' VAL . 32.5 m-80 -53.51 -44.06 68.78 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.666 0.604 . . . . 0.0 111.354 -177.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.44 -38.64 17.02 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.55 -0.834 . . . . 0.0 112.88 -178.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 28' ' ' GLN . 0.3 OUTLIER -83.58 -28.51 7.58 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -172.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 29' ' ' VAL . 14.9 p -68.6 -30.35 47.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 175.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -70.59 -40.21 73.37 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.689 -1.142 . . . . 0.0 109.931 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.53 -22.02 28.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.995 -177.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.404 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . . . -63.92 -28.91 70.15 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.568 0.223 . . . . 0.0 111.498 -174.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.39 -39.13 92.23 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.081 0.943 . . . . 0.0 108.706 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.489 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.85 -23.12 29.15 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.249 178.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.404 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . 1.1 t80 -69.5 -41.71 75.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.15 0.5 . . . . 0.0 109.829 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.569 HD11 HD21 ' A' ' 58' ' ' LEU . 54.8 mt -73.71 -34.63 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.188 -177.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.489 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 9.1 pt-20 -69.63 -23.65 63.53 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.423 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 44.4 mm-40 -73.59 -36.37 65.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.643 175.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -129.61 70.71 82.04 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.324 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -94.47 176.49 1.1 Allowed 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.766 2.311 . . . . 0.0 113.443 -174.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -115.95 147.85 40.08 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.73 175.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -37.23 -37.81 0.42 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.246 3.297 . . . . 0.0 115.13 -174.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.459 ' HA3' ' HB2' ' A' ' 66' ' ' GLU . . . -103.24 17.62 51.01 Favored Glycine 0 C--O 1.224 -0.486 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.025 -176.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -59.77 129.39 41.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.986 0.422 . . . . 0.0 110.62 176.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.59 HG12 ' HA ' ' A' ' 62' ' ' TYR . 39.5 mm -106.07 -57.8 4.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.526 -174.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 13.5 tp10 -164.18 157.52 18.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.681 0.277 . . . . 0.0 110.544 -172.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.4 p -150.79 118.4 6.12 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 172.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.748 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.9 pt -119.94 135.21 24.14 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -176.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 2.5 Cg_endo -80.95 120.67 3.84 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.13 2.553 . . . . 0.0 112.234 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -109.51 52.74 0.71 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.601 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.505 ' O ' HG11 ' A' ' 33' ' ' VAL . 39.5 t80 72.64 -57.79 0.62 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.263 173.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.0 t -132.5 -2.4 3.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.695 0.759 . . . . 0.0 110.14 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.6 m -122.44 140.57 52.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.211 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.569 HD21 HD11 ' A' ' 40' ' ' ILE . 50.5 tp -106.18 115.98 31.14 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.748 ' HB ' HG13 ' A' ' 52' ' ' ILE . 4.7 m -93.28 106.27 18.25 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.784 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.0 t -104.75 123.98 59.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.386 0.612 . . . . 0.0 111.292 -173.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.427 ' CE1' HG22 ' A' ' 59' ' ' THR . 87.8 m-85 -114.96 145.96 41.69 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.57 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.59 ' HA ' HG12 ' A' ' 49' ' ' ILE . 2.4 p90 -166.54 171.29 11.92 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.125 0.488 . . . . 0.0 110.9 -175.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -99.49 111.34 23.7 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.398 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.547 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -61.91 -21.74 65.0 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.234 -176.546 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.52 ' CE1' ' HG2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -71.39 -23.08 61.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.757 0.313 . . . . 0.0 110.981 -176.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.52 ' HG2' ' CE1' ' A' ' 65' ' ' TYR . 22.5 mm-40 -91.51 -34.41 14.79 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.196 0.522 . . . . 0.0 110.458 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.547 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.4 m -70.54 -29.86 40.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.102 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.76 ' HA ' HD23 ' A' ' 71' ' ' LEU . 2.5 m-85 -55.48 -24.96 34.22 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.704 172.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -66.69 -24.32 66.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.596 0.712 . . . . 0.0 109.824 176.749 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -102.15 -32.49 10.07 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.249 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.824 HD21 ' HA ' ' A' ' 78' ' ' PRO . 1.6 mm? -26.36 95.01 0.06 OUTLIER Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 125.514 1.526 . . . . 0.0 113.735 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.547 ' HD2' HG13 ' A' ' 75' ' ' ILE . 20.5 Cg_exo -70.4 161.04 47.45 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 123.594 2.863 . . . . 0.0 111.93 174.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -62.36 -40.34 96.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -173.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.41 -21.37 78.94 Favored Glycine 0 CA--C 1.511 -0.202 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.45 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.548 HG21 ' HB2' ' A' ' 81' ' ' SER . 10.7 mm -81.97 100.26 5.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.057 -0.571 . . . . 0.0 109.919 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.4 m -82.52 -9.87 59.24 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.216 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.2 m -131.15 130.82 22.8 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.738 -175.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.824 ' HA ' HD21 ' A' ' 71' ' ' LEU . 83.4 Cg_exo -46.54 -48.91 12.79 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.408 2.739 . . . . 0.0 113.483 176.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.457 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 1.4 p90 -59.9 -27.4 66.7 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.485 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.667 ' HG3' ' HD2' ' A' ' 83' ' ' LYS . 8.8 tt0 -81.93 -17.83 45.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.887 0.375 . . . . 0.0 110.869 -174.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.548 ' HB2' HG21 ' A' ' 75' ' ' ILE . 48.0 t -79.26 -35.6 41.17 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.459 HG11 ' CE2' ' A' ' 62' ' ' TYR . 49.0 t -67.06 -25.32 33.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.28 178.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.667 ' HD2' ' HG3' ' A' ' 80' ' ' GLU . 94.5 mttt -51.59 -41.92 61.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.967 177.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.604 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 0.7 OUTLIER -60.9 -50.56 72.91 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.851 -177.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -64.88 -37.04 86.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.796 -177.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.62 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 31.2 m -83.36 -48.22 17.6 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 CA-C-O 118.947 -0.549 . . . . 0.0 112.023 -175.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.521 ' HG2' ' OH ' ' A' ' 7' ' ' TYR . 92.5 mt-10 -49.27 -53.64 20.76 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 118.25 0.477 . . . . 0.0 111.902 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.758 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 11.1 pt-20 -60.35 -27.22 67.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.394 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.59 -24.36 22.86 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 175.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 86' ' ' VAL . 13.0 mt -60.95 -72.88 0.1 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -163.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -90.35 -78.11 0.38 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 118.363 -1.335 . . . . 0.0 112.213 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.42 ' O ' HG23 ' A' ' 93' ' ' ILE . 10.7 mp0 -103.38 -57.81 1.98 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.811 1.291 . . . . 0.0 109.086 164.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.758 ' HA ' ' O ' ' A' ' 88' ' ' GLU . 12.9 pt -174.33 55.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 111.309 -2.678 . . . . 0.0 104.863 -168.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.93 15.18 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.627 -171.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.428 ' H ' ' C ' ' A' ' 93' ' ' ILE . 1.2 pt-20 -59.9 -14.57 16.14 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.269 0.557 . . . . 0.0 109.743 165.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -52.34 -22.7 4.84 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.601 177.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.498 ' HE1' HG23 ' A' ' 4' ' ' THR . 2.0 m-30 -71.83 -5.91 37.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.832 -176.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.426 ' O ' ' HB ' ' A' ' 99' ' ' VAL . 57.4 mm-40 61.12 45.85 8.69 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 123.67 0.606 . . . . 0.0 109.906 -177.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.426 ' HB ' ' O ' ' A' ' 98' ' ' GLU . 95.6 t 72.18 97.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.117 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.775 -175.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -69.52 114.7 7.99 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 35.3 ttp180 . . . . . 0 C--N 1.31 -1.137 0 CA-C-O 118.593 -0.717 . . . . 0.0 109.935 -173.162 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.2 m -82.45 79.06 9.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.236 0.541 . . . . 0.0 110.444 177.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.652 ' O ' HG22 ' A' ' 4' ' ' THR . 20.4 ptm -77.43 21.19 0.27 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.979 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.652 HG22 ' O ' ' A' ' 3' ' ' MET . 0.6 OUTLIER 71.16 -3.27 2.1 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.875 0.87 . . . . 0.0 110.963 177.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 67.18 149.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.853 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.492 ' HA ' ' CE1' ' A' ' 97' ' ' TYR . 29.0 mmt180 -122.23 79.09 1.56 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.387 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.507 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 15.0 p90 -104.67 146.3 29.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.45 -172.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.431 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 5.6 tp60 -125.49 139.61 53.48 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.559 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 1.057 HG12 HG12 ' A' ' 19' ' ' ILE . 25.6 mt -104.36 122.35 57.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.067 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -116.22 159.99 21.05 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.862 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -86.24 124.4 32.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.53 0.681 . . . . 0.0 110.182 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.703 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -63.45 -48.22 78.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.658 -177.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -165.96 -73.17 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.652 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -128.7 -49.31 1.25 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.582 0.23 . . . . 0.0 111.522 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.08 41.35 1.66 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.639 0.733 . . . . 0.0 110.945 -172.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -143.88 152.22 40.86 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.759 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 29.0 ttp -121.28 135.42 55.12 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -174.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.703 ' HB2' HD22 ' A' ' 12' ' ' LEU . 46.8 ttm -122.22 132.4 54.42 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.145 177.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.057 HG12 HG12 ' A' ' 9' ' ' ILE . 5.7 mt -129.69 143.27 41.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.486 -175.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -125.48 126.66 45.26 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 174.11 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.837 ' HB2' HG23 ' A' ' 29' ' ' VAL . 4.9 m-85 -102.98 -158.59 0.68 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.121 0.486 . . . . 0.0 109.709 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.09 179.36 4.81 Favored Glycine 0 N--CA 1.453 -0.188 0 CA-C-N 114.841 -1.072 . . . . 0.0 113.547 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -165.28 -76.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.949 0.404 . . . . 0.0 111.281 173.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -89.7 -78.35 0.36 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.292 0.567 . . . . 0.0 111.598 -172.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.3 pt -147.01 27.26 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.63 -174.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.505 ' O ' HG12 ' A' ' 29' ' ' VAL . 19.9 p-10 -87.24 118.74 26.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.209 0.528 . . . . 0.0 111.851 -172.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -63.24 -19.1 64.25 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.38 176.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.423 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 46.6 tt0 -46.98 -49.85 20.08 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.642 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.837 HG23 ' HB2' ' A' ' 21' ' ' PHE . 2.8 p -64.22 -47.98 87.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.779 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -54.92 -42.66 72.51 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.317 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.11 -39.5 10.01 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.182 -1.009 . . . . 0.0 112.537 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.423 ' HB ' ' O ' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -82.5 -21.35 9.56 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -171.459 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.454 HG11 ' O ' ' A' ' 55' ' ' PHE . 12.1 p -72.08 -30.3 35.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -75.46 -38.55 59.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.214 175.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.02 -20.75 51.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.977 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.542 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . . . -68.96 -28.25 66.46 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 120.873 0.368 . . . . 0.0 110.888 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.87 -42.63 99.83 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.793 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -79.13 -30.91 43.94 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.078 176.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.542 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -54.84 -44.93 74.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.433 0.635 . . . . 0.0 110.133 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 45.9 mt -79.62 -30.83 13.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.646 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.793 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 9.2 pt-20 -76.36 -25.06 54.26 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.64 -177.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -82.4 -27.99 31.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.01 0.433 . . . . 0.0 110.396 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.435 ' HB3' ' NH1' ' A' ' 89' ' ' ARG . 43.8 mt-30 -131.7 70.41 81.21 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.244 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -99.32 -178.06 0.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.395 2.73 . . . . 0.0 113.854 -173.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.437 ' CE2' HG13 ' A' ' 82' ' ' VAL . 6.0 p90 -115.93 147.41 39.1 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.92 171.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.449 ' HB2' ' CD ' ' A' ' 66' ' ' GLU . 59.0 Cg_exo -38.55 -39.35 1.12 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.987 3.125 . . . . 0.0 115.147 -174.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 66' ' ' GLU . . . -96.66 13.76 64.96 Favored Glycine 0 C--O 1.228 -0.245 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.098 -174.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -59.07 132.75 54.97 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.052 0.453 . . . . 0.0 110.777 175.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.47 HG12 ' HA ' ' A' ' 62' ' ' TYR . 35.9 mm -106.0 -59.37 3.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.261 -175.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -163.55 158.99 21.4 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 120.66 0.267 . . . . 0.0 110.571 -173.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.3 p -150.02 118.01 6.3 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 176.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.754 HG13 ' HB ' ' A' ' 59' ' ' THR . 5.9 pt -120.97 131.58 24.44 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-O 121.106 0.479 . . . . 0.0 112.186 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 72.2 Cg_endo -86.51 141.94 6.86 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.413 2.742 . . . . 0.0 112.499 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.89 59.58 1.61 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.629 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.454 ' O ' HG11 ' A' ' 33' ' ' VAL . 52.0 t80 69.31 -54.34 0.58 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.115 0.966 . . . . 0.0 112.581 175.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.2 t -130.98 -15.74 3.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.767 0.318 . . . . 0.0 111.164 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.0 p -115.18 149.75 37.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.956 0.407 . . . . 0.0 110.936 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 38.6 tp -118.24 125.83 50.94 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.754 ' HB ' HG13 ' A' ' 52' ' ' ILE . 3.1 m -105.59 107.65 18.76 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.038 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.2 t -105.45 123.05 59.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.416 0.627 . . . . 0.0 111.473 -173.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -113.08 147.83 36.48 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.803 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.568 ' OH ' ' HB2' ' A' ' 79' ' ' PHE . 2.6 p90 -165.89 171.71 12.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.757 -175.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -107.74 108.6 19.89 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 121.492 0.663 . . . . 0.0 109.851 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.551 ' O ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -55.63 -31.21 62.11 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.8 -176.681 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.8 -23.5 65.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.149 0.5 . . . . 0.0 110.742 -177.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' A' ' 69' ' ' LYS . 4.0 tm-20 -92.09 -41.67 10.37 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -177.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 64' ' ' MET . 2.5 m -61.94 -28.48 44.4 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.698 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.72 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.82 ' HA ' HD12 ' A' ' 71' ' ' LEU . 4.3 m-85 -50.56 -32.51 18.77 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.407 0.683 . . . . 0.0 111.648 169.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -66.95 -30.96 71.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.203 0.525 . . . . 0.0 110.509 178.432 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -93.46 -37.71 11.8 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.144 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.82 HD12 ' HA ' ' A' ' 68' ' ' TYR . 13.4 mt -32.75 99.5 0.15 Allowed Pre-proline 0 N--CA 1.465 0.315 0 C-N-CA 125.509 1.524 . . . . 0.0 113.463 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.44 ' HD2' HG13 ' A' ' 75' ' ' ILE . 13.9 Cg_exo -74.54 154.91 45.19 Favored 'Trans proline' 0 C--N 1.332 -0.302 0 C-N-CA 124.128 3.219 . . . . 0.0 110.586 174.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -64.34 -21.25 66.55 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -171.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.3 -18.04 76.93 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.113 176.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.539 HG23 ' HB3' ' A' ' 80' ' ' GLU . 2.8 mm -101.86 105.79 18.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.97 -0.615 . . . . 0.0 110.179 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.8 t -93.0 -3.34 54.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.006 0.432 . . . . 0.0 110.506 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' ' 80' ' ' GLU . 17.1 m -121.45 116.19 30.86 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.984 -178.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.665 ' HG3' ' CE1' ' A' ' 68' ' ' TYR . 14.4 Cg_exo -35.75 -56.6 0.58 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 124.357 3.371 . . . . 0.0 114.071 171.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.568 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -57.77 -32.74 67.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.227 -179.358 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.539 ' HB3' HG23 ' A' ' 75' ' ' ILE . 2.2 tp10 -70.19 -29.43 66.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.722 -174.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.64 ' HB2' HD23 ' A' ' 71' ' ' LEU . 46.5 t -79.37 -35.58 40.6 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.478 HG11 ' CE2' ' A' ' 62' ' ' TYR . 92.1 t -60.15 -39.95 82.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.936 177.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.759 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 17.6 mtmt -54.95 -48.31 73.34 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 21.7 mmm180 -63.01 -32.68 74.09 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.228 -174.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 13.8 t70 -69.52 -40.57 76.85 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.433 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.408 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 34.1 m -86.34 -35.59 9.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.546 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -62.27 -37.2 84.56 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 122.801 0.44 . . . . 0.0 111.891 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.802 ' HG3' ' HD3' ' A' ' 89' ' ' ARG . 13.0 pt-20 -58.03 -29.1 65.08 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.227 -0.589 . . . . 0.0 109.903 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.802 ' HD3' ' HG3' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -87.5 -42.58 12.67 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.609 172.802 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 86' ' ' VAL . 82.9 mt -84.05 -64.46 1.16 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 122.976 0.51 . . . . 0.0 112.236 -174.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.611 ' HA ' ' HB3' ' A' ' 94' ' ' ALA . . . -60.12 -17.03 37.33 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.614 0.765 . . . . 0.0 112.132 -178.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -59.77 -29.54 68.26 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.045 0.45 . . . . 0.0 109.949 172.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.408 HG13 ' N ' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -103.93 -33.97 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.611 ' HB3' ' HA ' ' A' ' 91' ' ' ALA . . . -82.39 63.9 6.78 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 165.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.41 ' HG2' ' OG1' ' A' ' 4' ' ' THR . 9.4 pt-20 -42.22 -32.68 0.51 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 112.991 -1.913 . . . . 0.0 112.424 -170.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -77.29 -27.73 53.12 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.969 -172.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.492 ' CE1' ' HA ' ' A' ' 6' ' ' ARG . 71.5 m-85 -99.51 13.73 32.37 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -167.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -59.29 -20.51 54.95 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.912 0.863 . . . . 0.0 109.567 172.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 p -114.01 79.96 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.182 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.33 -26.58 61.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.667 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.221 -0.895 . . . . 0.0 109.697 175.932 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.698 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.2 m 69.04 167.38 0.28 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.121 0.486 . . . . 0.0 110.804 -177.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.654 ' HG2' ' HB3' ' A' ' 26' ' ' ASN . 23.8 ptm -153.13 160.02 42.82 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.091 0.472 . . . . 0.0 110.317 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.667 ' O ' HG22 ' A' ' 5' ' ' VAL . 4.7 t -93.37 31.53 1.49 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.657 -178.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.693 HG12 ' ND2' ' A' ' 26' ' ' ASN . 3.2 m 64.68 160.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.837 1.655 . . . . 0.0 113.828 -178.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -142.65 105.14 4.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.418 -1.719 . . . . 0.0 107.35 172.219 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -115.17 171.53 7.62 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.353 -166.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.563 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -140.04 121.75 15.35 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -178.255 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.946 HG12 HG12 ' A' ' 19' ' ' ILE . 29.3 mt -87.6 112.0 22.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.805 0.812 . . . . 0.0 110.911 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 18' ' ' MET . 4.0 pt-20 -106.87 161.48 14.66 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.489 -173.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.432 ' HA ' ' NE2' ' A' ' 11' ' ' GLN . 6.0 tp-100 -90.91 124.75 35.44 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.667 0.746 . . . . 0.0 110.686 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.561 HD21 HG22 ' A' ' 59' ' ' THR . 0.2 OUTLIER -70.69 -46.84 62.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.993 -176.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -157.92 -79.72 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -137.36 -36.1 0.66 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.865 0.364 . . . . 0.0 110.807 176.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.5 p -141.97 39.18 1.63 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.823 0.82 . . . . 0.0 110.201 -174.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -143.63 151.94 40.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.277 176.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.473 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 35.4 ttp -123.16 137.89 54.79 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.063 -0.655 . . . . 0.0 112.314 -173.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.596 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 24.7 ttt -126.51 138.16 53.46 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.946 HG12 HG12 ' A' ' 9' ' ' ILE . 4.7 mt -133.13 118.79 33.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.674 -174.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.563 ' HD3' ' HB3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -102.95 125.71 49.81 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.674 177.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.511 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 0.7 OUTLIER -109.4 -159.42 0.68 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 176.347 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.778 ' HA2' HD21 ' A' ' 26' ' ' ASN . . . 68.93 107.26 0.03 OUTLIER Glycine 0 CA--C 1.51 -0.26 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.541 177.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -108.13 -79.99 0.57 Allowed 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 119.604 -0.839 . . . . 0.0 111.734 -176.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -91.13 -78.21 0.4 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.019 0.438 . . . . 0.0 111.869 -171.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.3 pp -135.24 26.36 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.079 0.466 . . . . 0.0 111.825 -171.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.778 HD21 ' HA2' ' A' ' 22' ' ' GLY . 6.0 p-10 -91.77 93.27 8.79 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.637 0.732 . . . . 0.0 111.559 -174.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -61.39 -19.04 61.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.857 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.7 tm0? -49.11 -35.84 17.35 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.925 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.537 ' O ' HG12 ' A' ' 33' ' ' VAL . 11.1 p -64.1 -41.23 91.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.315 -176.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -60.1 -25.48 65.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.423 -175.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -92.57 -39.86 5.18 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.026 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -81.8 -27.24 9.71 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -173.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 29' ' ' VAL . 11.1 p -70.54 -30.92 44.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 119.307 -0.957 . . . . 0.0 108.486 175.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -71.46 -35.17 70.77 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.695 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.64 -22.01 30.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.39 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.479 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . . . -64.09 -21.07 66.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.351 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.93 -43.36 88.28 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.737 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -81.81 -29.9 32.45 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.802 176.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.558 ' HE1' ' HB3' ' A' ' 89' ' ' ARG . 7.8 t80 -51.59 -46.03 63.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.498 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.437 HD11 HD21 ' A' ' 58' ' ' LEU . 58.0 mt -80.4 -29.15 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.965 -175.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.737 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 10.3 pt-20 -75.81 -26.76 57.54 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.096 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 51.4 mt-10 -74.54 -35.65 63.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.061 173.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -125.19 74.94 67.88 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.244 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -95.02 -164.51 0.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.385 2.723 . . . . 0.0 113.749 -171.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -138.78 147.63 55.13 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.208 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -44.26 -22.6 0.57 Allowed 'Trans proline' 0 N--CA 1.482 0.808 0 C-N-CA 124.447 3.431 . . . . 0.0 115.881 -170.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.405 ' HA3' ' HB3' ' A' ' 66' ' ' GLU . . . -116.59 27.09 8.16 Favored Glycine 0 C--O 1.228 -0.265 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.314 -177.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -67.91 136.0 53.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.051 0.453 . . . . 0.0 111.76 177.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.7 mm -109.33 -60.34 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.257 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 40.6 tt0 -162.28 157.41 22.81 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.781 -172.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 59' ' ' THR . 2.1 p -152.05 118.23 5.56 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 173.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.537 HG13 ' HB ' ' A' ' 59' ' ' THR . 7.7 pt -126.59 142.1 42.15 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.604 -176.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.516 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 1.6 Cg_endo -84.64 139.59 7.78 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.31 2.674 . . . . 0.0 112.673 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.7 66.94 1.54 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 92.5 t80 75.91 -68.97 0.18 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.316 0.647 . . . . 0.0 111.588 171.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.1 t -134.92 2.43 3.11 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.613 0.72 . . . . 0.0 109.673 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 15.2 m -120.65 137.47 54.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.38 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.437 HD21 HD11 ' A' ' 40' ' ' ILE . 61.6 tp -102.48 126.89 49.68 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.561 HG22 HD21 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -101.42 106.8 17.98 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -177.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.1 t -109.35 119.21 58.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.459 0.647 . . . . 0.0 111.067 -174.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 85.1 m-85 -112.9 146.59 38.68 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.513 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.563 ' CE2' HG11 ' A' ' 82' ' ' VAL . 3.6 p90 -164.78 170.32 15.63 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.873 -173.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -104.24 112.29 25.25 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.73 -177.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.469 ' HA ' HG22 ' A' ' 67' ' ' VAL . 1.4 pmm? -63.22 -26.51 68.83 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.735 -174.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.68 -27.89 66.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.201 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.405 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 4.0 tp10 -90.71 -41.17 11.43 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -173.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.469 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.5 m -68.06 -30.63 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.089 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.712 ' HA ' HD23 ' A' ' 71' ' ' LEU . 3.5 m-85 -53.94 -29.45 42.41 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.495 173.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.479 ' HE2' ' HB2' ' A' ' 69' ' ' LYS . 0.3 OUTLIER -67.62 -34.96 78.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.11 0.481 . . . . 0.0 110.601 178.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 33.9 t60 -93.05 -30.82 15.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.491 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.712 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.5 OUTLIER -16.2 91.56 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 125.618 1.567 . . . . 0.0 112.672 177.124 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.473 ' HD2' HG13 ' A' ' 75' ' ' ILE . 31.8 Cg_exo -61.71 149.99 87.61 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.057 2.504 . . . . 0.0 111.352 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -63.22 -22.09 66.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.628 -172.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -83.83 -13.76 74.38 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.775 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.502 HG21 ' HB3' ' A' ' 81' ' ' SER . 4.5 mm -96.35 130.84 44.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 122.837 0.455 . . . . 0.0 109.944 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.3 t -114.34 0.07 14.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.164 0.507 . . . . 0.0 109.952 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.9 m -134.5 120.14 14.49 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.962 -177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.619 ' HA ' HD21 ' A' ' 71' ' ' LEU . 95.2 Cg_exo -46.46 -38.5 21.23 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 124.122 3.215 . . . . 0.0 113.882 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.9 -34.65 76.42 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.123 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.627 ' HA ' ' HD3' ' A' ' 83' ' ' LYS . 16.7 tt0 -83.46 -20.7 33.56 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.456 -174.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.502 ' HB3' HG21 ' A' ' 75' ' ' ILE . 62.5 p -75.93 -30.09 58.58 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 177.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 78' ' ' PRO . 97.7 t -67.59 -34.46 68.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.724 174.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.627 ' HD3' ' HA ' ' A' ' 80' ' ' GLU . 59.7 mtpt -51.85 -45.43 64.01 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 174.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.496 ' HE ' HD11 ' A' ' 75' ' ' ILE . 21.1 mmt180 -60.81 -35.9 77.69 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.874 -177.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -72.31 -42.4 65.51 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.047 0.451 . . . . 0.0 111.426 -177.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.425 ' O ' HD23 ' A' ' 90' ' ' LEU . 34.6 m -87.15 -46.12 16.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.17 -177.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 83' ' ' LYS . 14.9 mm-40 -62.7 -28.47 69.97 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.796 -175.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.654 ' HG3' ' HD3' ' A' ' 89' ' ' ARG . 11.9 pt-20 -64.48 -27.9 69.3 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.88 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.654 ' HD3' ' HG3' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -85.23 -47.45 10.07 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 176.173 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 87' ' ' GLU . 4.5 mm? -60.09 -32.86 71.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.535 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.631 ' O ' ' HB2' ' A' ' 96' ' ' ASP . . . -44.17 -49.15 9.18 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.913 -178.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -62.57 -6.05 3.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.202 -174.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.455 HG23 ' O ' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -98.96 -37.36 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 121.2 -0.2 . . . . 0.0 111.139 179.174 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.45 ' HB2' ' OG1' ' A' ' 4' ' ' THR . . . -164.88 -53.68 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.74 0.781 . . . . 0.0 111.258 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.627 ' HG2' ' HA ' ' A' ' 91' ' ' ALA . 1.2 pm0 -61.19 -3.41 0.86 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.806 -173.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.631 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 15.6 t70 -44.23 -23.88 0.13 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 121.29 0.567 . . . . 0.0 111.564 167.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -72.1 -2.32 18.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.857 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 62.06 42.97 9.3 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.397 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.1 m -97.07 35.97 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.385 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -89.97 85.6 6.38 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.955 -176.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 . . . . . 0 C--N 1.3 -1.551 0 CA-C-O 118.506 -0.759 . . . . 0.0 109.315 178.648 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.657 0 N-CA-C 112.194 -0.362 . . . . 0.0 112.194 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.3 t -118.53 74.91 0.99 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -89.28 168.69 12.06 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.147 -175.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.48 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 10.0 t -125.04 16.93 8.51 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.54 -177.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 4' ' ' THR . 40.0 t 74.54 141.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 114.946 -1.025 . . . . 0.0 112.989 171.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -129.55 84.94 2.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.993 173.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.649 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 38.9 p90 -107.74 155.68 19.94 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.747 0.784 . . . . 0.0 111.941 -172.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.562 ' HB2' ' NE ' ' A' ' 20' ' ' ARG . 40.1 mt-30 -128.16 139.54 52.43 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.701 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 1.001 HG12 HG12 ' A' ' 19' ' ' ILE . 15.9 mt -101.03 120.25 50.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.764 177.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 18' ' ' MET . 11.9 pt-20 -119.85 159.17 25.12 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.846 -177.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.627 HE21 ' HA ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -88.49 129.91 35.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.971 177.492 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.675 HD21 HG23 ' A' ' 59' ' ' THR . 0.0 OUTLIER -66.4 -42.65 87.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.619 -177.653 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.83 -55.48 0.36 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.426 176.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -103.43 -74.71 0.63 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.947 0.403 . . . . 0.0 111.07 -176.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.4 p -149.58 48.15 0.95 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.686 0.755 . . . . 0.0 110.562 -177.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.555 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -142.57 155.08 44.95 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.835 176.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.502 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 37.5 ttp -128.06 124.45 37.09 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -174.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.477 ' HB2' HD22 ' A' ' 12' ' ' LEU . 51.3 ttm -109.49 139.49 44.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.131 0.491 . . . . 0.0 110.248 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.001 HG12 HG12 ' A' ' 9' ' ' ILE . 6.4 mt -128.21 112.67 27.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.913 -176.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.576 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -96.0 124.22 39.92 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.89 178.599 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.649 ' HA ' ' CB ' ' A' ' 7' ' ' TYR . 8.0 m-85 -97.84 -153.71 0.43 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.52 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.615 ' HA2' HG21 ' A' ' 29' ' ' VAL . . . 104.25 -175.86 23.13 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.28 176.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -149.14 -72.2 0.19 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 173.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -134.33 -69.94 0.52 Allowed 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.031 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 31.7 pt -138.96 38.24 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.402 0.62 . . . . 0.0 110.583 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.404 ' ND2' HG23 ' A' ' 29' ' ' VAL . 15.5 p-10 -86.62 115.09 23.86 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.606 0.717 . . . . 0.0 111.873 -175.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.494 ' HA ' HD22 ' A' ' 30' ' ' ASN . 12.7 pt-20 -68.39 -19.1 64.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.129 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.4 tm0? -46.89 -45.51 20.53 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.591 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.615 HG21 ' HA2' ' A' ' 22' ' ' GLY . 83.3 t -63.16 -41.66 93.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.395 -177.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.494 HD22 ' HA ' ' A' ' 27' ' ' GLU . 43.5 m-80 -52.61 -32.75 43.21 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.595 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.53 -42.23 6.2 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.731 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -80.03 -22.17 11.8 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.79 0 C-N-CA 120.539 -0.464 . . . . 0.0 112.105 -173.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 29' ' ' VAL . 14.3 p -74.12 -29.5 25.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 119.593 -0.843 . . . . 0.0 108.865 174.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -70.85 -34.63 71.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.47 174.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.12 -21.44 29.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.306 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.461 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . . . -65.15 -26.54 68.22 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.031 -177.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.54 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . . . -62.0 -43.59 98.52 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.86 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -77.85 -29.66 50.59 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.846 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.461 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -55.57 -44.71 77.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.257 0.551 . . . . 0.0 109.639 177.264 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.522 ' CD1' HD21 ' A' ' 58' ' ' LEU . 41.5 mt -83.15 -37.47 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.82 -175.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.86 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 12.2 pt-20 -74.12 -20.89 60.1 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.29 -176.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.454 ' C ' ' HD3' ' A' ' 44' ' ' PRO . 38.1 mm-40 -85.72 -25.68 26.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.932 0.396 . . . . 0.0 110.684 175.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -122.76 63.36 19.99 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.454 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 50.0 Cg_endo -93.42 174.2 1.69 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.546 2.164 . . . . 0.0 114.039 -167.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -114.01 146.48 35.75 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 114.152 -1.385 . . . . 0.0 108.052 175.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.44 -15.33 3.85 Favored 'Trans proline' 0 N--CA 1.48 0.699 0 C-N-CA 123.82 3.013 . . . . 0.0 114.844 -169.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 66' ' ' GLU . . . -109.39 20.18 28.21 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.11 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.516 ' HE2' HG22 ' A' ' 40' ' ' ILE . 4.2 t80 -62.01 132.33 52.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.986 0.422 . . . . 0.0 110.778 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.646 HG22 ' CG ' ' A' ' 50' ' ' GLU . 28.9 mm -109.48 -62.99 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.17 176.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.646 ' CG ' HG22 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -154.69 175.8 13.24 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.522 0.677 . . . . 0.0 110.393 178.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' A' ' 37' ' ' ALA . 7.5 p -161.55 119.7 2.34 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.838 162.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.767 HG13 ' HB ' ' A' ' 59' ' ' THR . 9.5 pt -114.77 134.07 22.48 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-O 120.975 0.417 . . . . 0.0 112.039 -173.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.482 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 2.0 Cg_endo -82.04 120.45 3.37 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.295 2.664 . . . . 0.0 112.342 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.52 32.95 3.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.328 178.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 71.04 -34.64 0.31 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.096 175.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -128.82 -21.35 3.39 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.85 -0.531 . . . . 0.0 111.214 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 9.5 p -124.65 141.29 52.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.139 0.495 . . . . 0.0 110.571 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.522 HD21 ' CD1' ' A' ' 40' ' ' ILE . 57.5 tp -102.44 111.98 24.5 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.767 ' HB ' HG13 ' A' ' 52' ' ' ILE . 5.2 m -90.32 105.54 17.88 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.7 t -101.25 125.36 55.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.086 0.47 . . . . 0.0 111.122 -172.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -114.73 145.87 41.58 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.613 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.502 ' OH ' ' HB2' ' A' ' 17' ' ' MET . 2.4 p90 -165.09 169.1 16.62 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.371 0.605 . . . . 0.0 110.695 -174.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -96.61 118.95 34.17 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.616 -176.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.478 ' HA ' HG22 ' A' ' 67' ' ' VAL . 1.3 pmm? -69.34 -22.8 63.73 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.833 -172.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.42 -28.83 69.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 111.144 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.401 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 13.8 tp10 -89.83 -30.98 17.58 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.769 0.795 . . . . 0.0 109.477 -173.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.478 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.2 m -77.75 -33.81 19.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.339 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.907 ' HA ' HD23 ' A' ' 71' ' ' LEU . 59.8 t80 -68.29 -22.87 64.7 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.245 175.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -38.87 71.43 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 172.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -87.54 -74.68 0.43 Allowed 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.421 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.907 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER 32.44 66.95 1.04 Allowed Pre-proline 0 N--CA 1.471 0.593 0 O-C-N 124.186 0.929 . . . . 0.0 111.574 -178.236 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.669 ' HD2' HG13 ' A' ' 75' ' ' ILE . 33.2 Cg_exo -60.45 135.61 62.32 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.475 2.117 . . . . 0.0 111.371 -175.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -58.7 109.32 0.78 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.907 0.861 . . . . 0.0 110.964 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 136.42 -31.56 2.58 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 108.549 -1.82 . . . . 0.0 108.549 -169.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.669 HG13 ' HD2' ' A' ' 72' ' ' PRO . 14.3 mm -84.78 116.38 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 114.049 -1.076 . . . . 0.0 108.764 169.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.9 m -94.94 -4.32 47.0 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.162 0.506 . . . . 0.0 110.716 -175.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.607 ' HB2' ' HB2' ' A' ' 80' ' ' GLU . 58.0 m -141.35 134.54 14.43 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.227 -170.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.649 ' HA ' HD21 ' A' ' 71' ' ' LEU . 82.8 Cg_exo -51.92 -43.63 50.72 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.509 2.806 . . . . 0.0 113.157 173.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -67.11 -23.39 65.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.185 0.516 . . . . 0.0 110.748 176.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 77' ' ' SER . 39.9 tt0 -81.34 -20.73 40.03 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.159 -174.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.538 ' HB3' HG21 ' A' ' 75' ' ' ILE . 63.7 p -81.95 -37.33 26.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 78' ' ' PRO . 26.2 t -64.22 -26.02 39.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.129 177.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.564 ' HG3' ' HA ' ' A' ' 80' ' ' GLU . 93.5 mttt -50.17 -45.08 53.11 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.126 175.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.458 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 17.9 mmt180 -69.5 -35.14 75.24 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.042 -173.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -62.33 -41.79 98.85 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.843 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.9 m -87.41 -42.96 15.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -178.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -62.53 -33.63 75.3 Favored 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.5 ' HG3' ' HD3' ' A' ' 89' ' ' ARG . 11.0 pt-20 -59.21 -29.19 67.31 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.579 176.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.5 ' HD3' ' HG3' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -88.62 -37.88 15.28 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.738 173.642 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 93' ' ' ILE . 88.4 mt -85.74 -67.57 0.8 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.45 0.643 . . . . 0.0 112.388 -176.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.6 -16.47 48.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.832 -175.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.666 ' HG3' HG22 ' A' ' 93' ' ' ILE . 7.8 pt-20 -56.03 -39.89 72.61 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.99 -0.444 . . . . 0.0 110.983 176.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.666 HG22 ' HG3' ' A' ' 92' ' ' GLU . 0.5 OUTLIER -90.43 -42.36 14.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.607 -178.193 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.614 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . . . -87.29 28.0 1.0 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.784 0.802 . . . . 0.0 110.313 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' A' ' 96' ' ' ASP . 10.7 pt-20 -46.41 -55.54 7.24 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.756 -1.565 . . . . 0.0 113.645 -173.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.506 ' N ' ' HG3' ' A' ' 95' ' ' GLU . 36.2 t70 -79.81 -22.26 43.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.021 0.438 . . . . 0.0 111.562 -172.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.614 ' CD2' ' HA ' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -93.62 -54.81 3.5 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.582 -170.556 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.564 ' HG3' ' H ' ' A' ' 7' ' ' TYR . 8.4 mm-40 -135.26 102.99 5.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.18 0.514 . . . . 0.0 110.892 -177.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 p -119.96 88.95 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.859 0.838 . . . . 0.0 108.934 174.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -71.56 90.11 1.0 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.088 -175.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 . . . . . 0 C--O 1.244 0.791 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.627 173.28 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.659 0 N-CA-C 112.106 -0.398 . . . . 0.0 112.106 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.1 m -84.43 166.97 16.88 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.4 ' HG3' ' HG2' ' A' ' 6' ' ' ARG . 1.8 pmm? -148.65 149.91 32.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.202 0.525 . . . . 0.0 111.185 -178.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.494 ' CG2' ' HE2' ' A' ' 97' ' ' TYR . 14.9 t -82.72 -26.14 32.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 122.257 1.027 . . . . 0.0 108.296 171.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.711 HG23 HD22 ' A' ' 26' ' ' ASN . 2.3 p 178.27 159.57 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 113.291 -1.777 . . . . 0.0 109.412 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.4 ' HG2' ' HG3' ' A' ' 3' ' ' MET . 40.5 mmt180 -144.91 120.08 10.14 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 176.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 5.9 p90 -123.52 168.28 12.8 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.478 0.656 . . . . 0.0 111.853 -171.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.508 ' HB3' ' NE ' ' A' ' 20' ' ' ARG . 8.1 tp60 -146.79 115.25 6.71 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.125 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.82 HG12 HG12 ' A' ' 19' ' ' ILE . 30.5 mt -82.73 122.75 37.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.036 0.446 . . . . 0.0 110.281 176.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.428 ' OE2' ' HD2' ' A' ' 20' ' ' ARG . 12.4 pt-20 -120.7 169.68 10.16 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.209 -178.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -93.85 128.43 40.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.473 0.654 . . . . 0.0 110.56 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.64 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -69.56 -47.65 62.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.703 -177.589 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -161.61 -72.09 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -142.41 -34.42 0.45 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.223 -0.191 . . . . 0.0 111.513 177.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.1 p -144.1 42.95 1.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.795 0.807 . . . . 0.0 111.234 -176.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -150.45 152.75 34.76 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.204 177.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.499 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 30.8 ttp -125.4 133.12 52.62 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.751 -0.78 . . . . 0.0 112.484 -173.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.64 ' HB2' HD22 ' A' ' 12' ' ' LEU . 53.7 ttm -119.02 131.76 56.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.965 176.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.82 HG12 HG12 ' A' ' 9' ' ' ILE . 7.3 mt -123.44 109.04 22.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.65 -176.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -102.76 134.42 46.18 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.501 -179.343 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 35.3 m-85 -101.63 -144.57 0.35 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.532 ' O ' HG11 ' A' ' 29' ' ' VAL . . . -93.43 -176.09 40.3 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 176.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.64 -45.77 0.11 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 117.414 0.607 . . . . 0.0 112.242 -175.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -59.45 -58.2 9.65 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -171.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.7 pp -120.75 20.88 5.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.123 0.487 . . . . 0.0 111.137 -175.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.711 HD22 HG23 ' A' ' 5' ' ' VAL . 1.9 m-20 -101.52 101.7 12.32 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.304 -173.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -77.62 -33.42 53.64 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.394 175.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.4 tm0? -58.07 -47.84 81.93 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.37 -177.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.694 ' O ' HG22 ' A' ' 33' ' ' VAL . 4.9 p -60.31 -55.38 24.64 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.113 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -175.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.451 ' N ' HG13 ' A' ' 29' ' ' VAL . 51.9 m-80 -55.88 -29.48 60.03 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.389 0.431 . . . . 0.0 111.355 -176.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.68 -35.98 17.7 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.362 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.591 HG21 HD12 ' A' ' 93' ' ' ILE . 0.4 OUTLIER -93.48 -28.55 4.37 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.872 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -170.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 29' ' ' VAL . 3.1 m -62.7 -35.68 71.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.744 176.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.5 t60 -71.93 -33.13 68.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.157 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.32 -32.81 24.11 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.124 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.635 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -64.9 -24.11 67.43 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 122.772 0.429 . . . . 0.0 111.203 -177.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.485 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . . . -61.38 -40.3 93.82 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.765 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -85.57 -32.64 22.01 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.102 174.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.635 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 4.4 t80 -54.67 -42.53 71.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.126 0.489 . . . . 0.0 110.603 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.531 HD11 HD21 ' A' ' 58' ' ' LEU . 51.9 mt -78.06 -31.86 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.237 -177.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.765 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 10.0 pt-20 -79.5 -23.73 42.76 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.763 -177.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -78.12 -33.28 50.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.497 174.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -126.88 68.88 71.68 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.832 0.349 . . . . 0.0 110.302 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -96.03 179.17 0.57 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.109 2.539 . . . . 0.0 113.972 -171.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -111.29 146.48 34.67 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.1 171.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -43.03 -35.19 4.44 Favored 'Trans proline' 0 N--CA 1.479 0.636 0 C-N-CA 123.457 2.771 . . . . 0.0 114.992 -171.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.499 ' HA3' ' CB ' ' A' ' 66' ' ' GLU . . . -98.73 16.18 59.95 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.713 -175.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -60.68 135.99 57.93 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.08 0.466 . . . . 0.0 111.099 175.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.88 HG22 ' HG2' ' A' ' 50' ' ' GLU . 40.6 mm -110.65 -61.36 2.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.065 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.88 ' HG2' HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -153.19 169.57 22.67 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.471 0.653 . . . . 0.0 111.16 -178.315 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 59' ' ' THR . 4.2 p -161.76 117.54 2.05 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.096 167.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.607 HG12 ' HB ' ' A' ' 59' ' ' THR . 0.1 OUTLIER -127.75 136.48 29.04 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.691 -175.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 37' ' ' ALA . 71.1 Cg_endo -78.75 138.35 14.92 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.778 2.319 . . . . 0.0 112.546 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.97 58.53 1.02 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.683 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 62.9 t80 70.61 -65.53 0.33 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.695 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 t -119.11 -17.48 8.95 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.999 0.428 . . . . 0.0 111.454 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 4.3 p -112.9 144.79 41.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.204 0.526 . . . . 0.0 111.272 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.531 HD21 HD11 ' A' ' 40' ' ' ILE . 53.0 tp -102.75 118.24 36.4 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.607 ' HB ' HG12 ' A' ' 52' ' ' ILE . 0.7 OUTLIER -93.76 106.55 18.51 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.71 -177.245 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.6 t -106.2 126.12 61.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.308 0.575 . . . . 0.0 111.177 -173.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.589 ' HB2' ' HG3' ' A' ' 50' ' ' GLU . 89.5 m-85 -120.15 147.06 45.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.245 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.499 ' OH ' ' HB2' ' A' ' 17' ' ' MET . 1.9 p90 -166.11 172.39 11.37 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.292 0.567 . . . . 0.0 111.065 -172.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.412 ' OD1' ' HB3' ' A' ' 65' ' ' TYR . 10.9 t0 -99.0 113.41 25.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.662 -179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.535 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -60.78 -20.5 61.57 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.48 -178.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.412 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -70.54 -31.79 68.98 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.94 0.4 . . . . 0.0 110.789 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.499 ' CB ' ' HA3' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -90.36 -29.56 17.98 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.503 0.668 . . . . 0.0 109.724 -173.528 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.535 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.4 m -74.9 -32.15 27.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.392 176.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.774 ' HA ' HD23 ' A' ' 71' ' ' LEU . 50.7 t80 -66.2 -24.0 66.55 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.636 175.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.82 -32.75 69.66 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.869 0.842 . . . . 0.0 108.732 174.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -91.89 -69.37 0.74 Allowed 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.197 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.774 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER 22.73 76.75 0.23 Allowed Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 124.804 1.242 . . . . 0.0 113.567 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.426 ' HD2' HG13 ' A' ' 75' ' ' ILE . 44.1 Cg_exo -58.02 153.03 47.43 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.513 2.142 . . . . 0.0 111.639 176.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -61.0 -29.19 69.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.481 -173.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.83 -30.16 56.36 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.328 -0.939 . . . . 0.0 111.025 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.615 HG21 ' HB3' ' A' ' 81' ' ' SER . 14.1 mm -76.78 108.26 9.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.947 -0.627 . . . . 0.0 110.079 177.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.2 t -89.29 -8.85 52.51 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.322 0.582 . . . . 0.0 110.464 -176.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 69.9 m -133.36 134.21 23.68 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.073 -173.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.713 ' HA ' HD21 ' A' ' 71' ' ' LEU . 84.8 Cg_exo -49.55 -49.23 16.28 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.539 2.826 . . . . 0.0 113.132 176.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.446 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -60.35 -26.88 66.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.008 0.432 . . . . 0.0 111.544 178.546 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -79.11 -21.47 46.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.075 -175.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.615 ' HB3' HG21 ' A' ' 75' ' ' ILE . 78.4 p -82.33 -37.59 25.49 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 176.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 78' ' ' PRO . 59.8 t -59.4 -29.13 41.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.823 177.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.472 ' HE2' HG21 ' A' ' 9' ' ' ILE . 95.4 mttt -52.22 -47.02 65.87 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -63.46 -33.26 75.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.654 -174.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -70.61 -38.26 73.94 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.384 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.431 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 35.7 m -87.3 -44.53 16.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -52.31 -45.19 65.46 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.117 0.567 . . . . 0.0 111.994 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.506 ' HG3' ' HD3' ' A' ' 89' ' ' ARG . 9.0 pt-20 -57.89 -31.01 66.32 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.974 0.416 . . . . 0.0 111.301 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.506 ' HD3' ' HG3' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -86.46 -38.33 17.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.295 0.569 . . . . 0.0 110.913 177.332 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.737 ' O ' HG12 ' A' ' 93' ' ' ILE . 81.9 mt -70.71 -35.5 72.78 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.453 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 96' ' ' ASP . . . -49.19 -26.58 2.95 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.776 175.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -78.78 -6.94 57.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.643 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.737 HG12 ' O ' ' A' ' 90' ' ' LEU . 5.9 pt -105.48 -41.81 6.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -174.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -179.28 -39.67 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 120.786 0.326 . . . . 0.0 111.738 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.65 ' HG2' ' HB3' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -65.16 -4.82 5.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.699 -173.088 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 9.9 t70 -38.75 -36.18 0.25 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.903 167.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.494 ' HE2' ' CG2' ' A' ' 4' ' ' THR . 3.3 m-85 -75.32 -14.79 60.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.637 -174.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -161.1 96.13 1.08 Allowed 'General case' 0 C--O 1.22 -0.461 0 CA-C-O 120.923 0.392 . . . . 0.0 111.526 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 m -82.05 87.53 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.607 ' OD1' ' HB ' ' A' ' 9' ' ' ILE . 5.2 t-20 -6.25 -88.07 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 113.123 -1.853 . . . . 0.0 114.028 -172.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.546 ' NE ' ' HA ' ' A' ' 101' ' ' ARG . 4.9 mmp_? . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.748 -0.644 . . . . 0.0 109.951 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.647 0 N-CA-C 111.511 -0.635 . . . . 0.0 111.511 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.7 p -90.12 2.65 55.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.87 0.367 . . . . 0.0 111.521 -176.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -59.37 156.01 13.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.263 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.562 ' O ' HG12 ' A' ' 5' ' ' VAL . 12.3 t -84.22 40.99 0.8 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.822 -174.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.668 HG22 HG12 ' A' ' 29' ' ' VAL . 0.3 OUTLIER 67.6 153.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.713 1.205 . . . . 0.0 112.665 -179.542 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.422 ' CG ' ' HB2' ' A' ' 23' ' ' GLU . 28.0 mmt180 -133.43 144.55 49.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.052 175.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.575 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . 20.0 p90 -164.25 161.1 21.8 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.417 HE21 ' HB3' ' A' ' 8' ' ' GLN . 13.6 mt-30 -139.39 133.31 30.89 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.842 176.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.876 HG12 HG12 ' A' ' 19' ' ' ILE . 26.8 mt -95.53 127.54 47.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.132 -178.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 18' ' ' MET . 11.4 pt-20 -122.57 171.43 9.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.423 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.66 137.73 32.08 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.179 0.514 . . . . 0.0 110.947 177.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.587 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -79.59 -20.33 47.19 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.01 175.322 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.2 -80.96 0.19 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.733 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -107.05 -55.44 2.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.842 0.353 . . . . 0.0 111.778 -175.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.539 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 4.6 p -149.29 42.01 0.91 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.648 0.737 . . . . 0.0 110.984 -172.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.522 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -142.65 157.91 44.2 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.47 173.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.733 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 35.1 ttp -130.02 133.02 46.46 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.929 -174.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.587 ' HB2' HD22 ' A' ' 12' ' ' LEU . 32.8 ttp -124.06 135.38 53.53 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.109 175.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.876 HG12 HG12 ' A' ' 9' ' ' ILE . 5.0 mt -120.05 124.4 72.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.114 -176.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.518 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -104.53 118.76 37.39 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.237 178.347 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.575 ' CD2' ' HB3' ' A' ' 7' ' ' TYR . 53.3 m-85 -83.64 -176.74 6.44 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.748 173.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.645 ' HA2' HG21 ' A' ' 29' ' ' VAL . . . 126.89 131.34 3.5 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.403 176.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.798 ' HG2' ' HG2' ' A' ' 24' ' ' GLU . 39.1 tt0 -128.3 -84.27 0.58 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.876 0.37 . . . . 0.0 110.265 175.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.798 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 13.5 mm-40 -103.78 -77.77 0.57 Allowed 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.2 pt -149.02 31.22 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 114.435 -1.257 . . . . 0.0 107.813 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.591 ' HB2' HG22 ' A' ' 29' ' ' VAL . 1.7 m-20 -60.6 125.3 23.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.734 -1.575 . . . . 0.0 113.378 -166.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -60.13 -34.99 74.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.463 166.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -58.8 -51.93 67.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.976 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.668 HG12 HG22 ' A' ' 5' ' ' VAL . 17.0 m -65.97 -43.82 92.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.821 0.344 . . . . 0.0 110.251 -177.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.82 -41.66 95.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.762 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.51 -37.88 29.88 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.394 -175.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.451 HG13 HD12 ' A' ' 93' ' ' ILE . 0.3 OUTLIER -79.1 -29.06 13.78 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.749 0 C-N-CA 120.224 -0.591 . . . . 0.0 111.946 -175.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.45 HG23 ' HB2' ' A' ' 58' ' ' LEU . 14.1 p -71.02 -28.81 34.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -69.71 -40.27 76.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.074 173.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.09 -20.64 30.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.931 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.87 -30.44 70.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.722 0.296 . . . . 0.0 111.469 -173.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.22 98.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.719 0.771 . . . . 0.0 108.99 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.528 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -78.29 -25.67 46.73 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.73 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -66.14 -45.01 82.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.344 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.497 ' CD1' HD21 ' A' ' 58' ' ' LEU . 41.8 mt -76.25 -38.05 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.346 -175.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 14.4 pt-20 -69.6 -19.99 63.64 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.238 -175.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -91.95 -24.37 19.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.609 0.242 . . . . 0.0 110.762 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -127.1 68.84 72.88 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 175.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -95.56 -171.0 0.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.451 2.767 . . . . 0.0 113.816 -170.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -127.29 147.07 60.49 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.376 176.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -40.69 -36.74 2.0 Allowed 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.107 3.204 . . . . 0.0 115.317 -170.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -102.51 19.31 48.37 Favored Glycine 0 C--O 1.226 -0.404 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.518 -174.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -64.36 135.8 56.51 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.081 0.467 . . . . 0.0 111.211 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.447 HG12 ' HA ' ' A' ' 62' ' ' TYR . 32.6 mm -107.67 -58.54 3.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.236 -178.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -167.17 160.86 14.15 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.197 -176.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 59' ' ' THR . 5.6 p -149.97 119.76 7.08 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 172.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.807 HG13 ' HB ' ' A' ' 59' ' ' THR . 5.3 pt -114.56 132.58 22.79 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-O 121.2 0.524 . . . . 0.0 111.845 -175.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -85.61 123.03 2.44 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.243 2.629 . . . . 0.0 112.395 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.18 27.72 7.97 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.299 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 70.92 -28.5 0.18 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.248 -0.887 . . . . 0.0 113.298 174.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -140.84 7.23 2.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.336 0.589 . . . . 0.0 110.711 171.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 47.3 m -148.18 144.36 27.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.775 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.497 HD21 ' CD1' ' A' ' 40' ' ' ILE . 54.4 tp -115.61 111.66 20.98 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.95 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.807 ' HB ' HG13 ' A' ' 52' ' ' ILE . 3.8 m -90.18 106.68 18.65 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.6 t -104.9 117.41 50.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.541 0.686 . . . . 0.0 110.88 -174.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.422 ' CE1' HG22 ' A' ' 59' ' ' THR . 80.8 m-85 -105.5 147.15 28.64 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.791 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.573 ' CE2' HG11 ' A' ' 82' ' ' VAL . 3.8 p90 -165.75 164.64 18.84 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.382 -176.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -99.31 114.5 27.4 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.333 -175.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.58 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -65.12 -20.85 66.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.65 -169.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.659 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 0.5 OUTLIER -68.41 -29.5 68.19 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.267 -178.07 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -91.88 -35.56 13.98 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 121.445 0.641 . . . . 0.0 109.513 -175.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.58 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.3 m -68.37 -29.91 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.85 177.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 1.029 ' HA ' HD23 ' A' ' 71' ' ' LEU . 30.1 t80 -69.61 -22.93 63.45 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.516 174.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' A' ' 65' ' ' TYR . 27.4 mmmt -76.25 -25.42 54.97 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -89.5 -35.6 15.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.428 178.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.029 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -16.89 90.21 0.04 OUTLIER Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 125.606 1.562 . . . . 0.0 112.779 178.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.635 ' HD2' HG13 ' A' ' 75' ' ' ILE . 22.8 Cg_exo -66.33 136.62 44.28 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.196 2.597 . . . . 0.0 110.941 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -65.61 100.17 0.5 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.818 0.818 . . . . 0.0 110.417 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.46 -26.02 1.83 Allowed Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -171.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.65 HG22 ' H ' ' A' ' 77' ' ' SER . 11.6 mm -87.75 132.9 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 114.627 -0.787 . . . . 0.0 109.636 172.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.5 t -103.44 1.11 32.07 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.159 0.504 . . . . 0.0 110.522 -176.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.65 ' H ' HG22 ' A' ' 75' ' ' ILE . 21.0 t -146.57 129.41 7.98 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -170.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.694 ' HA ' HD21 ' A' ' 71' ' ' LEU . 95.8 Cg_exo -47.51 -44.42 25.44 Favored 'Trans proline' 0 C--O 1.221 -0.352 0 C-N-CA 123.577 2.851 . . . . 0.0 112.807 169.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -36.8 82.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.034 0.445 . . . . 0.0 110.913 176.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 77' ' ' SER . 39.9 tt0 -71.33 -27.09 63.13 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.595 -174.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.597 ' HB3' HG21 ' A' ' 75' ' ' ILE . 76.9 p -77.6 -37.64 49.88 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 78' ' ' PRO . 58.2 t -60.73 -34.71 59.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.102 178.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.733 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 5.3 mtmp? -53.21 -42.7 66.56 Favored 'General case' 0 C--O 1.213 -0.82 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 176.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.56 -34.24 73.91 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.483 -175.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -62.72 -41.55 99.21 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.455 176.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.473 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 32.7 m -84.29 -39.69 14.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.924 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.465 ' OE2' ' HB3' ' A' ' 83' ' ' LYS . 39.9 mt-10 -48.66 -52.42 23.37 Favored 'General case' 0 C--O 1.218 -0.572 0 C-N-CA 123.207 0.603 . . . . 0.0 112.083 178.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -63.53 -28.52 70.0 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.356 -176.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.33 -42.72 22.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.475 0.655 . . . . 0.0 110.31 176.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.725 ' HB3' ' HG2' ' A' ' 95' ' ' GLU . 95.5 mt -64.09 -37.21 86.63 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.604 177.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.563 ' O ' ' HB2' ' A' ' 96' ' ' ASP . . . -47.19 -34.42 6.31 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.644 175.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -70.15 -7.8 44.6 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.488 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.717 HG12 ' O ' ' A' ' 90' ' ' LEU . 2.8 pt -104.59 -43.64 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 120.465 -0.494 . . . . 0.0 112.066 -173.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 179.61 -42.46 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.905 0.383 . . . . 0.0 111.674 -173.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.725 ' HG2' ' HB3' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -62.61 -16.91 58.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.11 -170.877 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.563 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 23.4 t70 -48.83 -28.48 3.75 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.591 0.557 . . . . 0.0 112.316 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.494 ' HB2' HG21 ' A' ' 4' ' ' THR . 1.3 m-30 -72.02 -23.6 61.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.367 -173.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -128.17 -59.95 1.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.86 -0.155 . . . . 0.0 111.245 -177.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.1 t 73.53 123.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.593 0.711 . . . . 0.0 111.659 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -78.14 58.9 2.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.849 175.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 . . . . . 0 C--O 1.25 1.119 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.994 -179.459 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.745 0 N-CA-C 112.314 -0.314 . . . . 0.0 112.314 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.0 m -84.54 81.24 8.93 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -151.24 176.44 11.21 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.148 0.499 . . . . 0.0 111.726 -176.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.6 t -63.4 150.22 44.07 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.007 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.695 ' HA ' HD21 ' A' ' 26' ' ' ASN . 0.7 OUTLIER -85.83 -170.86 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.977 179.038 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -148.29 117.72 6.96 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.478 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . 27.0 p90 -143.63 162.86 34.83 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.8 0.809 . . . . 0.0 112.378 -176.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.411 ' HA ' HD21 ' A' ' 100' ' ' ASN . 0.0 OUTLIER -135.26 140.44 45.21 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.135 -1.393 . . . . 0.0 108.511 179.347 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.754 HG21 ' HD3' ' A' ' 83' ' ' LYS . 34.2 mt -113.81 131.26 66.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.9 -175.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -121.85 169.53 10.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.203 0.525 . . . . 0.0 110.432 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.64 HE21 ' HA ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -94.42 131.29 40.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.642 176.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.682 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -69.05 -50.11 51.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.639 -176.289 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.99 -69.96 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.703 176.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -110.57 -71.06 0.78 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.983 0.42 . . . . 0.0 111.433 -176.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.9 p -135.91 47.07 2.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.674 0.75 . . . . 0.0 110.792 -175.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.29 153.75 42.34 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.006 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.475 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 26.7 ttp -121.52 136.61 54.94 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.652 -0.419 . . . . 0.0 112.112 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.682 ' HB2' HD22 ' A' ' 12' ' ' LEU . 49.5 ttm -122.49 131.82 54.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.31 0.576 . . . . 0.0 110.049 176.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.743 HG12 HG12 ' A' ' 9' ' ' ILE . 4.0 mt -118.64 140.58 41.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.459 -178.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.408 ' N ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -123.26 117.56 25.57 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.361 0.601 . . . . 0.0 109.935 176.074 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.478 ' CD2' ' HB3' ' A' ' 7' ' ' TYR . 35.8 m-85 -82.71 -174.63 5.34 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.108 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.463 ' C ' HG21 ' A' ' 29' ' ' VAL . . . -84.44 -138.09 3.86 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.688 178.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 170.45 -61.59 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.331 0.586 . . . . 0.0 109.548 -174.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -61.89 136.18 57.87 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.158 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.5 pt 50.36 23.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 O-C-N 124.862 1.351 . . . . 0.0 112.752 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.695 HD21 ' HA ' ' A' ' 5' ' ' VAL . 67.3 t30 -162.53 76.86 0.46 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.287 0.565 . . . . 0.0 110.549 176.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -62.69 -17.93 61.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.656 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -32.8 66.72 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.004 -179.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 26' ' ' ASN . 35.4 m -55.19 -41.95 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 120.799 0.333 . . . . 0.0 110.931 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.401 ' N ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -66.91 -19.75 65.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.272 -177.138 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.71 -45.56 4.85 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.254 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.11 -21.35 12.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.687 -175.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.5 p -70.76 -31.11 44.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 174.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -77.67 -36.71 51.07 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.03 177.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.79 -20.79 45.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.005 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.409 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -65.49 -26.99 68.17 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.659 0.266 . . . . 0.0 110.764 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.511 ' O ' ' HG3' ' A' ' 41' ' ' GLU . . . -62.75 -46.17 89.32 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.2 -34.94 63.88 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.607 176.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.409 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 19.3 t80 -54.98 -41.14 70.83 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.79 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.416 HD11 HD21 ' A' ' 58' ' ' LEU . 48.8 mt -76.74 -27.01 16.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.239 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 37' ' ' ALA . 41.6 mt-10 -79.42 -41.55 27.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.957 0.408 . . . . 0.0 111.398 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -63.27 -35.35 80.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.181 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.49 ' HB2' ' NH1' ' A' ' 89' ' ' ARG . 40.2 mt-30 -129.55 75.93 79.26 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.897 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -95.17 177.98 0.78 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.754 2.303 . . . . 0.0 113.332 -174.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -121.46 146.47 45.17 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -45.23 -28.46 3.62 Favored 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 124.104 3.203 . . . . 0.0 115.307 -169.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.02 20.4 38.43 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.385 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -64.23 136.19 56.97 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.134 0.492 . . . . 0.0 111.375 177.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.432 HG12 ' HA ' ' A' ' 62' ' ' TYR . 39.1 mm -108.25 -58.96 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.449 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -165.94 161.16 17.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.678 0.275 . . . . 0.0 110.552 -175.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 2.4 p -152.09 119.16 5.86 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.769 HG13 ' HB ' ' A' ' 59' ' ' THR . 5.5 pt -123.81 136.12 27.02 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.834 -177.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 72.0 Cg_endo -87.28 158.91 8.29 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.127 2.552 . . . . 0.0 112.414 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.95 48.67 1.22 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.159 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 87.1 t80 72.54 -47.58 0.67 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.543 0.737 . . . . 0.0 112.323 174.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.1 t -133.66 -20.47 2.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.987 0.423 . . . . 0.0 110.729 177.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.4 m -108.21 152.12 25.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.011 0.434 . . . . 0.0 110.801 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.416 HD21 HD11 ' A' ' 40' ' ' ILE . 47.3 tp -126.01 122.69 36.61 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.608 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.769 ' HB ' HG13 ' A' ' 52' ' ' ILE . 5.2 m -104.16 107.18 17.97 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.188 -178.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.4 t -105.22 119.63 54.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.451 0.644 . . . . 0.0 111.241 -175.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -106.85 146.89 30.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.439 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.481 ' CD2' HG11 ' A' ' 82' ' ' VAL . 2.4 p90 -166.32 167.85 15.57 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.046 0.451 . . . . 0.0 110.64 -175.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.407 ' OD1' ' HD1' ' A' ' 65' ' ' TYR . 5.6 t0 -98.55 117.27 32.61 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.329 -178.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.618 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -64.01 -22.67 67.03 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.835 -174.641 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.407 ' HD1' ' OD1' ' A' ' 63' ' ' ASP . 0.2 OUTLIER -69.51 -28.16 65.8 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.699 0.285 . . . . 0.0 111.142 -175.485 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -89.53 -43.38 10.85 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -171.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 m -66.93 -27.69 40.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.853 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.883 ' HA ' HD23 ' A' ' 71' ' ' LEU . 12.1 t80 -66.71 -22.35 66.07 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.049 0.54 . . . . 0.0 110.777 175.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.73 -34.33 62.53 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 173.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -76.07 -38.13 57.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.576 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.883 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -20.33 92.21 0.04 OUTLIER Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 125.814 1.645 . . . . 0.0 113.545 178.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.706 ' HD2' HG13 ' A' ' 75' ' ' ILE . 20.9 Cg_exo -68.99 152.13 73.31 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 123.177 2.585 . . . . 0.0 110.264 173.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -67.77 -17.52 64.57 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -171.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.98 -19.04 70.95 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.19 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.706 HG13 ' HD2' ' A' ' 72' ' ' PRO . 11.4 mm -89.75 137.53 21.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.86 -0.67 . . . . 0.0 109.529 175.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.1 m -116.55 2.14 13.01 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.377 0.608 . . . . 0.0 110.568 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.485 ' HB3' ' HB3' ' A' ' 80' ' ' GLU . 31.2 t -141.22 130.7 12.79 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.969 -173.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.67 ' HA ' HD21 ' A' ' 71' ' ' LEU . 80.0 Cg_exo -43.95 -54.73 3.57 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.403 2.735 . . . . 0.0 112.265 169.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.467 ' HD1' ' HB2' ' A' ' 17' ' ' MET . 0.0 OUTLIER -53.35 -42.19 66.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.221 175.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 38.7 tt0 -72.39 -19.59 61.58 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.201 -173.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.461 ' HB2' HG21 ' A' ' 75' ' ' ILE . 48.2 t -81.09 -40.08 24.67 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.481 HG11 ' CD2' ' A' ' 62' ' ' TYR . 39.0 t -63.65 -30.77 50.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.987 177.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.754 ' HD3' HG21 ' A' ' 9' ' ' ILE . 7.4 mmmt -49.53 -47.61 48.81 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.208 173.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.562 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 19.7 mmt180 -67.9 -38.74 83.34 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.008 -172.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -63.85 -34.9 78.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.121 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.7 m -88.45 -44.69 15.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.501 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 83' ' ' LYS . 57.6 mt-10 -57.78 -42.41 84.06 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.562 ' HG2' ' O ' ' A' ' 84' ' ' ARG . 10.6 pt-20 -64.03 -28.91 70.12 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.399 0.619 . . . . 0.0 111.056 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.49 ' NH1' ' HB2' ' A' ' 43' ' ' GLN . 47.7 mtm180 -86.05 -46.02 10.88 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.119 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.653 ' O ' HD13 ' A' ' 93' ' ' ILE . 83.9 mt -51.66 -37.88 52.41 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.327 -0.852 . . . . 0.0 108.851 170.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 88' ' ' GLU . . . -51.05 -17.78 0.68 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.593 -1.185 . . . . 0.0 113.461 173.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 89' ' ' ARG . 67.7 mt-10 -49.52 -38.7 31.64 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 118.881 0.764 . . . . 0.0 110.484 173.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.653 HD13 ' O ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -117.66 -21.93 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.655 169.541 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.555 ' HB1' ' HD2' ' A' ' 97' ' ' TYR . . . -91.49 36.63 0.94 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.9 0.857 . . . . 0.0 109.645 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -44.17 -37.21 3.02 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.395 -1.729 . . . . 0.0 111.752 175.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -80.21 -22.31 41.99 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.143 -175.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.555 ' HD2' ' HB1' ' A' ' 94' ' ' ALA . 8.4 m-85 -100.69 15.94 26.57 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.526 -167.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -50.36 -29.81 10.81 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.311 0.577 . . . . 0.0 111.804 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.0 m -100.63 49.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.156 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.411 HD21 ' HA ' ' A' ' 8' ' ' GLN . 2.1 t30 -69.74 140.31 53.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.724 -173.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 . . . . . 0 N--CA 1.438 -1.073 0 CA-C-O 117.718 -1.134 . . . . 0.0 108.333 167.571 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.77 0 N-CA-C 111.893 -0.483 . . . . 0.0 111.893 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.5 m -90.51 32.55 0.95 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.781 0.324 . . . . 0.0 110.305 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.7 mpp? 64.22 171.73 0.18 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.256 -175.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.597 ' O ' HG12 ' A' ' 5' ' ' VAL . 5.1 t -124.05 12.04 8.95 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.777 175.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.597 HG12 ' O ' ' A' ' 4' ' ' THR . 0.5 OUTLIER 63.86 156.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 114.044 -1.434 . . . . 0.0 113.701 173.406 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.812 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 25.1 mmm180 -131.32 139.61 49.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.669 176.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.446 ' HD1' HG13 ' A' ' 5' ' ' VAL . 39.9 p90 -167.76 172.75 8.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.041 -174.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.507 ' O ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.11 121.6 20.55 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.858 178.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.924 HG12 HG12 ' A' ' 19' ' ' ILE . 18.6 mt -91.46 125.79 44.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.221 177.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -120.54 149.81 41.85 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.101 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -76.9 126.44 30.97 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.281 0.562 . . . . 0.0 110.21 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.684 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -67.47 -37.52 83.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.51 -177.589 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.54 -79.23 0.11 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.416 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -98.98 -68.73 0.79 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.802 0.334 . . . . 0.0 111.782 -177.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.9 p -143.46 49.79 1.41 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.975 0.893 . . . . 0.0 110.239 -174.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -142.46 152.11 42.41 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.371 177.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.516 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 34.1 ttp -124.0 130.55 52.75 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.443 -0.503 . . . . 0.0 112.016 -175.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.684 ' HB2' HD22 ' A' ' 12' ' ' LEU . 50.9 ttm -116.47 126.8 53.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.277 0.56 . . . . 0.0 110.43 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.924 HG12 HG12 ' A' ' 9' ' ' ILE . 7.9 mt -119.66 126.36 75.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.404 -176.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.507 ' HD3' ' O ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -115.06 122.51 46.37 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.89 176.128 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.684 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 28.2 m-85 -85.97 -166.3 1.49 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.882 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.666 ' HA2' HG21 ' A' ' 29' ' ' VAL . . . 111.91 104.05 2.72 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.812 ' HB3' ' HB2' ' A' ' 6' ' ' ARG . 12.3 pt-20 -114.21 -152.81 0.51 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -176.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.401 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 3.8 mp0 -53.47 -69.84 0.11 Allowed 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -176.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.0 pp -143.02 24.97 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.19 0.519 . . . . 0.0 111.566 -172.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.434 ' HB3' ' CG ' ' A' ' 23' ' ' GLU . 47.0 t30 -105.8 114.57 28.81 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.723 -172.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -78.63 -18.2 54.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.085 177.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.87 -29.69 60.34 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 110.696 -177.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.684 ' HB ' ' HB3' ' A' ' 21' ' ' PHE . 32.9 m -59.2 -33.47 50.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.083 0.468 . . . . 0.0 110.783 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -78.97 -18.59 53.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.557 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.83 -37.98 7.11 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.716 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.87 -27.57 12.4 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.994 -176.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.522 HG23 ' HB2' ' A' ' 58' ' ' LEU . 7.2 p -62.76 -32.03 54.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.177 0.513 . . . . 0.0 109.937 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -70.48 -39.11 74.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.171 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.35 -20.3 32.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.483 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.411 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -63.19 -23.9 67.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.432 -176.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.73 -42.32 99.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.746 0.784 . . . . 0.0 109.198 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.481 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.19 -29.67 26.4 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.699 176.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.411 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 1.5 t80 -59.21 -45.71 90.38 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.302 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.435 HD11 HD21 ' A' ' 58' ' ' LEU . 58.5 mt -71.12 -37.98 69.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.503 -176.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.481 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 13.0 pt-20 -75.37 -19.69 59.43 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.31 -174.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 33.5 mt-10 -80.7 -32.14 35.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.922 0.391 . . . . 0.0 110.613 175.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -126.3 64.25 54.01 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.969 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.419 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 72.9 Cg_endo -91.96 176.34 1.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.03 2.487 . . . . 0.0 114.059 -169.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.41 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 2.8 p90 -106.41 146.61 33.34 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.134 173.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 45' ' ' PHE . 73.7 Cg_exo -52.58 -5.99 0.21 Allowed 'Trans proline' 0 N--CA 1.482 0.847 0 C-N-CA 124.085 3.19 . . . . 0.0 115.3 -172.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.41 ' HA3' ' HB3' ' A' ' 66' ' ' GLU . . . -123.23 29.23 5.35 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.943 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -71.09 135.17 47.56 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.836 0.35 . . . . 0.0 111.12 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.2 mm -110.62 -60.34 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.46 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -164.85 155.88 14.7 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.907 -172.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 59' ' ' THR . 4.6 p -152.15 119.47 5.95 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.086 0.469 . . . . 0.0 110.094 173.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.768 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.0 pt -117.67 129.62 25.23 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-O 121.285 0.564 . . . . 0.0 112.068 -178.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 92.9 Cg_endo -85.82 139.03 6.3 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.378 2.719 . . . . 0.0 112.753 -177.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -126.49 46.06 2.54 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.947 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.2 t80 72.1 -40.01 0.46 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.539 0.735 . . . . 0.0 112.731 174.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.1 t -136.44 -18.4 1.48 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.702 0.287 . . . . 0.0 111.25 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 5.4 p -120.3 140.59 51.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.08 0.467 . . . . 0.0 110.966 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.522 ' HB2' HG23 ' A' ' 33' ' ' VAL . 40.8 tp -108.98 119.73 40.44 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.768 ' HB ' HG13 ' A' ' 52' ' ' ILE . 2.2 m -95.01 106.11 18.07 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.5 t -105.54 125.26 60.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.505 0.669 . . . . 0.0 111.507 -173.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -116.93 146.71 42.81 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.297 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.516 ' OH ' ' HB2' ' A' ' 17' ' ' MET . 2.1 p90 -164.96 170.71 14.91 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.011 0.434 . . . . 0.0 110.281 -174.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -101.09 107.97 19.53 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.533 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.474 ' SD ' ' N ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -62.41 -20.69 64.74 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.599 -176.422 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.29 -28.36 68.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.984 0.421 . . . . 0.0 110.207 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.41 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 4.6 tp10 -90.58 -39.12 12.72 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.667 0.746 . . . . 0.0 109.151 -172.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.469 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.4 m -67.24 -30.78 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.719 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.727 ' HA ' HD23 ' A' ' 71' ' ' LEU . 48.0 t80 -58.23 -26.93 63.46 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.563 0.745 . . . . 0.0 111.801 175.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.77 -26.4 59.73 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.415 0.626 . . . . 0.0 109.862 176.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -90.25 -33.56 16.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.146 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.727 HD23 ' HA ' ' A' ' 68' ' ' TYR . 1.1 mm? -23.48 91.75 0.04 OUTLIER Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 125.764 1.626 . . . . 0.0 113.037 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.643 ' HD2' HG13 ' A' ' 75' ' ' ILE . 12.1 Cg_exo -73.49 146.81 39.99 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 123.485 2.79 . . . . 0.0 111.676 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -69.43 108.92 3.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.439 0.638 . . . . 0.0 110.089 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 133.99 -30.68 2.91 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 -170.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.643 HG13 ' HD2' ' A' ' 72' ' ' PRO . 9.1 mm -86.01 108.36 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 114.196 -1.002 . . . . 0.0 108.504 170.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.2 t -90.13 -6.67 55.15 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.125 0.488 . . . . 0.0 110.461 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 74.0 m -135.17 131.86 19.9 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.682 ' HA ' HD21 ' A' ' 71' ' ' LEU . 56.3 Cg_exo -43.42 -55.5 2.88 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.719 2.946 . . . . 0.0 113.079 173.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.476 ' HZ ' ' HD3' ' A' ' 101' ' ' ARG . 0.4 OUTLIER -57.37 -30.96 65.31 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.763 -179.244 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -73.14 -27.45 61.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.955 -176.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.532 ' HB2' HG21 ' A' ' 75' ' ' ILE . 36.9 t -73.62 -35.95 65.39 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.429 HG11 ' CD2' ' A' ' 62' ' ' TYR . 41.7 t -66.13 -30.89 51.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.651 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.69 ' HB3' ' HZ3' ' A' ' 83' ' ' LYS . 9.8 mtpm? -52.5 -46.12 66.5 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.966 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.424 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 20.5 mmt180 -61.07 -41.82 97.36 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.983 -175.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -70.27 -38.47 75.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.6 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.523 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 32.6 m -87.04 -49.32 14.9 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.617 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -175.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.47 ' OE1' ' HB3' ' A' ' 83' ' ' LYS . 50.6 mt-10 -52.07 -49.73 62.94 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -174.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.833 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 6.8 pt-20 -66.44 -25.04 66.55 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.836 -178.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -87.83 -19.81 26.94 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 121.947 -0.471 . . . . 0.0 112.028 174.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 86' ' ' VAL . 14.4 mt -53.21 -71.81 0.06 Allowed 'General case' 0 C--N 1.319 -0.727 0 O-C-N 123.628 0.58 . . . . 0.0 112.54 -166.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.09 -78.21 0.43 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 118.328 -1.349 . . . . 0.0 112.356 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.527 ' O ' HG23 ' A' ' 93' ' ' ILE . 45.4 mm-40 -104.26 -59.72 1.69 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.752 0.787 . . . . 0.0 111.868 170.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.833 ' HA ' ' O ' ' A' ' 88' ' ' GLU . 5.6 pt -179.51 58.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-N 113.068 -1.878 . . . . 0.0 107.118 -164.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 87' ' ' GLU . . . -70.36 45.86 0.08 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.999 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.422 ' H ' ' C ' ' A' ' 93' ' ' ILE . 10.8 pt-20 -59.33 -35.26 73.5 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.917 176.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.33 -22.03 64.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.574 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.617 ' HE2' HH11 ' A' ' 6' ' ' ARG . 57.5 m-85 -94.3 16.22 15.54 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -170.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -47.3 -32.01 4.35 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.396 0.617 . . . . 0.0 110.241 169.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.9 m -87.35 31.25 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.133 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -73.64 -46.08 48.87 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 172.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.476 ' HD3' ' HZ ' ' A' ' 79' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.24 0 CA-C-N 114.602 -1.181 . . . . 0.0 107.922 171.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 112.006 -0.438 . . . . 0.0 112.006 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -79.21 59.4 2.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.191 0.52 . . . . 0.0 111.247 -176.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.4 ptp -93.59 164.14 13.28 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.74 178.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.3 t -79.81 45.58 0.71 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.338 0.589 . . . . 0.0 110.943 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.898 ' HA ' HD21 ' A' ' 26' ' ' ASN . 22.5 m 44.0 -175.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.547 1.139 . . . . 0.0 113.194 -174.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -151.44 72.25 1.03 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.59 ' HE1' HD11 ' A' ' 9' ' ' ILE . 37.1 p90 -113.03 152.03 29.95 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.641 0.734 . . . . 0.0 112.198 -174.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -128.46 134.82 48.83 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.488 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.59 HD11 ' HE1' ' A' ' 7' ' ' TYR . 4.5 mp -93.88 108.6 20.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.325 178.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -117.31 166.2 12.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.621 0.724 . . . . 0.0 111.214 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.66 140.87 41.09 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.643 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.517 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -84.88 -21.61 29.68 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.321 174.72 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 152.3 -68.56 0.31 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 119.903 -1.142 . . . . 0.0 113.464 176.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -119.26 -61.73 1.6 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.894 0.378 . . . . 0.0 111.393 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.1 p -141.26 39.85 1.76 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.447 0.642 . . . . 0.0 111.013 -175.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.509 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -141.76 160.36 40.33 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.133 175.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.435 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 34.0 ttp -129.48 136.62 50.12 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.61 -0.436 . . . . 0.0 112.115 -175.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.517 ' HB2' HD22 ' A' ' 12' ' ' LEU . 48.9 ttm -121.59 130.33 53.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.197 0.522 . . . . 0.0 110.685 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.4 mt -117.17 121.11 66.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.606 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -115.18 120.65 40.45 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.755 0.788 . . . . 0.0 110.957 -177.515 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.648 ' HD2' HG12 ' A' ' 29' ' ' VAL . 44.4 m-85 -86.07 -171.85 3.78 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 113.799 -1.546 . . . . 0.0 109.97 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' A' ' 23' ' ' GLU . . . -77.65 -115.43 0.17 Allowed Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.271 177.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.616 ' HG3' ' HG3' ' A' ' 24' ' ' GLU . 11.0 pt-20 158.78 -40.51 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.848 0.859 . . . . 0.0 110.675 168.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.616 ' HG3' ' HG3' ' A' ' 23' ' ' GLU . 42.1 mt-10 -83.25 132.1 35.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.151 -174.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.6 mt 54.69 31.38 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-O 122.135 0.969 . . . . 0.0 110.03 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.898 HD21 ' HA ' ' A' ' 5' ' ' VAL . 50.7 t-20 -142.07 85.42 1.92 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.617 -174.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -69.61 -22.73 63.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.212 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.84 -46.64 81.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.789 -177.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.648 HG12 ' HD2' ' A' ' 21' ' ' PHE . 35.5 m -63.9 -45.4 97.06 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.421 ' N ' HG23 ' A' ' 29' ' ' VAL . 39.9 t30 -53.9 -42.32 68.57 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.396 -176.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.26 -47.46 6.46 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.598 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -74.25 -29.55 24.94 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.509 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -170.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 29' ' ' VAL . 7.3 p -63.78 -32.21 56.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.663 177.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.597 ' CE1' ' HA ' ' A' ' 55' ' ' PHE . 34.4 m80 -81.59 -32.23 32.17 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.541 179.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.61 -24.38 36.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.845 0.355 . . . . 0.0 111.121 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.518 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -67.11 -20.92 65.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.43 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.64 98.72 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.647 0.737 . . . . 0.0 109.056 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.521 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.67 -32.32 23.68 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.76 175.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.518 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 17.0 t80 -53.53 -48.94 68.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.451 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.681 HD11 HD21 ' A' ' 58' ' ' LEU . 65.2 mt -69.1 -34.78 65.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.543 -177.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.521 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 12.5 pt-20 -76.92 -22.44 53.33 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.165 -173.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 95.0 mt-10 -74.91 -34.33 62.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.755 0.312 . . . . 0.0 110.607 177.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.854 ' HB2' HH12 ' A' ' 89' ' ' ARG . 4.5 mp0 -127.46 74.45 77.75 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -95.21 178.8 0.71 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 123.18 2.587 . . . . 0.0 113.48 -173.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 3.8 p90 -112.55 146.26 34.63 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.133 172.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 45' ' ' PHE . 42.5 Cg_exo -61.16 15.17 0.04 OUTLIER 'Trans proline' 0 N--CA 1.482 0.795 0 C-N-CA 123.992 3.128 . . . . 0.0 114.789 -174.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . -133.65 18.79 4.3 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 175.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -70.65 137.41 49.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.736 0.303 . . . . 0.0 110.608 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.1 mm -113.6 -56.88 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.39 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.431 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 9.4 tp10 -160.94 157.1 25.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.827 0.346 . . . . 0.0 110.702 -175.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 59' ' ' THR . 8.2 p -152.03 117.94 5.47 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 172.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.759 HG13 ' HB ' ' A' ' 59' ' ' THR . 7.1 pt -118.62 128.53 25.92 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-O 121.253 0.549 . . . . 0.0 112.142 -176.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.443 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 84.1 Cg_endo -86.46 120.85 1.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.497 2.798 . . . . 0.0 112.144 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.417 ' HB3' ' OG ' ' A' ' 57' ' ' SER . . . -114.41 59.86 0.68 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.686 0.279 . . . . 0.0 111.215 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.597 ' HA ' ' CE1' ' A' ' 34' ' ' HIS . 70.4 t80 74.34 -49.24 0.67 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.392 0.677 . . . . 0.0 111.817 173.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.411 ' HA ' HG11 ' A' ' 33' ' ' VAL . 14.0 t -140.05 -14.35 1.04 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.879 0.371 . . . . 0.0 111.475 176.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.417 ' OG ' ' HB3' ' A' ' 54' ' ' ALA . 18.3 p -108.66 133.75 52.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.413 0.625 . . . . 0.0 110.823 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.681 HD21 HD11 ' A' ' 40' ' ' ILE . 57.0 tp -102.58 111.77 24.23 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.759 ' HB ' HG13 ' A' ' 52' ' ' ILE . 1.8 m -95.43 107.04 19.16 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.743 -176.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.2 t -106.27 118.68 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.527 0.68 . . . . 0.0 111.243 -172.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.431 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 88.1 m-85 -111.6 148.54 33.08 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.572 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.448 ' OH ' ' HA ' ' A' ' 79' ' ' PHE . 2.1 p90 -165.82 169.62 14.78 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -175.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -102.29 113.07 26.05 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.527 -176.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.631 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -58.84 -19.69 43.87 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.455 -174.204 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -65.62 -28.42 69.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.637 0.256 . . . . 0.0 111.191 -177.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.536 ' O ' ' HD2' ' A' ' 70' ' ' HIS . 2.4 tm-20 -91.3 -41.32 11.0 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -176.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.631 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.0 m -64.53 -30.79 51.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.996 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.933 ' HA ' HD23 ' A' ' 71' ' ' LEU . 62.6 t80 -63.93 -26.65 68.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.402 173.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.03 -27.92 66.96 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 174.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.536 ' HD2' ' O ' ' A' ' 66' ' ' GLU . 16.7 m-70 -83.78 -69.18 0.66 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.705 175.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.933 HD23 ' HA ' ' A' ' 68' ' ' TYR . 1.1 mm? 18.75 71.07 0.22 Allowed Pre-proline 0 N--CA 1.474 0.758 0 O-C-N 124.929 1.393 . . . . 0.0 112.576 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.612 ' HD2' HG13 ' A' ' 75' ' ' ILE . 64.4 Cg_exo -53.14 153.46 16.19 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.166 2.577 . . . . 0.0 112.719 -173.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -69.84 93.82 0.78 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.53 0.681 . . . . 0.0 110.724 -175.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 139.67 -27.16 2.61 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -173.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.612 HG13 ' HD2' ' A' ' 72' ' ' PRO . 8.9 mm -80.49 125.97 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.615 -0.792 . . . . 0.0 109.038 172.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.4 m -110.76 -1.86 16.46 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.227 0.536 . . . . 0.0 110.781 -177.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.538 ' OG ' ' HD1' ' A' ' 79' ' ' PHE . 22.6 t -131.57 134.37 25.45 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.791 -175.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.497 ' O ' HG23 ' A' ' 82' ' ' VAL . 96.2 Cg_exo -47.05 -53.45 6.3 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.312 2.675 . . . . 0.0 112.436 171.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.538 ' HD1' ' OG ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -60.35 -34.21 73.53 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.311 0.577 . . . . 0.0 110.551 -179.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.544 ' HA ' ' CE ' ' A' ' 83' ' ' LYS . 56.6 tt0 -69.57 -27.81 65.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.177 -177.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.539 ' HB3' HG21 ' A' ' 75' ' ' ILE . 95.7 p -79.84 -31.37 40.55 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.501 0.667 . . . . 0.0 109.539 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 78' ' ' PRO . 36.3 t -73.68 -28.82 25.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.147 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.544 ' CE ' ' HA ' ' A' ' 80' ' ' GLU . 44.6 mtmt -54.73 -41.32 70.22 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 121.374 0.607 . . . . 0.0 109.578 173.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.649 ' NH1' ' HA ' ' A' ' 101' ' ' ARG . 21.4 mmm180 -66.11 -32.58 74.11 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.089 -176.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 14.6 t70 -77.1 -40.79 44.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.287 -178.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.6 m -83.5 -37.48 13.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.784 -177.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.475 ' OE2' ' HB2' ' A' ' 91' ' ' ALA . 10.3 mm-40 -62.96 -36.21 82.73 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.89 ' HG3' ' HD3' ' A' ' 89' ' ' ARG . 9.4 pt-20 -56.83 -29.37 62.74 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.74 176.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.89 ' HD3' ' HG3' ' A' ' 88' ' ' GLU . 0.8 OUTLIER -89.26 -34.18 16.7 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.982 0.42 . . . . 0.0 111.837 173.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 87' ' ' GLU . 88.6 mt -85.09 -66.71 0.87 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.372 0.606 . . . . 0.0 111.502 -177.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.704 ' HB1' ' HA ' ' A' ' 99' ' ' VAL . . . -58.02 -17.85 20.32 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.265 -0.879 . . . . 0.0 113.234 -177.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -58.78 -40.33 83.67 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.373 174.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.457 HD13 ' O ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -95.32 -25.19 4.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.074 0.464 . . . . 0.0 110.342 179.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -100.62 35.09 2.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.933 0.873 . . . . 0.0 110.371 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -55.62 -25.71 40.25 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.328 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -48.65 -30.54 5.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.069 -0.969 . . . . 0.0 113.342 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.46 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 5.7 m-30 -74.32 -62.12 1.63 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.926 -178.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 97' ' ' TYR . 10.9 pt-20 165.38 0.17 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.286 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.704 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 55.5 t 65.72 101.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -164.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -70.43 133.46 46.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.487 0.66 . . . . 0.0 111.05 -170.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.649 ' HA ' ' NH1' ' A' ' 84' ' ' ARG . 20.1 ttt180 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.199 -0.905 . . . . 0.0 109.609 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.845 0 N-CA-C 112.128 -0.389 . . . . 0.0 112.128 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.3 t -179.66 -76.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.581 ' HB3' ' H ' ' A' ' 5' ' ' VAL . 15.9 mmt 60.13 173.9 0.09 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 122.389 1.09 . . . . 0.0 113.66 173.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.541 ' O ' HG12 ' A' ' 5' ' ' VAL . 5.1 t -120.03 15.54 12.44 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.967 -1.469 . . . . 0.0 107.628 170.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.773 HG23 HD21 ' A' ' 26' ' ' ASN . 0.3 OUTLIER 64.65 150.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 113.446 -1.706 . . . . 0.0 112.317 -174.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.57 ' HA ' ' OH ' ' A' ' 97' ' ' TYR . 2.2 mpt_? -108.73 139.11 43.99 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 113.993 -1.458 . . . . 0.0 108.133 171.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 25.4 p90 -166.26 146.82 6.34 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.167 0.508 . . . . 0.0 111.011 178.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.431 ' HB2' ' HE ' ' A' ' 20' ' ' ARG . 4.9 mp0 -128.34 132.43 48.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.466 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.93 HG13 HG12 ' A' ' 19' ' ' ILE . 2.9 mp -83.47 114.74 24.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 171.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 18' ' ' MET . 12.4 pt-20 -110.21 150.11 29.14 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.121 0.486 . . . . 0.0 109.69 177.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -81.25 127.71 33.0 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.428 0.633 . . . . 0.0 110.208 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.649 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -70.41 -40.3 73.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.427 -174.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 172.84 -66.18 0.12 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.808 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -125.75 -58.87 1.38 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.835 0.35 . . . . 0.0 111.717 -173.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.2 p -142.01 37.62 1.59 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.517 0.675 . . . . 0.0 111.29 -173.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.95 158.26 43.77 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.781 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.626 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -128.03 149.37 50.4 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.046 -179.086 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.649 ' HB2' HD22 ' A' ' 12' ' ' LEU . 53.6 ttm -132.38 135.41 46.12 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 174.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.93 HG12 HG13 ' A' ' 9' ' ' ILE . 10.5 mt -114.58 106.18 20.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.514 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -91.94 131.44 37.24 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.296 0.57 . . . . 0.0 109.879 177.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 29.0 m-85 -98.74 -168.0 1.57 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.266 -178.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.78 177.15 50.13 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.621 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -144.09 -66.4 0.35 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.951 0.405 . . . . 0.0 111.562 -176.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -58.48 -52.57 65.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.226 -172.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.3 pt -117.23 26.14 4.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.1 -171.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.773 HD21 HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -120.93 103.82 9.35 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.684 -173.524 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.521 ' CD ' ' H ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -79.78 -45.14 19.36 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.887 176.701 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.71 -34.42 71.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.988 -171.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.819 HG13 HD22 ' A' ' 30' ' ' ASN . 2.4 p -56.4 -49.0 79.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.298 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.819 HD22 HG13 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -55.67 -29.19 58.9 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.579 0.549 . . . . 0.0 111.168 -173.247 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.76 -40.6 5.25 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.73 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -87.41 -29.7 5.65 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -171.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 29' ' ' VAL . 9.5 p -65.74 -30.98 51.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 118.968 0.804 . . . . 0.0 109.281 178.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.401 ' HA ' ' CB ' ' A' ' 53' ' ' PRO . 22.0 t60 -81.61 -30.2 32.98 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.999 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.43 -21.72 30.62 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.015 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.475 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -65.06 -23.48 67.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.181 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.89 98.77 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.841 0.829 . . . . 0.0 109.02 177.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.763 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.96 -27.17 26.69 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.948 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.475 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 5.8 t80 -59.73 -44.48 93.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.374 179.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.463 HD11 HD21 ' A' ' 58' ' ' LEU . 44.6 mt -78.59 -32.03 15.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.483 -176.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.763 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 10.8 pt-20 -73.64 -20.22 60.63 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.861 -176.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -88.21 -29.89 20.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.735 0.302 . . . . 0.0 110.384 173.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -124.72 69.8 56.3 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.177 0.513 . . . . 0.0 110.091 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -99.86 -161.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.693 2.929 . . . . 0.0 114.083 -169.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.45 ' HE1' ' HB3' ' A' ' 62' ' ' TYR . 1.6 p90 -138.37 147.35 55.07 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 114.022 -1.444 . . . . 0.0 107.966 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.75 -21.26 0.86 Allowed 'Trans proline' 0 N--CA 1.482 0.842 0 C-N-CA 124.25 3.3 . . . . 0.0 115.55 -169.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.419 ' HA3' ' HB3' ' A' ' 66' ' ' GLU . . . -119.36 30.7 5.7 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.188 -0.53 . . . . 0.0 111.947 -179.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.505 ' HZ ' ' HG ' ' A' ' 51' ' ' CYS . 47.2 t80 -66.53 128.69 37.18 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.098 0.475 . . . . 0.0 110.82 175.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.4 mm -103.09 -61.71 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.108 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -164.56 155.48 15.0 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 120.767 0.317 . . . . 0.0 110.998 -174.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.505 ' HG ' ' HZ ' ' A' ' 48' ' ' PHE . 5.9 p -144.46 118.32 9.32 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 173.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.806 HG13 ' HB ' ' A' ' 59' ' ' THR . 5.5 pt -117.43 129.26 25.46 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-O 121.042 0.449 . . . . 0.0 112.001 -175.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.592 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 17.8 Cg_endo -86.73 124.33 2.23 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.498 2.799 . . . . 0.0 112.684 -178.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -117.73 58.73 0.8 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.15 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.458 ' O ' HG11 ' A' ' 33' ' ' VAL . 56.2 t80 72.34 -49.64 0.69 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.548 0.739 . . . . 0.0 112.087 173.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.1 t -137.23 -21.07 1.2 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.747 0.308 . . . . 0.0 111.253 178.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 16.1 m -108.2 133.11 52.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.071 0.463 . . . . 0.0 110.864 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.463 HD21 HD11 ' A' ' 40' ' ' ILE . 44.0 tp -102.77 111.96 24.53 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.806 ' HB ' HG13 ' A' ' 52' ' ' ILE . 2.9 m -89.15 107.96 19.34 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -177.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.626 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 64.6 t -104.0 113.66 41.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.575 0.702 . . . . 0.0 111.338 -172.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -103.76 148.88 25.56 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.872 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.53 ' CD2' HG11 ' A' ' 82' ' ' VAL . 2.3 p90 -165.13 168.53 17.13 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.164 -176.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -98.86 109.05 21.87 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.947 -175.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.653 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -61.97 -20.6 64.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.125 -177.725 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.41 ' CE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -67.47 -31.92 72.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.9 0.381 . . . . 0.0 110.281 179.481 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 10.2 tp10 -91.31 -30.69 16.44 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 122.059 0.933 . . . . 0.0 109.1 -170.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.653 HG22 ' HA ' ' A' ' 64' ' ' MET . 4.2 m -75.66 -34.12 28.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.26 176.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.855 ' HA ' HD23 ' A' ' 71' ' ' LEU . 52.4 t80 -71.28 -22.87 61.9 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.8 174.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 4.2 tppp? -59.42 -35.96 74.98 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -88.5 -65.8 0.98 Allowed 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.207 176.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.855 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER 24.93 78.7 0.22 Allowed Pre-proline 0 N--CA 1.48 1.038 0 C-N-CA 124.858 1.263 . . . . 0.0 113.463 178.356 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.686 ' HD2' HG13 ' A' ' 75' ' ' ILE . 32.1 Cg_exo -58.52 155.06 38.26 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.321 2.014 . . . . 0.0 110.989 175.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -71.38 -17.08 62.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.675 -171.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -77.8 -28.68 56.44 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 172.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.686 HG13 ' HD2' ' A' ' 72' ' ' PRO . 20.4 mm -77.44 129.8 36.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.791 -0.705 . . . . 0.0 109.638 175.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.2 m -110.0 1.64 19.13 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.337 0.589 . . . . 0.0 110.528 -177.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.658 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 43.8 t -146.9 132.97 9.5 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.261 -172.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.628 ' HA ' HD21 ' A' ' 71' ' ' LEU . 86.3 Cg_exo -45.74 -53.47 5.6 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.349 2.699 . . . . 0.0 112.732 170.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.407 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -58.26 -31.61 67.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.93 0.395 . . . . 0.0 111.385 177.373 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.658 ' HB2' ' HB3' ' A' ' 77' ' ' SER . 23.8 tt0 -72.83 -30.07 63.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.259 -173.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.558 ' HB3' HG21 ' A' ' 75' ' ' ILE . 91.4 p -76.38 -34.55 58.89 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.53 HG11 ' CD2' ' A' ' 62' ' ' TYR . 16.6 t -63.84 -31.73 54.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.537 176.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.495 ' HE3' HG12 ' A' ' 9' ' ' ILE . 2.4 mtpt -54.93 -38.01 67.14 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-O 121.171 0.51 . . . . 0.0 109.685 175.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -67.63 -31.89 72.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.175 -176.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -78.3 -36.72 46.21 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.357 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.8 m -86.78 -40.32 13.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.649 -177.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.403 ' HA ' ' HB2' ' A' ' 90' ' ' LEU . 6.1 mm-40 -69.07 -32.58 72.14 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -177.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -57.75 -26.33 61.69 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.976 175.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -88.32 -55.41 3.75 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.809 168.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.659 ' O ' HD13 ' A' ' 93' ' ' ILE . 90.1 mt -70.49 -67.44 0.5 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -173.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.411 ' HB1' ' HA ' ' A' ' 99' ' ' VAL . . . -56.6 -18.75 13.0 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -71.57 -47.23 56.28 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.555 -176.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.659 HD13 ' O ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -89.71 -20.23 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.455 0.645 . . . . 0.0 109.377 179.018 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -101.2 42.58 1.11 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 122.221 1.01 . . . . 0.0 108.616 174.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -57.2 -16.22 7.62 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.605 -1.634 . . . . 0.0 111.181 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -52.53 -23.79 6.95 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.389 176.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.57 ' OH ' ' HA ' ' A' ' 6' ' ' ARG . 27.9 m-85 -98.31 11.58 37.54 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.417 ' O ' ' HB ' ' A' ' 99' ' ' VAL . 8.9 pt-20 41.24 36.76 0.52 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.247 0.967 . . . . 0.0 111.39 -177.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 98' ' ' GLU . 67.0 t 71.74 115.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.244 -171.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.439 ' HB3' ' NZ ' ' A' ' 83' ' ' LYS . 6.1 t-20 -54.86 121.17 8.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.812 -171.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.131 -171.754 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.59 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -135.01 127.16 29.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.92 0.391 . . . . 0.0 110.263 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.67 ' SD ' ' HB2' ' A' ' 28' ' ' GLN . 0.4 OUTLIER -126.19 156.64 39.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.831 177.377 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.595 ' HA ' ' CD1' ' A' ' 97' ' ' TYR . 1.8 t -79.29 100.37 7.52 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.012 0.911 . . . . 0.0 109.487 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.739 HG12 ' CD2' ' A' ' 97' ' ' TYR . 4.6 p -72.56 163.95 3.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.271 -174.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -128.72 118.94 23.71 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.512 172.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.506 ' CB ' ' HA ' ' A' ' 21' ' ' PHE . 42.2 p90 -135.57 166.84 22.29 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.319 0.58 . . . . 0.0 111.028 -175.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.534 HE22 ' HB3' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -130.9 116.05 17.37 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.875 -174.384 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.884 HG12 HG12 ' A' ' 19' ' ' ILE . 22.3 mt -92.62 112.52 26.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.128 175.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.534 ' HB3' HE22 ' A' ' 8' ' ' GLN . 11.6 pt-20 -124.25 168.46 12.92 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.499 -175.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.694 HE21 ' HA ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -87.74 128.11 35.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.46 -179.183 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.679 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.3 OUTLIER -76.18 -46.41 28.6 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.127 -174.135 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -168.84 -90.62 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.629 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -110.62 -37.52 5.44 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -175.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.5 p -160.8 42.73 0.17 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.872 0.844 . . . . 0.0 110.696 -177.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.0 148.21 41.55 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.333 176.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.598 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 32.1 ttp -117.39 140.53 49.47 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 120.955 0.407 . . . . 0.0 111.504 -177.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.679 ' HB2' HD22 ' A' ' 12' ' ' LEU . 1.4 tmt? -124.69 126.05 45.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.44 0.638 . . . . 0.0 110.431 -176.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.884 HG12 HG12 ' A' ' 9' ' ' ILE . 6.6 mt -119.56 138.26 50.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.768 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.61 127.03 21.48 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.909 0.385 . . . . 0.0 110.369 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.506 ' HA ' ' CB ' ' A' ' 7' ' ' TYR . 8.1 m-85 -97.47 -152.94 0.41 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.865 -178.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.564 ' O ' HG11 ' A' ' 29' ' ' VAL . . . -83.13 178.79 52.96 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 174.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -151.27 161.34 42.89 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 71.61 -71.51 0.13 Allowed 'General case' 0 C--N 1.332 -0.18 0 O-C-N 124.007 0.817 . . . . 0.0 111.927 176.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.5 pt -92.57 14.93 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.303 0.573 . . . . 0.0 110.864 -173.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.527 ' ND2' HG23 ' A' ' 5' ' ' VAL . 65.9 t30 -121.78 91.84 3.6 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.161 -176.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -57.86 -37.78 74.53 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.879 175.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.67 ' HB2' ' SD ' ' A' ' 3' ' ' MET . 0.5 OUTLIER -50.76 -52.02 44.77 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.577 -176.835 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.564 HG11 ' O ' ' A' ' 22' ' ' GLY . 11.9 p -65.74 -50.58 70.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.36 -174.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.439 ' N ' HG13 ' A' ' 29' ' ' VAL . 70.9 m-20 -53.1 -42.68 66.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.144 0.497 . . . . 0.0 110.939 -177.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.82 -5.17 90.22 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.528 -0.76 . . . . 0.0 113.614 -176.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.22 -34.25 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.605 0 CA-C-N 117.987 0.894 . . . . 0.0 113.352 -176.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 29' ' ' VAL . 10.8 p -62.98 -32.72 57.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 118.467 0.576 . . . . 0.0 110.681 -174.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -80.27 -23.5 40.73 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.04 -23.85 26.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.069 0.461 . . . . 0.0 110.419 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.472 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -64.28 -22.82 67.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.098 -178.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.54 97.14 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.688 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -82.98 -30.45 28.2 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.812 175.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.622 ' HE1' ' HB3' ' A' ' 89' ' ' ARG . 16.0 t80 -57.05 -44.28 82.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.377 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.695 HD11 HD21 ' A' ' 58' ' ' LEU . 49.5 mt -77.06 -38.41 27.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.587 -176.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.688 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 13.3 pt-20 -68.73 -21.11 64.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.896 0.379 . . . . 0.0 111.017 -175.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -92.56 -21.14 20.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.868 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -133.14 64.71 71.29 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.894 0.378 . . . . 0.0 110.412 178.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -97.35 -175.81 0.25 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.494 2.796 . . . . 0.0 113.077 -173.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.606 ' HZ ' ' HB2' ' A' ' 62' ' ' TYR . 14.3 p90 -116.56 148.11 41.17 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 172.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -42.22 -24.87 0.36 Allowed 'Trans proline' 0 N--CA 1.481 0.791 0 C-N-CA 124.404 3.403 . . . . 0.0 115.926 -170.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.05 19.36 32.64 Favored Glycine 0 C--O 1.229 -0.21 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.413 -176.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.464 ' HZ ' ' HG ' ' A' ' 51' ' ' CYS . 37.1 t80 -69.21 134.86 49.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.007 0.432 . . . . 0.0 111.331 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.472 HG12 ' HA ' ' A' ' 62' ' ' TYR . 40.6 mm -106.17 -60.67 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.298 -177.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -160.99 156.31 24.58 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -171.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.464 ' HG ' ' HZ ' ' A' ' 48' ' ' PHE . 12.7 p -151.75 119.48 6.13 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 175.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.794 HG13 ' HB ' ' A' ' 59' ' ' THR . 9.3 pt -123.91 134.87 25.68 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.842 -175.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.427 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 78.5 Cg_endo -86.95 152.19 8.43 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.159 2.573 . . . . 0.0 112.463 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -137.61 47.83 2.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.116 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.408 ' O ' HG11 ' A' ' 33' ' ' VAL . 48.7 t80 72.09 -37.52 0.39 Allowed 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 173.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.0 t -138.43 -21.3 1.04 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.183 0.516 . . . . 0.0 110.933 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.3 p -113.52 155.1 25.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.61 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.695 HD21 HD11 ' A' ' 40' ' ' ILE . 48.1 tp -124.49 114.92 20.08 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.794 ' HB ' HG13 ' A' ' 52' ' ' ILE . 4.4 m -94.91 106.92 18.93 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.885 -176.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.0 t -106.04 121.5 58.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.47 0.653 . . . . 0.0 111.647 -172.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.408 ' CE1' HG22 ' A' ' 59' ' ' THR . 90.7 m-85 -110.99 148.51 32.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.939 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.606 ' HB2' ' HZ ' ' A' ' 45' ' ' PHE . 3.5 p90 -167.33 170.14 11.79 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.893 -173.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -102.26 120.45 40.49 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.291 0.567 . . . . 0.0 110.692 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.17 -22.39 65.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.266 -174.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.11 -25.82 67.94 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.75 0.31 . . . . 0.0 110.784 -177.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -89.49 -33.55 16.73 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.738 0.78 . . . . 0.0 109.011 -171.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.9 m -77.67 -36.61 23.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.898 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.763 ' HA ' HD23 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -62.9 -23.11 67.19 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.973 177.598 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.507 ' HE2' ' HB2' ' A' ' 69' ' ' LYS . 3.3 tppt? -54.86 -49.17 71.79 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 121.939 0.876 . . . . 0.0 108.877 177.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -89.94 -62.89 1.37 Allowed 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.858 -177.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.763 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER 34.5 77.3 0.38 Allowed Pre-proline 0 N--CA 1.473 0.707 0 O-C-N 124.533 1.146 . . . . 0.0 111.521 -178.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.444 ' HD2' HG13 ' A' ' 75' ' ' ILE . 50.5 Cg_exo -54.64 152.43 27.62 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.288 2.659 . . . . 0.0 112.839 -175.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -76.18 87.29 3.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.05 0.929 . . . . 0.0 110.495 -176.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 155.09 -31.19 0.65 Allowed Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 -173.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.514 HG21 ' HB2' ' A' ' 81' ' ' SER . 18.6 mm -79.77 115.7 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 114.028 -1.086 . . . . 0.0 108.808 169.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.5 m -97.76 -5.86 34.05 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.194 0.521 . . . . 0.0 110.239 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 47.6 m -138.72 132.38 16.25 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.943 -172.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.609 ' HA ' HD21 ' A' ' 71' ' ' LEU . 30.8 Cg_exo -45.23 -56.99 2.35 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.436 2.758 . . . . 0.0 113.305 173.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.606 ' HB2' ' OH ' ' A' ' 62' ' ' TYR . 0.8 OUTLIER -55.18 -30.82 60.67 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.203 0.525 . . . . 0.0 111.177 178.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.604 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 36.5 tt0 -73.64 -24.47 60.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.259 -176.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.514 ' HB2' HG21 ' A' ' 75' ' ' ILE . 17.4 t -76.24 -36.28 58.58 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.466 HG11 ' CD2' ' A' ' 62' ' ' TYR . 60.2 t -63.66 -30.18 49.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.248 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.604 ' HG3' ' HA ' ' A' ' 80' ' ' GLU . 14.9 mtmm -54.2 -37.85 64.98 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 176.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -64.59 -37.47 87.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.182 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.513 ' HA ' ' OE2' ' A' ' 88' ' ' GLU . 42.3 m-20 -70.92 -35.48 72.28 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.916 -176.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.9 m -86.79 -42.76 15.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.149 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -67.77 -33.77 75.49 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.536 ' HG3' ' HD3' ' A' ' 89' ' ' ARG . 12.2 pt-20 -57.83 -28.55 64.18 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.757 176.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.622 ' HB3' ' HE1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -87.07 -51.87 5.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.976 170.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.3 mt -73.47 -67.96 0.54 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.454 -174.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.653 ' HA ' ' HB3' ' A' ' 94' ' ' ALA . . . -56.45 -19.38 14.93 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -173.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -68.58 -36.54 78.87 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.836 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.626 HD13 ' N ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -92.49 -19.84 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.03 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.653 ' HB3' ' HA ' ' A' ' 91' ' ' ALA . . . -90.43 33.16 0.91 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.369 177.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -39.35 -56.32 1.58 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 112.929 -1.941 . . . . 0.0 112.907 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -81.38 -21.57 38.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.107 -176.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.739 ' CD2' HG12 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -70.03 -61.8 1.64 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.036 -168.04 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 171.46 116.83 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 O-C-N 123.93 0.769 . . . . 0.0 110.304 172.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.502 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 23.0 t -88.95 87.14 2.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.311 178.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -60.96 137.26 58.24 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.098 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 22.6 tpt180 . . . . . 0 C--O 1.249 1.044 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.896 176.843 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 p -117.87 144.88 45.02 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.6 ptt? -155.9 168.63 26.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.849 0.356 . . . . 0.0 110.839 -176.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.548 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 12.8 t -88.42 24.1 2.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.864 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.548 ' HB ' ' O ' ' A' ' 4' ' ' THR . 0.9 OUTLIER 77.12 140.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.991 -174.194 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -145.94 108.97 4.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.125 -1.398 . . . . 0.0 108.437 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.519 ' CE2' HD12 ' A' ' 93' ' ' ILE . 16.3 p90 -114.49 155.92 25.52 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.402 0.62 . . . . 0.0 111.891 -174.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.666 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . 1.8 mp0 -120.28 134.54 55.24 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.257 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.928 HG12 HG12 ' A' ' 19' ' ' ILE . 15.3 mt -101.92 114.14 40.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.291 174.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 18' ' ' MET . 10.4 pt-20 -109.12 153.1 24.19 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.691 -177.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.599 HE21 ' HA ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -76.99 126.9 31.74 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.758 0.79 . . . . 0.0 110.542 178.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.693 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.3 OUTLIER -79.72 -48.67 13.25 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.019 -173.233 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.88 100.87 0.16 Allowed Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 73.2 -64.16 0.41 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 176.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.515 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 11.5 p -150.64 60.06 0.94 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.338 0.589 . . . . 0.0 111.831 -172.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -160.89 154.64 22.35 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 176.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.917 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -121.18 138.64 54.12 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.091 -177.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.693 ' HB2' HD22 ' A' ' 12' ' ' LEU . 26.4 ttt -124.04 124.06 41.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.438 0.637 . . . . 0.0 110.396 177.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.928 HG12 HG12 ' A' ' 9' ' ' ILE . 9.3 mt -116.12 144.31 24.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.191 -175.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.666 ' HD3' ' HB2' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -134.93 132.75 38.83 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 173.577 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.477 ' HB2' HG21 ' A' ' 29' ' ' VAL . 6.8 m-85 -98.52 -147.85 0.33 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.707 ' O ' HG11 ' A' ' 29' ' ' VAL . . . -96.75 -175.84 35.28 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 174.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -139.88 -64.85 0.48 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 117.666 0.733 . . . . 0.0 111.151 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -69.85 130.76 43.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.931 -175.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.8 mm 65.87 14.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.936 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.489 ' HB3' HG12 ' A' ' 29' ' ' VAL . 5.8 m-20 -120.43 83.78 2.11 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.558 -176.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -78.68 -20.2 50.73 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 174.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -54.23 -53.79 48.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.068 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.707 HG11 ' O ' ' A' ' 22' ' ' GLY . 4.3 p -61.32 -46.34 96.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.757 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -53.71 -27.04 25.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.958 -177.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -97.55 -39.83 3.81 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.435 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -86.44 -22.4 7.15 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -171.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.6 HG12 ' O ' ' A' ' 29' ' ' VAL . 14.5 p -69.01 -28.45 39.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.371 177.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -77.79 -41.59 36.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.499 174.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.88 -26.0 60.33 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.503 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.478 ' HA ' ' CB ' ' A' ' 39' ' ' TYR . . . -67.12 -26.64 66.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.153 -178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.471 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . . . -62.29 -36.82 83.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 122.013 0.911 . . . . 0.0 109.119 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.81 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -84.75 -36.2 21.93 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.872 174.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.478 ' CB ' ' HA ' ' A' ' 36' ' ' ALA . 2.6 t80 -54.72 -42.08 71.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.342 0.591 . . . . 0.0 110.864 -178.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.598 HD11 HD21 ' A' ' 58' ' ' LEU . 33.5 mt -78.03 -29.41 15.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.295 -178.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.81 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 6.9 pt-20 -80.67 -32.97 35.85 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.439 -177.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 54.0 mt-10 -72.72 -29.72 63.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.097 0.475 . . . . 0.0 110.139 178.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -121.42 73.56 30.05 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 172.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -96.88 -168.92 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.932 2.421 . . . . 0.0 113.773 -170.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.416 ' C ' ' H ' ' A' ' 47' ' ' GLY . 2.8 p90 -136.43 147.17 58.92 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.14 176.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 45' ' ' PHE . 52.1 Cg_exo -58.23 7.87 0.06 OUTLIER 'Trans proline' 0 N--CA 1.483 0.864 0 C-N-CA 123.653 2.902 . . . . 0.0 114.702 -174.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . -127.18 28.24 4.61 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 174.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.559 ' HE2' HG22 ' A' ' 40' ' ' ILE . 6.0 t80 -71.19 132.09 44.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.998 0.427 . . . . 0.0 110.528 177.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.544 HG22 ' HG2' ' A' ' 50' ' ' GLU . 36.9 mm -111.35 -60.74 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.469 176.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.544 ' HG2' HG22 ' A' ' 49' ' ' ILE . 2.5 mm-40 -153.28 173.01 16.13 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.889 0.852 . . . . 0.0 111.231 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 59' ' ' THR . 5.1 p -161.2 118.27 2.28 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 113.839 -1.528 . . . . 0.0 108.964 154.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.668 HG13 ' HB ' ' A' ' 59' ' ' THR . 6.5 pt -112.93 130.46 23.5 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.251 -173.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 52' ' ' ILE . 6.1 Cg_exo -77.83 128.06 9.05 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.454 2.769 . . . . 0.0 111.897 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.491 ' HB3' ' HB2' ' A' ' 57' ' ' SER . . . -119.25 54.29 0.99 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.629 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.446 ' O ' HG11 ' A' ' 33' ' ' VAL . 47.6 t80 72.44 -59.33 0.56 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.469 176.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -126.59 -15.34 5.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.299 0.571 . . . . 0.0 110.441 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.491 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 19.8 m -108.58 148.43 30.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.157 0.503 . . . . 0.0 110.999 -177.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.598 HD21 HD11 ' A' ' 40' ' ' ILE . 49.7 tp -117.66 111.99 19.9 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.668 ' HB ' HG13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -94.96 106.74 18.75 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.966 -177.008 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.917 ' HB ' ' HG2' ' A' ' 17' ' ' MET . 53.7 t -107.15 109.33 27.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.252 0.549 . . . . 0.0 111.318 -171.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.439 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 74.6 m-85 -101.62 147.33 26.55 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.711 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.48 ' OH ' ' HB3' ' A' ' 17' ' ' MET . 2.7 p90 -165.22 167.85 17.63 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.172 0.51 . . . . 0.0 110.397 -176.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -98.36 111.25 23.65 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.121 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.515 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 1.0 OUTLIER -64.48 -20.3 66.11 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.546 -172.072 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -58.9 -26.02 63.92 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.571 0.224 . . . . 0.0 111.448 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.575 ' HA ' ' HE3' ' A' ' 69' ' ' LYS . 16.2 tp10 -89.76 -35.84 15.5 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.842 0.83 . . . . 0.0 109.433 -173.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.696 HG11 HG22 ' A' ' 82' ' ' VAL . 3.4 m -79.91 -31.31 13.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.912 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.967 ' HA ' HD23 ' A' ' 71' ' ' LEU . 23.2 t80 -68.98 -22.12 64.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.134 176.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.575 ' HE3' ' HA ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -53.3 -36.74 61.55 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 173.035 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.51 ' HD2' ' HB3' ' A' ' 69' ' ' LYS . 18.2 m170 -98.58 -70.53 0.72 Allowed 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.852 -177.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.967 HD23 ' HA ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER 41.34 71.95 1.19 Allowed Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 123.754 0.822 . . . . 0.0 112.265 -179.074 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.729 ' HD2' HG13 ' A' ' 75' ' ' ILE . 37.7 Cg_exo -61.74 173.95 2.59 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.134 2.556 . . . . 0.0 114.025 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.5 tp60 -62.52 -47.1 85.39 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -172.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.03 -20.74 79.11 Favored Glycine 0 CA--C 1.508 -0.37 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 -176.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.729 HG13 ' HD2' ' A' ' 72' ' ' PRO . 41.3 mm -76.95 102.96 3.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 114.51 -0.845 . . . . 0.0 109.989 175.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.3 m -84.91 -14.09 48.82 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.337 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.481 ' HB2' ' HG3' ' A' ' 80' ' ' GLU . 73.0 m -146.03 142.34 17.63 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.774 -172.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.606 ' HA ' HD21 ' A' ' 71' ' ' LEU . 79.2 Cg_exo -51.25 -36.28 56.05 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.338 2.692 . . . . 0.0 113.376 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.481 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 0.5 OUTLIER -66.11 -26.01 67.26 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.851 0.358 . . . . 0.0 111.138 178.877 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.744 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 5.0 mt-10 -72.69 -34.95 67.52 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.812 -178.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.574 ' HB3' HG21 ' A' ' 75' ' ' ILE . 18.9 p -69.38 -34.01 73.9 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -176.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.696 HG22 HG11 ' A' ' 67' ' ' VAL . 20.2 t -69.44 -36.53 72.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.565 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.744 ' HE2' ' HA ' ' A' ' 80' ' ' GLU . 54.2 mtmt -53.16 -45.57 68.51 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 23.0 mmt180 -67.75 -36.4 80.47 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.085 -172.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -62.05 -39.04 91.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.518 0.675 . . . . 0.0 110.33 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.663 ' O ' ' HB3' ' A' ' 90' ' ' LEU . 14.4 m -86.96 -46.91 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.334 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.471 ' OE1' ' HD3' ' A' ' 84' ' ' ARG . 43.6 mt-10 -53.89 -53.52 51.43 Favored 'General case' 0 C--O 1.211 -0.923 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -177.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.05 -26.11 68.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.06 0.457 . . . . 0.0 111.184 -172.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.614 ' NE ' ' HA ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -91.07 -36.39 14.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 122.39 1.091 . . . . 0.0 109.822 -177.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.679 ' O ' HG23 ' A' ' 93' ' ' ILE . 0.3 OUTLIER -84.08 -7.9 59.26 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.297 -1.774 . . . . 0.0 110.261 -177.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.533 ' C ' ' H ' ' A' ' 93' ' ' ILE . . . -40.5 -18.24 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 126.652 1.981 . . . . 0.0 116.273 -173.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -56.11 -2.09 0.06 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 118.159 0.436 . . . . 0.0 111.742 172.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.679 HG23 ' O ' ' A' ' 90' ' ' LEU . 3.0 pt -64.16 -57.49 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 C-N-CA 123.64 0.776 . . . . 0.0 110.004 -176.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.448 ' N ' ' CG1' ' A' ' 93' ' ' ILE . . . 140.43 -63.98 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 O-C-N 125.413 1.696 . . . . 0.0 110.58 -170.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.687 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 1.8 pm0 -65.53 -18.1 65.06 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -170.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.446 ' HB2' HD11 ' A' ' 93' ' ' ILE . 31.4 t70 -61.22 -22.53 64.87 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.115 0.483 . . . . 0.0 111.027 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.506 ' HE1' ' O ' ' A' ' 91' ' ' ALA . 38.9 m-85 -82.57 -6.75 59.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.875 -175.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.687 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 0.9 OUTLIER -108.25 -91.08 0.44 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.867 168.334 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.4 p 177.05 120.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.39 0.614 . . . . 0.0 110.76 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -93.87 99.66 11.98 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.617 0.722 . . . . 0.0 109.552 173.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.311 -1.075 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.71 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.719 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.8 p -101.85 128.14 48.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.114 0.483 . . . . 0.0 110.711 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.417 ' C ' ' H ' ' A' ' 5' ' ' VAL . 15.5 ptp -74.95 160.83 30.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.928 175.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.514 ' O ' HG22 ' A' ' 5' ' ' VAL . 9.2 t -82.93 18.91 1.48 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.333 0.587 . . . . 0.0 109.843 179.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.668 HG12 HD22 ' A' ' 26' ' ' ASN . 5.0 m 53.81 170.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.698 1.599 . . . . 0.0 113.041 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.465 ' HD2' ' C ' ' A' ' 5' ' ' VAL . 3.3 mpt_? -123.5 74.41 1.25 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.422 173.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 10.6 p90 -99.98 145.59 27.7 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.349 -173.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -130.87 143.17 50.53 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.826 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.923 HG12 HG12 ' A' ' 19' ' ' ILE . 21.3 mt -106.21 120.99 58.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.471 -177.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 18' ' ' MET . 9.0 pt-20 -113.6 163.37 15.04 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.244 -176.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -92.97 126.28 37.98 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 173.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.582 HD22 ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -65.68 -43.71 88.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.766 -174.674 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.34 -67.17 0.1 Allowed Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 178.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -114.34 -70.67 0.79 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.186 0.517 . . . . 0.0 111.514 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.2 p -135.43 51.0 2.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.92 0.867 . . . . 0.0 110.119 -173.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . . . -148.1 151.75 36.17 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.062 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.688 ' SD ' ' HG2' ' A' ' 83' ' ' LYS . 38.2 ttp -126.97 128.59 46.63 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.234 -176.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.582 ' HB2' HD22 ' A' ' 12' ' ' LEU . 33.3 ttp -118.68 138.85 52.34 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.494 177.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.923 HG12 HG12 ' A' ' 9' ' ' ILE . 6.4 mt -126.68 124.3 64.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.022 -176.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -109.9 137.26 47.94 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 177.839 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.501 ' HB2' ' CG1' ' A' ' 29' ' ' VAL . 5.3 m-85 -107.35 -150.34 0.44 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -83.22 -160.46 29.45 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 174.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -161.46 -67.75 0.06 Allowed 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.469 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -44.55 -64.33 0.71 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 124.096 0.872 . . . . 0.0 113.101 -168.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.3 pt -109.7 31.83 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.628 0.728 . . . . 0.0 110.312 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.668 HD22 HG12 ' A' ' 5' ' ' VAL . 11.2 m120 -105.77 68.98 0.8 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.173 -176.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -55.41 -39.84 70.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.164 0.506 . . . . 0.0 110.064 176.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.519 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 23.9 tm0? -52.63 -44.22 65.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.36 176.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.563 ' O ' HG12 ' A' ' 33' ' ' VAL . 87.7 t -72.35 -60.8 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.18 -176.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -46.96 -33.04 4.29 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.757 0.661 . . . . 0.0 112.197 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.22 -44.04 5.44 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.35 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.519 ' HB ' ' O ' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -80.78 -25.43 10.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -172.156 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 29' ' ' VAL . 13.7 p -70.23 -29.68 40.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -76.57 -31.42 57.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.699 175.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.62 -23.6 29.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.972 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.476 ' HA ' ' HB3' ' A' ' 39' ' ' TYR . . . -63.57 -24.71 67.92 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.981 -177.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.82 -42.74 99.4 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.627 ' HA ' ' HG2' ' A' ' 41' ' ' GLU . . . -83.56 -34.84 25.12 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.759 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.588 ' CE1' ' HB3' ' A' ' 89' ' ' ARG . 32.8 t80 -52.58 -44.52 65.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.998 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.5 mt -72.42 -33.61 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.238 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.627 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 7.8 pt-20 -80.63 -19.65 44.92 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.014 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.539 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 34.0 mt-10 -82.06 -29.78 31.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.857 0.36 . . . . 0.0 110.484 175.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -127.83 66.7 71.77 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.63 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -98.34 173.92 0.53 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.3 2.667 . . . . 0.0 114.727 -168.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -111.71 147.35 36.61 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 113.785 -1.552 . . . . 0.0 108.337 175.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.67 -8.13 0.73 Allowed 'Trans proline' 0 N--CA 1.484 0.923 0 C-N-CA 123.987 3.125 . . . . 0.0 114.957 -171.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.39 27.52 6.6 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.104 -0.569 . . . . 0.0 111.837 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -73.86 131.61 41.67 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.064 0.459 . . . . 0.0 111.552 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.3 mm -106.35 -61.21 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.242 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 42.5 tt0 -161.86 162.34 29.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.711 0.291 . . . . 0.0 110.602 -172.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.615 ' HB2' HD11 ' A' ' 58' ' ' LEU . 2.6 p -158.69 118.38 3.14 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 176.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.702 HG13 ' HB ' ' A' ' 59' ' ' THR . 9.6 pt -120.68 139.46 28.97 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-O 121.007 0.432 . . . . 0.0 111.749 -175.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.47 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 4.6 Cg_endo -84.5 133.75 5.43 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.18 2.587 . . . . 0.0 112.21 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -118.1 43.52 2.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.474 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 39.0 t80 72.34 -40.55 0.48 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.448 175.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -134.18 -18.93 1.99 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.898 0.38 . . . . 0.0 111.22 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 9.1 p -121.19 142.52 49.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.776 0.322 . . . . 0.0 111.107 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' A' ' 51' ' ' CYS . 0.9 OUTLIER -103.17 114.42 28.69 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.637 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.702 ' HB ' HG13 ' A' ' 52' ' ' ILE . 3.0 m -87.59 106.05 17.75 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.539 HG22 HD12 ' A' ' 58' ' ' LEU . 57.7 t -101.45 124.36 55.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.397 0.617 . . . . 0.0 111.56 -174.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.424 ' CE1' HG22 ' A' ' 59' ' ' THR . 89.0 m-85 -115.79 147.27 41.15 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.419 177.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.5 ' CE2' HG11 ' A' ' 82' ' ' VAL . 3.4 p90 -165.99 169.97 14.11 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.934 0.397 . . . . 0.0 110.149 -174.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -99.92 112.45 24.72 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.75 -176.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.659 ' HA ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -62.37 -19.74 63.7 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.993 -176.017 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.7 -31.86 73.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 110.545 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.73 -25.64 19.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.902 0.858 . . . . 0.0 109.535 -175.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.659 HG22 ' HA ' ' A' ' 64' ' ' MET . 3.5 m -75.93 -38.83 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.459 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.835 ' HA ' HD13 ' A' ' 71' ' ' LEU . 2.5 m-85 -55.77 -30.97 62.16 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.07 0.548 . . . . 0.0 111.411 171.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -57.66 -43.75 85.21 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.989 0.899 . . . . 0.0 108.843 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -81.08 -51.12 8.82 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.934 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.847 HD11 ' HA ' ' A' ' 78' ' ' PRO . 0.1 OUTLIER -12.16 84.63 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.469 0 O-C-N 125.549 1.781 . . . . 0.0 114.325 -173.433 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.816 ' HD2' HG13 ' A' ' 75' ' ' ILE . 32.5 Cg_exo -61.76 170.21 6.11 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 123.469 2.78 . . . . 0.0 112.172 176.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.6 -27.13 65.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.032 -172.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.98 -22.31 71.89 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.125 176.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.816 HG13 ' HD2' ' A' ' 72' ' ' PRO . 24.1 mm -86.32 114.14 25.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.615 -0.792 . . . . 0.0 110.043 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.8 m -105.59 -1.74 24.33 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.327 0.584 . . . . 0.0 110.604 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.532 ' HB2' ' HG3' ' A' ' 80' ' ' GLU . 70.6 m -141.45 141.4 22.88 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.704 -178.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.847 ' HA ' HD11 ' A' ' 71' ' ' LEU . 77.0 Cg_exo -44.45 -58.13 1.66 Allowed 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 123.18 2.587 . . . . 0.0 113.275 177.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.45 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 0.2 OUTLIER -56.06 -28.64 58.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.068 -176.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.662 ' HB2' HG23 ' A' ' 75' ' ' ILE . 48.6 mt-10 -67.96 -32.46 72.91 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.001 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.551 ' HB2' HG21 ' A' ' 75' ' ' ILE . 32.4 t -70.33 -33.99 72.14 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' A' ' 62' ' ' TYR . 26.2 t -76.95 -29.36 17.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.44 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.688 ' HG2' ' SD ' ' A' ' 17' ' ' MET . 8.2 mtmp? -54.04 -42.09 68.81 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.463 176.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -63.88 -39.8 95.04 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.913 -176.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -61.95 -38.37 88.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.376 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.457 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 22.3 m -88.38 -35.21 7.72 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.86 -179.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.439 ' OE2' ' HB3' ' A' ' 83' ' ' LYS . 40.4 mt-10 -62.54 -38.93 91.92 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 122.472 0.309 . . . . 0.0 111.587 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.64 -20.56 63.52 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.454 0.645 . . . . 0.0 110.505 176.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.588 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 9.8 mmt180 -88.28 -51.1 5.94 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.622 0.725 . . . . 0.0 110.022 170.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.587 ' O ' HD13 ' A' ' 93' ' ' ILE . 75.7 mt -80.76 -65.22 1.04 Allowed 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 114.715 -1.13 . . . . 0.0 112.406 -171.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.861 ' HB1' ' HA ' ' A' ' 98' ' ' GLU . . . -56.15 -17.53 7.51 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.71 -175.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -73.23 -45.5 55.72 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.92 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.587 HD13 ' O ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -90.97 -17.86 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 121.663 0.744 . . . . 0.0 109.73 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.434 ' N ' HD13 ' A' ' 93' ' ' ILE . . . -102.94 45.61 0.95 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 167.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 0.1 OUTLIER -35.4 -32.61 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 111.887 -2.415 . . . . 0.0 113.94 -179.226 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -66.77 -33.13 74.95 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.191 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.442 ' OH ' ' HG3' ' A' ' 6' ' ' ARG . 47.1 m-85 -99.22 15.4 26.2 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -170.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.861 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 4.3 pt-20 -56.33 -16.36 5.47 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.324 0.583 . . . . 0.0 111.138 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.9 m -100.44 74.06 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.861 173.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -48.13 130.14 15.54 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.729 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.5 tpp180 . . . . . 0 C--O 1.248 0.98 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.321 -178.523 . . . . . . . . 0 0 . 1 stop_ save_